Set	Ontology	Term	Observed	Mean Expected N Genes	Enrichment	P Value	System
Altai	GWAS	Blood metabolite ratios	7	0.401	17.4563591	1.00E-04	metabolic
Altai	GWAS	Blood metabolite levels	9	1.6601	5.421360159	1.00E-04	metabolic
Altai	GWAS	Metabolic traits	5	0.4846	10.31778787	0.00019998	metabolic
Altai	GWAS	Malaria	3	0.0632	47.46835443	0.00019998	immune
Altai	GWAS	Liver enzyme levels (alkaline phosphatase)	4	0.3757	10.64679265	0.00069993	other
Altai	GWAS	Urinary metabolites (H-NMR features)	3	0.1475	20.33898305	0.00079992	metabolic
Altai	GWAS	Elevated serum carcinoembryonic antigen levels	2	0.0493	40.56795132	0.00089991	other
Altai	GWAS	Tumor biomarkers	2	0.0515	38.83495146	0.0009999	immune
Altai	GWAS	Thrombosis	3	0.1576	19.03553299	0.0009999	hematologic
Altai	GWAS	Ischemic stroke	6	1.235	4.858299595	0.00129987	cardiovascular
Altai	GWAS	White blood cell count	11	3.5726	3.078990091	0.00149985	immune
Altai	GWAS	Blood protein levels	34	19.4266	1.750177592	0.00149985	other
Altai	GWAS	Ulcerative colitis	14	5.4511	2.568288969	0.00159984	digestive
Altai	GWAS	Alzheimer's disease (late onset)	9	2.8732	3.132395935	0.00239976	nervous
Altai	GWAS	Coagulation factor levels	2	0.0883	22.65005663	0.00269973	hematologic
Altai	GWAS	Stroke	6	1.4075	4.262877442	0.00349965	cardiovascular
Altai	GWAS	Urinary metabolite concentrations in chronic kidney disease	4	0.6166	6.487187804	0.00359964	metabolic
Altai	GWAS	Response to metformin (IC50)	2	0.0929	21.5285253	0.00369963	other
Altai	GWAS	Monocyte count	9	3.118	2.886465683	0.00589941	immune
Altai	GWAS	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	2	0.1093	18.29826167	0.00639936	other
Altai	GWAS	Serum metabolite levels	4	0.6979	5.731480155	0.00649935	metabolic
Altai	GWAS	Calcium levels	6	1.6339	3.672195361	0.00649935	other
Altai	GWAS	Prostate cancer	11	4.4667	2.462668189	0.00669933	reproductive
Altai	GWAS	Venous thromboembolism	3	0.3952	7.591093117	0.00719928	hematologic
Altai	GWAS	Clinical laboratory measurements	2	0.1342	14.90312966	0.0079992	other
Altai	GWAS	Common carotid intima-media thickness in HIV negative individuals	5	1.2581	3.97424688	0.00929907	cardiovascular
Altai	GWAS	Electroencephalogram traits	3	0.4265	7.033997655	0.00949905	nervous
Altai	GWAS	Biomedical quantitative traits	2	0.1688	11.84834123	0.01209879	other
Altai	GWAS	Hippocampal volume in mild cognitive impairment	3	0.5042	5.950019833	0.01239876	nervous
Altai	GWAS	Plasma omega-3 polyunsaturated fatty acid level (eicosapentaenoic acid)	2	0.1809	11.05583195	0.01449855	other
Altai	GWAS	GIP levels in response to oral glucose tolerance test (120 minutes)	2	0.1899	10.53185887	0.01459854	metabolic
Altai	GWAS	Lipid traits	3	0.5316	5.643340858	0.01469853	metabolic
Altai	GWAS	Circulating fibroblast growth factor 23 levels	3	0.515	5.825242718	0.01479852	other
Altai	GWAS	End-stage coagulation	2	0.1923	10.40041602	0.01569843	hematologic
Altai	GWAS	Menstruation quality of life impact (dysmenorrhea)	1	0.0159	62.89308176	0.01589841	reproductive
Altai	GWAS	Pain medicine use during menstruation	1	0.0159	62.89308176	0.01589841	reproductive
Altai	GWAS	TB-LM or TBLH-BMD (pleiotropy)	2	0.1928	10.37344398	0.01689831	skeletal muscle
Altai	GWAS	Waist-to-hip ratio adjusted for BMI (age >50)	5	1.4733	3.39374194	0.01709829	skeletal
Altai	GWAS	Childhood ear infection	4	1.0059	3.976538423	0.01719828	immune
Altai	GWAS	Hemoglobin levels	3	0.5436	5.518763797	0.01719828	hematologic
Altai	GWAS	Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid)	2	0.1972	10.14198783	0.01779822	other
Altai	GWAS	Iron status biomarkers (ferritin levels)	2	0.2239	8.932559178	0.01789821	other
Altai	GWAS	Thyroid cancer	2	0.1948	10.26694045	0.01829817	endocrine
Altai	GWAS	Hypertriglyceridemia	2	0.2074	9.643201543	0.01909809	metabolic
Altai	GWAS	Waist Circumference - Triglycerides (WC-TG)	1	0.0212	47.16981132	0.02119788	skeletal
Altai	GWAS	Lymphocyte counts	8	3.409	2.346729246	0.02279772	lymphatic
Altai	GWAS	Epilepsy and lamotrigine-induced maculopapular eruptions	3	0.6193	4.844178912	0.02449755	nervous
Altai	GWAS	Vitamin B levels in ischemic stroke	2	0.2319	8.624407072	0.02559744	other
Altai	GWAS	Vitamin B12 levels	1	0.0261	38.31417625	0.02579742	other
Altai	GWAS	Red blood cell fatty acid levels	2	0.2546	7.855459544	0.0259974	hematologic
Altai	GWAS	HDL Cholesterol - Triglycerides (HDLC-TG)	1	0.0265	37.73584906	0.02629737	metabolic
Altai	GWAS	Heart rate response to recovery post exercise (10 sec)	3	0.6542	4.585753592	0.02769723	cardiovascular
Altai	GWAS	Vitamin E levels	1	0.0298	33.55704698	0.02939706	other
Altai	GWAS	Myeloid white cell count	6	2.3152	2.591568763	0.02949705	immune
Altai	GWAS	Chronic lymphocytic leukemia	4	1.1688	3.422313484	0.03039696	lymphatic
Altai	GWAS	Estradiol levels	2	0.2661	7.515971439	0.03159684	endocrine
Altai	GWAS	Cognitive flexibility	1	0.0323	30.95975232	0.03189681	nervous
Altai	GWAS	Body mass index (adult)	2	0.2906	6.882312457	0.03359664	metabolic
Altai	GWAS	Triglycerides-Blood Pressure (TG-BP)	1	0.0343	29.15451895	0.03379662	metabolic
Altai	GWAS	Triglycerides	7	3.0002	2.333177788	0.03509649	metabolic
Altai	GWAS	Monocyte percentage of white cells	6	2.414	2.485501243	0.03539646	immune
Altai	GWAS	Reticulocyte count	6	2.3592	2.543234995	0.03579642	immune
Altai	GWAS	Liver enzyme levels	2	0.3091	6.470397929	0.03839616	other
Altai	GWAS	D-dimer levels	3	0.7421	4.042581862	0.03959604	other
Altai	GWAS	Low vWF levels	2	0.3143	6.363347121	0.04019598	hematologic
Altai	GWAS	QT interval (drug interaction)	4	1.2778	3.130380341	0.04069593	cardiovascular
Altai	GWAS	Tonsillectomy	4	1.2842	3.114779629	0.04089591	lymphatic
Altai	GWAS	Waist circumference	7	3.1737	2.205627501	0.04229577	skeletal
Altai	GWAS	"Bone mineral density (paediatric, skull)"	2	0.3368	5.93824228	0.04339566	skeletal
Altai	GWAS	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	2	0.33	6.060606061	0.04379562	other
Altai	GWAS	Plasma omega-6 polyunsaturated fatty acid levels (adrenic acid)	2	0.3301	6.05877007	0.04449555	other
Altai	GWAS	vWF and FVIII levels	2	0.3424	5.841121495	0.04519548	hematologic
Altai	GWAS	Urinary magnesium-to-creatinine ratio	1	0.0475	21.05263158	0.04629537	metabolic
Altai	GWAS	Crohn's disease	14	8.3771	1.671222738	0.04779522	immune
Altai	GWAS	Delirium	3	0.7994	3.752814611	0.0479952	behavior
Altai	GWAS	Coronary artery disease or ischemic stroke	2	0.3475	5.755395683	0.04879512	cardiovascular
Altai	GWAS	Visceral adipose tissue adjusted for BMI	4	1.364	2.93255132	0.050094991	metabolic
Altai	GWAS	Metabolite levels (lipoprotein measures)	2	0.3856	5.186721992	0.055394461	metabolic
Altai	GWAS	Lead levels in blood	3	0.8663	3.463003578	0.055494451	other
Altai	GWAS	Serum parathyroid hormone levels	1	0.0622	16.07717042	0.060493951	endocrine
Altai	GWAS	Activated partial thromboplastin time	3	0.9127	3.286950805	0.060693931	hematologic
Altai	GWAS	Borderline personality disorder	3	0.9121	3.289113036	0.060693931	behavior
Altai	GWAS	Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	2	0.3945	5.069708492	0.060693931	other
Altai	GWAS	Uterine fibroid number (single vs multiple)	3	0.8873	3.381043615	0.061393861	reproductive
Altai	GWAS	Suffering from nerves	1	0.0672	14.88095238	0.065193481	behavior
Altai	GWAS	Body mass index (age>50)	4	1.5155	2.63939294	0.065593441	metabolic
Altai	GWAS	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	2	0.4196	4.766444233	0.066893311	immune
Altai	GWAS	Gout	5	2.1733	2.300648783	0.066993301	skeletal
Altai	GWAS	Diastolic blood pressure night-to-day ratio in hypertension	1	0.0711	14.06469761	0.068693131	cardiovascular
Altai	GWAS	Testicular germ cell tumor	3	0.9339	3.212335368	0.069193081	reproductive
Altai	GWAS	Ischemic stroke (cardioembolic)	2	0.4226	4.732607667	0.069393061	cardiovascular
Altai	GWAS	Vogt-Koyanagi-Harada syndrome	2	0.4287	4.665267087	0.069893011	integumentary
Altai	GWAS	Sum neutrophil eosinophil counts	5	2.222	2.250225023	0.074192581	hematologic
Altai	GWAS	Thiopurine-induced leukopenia in inflammatory bowel disease	1	0.0769	13.00390117	0.074292571	other
Altai	GWAS	Granulocyte count	5	2.2402	2.231943576	0.077192281	immune
Altai	GWAS	Facial morphology	1	0.0813	12.300123	0.077892211	skeletal
Altai	GWAS	Interferon alpha levels in systemic lupus erythematosus	2	0.4681	4.272591327	0.079192081	immune
Altai	GWAS	LDL cholesterol levels	2	0.465	4.301075269	0.080191981	metabolic
Altai	GWAS	Telomere length	3	0.9944	3.01689461	0.080391961	other
Altai	GWAS	Serum thyroid-stimulating hormone levels	3	1.0043	2.987155233	0.081091891	endocrine
Altai	GWAS	Entorhinal cortical thickness	1	0.0875	11.42857143	0.082591741	nervous
Altai	GWAS	Red cell distribution width	6	3.027	1.982160555	0.083191681	hematologic
Altai	GWAS	Subjective response to lithium treatment in bipolar disorder	1	0.0886	11.28668172	0.085491451	other
Altai	GWAS	Urinary metabolite ratios in chronic kidney disease	1	0.09	11.11111111	0.085991401	metabolic
Altai	GWAS	Granulocyte percentage of myeloid white cells	5	2.3177	2.157311127	0.086791321	immune
Altai	GWAS	Autism spectrum disorder or schizophrenia	11	6.8095	1.615390264	0.087291271	behavior
Altai	GWAS	Suicide behavior	1	0.0915	10.92896175	0.087691231	behavior
Altai	GWAS	Coronary artery disease or large artery stroke	2	0.4884	4.095004095	0.087991201	cardiovascular
Altai	GWAS	Lactate dehydrogenase levels	2	0.5031	3.975352813	0.090590941	metabolic
Altai	GWAS	Tandem gait	1	0.0949	10.5374078	0.090790921	skeletal muscle
Altai	GWAS	Sum eosinophil basophil counts	6	3.066	1.956947162	0.090790921	hematologic
Altai	GWAS	Graves' disease	2	0.5075	3.9408867	0.091690831	endocrine
Altai	GWAS	Protein C levels	1	0.0974	10.26694045	0.092490751	other
Altai	GWAS	Asparaginase hypersensitivity in acute lymphoblastic leukemia	2	0.5086	3.93236335	0.092790721	other
Altai	GWAS	Rapid functional decline in sporadic amyotrophic lateral sclerosis	1	0.0967	10.34126163	0.093090691	nervous
Altai	GWAS	Hematological and biochemical traits	2	0.5071	3.943995267	0.093690631	hematologic
Altai	GWAS	Serum bilirubin levels x Mediterranean diet adherence interaction in metabolic syndrome	2	0.5087	3.931590328	0.093790621	digestive
Altai	GWAS	Metabolic syndrome (bivariate traits)	1	0.0992	10.08064516	0.093990601	metabolic
Altai	GWAS	Inflammatory bowel disease	12	7.7083	1.556763489	0.094090591	digestive
Altai	GWAS	HIV-1 susceptibility	2	0.5126	3.901677721	0.094390561	immune
Altai	GWAS	Non-albumin protein levels	3	1.081	2.775208141	0.095190481	other
Altai	GWAS	Pediatric bone mineral content (radius)	1	0.0998	10.02004008	0.096090391	skeletal
Altai	GWAS	Age-related cataracts (age at onset)	1	0.1042	9.596928983	0.098290171	integumentary
Altai	GWAS	Osteoprotegerin levels	1	0.1064	9.398496241	0.100389961	skeletal
Altai	GWAS	Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)	7	3.8446	1.820735577	0.100489951	skeletal
Altai	GWAS	Blond vs. brown/black hair color	7	3.8949	1.797222008	0.100689931	integumentary
Altai	GWAS	Body mass index x sex x age interaction (4df test)	5	2.475	2.02020202	0.100889911	metabolic
Altai	GWAS	Total bilirubin levels	2	0.5389	3.711263685	0.102089791	digestive
Altai	GWAS	Response to selective serotonin reuptake inhibitors and depression	2	0.5325	3.755868545	0.102489751	other
Altai	GWAS	Obesity	5	2.4408	2.048508686	0.102589741	metabolic
Altai	GWAS	Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)	3	1.126	2.664298401	0.103089691	skeletal
Altai	GWAS	Red blood cell traits	3	1.1041	2.717145186	0.104489551	hematologic
Altai	GWAS	Type 2 diabetes nephropathy	2	0.5557	3.599064243	0.105989401	metabolic
Altai	GWAS	Lymphoma	2	0.5576	3.586800574	0.107789221	lymphatic
Altai	GWAS	Psoriasis	3	1.1433	2.623983207	0.109789021	integumentary
Altai	GWAS	Amino acid levels	1	0.1166	8.576329331	0.110288971	other
Altai	GWAS	Creatine kinase levels	2	0.5737	3.486142583	0.111388861	other
Altai	GWAS	Immune reponse to smallpox (secreted IFN-alpha)	2	0.572	3.496503497	0.111488851	immune
Altai	GWAS	Allergic rhinitis	6	3.2855	1.826206057	0.111588841	immune
Altai	GWAS	Lipoprotein (a) levels	3	1.1594	2.587545282	0.112488751	metabolic
Altai	GWAS	Household income	1	0.1178	8.488964346	0.112788721	other
Altai	GWAS	Cardiovascular risk factors (age interaction)	1	0.1184	8.445945946	0.112888711	cardiovascular
Altai	GWAS	Total cholesterol levels	5	2.5631	1.950762748	0.114488551	metabolic
Altai	GWAS	Smooth-surface caries	3	1.1879	2.525465106	0.114988501	skeletal
Altai	GWAS	Hepatitis B vaccine response	1	0.1222	8.183306056	0.115888411	immune
Altai	GWAS	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	2	0.574	3.484320557	0.116588341	immune
Altai	GWAS	Palmitoleic acid (16:1n-7) levels	1	0.128	7.8125	0.119388061	other
Altai	GWAS	Systemic sclerosis	3	1.177	2.548853016	0.119488051	other
Altai	GWAS	Cardiovascular disease risk factors	1	0.1273	7.855459544	0.119988001	cardiovascular
Altai	GWAS	Hip circumference	4	1.8882	2.118419659	0.120387961	skeletal
Altai	GWAS	Adolescent idiopathic scoliosis	3	1.1932	2.514247402	0.120987901	skeletal
Altai	GWAS	Serum alkaline phosphatase levels	2	0.6084	3.28731098	0.121287871	other
Altai	GWAS	Ovarian cancer	3	1.2064	2.486737401	0.121487851	reproductive
Altai	GWAS	Optic nerve measurement (rim area)	1	0.1324	7.552870091	0.124087591	nervous
Altai	GWAS	Blond vs. brown hair color	1	0.1322	7.56429652	0.124187581	integumentary
Altai	GWAS	Folate pathway vitamin levels	1	0.1385	7.220216606	0.127087291	other
Altai	GWAS	Adiponectin levels	3	1.2377	2.423850691	0.129387061	other
Altai	GWAS	Plasma amyloid beta peptide concentrations (ABx-42)	1	0.1401	7.137758744	0.130486951	nervous
Altai	GWAS	Osteoarthritis (hip)	2	0.6259	3.195398626	0.130686931	skeletal
Altai	GWAS	Childhood steroid-sensitive nephrotic syndrome	1	0.1394	7.173601148	0.130886911	other
Altai	GWAS	Cold sores	1	0.1402	7.132667618	0.131986801	immune
Altai	GWAS	"Bone mineral density (paediatric, upper limb)"	1	0.1409	7.097232079	0.132286771	skeletal
Altai	GWAS	Sum basophil neutrophil counts	5	2.6769	1.867832194	0.132986701	hematologic
Altai	GWAS	Birdshot chorioretinopathy	1	0.1441	6.93962526	0.133486651	immune
Altai	GWAS	High altitude adaptation	1	0.1459	6.854009596	0.135286471	other
Altai	GWAS	Strenuous sports or other exercises	1	0.1486	6.729475101	0.137786221	behavior
Altai	GWAS	Cerebrospinal fluid t-tau levels in Alzheimer's disease dementia	1	0.1483	6.743088334	0.138986101	nervous
Altai	GWAS	Ulna and radius bone mineral density	1	0.1479	6.76132522	0.139286071	skeletal
Altai	GWAS	Dietary macronutrient intake	1	0.1497	6.68002672	0.139986001	behavior
Altai	GWAS	Body mass index in physically inactive individuals	2	0.6584	3.037667072	0.141085891	metabolic
Altai	GWAS	Epithelial ovarian cancer	2	0.663	3.016591252	0.143385661	reproductive
Altai	GWAS	Waist circumference adjusted for BMI in non-smokers	3	1.3068	2.295684114	0.144285571	skeletal
Altai	GWAS	Microalbuminuria	2	0.6751	2.962524071	0.145185481	other
Altai	GWAS	circulating leptin levels	1	0.1554	6.435006435	0.145485451	metabolic
Altai	GWAS	Parental lifespan	1	0.1571	6.365372374	0.145785421	other
Altai	GWAS	Nephrolithiasis	1	0.1591	6.285355123	0.146885311	urinary
Altai	GWAS	Epstein-Barr virus immune response (EBNA-1)	1	0.1594	6.273525721	0.148285171	immune
Altai	GWAS	Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	2	0.6783	2.94854784	0.150484952	other
Altai	GWAS	"B-cell malignancies (CLL, Hodgkin lymphoma or multiple myeloma) (pleiotropy)"	1	0.1638	6.105006105	0.151884812	immune
Altai	GWAS	Yeast infection	1	0.1672	5.980861244	0.155184482	immune
Altai	GWAS	Myasthenia gravis	1	0.169	5.917159763	0.155384462	skeletal muscle
Altai	GWAS	Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)	4	2.0789	1.924094473	0.156984302	cardiovascular
Altai	GWAS	Psychosis and Alzheimer's disease	1	0.1715	5.83090379	0.157584242	behavior
Altai	GWAS	Diffuse large B cell lymphoma	1	0.1748	5.720823799	0.160583942	lymphatic
Altai	GWAS	Airway wall thickness	2	0.7152	2.796420582	0.160683932	respiratory
Altai	GWAS	White matter integrity	1	0.1731	5.77700751	0.160683932	nervous
Altai	GWAS	Initial pursuit acceleration	5	2.8339	1.764353012	0.160883912	nervous
Altai	GWAS	Body mass index in asthmatics	1	0.1753	5.70450656	0.162383762	metabolic
Altai	GWAS	"Bone mineral density (paediatric, lower limb)"	1	0.1766	5.662514156	0.162783722	skeletal
Altai	GWAS	Pursuit maintenance gain	6	3.6649	1.637152446	0.163183682	skeletal muscle
Altai	GWAS	Neuromyelitis optica (AQP4-IgG-positive)	1	0.1784	5.605381166	0.164083592	nervous
Altai	GWAS	Neuromyelitis optica	1	0.1784	5.605381166	0.164083592	nervous
Altai	GWAS	Optic cup area	2	0.7255	2.756719504	0.164783522	nervous
Altai	GWAS	Nodular sclerosis Hodgkin lymphoma	2	0.7364	2.715915263	0.165083492	lymphatic
Altai	GWAS	Yu-Zhi constitution type in type 2 diabetes	1	0.1772	5.643340858	0.165383462	hematologic
Altai	GWAS	Platelet count	8	5.3115	1.506165867	0.165983402	hematologic
Altai	GWAS	Pneumonia	1	0.1817	5.503577325	0.166983302	respiratory
Altai	GWAS	Bipolar disorder lithium response (categorical) or schizophrenia	1	0.1815	5.509641873	0.167183282	behavior
Altai	GWAS	Blond vs non-blond hair color	1	0.1835	5.449591281	0.167883212	integumentary
Altai	GWAS	Chronic kidney disease	3	1.4208	2.111486486	0.168283172	urinary
Altai	GWAS	Rheumatoid arthritis (rheumatoid factor and/or anti-CCP seropositive)	1	0.185	5.405405405	0.171082892	immune
Altai	GWAS	Strep throat	1	0.1868	5.353319058	0.171182882	immune
Altai	GWAS	Phosphorus levels	1	0.1882	5.313496281	0.171282872	other
Altai	GWAS	Age-related hearing impairment	3	1.4403	2.082899396	0.172082792	nervous
Altai	GWAS	Heart rate response to recovery post exercise (20 sec)	2	0.752	2.659574468	0.172582742	cardiovascular
Altai	GWAS	Glycated hemoglobin levels	3	1.4278	2.101134613	0.172582742	metabolic
Altai	GWAS	Myositis	1	0.1888	5.296610169	0.172882712	skeletal muscle
Altai	GWAS	Plantar warts	1	0.1901	5.260389269	0.173382662	integumentary
Altai	GWAS	Light vs. dark hair color	1	0.1907	5.24383849	0.173882612	integumentary
Altai	GWAS	Brown vs. non-brown hair color	1	0.1907	5.24383849	0.173882612	integumentary
Altai	GWAS	Joint mobility (Beighton score)	2	0.7519	2.659928182	0.174682532	skeletal
Altai	GWAS	Ankylosing spondylitis	2	0.7531	2.655689815	0.176182382	skeletal
Altai	GWAS	Blood urea nitrogen levels	3	1.4269	2.102459878	0.176182382	other
Altai	GWAS	Logical memory (immediate recall) in mild cognitive impairment	1	0.1929	5.184033178	0.176982302	nervous
Altai	GWAS	Hemoglobin concentration	4	2.1819	1.833264586	0.179682032	hematologic
Altai	GWAS	Parental longevity (mother's attained age)	1	0.1986	5.035246727	0.180281972	other
Altai	GWAS	Cervical cancer	2	0.7631	2.620888481	0.182181782	reproductive
Altai	GWAS	Extremely high intelligence	3	1.4836	2.022108385	0.182481752	other
Altai	GWAS	Atrial fibrillation	8	5.4292	1.473513593	0.182481752	cardiovascular
Altai	GWAS	Pursuit maintenance gain in psychotic disorders	1	0.2015	4.962779156	0.183781622	skeletal muscle
Altai	GWAS	Febrile seizures (MMR vaccine-related)	1	0.2051	4.875670405	0.183881612	nervous
Altai	GWAS	Giant cell arteritis	1	0.2036	4.911591356	0.184381562	cardiovascular
Altai	GWAS	Thyroid hormone levels	2	0.7819	2.557871851	0.186481352	endocrine
Altai	GWAS	Serum metabolite ratios in chronic kidney disease	1	0.205	4.87804878	0.186981302	urinary
Altai	GWAS	Limited cutaneous systemic scleroderma	1	0.2096	4.770992366	0.188081192	integumentary
Altai	GWAS	Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)	3	1.4893	2.014369167	0.188481152	skeletal
Altai	GWAS	Celiac disease	4	2.2454	1.781419792	0.189581042	digestive
Altai	GWAS	Hemoglobin	2	0.7982	2.505637685	0.189681032	hematologic
Altai	GWAS	Hippocampal subfield CA3 volume	1	0.2122	4.712535344	0.191880812	nervous
Altai	GWAS	Small cell lung carcinoma	3	1.5104	1.986228814	0.193780622	respiratory
Altai	GWAS	Post bronchodilator percent predicted FEV1 in smoking	1	0.2158	4.633920297	0.193980602	other
Altai	GWAS	Epilepsy	1	0.2125	4.705882353	0.194280572	nervous
Altai	GWAS	Waist-to-hip ratio adjusted for BMI	5	3.0669	1.630310737	0.197380262	skeletal
Altai	GWAS	Multiple sclerosis (OCB status)	1	0.2199	4.547521601	0.197380262	nervous
Altai	GWAS	Pulse pressure	17	13.501	1.259165988	0.197980202	cardiovascular
Altai	GWAS	Metabolic syndrome	2	0.8274	2.417210539	0.198580142	metabolic
Altai	GWAS	IgE grass sensitization	1	0.2239	4.466279589	0.200579942	immune
Altai	GWAS	Adverse response to chemotherapy in breast cancer (alopecia) (FDC/DC)	2	0.8213	2.435163765	0.200579942	other
Altai	GWAS	Language performance in older adults (adjusted for episodic memory)	1	0.2244	4.456327986	0.201979802	nervous
Altai	GWAS	Skin pigmentation	1	0.2312	4.325259516	0.204879512	integumentary
Altai	GWAS	Post bronchodilator FEV1/FVC ratio in smoking	1	0.2304	4.340277778	0.206679332	other
Altai	GWAS	Mean corpuscular hemoglobin concentration	3	1.549	1.936733376	0.206779322	hematologic
Altai	GWAS	"Bone mineral density (paediatric, total body less head)"	1	0.2328	4.295532646	0.207579242	skeletal
Altai	GWAS	Childhood body mass index	2	0.8503	2.35211102	0.209879012	metabolic
Altai	GWAS	Response to Vitamin E supplementation	1	0.2366	4.226542688	0.211278872	other
Altai	GWAS	Sulfasalazine-induced agranulocytosis	1	0.2352	4.25170068	0.211778822	hematologic
Altai	GWAS	Adiposity	1	0.237	4.219409283	0.212778722	metabolic
Altai	GWAS	Lung function (FEV1)	3	1.5836	1.894417782	0.213378662	respiratory
Altai	GWAS	Nephropathy	1	0.2412	4.145936982	0.214178582	urinary
Altai	GWAS	Hippocampal subfield CA1 volume	1	0.2401	4.164931279	0.214378562	nervous
Altai	GWAS	Smoking cessation in chronic obstructive pulmonary disease	1	0.2393	4.178854994	0.215078492	respiratory
Altai	GWAS	Kidney function decline traits	1	0.2389	4.185851821	0.215578442	urinary
Altai	GWAS	Black vs. red hair color	1	0.2432	4.111842105	0.216578342	integumentary
Altai	GWAS	Chlamydia trachomatis seropositivity	1	0.2426	4.122011542	0.217478252	immune
Altai	GWAS	Brown vs. black hair color	2	0.8828	2.265518804	0.218378162	integumentary
Altai	GWAS	Lead levels	2	0.8875	2.253521127	0.220177982	other
Altai	GWAS	Low density lipoprotein cholesterol levels	2	0.8907	2.245424947	0.222577742	metabolic
Altai	GWAS	Hepatocellular carcinoma	1	0.2539	3.938558488	0.222977702	digestive
Altai	GWAS	Obesity (extreme)	2	0.8984	2.226179875	0.224377562	metabolic
Altai	GWAS	Inflammatory biomarkers	2	0.8809	2.270405267	0.224477552	immune
Altai	GWAS	Amyotrophic lateral sclerosis (age of onset)	2	0.9	2.222222222	0.225677432	nervous
Altai	GWAS	Visceral adipose tissue/subcutaneous adipose tissue ratio	4	2.3987	1.667569934	0.226177382	metabolic
Altai	GWAS	Black vs. blond hair color	1	0.2579	3.877471888	0.227677232	integumentary
Altai	GWAS	Midgestational circulating levels of PBDEs (fetal genetic effect)	1	0.265	3.773584906	0.230376962	reproductive
Altai	GWAS	Bone mineral density (femoral neck) in inflammatory bowel disease	1	0.2592	3.858024691	0.230676932	skeletal
Altai	GWAS	Renal function-related traits (sCR)	1	0.263	3.802281369	0.230776922	urinary
Altai	GWAS	Central corneal thickness	3	1.6495	1.818732949	0.232276772	nervous
Altai	GWAS	Neuroticism	4	2.489	1.607071113	0.235476452	behavior
Altai	GWAS	Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)	1	0.271	3.6900369	0.236176382	other
Altai	GWAS	Coronary artery disease	12	9.4071	1.275632235	0.238676132	cardiovascular
Altai	GWAS	Waist-to-hip ratio adjusted for BMI in active individuals	2	0.9299	2.1507689	0.239376062	skeletal
Altai	GWAS	Electrodermal activity	2	0.9408	2.12585034	0.242375762	integumentary
Altai	GWAS	Chronic mucus hypersecretion	1	0.2759	3.624501631	0.242575742	immune
Altai	GWAS	Dentate gyrus molecular layer volume	1	0.2791	3.582945181	0.245175482	nervous
Altai	GWAS	Erosive tooth wear (severe vs none or mild)	2	0.9418	2.12359312	0.246875312	skeletal
Altai	GWAS	Prothrombin time	1	0.2886	3.465003465	0.248975102	hematologic
Altai	GWAS	Waist circumference adjusted for BMI (adjusted for smoking behaviour)	3	1.7478	1.716443529	0.251974803	skeletal
Altai	GWAS	Subiculum volume	1	0.2881	3.471017008	0.252574743	nervous
Altai	GWAS	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	2	0.9771	2.046873401	0.253574643	other
Altai	GWAS	Erectile dysfunction	3	1.7332	1.730902377	0.253874613	reproductive
Altai	GWAS	Lumbar spine bone mineral density	2	0.9819	2.036867298	0.260173983	skeletal
Altai	GWAS	Hippocampal volume in normal cognition	1	0.3038	3.291639236	0.260773923	nervous
Altai	GWAS	Obese vs. thin	1	0.302	3.311258278	0.261373863	metabolic
Altai	GWAS	Small vessel stroke	1	0.3064	3.263707572	0.265173483	cardiovascular
Altai	GWAS	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis	1	0.3073	3.25414904	0.265273473	other
Altai	GWAS	BMI in smokers	2	0.9946	2.010858637	0.266373363	metabolic
Altai	GWAS	Hirschsprung disease	1	0.3101	3.224766204	0.266673333	digestive
Altai	GWAS	Cancer	1	0.3102	3.223726628	0.266973303	other
Altai	GWAS	Allergy	2	1.0157	1.96908536	0.267173283	immune
Altai	GWAS	Body mass index (SNP x SNP interaction)	1	0.3163	3.161555485	0.267273273	metabolic
Altai	GWAS	Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)	3	1.7937	1.672520488	0.267373263	skeletal
Altai	GWAS	Heart rate response to exercise	2	1.0065	1.987083954	0.267773223	cardiovascular
Altai	GWAS	Shingles	1	0.3127	3.19795331	0.269673033	immune
Altai	GWAS	Insomnia	2	1.0131	1.974138782	0.270872913	behavior
Altai	GWAS	Rheumatoid arthritis (ACPA-negative)	1	0.3186	3.138731952	0.273172683	immune
Altai	GWAS	Staphylococcus aureus infection	1	0.3177	3.147623544	0.273172683	immune
Altai	GWAS	Ischemic stroke (small-vessel)	1	0.3178	3.146633103	0.274272573	cardiovascular
Altai	GWAS	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	1	0.3217	3.108486167	0.277072293	other
Altai	GWAS	Alzheimer's disease	3	1.8312	1.638269987	0.278172183	nervous
Altai	GWAS	Metabolite levels (Pyroglutamine)	2	1.0299	1.94193611	0.279572043	metabolic
Altai	GWAS	IgG glycosylation	1	0.33	3.03030303	0.279872013	immune
Altai	GWAS	Diabetic kidney disease	3	1.8372	1.63291966	0.280171983	metabolic
Altai	GWAS	Weight	2	1.0385	1.925854598	0.281071893	skeletal
Altai	GWAS	Urate levels	2	1.0461	1.911863111	0.281171883	metabolic
Altai	GWAS	Serum metabolite concentrations in chronic kidney disease	2	1.0631	1.881290565	0.281871813	urinary
Altai	GWAS	Dentate gyrus granule cell layer volume	1	0.3349	2.98596596	0.286171383	nervous
Altai	GWAS	Homeostasis model assessment of beta-cell function (dietary factor interaction)	2	1.0594	1.887861053	0.286171383	metabolic
Altai	GWAS	Hippocampal subfield CA4 volume	1	0.3349	2.98596596	0.286171383	nervous
Altai	GWAS	Hypersomnia (HLA-DQB1*06:02 negative)	1	0.3372	2.965599051	0.289871013	behavior
Altai	GWAS	Myocardial infarction	2	1.0623	1.882707333	0.290470953	cardiovascular
Altai	GWAS	White blood cell types	1	0.3454	2.895193978	0.294370563	immune
Altai	GWAS	Tanning	1	0.3485	2.869440459	0.294870513	integumentary
Altai	GWAS	Hypothyroidism	4	2.7637	1.447335094	0.296770323	endocrine
Altai	GWAS	Gait speed in old age	2	1.0831	1.846551565	0.296970303	other
Altai	GWAS	PR interval	3	1.8931	1.58470234	0.298170183	cardiovascular
Altai	GWAS	Primary tooth development (number of teeth)	1	0.3542	2.823263693	0.298970103	skeletal
Altai	GWAS	Basal cell carcinoma	2	1.0911	1.833012556	0.299670033	integumentary
Altai	GWAS	Waist-to-hip ratio adjusted for BMI (age <50)	2	1.1089	1.803589142	0.300169983	skeletal
Altai	GWAS	Coronary heart disease	2	1.0897	1.835367532	0.300569943	cardiovascular
Altai	GWAS	Preeclampsia	1	0.3631	2.754062242	0.301369863	reproductive
Altai	GWAS	Sex hormone-binding globulin levels	1	0.3602	2.776235425	0.304069593	endocrine
Altai	GWAS	Neutrophil count	5	3.6539	1.368400887	0.305569443	lymphatic
Altai	GWAS	Primary tooth development (time to first tooth eruption)	1	0.3673	2.722570106	0.308669133	skeletal
Altai	GWAS	"Coronary artery disease (myocardial infarction, PTCA, CABG, angina or CIHD)"	3	1.9334	1.551670632	0.308769123	cardiovascular
Altai	GWAS	Lung function (FEV1/FVC)	4	2.8675	1.39494333	0.310368963	respiratory
Altai	GWAS	Psoriatic arthritis	1	0.3676	2.720348205	0.310768923	integumentary
Altai	GWAS	Obesity (early onset extreme)	2	1.1204	1.785076758	0.311168883	metabolic
Altai	GWAS	Leprosy	1	0.3786	2.64131009	0.312068793	immune
Altai	GWAS	Arthritis (juvenile idiopathic)	1	0.3718	2.689618074	0.313368663	skeletal
Altai	GWAS	Mean corpuscular volume	6	4.5913	1.306819419	0.314568543	hematologic
Altai	GWAS	Major depressive disorder (broad)	1	0.3806	2.627430373	0.315168483	behavior
Altai	GWAS	Metabolite levels	3	1.9797	1.515381118	0.315568443	metabolic
Altai	GWAS	P wave duration	1	0.3736	2.676659529	0.316868313	cardiovascular
Altai	GWAS	Response to fenofibrate (adiponectin levels)	2	1.1372	1.758705593	0.318968103	other
Altai	GWAS	Parkinson's disease	5	3.7652	1.327950706	0.319668033	nervous
Altai	GWAS	Bone mineral density (hip)	2	1.1571	1.728459079	0.320067993	skeletal
Altai	GWAS	Personality traits in bipolar disorder	1	0.389	2.570694087	0.321367863	behavior
Altai	GWAS	Magnesium levels	1	0.3902	2.562788314	0.321967803	other
Altai	GWAS	Heschl's gyrus morphology	2	1.1714	1.707358716	0.323467653	nervous
Altai	GWAS	Asthma (sex interaction)	1	0.3879	2.577984016	0.324167583	respiratory
Altai	GWAS	Polycystic ovary syndrome	2	1.1696	1.70998632	0.324467553	reproductive
Altai	GWAS	Coffee consumption	1	0.3883	2.575328354	0.324767523	behavior
Altai	GWAS	Problematic alcohol use in trauma-exposed individuals	1	0.3966	2.521432173	0.325067493	behavior
Altai	GWAS	Type 2 diabetes nephropathy including microalbuminuria	1	0.3929	2.54517689	0.326367363	metabolic
Altai	GWAS	Angiotensin-converting enzyme inhibitor intolerance	4	2.8948	1.381788034	0.326767323	other
Altai	GWAS	Logical memory (delayed recall) in mild cognitive impairment	1	0.3984	2.510040161	0.327067293	nervous
Altai	GWAS	Recurrent major depressive disorder	1	0.3968	2.52016129	0.328267173	behavior
Altai	GWAS	Freckles	1	0.3931	2.543881964	0.328967103	integumentary
Altai	GWAS	Body fat percentage	1	0.3966	2.521432173	0.329167083	metabolic
Altai	GWAS	Dental caries	3	2.0157	1.488316714	0.331366863	skeletal
Altai	GWAS	Insulin-like growth factors	1	0.4036	2.477700694	0.332466753	immune
Altai	GWAS	Non-melanoma skin cancer	1	0.4091	2.444390125	0.333266673	integumentary
Altai	GWAS	Heel bone mineral density	23	20.6734	1.112540753	0.334466553	skeletal
Altai	GWAS	Osteoarthritis	1	0.4064	2.460629921	0.334466553	skeletal
Altai	GWAS	Regular attendance at a religious group	2	1.2	1.666666667	0.334966503	behavior
Altai	GWAS	Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)	1	0.4052	2.467917078	0.335066493	immune
Altai	GWAS	Self-reported risk-taking behaviour	2	1.1945	1.674340728	0.335266473	behavior
Altai	GWAS	Body mass index (age <50)	2	1.1955	1.672940192	0.336266373	metabolic
Altai	GWAS	Breast size	3	2.0735	1.446829033	0.339066093	reproductive
Altai	GWAS	Chronic central serous retinopathy	1	0.4169	2.398656752	0.340665933	nervous
Altai	GWAS	Metabolite levels (HVA/5-HIAA ratio)	1	0.4179	2.392916966	0.341265873	metabolic
Altai	GWAS	Hippocampal atrophy	2	1.2158	1.645007403	0.341565843	nervous
Altai	GWAS	Hippocampal volume	2	1.2077	1.656040407	0.341565843	nervous
Altai	GWAS	Immune response to anthrax vaccine	1	0.418	2.392344498	0.342665733	immune
Altai	GWAS	Feeling nervous	2	1.2341	1.620614213	0.347665233	behavior
Altai	GWAS	Mortality in heart failure	1	0.432	2.314814815	0.349565043	cardiovascular
Altai	GWAS	IgA nephropathy	1	0.4299	2.326122354	0.351064894	immune
Altai	GWAS	Prudent dietary pattern	2	1.2455	1.605780811	0.351064894	behavior
Altai	GWAS	Selective IgA deficiency	2	1.2474	1.603334937	0.351964804	immune
Altai	GWAS	"Parental longevity (combined parental attained age, Martingale residuals)"	1	0.4391	2.277385561	0.352864714	other
Altai	GWAS	Response to radiotherapy in cancer (late toxicity)	2	1.2386	1.614726304	0.354664534	other
Altai	GWAS	Food addiction	1	0.4377	2.284669865	0.355364464	behavior
Altai	GWAS	Colorectal cancer (diet interaction)	1	0.4453	2.245677072	0.356364364	digestive
Altai	GWAS	Response to antipsychotic treatment in schizophrenia (working memory)	1	0.444	2.252252252	0.357064294	other
Altai	GWAS	Metabolite levels (small molecules and protein measures)	1	0.445	2.247191011	0.357564244	metabolic
Altai	GWAS	Platelet distribution width	5	3.9263	1.273463566	0.357764224	hematologic
Altai	GWAS	Waist-to-hip ratio adjusted for body mass index	4	3.0107	1.328594679	0.358764124	skeletal
Altai	GWAS	Essential tremor	1	0.4442	2.251238181	0.359564044	nervous
Altai	GWAS	Red blood cell count	5	3.9547	1.264318406	0.359664034	hematologic
Altai	GWAS	Type 2 diabetes	12	10.521	1.140575991	0.361163884	metabolic
Altai	GWAS	Lean body mass	1	0.4499	2.222716159	0.361263874	skeletal muscle
Altai	GWAS	Cytomegalovirus antibody response	1	0.4518	2.213368747	0.362763724	immune
Altai	GWAS	LDL cholesterol	3	2.1515	1.394376017	0.364463554	metabolic
Altai	GWAS	Glaucoma (primary angle closure)	1	0.4527	2.208968412	0.365763424	nervous
Altai	GWAS	Sjogren's syndrome	2	1.2902	1.550147264	0.366463354	immune
Altai	GWAS	Serum folate levels	1	0.4594	2.176752286	0.366463354	other
Altai	GWAS	Lipid traits (pleiotropy) (HIPO component 1)	1	0.4642	2.15424386	0.371662834	metabolic
Altai	GWAS	Plateletcrit	5	3.9752	1.25779835	0.372262774	hematologic
Altai	GWAS	Renal function-related traits (eGRFcrea)	1	0.4692	2.131287298	0.375262474	urinary
Altai	GWAS	Depression	4	3.0867	1.295882334	0.375362464	behavior
Altai	GWAS	Memory dysfunction in frontotemporal lobe dementia	1	0.4703	2.12630236	0.375662434	nervous
Altai	GWAS	Familial lung cancer	1	0.4754	2.103491796	0.377462254	respiratory
Altai	GWAS	Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)	1	0.4723	2.117298327	0.378962104	other
Altai	GWAS	Erosive tooth wear (severe vs non-severe)	2	1.3267	1.507499812	0.381061894	skeletal
Altai	GWAS	Hemostatic factors and hematological phenotypes	1	0.4772	2.095557418	0.381261874	hematologic
Altai	GWAS	White matter hyperintensity burden	1	0.4911	2.036245164	0.386361364	nervous
Altai	GWAS	Red vs. brown/black hair color	1	0.4897	2.042066571	0.387861214	integumentary
Altai	GWAS	Systolic blood pressure x smoking status (ever vs never) interaction (2df test)	2	1.3314	1.502178158	0.389661034	cardiovascular
Altai	GWAS	Airway imaging phenotypes	1	0.5033	1.986886549	0.390260974	respiratory
Altai	GWAS	Cutaneous squamous cell carcinoma	1	0.4938	2.025111381	0.391360864	integumentary
Altai	GWAS	Quantitative traits	2	1.3566	1.47427392	0.394160584	other
Altai	GWAS	Alzheimer's disease (survival time)	1	0.5056	1.977848101	0.395360464	nervous
Altai	GWAS	Night sleep phenotypes	14	12.6855	1.103622246	0.395460454	behavior
Altai	GWAS	Total hippocampal volume	1	0.5003	1.99880072	0.397860214	nervous
Altai	GWAS	HDL cholesterol levels	2	1.3764	1.453065969	0.400059994	metabolic
Altai	GWAS	Cerebrospinal fluid p-tau levels	1	0.5194	1.925298421	0.400059994	nervous
Altai	GWAS	Amyotrophic lateral sclerosis	2	1.3809	1.448330799	0.401559844	nervous
Altai	GWAS	Bilirubin levels	1	0.5197	1.924187031	0.402059794	digestive
Altai	GWAS	Vigorous physical activity	1	0.512	1.953125	0.402859714	behavior
Altai	GWAS	Hypertension (SNP x SNP interaction)	1	0.5148	1.942501943	0.404459554	cardiovascular
Altai	GWAS	Subcutaneous adipose tissue	3	2.2977	1.30565348	0.404659534	metabolic
Altai	GWAS	Barrett's esophagus  or Esophageal adenocarcinoma	1	0.5246	1.906214258	0.405159484	digestive
Altai	GWAS	Papillary thyroid cancer	1	0.5231	1.911680367	0.405559444	endocrine
Altai	GWAS	Differentiated thyroid cancer	1	0.5231	1.911680367	0.405559444	endocrine
Altai	GWAS	Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)	2	1.3805	1.448750453	0.408659134	cardiovascular
Altai	GWAS	Acute graft versus host disease in bone marrow transplantation (recipient effect)	1	0.528	1.893939394	0.410458954	other
Altai	GWAS	Upper eyelid morphology	1	0.5379	1.859081614	0.412958704	integumentary
Altai	GWAS	Renal cell carcinoma	1	0.5293	1.889287739	0.413858614	urinary
Altai	GWAS	Urinary albumin-to-creatinine ratio in non-diabetics	1	0.5413	1.847404397	0.414358564	metabolic
Altai	GWAS	Bone mineral density	4	3.2398	1.234644114	0.414658534	skeletal
Altai	GWAS	BMI in non-smokers	3	2.339	1.282599401	0.416658334	metabolic
Altai	GWAS	Glomerular filtration rate	3	2.3745	1.263423879	0.420457954	hematologic
Altai	GWAS	Panic disorder	1	0.551	1.814882033	0.422257774	behavior
Altai	GWAS	Monobrow thickness	1	0.5484	1.823486506	0.422757724	integumentary
Altai	GWAS	Frontotemporal dementia	1	0.5465	1.829826167	0.423457654	nervous
Altai	GWAS	Alcohol dependence symptom count	1	0.5589	1.789228842	0.425257474	behavior
Altai	GWAS	"Cholesterol, total"	2	1.4477	1.381501692	0.425257474	metabolic
Altai	GWAS	Disease progression in age-related macular degeneration	4	3.3367	1.198789223	0.425757424	nervous
Altai	GWAS	Neurofibrillary tangles	1	0.5579	1.79243592	0.428457154	nervous
Altai	GWAS	Uterine fibroid size (maximum volume)	2	1.4706	1.35998912	0.429557044	reproductive
Altai	GWAS	Age-related nuclear cataracts	1	0.5588	1.789549034	0.430156984	nervous
Altai	GWAS	Copper levels	2	1.4778	1.353363107	0.430856914	other
Altai	GWAS	Peanut allergy	1	0.5641	1.772735331	0.432256774	immune
Altai	GWAS	Glucocorticoid-induced osteonecrosis	1	0.5671	1.763357433	0.432656734	other
Altai	GWAS	Cerebral amyloid deposition (PET imaging)	1	0.5672	1.763046544	0.432856714	nervous
Altai	GWAS	Triglyceride levels	2	1.4698	1.360729351	0.434756524	metabolic
Altai	GWAS	Late-onset myasthenia gravis	1	0.5651	1.769598301	0.435056494	skeletal muscle
Altai	GWAS	Lung cancer	3	2.4067	1.246520131	0.435256474	respiratory
Altai	GWAS	Accelerated cognitive decline after conversion of MCI to Alzheimer's disease	1	0.5747	1.740038281	0.436156384	nervous
Altai	GWAS	Age at voice drop	1	0.5711	1.751006829	0.438356164	endocrine
Altai	GWAS	Free thyroxine concentration	1	0.5799	1.724435247	0.439056094	endocrine
Altai	GWAS	Glaucoma (primary open-angle)	3	2.4487	1.22513987	0.439956004	nervous
Altai	GWAS	Lung adenocarcinoma	3	2.4472	1.225890814	0.440155984	respiratory
Altai	GWAS	Loneliness (multivariate analysis)	2	1.5077	1.326523844	0.443655634	behavior
Altai	GWAS	Cutaneous malignant melanoma	1	0.5881	1.70039109	0.445655434	integumentary
Altai	GWAS	Body mass index and waist-hip ratio (pleiotropy)	1	0.5839	1.712622024	0.448455154	metabolic
Altai	GWAS	Schizophrenia	20	19.0595	1.049345471	0.449555044	behavior
Altai	GWAS	Osteoporosis-related phenotypes	1	0.616	1.623376623	0.455154485	skeletal
Altai	GWAS	Mammographic density (dense area)	1	0.6125	1.632653061	0.455254475	reproductive
Altai	GWAS	Response to platinum-based chemotherapy in non-small-cell lung cancer	1	0.6033	1.657550141	0.455354465	other
Altai	GWAS	Mean arterial pressure (alcohol consumption interaction)	1	0.6085	1.643385374	0.457354265	cardiovascular
Altai	GWAS	Irritable mood	2	1.5542	1.286835671	0.460053995	behavior
Altai	GWAS	Optic disc area	1	0.6031	1.658099818	0.460653935	nervous
Altai	GWAS	Body mass index	27	26.1471	1.032619296	0.462153785	metabolic
Altai	GWAS	Placental abruption	1	0.6194	1.614465612	0.462253775	reproductive
Altai	GWAS	Male-pattern baldness	5	4.5041	1.110099687	0.466353365	integumentary
Altai	GWAS	Bone mineral density (spine)	1	0.6265	1.596169194	0.469053095	skeletal
Altai	GWAS	Neutrophil percentage of white cells	2	1.5825	1.263823065	0.470552945	lymphatic
Altai	GWAS	Chromium levels	1	0.6418	1.558117794	0.473652635	other
Altai	GWAS	Iron status biomarkers (iron levels)	1	0.6455	1.549186677	0.474852515	other
Altai	GWAS	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	1	0.6413	1.559332606	0.478052195	other
Altai	GWAS	Hematocrit	3	2.5796	1.162971003	0.480251975	hematologic
Altai	GWAS	Waist circumference adjusted for BMI in active individuals	2	1.6213	1.233577993	0.481151885	skeletal
Altai	GWAS	Waist circumference adjusted for body mass index	3	2.6093	1.149733645	0.482851715	skeletal
Altai	GWAS	Temperament (bipolar disorder)	1	0.6615	1.511715797	0.483251675	behavior
Altai	GWAS	Gut microbiota (functional units)	2	1.6228	1.232437762	0.483951605	digestive
Altai	GWAS	Blood pressure	4	3.6094	1.108217432	0.485251475	hematologic
Altai	GWAS	Pediatric autoimmune diseases	1	0.6674	1.498351813	0.485751425	immune
Altai	GWAS	Hypospadias	1	0.6638	1.506477855	0.487851215	urinary
Altai	GWAS	JT interval (sulfonylurea treatment interaction)	1	0.669	1.494768311	0.491150885	cardiovascular
Altai	GWAS	Periodontitis (PAL4Q3)	1	0.6773	1.476450613	0.492450755	immune
Altai	GWAS	Feeling guilty	1	0.6749	1.481700993	0.492650735	behavior
Altai	GWAS	Attention deficit hyperactivity disorder	4	3.6332	1.100957833	0.493350665	behavior
Altai	GWAS	Early-onset Parkinson's disease	1	0.6715	1.489203276	0.494450555	nervous
Altai	GWAS	Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)	2	1.6427	1.217507762	0.494650535	cardiovascular
Altai	GWAS	Melanoma	2	1.6628	1.202790474	0.499250075	integumentary
Altai	GWAS	Immunoglobulin A	1	0.6934	1.442169022	0.500349965	immune
Altai	GWAS	Itch intensity from mosquito bite	2	1.6877	1.185044735	0.501049895	immune
Altai	GWAS	Waist-hip ratio	3	2.6879	1.116112951	0.501249875	skeletal
Altai	GWAS	Psoriasis vulgaris	1	0.701	1.426533524	0.502149785	integumentary
Altai	GWAS	Breast milk fatty acid composition (infant genotype effect)	1	0.7053	1.417836382	0.505849415	reproductive
Altai	GWAS	Dimensional psychopathology (Positive)	1	0.7081	1.412229911	0.506749325	behavior
Altai	GWAS	Eyebrow thickness	1	0.7088	1.410835214	0.508549145	integumentary
Altai	GWAS	Regular attendance at a gym or sports club	1	0.7195	1.389854065	0.510348965	behavior
Altai	GWAS	Low tan response	1	0.7208	1.387347392	0.512148785	integumentary
Altai	GWAS	LDL peak particle diameter (total fat intake interaction)	1	0.7117	1.405086413	0.514248575	metabolic
Altai	GWAS	Hand grip strength	5	4.7631	1.049736516	0.514948505	skeletal muscle
Altai	GWAS	Social communication problems	1	0.7216	1.385809313	0.516048395	behavior
Altai	GWAS	Eye morphology	1	0.7213	1.386385692	0.516948305	nervous
Altai	GWAS	Zinc levels	1	0.7261	1.377220768	0.518248175	other
Altai	GWAS	Palmitic acid (16:0) levels	1	0.7245	1.38026225	0.518348165	other
Altai	GWAS	Thrombin-activatable fibrinolysis inhibitor activation peptide	1	0.7404	1.350621286	0.518448155	hematologic
Altai	GWAS	Obstructive sleep apnea trait (average respiratory event duration)	1	0.727	1.375515818	0.519848015	other
Altai	GWAS	Hodgkin's lymphoma	1	0.7444	1.343363783	0.522647735	lymphatic
Altai	GWAS	Height	10	9.8921	1.010907694	0.524647535	skeletal
Altai	GWAS	Systolic blood pressure x smoking status (current vs non-current) interaction (1df test)	1	0.7463	1.339943722	0.524947505	cardiovascular
Altai	GWAS	White blood cell count (basophil)	2	1.7492	1.143379831	0.525247475	immune
Altai	GWAS	Breast milk fatty acid composition (maternal genotype effect)	1	0.7481	1.33671969	0.526847315	reproductive
Altai	GWAS	Worry too long after an embarrassing experience	1	0.7474	1.337971635	0.528147185	behavior
Altai	GWAS	Itch intensity from mosquito bite adjusted by bite size	5	4.8463	1.031714917	0.531746825	immune
Altai	GWAS	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)	1	0.7666	1.304461258	0.532346765	other
Altai	GWAS	Diabetic retinopathy	1	0.7787	1.284191601	0.538846115	metabolic
Altai	GWAS	Partial epilepsies	1	0.7728	1.293995859	0.538946105	nervous
Altai	GWAS	Breast cancer (estrogen-receptor negative)	1	0.7833	1.27665007	0.539746025	reproductive
Altai	GWAS	Dimensional psychopathology (Arousal)	1	0.781	1.280409731	0.539846015	behavior
Altai	GWAS	Regular attendance at a pub or social club	1	0.7785	1.284521516	0.540545945	behavior
Altai	GWAS	Response to platinum-based neoadjuvant chemotherapy in cervical cancer	1	0.7864	1.271617497	0.541345865	other
Altai	GWAS	Cerebrospinal fluid beta-site APP cleaving enzyme levels	1	0.7872	1.270325203	0.545745425	nervous
Altai	GWAS	Sleep duration	2	1.821	1.098297639	0.546445355	behavior
Altai	GWAS	Plasma amyloid beta peptide concentrations (ABx-40)	1	0.7817	1.279263144	0.546745325	nervous
Altai	GWAS	Dimensional psychopathology (Cognitive)	1	0.7848	1.27420999	0.546945305	behavior
Altai	GWAS	Chronic inflammatory diseases (pleiotropy)	3	2.8742	1.043768701	0.547245275	immune
Altai	GWAS	Radiation response	1	0.8003	1.249531426	0.547945205	other
Altai	GWAS	Bone mineral density (total hip)	1	0.7982	1.252818842	0.549245075	skeletal
Altai	GWAS	Iron status biomarkers (transferrin saturation)	1	0.7976	1.253761284	0.549745025	other
Altai	GWAS	Molybdenum levels	1	0.8122	1.231223836	0.550544946	other
Altai	GWAS	Headache	1	0.8049	1.242390359	0.552244776	nervous
Altai	GWAS	Response to anti-depressant treatment in major depressive disorder	1	0.8058	1.24100273	0.553244676	other
Altai	GWAS	Creatinine levels	2	1.8812	1.06315118	0.556244376	other
Altai	GWAS	Cerebrospinal fluid AB1-42 levels	1	0.8074	1.238543473	0.557744226	nervous
Altai	GWAS	Immature fraction of reticulocytes	2	1.8686	1.070320026	0.561143886	hematologic
Altai	GWAS	Aluminium levels	1	0.8316	1.202501203	0.562143786	other
Altai	GWAS	Serum uric acid levels in response to allopurinol in gout	1	0.8441	1.184693757	0.562943706	other
Altai	GWAS	Atopic dermatitis	1	0.8393	1.191469081	0.566043396	integumentary
Altai	GWAS	BMI (adjusted for smoking behaviour)	3	2.934	1.022494888	0.566043396	metabolic
Altai	GWAS	Periodontitis (Mean PAL)	2	1.9053	1.049703459	0.566743326	immune
Altai	GWAS	Body mass index (joint analysis main effects and smoking interaction)	3	2.9375	1.021276596	0.567343266	metabolic
Altai	GWAS	Pancreatic cancer	3	2.9786	1.007184583	0.570042996	endocrine
Altai	GWAS	Knee osteoarthritis	1	0.8468	1.180916391	0.572042796	skeletal
Altai	GWAS	Liver enzyme levels (gamma-glutamyl transferase)	1	0.8647	1.156470452	0.574942506	other
Altai	GWAS	Loneliness (MTAG)	1	0.8569	1.166997316	0.577442256	behavior
Altai	GWAS	Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes	3	2.997	1.001001001	0.577542246	cardiovascular
Altai	GWAS	Intelligence	2	1.9652	1.017708121	0.581041896	other
Altai	GWAS	"Allergic disease (asthma, hay fever or eczema)"	3	3.0157	0.994793912	0.581241876	immune
Altai	GWAS	Nicotine dependence	1	0.8678	1.152339249	0.582441756	behavior
Altai	GWAS	Rosacea symptom severity	5	5.1399	0.972781572	0.584641536	integumentary
Altai	GWAS	Isovolumetric relaxation time	1	0.8755	1.142204455	0.585241476	cardiovascular
Altai	GWAS	Pelvic organ prolapse	1	0.8773	1.139860937	0.586041396	skeletal muscle
Altai	GWAS	Mosquito bite size	4	4.1044	0.974563883	0.588441156	other
Altai	GWAS	Amyotrophic lateral sclerosis (sporadic)	6	6.2203	0.964583702	0.588641136	nervous
Altai	GWAS	Restless legs syndrome	2	1.9867	1.006694519	0.593840616	nervous
Altai	GWAS	Cerebrospinal AB1-42 levels in normal cognition	1	0.9216	1.085069444	0.600939906	nervous
Altai	GWAS	Plasma clusterin levels	1	0.9216	1.085069444	0.602039796	other
Altai	GWAS	Body mass index in physically active individuals	3	3.1133	0.963607747	0.602939706	metabolic
Altai	GWAS	Glomerular filtration rate in non diabetics (creatinine)	1	0.9248	1.081314879	0.603939606	hematologic
Altai	GWAS	Loneliness	3	3.1307	0.958252148	0.605939406	behavior
Altai	GWAS	Rheumatoid arthritis	3	3.1404	0.955292319	0.607539246	immune
Altai	GWAS	Primary biliary cirrhosis	1	0.9377	1.06643916	0.608439156	digestive
Altai	GWAS	Initial alcohol sensitivity	1	0.932	1.072961373	0.610138986	other
Altai	GWAS	Primary sclerosing cholangitis	1	0.945	1.058201058	0.611538846	digestive
Altai	GWAS	Lung function (FVC)	2	2.0639	0.969039198	0.611638836	respiratory
Altai	GWAS	Migraine	2	2.0683	0.966977711	0.611938806	nervous
Altai	GWAS	Response to antipsychotic treatment	2	2.0831	0.960107532	0.613638636	other
Altai	GWAS	Tuberculosis	2	2.0529	0.974231575	0.614238576	immune
Altai	GWAS	Hip circumference adjusted for BMI	2	2.0824	0.960430273	0.614338566	skeletal
Altai	GWAS	Lymphocyte percentage of white cells	2	2.0722	0.965157803	0.615938406	lymphatic
Altai	GWAS	Fractional exhaled nitric oxide (childhood)	1	0.9494	1.053296819	0.616438356	respiratory
Altai	GWAS	Severe gingival inflammation	1	0.9538	1.048437828	0.616738326	immune
Altai	GWAS	Daytime sleep phenotypes	5	5.3469	0.935121285	0.617438256	behavior
Altai	GWAS	Resting heart rate	3	3.1653	0.947777462	0.620437956	cardiovascular
Altai	GWAS	Educational attainment	2	2.1021	0.951429523	0.622837716	other
Altai	GWAS	Contrast sensitivity	1	0.9727	1.028066207	0.623037696	nervous
Altai	GWAS	Basophil percentage of white cells	1	0.9731	1.027643613	0.625137486	immune
Altai	GWAS	Social science traits (pleiotropy) (HIPO component 1)	1	0.9808	1.019575856	0.625837416	behavior
Altai	GWAS	Systemic lupus erythematosus	6	6.4857	0.92511217	0.626037396	immune
Altai	GWAS	Feeling tense	1	0.9961	1.00391527	0.626237376	behavior
Altai	GWAS	Macular thickness	4	4.3369	0.922317785	0.628537146	nervous
Altai	GWAS	Post bronchodilator FEV1/FVC ratio	10	10.7218	0.932679214	0.629437056	other
Altai	GWAS	Plasma parathyroid hormone levels	1	0.9992	1.000800641	0.634036596	endocrine
Altai	GWAS	Anorexia nervosa	2	2.1484	0.93092534	0.637836216	behavior
Altai	GWAS	Bronchopulmonary dysplasia	2	2.164	0.924214418	0.638736126	respiratory
Altai	GWAS	Fibrinogen levels	1	1.0237	0.976848686	0.639736026	hematologic
Altai	GWAS	Response to antidepressants (symptom improvement)	1	1.0458	0.956205775	0.645435456	other
Altai	GWAS	Age-related macular degeneration	1	1.0326	0.968429208	0.647735226	nervous
Altai	GWAS	Adverse response to lamotrigine and phenytoin	1	1.0277	0.973046609	0.648035196	other
Altai	GWAS	Metabolite levels (HVA/MHPG ratio)	1	1.0671	0.937119295	0.654134587	metabolic
Altai	GWAS	High light scatter reticulocyte percentage of red cells	2	2.2487	0.889402766	0.659834017	metabolic
Altai	GWAS	Hair color	1	1.0812	0.924898261	0.660133987	integumentary
Altai	GWAS	Dimensional psychopathology (Negative)	1	1.0919	0.915834783	0.662633737	behavior
Altai	GWAS	Urate levels (BMI interaction)	1	1.0978	0.910912735	0.662833717	metabolic
Altai	GWAS	Basophil percentage of granulocytes	1	1.088	0.919117647	0.663433657	immune
Altai	GWAS	Paclitaxel disposition in epithelial ovarian cancer	2	2.2784	0.877808989	0.664533547	other
Altai	GWAS	HIV-1 viral setpoint	1	1.0816	0.924556213	0.667133287	immune
Altai	GWAS	Type 2 diabetes (age of onset)	1	1.0906	0.916926462	0.667333267	metabolic
Altai	GWAS	Body mass index (joint analysis main effects and physical activity interaction)	3	3.4373	0.872778053	0.667533247	metabolic
Altai	GWAS	Mercury levels	1	1.101	0.908265213	0.669633037	other
Altai	GWAS	Seasonality and depression	1	1.1257	0.888336146	0.669833017	behavior
Altai	GWAS	Albumin-globulin ratio	1	1.1063	0.903913947	0.670232977	other
Altai	GWAS	Mean arterial pressure x alcohol consumption interaction (2df test)	1	1.0935	0.914494742	0.670632937	cardiovascular
Altai	GWAS	Bortezomib-induced peripheral neuropathy in multiple myeloma	1	1.1243	0.88944232	0.674132587	nervous
Altai	GWAS	Systolic blood pressure x alcohol consumption interaction (2df test)	2	2.3565	0.848716317	0.679332067	cardiovascular
Altai	GWAS	Vertical cup-disc ratio	1	1.1444	0.873820343	0.681131887	nervous
Altai	GWAS	Gut microbiota (bacterial taxa)	1	1.1363	0.880049283	0.681531847	digestive
Altai	GWAS	Depression in smokers	1	1.1393	0.877731941	0.682031797	behavior
Altai	GWAS	Eating disorders	1	1.1303	0.884720871	0.684031597	behavior
Altai	GWAS	Mean corpuscular hemoglobin	3	3.5238	0.851353652	0.685031497	hematologic
Altai	GWAS	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)	1	1.1592	0.862663906	0.686431357	other
Altai	GWAS	Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma	1	1.1608	0.861474845	0.691130887	other
Altai	GWAS	Pulse pressure x alcohol consumption interaction (2df test)	1	1.1685	0.855798032	0.692130787	cardiovascular
Altai	GWAS	Periodontal disease-related phenotypes	1	1.1724	0.852951211	0.692430757	immune
Altai	GWAS	Craniofacial microsomia	1	1.1734	0.852224305	0.693430657	skeletal
Altai	GWAS	Serum uric acid levels	1	1.1754	0.850774205	0.693630637	other
Altai	GWAS	Loneliness (linear analysis)	1	1.1891	0.840972164	0.698330167	behavior
Altai	GWAS	Orofacial clefts	1	1.194	0.837520938	0.698430157	other
Altai	GWAS	Cerebral amyloid deposition in APOEe4 non-carriers (PET imaging)	1	1.1937	0.837731423	0.701229877	nervous
Altai	GWAS	Coronary artery aneurysm in Kawasaki disease	2	2.4721	0.809028761	0.704129587	cardiovascular
Altai	GWAS	Diastolic blood pressure	14	15.7091	0.891203188	0.706529347	cardiovascular
Altai	GWAS	Gamma glutamyl transferase levels	1	1.2586	0.794533609	0.712128787	other
Altai	GWAS	Metabolite levels  (X-11787)	1	1.242	0.805152979	0.712828717	metabolic
Altai	GWAS	Depression (quantitative trait)	1	1.2671	0.789203693	0.714128587	behavior
Altai	GWAS	Feeling hurt	1	1.253	0.798084597	0.714528547	behavior
Altai	GWAS	Multiple system atrophy	1	1.2446	0.803470995	0.715628437	nervous
Altai	GWAS	Manganese levels	1	1.2567	0.795734861	0.717128287	other
Altai	GWAS	Cerebrospinal fluid t-tau:AB1-42 ratio	1	1.2625	0.792079208	0.718028197	nervous
Altai	GWAS	Pulmonary function (smoking interaction)	1	1.2753	0.784129224	0.718228177	respiratory
Altai	GWAS	Bipolar disorder	3	3.7079	0.809083309	0.720727927	behavior
Altai	GWAS	Urate levels in lean individuals	1	1.294	0.772797527	0.722827717	metabolic
Altai	GWAS	Myopia (pathological)	2	2.5557	0.782564464	0.723327667	nervous
Altai	GWAS	Cognitive performance	2	2.5679	0.778846528	0.724327567	nervous
Altai	GWAS	Primary biliary cholangitis	1	1.2984	0.770178681	0.726827317	digestive
Altai	GWAS	Sudden cardiac arrest	1	1.3044	0.766636001	0.726927307	cardiovascular
Altai	GWAS	Alcohol consumption	1	1.2944	0.772558714	0.730526947	behavior
Altai	GWAS	Cognitive function	2	2.6297	0.760543028	0.733526647	nervous
Altai	GWAS	Major depressive disorder	5	6.1549	0.812360883	0.733626637	behavior
Altai	GWAS	Alopecia areata	1	1.3118	0.762311328	0.738026197	integumentary
Altai	GWAS	Periodontal microbiota	1	1.3398	0.746380057	0.738726127	immune
Altai	GWAS	Asthma	5	6.2123	0.804854885	0.740725927	respiratory
Altai	GWAS	Subcortical brain region volumes	1	1.364	0.73313783	0.742125787	nervous
Altai	GWAS	Glaucoma	1	1.3746	0.727484359	0.743925607	nervous
Altai	GWAS	Obsessive-compulsive disorder	1	1.3511	0.740137666	0.744925507	behavior
Altai	GWAS	Logical memory (delayed recall) in normal cognition	1	1.3519	0.739699682	0.746025397	nervous
Altai	GWAS	Birth weight	1	1.3774	0.726005518	0.746925307	skeletal
Altai	GWAS	Takayasu arteritis	1	1.3741	0.727749072	0.747425257	cardiovascular
Altai	GWAS	Intraocular pressure	7	8.5708	0.81672656	0.748325167	nervous
Altai	GWAS	Chronic obstructive pulmonary disease	1	1.4034	0.712555223	0.749225077	respiratory
Altai	GWAS	Multiple sclerosis	4	5.1008	0.784190715	0.752424758	nervous
Altai	GWAS	High light scatter reticulocyte count	2	2.6949	0.742142566	0.753724628	metabolic
Altai	GWAS	Breast cancer	4	5.1384	0.778452437	0.754124588	reproductive
Altai	GWAS	Bipolar disorder and schizophrenia	2	2.7203	0.735213028	0.755524448	behavior
Altai	GWAS	Blood pressure (smoking interaction)	2	2.7154	0.736539736	0.755824418	hematologic
Altai	GWAS	Systolic blood pressure	14	16.3673	0.855364049	0.758224178	cardiovascular
Altai	GWAS	Type 1 diabetes	1	1.429	0.699790063	0.761423858	metabolic
Altai	GWAS	Protein quantitative trait loci	2	2.7919	0.716358036	0.763923608	other
Altai	GWAS	Diverticular disease	3	4.0448	0.741693038	0.766323368	digestive
Altai	GWAS	Emphysema-related traits	1	1.4595	0.685166153	0.766523348	respiratory
Altai	GWAS	Systolic blood pressure in sickle cell anemia	1	1.4612	0.684369012	0.771822818	cardiovascular
Altai	GWAS	Cadmium levels	1	1.4579	0.685918101	0.772622738	other
Altai	GWAS	Colorectal cancer	2	2.8435	0.703358537	0.774822518	digestive
Altai	GWAS	Waist-to-hip ratio adjusted for BMI x sex interaction	1	1.49	0.67114094	0.775822418	skeletal
Altai	GWAS	Menarche (age at onset)	7	8.7924	0.796142123	0.775922408	reproductive
Altai	GWAS	Prostate cancer (SNP x SNP interaction)	1	1.4925	0.67001675	0.778622138	reproductive
Altai	GWAS	Response to fenofibrate (total cholesterol levels)	1	1.5279	0.654493095	0.780021998	other
Altai	GWAS	Severe influenza A (H1N1) infection	1	1.5241	0.656124926	0.780821918	immune
Altai	GWAS	Inflammatory skin disease	2	2.8838	0.693529371	0.781321868	integumentary
Altai	GWAS	Epstein-Barr virus copy number in lymphoblastoid cell lines	2	2.8686	0.697204211	0.783521648	immune
Altai	GWAS	Response to statin therapy	1	1.5317	0.652869361	0.785021498	other
Altai	GWAS	Endometriosis	1	1.5469	0.646454199	0.786221378	reproductive
Altai	GWAS	Total body bone mineral density	1	1.5564	0.642508353	0.790220978	skeletal
Altai	GWAS	Lung cancer in ever smokers	2	2.9208	0.684743906	0.790720928	respiratory
Altai	GWAS	Urate levels in obese individuals	1	1.5932	0.627667587	0.793120688	metabolic
Altai	GWAS	Feeling miserable	1	1.6019	0.624258693	0.795720428	behavior
Altai	GWAS	Hepcidin/ferritin ratio	1	1.6141	0.619540301	0.798420158	digestive
Altai	GWAS	Personality dimensions	1	1.6135	0.619770685	0.803419658	behavior
Altai	GWAS	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	1	1.656	0.603864734	0.807719228	other
Altai	GWAS	Pulmonary function decline	1	1.6307	0.613233581	0.809119088	respiratory
Altai	GWAS	Pulmonary function	1	1.6831	0.594141762	0.815018498	respiratory
Altai	GWAS	Diisocyanate-induced asthma	5	6.918	0.722752241	0.816718328	respiratory
Altai	GWAS	Eosinophil counts	2	3.1458	0.635768326	0.820617938	immune
Altai	GWAS	HDL cholesterol	3	4.4825	0.669269381	0.822017798	metabolic
Altai	GWAS	Idiopathic dilated cardiomyopathy	1	1.7185	0.581902822	0.825017498	cardiovascular
Altai	GWAS	High density lipoprotein cholesterol levels	1	1.727	0.579038796	0.826417358	metabolic
Altai	GWAS	Glomerular filtration rate (creatinine)	1	1.8093	0.552699939	0.838716128	hematologic
Altai	GWAS	Nickel levels	1	1.862	0.537056928	0.844215578	other
Altai	GWAS	Temperament	1	1.8492	0.540774389	0.845615438	behavior
Altai	GWAS	Acute lymphoblastic leukemia (childhood)	1	1.8818	0.531406101	0.848615138	lymphatic
Altai	GWAS	Carotid plaque burden	1	1.9069	0.524411348	0.852914709	cardiovascular
Altai	GWAS	Toenail selenium levels	1	1.9887	0.502841052	0.865713429	other
Altai	GWAS	QRS duration	1	1.9837	0.504108484	0.865713429	cardiovascular
Altai	GWAS	Cognitive ability (MTAG)	1	2.017	0.495785821	0.870812919	nervous
Altai	GWAS	Cognitive ability	1	2.0465	0.48863914	0.872412759	nervous
Altai	GWAS	Vitiligo	1	2.0361	0.491135013	0.873412659	integumentary
Altai	GWAS	Myopia	2	3.6096	0.554078014	0.873712629	nervous
Altai	GWAS	Glucose homeostasis traits	2	3.6287	0.551161573	0.873912609	metabolic
Altai	GWAS	Intelligence (MTAG)	6	8.89	0.674915636	0.874912509	other
Altai	GWAS	Thiazide-induced adverse metabolic effects in hypertensive patients	1	2.0835	0.479961603	0.876812319	other
Altai	GWAS	"Autism spectrum disorder, ADHD, bipolar disorder, MDD, and schizophrenia (combined)"	2	3.6581	0.54673191	0.877612239	behavior
Altai	GWAS	Post bronchodilator FEV1	4	6.4853	0.616779486	0.890110989	other
Altai	GWAS	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes	1	2.2522	0.444010301	0.891910809	cardiovascular
Altai	GWAS	Immune response to smallpox vaccine (IL-6)	1	2.2374	0.44694735	0.892810719	immune
Altai	GWAS	Cognitive decline rate in late mild cognitive impairment	2	3.7658	0.53109565	0.893010699	nervous
Altai	GWAS	Chin dimples	1	2.2675	0.441014333	0.901009899	integumentary
Altai	GWAS	Obesity-related traits	20	25.9843	0.769695547	0.903209679	metabolic
Altai	GWAS	Hypertension	1	2.3536	0.424881033	0.906409359	cardiovascular
Altai	GWAS	Neutrophil percentage of granulocytes	1	2.3816	0.419885791	0.907709229	lymphatic
Altai	GWAS	Reticulocyte fraction of red cells	1	2.4381	0.410155449	0.912508749	immune
Altai	GWAS	Post bronchodilator FEV1 in COPD	1	2.5843	0.386951979	0.924407559	other
Altai	GWAS	Venous thromboembolism adjusted for sickle cell variant rs77121243-T	1	2.7201	0.367633543	0.933906609	hematologic
Altai	GWAS	Eosinophil percentage of granulocytes	1	2.6897	0.371788675	0.934006599	immune
Altai	GWAS	Nasopharyngeal carcinoma (SNP x SNP interaction)	2	4.4093	0.453586737	0.934706529	other
Altai	GWAS	Experiencing mood swings	1	2.7793	0.359802828	0.938806119	behavior
Altai	GWAS	Refractive astigmatism	1	2.9637	0.337416068	0.943505649	nervous
Altai	GWAS	Post bronchodilator FEV1/FVC ratio in COPD	1	2.8519	0.350643431	0.944505549	other
Altai	GWAS	Eosinophil percentage of white cells	1	2.8847	0.346656498	0.944605539	immune
Altai	GWAS	Response to methotrexate in juvenile idiopathic arthritis	1	2.9056	0.344162996	0.944805519	other
Altai	GWAS	Methadone dose in opioid dependence	1	2.9565	0.338237781	0.949905009	other
Altai	GWAS	Mean platelet volume	2	4.882	0.409668169	0.95320468	hematologic
Altai	GWAS	Response to amphetamines	1	3.1869	0.313784556	0.95670433	other
Altai	GWAS	General cognitive ability	3	6.8725	0.436522372	0.96690331	nervous
Altai	GWAS	QT interval	1	3.4815	0.287232515	0.97240276	cardiovascular
Altai	GWAS	Alzheimer's disease (cognitive decline)	1	3.8905	0.257036371	0.97920208	nervous
Altai	GWAS	Spherical equivalent or myopia (age of diagnosis)	2	6.109	0.327385824	0.98210179	nervous
Altai	GWAS	Monoclonal gammopathy of undetermined significance	1	4.2752	0.233907186	0.98450155	hematologic
Altai	GWAS	Neurociticism	1	4.2313	0.236333987	0.98630137	behavior
Altai	HPO	Choroideremia (HP:0001139)	2	0.0576	34.72222222	0.00119988	nervous
Altai	HPO	Malignant hyperthermia (HP:0002047)	3	0.2095	14.31980907	0.00129987	immune
Altai	HPO	Dyschromatopsia (HP:0007641)	2	0.0512	39.0625	0.00129987	nervous
Altai	HPO	Spinal rigidity (HP:0003306)	3	0.2692	11.14413076	0.00179982	skeletal
Altai	HPO	Polydipsia (HP:0001959)	2	0.0879	22.75312856	0.0019998	other
Altai	HPO	Abnormal drinking behavior (HP:0030082)	2	0.0879	22.75312856	0.0019998	behavior
Altai	HPO	Tetany (HP:0001281)	2	0.0789	25.34854246	0.00239976	endocrine
Altai	HPO	Arthralgia (HP:0002829)	6	1.3129	4.570035799	0.00269973	skeletal
Altai	HPO	Zonular cataract (HP:0010920)	2	0.0922	21.69197397	0.00349965	nervous
Altai	HPO	Asthma (HP:0002099)	5	1.0767	4.643819077	0.00389961	respiratory
Altai	HPO	Hypomagnesemia (HP:0002917)	2	0.0942	21.23142251	0.0039996	other
Altai	HPO	Macular degeneration (HP:0000608)	3	0.29	10.34482759	0.0039996	nervous
Altai	HPO	Abnormality of magnesium homeostasis (HP:0004921)	2	0.1006	19.88071571	0.00419958	other
Altai	HPO	Nephritis (HP:0000123)	3	0.3394	8.839127873	0.00519948	urinary
Altai	HPO	Paralysis (HP:0003470)	2	0.103	19.41747573	0.00519948	nervous
Altai	HPO	Decreased central vision (HP:0007663)	2	0.094	21.27659574	0.00569943	nervous
Altai	HPO	Type II diabetes mellitus (HP:0005978)	7	2.2222	3.1500315	0.00779922	metabolic
Altai	HPO	Progressive sensorineural hearing impairment (HP:0000408)	2	0.1375	14.54545455	0.00869913	nervous
Altai	HPO	Acrocyanosis (HP:0001063)	3	0.4625	6.486486486	0.01079892	integumentary
Altai	HPO	Polyuria (HP:0000103)	2	0.1628	12.28501229	0.0109989	urinary
Altai	HPO	Abnormal urine output (HP:0012590)	2	0.1703	11.74398121	0.01229877	urinary
Altai	HPO	Blepharophimosis (HP:0000581)	7	2.3576	2.96912114	0.01279872	integumentary
Altai	HPO	Hemorrhage of the eye (HP:0011885)	2	0.1724	11.60092807	0.01439856	cardiovascular
Altai	HPO	Skull defect (HP:0001362)	3	0.4961	6.04716791	0.01489851	skeletal
Altai	HPO	Pulmonary fibrosis (HP:0002206)	3	0.5117	5.86281024	0.01579842	respiratory
Altai	HPO	Congenital cataract (HP:0000519)	3	0.5388	5.567928731	0.01619838	nervous
Altai	HPO	Abnormality of renal excretion (HP:0011036)	2	0.1977	10.11633789	0.01669833	urinary
Altai	HPO	Autosomal dominant inheritance (HP:0000006)	30	19.403	1.546152657	0.0169983	other
Altai	HPO	Decreased electroretinogram (ERG) amplitude (HP:0000654)	2	0.1931	10.35732781	0.01719828	nervous
Altai	HPO	Paresthesia (HP:0003401)	4	1.001	3.996003996	0.01739826	nervous
Altai	HPO	Vertebral hypoplasia (HP:0008417)	2	0.2095	9.546539379	0.01759824	skeletal
Altai	HPO	Aplasia/Hypoplasia of the vertebrae (HP:0008515)	2	0.2095	9.546539379	0.01759824	skeletal
Altai	HPO	Autism (HP:0000717)	6	2.0728	2.894635276	0.01939806	nervous
Altai	HPO	Sprengel anomaly (HP:0000912)	3	0.5621	5.337128625	0.01959804	skeletal
Altai	HPO	Abnormality of the vitreous humor (HP:0004327)	3	0.5885	5.097706032	0.0209979	nervous
Altai	HPO	Metaphyseal cupping (HP:0003021)	1	0.0219	45.66210046	0.02179782	skeletal
Altai	HPO	Attention deficit hyperactivity disorder (HP:0007018)	5	1.5853	3.153977165	0.02349765	behavior
Altai	HPO	Hypertensive crisis (HP:0100735)	2	0.2554	7.830853563	0.02369763	cardiovascular
Altai	HPO	Myotonia (HP:0002486)	2	0.2397	8.343763037	0.02379762	skeletal muscle
Altai	HPO	Aplasia/Hypoplasia of the lens (HP:0008063)	3	0.6193	4.844178912	0.02479752	nervous
Altai	HPO	Progressive hearing impairment (HP:0001730)	2	0.2549	7.846214202	0.02779722	nervous
Altai	HPO	Abnormality of sodium homeostasis (HP:0010931)	2	0.2676	7.473841555	0.02839716	other
Altai	HPO	Hypokalemia (HP:0002900)	2	0.2748	7.278020378	0.02939706	other
Altai	HPO	Renovascular hypertension (HP:0100817)	2	0.2714	7.369196758	0.03069693	cardiovascular
Altai	HPO	Polycystic ovaries (HP:0000147)	4	1.1457	3.491315353	0.03079692	reproductive
Altai	HPO	Facial asymmetry (HP:0000324)	4	1.195	3.347280335	0.03109689	other
Altai	HPO	Bowel incontinence (HP:0002607)	2	0.2894	6.910850035	0.0329967	digestive
Altai	HPO	Abnormal large intestine physiology (HP:0012700)	2	0.2894	6.910850035	0.0329967	digestive
Altai	HPO	Acne (HP:0001061)	2	0.2812	7.112375533	0.03349665	integumentary
Altai	HPO	Obsessive-compulsive behavior (HP:0000722)	3	0.7057	4.2510982	0.03369663	behavior
Altai	HPO	Dry hair (HP:0011359)	1	0.0344	29.06976744	0.03379662	integumentary
Altai	HPO	Pulmonary infiltrates (HP:0002113)	2	0.3038	6.583278473	0.03669633	respiratory
Altai	HPO	Abnormal blistering of the skin (HP:0008066)	3	0.7418	4.04421677	0.03729627	integumentary
Altai	HPO	Generalized muscle weakness (HP:0003324)	2	0.3011	6.642311524	0.0379962	skeletal muscle
Altai	HPO	Abnormal vertebral ossification (HP:0100569)	2	0.3048	6.56167979	0.03829617	skeletal
Altai	HPO	Glomerulopathy (HP:0100820)	2	0.3182	6.285355123	0.04049595	urinary
Altai	HPO	Abdominal pain (HP:0002027)	4	1.3066	3.061380683	0.0449955	other
Altai	HPO	Difficulty walking (HP:0002355)	2	0.3489	5.732301519	0.04609539	other
Altai	HPO	Congestive heart failure (HP:0001635)	4	1.3401	2.984851877	0.04619538	cardiovascular
Altai	HPO	Ptosis (HP:0000508)	9	4.6544	1.933654177	0.04669533	skeletal muscle
Altai	HPO	Stage 5 chronic kidney disease (HP:0003774)	3	0.7825	3.833865815	0.04719528	urinary
Altai	HPO	Nail dystrophy (HP:0008404)	2	0.3501	5.712653528	0.04719528	integumentary
Altai	HPO	Bundle branch block (HP:0011710)	2	0.3558	5.621135469	0.04949505	cardiovascular
Altai	HPO	Proximal amyotrophy (HP:0007126)	2	0.3651	5.477951246	0.051194881	nervous
Altai	HPO	Abnormality of the lacrimal duct (HP:0011481)	2	0.3551	5.632216277	0.052094791	other
Altai	HPO	Vomiting (HP:0002013)	3	0.8445	3.552397869	0.052994701	digestive
Altai	HPO	Patent ductus arteriosus (HP:0001643)	5	2.0314	2.4613567	0.053394661	cardiovascular
Altai	HPO	Polyneuropathy (HP:0001271)	2	0.3703	5.401026195	0.053694631	nervous
Altai	HPO	Abnormality of the gastric mucosa (HP:0004295)	2	0.3715	5.383580081	0.053694631	digestive
Altai	HPO	Prominent nasal bridge (HP:0000426)	5	1.9884	2.514584591	0.054394561	integumentary
Altai	HPO	Abnormal atrioventricular conduction (HP:0005150)	2	0.3765	5.312084993	0.055094491	cardiovascular
Altai	HPO	Heart block (HP:0012722)	2	0.3765	5.312084993	0.055094491	cardiovascular
Altai	HPO	Prolonged bleeding time (HP:0003010)	2	0.3804	5.257623554	0.056094391	hematologic
Altai	HPO	Photophobia (HP:0000613)	6	2.7211	2.204990629	0.058394161	nervous
Altai	HPO	Umbilical hernia (HP:0001537)	7	3.4346	2.038083037	0.059294071	reproductive
Altai	HPO	Optic disc pallor (HP:0000543)	2	0.3919	5.103342689	0.059794021	nervous
Altai	HPO	Abnormality of the nasolacrimal system (HP:0000614)	2	0.3821	5.234231876	0.059794021	other
Altai	HPO	Nephrogenic diabetes insipidus (HP:0009806)	2	0.3915	5.108556833	0.060193981	urinary
Altai	HPO	Parakeratosis (HP:0001036)	1	0.0635	15.7480315	0.061593841	integumentary
Altai	HPO	Abnormality of aromatic amino acid family metabolism (HP:0004338)	1	0.0634	15.77287066	0.061693831	metabolic
Altai	HPO	Recurrent lower respiratory tract infections (HP:0002783)	2	0.4127	4.846135207	0.063093691	immune
Altai	HPO	Muscle stiffness (HP:0003552)	1	0.0664	15.06024096	0.064393561	skeletal muscle
Altai	HPO	Nephrocalcinosis (HP:0000121)	2	0.4185	4.778972521	0.066693331	urinary
Altai	HPO	Calf muscle hypertrophy (HP:0008981)	1	0.0691	14.47178003	0.066793321	skeletal muscle
Altai	HPO	Abnormality of the carotid arteries (HP:0005344)	2	0.4227	4.731488053	0.068093191	cardiovascular
Altai	HPO	Pustule (HP:0200039)	1	0.0712	14.04494382	0.068793121	integumentary
Altai	HPO	Aganglionic megacolon (HP:0002251)	4	1.5236	2.625360987	0.069193081	digestive
Altai	HPO	Vesicoureteral reflux (HP:0000076)	4	1.5171	2.63660932	0.070292971	urinary
Altai	HPO	Premature ovarian failure (HP:0008209)	1	0.0733	13.6425648	0.070592941	reproductive
Altai	HPO	Juvenile onset (HP:0003621)	3	0.9501	3.157562362	0.070992901	other
Altai	HPO	Epicanthus (HP:0000286)	9	5.0482	1.782813676	0.074692531	integumentary
Altai	HPO	Psychosis (HP:0000709)	2	0.4549	4.396570675	0.076892311	nervous
Altai	HPO	Clumsiness (HP:0002312)	1	0.081	12.34567901	0.079492051	behavior
Altai	HPO	Leukocytosis (HP:0001974)	2	0.4704	4.25170068	0.080091991	immune
Altai	HPO	Hyperhidrosis (HP:0000975)	3	0.9944	3.01689461	0.080691931	integumentary
Altai	HPO	Wrist flexion contracture (HP:0001239)	1	0.0862	11.60092807	0.082591741	skeletal
Altai	HPO	Abnormal urine phosphate concentration (HP:0012599)	1	0.0875	11.42857143	0.082891711	other
Altai	HPO	Muscle hypertrophy of the lower extremities (HP:0008968)	1	0.0871	11.48105626	0.083591641	skeletal muscle
Altai	HPO	Colon cancer (HP:0003003)	1	0.0876	11.41552511	0.083791621	digestive
Altai	HPO	Pulmonary hypertension (HP:0002092)	3	1.0252	2.926258291	0.084491551	cardiovascular
Altai	HPO	Abnormality of the pubic bones (HP:0003172)	2	0.4752	4.208754209	0.084891511	skeletal
Altai	HPO	Childhood onset (HP:0011463)	2	0.4918	4.066693778	0.085791421	other
Altai	HPO	Abnormality of potassium homeostasis (HP:0011042)	2	0.4994	4.004805767	0.089191081	other
Altai	HPO	Woolly hair (HP:0002224)	1	0.0924	10.82251082	0.089991001	integumentary
Altai	HPO	Splenomegaly (HP:0001744)	5	2.3675	2.111932418	0.090390961	lymphatic
Altai	HPO	Hepatitis (HP:0012115)	2	0.5098	3.923107101	0.091190881	immune
Altai	HPO	Hypermetropia (HP:0000540)	4	1.6902	2.366583836	0.091590841	nervous
Altai	HPO	Upslanted palpebral fissure (HP:0000582)	4	1.7123	2.336039245	0.092190781	integumentary
Altai	HPO	Neck muscle weakness (HP:0000467)	1	0.0974	10.26694045	0.092790721	skeletal muscle
Altai	HPO	Follicular hyperkeratosis (HP:0007502)	1	0.0967	10.34126163	0.093390661	integumentary
Altai	HPO	Carious teeth (HP:0000670)	4	1.688	2.369668246	0.094290571	skeletal
Altai	HPO	Epistaxis (HP:0000421)	2	0.5205	3.842459174	0.094290571	other
Altai	HPO	Myopathic facies (HP:0002058)	1	0.1001	9.99000999	0.094390561	skeletal muscle
Altai	HPO	Chondrocalcinosis (HP:0000934)	2	0.5201	3.845414343	0.098590141	skeletal
Altai	HPO	Abnormality of Sharpey fibers (HP:0100685)	2	0.5201	3.845414343	0.098590141	skeletal muscle
Altai	HPO	Seborrheic dermatitis (HP:0001051)	1	0.1031	9.699321048	0.098990101	integumentary
Altai	HPO	Lissencephaly (HP:0001339)	2	0.5309	3.767187794	0.099390061	nervous
Altai	HPO	Round face (HP:0000311)	4	1.7175	2.328966521	0.099590041	skeletal
Altai	HPO	Short neck (HP:0000470)	7	3.8845	1.802033724	0.100089991	skeletal
Altai	HPO	Cerebral palsy (HP:0100021)	1	0.1058	9.451795841	0.100089991	nervous
Altai	HPO	Dental crowding (HP:0000678)	3	1.1031	2.719608376	0.101189881	skeletal
Altai	HPO	Increased circulating renin level (HP:0000848)	1	0.1059	9.442870633	0.101889811	other
Altai	HPO	Overfolded helix (HP:0000396)	2	0.5436	3.679175865	0.102089791	integumentary
Altai	HPO	Abnormally folded helix (HP:0008544)	2	0.5436	3.679175865	0.102089791	integumentary
Altai	HPO	Stridor (HP:0010307)	1	0.1071	9.337068161	0.103789621	respiratory
Altai	HPO	Proteinuria (HP:0000093)	3	1.1135	2.694207454	0.103889611	other
Altai	HPO	Aplasia/Hypoplasia involving the vertebral column (HP:0008518)	2	0.5532	3.615328995	0.104389561	skeletal
Altai	HPO	Centrally nucleated skeletal muscle fibers (HP:0003687)	1	0.1104	9.057971014	0.105289471	skeletal muscle
Altai	HPO	Hypokalemic alkalosis (HP:0001949)	1	0.1099	9.099181074	0.105389461	other
Altai	HPO	Menstrual irregularities (HP:0000858)	1	0.1128	8.865248227	0.106489351	reproductive
Altai	HPO	Rimmed vacuoles (HP:0003805)	1	0.113	8.849557522	0.106689331	skeletal muscle
Altai	HPO	Microcytic anemia (HP:0001935)	1	0.1119	8.936550492	0.106789321	hematologic
Altai	HPO	Amyloidosis (HP:0011034)	1	0.1126	8.880994671	0.107089291	other
Altai	HPO	Retinitis pigmentosa (HP:0000510)	5	2.4996	2.000320051	0.107189281	integumentary
Altai	HPO	Interstitial pulmonary disease (HP:0006530)	1	0.1131	8.84173298	0.107389261	respiratory
Altai	HPO	Trismus (HP:0000211)	1	0.1131	8.84173298	0.107689231	skeletal muscle
Altai	HPO	Hematuria (HP:0000790)	2	0.5677	3.522987493	0.109189081	urinary
Altai	HPO	Cupped ribs (HP:0000887)	1	0.1172	8.532423208	0.109489051	skeletal
Altai	HPO	Retinal detachment (HP:0000541)	3	1.1729	2.55776281	0.110588941	nervous
Altai	HPO	Somatic mutation (HP:0001428)	3	1.1571	2.592688618	0.114288571	other
Altai	HPO	Abnormal hemoglobin (HP:0011902)	1	0.1228	8.143322476	0.116988301	hematologic
Altai	HPO	Wide nasal bridge (HP:0000431)	8	4.8649	1.644432568	0.118488151	integumentary
Altai	HPO	Palmoplantar keratoderma (HP:0000982)	3	1.203	2.493765586	0.119388061	integumentary
Altai	HPO	Atelectasis (HP:0100750)	1	0.1252	7.987220447	0.120287971	respiratory
Altai	HPO	Hypothyroidism (HP:0000821)	4	1.8662	2.143392991	0.121087891	endocrine
Altai	HPO	Hypocalcemia (HP:0002901)	2	0.6087	3.285690816	0.122487751	other
Altai	HPO	Azoospermia (HP:0000027)	1	0.1293	7.733952049	0.122487751	reproductive
Altai	HPO	Hypotelorism (HP:0000601)	2	0.604	3.311258278	0.123087691	other
Altai	HPO	Tetralogy of Fallot (HP:0001636)	3	1.2359	2.427380856	0.123187681	cardiovascular
Altai	HPO	Obstructive lung disease (HP:0006536)	1	0.1329	7.524454477	0.124087591	respiratory
Altai	HPO	Chronic obstructive pulmonary disease (HP:0006510)	1	0.1329	7.524454477	0.124087591	respiratory
Altai	HPO	Abnormality of nucleobase metabolism (HP:0010932)	2	0.6087	3.285690816	0.124387561	metabolic
Altai	HPO	Tubulointerstitial nephritis (HP:0001970)	1	0.1335	7.490636704	0.124587541	urinary
Altai	HPO	Slender build (HP:0001533)	1	0.1316	7.598784195	0.125287471	other
Altai	HPO	Bilateral sensorineural hearing impairment (HP:0008619)	1	0.145	6.896551724	0.133286671	nervous
Altai	HPO	Subacute progressive viral hepatitis (HP:0006572)	1	0.1456	6.868131868	0.134386561	immune
Altai	HPO	Ankle contracture (HP:0006466)	1	0.1444	6.925207756	0.135586441	skeletal muscle
Altai	HPO	Conjugated hyperbilirubinemia (HP:0002908)	1	0.1461	6.844626968	0.136486351	digestive
Altai	HPO	Long philtrum (HP:0000343)	6	3.4602	1.734003815	0.137386261	integumentary
Altai	HPO	Irritability (HP:0000737)	2	0.6396	3.126954346	0.139186081	behavior
Altai	HPO	Erythema (HP:0010783)	1	0.151	6.622516556	0.139986001	integumentary
Altai	HPO	Stomach cancer (HP:0012126)	1	0.1516	6.596306069	0.139986001	digestive
Altai	HPO	Abnormality of the neuromuscular junction (HP:0003398)	1	0.152	6.578947368	0.141985801	nervous
Altai	HPO	Fatigable weakness (HP:0003473)	1	0.152	6.578947368	0.141985801	skeletal muscle
Altai	HPO	Vaginal atresia (HP:0000148)	2	0.6569	3.04460344	0.142385761	reproductive
Altai	HPO	Vertebral clefting (HP:0008428)	1	0.1534	6.518904824	0.142585741	skeletal
Altai	HPO	Hypoplastic ischia (HP:0003175)	1	0.1526	6.553079948	0.143085691	skeletal
Altai	HPO	Microcornea (HP:0000482)	3	1.2918	2.32234092	0.144985501	nervous
Altai	HPO	Hyponatremia (HP:0002902)	1	0.1569	6.373486297	0.145785421	other
Altai	HPO	Hydrocephalus (HP:0000238)	5	2.7814	1.797655857	0.147085291	nervous
Altai	HPO	Pes planus (HP:0001763)	4	1.9984	2.001601281	0.147585241	skeletal
Altai	HPO	Truncus arteriosus (HP:0001660)	1	0.1578	6.337135615	0.147685231	cardiovascular
Altai	HPO	Genital tract atresia (HP:0001827)	2	0.6785	2.947678703	0.148885111	reproductive
Altai	HPO	Hypoparathyroidism (HP:0000829)	1	0.1599	6.253908693	0.149685031	endocrine
Altai	HPO	Precocious puberty (HP:0000826)	2	0.672	2.976190476	0.149985001	endocrine
Altai	HPO	Colitis (HP:0002583)	1	0.1627	6.1462815	0.150184982	digestive
Altai	HPO	Viral hepatitis (HP:0006562)	1	0.1658	6.031363088	0.151684832	immune
Altai	HPO	IgM deficiency (HP:0002850)	1	0.1664	6.009615385	0.152184782	immune
Altai	HPO	Hallux valgus (HP:0001822)	2	0.6885	2.90486565	0.152784722	skeletal
Altai	HPO	Fused cervical vertebrae (HP:0002949)	1	0.166	6.024096386	0.153484652	skeletal
Altai	HPO	Flexion contracture of toe (HP:0005830)	2	0.6957	2.874802357	0.154284572	skeletal muscle
Altai	HPO	Joint contractures involving the joints of the feet (HP:0100492)	2	0.6957	2.874802357	0.154284572	skeletal
Altai	HPO	Overgrowth (HP:0001548)	1	0.1678	5.959475566	0.155084492	other
Altai	HPO	Bilateral microphthalmos (HP:0007633)	1	0.168	5.952380952	0.155184482	nervous
Altai	HPO	Micronodular cirrhosis (HP:0001413)	1	0.169	5.917159763	0.155484452	digestive
Altai	HPO	Diaphragmatic weakness (HP:0009113)	1	0.1683	5.941770648	0.156184382	respiratory
Altai	HPO	Abnormality of the thymus (HP:0000777)	2	0.6989	2.86163972	0.157184282	lymphatic
Altai	HPO	Retinopathy (HP:0000488)	2	0.7172	2.788622421	0.157384262	nervous
Altai	HPO	Absent eyebrow (HP:0002223)	1	0.1717	5.824111823	0.157384262	integumentary
Altai	HPO	Short 1st metacarpal (HP:0010034)	1	0.1714	5.834305718	0.157884212	skeletal
Altai	HPO	Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026)	1	0.1714	5.834305718	0.157884212	skeletal
Altai	HPO	Abnormality of the 1st metacarpal (HP:0010009)	1	0.1714	5.834305718	0.157884212	skeletal
Altai	HPO	Insomnia (HP:0100785)	1	0.1738	5.753739931	0.158284172	behavior
Altai	HPO	Aplasia/Hypoplasia of the pubic bone (HP:0009104)	1	0.1717	5.824111823	0.158484152	skeletal
Altai	HPO	Steppage gait (HP:0003376)	1	0.1712	5.841121495	0.158784122	skeletal muscle
Altai	HPO	Patellar dislocation (HP:0002999)	2	0.7207	2.775079784	0.159084092	skeletal
Altai	HPO	Polycythemia (HP:0001901)	1	0.1709	5.851375073	0.159184082	lymphatic
Altai	HPO	Dilated cardiomyopathy (HP:0001644)	2	0.7181	2.78512742	0.159884012	cardiovascular
Altai	HPO	Deviation of the hallux (HP:0010051)	2	0.7099	2.817298211	0.160283972	skeletal
Altai	HPO	Hyperacusis (HP:0010780)	1	0.1766	5.662514156	0.160883912	nervous
Altai	HPO	Memory impairment (HP:0002354)	2	0.7131	2.804655729	0.161283872	nervous
Altai	HPO	Blindness (HP:0000618)	2	0.7141	2.800728189	0.161983802	nervous
Altai	HPO	Female pseudohermaphroditism (HP:0010458)	2	0.7229	2.766634389	0.162283772	reproductive
Altai	HPO	Type 1 muscle fiber predominance (HP:0003803)	1	0.1781	5.614823133	0.164383562	skeletal muscle
Altai	HPO	Abnormal spermatogenesis (HP:0008669)	1	0.1782	5.611672278	0.164883512	reproductive
Altai	HPO	Chronic hepatic failure (HP:0100626)	1	0.1809	5.527915976	0.164983502	digestive
Altai	HPO	Neoplasm of the oral cavity (HP:0100649)	1	0.1817	5.503577325	0.166783322	other
Altai	HPO	Menorrhagia (HP:0000132)	1	0.1808	5.530973451	0.167183282	reproductive
Altai	HPO	Slow progression (HP:0003677)	3	1.3938	2.152389152	0.167483252	other
Altai	HPO	Neonatal onset (HP:0003623)	1	0.1822	5.488474204	0.167483252	other
Altai	HPO	Decreased testicular size (HP:0008734)	2	0.7267	2.752167332	0.168683132	reproductive
Altai	HPO	Mildly elevated creatine phosphokinase (HP:0008180)	1	0.1825	5.479452055	0.168883112	other
Altai	HPO	Ketoacidosis (HP:0001993)	1	0.1849	5.408328826	0.169783022	metabolic
Altai	HPO	Secondary amenorrhea (HP:0000869)	1	0.1879	5.321979776	0.170082992	reproductive
Altai	HPO	Short phalanx of the thumb (HP:0009660)	1	0.1868	5.353319058	0.170782922	skeletal
Altai	HPO	Morphological abnormality of the middle ear (HP:0008609)	1	0.1883	5.310674456	0.171082892	skeletal
Altai	HPO	Pruritus (HP:0000989)	2	0.7424	2.693965517	0.172482752	integumentary
Altai	HPO	Narrow mouth (HP:0000160)	4	2.1541	1.856924005	0.172982702	skeletal
Altai	HPO	Protrusio acetabuli (HP:0003179)	1	0.1916	5.219206681	0.173582642	skeletal
Altai	HPO	Increased connective tissue (HP:0009025)	1	0.1892	5.285412262	0.173882612	other
Altai	HPO	Hypoventilation (HP:0002791)	1	0.1921	5.205622072	0.174282572	respiratory
Altai	HPO	Hyperuricemia (HP:0002149)	1	0.1915	5.221932115	0.174682532	other
Altai	HPO	Increased purine levels (HP:0004368)	1	0.1915	5.221932115	0.174682532	other
Altai	HPO	Generalized hyperpigmentation (HP:0007440)	1	0.1892	5.285412262	0.174982502	integumentary
Altai	HPO	Insulin-resistant diabetes mellitus (HP:0000831)	1	0.1933	5.173305742	0.175882412	metabolic
Altai	HPO	Absent eyelashes (HP:0000561)	1	0.1952	5.12295082	0.176482352	integumentary
Altai	HPO	Weight loss (HP:0001824)	3	1.4424	2.079866889	0.176582342	metabolic
Altai	HPO	Occipital encephalocele (HP:0002085)	1	0.1947	5.136106831	0.178282172	nervous
Altai	HPO	Increased mean platelet volume (HP:0011877)	1	0.1986	5.035246727	0.179482052	hematologic
Altai	HPO	Abnormal platelet volume (HP:0011876)	1	0.1986	5.035246727	0.179482052	hematologic
Altai	HPO	Rhinitis (HP:0012384)	1	0.1967	5.083884087	0.179682032	respiratory
Altai	HPO	Self-mutilation (HP:0000742)	1	0.1976	5.060728745	0.179782022	behavior
Altai	HPO	Abnormality of the ischium (HP:0003174)	1	0.1972	5.070993915	0.180581942	skeletal
Altai	HPO	Muscular dystrophy (HP:0003560)	2	0.7641	2.617458448	0.180581942	skeletal muscle
Altai	HPO	Renal duplication (HP:0000075)	1	0.1995	5.012531328	0.181181882	urinary
Altai	HPO	Thoracolumbar scoliosis (HP:0002944)	1	0.1999	5.002501251	0.181281872	skeletal
Altai	HPO	IgA deficiency (HP:0002720)	1	0.2044	4.892367906	0.183681632	immune
Altai	HPO	Absent hair (HP:0002298)	1	0.2041	4.89955904	0.183681632	integumentary
Altai	HPO	Lumbar hyperlordosis (HP:0002938)	2	0.7825	2.555910543	0.185681432	skeletal
Altai	HPO	Myocardial infarction (HP:0001658)	1	0.2053	4.870920604	0.186281372	cardiovascular
Altai	HPO	Autosomal recessive inheritance (HP:0000007)	31	26.0112	1.191794304	0.186381362	other
Altai	HPO	Fine hair (HP:0002213)	2	0.7829	2.554604675	0.186981302	integumentary
Altai	HPO	Increased variability in muscle fiber diameter (HP:0003557)	1	0.2083	4.800768123	0.188381162	skeletal muscle
Altai	HPO	Elfin facies (HP:0004428)	1	0.2103	4.755111745	0.188981102	other
Altai	HPO	Gastrointestinal inflammation (HP:0004386)	1	0.2094	4.775549188	0.189481052	digestive
Altai	HPO	Inflammation of the large intestine (HP:0002037)	1	0.2094	4.775549188	0.189481052	digestive
Altai	HPO	Abnormality of skeletal muscle fiber size (HP:0012084)	1	0.212	4.716981132	0.191780822	skeletal muscle
Altai	HPO	Lipoatrophy (HP:0100578)	2	0.811	2.466091245	0.194280572	metabolic
Altai	HPO	Long nose (HP:0003189)	1	0.2145	4.662004662	0.195180482	skeletal
Altai	HPO	Hypotrichosis (HP:0001006)	1	0.2188	4.570383912	0.196380362	integumentary
Altai	HPO	Subcapsular cataract (HP:0000523)	1	0.2201	4.543389368	0.196780322	nervous
Altai	HPO	Hypoalphalipoproteinemia (HP:0003233)	1	0.2172	4.604051565	0.196880312	metabolic
Altai	HPO	Papillary thyroid carcinoma (HP:0002895)	1	0.2193	4.55996352	0.196880312	endocrine
Altai	HPO	Short palpebral fissure (HP:0012745)	1	0.2197	4.551661356	0.197780222	integumentary
Altai	HPO	Long face (HP:0000276)	3	1.5351	1.95427008	0.198380162	skeletal
Altai	HPO	Lymphangioma (HP:0100764)	1	0.2209	4.526935265	0.200279972	lymphatic
Altai	HPO	Abnormality of renin-angiotensin system (HP:0000847)	1	0.2225	4.494382022	0.200879912	other
Altai	HPO	Overriding aorta (HP:0002623)	1	0.2248	4.448398577	0.200979902	cardiovascular
Altai	HPO	Alkalosis (HP:0001948)	1	0.2282	4.382120947	0.203479652	other
Altai	HPO	Generalized amyotrophy (HP:0003700)	1	0.2259	4.426737494	0.204179582	nervous
Altai	HPO	Nephrolithiasis (HP:0000787)	2	0.8416	2.376425856	0.205379462	urinary
Altai	HPO	Cone-rod dystrophy (HP:0000548)	1	0.2309	4.330879168	0.205679432	nervous
Altai	HPO	Oligodontia (HP:0000677)	1	0.2338	4.277159966	0.206679332	skeletal
Altai	HPO	Nasolacrimal duct obstruction (HP:0000579)	1	0.2306	4.336513443	0.206779322	other
Altai	HPO	Multicystic kidney dysplasia (HP:0000003)	3	1.5852	1.892505678	0.210278972	urinary
Altai	HPO	Mask-like facies (HP:0000298)	1	0.238	4.201680672	0.211178882	other
Altai	HPO	Abnormality of purine metabolism (HP:0004352)	1	0.2414	4.142502071	0.214078592	metabolic
Altai	HPO	Abnormality of the tricuspid valve (HP:0001702)	1	0.2372	4.215851602	0.214278572	cardiovascular
Altai	HPO	Protuberant abdomen (HP:0001538)	1	0.2387	4.189359028	0.214278572	metabolic
Altai	HPO	Meckel diverticulum (HP:0002245)	1	0.2421	4.130524577	0.215278472	digestive
Altai	HPO	Hyperthyroidism (HP:0000836)	1	0.2457	4.07000407	0.216778322	endocrine
Altai	HPO	Mediastinal lymphadenopathy (HP:0100721)	1	0.2453	4.076640848	0.217078292	lymphatic
Altai	HPO	Short hallux (HP:0010109)	1	0.2444	4.091653028	0.217078292	skeletal
Altai	HPO	Cryptorchidism (HP:0000028)	9	6.5799	1.367801942	0.217778222	reproductive
Altai	HPO	Abnormality of the acetabulum (HP:0003170)	2	0.8853	2.259121202	0.218578142	skeletal
Altai	HPO	Platyspondyly (HP:0000926)	2	0.8777	2.278682921	0.220077992	skeletal
Altai	HPO	Blue sclerae (HP:0000592)	2	0.8877	2.253013405	0.221677832	integumentary
Altai	HPO	Difficulty running (HP:0009046)	1	0.2505	3.992015968	0.222977702	other
Altai	HPO	Abnormality of the preputium (HP:0100587)	1	0.2531	3.951007507	0.223077692	reproductive
Altai	HPO	Cellulitis (HP:0100658)	1	0.2541	3.935458481	0.223577642	integumentary
Altai	HPO	Chest pain (HP:0100749)	1	0.251	3.984063745	0.223777622	other
Altai	HPO	EEG with generalized epileptiform discharges (HP:0011198)	2	0.8809	2.270405267	0.223877612	nervous
Altai	HPO	Bell-shaped thorax (HP:0001591)	1	0.25	4	0.223977602	skeletal
Altai	HPO	Ectopia lentis (HP:0001083)	2	0.9033	2.214103841	0.225277472	nervous
Altai	HPO	Achilles tendon contracture (HP:0001771)	1	0.2561	3.904724717	0.225677432	skeletal muscle
Altai	HPO	Abnormality of the Achilles tendon (HP:0005109)	1	0.2561	3.904724717	0.225677432	skeletal muscle
Altai	HPO	Thin skin (HP:0000963)	2	0.8903	2.246433786	0.225777422	integumentary
Altai	HPO	Vitreoretinal degeneration (HP:0000655)	1	0.2525	3.96039604	0.226377362	nervous
Altai	HPO	Limb-girdle muscle weakness (HP:0003325)	1	0.2553	3.916960439	0.227277272	skeletal muscle
Altai	HPO	Hepatocellular carcinoma (HP:0001402)	1	0.2622	3.813882532	0.230376962	digestive
Altai	HPO	Dehydration (HP:0001944)	2	0.9157	2.184121437	0.233376662	other
Altai	HPO	Gingivitis (HP:0000230)	1	0.2681	3.729951511	0.233676632	other
Altai	HPO	Hyperkalemia (HP:0002153)	1	0.2713	3.685956506	0.236476352	other
Altai	HPO	Flat acetabular roof (HP:0003180)	1	0.2701	3.702332469	0.236776322	skeletal
Altai	HPO	Hypophosphatemia (HP:0002148)	1	0.2724	3.671071953	0.237476252	other
Altai	HPO	Melanoma (HP:0002861)	1	0.2727	3.66703337	0.238076192	integumentary
Altai	HPO	Osteomyelitis (HP:0002754)	1	0.2727	3.66703337	0.238676132	skeletal
Altai	HPO	Aplasia/Hypoplasia of the macula (HP:0008059)	1	0.2725	3.669724771	0.238976102	nervous
Altai	HPO	Hypertriglyceridemia (HP:0002155)	1	0.2736	3.65497076	0.241475852	metabolic
Altai	HPO	Aplasia/Hypoplasia affecting the retina (HP:0008061)	1	0.2762	3.620564808	0.242075792	nervous
Altai	HPO	Hypolipoproteinemia (HP:0010981)	1	0.2778	3.599712023	0.243075692	metabolic
Altai	HPO	Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658)	1	0.2778	3.599712023	0.243975602	skeletal
Altai	HPO	Neoplasm of the colon (HP:0100273)	1	0.2804	3.566333809	0.244575542	digestive
Altai	HPO	Prenatal maternal abnormality (HP:0002686)	1	0.2777	3.601008282	0.245275472	reproductive
Altai	HPO	Aplasia/Hypoplasia of the hallux (HP:0008362)	1	0.2813	3.554923569	0.246175382	skeletal
Altai	HPO	Abnormality of chromosome stability (HP:0003220)	1	0.2858	3.498950315	0.248275172	other
Altai	HPO	Intestinal polyposis (HP:0200008)	1	0.2863	3.492839679	0.248475152	digestive
Altai	HPO	Fair hair (HP:0002286)	1	0.2875	3.47826087	0.249875012	integumentary
Altai	HPO	Recurrent pneumonia (HP:0006532)	1	0.2841	3.519887364	0.250174983	immune
Altai	HPO	Bladder diverticulum (HP:0000015)	1	0.2901	3.447087211	0.250974903	urinary
Altai	HPO	Opacification of the corneal stroma (HP:0007759)	3	1.727	1.737116387	0.250974903	nervous
Altai	HPO	Fasciculations (HP:0002380)	1	0.2884	3.46740638	0.251674833	skeletal muscle
Altai	HPO	Eosinophilia (HP:0001880)	1	0.2886	3.465003465	0.252374763	hematologic
Altai	HPO	"Low-set, posteriorly rotated ears (HP:0000368)"	8	5.9901	1.335536969	0.252874713	other
Altai	HPO	Abnormality of the musculature of the hand (HP:0001421)	1	0.2974	3.362474781	0.256374363	skeletal muscle
Altai	HPO	Myelomeningocele (HP:0002475)	1	0.2948	3.392130258	0.256474353	nervous
Altai	HPO	Intestinal polyp (HP:0005266)	1	0.2977	3.359086329	0.256674333	digestive
Altai	HPO	Vertebral fusion (HP:0002948)	1	0.2994	3.34001336	0.257274273	skeletal
Altai	HPO	Venous insufficiency (HP:0005293)	1	0.2947	3.393281303	0.257674233	cardiovascular
Altai	HPO	Midline defect of the nose (HP:0004122)	1	0.2973	3.363605785	0.257874213	other
Altai	HPO	Capillary hemangiomas (HP:0005306)	1	0.2969	3.36813742	0.258374163	cardiovascular
Altai	HPO	Polar cataract (HP:0010696)	1	0.3032	3.298153034	0.258674133	nervous
Altai	HPO	Deeply set eye (HP:0000490)	3	1.7664	1.698369565	0.258674133	nervous
Altai	HPO	Constricted visual fields (HP:0001133)	2	0.9814	2.037905034	0.259574043	nervous
Altai	HPO	Hypopigmented skin patches (HP:0001053)	2	0.9795	2.041858091	0.260073993	integumentary
Altai	HPO	Pulmonary hypoplasia (HP:0002089)	2	0.9892	2.021835827	0.260373963	respiratory
Altai	HPO	Aplasia/Hypoplasia of the uvula (HP:0010293)	1	0.3013	3.318951211	0.260773923	skeletal
Altai	HPO	Abnormality of the calf musculature (HP:0001430)	1	0.3022	3.309066843	0.261673833	skeletal muscle
Altai	HPO	Abnormality of the foot musculature (HP:0001436)	1	0.301	3.322259136	0.263173683	skeletal muscle
Altai	HPO	Foot dorsiflexor weakness (HP:0009027)	1	0.301	3.322259136	0.263173683	skeletal muscle
Altai	HPO	Granulocytopenia (HP:0001913)	1	0.3026	3.304692664	0.263473653	immune
Altai	HPO	Aplasia/Hypoplasia of the sternum (HP:0006714)	1	0.3052	3.276539974	0.264473553	skeletal
Altai	HPO	Torticollis (HP:0000473)	1	0.307	3.25732899	0.265173483	skeletal
Altai	HPO	Abnormality of the ileum (HP:0001549)	1	0.31	3.225806452	0.265473453	digestive
Altai	HPO	Aggressive behavior (HP:0000718)	2	1.0069	1.986294567	0.267573243	behavior
Altai	HPO	Conical tooth (HP:0000698)	1	0.3099	3.22684737	0.268573143	skeletal
Altai	HPO	Generalized hypopigmentation (HP:0007513)	1	0.3141	3.183699459	0.268573143	integumentary
Altai	HPO	Abnormality of the level of lipoprotein cholesterol (HP:0010979)	1	0.3132	3.19284802	0.269073093	metabolic
Altai	HPO	Insulin resistance (HP:0000855)	1	0.3127	3.19795331	0.269273073	metabolic
Altai	HPO	Ketosis (HP:0001946)	1	0.3149	3.175611305	0.269473053	metabolic
Altai	HPO	Flat cornea (HP:0007720)	1	0.316	3.164556962	0.270972903	nervous
Altai	HPO	Cutaneous photosensitivity (HP:0000992)	1	0.3167	3.157562362	0.271372863	integumentary
Altai	HPO	Severe short stature (HP:0003510)	1	0.3171	3.153579313	0.273172683	skeletal
Altai	HPO	Coxa vara (HP:0002812)	1	0.3181	3.143665514	0.273472653	skeletal
Altai	HPO	Clitoromegaly (HP:0000057)	1	0.3198	3.126954346	0.274772523	reproductive
Altai	HPO	Tetraplegia (HP:0002445)	1	0.3221	3.104625893	0.275872413	nervous
Altai	HPO	Focal dystonia (HP:0004373)	1	0.3225	3.100775194	0.276872313	nervous
Altai	HPO	Craniofacial dystonia (HP:0012179)	1	0.3225	3.100775194	0.276872313	skeletal muscle
Altai	HPO	Hypercalcemia (HP:0003072)	1	0.3269	3.059039462	0.278372163	other
Altai	HPO	Generalized hypopigmentation of hair (HP:0011358)	1	0.328	3.048780488	0.278772123	integumentary
Altai	HPO	Cheekbone underdevelopment (HP:0010669)	2	1.0456	1.912777353	0.279572043	skeletal
Altai	HPO	Radial deviation of finger (HP:0009466)	6	4.4071	1.361439495	0.281071893	skeletal
Altai	HPO	Sacral dimple (HP:0000960)	2	1.0539	1.897713256	0.281871813	integumentary
Altai	HPO	Bone marrow hypocellularity (HP:0005528)	1	0.3362	2.974419988	0.282571743	other
Altai	HPO	Progressive neurologic deterioration (HP:0002344)	2	1.0529	1.899515624	0.286871313	nervous
Altai	HPO	Epileptiform EEG discharges (HP:0011182)	2	1.0563	1.893401496	0.287871213	nervous
Altai	HPO	Cardiomegaly (HP:0001640)	1	0.3398	2.942907593	0.289571043	cardiovascular
Altai	HPO	Pectus excavatum (HP:0000767)	3	1.8814	1.594557245	0.291970803	skeletal
Altai	HPO	Mucosal telangiectasiae (HP:0100579)	1	0.3399	2.942041777	0.292270773	integumentary
Altai	HPO	Constipation (HP:0002019)	4	2.7473	1.455974957	0.292370763	digestive
Altai	HPO	Thyroiditis (HP:0100646)	1	0.3501	2.856326764	0.297470253	endocrine
Altai	HPO	Choanal stenosis (HP:0000452)	1	0.3497	2.859593938	0.297470253	respiratory
Altai	HPO	Coxa valga (HP:0002673)	1	0.3551	2.816108139	0.298170183	skeletal
Altai	HPO	Tracheoesophageal fistula (HP:0002575)	2	1.0993	1.81933958	0.298570143	respiratory
Altai	HPO	Kyphoscoliosis (HP:0002751)	2	1.0883	1.837728567	0.298870113	skeletal
Altai	HPO	Dry skin (HP:0000958)	2	1.0888	1.836884644	0.299270073	integumentary
Altai	HPO	Telecanthus (HP:0000506)	3	1.9045	1.575216592	0.299470053	skeletal
Altai	HPO	Hip contracture (HP:0003273)	1	0.3549	2.817695125	0.299670033	skeletal muscle
Altai	HPO	Abnormality of the diencephalon (HP:0010662)	1	0.3565	2.805049088	0.299870013	nervous
Altai	HPO	Abnormality of eosinophils (HP:0001879)	1	0.3535	2.828854314	0.300069993	hematologic
Altai	HPO	Bowel diverticulosis (HP:0005222)	1	0.3617	2.764722145	0.300469953	digestive
Altai	HPO	Absence seizures (HP:0002121)	1	0.3581	2.792516057	0.301569843	nervous
Altai	HPO	Wide intermamillary distance (HP:0006610)	1	0.3601	2.777006387	0.302669733	reproductive
Altai	HPO	Acanthosis nigricans (HP:0000956)	1	0.3572	2.799552072	0.304169583	integumentary
Altai	HPO	Xerostomia (HP:0000217)	1	0.3581	2.792516057	0.304569543	digestive
Altai	HPO	Abnormality of the endocardium (HP:0004306)	1	0.3626	2.757859901	0.305369463	cardiovascular
Altai	HPO	Skin ulcer (HP:0200042)	2	1.1092	1.803101334	0.306469353	integumentary
Altai	HPO	Abnormality of the peritoneum (HP:0002585)	1	0.3698	2.704164413	0.308069193	digestive
Altai	HPO	Hypercalciuria (HP:0002150)	1	0.363	2.754820937	0.308369163	other
Altai	HPO	Recurrent urinary tract infections (HP:0000010)	2	1.1161	1.791954126	0.309069093	immune
Altai	HPO	Cleft eyelid (HP:0000625)	1	0.3714	2.692514809	0.309069093	integumentary
Altai	HPO	Abnormality of pyrimidine metabolism (HP:0004353)	1	0.3673	2.722570106	0.309669033	metabolic
Altai	HPO	Tubulointerstitial abnormality (HP:0001969)	1	0.377	2.652519894	0.309769023	urinary
Altai	HPO	High palate (HP:0000218)	4	2.8201	1.418389419	0.310568943	skeletal
Altai	HPO	Delayed gross motor development (HP:0002194)	2	1.1179	1.78906879	0.311068893	nervous
Altai	HPO	Lower limb muscle weakness (HP:0007340)	1	0.3714	2.692514809	0.311668833	skeletal muscle
Altai	HPO	Abdominal distention (HP:0003270)	1	0.373	2.680965147	0.313368663	other
Altai	HPO	Congenital primary aphakia (HP:0007707)	1	0.3792	2.637130802	0.314368563	nervous
Altai	HPO	Scapular winging (HP:0003691)	1	0.3804	2.628811777	0.314668533	skeletal
Altai	HPO	Posterior embryotoxon (HP:0000627)	1	0.3785	2.642007926	0.315268473	nervous
Altai	HPO	Tracheal stenosis (HP:0002777)	1	0.379	2.638522427	0.315568443	respiratory
Altai	HPO	Abnormality of hair growth rate (HP:0011363)	1	0.3753	2.664535039	0.315668433	integumentary
Altai	HPO	Slow-growing hair (HP:0002217)	1	0.3753	2.664535039	0.315668433	integumentary
Altai	HPO	Infantile onset (HP:0003593)	5	3.726	1.341921632	0.317868213	other
Altai	HPO	Restrictive lung disease (HP:0002091)	1	0.3803	2.629503024	0.318668133	respiratory
Altai	HPO	Aortic aneurysm (HP:0004942)	1	0.3861	2.59000259	0.321167883	cardiovascular
Altai	HPO	Long eyelashes (HP:0000527)	1	0.3815	2.621231979	0.323467653	integumentary
Altai	HPO	EMG: myopathic abnormalities (HP:0003458)	1	0.3888	2.572016461	0.323467653	nervous
Altai	HPO	Skin rash (HP:0000988)	1	0.396	2.525252525	0.323567643	immune
Altai	HPO	Abnormal lung lobation (HP:0002101)	1	0.3843	2.60213375	0.323567643	respiratory
Altai	HPO	Anophthalmia (HP:0000528)	1	0.4007	2.495632643	0.328967103	nervous
Altai	HPO	Clinodactyly of the 5th finger (HP:0004209)	5	3.8013	1.315339489	0.330266973	skeletal
Altai	HPO	Urticaria (HP:0001025)	1	0.3982	2.511300854	0.331866813	immune
Altai	HPO	Tachypnea (HP:0002789)	1	0.4049	2.469745616	0.332066793	respiratory
Altai	HPO	Corneal erosion (HP:0200020)	1	0.4004	2.497502498	0.332366763	nervous
Altai	HPO	Thyroid carcinoma (HP:0002890)	1	0.4029	2.48200546	0.333766623	endocrine
Altai	HPO	Gait imbalance (HP:0002141)	1	0.4131	2.420721375	0.335566443	nervous
Altai	HPO	Everted lower lip vermilion (HP:0000232)	2	1.1892	1.681802893	0.336966303	integumentary
Altai	HPO	Hirsutism (HP:0001007)	2	1.196	1.672240803	0.340265973	integumentary
Altai	HPO	Congenital hip dislocation (HP:0001374)	1	0.4177	2.394062724	0.340365963	skeletal
Altai	HPO	Wide nose (HP:0000445)	1	0.4155	2.406738869	0.340765923	skeletal
Altai	HPO	Increased nuchal translucency (HP:0010880)	1	0.4233	2.362390739	0.341465853	other
Altai	HPO	Attenuation of retinal blood vessels (HP:0007843)	2	1.2301	1.625884074	0.343165683	cardiovascular
Altai	HPO	Abnormality of the line of Schwalbe (HP:0008048)	1	0.4229	2.364625207	0.345565443	nervous
Altai	HPO	Optic atrophy (HP:0000648)	7	5.6985	1.228393437	0.346165383	nervous
Altai	HPO	Bifid tongue (HP:0010297)	1	0.4237	2.360160491	0.346465353	other
Altai	HPO	Bradycardia (HP:0001662)	1	0.4266	2.344116268	0.346465353	cardiovascular
Altai	HPO	Blue irides (HP:0000635)	1	0.4283	2.334812048	0.347765223	integumentary
Altai	HPO	Severe Myopia (HP:0011003)	1	0.4294	2.328830927	0.347865213	nervous
Altai	HPO	Short foot (HP:0001773)	2	1.2124	1.649620587	0.348065193	skeletal
Altai	HPO	Wormian bones (HP:0002645)	1	0.4306	2.32234092	0.348565143	skeletal
Altai	HPO	High pitched voice (HP:0001620)	1	0.4316	2.316960148	0.349065093	other
Altai	HPO	Abnormal social behavior (HP:0012433)	2	1.2264	1.630789302	0.350964904	behavior
Altai	HPO	Impaired social interactions (HP:0000735)	2	1.2264	1.630789302	0.350964904	behavior
Altai	HPO	Abnormality of the pupil (HP:0000615)	1	0.4333	2.307869836	0.351664834	nervous
Altai	HPO	Respiratory failure (HP:0002878)	1	0.4311	2.319647414	0.351764824	respiratory
Altai	HPO	Abnormality of the pleura (HP:0002103)	1	0.4302	2.324500232	0.354064594	respiratory
Altai	HPO	Scrotal hypoplasia (HP:0000046)	1	0.4323	2.31320842	0.354764524	reproductive
Altai	HPO	Short thumb (HP:0009778)	1	0.4453	2.245677072	0.356664334	skeletal
Altai	HPO	Testicular neoplasm (HP:0010788)	1	0.442	2.262443439	0.358564144	reproductive
Altai	HPO	Megalocornea (HP:0000485)	1	0.4525	2.209944751	0.358864114	nervous
Altai	HPO	Medial flaring of the eyebrow (HP:0010747)	1	0.4478	2.233139795	0.359564044	integumentary
Altai	HPO	Abnormality of the clitoris (HP:0000056)	1	0.4387	2.279462047	0.359864014	reproductive
Altai	HPO	Meningitis (HP:0001287)	1	0.4525	2.209944751	0.362763724	nervous
Altai	HPO	Venous abnormality (HP:0002624)	1	0.4455	2.244668911	0.362963704	cardiovascular
Altai	HPO	Bone pain (HP:0002653)	1	0.4535	2.205071665	0.363363664	skeletal
Altai	HPO	Dialeptic seizures (HP:0011146)	1	0.4544	2.200704225	0.363463654	nervous
Altai	HPO	Male pseudohermaphroditism (HP:0000037)	1	0.4515	2.214839424	0.366363364	reproductive
Altai	HPO	Molar tooth sign on MRI (HP:0002419)	1	0.462	2.164502165	0.370462954	nervous
Altai	HPO	Abnormality of midbrain morphology (HP:0002418)	1	0.462	2.164502165	0.370462954	nervous
Altai	HPO	Bifid uvula (HP:0000193)	1	0.4613	2.16778669	0.371762824	other
Altai	HPO	Clubbing of toes (HP:0100760)	1	0.4703	2.12630236	0.372162784	integumentary
Altai	HPO	Downturned corners of mouth (HP:0002714)	2	1.2997	1.53881665	0.372162784	skeletal muscle
Altai	HPO	Polycystic kidney dysplasia (HP:0000113)	2	1.3047	1.532919445	0.373762624	urinary
Altai	HPO	Astigmatism (HP:0000483)	2	1.3076	1.529519731	0.374162584	nervous
Altai	HPO	Coarse hair (HP:0002208)	1	0.4666	2.143163309	0.376762324	integumentary
Altai	HPO	Neonatal death (HP:0003811)	1	0.4742	2.108814846	0.378162184	other
Altai	HPO	Arnold-Chiari malformation (HP:0002308)	1	0.4679	2.137208805	0.379862014	skeletal
Altai	HPO	Aplasia/Hypoplasia affecting the fundus (HP:0008057)	1	0.4812	2.078137988	0.381361864	nervous
Altai	HPO	Neonatal hypotonia (HP:0001319)	2	1.3155	1.520334474	0.382261774	skeletal muscle
Altai	HPO	Sudden death (HP:0001699)	1	0.4798	2.084201751	0.382661734	other
Altai	HPO	Lack of skin elasticity (HP:0100679)	1	0.4932	2.02757502	0.384761524	integumentary
Altai	HPO	Anxiety (HP:0000739)	1	0.4848	2.062706271	0.386061394	behavior
Altai	HPO	Abnormality of the shoulder girdle musculature (HP:0001435)	1	0.4932	2.02757502	0.387361264	skeletal muscle
Altai	HPO	Hyperbilirubinemia (HP:0002904)	1	0.4855	2.059732235	0.390460954	digestive
Altai	HPO	Absent toe (HP:0010760)	1	0.5016	1.993620415	0.393960604	skeletal
Altai	HPO	Hypergonadotropic hypogonadism (HP:0000815)	1	0.5012	1.995211492	0.395160484	endocrine
Altai	HPO	Vasculitis (HP:0002633)	1	0.4975	2.010050251	0.397860214	cardiovascular
Altai	HPO	Pachygyria (HP:0001302)	1	0.5109	1.957330202	0.398860114	nervous
Altai	HPO	Bicornuate uterus (HP:0000813)	1	0.5039	1.984520738	0.398860114	reproductive
Altai	HPO	Gonadal dysgenesis (HP:0000133)	1	0.5073	1.971220185	0.399060094	other
Altai	HPO	Aplasia/Hypoplasia of the thymus (HP:0010515)	1	0.5093	1.963479285	0.400359964	lymphatic
Altai	HPO	Myelodysplasia (HP:0002863)	1	0.5073	1.971220185	0.400459954	hematologic
Altai	HPO	Poor coordination (HP:0002370)	1	0.5143	1.944390434	0.402459754	nervous
Altai	HPO	Ventricular tachycardia (HP:0004756)	1	0.5057	1.97745699	0.402559744	cardiovascular
Altai	HPO	Aplasia/Hypoplasia involving the pelvis (HP:0009103)	1	0.5168	1.93498452	0.403259674	skeletal
Altai	HPO	Hypohidrosis (HP:0000966)	1	0.5213	1.91828122	0.403259674	endocrine
Altai	HPO	Arteriovenous malformation (HP:0100026)	1	0.5238	1.90912562	0.408559144	cardiovascular
Altai	HPO	Rhizomelia (HP:0008905)	1	0.5228	1.912777353	0.410458954	skeletal muscle
Altai	HPO	Widely spaced teeth (HP:0000687)	1	0.5377	1.859773108	0.411458854	skeletal
Altai	HPO	Meningocele (HP:0002435)	1	0.5301	1.886436521	0.413058694	nervous
Altai	HPO	Macroglossia (HP:0000158)	1	0.5393	1.854255516	0.415658434	other
Altai	HPO	Incomplete penetrance (HP:0003829)	2	1.4203	1.408153207	0.416258374	other
Altai	HPO	Arachnodactyly (HP:0001166)	2	1.4418	1.387154945	0.420057994	skeletal
Altai	HPO	Neoplasm of the thyroid gland (HP:0100031)	1	0.5498	1.818843216	0.424557544	endocrine
Altai	HPO	Inguinal hernia (HP:0000023)	2	1.4452	1.383891503	0.424757524	digestive
Altai	HPO	Prolonged QT interval (HP:0001657)	1	0.5563	1.797591228	0.424857514	cardiovascular
Altai	HPO	Facial cleft (HP:0002006)	1	0.565	1.769911504	0.429257074	other
Altai	HPO	Dental malocclusion (HP:0000689)	2	1.4607	1.369206545	0.429357064	skeletal
Altai	HPO	Gynecomastia (HP:0000771)	1	0.5604	1.784439686	0.430656934	endocrine
Altai	HPO	Protruding ear (HP:0000411)	1	0.5652	1.769285209	0.434756524	other
Altai	HPO	Hypoplastic toenails (HP:0001800)	1	0.5755	1.737619461	0.435256474	integumentary
Altai	HPO	Cutaneous finger syndactyly (HP:0010554)	1	0.5677	1.761493747	0.435356464	integumentary
Altai	HPO	Cellular immunodeficiency (HP:0005374)	1	0.5712	1.75070028	0.436756324	immune
Altai	HPO	Cutaneous syndactyly (HP:0012725)	1	0.5756	1.737317582	0.439356064	integumentary
Altai	HPO	Specific learning disability (HP:0001328)	1	0.5875	1.70212766	0.442555744	other
Altai	HPO	Preaxial foot polydactyly (HP:0001841)	1	0.5877	1.701548409	0.444655534	skeletal
Altai	HPO	Portal hypertension (HP:0001409)	1	0.585	1.709401709	0.445455454	cardiovascular
Altai	HPO	Atresia of the external auditory canal (HP:0000413)	1	0.5918	1.689760054	0.445455454	nervous
Altai	HPO	Sudden cardiac death (HP:0001645)	2	1.5121	1.322663845	0.448355164	cardiovascular
Altai	HPO	Lymphedema (HP:0001004)	1	0.5897	1.695777514	0.450854915	lymphatic
Altai	HPO	Adducted thumb (HP:0001181)	1	0.6081	1.644466371	0.452054795	skeletal
Altai	HPO	Leiomyosarcoma (HP:0100243)	1	0.6076	1.645819618	0.452654735	skeletal muscle
Altai	HPO	Uterine leiomyosarcoma (HP:0002891)	1	0.6076	1.645819618	0.452654735	reproductive
Altai	HPO	Abnormality of the hepatic vasculature (HP:0006707)	1	0.6019	1.661405549	0.455154485	skeletal muscle
Altai	HPO	Neoplasm of the liver (HP:0002896)	1	0.6112	1.636125654	0.455254475	digestive
Altai	HPO	Polyhydramnios (HP:0001561)	2	1.5277	1.309157557	0.455454455	reproductive
Altai	HPO	Cranial hyperostosis (HP:0004437)	1	0.6113	1.635858008	0.456354365	skeletal
Altai	HPO	Depressed nasal bridge (HP:0005280)	5	4.427	1.129433025	0.457354265	skeletal
Altai	HPO	Elbow flexion contracture (HP:0002987)	1	0.608	1.644736842	0.457754225	skeletal
Altai	HPO	Goiter (HP:0000853)	1	0.6117	1.634788295	0.458454155	endocrine
Altai	HPO	Oculomotor apraxia (HP:0000657)	1	0.6147	1.626809826	0.459254075	nervous
Altai	HPO	Small intestinal stenosis (HP:0012848)	1	0.6133	1.630523398	0.459554045	digestive
Altai	HPO	Duodenal stenosis (HP:0100867)	1	0.6133	1.630523398	0.459554045	digestive
Altai	HPO	Ectopic anus (HP:0004397)	1	0.6227	1.605909748	0.463053695	digestive
Altai	HPO	Abnormality involving the epiphyses of the lower limbs (HP:0006500)	1	0.6206	1.611343861	0.463053695	skeletal
Altai	HPO	Abnormality of femoral epiphyses (HP:0006499)	1	0.6206	1.611343861	0.463053695	skeletal
Altai	HPO	Spina bifida occulta (HP:0003298)	1	0.6251	1.599744041	0.463553645	skeletal
Altai	HPO	Hereditary nonpolyposis colorectal carcinoma (HP:0006716)	1	0.6277	1.593117731	0.464753525	digestive
Altai	HPO	Camptodactyly of toe (HP:0001836)	1	0.6319	1.582528881	0.466953305	skeletal
Altai	HPO	Polymicrogyria (HP:0002126)	1	0.63	1.587301587	0.468453155	nervous
Altai	HPO	Hypermelanotic macule (HP:0001034)	1	0.6288	1.590330789	0.470552945	integumentary
Altai	HPO	Aplasia/Hypoplasia of the earlobes (HP:0009906)	1	0.6303	1.586546089	0.471452855	integumentary
Altai	HPO	Delayed skeletal maturation (HP:0002750)	3	2.5736	1.165682313	0.473052695	skeletal
Altai	HPO	Focal seizures (HP:0007359)	1	0.6417	1.558360605	0.475452455	nervous
Altai	HPO	Narrow chest (HP:0000774)	2	1.6013	1.2489852	0.476852315	skeletal
Altai	HPO	Generalized tonic-clonic seizures (HP:0002069)	1	0.6556	1.525320317	0.480051995	nervous
Altai	HPO	Genu valgum (HP:0002857)	2	1.6233	1.232058153	0.480751925	skeletal
Altai	HPO	Flat face (HP:0012368)	1	0.659	1.517450683	0.483551645	skeletal
Altai	HPO	Talipes equinovarus (HP:0001762)	3	2.5845	1.160766106	0.484451555	skeletal
Altai	HPO	Cupped ear (HP:0000378)	1	0.6666	1.500150015	0.485351465	other
Altai	HPO	Limited hip movement (HP:0008800)	1	0.6653	1.503081317	0.485651435	other
Altai	HPO	Tapered finger (HP:0001182)	1	0.677	1.477104874	0.487351265	skeletal
Altai	HPO	Congenital sensorineural hearing impairment (HP:0008527)	1	0.6641	1.50579732	0.488451155	nervous
Altai	HPO	Teleangiectasia of the skin (HP:0100585)	1	0.6658	1.501952538	0.489151085	cardiovascular
Altai	HPO	Leukopenia (HP:0001882)	1	0.6744	1.482799526	0.490250975	immune
Altai	HPO	Narrow face (HP:0000275)	1	0.67	1.492537313	0.491450855	skeletal
Altai	HPO	Malignant gastrointestinal tract tumors (HP:0006749)	1	0.6789	1.472970982	0.491550845	digestive
Altai	HPO	Gastrointestinal carcinoma (HP:0002672)	1	0.6789	1.472970982	0.491550845	digestive
Altai	HPO	Transitional cell carcinoma of the bladder (HP:0006740)	1	0.6822	1.465845793	0.492050795	urinary
Altai	HPO	Bladder neoplasm (HP:0009725)	1	0.6822	1.465845793	0.492050795	urinary
Altai	HPO	Bladder carcinoma (HP:0002862)	1	0.6822	1.465845793	0.492050795	urinary
Altai	HPO	Intrauterine growth retardation (HP:0001511)	5	4.6439	1.076681238	0.492650735	other
Altai	HPO	Complete atrioventricular canal defect (HP:0001674)	1	0.6812	1.467997651	0.495050495	cardiovascular
Altai	HPO	Cutis marmorata (HP:0000965)	1	0.68	1.470588235	0.495450455	integumentary
Altai	HPO	Atrioventricular canal defect (HP:0006695)	1	0.6857	1.458363716	0.497850215	cardiovascular
Altai	HPO	Renal cell carcinoma (HP:0005584)	1	0.7012	1.42612664	0.499750025	urinary
Altai	HPO	Hypsarrhythmia (HP:0002521)	1	0.706	1.416430595	0.505749425	cardiovascular
Altai	HPO	Cafe-au-lait spot (HP:0000957)	1	0.7094	1.409641951	0.505849415	integumentary
Altai	HPO	Full cheeks (HP:0000293)	1	0.717	1.394700139	0.507449255	other
Altai	HPO	Arthrogryposis multiplex congenita (HP:0002804)	1	0.7105	1.407459536	0.510048995	skeletal muscle
Altai	HPO	Nephronophthisis (HP:0000090)	1	0.7197	1.389467834	0.512248775	urinary
Altai	HPO	Left ventricular hypertrophy (HP:0001712)	1	0.7281	1.373437715	0.516048395	cardiovascular
Altai	HPO	Muscular hypotonia of the trunk (HP:0008936)	1	0.7143	1.399972001	0.516748325	skeletal muscle
Altai	HPO	Neoplasm of the lung (HP:0100526)	1	0.7354	1.359804188	0.519148085	respiratory
Altai	HPO	Cerebral ischemia (HP:0002637)	1	0.7267	1.376083666	0.521547845	nervous
Altai	HPO	Variable expressivity (HP:0003828)	2	1.7741	1.127332168	0.528247175	other
Altai	HPO	Neoplasm of the respiratory system (HP:0100606)	1	0.7583	1.318739285	0.529547045	respiratory
Altai	HPO	Abnormal EKG (HP:0003115)	1	0.7631	1.310444241	0.531546845	cardiovascular
Altai	HPO	Spastic tetraplegia (HP:0002510)	1	0.7656	1.306165099	0.532246775	nervous
Altai	HPO	High forehead (HP:0000348)	2	1.7874	1.118943717	0.534546545	skeletal
Altai	HPO	Primary adrenal insufficiency (HP:0008207)	1	0.7544	1.325556734	0.534746525	endocrine
Altai	HPO	Renal hypoplasia (HP:0000089)	1	0.7682	1.301744337	0.541245875	urinary
Altai	HPO	Abnormality of the duodenum (HP:0002246)	1	0.7903	1.265342275	0.545745425	digestive
Altai	HPO	Growth hormone deficiency (HP:0000824)	1	0.783	1.277139208	0.546245375	endocrine
Altai	HPO	Syncope (HP:0001279)	1	0.7918	1.262945188	0.547145285	nervous
Altai	HPO	Radioulnar synostosis (HP:0002974)	1	0.788	1.269035533	0.548445155	skeletal
Altai	HPO	Protruding tongue (HP:0010808)	1	0.8091	1.235941169	0.551644836	other
Altai	HPO	Triphalangeal thumb (HP:0001199)	1	0.81	1.234567901	0.553044696	skeletal
Altai	HPO	Downslanted palpebral fissures (HP:0000494)	4	3.9481	1.013145564	0.554944506	integumentary
Altai	HPO	Underdeveloped nasal alae (HP:0000430)	1	0.8238	1.213886866	0.558644136	integumentary
Altai	HPO	Hepatomegaly (HP:0002240)	3	2.921	1.027045532	0.559144086	digestive
Altai	HPO	Uterine neoplasm (HP:0010784)	1	0.825	1.212121212	0.560543946	reproductive
Altai	HPO	Pointed chin (HP:0000307)	1	0.8368	1.195028681	0.567143286	skeletal
Altai	HPO	Choanal atresia (HP:0000453)	1	0.8357	1.196601651	0.569343066	respiratory
Altai	HPO	Smooth philtrum (HP:0000319)	1	0.8606	1.161980014	0.576542346	integumentary
Altai	HPO	Broad foot (HP:0001769)	1	0.8819	1.13391541	0.582941706	skeletal
Altai	HPO	Micropenis (HP:0000054)	2	1.9739	1.013222554	0.586741326	reproductive
Altai	HPO	Hypertelorism (HP:0000316)	6	6.2384	0.961785073	0.589641036	skeletal
Altai	HPO	Elevated hepatic transaminases (HP:0002910)	1	0.8889	1.124985938	0.590540946	digestive
Altai	HPO	Respiratory insufficiency due to muscle weakness (HP:0002747)	1	0.9044	1.10570544	0.591340866	respiratory
Altai	HPO	Abnormality of the fingernails (HP:0001231)	2	2.0225	0.988875155	0.600139986	integumentary
Altai	HPO	Lethargy (HP:0001254)	1	0.9151	1.092776746	0.603239676	behavior
Altai	HPO	Abnormality of the renal medulla (HP:0100957)	1	0.932	1.072961373	0.603439656	urinary
Altai	HPO	Coarse facial features (HP:0000280)	2	2.0152	0.992457324	0.604339566	integumentary
Altai	HPO	Truncal obesity (HP:0001956)	1	0.9376	1.066552901	0.605839416	metabolic
Altai	HPO	Heterogeneous (HP:0001425)	2	2.0688	0.966744006	0.608439156	other
Altai	HPO	Osteoporosis (HP:0000939)	1	0.954	1.048218029	0.616738326	skeletal
Altai	HPO	Aneurysm (HP:0002617)	1	0.9838	1.016466762	0.622137786	nervous
Altai	HPO	Omphalocele (HP:0001539)	1	0.98	1.020408163	0.622437756	other
Altai	HPO	Ventricular septal defect (HP:0001629)	3	3.1926	0.939672994	0.622837716	cardiovascular
Altai	HPO	Primary amenorrhea (HP:0000786)	1	0.9756	1.02501025	0.623437656	reproductive
Altai	HPO	Broad-based gait (HP:0002136)	1	0.9822	1.018122582	0.624337566	other
Altai	HPO	Laryngomalacia (HP:0001601)	1	0.9714	1.029442042	0.626037396	other
Altai	HPO	Convex nasal ridge (HP:0000444)	1	0.9744	1.026272578	0.626437356	skeletal
Altai	HPO	Bulbous nose (HP:0000414)	1	0.9705	1.030396703	0.627037296	other
Altai	HPO	Nephrotic syndrome (HP:0000100)	1	0.9976	1.002405774	0.628937106	urinary
Altai	HPO	Low anterior hairline (HP:0000294)	1	0.9784	1.02207686	0.629637036	integumentary
Altai	HPO	Cerebral cortical atrophy (HP:0002120)	2	2.1371	0.935847644	0.636136386	nervous
Altai	HPO	Oligohydramnios (HP:0001562)	1	1.0072	0.992851469	0.636736326	reproductive
Altai	HPO	Postaxial hand polydactyly (HP:0001162)	2	2.162	0.92506938	0.636836316	skeletal
Altai	HPO	Chorioretinal coloboma (HP:0000567)	1	1.0149	0.985318751	0.638636136	nervous
Altai	HPO	Facial edema (HP:0000282)	1	1.0207	0.9797198	0.640135986	immune
Altai	HPO	Periorbital edema (HP:0100539)	1	1.0207	0.9797198	0.640135986	other
Altai	HPO	Holoprosencephaly (HP:0001360)	1	1.009	0.991080278	0.643235676	nervous
Altai	HPO	Pyloric stenosis (HP:0002021)	1	1.0306	0.970308558	0.643935606	digestive
Altai	HPO	Developmental regression (HP:0002376)	1	1.0475	0.954653938	0.645135486	behavior
Altai	HPO	Accelerated skeletal maturation (HP:0005616)	1	1.0502	0.952199581	0.647135286	skeletal
Altai	HPO	Open mouth (HP:0000194)	1	1.0547	0.948136911	0.648235176	other
Altai	HPO	Hypodontia (HP:0000668)	1	1.0479	0.954289531	0.650734927	skeletal
Altai	HPO	Malar flattening (HP:0000272)	3	3.3571	0.893628429	0.656134387	skeletal
Altai	HPO	Intestinal malrotation (HP:0002566)	1	1.0653	0.938702713	0.657634237	digestive
Altai	HPO	Migraine (HP:0002076)	1	1.071	0.933706816	0.664133587	nervous
Altai	HPO	Ovarian neoplasm (HP:0100615)	1	1.0709	0.933794005	0.665433457	reproductive
Altai	HPO	Midface retrusion (HP:0011800)	1	1.0853	0.92140422	0.666233377	skeletal
Altai	HPO	"Intellectual disability, mild (HP:0001256)"	1	1.1221	0.891186169	0.681831817	nervous
Altai	HPO	Abnormality of salivation (HP:0100755)	1	1.1481	0.871004268	0.689731027	digestive
Altai	HPO	Gingival overgrowth (HP:0000212)	1	1.1753	0.850846592	0.689831017	immune
Altai	HPO	Joint laxity (HP:0001388)	1	1.1841	0.844523267	0.694230577	skeletal
Altai	HPO	External ear malformation (HP:0008572)	1	1.2143	0.823519723	0.700429957	other
Altai	HPO	Broad forehead (HP:0000337)	1	1.2039	0.830633774	0.701029897	skeletal
Altai	HPO	Narrow forehead (HP:0000341)	1	1.2295	0.813338756	0.706529347	skeletal
Altai	HPO	Frontal bossing (HP:0002007)	3	3.7067	0.80934524	0.717428257	skeletal
Altai	HPO	Bruising susceptibility (HP:0000978)	1	1.3721	0.728809854	0.746725327	other
Altai	HPO	Hypospadias (HP:0000047)	1	1.3706	0.729607471	0.748425157	urinary
Altai	HPO	Short palm (HP:0004279)	1	1.4085	0.709975151	0.755824418	skeletal
Altai	HPO	Thick lower lip vermilion (HP:0000179)	1	1.4602	0.684837693	0.764923508	integumentary
Altai	HPO	Progressive disorder (HP:0003676)	1	1.4823	0.674627268	0.773122688	other
Altai	HPO	Triangular face (HP:0000325)	1	1.4662	0.682035193	0.773222678	other
Altai	HPO	Depressed nasal ridge (HP:0000457)	1	1.4854	0.673219335	0.777422258	skeletal
Altai	HPO	Macrotia (HP:0000400)	1	1.5206	0.657635144	0.778922108	other
Altai	HPO	Pes cavus (HP:0001761)	1	1.5259	0.65535094	0.783921608	skeletal
Altai	HPO	Dandy-Walker malformation (HP:0001305)	1	1.5146	0.660240327	0.785021498	nervous
Altai	HPO	Pectus carinatum (HP:0000768)	1	1.5351	0.65142336	0.785921408	skeletal
Altai	HPO	Brachydactyly syndrome (HP:0001156)	3	4.1676	0.719838756	0.786921308	skeletal
Altai	HPO	Sloping forehead (HP:0000340)	1	1.6106	0.620886626	0.793320668	skeletal
Altai	HPO	Microdontia (HP:0000691)	1	1.5974	0.626017278	0.793720628	skeletal
Altai	HPO	Highly arched eyebrow (HP:0002553)	1	1.6073	0.622161389	0.803919608	integumentary
Altai	HPO	Iris coloboma (HP:0000612)	1	1.7328	0.577100646	0.823417658	nervous
Altai	HPO	Recurrent fractures (HP:0002757)	1	1.8657	0.535991853	0.846515348	skeletal
Altai	HPO	Dolichocephaly (HP:0000268)	1	1.9255	0.519345625	0.853614639	skeletal
Altai	HPO	Hypoplasia of the corpus callosum (HP:0002079)	1	1.9258	0.519264721	0.856514349	nervous
Altai	HPO	Wide mouth (HP:0000154)	1	2.0464	0.488663018	0.869013099	skeletal
Altai	HPO	Camptodactyly of finger (HP:0100490)	1	2.1488	0.465376024	0.885011499	skeletal
Altai	HPO	Short nose (HP:0003196)	1	2.1652	0.461851099	0.888611139	skeletal
Altai	HPO	Congenital onset (HP:0003577)	1	2.2622	0.442047564	0.896310369	other
Altai	HPO	Micromelia (HP:0002983)	1	2.2101	0.452468214	0.898810119	skeletal
Altai	HPO	Cerebellar atrophy (HP:0001272)	1	2.464	0.405844156	0.914108589	nervous
Archaic-specific	GWAS	Ulcerative colitis	66	41.6513	1.584584395	1.00E-04	digestive
Archaic-specific	GWAS	Blood metabolite levels	37	16.315	2.26785167	1.00E-04	metabolic
Archaic-specific	GWAS	Blood metabolite ratios	17	4.9513	3.433441722	1.00E-04	metabolic
Archaic-specific	GWAS	Inflammatory bowel disease	93	62.9062	1.478391637	0.00029997	digestive
Archaic-specific	GWAS	IgA nephropathy	13	4.5132	2.880439599	0.00079992	immune
Archaic-specific	GWAS	Metabolic traits	14	4.9617	2.82161356	0.00089991	metabolic
Archaic-specific	GWAS	Malaria	5	0.7023	7.119464616	0.0009999	immune
Archaic-specific	GWAS	Liver enzyme levels (alkaline phosphatase)	10	3.0791	3.247702251	0.0009999	other
Archaic-specific	GWAS	Cold sores	6	1.2311	4.873690196	0.00129987	immune
Archaic-specific	GWAS	IgE levels	5	0.8934	5.596597269	0.00179982	immune
Archaic-specific	GWAS	Psoriasis	20	9.8852	2.023226642	0.00239976	integumentary
Archaic-specific	GWAS	Mumps	3	0.3067	9.781545484	0.00319968	immune
Archaic-specific	GWAS	Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor	3	0.3158	9.499683344	0.00359964	hematologic
Archaic-specific	GWAS	Liver enzyme levels	9	2.8843	3.120341157	0.00359964	other
Archaic-specific	GWAS	Iron status biomarkers (ferritin levels)	6	1.4706	4.07996736	0.00359964	other
Archaic-specific	GWAS	Crohn's disease	92	68.8265	1.336694442	0.00409959	immune
Archaic-specific	GWAS	Factor VII	3	0.3367	8.91000891	0.00419958	hematologic
Archaic-specific	GWAS	Complement C3 and C4 levels	3	0.3339	8.984725966	0.00429957	immune
Archaic-specific	GWAS	Hypertriglyceridemia	7	1.8965	3.691009755	0.00429957	metabolic
Archaic-specific	GWAS	Amino acid levels	5	1.0101	4.95000495	0.00459954	other
Archaic-specific	GWAS	Plantar warts	6	1.5539	3.861252333	0.00459954	integumentary
Archaic-specific	GWAS	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	5	1.028	4.86381323	0.00479952	other
Archaic-specific	GWAS	Circulating fibroblast growth factor 23 levels	9	3.2634	2.757859901	0.0069993	other
Archaic-specific	GWAS	Graves' disease	10	3.8918	2.569505113	0.00739926	endocrine
Archaic-specific	GWAS	Systemic lupus erythematosus and Systemic sclerosis	9	3.2971	2.72967153	0.00749925	immune
Archaic-specific	GWAS	Triglycerides-Blood Pressure (TG-BP)	2	0.1215	16.46090535	0.00769923	metabolic
Archaic-specific	GWAS	PCA3 expression level	2	0.1314	15.22070015	0.00839916	other
Archaic-specific	GWAS	Cancer	8	2.8002	2.85693879	0.00839916	other
Archaic-specific	GWAS	Shingles	7	2.2719	3.081121528	0.00889911	immune
Archaic-specific	GWAS	Serum metabolite levels	14	6.7851	2.063344682	0.00939906	metabolic
Archaic-specific	GWAS	HDL Cholesterol - Triglycerides (HDLC-TG)	2	0.141	14.18439716	0.00959904	metabolic
Archaic-specific	GWAS	Progranulin levels	5	1.2346	4.049894703	0.00979902	nervous
Archaic-specific	GWAS	Nephrolithiasis	4	0.867	4.61361015	0.01009899	urinary
Archaic-specific	GWAS	Serum parathyroid hormone levels	3	0.455	6.593406593	0.01009899	endocrine
Archaic-specific	GWAS	Clinical laboratory measurements	4	0.8339	4.796738218	0.01109889	other
Archaic-specific	GWAS	Beta-2 microglubulin plasma levels	3	0.497	6.036217304	0.01179882	immune
Archaic-specific	GWAS	Chronic lymphocytic leukemia	16	8.5466	1.872089486	0.01429857	lymphatic
Archaic-specific	GWAS	HIV-1 control	4	0.9276	4.312203536	0.0149985	immune
Archaic-specific	GWAS	Obese vs. thin	7	2.5043	2.795192269	0.01529847	metabolic
Archaic-specific	GWAS	Tumor biomarkers	3	0.493	6.085192698	0.01529847	immune
Archaic-specific	GWAS	Macular telangiectasia type 2	3	0.5187	5.783689994	0.01709829	nervous
Archaic-specific	GWAS	Elevated serum carcinoembryonic antigen levels	3	0.5354	5.603287262	0.01779822	other
Archaic-specific	GWAS	Lipid traits	8	3.2829	2.436869841	0.01839816	metabolic
Archaic-specific	GWAS	"Thyroid cancer (Papillary, radiation-related)"	2	0.2042	9.794319295	0.01859814	endocrine
Archaic-specific	GWAS	Hematological and biochemical traits	11	5.2606	2.091016234	0.01879812	hematologic
Archaic-specific	GWAS	Thrombosis	4	1.0175	3.931203931	0.02089791	hematologic
Archaic-specific	GWAS	Waist-to-hip ratio adjusted for BMI	41	29.2477	1.40181963	0.02189781	skeletal
Archaic-specific	GWAS	Temporomandibular joint disorder	4	1.078	3.710575139	0.0219978	skeletal muscle
Archaic-specific	GWAS	Body mass index (age>50)	18	10.6651	1.687747888	0.02309769	metabolic
Archaic-specific	GWAS	Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)	46	33.6552	1.366802158	0.02369763	skeletal
Archaic-specific	GWAS	Peanut allergy (parent-of-origin effect)	4	1.062	3.766478343	0.02539746	immune
Archaic-specific	GWAS	Coagulation factor levels	3	0.6543	4.585052728	0.02749725	hematologic
Archaic-specific	GWAS	Autism spectrum disorder or schizophrenia	72	56.9239	1.264846576	0.02809719	behavior
Archaic-specific	GWAS	Response to fenofibrate (LDL cholesterol levels)	6	2.2757	2.636551391	0.02889711	other
Archaic-specific	GWAS	White blood cell count (basophil)	22	13.9248	1.579914972	0.02929707	immune
Archaic-specific	GWAS	Aspartate aminotransferase levels	9	4.2101	2.137716444	0.03009699	other
Archaic-specific	GWAS	Pain medicine use during menstruation	2	0.2726	7.336757153	0.03049695	reproductive
Archaic-specific	GWAS	Menstruation quality of life impact (dysmenorrhea)	2	0.2726	7.336757153	0.03049695	reproductive
Archaic-specific	GWAS	Serum prostate-specific antigen levels	3	0.7053	4.253509145	0.03339666	reproductive
Archaic-specific	GWAS	Barrett's esophagus  or Esophageal adenocarcinoma	10	5.1161	1.954613866	0.03659634	digestive
Archaic-specific	GWAS	Atopic dermatitis	11	5.8869	1.868555607	0.03729627	integumentary
Archaic-specific	GWAS	Multiple sclerosis--Brain Glutamate Levels	3	0.7394	4.057343792	0.0419958	nervous
Archaic-specific	GWAS	Osteoarthritis (hip)	12	6.7108	1.788162365	0.04249575	skeletal
Archaic-specific	GWAS	Kidney function decline traits	5	1.8938	2.640194318	0.04409559	urinary
Archaic-specific	GWAS	Esophageal cancer (squamous cell)	3	0.7768	3.86199794	0.04439556	digestive
Archaic-specific	GWAS	Basophil percentage of white cells	13	7.6331	1.703108829	0.04539546	immune
Archaic-specific	GWAS	Osteoarthritis	7	3.2171	2.17587268	0.04749525	skeletal
Archaic-specific	GWAS	Pulmonary function in asthmatics	3	0.8127	3.69139904	0.04819518	respiratory
Archaic-specific	GWAS	Thyroid cancer	6	2.555	2.348336595	0.04839516	endocrine
Archaic-specific	GWAS	Prostate cancer	50	39.0263	1.281187302	0.0489951	reproductive
Archaic-specific	GWAS	Response to metformin (IC50)	2	0.3606	5.546311703	0.04929507	other
Archaic-specific	GWAS	Lipid metabolism phenotypes	5	1.9793	2.526145607	0.050094991	metabolic
Archaic-specific	GWAS	Serum alkaline phosphatase levels	9	4.6914	1.918403888	0.050394961	other
Archaic-specific	GWAS	Electroencephalogram traits	8	3.9989	2.000550151	0.051294871	nervous
Archaic-specific	GWAS	Nasopharyngeal carcinoma	4	1.357	2.947678703	0.051594841	other
Archaic-specific	GWAS	Urinary metabolites (H-NMR features)	4	1.3827	2.892890721	0.054794521	metabolic
Archaic-specific	GWAS	Lower body strength	4	1.4366	2.784351942	0.054894511	skeletal muscle
Archaic-specific	GWAS	Plasma homocysteine levels (post-methionine load test)	2	0.3754	5.327650506	0.055694431	other
Archaic-specific	GWAS	Delta-5 desaturase activity response to n3-polyunsaturated fat supplement	2	0.382	5.235602094	0.055894411	other
Archaic-specific	GWAS	Hippocampal volume in mild cognitive impairment	7	3.3861	2.067275036	0.055994401	nervous
Archaic-specific	GWAS	Waist-to-hip ratio adjusted for BMI (age >50)	24	16.8415	1.425051213	0.056994301	skeletal
Archaic-specific	GWAS	Esophageal adenocarcinoma	4	1.4486	2.76128676	0.057294271	digestive
Archaic-specific	GWAS	"B-cell malignancies (CLL, Hodgkin lymphoma or multiple myeloma) (pleiotropy)"	6	2.7289	2.198688116	0.060193981	immune
Archaic-specific	GWAS	Activated partial thromboplastin time	9	4.9616	1.81393099	0.060993901	hematologic
Archaic-specific	GWAS	Reticulocyte count	31	23.1224	1.340691278	0.062193781	immune
Archaic-specific	GWAS	Yeast infection	4	1.4946	2.676301352	0.062993701	immune
Archaic-specific	GWAS	Barrett's esophagus	6	2.7634	2.17123833	0.064093591	digestive
Archaic-specific	GWAS	Body mass index (adult)	6	2.8212	2.126754573	0.065193481	metabolic
Archaic-specific	GWAS	Vitamin B levels in ischemic stroke	5	2.1518	2.323636026	0.066993301	other
Archaic-specific	GWAS	Triglycerides	35	26.6581	1.312921776	0.067093291	metabolic
Archaic-specific	GWAS	Food allergy (parent-of-origin effect)	3	0.9193	3.263352551	0.067393261	immune
Archaic-specific	GWAS	Strep throat	4	1.5217	2.628639022	0.067593241	immune
Archaic-specific	GWAS	Immunoglobulin A	10	5.8029	1.723276293	0.069593041	immune
Archaic-specific	GWAS	Creatine kinase levels	11	6.5965	1.667550974	0.069893011	other
Archaic-specific	GWAS	Low vWF levels	5	2.1971	2.275727095	0.070492951	hematologic
Archaic-specific	GWAS	Osteoprotegerin levels	3	0.9565	3.136434919	0.071392861	skeletal
Archaic-specific	GWAS	GIP levels in response to oral glucose tolerance test (120 minutes)	5	2.2087	2.263775071	0.072092791	metabolic
Archaic-specific	GWAS	Childhood ear infection	13	8.177	1.589825119	0.072492751	immune
Archaic-specific	GWAS	Cerebral amyloid deposition (PET imaging)	9	5.0835	1.770433756	0.074892511	nervous
Archaic-specific	GWAS	Optic nerve measurement (rim area)	3	0.9871	3.039205754	0.076492351	nervous
Archaic-specific	GWAS	Sex hormone levels	3	1.0128	2.962085308	0.076692331	endocrine
Archaic-specific	GWAS	Waist Circumference - Triglycerides (WC-TG)	1	0.0831	12.03369434	0.080091991	skeletal
Archaic-specific	GWAS	Pancreatic ductal adenocarcinoma	3	0.9988	3.003604325	0.080191981	endocrine
Archaic-specific	GWAS	Tonsillectomy	15	10.0316	1.495274931	0.082591741	lymphatic
Archaic-specific	GWAS	Amyotrophic lateral sclerosis	16	10.9268	1.464289636	0.083791621	nervous
Archaic-specific	GWAS	Adiposity	6	2.9937	2.004208839	0.084091591	metabolic
Archaic-specific	GWAS	Phosphorus levels	5	2.3231	2.1522965	0.084591541	other
Archaic-specific	GWAS	Cardiovascular disease risk factors	3	1.0232	2.931978108	0.085291471	cardiovascular
Archaic-specific	GWAS	Vitiligo	24	17.7071	1.355388516	0.086291371	integumentary
Archaic-specific	GWAS	Hepatitis B vaccine response	3	1.0268	2.921698481	0.086691331	immune
Archaic-specific	GWAS	LDL cholesterol levels	9	5.3323	1.687827016	0.088191181	metabolic
Archaic-specific	GWAS	Economic and political preferences	5	2.3552	2.122961957	0.091090891	other
Archaic-specific	GWAS	Vitamin D levels (dietary vitamin D intake interaction)	2	0.5267	3.797228024	0.093290671	other
Archaic-specific	GWAS	Leprosy	6	3.1125	1.927710843	0.094990501	immune
Archaic-specific	GWAS	Waist-to-hip ratio adjusted for BMI (age <50)	15	10.2833	1.458675717	0.095390461	skeletal
Archaic-specific	GWAS	Binge eating behaviour and bipolar disorder	1	0.1009	9.910802775	0.096990301	behavior
Archaic-specific	GWAS	Fasting blood insulin	5	2.4183	2.067568126	0.097590241	metabolic
Archaic-specific	GWAS	End-stage coagulation	5	2.4226	2.063898291	0.100389961	hematologic
Archaic-specific	GWAS	Caffeine consumption	2	0.5359	3.73203956	0.100489951	behavior
Archaic-specific	GWAS	Polymyositis	3	1.1271	2.661698163	0.103189681	skeletal muscle
Archaic-specific	GWAS	Childhood steroid-sensitive nephrotic syndrome	3	1.1282	2.659102996	0.103889611	other
Archaic-specific	GWAS	Sulfasalazine-induced agranulocytosis	5	2.4311	2.05668216	0.104289571	hematologic
Archaic-specific	GWAS	Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid)	4	1.7978	2.224941595	0.105589441	other
Archaic-specific	GWAS	Plasma omega-3 polyunsaturated fatty acid level (eicosapentaenoic acid)	4	1.783	2.243409983	0.106589341	other
Archaic-specific	GWAS	Response to taxane treatment (placlitaxel)	3	1.1327	2.648538889	0.106589341	other
Archaic-specific	GWAS	Febrile seizures (MMR vaccine-related)	3	1.1426	2.625590758	0.107489251	nervous
Archaic-specific	GWAS	Neurofibrillary tangles	7	3.9773	1.759987932	0.107789221	nervous
Archaic-specific	GWAS	Chronic hepatitis B infection	2	0.5675	3.524229075	0.111888811	immune
Archaic-specific	GWAS	Post bronchodilator percent predicted FEV1 in smoking	4	1.8216	2.195871761	0.112988701	other
Archaic-specific	GWAS	Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)	24	18.2609	1.314283524	0.114088591	cardiovascular
Archaic-specific	GWAS	Nonsyndromic cleft lip with cleft palate	6	3.2743	1.832452738	0.115888411	other
Archaic-specific	GWAS	Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)	1	0.1284	7.788161994	0.121287871	integumentary
Archaic-specific	GWAS	Glioblastoma (age-stratified)	2	0.609	3.28407225	0.121587841	nervous
Archaic-specific	GWAS	Total bilirubin levels	7	4.0944	1.709652208	0.122487751	digestive
Archaic-specific	GWAS	Hepatocellular carcinoma	5	2.6152	1.911899664	0.123987601	digestive
Archaic-specific	GWAS	Early onset atrial fibrillation	3	1.2198	2.459419577	0.126487351	cardiovascular
Archaic-specific	GWAS	Delirium	11	7.3921	1.488075107	0.126987301	behavior
Archaic-specific	GWAS	Type 2 diabetes nephropathy including microalbuminuria	4	1.9371	2.06494244	0.127087291	metabolic
Archaic-specific	GWAS	Nonalcoholic fatty liver disease	3	1.2235	2.451982019	0.127487251	digestive
Archaic-specific	GWAS	Birdshot chorioretinopathy	2	0.6276	3.186743149	0.129387061	immune
Archaic-specific	GWAS	Idiopathic intracranial hypertension	3	1.2278	2.44339469	0.129687031	cardiovascular
Archaic-specific	GWAS	Nephropathy	4	1.9284	2.074258453	0.129687031	urinary
Archaic-specific	GWAS	Calcium levels	16	11.6897	1.368726315	0.132086791	other
Archaic-specific	GWAS	LDL cholesterol	27	21.3656	1.263713633	0.133586641	metabolic
Archaic-specific	GWAS	Hematological parameters	2	0.6459	3.09645456	0.134086591	hematologic
Archaic-specific	GWAS	Vogt-Koyanagi-Harada syndrome	4	1.9835	2.016637257	0.136186381	integumentary
Archaic-specific	GWAS	Lipoprotein-associated phospholipase A2 activity and mass	2	0.6386	3.131850924	0.136386361	metabolic
Archaic-specific	GWAS	Metabolic syndrome (bivariate traits)	2	0.65	3.076923077	0.138186181	metabolic
Archaic-specific	GWAS	Eye color traits	2	0.6595	3.032600455	0.138786121	integumentary
Archaic-specific	GWAS	Dietary macronutrient intake	3	1.3044	2.299908004	0.141885811	behavior
Archaic-specific	GWAS	Epstein-Barr virus immune response (EBNA-1)	3	1.3035	2.301495972	0.143185681	immune
Archaic-specific	GWAS	Neuritic plaques or neurofibrillary tangles (pleiotropy)	1	0.1564	6.393861893	0.145685431	nervous
Archaic-specific	GWAS	Biomedical quantitative traits	3	1.3091	2.291650752	0.146385361	other
Archaic-specific	GWAS	HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	4	2.0403	1.960496005	0.146685331	metabolic
Archaic-specific	GWAS	Metabolic syndrome (multivariate analysis)	1	0.1589	6.293266205	0.147985201	metabolic
Archaic-specific	GWAS	Systemic sclerosis	14	10.1771	1.375637461	0.148785121	other
Archaic-specific	GWAS	Metabolic syndrome	9	6.0107	1.497329762	0.152284772	metabolic
Archaic-specific	GWAS	Body mass index in asthmatics	4	2.05	1.951219512	0.153284672	metabolic
Archaic-specific	GWAS	Branched-chain amino acid levels (Isoleucine)	1	0.1664	6.009615385	0.153484652	other
Archaic-specific	GWAS	Red vs. brown/black hair color	6	3.6138	1.660302175	0.157984202	integumentary
Archaic-specific	GWAS	Crohn's disease (time to surgery)	1	0.1777	5.627462015	0.161283872	immune
Archaic-specific	GWAS	Rheumatoid arthritis (rheumatoid factor and/or anti-CCP seropositive)	3	1.3832	2.168883748	0.163683632	immune
Archaic-specific	GWAS	Rapid functional decline in sporadic amyotrophic lateral sclerosis	2	0.7224	2.76854928	0.164083592	nervous
Archaic-specific	GWAS	Dehydroepiandrosterone sulphate levels	3	1.4168	2.11744777	0.164583542	other
Archaic-specific	GWAS	Bipolar disorder with mood-incongruent psychosis	4	2.1102	1.895554924	0.165383462	behavior
Archaic-specific	GWAS	Limited cutaneous systemic scleroderma	3	1.3925	2.154398564	0.165683432	integumentary
Archaic-specific	GWAS	Lung cancer	25	20.0832	1.244821542	0.166583342	respiratory
Archaic-specific	GWAS	Glioma	5	2.8733	1.740159399	0.166983302	nervous
Archaic-specific	GWAS	Neutrophil percentage of white cells	17	13.0499	1.302691975	0.168083192	lymphatic
Archaic-specific	GWAS	Schizophrenia or bipolar disorder	5	2.9397	1.700853829	0.171082892	behavior
Archaic-specific	GWAS	ALT levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	14	10.4843	1.33532997	0.173282672	other
Archaic-specific	GWAS	Systemic lupus erythematosus or rheumatoid arthritis	3	1.4405	2.082610205	0.175382462	immune
Archaic-specific	GWAS	White matter hyperintensity burden	7	4.5553	1.536671569	0.176482352	nervous
Archaic-specific	GWAS	Response to ziprazidone in schizophrenia	1	0.1977	5.058168943	0.177482252	other
Archaic-specific	GWAS	Ischemic stroke (cardioembolic)	5	2.9688	1.684182161	0.178982102	cardiovascular
Archaic-specific	GWAS	Facial morphology	2	0.7591	2.634698986	0.179382062	skeletal
Archaic-specific	GWAS	Age at smoking initiation in chronic obstructive pulmonary disease	5	2.9652	1.686226899	0.180481952	respiratory
Archaic-specific	GWAS	D-dimer levels	9	6.3164	1.424862263	0.181381862	other
Archaic-specific	GWAS	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	1	0.2023	4.943153732	0.181581842	nervous
Archaic-specific	GWAS	Parental lifespan	3	1.4698	2.041094026	0.185181482	other
Archaic-specific	GWAS	Neuromyelitis optica (AQP4-IgG-positive)	3	1.468	2.04359673	0.186981302	nervous
Archaic-specific	GWAS	Neuromyelitis optica	3	1.468	2.04359673	0.186981302	nervous
Archaic-specific	GWAS	Diffusing capacity of the lung for carbon monoxide traits	5	3.0119	1.660081676	0.187281272	respiratory
Archaic-specific	GWAS	Alcoholic chronic pancreatitis	14	10.6321	1.316767149	0.188081192	endocrine
Archaic-specific	GWAS	Subjective response to lithium treatment in bipolar disorder	2	0.8029	2.490970233	0.188981102	other
Archaic-specific	GWAS	Language performance in older adults (adjusted for episodic memory)	3	1.4934	2.008838891	0.189081092	nervous
Archaic-specific	GWAS	Lymphoma	5	3.0545	1.636929121	0.189781022	lymphatic
Archaic-specific	GWAS	Cytomegalovirus antibody response	5	3.0242	1.653329806	0.189981002	immune
Archaic-specific	GWAS	Pneumonia	3	1.4863	2.01843504	0.191580842	respiratory
Archaic-specific	GWAS	Myasthenia gravis	3	1.4776	2.030319437	0.191780822	skeletal muscle
Archaic-specific	GWAS	Metabolite levels (lipid measures)	2	0.8015	2.495321273	0.195780422	metabolic
Archaic-specific	GWAS	Red blood cell traits	14	10.82	1.293900185	0.195980402	hematologic
Archaic-specific	GWAS	Suicide behavior	2	0.8222	2.432498176	0.196580342	behavior
Archaic-specific	GWAS	Vitamin E levels	1	0.2216	4.512635379	0.199180082	other
Archaic-specific	GWAS	"Bone mineral density (paediatric, lower limb)"	3	1.5381	1.950458358	0.202979702	skeletal
Archaic-specific	GWAS	Bilirubin levels	6	3.9514	1.518449157	0.204979502	digestive
Archaic-specific	GWAS	Non-glioblastoma glioma	8	5.5948	1.429899192	0.207179282	nervous
Archaic-specific	GWAS	Fasting blood insulin (BMI interaction)	8	5.6476	1.416530916	0.207679232	metabolic
Archaic-specific	GWAS	IgG glycosylation	5	3.1549	1.584836286	0.210378962	immune
Archaic-specific	GWAS	Lipoprotein phospholipase A2 activity in cardiovascular disease	4	2.347	1.704303366	0.210978902	metabolic
Archaic-specific	GWAS	Lupus nephritis in systemic lupus erythematosus	4	2.3488	1.702997275	0.212278772	urinary
Archaic-specific	GWAS	Cingulate cortical amyloid beta load	1	0.2451	4.07996736	0.215878412	nervous
Archaic-specific	GWAS	Egg allergy (maternal genetic effects)	1	0.2443	4.093327876	0.216678332	immune
Archaic-specific	GWAS	Myositis	3	1.5847	1.893102795	0.216678332	skeletal muscle
Archaic-specific	GWAS	Total bilirubin levels in HIV-1 infection	2	0.868	2.304147465	0.218078192	digestive
Archaic-specific	GWAS	Cerebrospinal AB1-42 levels in normal cognition	10	7.4552	1.341345638	0.219578042	nervous
Archaic-specific	GWAS	Systemic sclerosis (anti-centromere-positive)	2	0.8792	2.274795268	0.220277972	other
Archaic-specific	GWAS	Systemic sclerosis (anti-topoisomerase-positive)	1	0.2507	3.988831272	0.220377962	other
Archaic-specific	GWAS	Ischemic stroke	14	11.0159	1.270890259	0.220877912	cardiovascular
Archaic-specific	GWAS	Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)	3	1.6369	1.832732604	0.225677432	endocrine
Archaic-specific	GWAS	Telomere length	11	8.4317	1.304600496	0.226777322	other
Archaic-specific	GWAS	Giant cell arteritis	3	1.619	1.852995676	0.226777322	cardiovascular
Archaic-specific	GWAS	Lead levels in blood	9	6.6752	1.348274209	0.227577242	other
Archaic-specific	GWAS	Sitting height ratio	5	3.2698	1.529145513	0.232476752	skeletal
Archaic-specific	GWAS	Type 1 diabetes in high risk HLA genotype individuals (time to event)	1	0.2684	3.725782414	0.232676732	metabolic
Archaic-specific	GWAS	Urinary bladder cancer	1	0.27	3.703703704	0.236876312	metabolic
Archaic-specific	GWAS	Blood pressure measurement (high sodium and potassium intervention)	1	0.27	3.703703704	0.237876212	hematologic
Archaic-specific	GWAS	Tacrolimus trough concentration in kidney transplant patients	1	0.2713	3.685956506	0.238576142	immune
Archaic-specific	GWAS	Cisplatin-induced ototoxicity	2	0.934	2.141327623	0.239076092	other
Archaic-specific	GWAS	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7	5.0062	1.39826615	0.240375962	immune
Archaic-specific	GWAS	Hippocampal subfield CA3 volume	3	1.7109	1.75346309	0.240975902	nervous
Archaic-specific	GWAS	Asparaginase hypersensitivity in acute lymphoblastic leukemia	6	4.1774	1.436300091	0.241975802	other
Archaic-specific	GWAS	Decline in glucose metabolism in posterior cingulate cortex	5	3.3384	1.49772346	0.243975602	nervous
Archaic-specific	GWAS	Urinary metabolites	3	1.687	1.778304683	0.247075292	metabolic
Archaic-specific	GWAS	Abdominal aortic aneurysm	3	1.7277	1.736412572	0.247375262	cardiovascular
Archaic-specific	GWAS	Parental longevity (mother's attained age)	3	1.7115	1.752848379	0.250474953	other
Archaic-specific	GWAS	Cognitive flexibility	1	0.2902	3.44589938	0.252874713	nervous
Archaic-specific	GWAS	Hip circumference adjusted for BMI	22	18.7117	1.175734968	0.253074693	skeletal
Archaic-specific	GWAS	Clozapine-induced agranulocytosis	8	5.9966	1.334089317	0.253674633	other
Archaic-specific	GWAS	Systolic blood pressure x smoking status (current vs non-current) interaction (1df test)	6	4.2409	1.41479403	0.255374463	cardiovascular
Archaic-specific	GWAS	Type 1 diabetes and autoimmune thyroid diseases	2	0.9756	2.0500205	0.256074393	metabolic
Archaic-specific	GWAS	Lung adenocarcinoma	24	20.6246	1.163658932	0.256174383	respiratory
Archaic-specific	GWAS	Blood trace element (Se levels)	2	0.9899	2.020406102	0.256274373	other
Archaic-specific	GWAS	Hippocampal subfield CA1 volume	3	1.7723	1.69271568	0.256774323	nervous
Archaic-specific	GWAS	Chronotype	13	10.5258	1.235060518	0.259874013	behavior
Archaic-specific	GWAS	Immunoglobulin light chain (AL) amyloidosis	3	1.7461	1.718114656	0.259974003	immune
Archaic-specific	GWAS	Dimensional psychopathology (Cognitive)	7	5.1641	1.355512093	0.260273973	behavior
Archaic-specific	GWAS	Palmitoleic acid (16:1n-7) levels	3	1.7848	1.680860601	0.263673633	other
Archaic-specific	GWAS	Smoking initiation	4	2.6088	1.533272002	0.265073493	behavior
Archaic-specific	GWAS	Circulating phylloquinone levels	1	0.3091	3.235198965	0.265273473	other
Archaic-specific	GWAS	Hair shape	3	1.8076	1.659659217	0.266073393	integumentary
Archaic-specific	GWAS	Premature menopause in childhood cancer survivors	3	1.7867	1.679073152	0.266173383	other
Archaic-specific	GWAS	QRS complex (Cornell)	1	0.3113	3.212335368	0.266973303	cardiovascular
Archaic-specific	GWAS	Hemoglobin levels	8	6.0795	1.315897689	0.268273173	hematologic
Archaic-specific	GWAS	Yu-Zhi constitution type in type 2 diabetes	3	1.8014	1.665371378	0.269373063	hematologic
Archaic-specific	GWAS	Thiopurine-induced leukopenia in inflammatory bowel disease	2	1.0189	1.962901168	0.270172983	other
Archaic-specific	GWAS	S-phenylmercapturic acid levels in smokers	1	0.3151	3.173595684	0.271172883	other
Archaic-specific	GWAS	Dysmenorrheic pain severity	1	0.3135	3.189792663	0.271672833	reproductive
Archaic-specific	GWAS	Febrile seizures	2	1.0206	1.959631589	0.273272673	nervous
Archaic-specific	GWAS	HDL cholesterol	45	40.8902	1.10050819	0.273472653	metabolic
Archaic-specific	GWAS	Pursuit maintenance gain in psychotic disorders	3	1.8168	1.651254954	0.273472653	skeletal muscle
Archaic-specific	GWAS	"Functional impairment in major depressive disorder, bipolar disorder and schizophrenia"	2	1.0383	1.926225561	0.273972603	nervous
Archaic-specific	GWAS	Skin sensitivity to sun	2	1.0269	1.94760931	0.274472553	integumentary
Archaic-specific	GWAS	Platelet count	53	48.4385	1.094170959	0.275072493	hematologic
Archaic-specific	GWAS	Helping behaviour (self reported)	1	0.3183	3.141690229	0.276372363	behavior
Archaic-specific	GWAS	Prostate cancer (early onset)	2	1.0426	1.91828122	0.277572243	reproductive
Archaic-specific	GWAS	Serum folate levels	5	3.5064	1.425963952	0.279272073	other
Archaic-specific	GWAS	Disrupted circadian rhythm (low relative amplitude of rest-activity cycles)	3	1.8435	1.6273393	0.280671933	behavior
Archaic-specific	GWAS	Urate levels in lean individuals	11	8.917	1.233598744	0.284871513	metabolic
Archaic-specific	GWAS	Hippocampal volume in normal cognition	3	1.8471	1.624167614	0.284871513	nervous
Archaic-specific	GWAS	Coffee consumption	6	4.4494	1.348496426	0.285071493	behavior
Archaic-specific	GWAS	Visceral adipose tissue	2	1.0573	1.891610707	0.286471353	metabolic
Archaic-specific	GWAS	Red blood cell fatty acid levels	2	1.0651	1.877757957	0.287371263	hematologic
Archaic-specific	GWAS	Blood and toenail selenium levels	3	1.8898	1.587469573	0.290470953	other
Archaic-specific	GWAS	Preeclampsia	5	3.6143	1.383393742	0.291670833	reproductive
Archaic-specific	GWAS	Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)	1	0.3493	2.862868594	0.293070693	other
Archaic-specific	GWAS	Plasma PCSK9 levels in stable coronary artery disease	3	1.9072	1.572986577	0.293670633	cardiovascular
Archaic-specific	GWAS	Small cell lung carcinoma	17	14.5326	1.169783796	0.294670533	respiratory
Archaic-specific	GWAS	Black vs. blond hair color	3	1.898	1.58061117	0.295670433	integumentary
Archaic-specific	GWAS	Dialysis-related mortality	11	8.9895	1.223649814	0.295670433	other
Archaic-specific	GWAS	Age-related macular degeneration (choroidal neovascularisation)	1	0.3522	2.839295855	0.298970103	nervous
Archaic-specific	GWAS	Mean arterial pressure (long-term average)	1	0.3533	2.830455703	0.300169983	cardiovascular
Archaic-specific	GWAS	Blond vs non-blond hair color	3	1.917	1.564945227	0.301469853	integumentary
Archaic-specific	GWAS	Suicide in bipolar disorder	1	0.358	2.793296089	0.302969703	behavior
Archaic-specific	GWAS	Brown vs. non-brown hair color	3	1.9233	1.559819061	0.303469653	integumentary
Archaic-specific	GWAS	Light vs. dark hair color	3	1.9233	1.559819061	0.303469653	integumentary
Archaic-specific	GWAS	Testicular germ cell tumor	11	9.0929	1.209735068	0.304369563	reproductive
Archaic-specific	GWAS	Dentate gyrus molecular layer volume	4	2.7821	1.437762841	0.304669533	nervous
Archaic-specific	GWAS	Type 2 diabetes (dietary heme iron intake interaction)	2	1.122	1.782531194	0.308069193	metabolic
Archaic-specific	GWAS	Serum metabolite concentrations in chronic kidney disease	11	9.1422	1.203211481	0.308369163	urinary
Archaic-specific	GWAS	"Cholesterol, total"	15	12.8942	1.163313738	0.313268673	metabolic
Archaic-specific	GWAS	Blond vs. brown/black hair color	38	34.6965	1.095211333	0.313868613	integumentary
Archaic-specific	GWAS	Egg allergy	2	1.1453	1.746267354	0.314168583	immune
Archaic-specific	GWAS	Event free survival in diffuse large B-cell lymphoma treated with immunochemotherapy	1	0.3797	2.633658151	0.315268473	other
Archaic-specific	GWAS	Estradiol levels	3	1.9894	1.50799236	0.315368463	endocrine
Archaic-specific	GWAS	Epilepsy and lamotrigine-induced maculopapular eruptions	7	5.5623	1.258472215	0.319568043	nervous
Archaic-specific	GWAS	Fuchs's corneal dystrophy	3	1.9871	1.509737809	0.320967903	nervous
Archaic-specific	GWAS	Non-alcoholic fatty liver disease histology (lobular)	4	2.8755	1.391062424	0.322267773	digestive
Archaic-specific	GWAS	Conotruncal heart defects (inherited effects)	2	1.1672	1.713502399	0.323467653	cardiovascular
Archaic-specific	GWAS	Staphylococcus aureus nasal carriage (intermittent)	2	1.1673	1.713355607	0.324867513	immune
Archaic-specific	GWAS	Heart failure	3	2.0199	1.485222041	0.327267273	cardiovascular
Archaic-specific	GWAS	Hair color	11	9.2657	1.187174202	0.327467253	integumentary
Archaic-specific	GWAS	Depressive symptoms (SSRI exposure interaction)	4	2.8822	1.387828742	0.327967203	behavior
Archaic-specific	GWAS	Caffeine metabolism (plasma caffeine) level)	1	0.4018	2.488800398	0.329667033	metabolic
Archaic-specific	GWAS	White blood cell count	36	33.1818	1.084932101	0.334966503	immune
Archaic-specific	GWAS	Urate levels	14	12.1615	1.151173786	0.335566443	metabolic
Archaic-specific	GWAS	Visceral adipose tissue adjusted for BMI	12	10.2735	1.16805373	0.337066293	metabolic
Archaic-specific	GWAS	Bipolar disorder lithium response (categorical) or schizophrenia	2	1.2078	1.655903295	0.338666133	behavior
Archaic-specific	GWAS	Lung disease severity in cystic fibrosis	1	0.4117	2.428953121	0.339866013	respiratory
Archaic-specific	GWAS	Cerebrospinal fluid t-tau levels in mild cognitive impairment	2	1.2079	1.655766206	0.341065893	nervous
Archaic-specific	GWAS	Blood protein levels	177	171.4492	1.032375771	0.341165883	other
Archaic-specific	GWAS	Body mass index (change over time) in chronic obstructive pulmonary disease	5	3.842	1.301405518	0.341465853	metabolic
Archaic-specific	GWAS	Metabolite levels (lipoprotein measures)	5	3.8594	1.295538167	0.341765823	metabolic
Archaic-specific	GWAS	Logical memory (immediate recall) in Alzheimer's disease dementia	1	0.4157	2.405580948	0.344565543	nervous
Archaic-specific	GWAS	Diastolic blood pressure night-to-day ratio in hypertension	1	0.4242	2.357378595	0.345465453	cardiovascular
Archaic-specific	GWAS	Parent of origin effect on language impairment (paternal)	1	0.4188	2.387774594	0.345565443	nervous
Archaic-specific	GWAS	Waist-to-hip ratio adjusted for BMI in inactive individuals	3	2.072	1.447876448	0.346065393	skeletal
Archaic-specific	GWAS	Systemic lupus erythematosus	63	59.5571	1.057808389	0.347765223	immune
Archaic-specific	GWAS	circulating leptin levels	2	1.231	1.62469537	0.348665133	metabolic
Archaic-specific	GWAS	Lumbar spine bone mineral density	10	8.4978	1.176775165	0.349065093	skeletal
Archaic-specific	GWAS	Obesity (extreme)	9	7.5896	1.185833245	0.349165083	metabolic
Archaic-specific	GWAS	Hair greying	8	6.6031	1.21155215	0.349865013	integumentary
Archaic-specific	GWAS	Erosive tooth wear (severe vs none or mild)	15	13.2203	1.13461873	0.351164884	skeletal
Archaic-specific	GWAS	Sexual dysfunction (SSRI/SNRI-related)	3	2.1016	1.427483822	0.351464854	reproductive
Archaic-specific	GWAS	Psychosis in Alzheimer's disease	2	1.2427	1.60939889	0.351764824	behavior
Archaic-specific	GWAS	Neonatal cytokine/chemokine levels (fetal genetic effect)	2	1.2336	1.621271077	0.354064594	other
Archaic-specific	GWAS	Breastfeeding duration	4	2.9961	1.335068923	0.354864514	reproductive
Archaic-specific	GWAS	Vitamin B12 levels	1	0.4366	2.290426019	0.356264374	other
Archaic-specific	GWAS	Atrial fibrillation	51	48.1267	1.059702826	0.358764124	cardiovascular
Archaic-specific	GWAS	Congenital left-sided heart lesions	1	0.4546	2.199736032	0.361863814	cardiovascular
Archaic-specific	GWAS	Left superior temporal gyrus thickness (schizophrenia interaction)	1	0.4536	2.204585538	0.365663434	nervous
Archaic-specific	GWAS	Serum metabolite ratios in chronic kidney disease	4	3.0924	1.293493727	0.366463354	urinary
Archaic-specific	GWAS	Hemoglobin concentration	26	23.9847	1.084024399	0.366663334	hematologic
Archaic-specific	GWAS	TB-LM or TBLH-BMD (pleiotropy)	2	1.2827	1.559211039	0.366763324	skeletal muscle
Archaic-specific	GWAS	Mean corpuscular volume	42	39.6277	1.059864691	0.369463054	hematologic
Archaic-specific	GWAS	L-arginine levels	1	0.4635	2.157497303	0.374462554	other
Archaic-specific	GWAS	Glomerular filtration rate (cystatin C)	1	0.4596	2.175805048	0.374562544	hematologic
Archaic-specific	GWAS	EGFR mutation-positive lung adenocarcinoma	1	0.4723	2.117298327	0.376262374	respiratory
Archaic-specific	GWAS	Lactate dehydrogenase levels	4	3.1437	1.272386042	0.378062194	metabolic
Archaic-specific	GWAS	Late-onset myasthenia gravis	6	4.946	1.213101496	0.378262174	skeletal muscle
Archaic-specific	GWAS	Alcohol use disorder (dependence and problematic use scores)	1	0.4695	2.129925453	0.378862114	behavior
Archaic-specific	GWAS	Facial emotion recognition (sad faces)	3	2.2045	1.360852801	0.379862014	nervous
Archaic-specific	GWAS	Chronic hepatitis C infection	1	0.4782	2.09117524	0.380961904	immune
Archaic-specific	GWAS	Monocyte count	26	24.132	1.077407592	0.382461754	immune
Archaic-specific	GWAS	Diffuse large B cell lymphoma	2	1.3157	1.520103367	0.382861714	lymphatic
Archaic-specific	GWAS	Central corneal thickness	16	14.5406	1.100367248	0.383261674	nervous
Archaic-specific	GWAS	White matter integrity	2	1.3181	1.517335559	0.383661634	nervous
Archaic-specific	GWAS	Midgestational circulating levels of PBDEs (fetal genetic effect)	5	4.0513	1.234171747	0.383661634	reproductive
Archaic-specific	GWAS	Hirschsprung disease	3	2.2139	1.355074755	0.383861614	digestive
Archaic-specific	GWAS	Multiple sclerosis (OCB status)	3	2.2221	1.350074254	0.385261474	nervous
Archaic-specific	GWAS	Interstitial lung disease	3	2.218	1.352569883	0.385561444	respiratory
Archaic-specific	GWAS	Nodular sclerosis Hodgkin lymphoma	5	4.0655	1.229861026	0.386561344	lymphatic
Archaic-specific	GWAS	Response to selective serotonin reuptake inhibitors and depression	5	4.077	1.226391955	0.387461254	other
Archaic-specific	GWAS	Smoking cessation in chronic obstructive pulmonary disease	3	2.2264	1.347466762	0.388361164	respiratory
Archaic-specific	GWAS	High density lipoprotein cholesterol levels	16	14.5997	1.09591293	0.390160984	metabolic
Archaic-specific	GWAS	Glycerophospholipid levels	2	1.3605	1.470047777	0.394260574	metabolic
Archaic-specific	GWAS	Serum albumin level	4	3.1865	1.255295779	0.394660534	other
Archaic-specific	GWAS	Caffeine metabolism (plasma paraxanthine caffeine ratio)	1	0.5119	1.953506544	0.397160284	metabolic
Archaic-specific	GWAS	Obstructive sleep apnea during REM sleep (apnea hypopnea index)	1	0.5112	1.956181534	0.397960204	other
Archaic-specific	GWAS	Coffee consumption (cups per day)	2	1.3689	1.461027102	0.398260174	behavior
Archaic-specific	GWAS	Facial pigmentation	1	0.5079	1.968891514	0.399760024	integumentary
Archaic-specific	GWAS	Colorectal cancer (calcium intake interaction)	2	1.371	1.458789205	0.401059894	digestive
Archaic-specific	GWAS	Plasma omega-6 polyunsaturated fatty acid levels (adrenic acid)	3	2.2962	1.306506402	0.401459854	other
Archaic-specific	GWAS	"Bone mineral density (paediatric, total body less head)"	3	2.2995	1.304631442	0.401659834	skeletal
Archaic-specific	GWAS	Schizophrenia (inflammation and infection response interaction)	3	2.2965	1.306335728	0.401959804	behavior
Archaic-specific	GWAS	Prostate cancer (advanced)	4	3.2126	1.245097429	0.402659734	reproductive
Archaic-specific	GWAS	Body mass index in physically inactive individuals	6	5.1107	1.174007475	0.404759524	metabolic
Archaic-specific	GWAS	Sex hormone-binding globulin levels	4	3.2354	1.236323175	0.406159384	endocrine
Archaic-specific	GWAS	Gastric adenocarcinoma (histologically verified)	1	0.5168	1.93498452	0.406159384	digestive
Archaic-specific	GWAS	Disease progression in age-related macular degeneration	26	24.4762	1.062256396	0.407059294	nervous
Archaic-specific	GWAS	Lumbar spine bone mineral density (trabecular)	6	5.1218	1.171463157	0.408059194	skeletal
Archaic-specific	GWAS	Glioblastoma	3	2.3353	1.284631525	0.410758924	nervous
Archaic-specific	GWAS	Mean diameter of HDL particles	2	1.4062	1.422272792	0.410958904	metabolic
Archaic-specific	GWAS	Lentiform nucleus volume	1	0.5334	1.874765654	0.412358764	nervous
Archaic-specific	GWAS	Antibody level in response to infection	1	0.5337	1.873711823	0.413458654	immune
Archaic-specific	GWAS	Dysmenorrheic pain	1	0.5343	1.871607711	0.414158584	reproductive
Archaic-specific	GWAS	Heart rate response to recovery post exercise (10 sec)	6	5.1528	1.164415463	0.414158584	cardiovascular
Archaic-specific	GWAS	Venous thromboembolism	5	4.1953	1.191809882	0.415658434	hematologic
Archaic-specific	GWAS	Proinsulin levels	2	1.4201	1.408351525	0.415858414	metabolic
Archaic-specific	GWAS	Mean corpuscular hemoglobin concentration	13	11.9401	1.088768101	0.416158384	hematologic
Archaic-specific	GWAS	Staphylococcus aureus infection	3	2.3405	1.281777398	0.416358364	immune
Archaic-specific	GWAS	Epilepsy	2	1.4291	1.399482192	0.417258274	nervous
Archaic-specific	GWAS	Major depressive disorder (broad)	3	2.348	1.277683135	0.420457954	behavior
Archaic-specific	GWAS	Plateletcrit	43	41.2828	1.041596016	0.421957804	hematologic
Archaic-specific	GWAS	Ossification of the posterior longitudinal ligament of the spine	3	2.3747	1.263317472	0.422957704	skeletal
Archaic-specific	GWAS	Normalized brain volume	2	1.4415	1.387443635	0.423257674	nervous
Archaic-specific	GWAS	Prevalent atrial fibrillation	3	2.3882	1.2561762	0.423357664	cardiovascular
Archaic-specific	GWAS	Systolic blood pressure x smoking status (ever vs never) interaction (2df test)	14	13.0439	1.07329863	0.423657634	cardiovascular
Archaic-specific	GWAS	Suffering from nerves	2	1.4528	1.376651982	0.424557544	behavior
Archaic-specific	GWAS	Amyotrophic lateral sclerosis in C9orf72 mutation negative individuals	2	1.4429	1.386097443	0.424657534	nervous
Archaic-specific	GWAS	Sexual dimorphism in anthropometric traits	2	1.4462	1.382934587	0.424957504	skeletal
Archaic-specific	GWAS	Age-related macular degeneration (geographic atrophy)	1	0.5529	1.808645325	0.425357464	nervous
Archaic-specific	GWAS	Elevated fasting plasma glucose	1	0.5578	1.792757261	0.428757124	metabolic
Archaic-specific	GWAS	White blood cell count (monocyte)	1	0.5577	1.793078716	0.428757124	immune
Archaic-specific	GWAS	Hematocrit	27	25.8194	1.045725307	0.430156984	hematologic
Archaic-specific	GWAS	Arthritis (juvenile idiopathic)	4	3.3457	1.195564456	0.430456954	skeletal
Archaic-specific	GWAS	Logical memory (immediate recall) in mild cognitive impairment	3	2.403	1.248439451	0.432656734	nervous
Archaic-specific	GWAS	Iron status biomarkers	4	3.3713	1.186485925	0.434256574	other
Archaic-specific	GWAS	Psychosis and Alzheimer's disease	2	1.4691	1.361377714	0.434856514	behavior
Archaic-specific	GWAS	Cerebrospinal fluid t-tau levels in Alzheimer's disease dementia	2	1.4664	1.363884343	0.435856414	nervous
Archaic-specific	GWAS	Black vs. red hair color	2	1.4759	1.355105359	0.436856314	integumentary
Archaic-specific	GWAS	Smooth-surface caries	8	7.2325	1.106118216	0.438056194	skeletal
Archaic-specific	GWAS	Body mass index x sex x age interaction (4df test)	20	19.0407	1.050381551	0.443155684	metabolic
Archaic-specific	GWAS	Resting metabolic rate	1	0.5926	1.687478907	0.444555544	metabolic
Archaic-specific	GWAS	Plasma factor VII activating protease levels	3	2.4634	1.217829017	0.445355464	other
Archaic-specific	GWAS	Left ventricular obstructive tract defect (maternal effect)	3	2.4694	1.214870009	0.447055294	cardiovascular
Archaic-specific	GWAS	Hippocampal volume in Alzheimer's disease dementia	6	5.387	1.113792463	0.450554945	nervous
Archaic-specific	GWAS	Incident atrial fibrillation	2	1.5307	1.306591755	0.452154785	cardiovascular
Archaic-specific	GWAS	Electroencephalographic traits in alcoholism	2	1.5234	1.312852829	0.452954705	nervous
Archaic-specific	GWAS	Subclinical trait of interstitial lung disease (basilar peel-core ratio of HAA on CT scan)	3	2.5003	1.199856017	0.454354565	respiratory
Archaic-specific	GWAS	Oropharynx cancer	5	4.4253	1.129866902	0.454554545	other
Archaic-specific	GWAS	Circulating myeloperoxidase levels (plasma)	1	0.6086	1.643115347	0.457054295	other
Archaic-specific	GWAS	Basophil percentage of granulocytes	9	8.3766	1.074421603	0.462453755	immune
Archaic-specific	GWAS	Total cholesterol levels in HDL	1	0.6196	1.61394448	0.463953605	metabolic
Archaic-specific	GWAS	Apolipoprotein A1 levels	1	0.6197	1.613684041	0.464453555	metabolic
Archaic-specific	GWAS	Total cholesterol levels	26	25.1863	1.032307246	0.465153485	metabolic
Archaic-specific	GWAS	Immune reponse to smallpox (secreted IL-12p40)	3	2.5432	1.179616232	0.465653435	immune
Archaic-specific	GWAS	Hearing function	3	2.5752	1.164958062	0.469553045	nervous
Archaic-specific	GWAS	Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)	2	1.5882	1.259287243	0.469753025	immune
Archaic-specific	GWAS	Prostate-specific antigen levels	4	3.5491	1.127046293	0.470752925	reproductive
Archaic-specific	GWAS	Brown vs. black hair color	8	7.4817	1.069275699	0.471352865	integumentary
Archaic-specific	GWAS	Cholangiocarcinoma in primary sclerosing cholangitis (time to event)	3	2.5329	1.184413123	0.472452755	digestive
Archaic-specific	GWAS	Household income	2	1.6002	1.24984377	0.472752725	other
Archaic-specific	GWAS	LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	2	1.5929	1.255571599	0.473752625	metabolic
Archaic-specific	GWAS	Iron status biomarkers (transferrin saturation)	7	6.5146	1.074509563	0.477552245	other
Archaic-specific	GWAS	Reading disability or specific language impairment (pleiotropy)	1	0.6513	1.535390757	0.479152085	other
Archaic-specific	GWAS	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy	1	0.6532	1.530924679	0.479552045	metabolic
Archaic-specific	GWAS	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	1	0.6486	1.5417823	0.480551945	nervous
Archaic-specific	GWAS	Eye color	4	3.5681	1.121044814	0.480951905	integumentary
Archaic-specific	GWAS	vWF and FVIII levels	3	2.6016	1.153136531	0.481751825	hematologic
Archaic-specific	GWAS	Intrinsic epigenetic age acceleration	2	1.6223	1.232817605	0.482151785	other
Archaic-specific	GWAS	Body mass index (alcohol intake interaction)	1	0.6599	1.515381118	0.484051595	metabolic
Archaic-specific	GWAS	Pubertal anthropometrics	5	4.5792	1.091893781	0.484251575	skeletal
Archaic-specific	GWAS	IgG fucosylation phenotypes (multivariate analysis)	1	0.6492	1.540357363	0.484551545	immune
Archaic-specific	GWAS	Thiopurine-induced alopecia in inflammatory bowel disease	1	0.6665	1.500375094	0.484751525	other
Archaic-specific	GWAS	Non-albumin protein levels	12	11.4919	1.044213751	0.484751525	other
Archaic-specific	GWAS	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	5	4.6089	1.084857558	0.488951105	metabolic
Archaic-specific	GWAS	DNA methylation (variation)	3	2.6267	1.142117486	0.490850915	other
Archaic-specific	GWAS	Skin pigmentation	2	1.6508	1.211533802	0.490850915	integumentary
Archaic-specific	GWAS	Sporadic pituitary adenoma	4	3.6511	1.095560242	0.490950905	nervous
Archaic-specific	GWAS	"Schizophrenia, bipolar disorder and depression (combined)"	3	2.6509	1.131691124	0.493250675	behavior
Archaic-specific	GWAS	Iron status biomarkers (transferrin levels)	1	0.6861	1.457513482	0.493750625	other
Archaic-specific	GWAS	Metabolite levels	18	17.6322	1.020859564	0.494150585	metabolic
Archaic-specific	GWAS	Lymphocyte counts	28	27.6225	1.013666395	0.494750525	lymphatic
Archaic-specific	GWAS	Serum uric acid levels	11	10.6211	1.035674271	0.495250475	other
Archaic-specific	GWAS	Periodontitis	2	1.6687	1.198537784	0.495950405	immune
Archaic-specific	GWAS	Blond vs. brown hair color	2	1.6629	1.202718143	0.496450355	integumentary
Archaic-specific	GWAS	Hair morphology	3	2.6555	1.129730748	0.497150285	integumentary
Archaic-specific	GWAS	Pyoderma gangrenosum in inflammatory bowel disease	3	2.6646	1.125872551	0.502749725	digestive
Archaic-specific	GWAS	Primary biliary cholangitis	12	11.67	1.028277635	0.502949705	digestive
Archaic-specific	GWAS	Cerebral cortical growth	2	1.7042	1.173571177	0.503749625	nervous
Archaic-specific	GWAS	Serum thyroid-stimulating hormone levels	11	10.7234	1.025794058	0.504349565	endocrine
Archaic-specific	GWAS	Cardiometabolic and hematological traits	3	2.6793	1.119695443	0.504749525	cardiovascular
Archaic-specific	GWAS	Response to antidepressants (symptom remission)	2	1.6877	1.185044735	0.506249375	other
Archaic-specific	GWAS	Subjective response to lithium treatment	3	2.7026	1.110042182	0.507149285	other
Archaic-specific	GWAS	Narcolepsy	1	0.7149	1.398797035	0.507249275	behavior
Archaic-specific	GWAS	Small LDL particle concentration	1	0.7123	1.40390285	0.507949205	metabolic
Archaic-specific	GWAS	Hematology traits	2	1.7075	1.171303075	0.510148985	hematologic
Archaic-specific	GWAS	Blood pressure measurement (low sodium intervention)	1	0.7218	1.385425326	0.510948905	hematologic
Archaic-specific	GWAS	Total cholesterol levels in LDL	1	0.7206	1.387732445	0.511748825	metabolic
Archaic-specific	GWAS	Serum total cholesterol levels	1	0.7206	1.387732445	0.511748825	metabolic
Archaic-specific	GWAS	Basal cell carcinoma	8	7.7765	1.028740436	0.512048795	integumentary
Archaic-specific	GWAS	Protein C levels	1	0.7194	1.390047262	0.513248675	other
Archaic-specific	GWAS	Urinary metabolite concentrations in chronic kidney disease	6	5.7365	1.045933932	0.513648635	metabolic
Archaic-specific	GWAS	Mitral valve prolapse	3	2.75	1.090909091	0.514148585	cardiovascular
Archaic-specific	GWAS	"1,5-anhydroglucitol levels"	1	0.7184	1.391982183	0.515048495	other
Archaic-specific	GWAS	Large HDL particle concentration	2	1.7345	1.153070049	0.515548445	metabolic
Archaic-specific	GWAS	Strenuous sports or other exercises	2	1.735	1.152737752	0.517548245	behavior
Archaic-specific	GWAS	Hippocampal tail volume	3	2.7521	1.090076669	0.518348165	nervous
Archaic-specific	GWAS	Metabolite levels (HVA)	2	1.7287	1.15693874	0.518948105	metabolic
Archaic-specific	GWAS	Excessive hairiness	1	0.7271	1.37532664	0.518948105	integumentary
Archaic-specific	GWAS	Skin colour saturation	2	1.7147	1.16638479	0.520047995	integumentary
Archaic-specific	GWAS	Iris characteristics	1	0.7371	1.356668023	0.520247975	integumentary
Archaic-specific	GWAS	IgG monogalactosylation phenotypes (multivariate analysis)	1	0.7245	1.38026225	0.520247975	immune
Archaic-specific	GWAS	Phospholipid levels in large HDL	2	1.752	1.141552511	0.520747925	metabolic
Archaic-specific	GWAS	Loneliness (MTAG)	9	8.8055	1.022088467	0.520847915	behavior
Archaic-specific	GWAS	Immature fraction of reticulocytes	15	14.8749	1.008410141	0.522547745	hematologic
Archaic-specific	GWAS	Autism spectrum disorder	2	1.7553	1.139406369	0.525647435	behavior
Archaic-specific	GWAS	Resistin levels	1	0.7486	1.335826877	0.529147085	other
Archaic-specific	GWAS	Eyebrow thickness	7	6.8448	1.022674147	0.529547045	integumentary
Archaic-specific	GWAS	Urate levels in obese individuals	16	15.9375	1.003921569	0.529647035	metabolic
Archaic-specific	GWAS	Lipid traits (pleiotropy) (HIPO component 1)	4	3.8061	1.050944536	0.530246975	metabolic
Archaic-specific	GWAS	Sjogren's syndrome	9	8.8505	1.016891701	0.530546945	immune
Archaic-specific	GWAS	Optic cup area	7	6.8747	1.01822625	0.530646935	nervous
Archaic-specific	GWAS	Paget's disease	1	0.7603	1.315270288	0.531546845	skeletal
Archaic-specific	GWAS	Rheumatoid arthritis (ACPA-negative)	3	2.8188	1.064282673	0.535046495	immune
Archaic-specific	GWAS	Cystic fibrosis severity	2	1.7829	1.121767906	0.535346465	respiratory
Archaic-specific	GWAS	Tanning	2	1.8073	1.106623139	0.536646335	integumentary
Archaic-specific	GWAS	Pneumococcal bacteremia	2	1.793	1.115448968	0.536946305	respiratory
Archaic-specific	GWAS	Ischemic stroke (small-vessel)	3	2.8385	1.056896248	0.538046195	cardiovascular
Archaic-specific	GWAS	Cervical cancer	9	8.9489	1.005710199	0.539146085	reproductive
Archaic-specific	GWAS	Weight loss (gastric bypass surgery)	2	1.7963	1.113399766	0.539946005	skeletal
Archaic-specific	GWAS	Bipolar disorder or attention deficit hyperactivity disorder	3	2.8489	1.053038015	0.540245975	behavior
Archaic-specific	GWAS	Non-obstructive azoospermia	1	0.7894	1.2667849	0.540845915	reproductive
Archaic-specific	GWAS	Urinary metabolite ratios in chronic kidney disease	1	0.7737	1.292490629	0.541345865	metabolic
Archaic-specific	GWAS	Prothrombin time	3	2.8809	1.041341248	0.541945805	hematologic
Archaic-specific	GWAS	Response to serotonin reuptake inhibitors in MDD (plasma drug and metabolite levels)	1	0.7785	1.284521516	0.541945805	other
Archaic-specific	GWAS	White matter integrity (bipolar disorder risk interaction)	1	0.7826	1.277791975	0.544145585	nervous
Archaic-specific	GWAS	IgG sialylation phenotypes (multivariate analysis)	1	0.7843	1.275022313	0.547945205	immune
Archaic-specific	GWAS	IgG digalactosylation phenotypes (multivariate analysis)	1	0.7843	1.275022313	0.547945205	immune
Archaic-specific	GWAS	Hepcidin levels	3	2.8835	1.040402289	0.548745125	digestive
Archaic-specific	GWAS	Total ventricular volume	5	4.9561	1.008857771	0.549845015	cardiovascular
Archaic-specific	GWAS	Chronic central serous retinopathy	3	2.9008	1.034197463	0.550144986	nervous
Archaic-specific	GWAS	Homocysteine levels	2	1.8514	1.080263584	0.550344966	other
Archaic-specific	GWAS	Ovarian reserve	2	1.8471	1.082778409	0.551644836	reproductive
Archaic-specific	GWAS	Colorectal cancer	26	26.2392	0.990883868	0.552144786	digestive
Archaic-specific	GWAS	Psychosis (atypical)	5	4.9579	1.008491498	0.552744726	behavior
Archaic-specific	GWAS	Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)	2	1.8436	1.08483402	0.553044696	other
Archaic-specific	GWAS	Erectile dysfunction in type 1 diabetes	1	0.7966	1.255335174	0.553844616	reproductive
Archaic-specific	GWAS	Acylcarnitine levels	1	0.8139	1.228652169	0.555944406	other
Archaic-specific	GWAS	Chronic kidney disease	14	14.2134	0.984985999	0.556844316	urinary
Archaic-specific	GWAS	Food antigen IgG levels	1	0.8154	1.226391955	0.557144286	immune
Archaic-specific	GWAS	IgG N-glycosylation phenotypes (multivariate analysis)	1	0.7981	1.252975818	0.557244276	immune
Archaic-specific	GWAS	Gut microbiota (bacterial taxa)	13	13.2208	0.983299044	0.557544246	digestive
Archaic-specific	GWAS	Empathy quotient	2	1.8599	1.07532663	0.557644236	behavior
Archaic-specific	GWAS	Cutaneous psoriasis	2	1.8511	1.080438658	0.558144186	integumentary
Archaic-specific	GWAS	Type 2 diabetes nephropathy	5	4.9744	1.005146349	0.558744126	metabolic
Archaic-specific	GWAS	Coronary artery disease or ischemic stroke	4	3.9531	1.011864107	0.560243976	cardiovascular
Archaic-specific	GWAS	Epithelial ovarian cancer	5	5.0112	0.997765006	0.560343966	reproductive
Archaic-specific	GWAS	Alcohol use disorder (consumption score)	1	0.8161	1.225340032	0.561043896	behavior
Archaic-specific	GWAS	Hemoglobin	9	9.1297	0.985793619	0.562143786	hematologic
Archaic-specific	GWAS	Response to Vitamin E supplementation	3	2.9287	1.024345273	0.563043696	other
Archaic-specific	GWAS	Logical memory (delayed recall) in mild cognitive impairment	4	3.9729	1.006821214	0.563643636	nervous
Archaic-specific	GWAS	Bone mineral density (total hip)	6	6.0555	0.990834778	0.565943406	skeletal
Archaic-specific	GWAS	Pediatric non-alcoholic fatty liver disease activity score	4	3.9787	1.005353507	0.566143386	digestive
Archaic-specific	GWAS	"Parental longevity (combined parental attained age, Martingale residuals)"	4	4.0187	0.995346754	0.569543046	other
Archaic-specific	GWAS	Waist-to-hip circumference ratio (dietary energy interaction)	1	0.844	1.184834123	0.570442956	skeletal
Archaic-specific	GWAS	Multiple myeloma	5	5.0656	0.987049905	0.571842816	immune
Archaic-specific	GWAS	Body fat percentage	3	2.9679	1.010815728	0.572342766	metabolic
Archaic-specific	GWAS	Initial pursuit acceleration	22	22.552	0.975523235	0.573342666	nervous
Archaic-specific	GWAS	Morning vs. evening chronotype	10	10.1993	0.980459443	0.573342666	behavior
Archaic-specific	GWAS	Cerebellum growth	1	0.8553	1.169180405	0.573342666	nervous
Archaic-specific	GWAS	Diffuse cutaneous systemic sclerosis	1	0.8724	1.146263182	0.580341966	immune
Archaic-specific	GWAS	Response to antineoplastic agents	1	0.8738	1.144426642	0.582141786	other
Archaic-specific	GWAS	Age-related cataracts (age at onset)	2	1.9727	1.013838901	0.583041696	integumentary
Archaic-specific	GWAS	Bipolar disorder (inflammation and infection response interaction)	2	1.9556	1.022704029	0.585241476	behavior
Archaic-specific	GWAS	CSF tryptophan concentration in tuberculous meningitis	3	3.0566	0.981482693	0.585641436	nervous
Archaic-specific	GWAS	Acute insulin response	2	1.9691	1.015692448	0.587441256	metabolic
Archaic-specific	GWAS	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	3	3.0725	0.97640358	0.588141186	other
Archaic-specific	GWAS	Sporadic neuroblastoma	1	0.889	1.124859393	0.589541046	nervous
Archaic-specific	GWAS	Red blood cell count	38	39.0848	0.972244965	0.590240976	hematologic
Archaic-specific	GWAS	Inflammatory bowel disease (early onset)	1	0.8987	1.112718371	0.594740526	digestive
Archaic-specific	GWAS	Response to anti-TNF therapy in rheumatoid arthritis	4	4.1662	0.960107532	0.594940506	other
Archaic-specific	GWAS	Phospholipid levels in medium HDL	1	0.9085	1.100715465	0.595640436	metabolic
Archaic-specific	GWAS	Breast cancer (estrogen-receptor negative)	5	5.2307	0.955895004	0.599740026	reproductive
Archaic-specific	GWAS	Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test)	3	3.0947	0.969399296	0.600439956	cardiovascular
Archaic-specific	GWAS	Immune reponse to smallpox (secreted IL-1beta)	3	3.1099	0.964661243	0.601639836	immune
Archaic-specific	GWAS	Zinc levels	7	7.3083	0.957815087	0.602039796	other
Archaic-specific	GWAS	Survival in sporadic amyotrophic lateral sclerosis	3	3.0998	0.967804374	0.605039496	other
Archaic-specific	GWAS	Post bronchodilator FEV1/FVC ratio in smoking	2	2.0495	0.975847768	0.605639436	other
Archaic-specific	GWAS	Red cell distribution width	23	23.9283	0.961204933	0.607039296	hematologic
Archaic-specific	GWAS	Selective IgA deficiency	8	8.4567	0.945995483	0.607839216	immune
Archaic-specific	GWAS	Response to quetiapine in schizophrenia	2	2.0779	0.962510227	0.610138986	other
Archaic-specific	GWAS	Eosinophil percentage of granulocytes	20	20.9874	0.952952724	0.613538646	immune
Archaic-specific	GWAS	Optic disc area	6	6.3982	0.937763746	0.613838616	nervous
Archaic-specific	GWAS	Response to SSRI (symptom remission)	4	4.2615	0.93863663	0.615038496	other
Archaic-specific	GWAS	Granulocyte percentage of myeloid white cells	20	21.0245	0.951271136	0.615938406	immune
Archaic-specific	GWAS	Blood urea nitrogen levels	13	13.7914	0.942616413	0.616438356	other
Archaic-specific	GWAS	Serum 25-Hydroxyvitamin D levels	1	0.9776	1.022913257	0.618638136	other
Archaic-specific	GWAS	IgG galactosylation phenotypes (multivariate analysis)	1	0.9498	1.052853232	0.619038096	immune
Archaic-specific	GWAS	Plasma trimethylamine N-oxide levels	1	0.9633	1.038098204	0.620137986	other
Archaic-specific	GWAS	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	3	3.2068	0.935512037	0.620637936	other
Archaic-specific	GWAS	Cerebrospinal fluid beta-site APP cleaving enzyme levels	6	6.4664	0.927873314	0.623737626	nervous
Archaic-specific	GWAS	Tenofovir clearance in HIV infection	3	3.2151	0.933096949	0.624537546	other
Archaic-specific	GWAS	Bacteremia	2	2.1108	0.947508054	0.624737526	immune
Archaic-specific	GWAS	Testicular germ cell cancer	1	0.9805	1.019887812	0.626537346	reproductive
Archaic-specific	GWAS	Spontaneous preterm birth (preterm birth)	1	0.9836	1.016673444	0.628137186	reproductive
Archaic-specific	GWAS	Cancer (pleiotropy)	3	3.2402	0.925868774	0.628937106	other
Archaic-specific	GWAS	Lung function (FEV1)	13	13.8271	0.940182685	0.631536846	respiratory
Archaic-specific	GWAS	Anxiety disorder	3	3.2517	0.922594335	0.631636836	behavior
Archaic-specific	GWAS	Albumin-globulin ratio	11	11.8165	0.930901705	0.631936806	other
Archaic-specific	GWAS	Glycated hemoglobin levels	12	12.8225	0.935854942	0.632436756	metabolic
Archaic-specific	GWAS	Depression in smokers	10	10.7581	0.929532166	0.633436656	behavior
Archaic-specific	GWAS	Primary sclerosing cholangitis	7	7.5694	0.924776072	0.634236576	digestive
Archaic-specific	GWAS	Iron status biomarkers (total iron binding capacity)	4	4.3705	0.915227091	0.634836516	other
Archaic-specific	GWAS	Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)	11	11.8442	0.928724608	0.635136486	skeletal
Archaic-specific	GWAS	N-glycan levels	1	1.0204	0.98000784	0.636936306	endocrine
Archaic-specific	GWAS	Social communication problems	6	6.5515	0.915820804	0.637436256	behavior
Archaic-specific	GWAS	Osteosarcoma	2	2.1732	0.920301859	0.637936206	skeletal
Archaic-specific	GWAS	Familial lung cancer	3	3.2762	0.915695013	0.639036096	respiratory
Archaic-specific	GWAS	Body mass index (recreational physical activity interaction)	1	1.0256	0.975039002	0.639636036	metabolic
Archaic-specific	GWAS	Bone mineral density (spine)	5	5.4709	0.913926411	0.641235876	skeletal
Archaic-specific	GWAS	Liver enzyme levels (alanine transaminase)	6	6.563	0.91421606	0.643535646	other
Archaic-specific	GWAS	Airway wall thickness	5	5.4921	0.910398572	0.644135586	respiratory
Archaic-specific	GWAS	Creatinine levels	17	18.2482	0.931598733	0.644735526	other
Archaic-specific	GWAS	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	2	2.219	0.901306895	0.646735326	other
Archaic-specific	GWAS	Paclitaxel-induced neuropathy	3	3.3448	0.896914614	0.648635136	other
Archaic-specific	GWAS	Susceptibility to persistent hepatitis B virus infection	1	1.0422	0.959508732	0.649135086	immune
Archaic-specific	GWAS	"Bone mineral density (paediatric, skull)"	3	3.352	0.894988067	0.649535046	skeletal
Archaic-specific	GWAS	Egg allergy (parent-of-origin effect)	1	1.0668	0.937382827	0.651834817	immune
Archaic-specific	GWAS	Total cholesterol levels in small LDL	1	1.0598	0.943574259	0.653334667	metabolic
Archaic-specific	GWAS	Total cholesterol levels in large LDL	1	1.0598	0.943574259	0.653334667	metabolic
Archaic-specific	GWAS	Medium LDL particle concentration	1	1.0598	0.943574259	0.653334667	metabolic
Archaic-specific	GWAS	Cholesterol ester levels in medium LDL	1	1.0598	0.943574259	0.653334667	metabolic
Archaic-specific	GWAS	Cholesterol ester levels in large LDL	1	1.0598	0.943574259	0.653334667	metabolic
Archaic-specific	GWAS	Total cholesterol levels in medium LDL	1	1.0598	0.943574259	0.653334667	metabolic
Archaic-specific	GWAS	Large LDL particle concentration	1	1.0598	0.943574259	0.653334667	metabolic
Archaic-specific	GWAS	Lobe attachment (rater-scored or self-reported)	1	1.0612	0.942329438	0.653734627	integumentary
Archaic-specific	GWAS	Hyperthyroidism	3	3.3857	0.886079688	0.654434557	endocrine
Archaic-specific	GWAS	Erosive tooth wear (severe vs non-severe)	15	16.2979	0.920363973	0.654834517	skeletal
Archaic-specific	GWAS	Bulimia nervosa	7	7.7188	0.906876717	0.656034397	behavior
Archaic-specific	GWAS	Entorhinal cortical thickness	2	2.2483	0.889561002	0.656034397	nervous
Archaic-specific	GWAS	Idiopathic membranous nephropathy	1	1.069	0.935453695	0.656434357	urinary
Archaic-specific	GWAS	Liver fibrosis in pediatric non-alcoholic fatty acid liver disease	3	3.3682	0.890683451	0.656834317	other
Archaic-specific	GWAS	Personality traits in bipolar disorder	3	3.3823	0.886970405	0.657234277	behavior
Archaic-specific	GWAS	Neurocognitive impairment in HIV-1 infection (continuous)	1	1.0785	0.927213723	0.657434257	nervous
Archaic-specific	GWAS	Triglyceride levels	11	12.0745	0.911010808	0.657534247	metabolic
Archaic-specific	GWAS	Obsessive-compulsive disorder or autism spectrum disorder	1	1.0713	0.933445347	0.658734127	behavior
Archaic-specific	GWAS	Corneal curvature	3	3.4031	0.881549176	0.659834017	nervous
Archaic-specific	GWAS	Bronchopulmonary dysplasia in preterm infants	3	3.4218	0.876731545	0.660933907	respiratory
Archaic-specific	GWAS	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)	1	1.0749	0.930319099	0.661133887	other
Archaic-specific	GWAS	Heschl's gyrus morphology	9	10.004	0.899640144	0.663333667	nervous
Archaic-specific	GWAS	Adiponectin levels	10	11.0079	0.908438485	0.664733527	other
Archaic-specific	GWAS	Erectile dysfunction and prostate cancer treatment	6	6.7587	0.887744685	0.666833317	reproductive
Archaic-specific	GWAS	Select biomarker traits	1	1.1032	0.906453952	0.666933307	other
Archaic-specific	GWAS	Regular attendance at a pub or social club	7	7.8445	0.892344955	0.667333267	behavior
Archaic-specific	GWAS	Height	87	90.8927	0.957172578	0.668533147	skeletal
Archaic-specific	GWAS	Menopause (age at onset)	7	7.8513	0.891572096	0.668633137	reproductive
Archaic-specific	GWAS	Response to serotonin reuptake inhibitors in major depressive disorder	4	4.5719	0.874909775	0.668633137	other
Archaic-specific	GWAS	Nose morphology	8	8.9252	0.896338457	0.669233077	skeletal
Archaic-specific	GWAS	Eosinophil counts	22	23.7564	0.926066239	0.670232977	immune
Archaic-specific	GWAS	Esophageal squamous cell carcinoma	3	3.4522	0.869011065	0.670332967	digestive
Archaic-specific	GWAS	Myocardial infarction (early onset)	2	2.3305	0.858184939	0.673232677	cardiovascular
Archaic-specific	GWAS	Urinary magnesium-to-creatinine ratio	1	1.1158	0.89621796	0.674032597	metabolic
Archaic-specific	GWAS	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	3	3.4764	0.862961685	0.675532447	immune
Archaic-specific	GWAS	Response to antidepressants	2	2.3294	0.858590195	0.676732327	other
Archaic-specific	GWAS	Upper eyelid morphology	3	3.4693	0.864727755	0.677332267	integumentary
Archaic-specific	GWAS	Age-related macular degeneration (extreme sampling)	1	1.1416	0.87596356	0.678832117	nervous
Archaic-specific	GWAS	Pediatric bone mineral content (radius)	1	1.1435	0.874508089	0.679032097	skeletal
Archaic-specific	GWAS	Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)	13	14.3484	0.906024365	0.680431957	cardiovascular
Archaic-specific	GWAS	Aging (time to event)	2	2.3486	0.851571149	0.680531947	other
Archaic-specific	GWAS	Urinary albumin-to-creatinine ratio in non-diabetics	4	4.6399	0.862087545	0.680531947	metabolic
Archaic-specific	GWAS	HDL cholesterol levels	12	13.3783	0.896974952	0.680731927	metabolic
Archaic-specific	GWAS	Serum total protein level	7	7.9518	0.880303831	0.681131887	other
Archaic-specific	GWAS	Esophageal cancer	3	3.5196	0.852369587	0.681931807	digestive
Archaic-specific	GWAS	Bipolar disorder	28	30.1995	0.927167668	0.682131787	behavior
Archaic-specific	GWAS	Birth length	1	1.1392	0.877808989	0.683131687	skeletal
Archaic-specific	GWAS	Cholesterol efflux capacity (ABCA-1 dependent assay)	1	1.1439	0.87420229	0.683731627	metabolic
Archaic-specific	GWAS	Conduct disorder (maternal expressed emotions interaction)	1	1.1446	0.873667657	0.684631537	behavior
Archaic-specific	GWAS	Gallstone disease	4	4.6587	0.858608625	0.686831317	digestive
Archaic-specific	GWAS	Myocardial infarction	9	10.1754	0.884486114	0.687231277	cardiovascular
Archaic-specific	GWAS	PR interval in Tripanosoma cruzi seropositivity	3	3.5293	0.850026918	0.688331167	cardiovascular
Archaic-specific	GWAS	Metabolite levels (5-HIAA/ MHPG Ratio)	2	2.3492	0.851353652	0.688431157	metabolic
Archaic-specific	GWAS	Bone ultrasound measurement (velocity of sound)	4	4.7091	0.84941921	0.688731127	skeletal
Archaic-specific	GWAS	Idiopathic pulmonary fibrosis	4	4.6902	0.852842096	0.689331067	respiratory
Archaic-specific	GWAS	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease	1	1.1711	0.853898045	0.689731027	metabolic
Archaic-specific	GWAS	Moyamoya disease	4	4.6942	0.852115376	0.690230977	cardiovascular
Archaic-specific	GWAS	Iron status biomarkers (iron levels)	5	5.8369	0.856619096	0.690530947	other
Archaic-specific	GWAS	Homeostasis model assessment of beta-cell function (dietary factor interaction)	8	9.1002	0.879101558	0.690730927	metabolic
Archaic-specific	GWAS	C-reactive protein	1	1.1823	0.845809016	0.694130587	immune
Archaic-specific	GWAS	Self-reported risk-taking behaviour	10	11.3319	0.882464547	0.694930507	behavior
Archaic-specific	GWAS	Multiple myeloma and monoclonal gammopathy	3	3.5818	0.837567703	0.695130487	immune
Archaic-specific	GWAS	Body mass index (age <50)	10	11.2933	0.885480772	0.696230377	metabolic
Archaic-specific	GWAS	Global electrical heterogeneity phenotypes	2	2.405	0.831600832	0.697330267	cardiovascular
Archaic-specific	GWAS	Accelerated cognitive decline after conversion of MCI to Alzheimer's disease	3	3.6092	0.831209132	0.699230077	nervous
Archaic-specific	GWAS	Inflammatory biomarkers	6	6.9838	0.859131132	0.700029997	immune
Archaic-specific	GWAS	Joint mobility (Beighton score)	7	8.0972	0.864496369	0.700129987	skeletal
Archaic-specific	GWAS	Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	4	4.7473	0.842584206	0.700329967	other
Archaic-specific	GWAS	Corticobasal degeneration	1	1.2064	0.828912467	0.700629937	nervous
Archaic-specific	GWAS	Melanoma	10	11.3604	0.880250695	0.700929907	integumentary
Archaic-specific	GWAS	PR interval	15	16.8021	0.89274555	0.701129887	cardiovascular
Archaic-specific	GWAS	Common carotid intima-media thickness	2	2.4789	0.806809472	0.702729727	cardiovascular
Archaic-specific	GWAS	Sum neutrophil eosinophil counts	18	19.9416	0.902635696	0.702929707	hematologic
Archaic-specific	GWAS	Adult asthma	3	3.6666	0.818196694	0.706229377	respiratory
Archaic-specific	GWAS	Common carotid intima-media thickness in HIV negative individuals	9	10.3821	0.866876643	0.707629237	cardiovascular
Archaic-specific	GWAS	Bone properties (heel)	2	2.4785	0.806939681	0.708229177	skeletal
Archaic-specific	GWAS	Hip circumference	15	16.8863	0.888294061	0.708229177	skeletal
Archaic-specific	GWAS	Periodontal microbiota	11	12.5548	0.876158919	0.709329067	immune
Archaic-specific	GWAS	Interferon alpha levels in systemic lupus erythematosus	4	4.7939	0.834393709	0.709929007	immune
Archaic-specific	GWAS	Extremely high intelligence	13	14.7719	0.880049283	0.711528847	other
Archaic-specific	GWAS	Folate pathway vitamin levels	1	1.2461	0.802503812	0.712228777	other
Archaic-specific	GWAS	Metabolite levels (small molecules and protein measures)	4	4.846	0.825423029	0.712328767	metabolic
Archaic-specific	GWAS	Serum bilirubin levels x sex interaction in metabolic syndrome	2	2.5079	0.797479963	0.713128687	digestive
Archaic-specific	GWAS	Reticulocyte fraction of red cells	21	23.346	0.899511694	0.714228577	immune
Archaic-specific	GWAS	middle facial morphology traits (quantitative measurement)	2	2.505	0.798403194	0.716028397	skeletal
Archaic-specific	GWAS	Sphingolipid levels	3	3.6697	0.817505518	0.716228377	metabolic
Archaic-specific	GWAS	Immune reponse to smallpox (secreted IFN-alpha)	4	4.8804	0.81960495	0.716528347	immune
Archaic-specific	GWAS	Panic disorder	3	3.7039	0.809957072	0.716728327	behavior
Archaic-specific	GWAS	Migraine without aura	7	8.2899	0.844401018	0.719128087	nervous
Archaic-specific	GWAS	Suicide risk	2	2.5157	0.795007354	0.720827917	behavior
Archaic-specific	GWAS	Hyperactive-impulsive symptoms	1	1.2962	0.771485882	0.720927907	behavior
Archaic-specific	GWAS	Sum eosinophil basophil counts	21	23.398	0.897512608	0.721327867	hematologic
Archaic-specific	GWAS	Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	4	4.931	0.811194484	0.723827617	other
Archaic-specific	GWAS	Lobe attachment (rater scored)	1	1.2845	0.77851304	0.723827617	integumentary
Archaic-specific	GWAS	Myeloid white cell count	18	20.2863	0.887298324	0.724527547	immune
Archaic-specific	GWAS	Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)	1	1.2849	0.778270683	0.725227477	other
Archaic-specific	GWAS	Erythrocyte cadmium concentration	1	1.291	0.774593338	0.726227377	hematologic
Archaic-specific	GWAS	Alcohol and nicotine co-dependence	3	3.7936	0.790805567	0.726227377	behavior
Archaic-specific	GWAS	Alzheimer's disease (late onset)	20	22.374	0.893894699	0.726427357	nervous
Archaic-specific	GWAS	Heart rate response to recovery post exercise (30 sec)	3	3.7917	0.791201836	0.726727327	cardiovascular
Archaic-specific	GWAS	Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)	1	1.2729	0.785607668	0.726727327	metabolic
Archaic-specific	GWAS	Serum protein levels (sST2)	1	1.2962	0.771485882	0.727827217	other
Archaic-specific	GWAS	Response to citalopram or escitalopram in depression	1	1.2962	0.771485882	0.728127187	other
Archaic-specific	GWAS	P wave duration	3	3.8104	0.787318917	0.729427057	cardiovascular
Archaic-specific	GWAS	Eosinophilic esophagitis	2	2.5929	0.771337113	0.730526947	immune
Archaic-specific	GWAS	Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)	14	15.9964	0.875196919	0.730626937	skeletal
Archaic-specific	GWAS	Cardiac Troponin-T levels	4	4.9501	0.808064484	0.731426857	cardiovascular
Archaic-specific	GWAS	Childhood body mass index	6	7.1992	0.833425936	0.731626837	metabolic
Archaic-specific	GWAS	Response to lithium treatment in bipolar disorder	3	3.797	0.790097445	0.732326767	other
Archaic-specific	GWAS	Tandem gait	1	1.3326	0.750412727	0.733226677	skeletal muscle
Archaic-specific	GWAS	Granulocyte count	18	20.3578	0.884181984	0.733226677	immune
Archaic-specific	GWAS	Neonatal lupus	1	1.3238	0.755401118	0.733826617	immune
Archaic-specific	GWAS	Kawasaki disease	2	2.5855	0.773544769	0.734726527	cardiovascular
Archaic-specific	GWAS	Hippocampal subfield CA4 volume	3	3.7975	0.789993417	0.735026497	nervous
Archaic-specific	GWAS	Dentate gyrus granule cell layer volume	3	3.7975	0.789993417	0.735026497	nervous
Archaic-specific	GWAS	High light scatter reticulocyte percentage of red cells	18	20.3627	0.883969218	0.735726427	metabolic
Archaic-specific	GWAS	Emphysema distribution in smoking	2	2.6294	0.760629801	0.736626337	respiratory
Archaic-specific	GWAS	Cannabis use	5	6.1433	0.813894812	0.736826317	behavior
Archaic-specific	GWAS	Length of menstrual cycle	1	1.3331	0.750131273	0.737426257	reproductive
Archaic-specific	GWAS	Corneal structure	6	7.2979	0.822154318	0.737526247	nervous
Archaic-specific	GWAS	Systolic blood pressure change trajectories	1	1.3375	0.747663551	0.738826117	cardiovascular
Archaic-specific	GWAS	Longitudinal change in brain amyloid plaque burden	1	1.3466	0.74261102	0.739426057	nervous
Archaic-specific	GWAS	Low density lipoprotein cholesterol levels	5	6.1787	0.809231715	0.740725927	metabolic
Archaic-specific	GWAS	Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)	14	16.2402	0.862058349	0.742425757	cardiovascular
Archaic-specific	GWAS	Coronary artery disease or large artery stroke	5	6.1767	0.809493743	0.742525747	cardiovascular
Archaic-specific	GWAS	Psoriasis vulgaris	5	6.2644	0.798161037	0.745625437	integumentary
Archaic-specific	GWAS	Response to platinum-based chemotherapy (carboplatin)	2	2.6618	0.751371253	0.745825417	other
Archaic-specific	GWAS	Plasma amyloid beta peptide concentrations (ABx-42)	1	1.3778	0.725794745	0.746125387	nervous
Archaic-specific	GWAS	Heart rate response to recovery post exercise (40 sec)	3	3.925	0.76433121	0.749825017	cardiovascular
Archaic-specific	GWAS	Primary biliary cirrhosis	7	8.5092	0.822639026	0.749925007	digestive
Archaic-specific	GWAS	Body mass index (SNP x SNP interaction)	2	2.6896	0.743604997	0.750324968	metabolic
Archaic-specific	GWAS	Uterine fibroid number (single vs multiple)	7	8.5561	0.818129755	0.750324968	reproductive
Archaic-specific	GWAS	Ankylosing spondylitis	5	6.283	0.795798186	0.752324768	skeletal
Archaic-specific	GWAS	Metabolite levels (HVA-5-HIAA Factor score)	1	1.3981	0.715256419	0.752924708	metabolic
Archaic-specific	GWAS	HIV-1 susceptibility	5	6.3364	0.789091598	0.753324668	immune
Archaic-specific	GWAS	Anger	2	2.7148	0.73670252	0.753424658	behavior
Archaic-specific	GWAS	Generalized epilepsy	2	2.7133	0.737109793	0.753624638	nervous
Archaic-specific	GWAS	Serum bilirubin levels x Mediterranean diet adherence interaction in metabolic syndrome	3	3.9666	0.756315232	0.754024598	digestive
Archaic-specific	GWAS	Lymphocyte percentage of white cells	15	17.4507	0.859564373	0.755024498	lymphatic
Archaic-specific	GWAS	Age-related cataracts	1	1.3796	0.724847782	0.756024398	integumentary
Archaic-specific	GWAS	Stroke	11	13.0812	0.840901446	0.757124288	cardiovascular
Archaic-specific	GWAS	Asthma (sex interaction)	2	2.6985	0.741152492	0.757624238	respiratory
Archaic-specific	GWAS	Acne (severe)	13	15.3277	0.848137685	0.759124088	integumentary
Archaic-specific	GWAS	Response to bupropion and depression	2	2.7358	0.731047591	0.759324068	other
Archaic-specific	GWAS	Frontotemporal dementia (age at onset)	1	1.4259	0.701311452	0.760223978	nervous
Archaic-specific	GWAS	Waist-to-hip ratio adjusted for BMI in active individuals	7	8.6226	0.811820101	0.760323968	skeletal
Archaic-specific	GWAS	Corneal astigmatism	15	17.5141	0.856452801	0.761123888	nervous
Archaic-specific	GWAS	Pneumoconiosis in silica exposure	1	1.436	0.69637883	0.761923808	respiratory
Archaic-specific	GWAS	Lung function (FVC)	15	17.5828	0.853106445	0.762123788	respiratory
Archaic-specific	GWAS	Huntington's disease progression	8	9.83	0.813835198	0.764223578	nervous
Archaic-specific	GWAS	Hepcidin/ferritin ratio	9	10.9423	0.822496185	0.764623538	digestive
Archaic-specific	GWAS	Diabetic retinopathy	8	9.8831	0.809462618	0.764923508	metabolic
Archaic-specific	GWAS	"Bone mineral density (paediatric, upper limb)"	1	1.4555	0.687049124	0.767423258	skeletal
Archaic-specific	GWAS	Regular attendance at a gym or sports club	4	5.2603	0.760412904	0.769423058	behavior
Archaic-specific	GWAS	Lumbar spine bone mineral density (integral)	5	6.4987	0.769384646	0.770722928	skeletal
Archaic-specific	GWAS	Brain connectivity	6	7.5931	0.790191095	0.771722828	nervous
Archaic-specific	GWAS	Self-reported allergy	4	5.2324	0.764467548	0.773422658	immune
Archaic-specific	GWAS	IgE grass sensitization	1	1.4835	0.674081564	0.773622638	immune
Archaic-specific	GWAS	Monocyte percentage of white cells	19	22.1431	0.858055105	0.774322568	immune
Archaic-specific	GWAS	Serum sulfate level	2	2.8369	0.704994889	0.775122488	other
Archaic-specific	GWAS	Microalbuminuria	4	5.2613	0.760268375	0.775622438	other
Archaic-specific	GWAS	Thrombin-activatable fibrinolysis inhibitor activation peptide	5	6.5056	0.768568618	0.775622438	hematologic
Archaic-specific	GWAS	Heart rate variability traits (RMSSD)	2	2.8117	0.71131344	0.775722428	cardiovascular
Archaic-specific	GWAS	Bone fracture in osteoporosis	2	2.8674	0.697495989	0.776622338	skeletal
Archaic-specific	GWAS	Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	1	1.4834	0.674127006	0.776922308	other
Archaic-specific	GWAS	Mean corpuscular hemoglobin	30	33.9832	0.882789143	0.780921908	hematologic
Archaic-specific	GWAS	Mortality in heart failure	3	4.1453	0.723711191	0.781021898	cardiovascular
Archaic-specific	GWAS	Response to cytidine analogues (gemcitabine)	2	2.8645	0.69820213	0.781721828	other
Archaic-specific	GWAS	Bipolar disorder (body mass index interaction)	6	7.7253	0.776668867	0.781821818	behavior
Archaic-specific	GWAS	Response to anti-depressant treatment in major depressive disorder	5	6.5083	0.768249773	0.781821818	other
Archaic-specific	GWAS	Fat distribution (HIV)	2	2.8767	0.695241075	0.782021798	metabolic
Archaic-specific	GWAS	Cardiovascular risk factors (age interaction)	1	1.5201	0.657851457	0.783521648	cardiovascular
Archaic-specific	GWAS	Chronic venous disease	1	1.5107	0.661944794	0.784121588	cardiovascular
Archaic-specific	GWAS	Plasma amyloid beta peptide concentrations (ABx-40)	4	5.3575	0.746616892	0.784421558	nervous
Archaic-specific	GWAS	Celiac disease or Rheumatoid arthritis	2	2.8746	0.695748974	0.785321468	digestive
Archaic-specific	GWAS	Hodgkin's lymphoma	3	4.1639	0.720478398	0.787321268	lymphatic
Archaic-specific	GWAS	Papillary thyroid cancer	4	5.3414	0.748867338	0.788021198	endocrine
Archaic-specific	GWAS	Bone mineral density (femoral neck) in inflammatory bowel disease	2	2.9186	0.685260056	0.788221178	skeletal
Archaic-specific	GWAS	Rheumatoid arthritis (ACPA-positive)	7	8.9031	0.786242994	0.789021098	immune
Archaic-specific	GWAS	Prostate cancer (SNP x SNP interaction)	11	13.4514	0.817758746	0.791520848	reproductive
Archaic-specific	GWAS	Renal sinus fat	3	4.2241	0.710210459	0.792520748	urinary
Archaic-specific	GWAS	High altitude adaptation	1	1.5746	0.635081926	0.792820718	other
Archaic-specific	GWAS	Immune response to anthrax vaccine	3	4.2346	0.70844944	0.792920708	immune
Archaic-specific	GWAS	Stroke (ischemic)	2	2.9465	0.678771424	0.793520648	cardiovascular
Archaic-specific	GWAS	Type 1 diabetes	10	12.3624	0.80890442	0.795420458	metabolic
Archaic-specific	GWAS	Response to antidepressants (symptom improvement)	9	11.3572	0.792448843	0.795820418	other
Archaic-specific	GWAS	Differentiated thyroid cancer	4	5.4214	0.7378168	0.796920308	endocrine
Archaic-specific	GWAS	Atopic march	1	1.5961	0.62652716	0.798420158	immune
Archaic-specific	GWAS	Age-related nuclear cataracts	4	5.493	0.728199527	0.799020098	nervous
Archaic-specific	GWAS	Low tan response	4	5.4546	0.733326	0.799320068	integumentary
Archaic-specific	GWAS	Heart rate response to exercise	6	7.9192	0.757652288	0.799820018	cardiovascular
Archaic-specific	GWAS	Conduct disorder (symptom count)	1	1.6121	0.620308914	0.800319968	behavior
Archaic-specific	GWAS	Staphylococcus aureus nasal carriage (persistent)	1	1.591	0.628535512	0.801119888	immune
Archaic-specific	GWAS	Renal function-related traits (sCR)	2	2.9873	0.669500887	0.801519848	urinary
Archaic-specific	GWAS	Stearic acid (18:0) levels	4	5.4783	0.730153515	0.801519848	other
Archaic-specific	GWAS	Tourette's syndrome or obsessive-compulsive disorder	5	6.7278	0.743184994	0.802119788	behavior
Archaic-specific	GWAS	Cannabis dependence	1	1.6399	0.60979328	0.802419758	behavior
Archaic-specific	GWAS	Bipolar disorder and eating disorder	3	4.2874	0.699724775	0.802519748	behavior
Archaic-specific	GWAS	Response to taxane treatment (docetaxel)	3	4.2864	0.699888018	0.802719728	other
Archaic-specific	GWAS	Blood trace element (Zn levels)	2	3.038	0.658327847	0.802719728	other
Archaic-specific	GWAS	Frontotemporal dementia with GRN mutation (age at onset)	1	1.6165	0.618620476	0.803019698	nervous
Archaic-specific	GWAS	Breast cancer and/or colorectal cancer	2	3.0156	0.663217933	0.803119688	reproductive
Archaic-specific	GWAS	Bipolar disorder or major depressive disorder	2	3.0069	0.665136852	0.803719628	behavior
Archaic-specific	GWAS	Breast Cancer in BRCA1 mutation carriers	1	1.6566	0.603646022	0.804819518	reproductive
Archaic-specific	GWAS	Coronary heart disease	8	10.3181	0.775336545	0.804919508	cardiovascular
Archaic-specific	GWAS	Response to iloperidone treatment (QT prolongation)	3	4.3341	0.692185229	0.805119488	other
Archaic-specific	GWAS	Total hippocampal volume	4	5.5345	0.722739181	0.806219378	nervous
Archaic-specific	GWAS	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)	9	11.4962	0.782867382	0.806919308	other
Archaic-specific	GWAS	Alzheimer's disease (APOE e4 interaction)	1	1.6495	0.606244316	0.807719228	nervous
Archaic-specific	GWAS	C-reactive protein levels or LDL-cholesterol levels (pleiotropy)	2	3.0372	0.658501251	0.808219178	immune
Archaic-specific	GWAS	Heart rate	6	7.9366	0.755991231	0.808919108	cardiovascular
Archaic-specific	GWAS	C-reactive protein levels or triglyceride levels (pleiotropy)	1	1.6465	0.607348922	0.809019098	immune
Archaic-specific	GWAS	Alcohol dependence	14	17.1268	0.817432328	0.809719028	behavior
Archaic-specific	GWAS	Retinopathy in non-diabetics	3	4.3816	0.684681395	0.810018998	nervous
Archaic-specific	GWAS	Freckles	2	3.0692	0.651635605	0.811318868	integumentary
Archaic-specific	GWAS	Worry too long after an embarrassing experience	5	6.8718	0.727611397	0.811318868	behavior
Archaic-specific	GWAS	Waist circumference adjusted for BMI in non-smokers	10	12.6907	0.787978599	0.811618838	skeletal
Archaic-specific	GWAS	Psoriatic arthritis	3	4.3642	0.687411209	0.812318768	integumentary
Archaic-specific	GWAS	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)	5	6.8436	0.730609621	0.812618738	other
Archaic-specific	GWAS	Depressive and manic episodes in bipolar disorder	2	3.0885	0.647563542	0.813018698	behavior
Archaic-specific	GWAS	Response to platinum-based chemotherapy (cisplatin)	2	3.1251	0.639979521	0.816018398	other
Archaic-specific	GWAS	Non-melanoma skin cancer	2	3.1314	0.638691959	0.816118388	integumentary
Archaic-specific	GWAS	Facial emotion recognition	2	3.0859	0.648109142	0.817018298	nervous
Archaic-specific	GWAS	Asthma (bronchodilator response)	1	1.6963	0.589518363	0.817218278	respiratory
Archaic-specific	GWAS	Squamous cell lung carcinoma	14	17.3191	0.808356092	0.818318168	respiratory
Archaic-specific	GWAS	Vascular brain injury	2	3.1439	0.636152549	0.818618138	cardiovascular
Archaic-specific	GWAS	Rhegmatogenous retinal detachment	1	1.6813	0.59477785	0.818618138	nervous
Archaic-specific	GWAS	Pelvic organ prolapse (moderate/severe)	9	11.6145	0.774893452	0.819318068	skeletal muscle
Archaic-specific	GWAS	Coronary artery disease in type 1 diabetes	3	4.4597	0.672690988	0.819918008	cardiovascular
Archaic-specific	GWAS	Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)	12	15.0776	0.795882634	0.820117988	skeletal
Archaic-specific	GWAS	Adolescent idiopathic scoliosis	7	9.2568	0.756200847	0.820117988	skeletal
Archaic-specific	GWAS	Endometrial endometrioid carcinoma	1	1.7261	0.57934071	0.820617938	reproductive
Archaic-specific	GWAS	Seborrheic dermatitis	2	3.1084	0.643417836	0.822617738	integumentary
Archaic-specific	GWAS	Systolic blood pressure (alcohol consumption interaction)	1	1.7082	0.585411544	0.822617738	cardiovascular
Archaic-specific	GWAS	Gastric cancer	1	1.7204	0.581260172	0.823017698	digestive
Archaic-specific	GWAS	Renal function-related traits (BUN)	2	3.1435	0.636233498	0.823617638	urinary
Archaic-specific	GWAS	Hemoglobin A1c levels	4	5.7026	0.701434433	0.824617538	hematologic
Archaic-specific	GWAS	Perioperative myocardial infarction in coronary artery bypass surgery	2	3.1649	0.631931499	0.825517448	cardiovascular
Archaic-specific	GWAS	Preterm birth (maternal effect)	1	1.7354	0.576236026	0.825617438	reproductive
Archaic-specific	GWAS	Warfarin maintenance dose	1	1.7589	0.568537154	0.826217378	hematologic
Archaic-specific	GWAS	Change in LVEF in response to paclitaxel and trastuzumab in HER2+ breast cancer	1	1.7455	0.572901747	0.826817318	other
Archaic-specific	GWAS	Remission after SSRI treatment in MDD or neuroticism	2	3.1624	0.632431065	0.827717228	other
Archaic-specific	GWAS	Intelligence	14	17.4209	0.803632419	0.828117188	other
Archaic-specific	GWAS	Cocaine dependence	1	1.7378	0.575440212	0.829117088	behavior
Archaic-specific	GWAS	Heart rate response to recovery post exercise (20 sec)	5	7.019	0.712352187	0.829317068	cardiovascular
Archaic-specific	GWAS	Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test)	5	6.9973	0.714561331	0.829517048	cardiovascular
Archaic-specific	GWAS	Celiac disease	14	17.5446	0.797966326	0.830416958	digestive
Archaic-specific	GWAS	Pit-and-Fissure caries	9	11.8072	0.762246765	0.830916908	skeletal
Archaic-specific	GWAS	Problematic alcohol use in trauma-exposed individuals	2	3.197	0.625586487	0.831116888	behavior
Archaic-specific	GWAS	Middle childhood and early adolescence aggressive behavior	4	5.8366	0.685330501	0.831216878	behavior
Archaic-specific	GWAS	Cerebrospinal fluid p-tau levels in mild cognitive impairment	1	1.7741	0.563666084	0.831316868	nervous
Archaic-specific	GWAS	Thyroid hormone levels	5	7.0984	0.704384087	0.831916808	endocrine
Archaic-specific	GWAS	Alzheimer's disease in APOE e4+ carriers	2	3.1911	0.626743129	0.832016798	nervous
Archaic-specific	GWAS	Hip geometry	3	4.5427	0.660400203	0.832216778	skeletal
Archaic-specific	GWAS	Parental longevity (father's attained age)	1	1.8189	0.549782836	0.832516748	other
Archaic-specific	GWAS	High light scatter reticulocyte count	20	24.157	0.827917374	0.832816718	metabolic
Archaic-specific	GWAS	Lean body mass	2	3.237	0.61785604	0.833616638	skeletal muscle
Archaic-specific	GWAS	Peanut allergy	5	7.032	0.711035267	0.834116588	immune
Archaic-specific	GWAS	Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	3	4.5744	0.655823715	0.835016498	cardiovascular
Archaic-specific	GWAS	Allergy	4	5.9105	0.676761695	0.837016298	immune
Archaic-specific	GWAS	Blood osmolality (transformed sodium)	2	3.2566	0.614137444	0.837516248	hematologic
Archaic-specific	GWAS	Waist circumference adjusted for BMI (adjusted for smoking behaviour)	13	16.4724	0.789198902	0.837516248	skeletal
Archaic-specific	GWAS	Insulin-like growth factors	2	3.2562	0.614212886	0.837616238	immune
Archaic-specific	GWAS	Logical memory (immediate recall) in normal cognition	2	3.2945	0.607072393	0.837616238	nervous
Archaic-specific	GWAS	Hip minimal joint space width	1	1.8079	0.553127938	0.838316168	skeletal
Archaic-specific	GWAS	Chronic inflammatory diseases (pleiotropy)	18	22.1127	0.814011857	0.839016098	immune
Archaic-specific	GWAS	Anthropometric traits	1	1.8424	0.5427703	0.839116088	skeletal
Archaic-specific	GWAS	Response to antipsychotic therapy (extrapyramidal side effects)	1	1.8232	0.548486178	0.840315968	other
Archaic-specific	GWAS	Dimensional psychopathology (Arousal)	4	5.9056	0.677323219	0.840615938	behavior
Archaic-specific	GWAS	Progressive supranuclear palsy	1	1.8617	0.537143471	0.841615838	nervous
Archaic-specific	GWAS	Glucocorticoid-induced osteonecrosis (age 10 years and older)	3	4.6727	0.642027094	0.842415758	other
Archaic-specific	GWAS	Waist circumference adjusted for BMI in active individuals	11	14.2434	0.772287516	0.843715628	skeletal
Archaic-specific	GWAS	Psychosis proneness (hypomanic personality scale)	1	1.8545	0.539228903	0.843715628	behavior
Archaic-specific	GWAS	Optic nerve measurement (cup-to-disc ratio)	1	1.8667	0.53570472	0.843815618	nervous
Archaic-specific	GWAS	Cortisol levels (saliva)	2	3.3229	0.601883897	0.845015498	endocrine
Archaic-specific	GWAS	Response to lurasidone in schizophrenia	5	7.1867	0.695729612	0.845115488	other
Archaic-specific	GWAS	Eosinophil percentage of white cells	18	22.2657	0.80841833	0.845315468	immune
Archaic-specific	GWAS	Cortical amyloid beta load	1	1.8653	0.536106792	0.847215278	nervous
Archaic-specific	GWAS	Glomerular filtration rate	18	22.3644	0.804850566	0.847315268	hematologic
Archaic-specific	GWAS	Temperament (bipolar disorder)	4	6.0377	0.662503934	0.850614939	behavior
Archaic-specific	GWAS	Peripheral arterial disease (traffic-related air pollution interaction)	4	6.073	0.658653055	0.851814819	cardiovascular
Archaic-specific	GWAS	Chromium levels	4	6.0006	0.666600007	0.852214779	other
Archaic-specific	GWAS	White blood cell types	2	3.3775	0.59215396	0.852214779	immune
Archaic-specific	GWAS	Food addiction	2	3.3786	0.591961167	0.854314569	behavior
Archaic-specific	GWAS	Overweight status	1	1.9382	0.515942627	0.854714529	metabolic
Archaic-specific	GWAS	Psychosis proneness (hypomanic personality scale and revised physical anhedonia scale)	1	1.951	0.512557663	0.855914409	behavior
Archaic-specific	GWAS	Response to fenofibrate (HDL cholesterol levels)	7	9.8389	0.711461647	0.856914309	other
Archaic-specific	GWAS	Coronary artery disease	75	84.3196	0.88947291	0.858414159	cardiovascular
Archaic-specific	GWAS	Sleep quality	1	1.9557	0.511325868	0.858714129	behavior
Archaic-specific	GWAS	Glucocorticoid-induced osteonecrosis	3	4.838	0.620090947	0.860613939	other
Archaic-specific	GWAS	Borderline personality disorder	7	9.9106	0.706314451	0.861113889	behavior
Archaic-specific	GWAS	Breast cancer (survival)	1	1.9805	0.504922999	0.861313869	reproductive
Archaic-specific	GWAS	Brain structure	3	4.8365	0.620283263	0.861313869	nervous
Archaic-specific	GWAS	Lipoprotein (a) levels	8	11.0432	0.724427702	0.861913809	metabolic
Archaic-specific	GWAS	Hepatitis B	1	2.0085	0.497883993	0.862013799	immune
Archaic-specific	GWAS	Takayasu arteritis	8	11.0568	0.723536647	0.862813719	cardiovascular
Archaic-specific	GWAS	Bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder	1	1.9979	0.500525552	0.863813619	behavior
Archaic-specific	GWAS	"Coronary artery disease (myocardial infarction, PTCA, CABG, angina or CIHD)"	15	19.2764	0.778153597	0.864513549	cardiovascular
Archaic-specific	GWAS	Tourette syndrome	1	1.9915	0.50213407	0.864913509	behavior
Archaic-specific	GWAS	Total body bone mineral density	8	11.169	0.716268242	0.865113489	skeletal
Archaic-specific	GWAS	Quantitative traits	7	9.9006	0.707027857	0.865413459	other
Archaic-specific	GWAS	Glomerular filtration rate in non diabetics (creatinine)	7	9.9961	0.700273107	0.866713329	hematologic
Archaic-specific	GWAS	Alzheimer's disease	11	14.6331	0.751720415	0.866713329	nervous
Archaic-specific	GWAS	Neuritic plaques or neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	1	2.0168	0.495834986	0.866913309	nervous
Archaic-specific	GWAS	Non-response to bupropion and depression	1	2.0391	0.490412437	0.867113289	other
Archaic-specific	GWAS	Low high density lipoprotein cholesterol levels	2	3.5219	0.567875295	0.869513049	metabolic
Archaic-specific	GWAS	Recurrent major depressive disorder	2	3.5374	0.565387007	0.870412959	behavior
Archaic-specific	GWAS	Cutaneous malignant melanoma	4	6.2763	0.637318165	0.870512949	integumentary
Archaic-specific	GWAS	Hepcidin/transferrin saturation ratio	2	3.602	0.555247085	0.870712929	digestive
Archaic-specific	GWAS	Primary tooth development (number of teeth)	2	3.5614	0.561576908	0.871012899	skeletal
Archaic-specific	GWAS	Midgestational circulating levels of PBDEs	2	3.619	0.552638851	0.873412659	reproductive
Archaic-specific	GWAS	Hypospadias	4	6.261	0.638875579	0.873412659	urinary
Archaic-specific	GWAS	Glaucoma	10	13.652	0.732493408	0.874112589	nervous
Archaic-specific	GWAS	Idiopathic dilated cardiomyopathy	12	16.0344	0.748390959	0.874112589	cardiovascular
Archaic-specific	GWAS	Asthma exacerbations in inhaled corticosteroid treatment	2	3.6407	0.549344906	0.874312569	respiratory
Archaic-specific	GWAS	Craniofacial microsomia	8	11.2808	0.709169562	0.874412559	skeletal
Archaic-specific	GWAS	Gestational age at birth (maternal effect)	4	6.3443	0.630487209	0.874712529	reproductive
Archaic-specific	GWAS	Mean arterial pressure	10	13.6401	0.733132455	0.874712529	cardiovascular
Archaic-specific	GWAS	Severity of nausea and vomiting of pregnancy	2	3.6442	0.548817299	0.874712529	reproductive
Archaic-specific	GWAS	Response to platinum-based neoadjuvant chemotherapy in cervical cancer	4	6.2512	0.639877144	0.874712529	other
Archaic-specific	GWAS	Bortezomib-induced peripheral neuropathy in multiple myeloma	5	7.5251	0.664442997	0.875212479	nervous
Archaic-specific	GWAS	Common carotid intima-media thickness in HIV infection	4	6.3331	0.631602217	0.875812419	cardiovascular
Archaic-specific	GWAS	Primary tooth development (time to first tooth eruption)	2	3.6402	0.549420362	0.876312369	skeletal
Archaic-specific	GWAS	Mean arterial pressure (alcohol consumption interaction)	2	3.5818	0.558378469	0.876412359	cardiovascular
Archaic-specific	GWAS	Hippocampal volume	10	13.8636	0.721313367	0.876712329	nervous
Archaic-specific	GWAS	Chronic mucus hypersecretion	1	2.0738	0.482206577	0.876812319	immune
Archaic-specific	GWAS	Response to statins (LDL cholesterol change)	1	2.115	0.472813239	0.876912309	other
Archaic-specific	GWAS	Conotruncal heart defects (maternal effects)	1	2.1035	0.475398146	0.877712229	cardiovascular
Archaic-specific	GWAS	Modified Stumvoll Insulin Sensitivity Index (BMI interaction)	4	6.3523	0.629693182	0.877712229	metabolic
Archaic-specific	GWAS	Alcohol use disorder (total score)	1	2.1038	0.475330355	0.877912209	behavior
Archaic-specific	GWAS	Coenzyme Q10 levels	2	3.6234	0.551967765	0.878812119	other
Archaic-specific	GWAS	Cerebrospinal fluid t-tau levels	1	2.1209	0.471497949	0.879112089	nervous
Archaic-specific	GWAS	Dupuytren's disease	6	8.8836	0.675401864	0.879212079	integumentary
Archaic-specific	GWAS	Posterior cortical atrophy and Alzheimer's disease	1	2.0939	0.477577726	0.879812019	nervous
Archaic-specific	GWAS	Local histogram emphysema pattern	1	2.0992	0.476371951	0.880111989	respiratory
Archaic-specific	GWAS	Platelet distribution width	28	34.242	0.817709246	0.880411959	hematologic
Archaic-specific	GWAS	Beard thickness	3	5.0144	0.598276962	0.880911909	integumentary
Archaic-specific	GWAS	Ischemic stroke (large artery atherosclerosis)	2	3.6847	0.54278503	0.881311869	cardiovascular
Archaic-specific	GWAS	Serum bilirubin levels in metabolic syndrome	3	5.0836	0.590132977	0.883011699	digestive
Archaic-specific	GWAS	Response to platinum-based chemotherapy in non-small-cell lung cancer	3	5.0819	0.590330388	0.883311669	other
Archaic-specific	GWAS	Bone ultrasound measurement (broadband ultrasound attenuation)	5	7.6796	0.651075577	0.884511549	skeletal
Archaic-specific	GWAS	Reading and spelling	1	2.1512	0.464856824	0.885011499	other
Archaic-specific	GWAS	Waist circumference	22	27.742	0.793021412	0.886311369	skeletal
Archaic-specific	GWAS	Glucose homeostasis traits	21	26.6616	0.787649653	0.887311269	metabolic
Archaic-specific	GWAS	Liver enzyme levels (gamma-glutamyl transferase)	4	6.4396	0.621156594	0.887911209	other
Archaic-specific	GWAS	Feeling worry	10	14.035	0.712504453	0.887911209	behavior
Archaic-specific	GWAS	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	1	2.2286	0.448712196	0.888411159	nervous
Archaic-specific	GWAS	Bladder cancer	2	3.7493	0.533432907	0.888911109	urinary
Archaic-specific	GWAS	Plasma renin activity levels	1	2.1835	0.457980307	0.890010999	cardiovascular
Archaic-specific	GWAS	Type 2 diabetes (age of onset)	9	12.8065	0.702768126	0.891410859	metabolic
Archaic-specific	GWAS	Metabolite levels (5-HIAA)	4	6.606	0.605510142	0.891410859	metabolic
Archaic-specific	GWAS	Ulna and radius bone mineral density	1	2.2149	0.451487652	0.891710829	skeletal
Archaic-specific	GWAS	Aging traits	1	2.2123	0.452018262	0.892210779	other
Archaic-specific	GWAS	Uric acid levels	5	7.834	0.638243554	0.892510749	metabolic
Archaic-specific	GWAS	Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)	1	2.2377	0.446887429	0.893010699	other
Archaic-specific	GWAS	Anticoagulant levels	1	2.2814	0.438327343	0.893710629	hematologic
Archaic-specific	GWAS	Influenza A (H1N1) infection	8	11.5824	0.690703136	0.894210579	immune
Archaic-specific	GWAS	Cerebral amyloid deposition in APOEe4 non-carriers (PET imaging)	7	10.4619	0.669094524	0.894510549	nervous
Archaic-specific	GWAS	Pancreatic cancer	19	24.5258	0.774694403	0.894810519	endocrine
Archaic-specific	GWAS	Iris color (L* coordinate)	2	3.8481	0.519737013	0.895810419	integumentary
Archaic-specific	GWAS	Squamous cell carcinoma	5	7.8112	0.640106514	0.896010399	integumentary
Archaic-specific	GWAS	Copper levels	10	14.0898	0.709733282	0.896810319	other
Archaic-specific	GWAS	Metabolite levels (HVA/5-HIAA ratio)	1	2.2731	0.439927852	0.896910309	metabolic
Archaic-specific	GWAS	Potassium levels	1	2.2339	0.447647612	0.897010299	other
Archaic-specific	GWAS	Cholesterol efflux capacity	1	2.265	0.441501104	0.897810219	metabolic
Archaic-specific	GWAS	Small vessel stroke	1	2.2914	0.436414419	0.898310169	cardiovascular
Archaic-specific	GWAS	Waist circumference adjusted for body mass index	18	23.6024	0.762634308	0.898510149	skeletal
Archaic-specific	GWAS	Ovarian cancer	9	12.9455	0.695222278	0.899410059	reproductive
Archaic-specific	GWAS	Heart rate increase in response to exercise	2	3.8875	0.514469453	0.900709929	cardiovascular
Archaic-specific	GWAS	Response to selective serotonin reuptake inhibitors in depression	2	3.9066	0.511954129	0.900709929	other
Archaic-specific	GWAS	Radiation response	5	8.0616	0.620224273	0.900709929	other
Archaic-specific	GWAS	Femoral neck bone mineral density	7	10.5078	0.666171796	0.901309869	skeletal
Archaic-specific	GWAS	Capecitabine sensitivity	2	3.8178	0.52386191	0.901709829	other
Archaic-specific	GWAS	AIDS progression	2	3.9359	0.508142991	0.901809819	immune
Archaic-specific	GWAS	Ability to confide in someone	1	2.3346	0.428338902	0.902209779	behavior
Archaic-specific	GWAS	Fractures	4	6.6813	0.598685884	0.902209779	skeletal
Archaic-specific	GWAS	Corrected insulin response	1	2.3398	0.427386956	0.904109589	metabolic
Archaic-specific	GWAS	Corrected insulin response adjusted for insulin sensitivity index	1	2.3398	0.427386956	0.904109589	metabolic
Archaic-specific	GWAS	Allergic sensitization	3	5.4376	0.551713991	0.904309569	immune
Archaic-specific	GWAS	Vitamin D levels	2	3.859	0.518268982	0.904609539	other
Archaic-specific	GWAS	QRS duration	13	17.8757	0.727244248	0.905409459	cardiovascular
Archaic-specific	GWAS	Feeling nervous	10	14.2117	0.703645588	0.905609439	behavior
Archaic-specific	GWAS	Endometrial cancer (Non-endometrioid histology)	2	3.9711	0.50363879	0.906109389	reproductive
Archaic-specific	GWAS	Mood instability	6	9.4376	0.635754853	0.907109289	behavior
Archaic-specific	GWAS	Cannabis use (initiation)	1	2.3301	0.42916613	0.907209279	behavior
Archaic-specific	GWAS	Response to fenofibrate (triglyceride levels)	4	6.8147	0.586966411	0.908909109	other
Archaic-specific	GWAS	Very long-chain saturated fatty acid levels (fatty acid 20:0)	3	5.4635	0.549098563	0.909809019	metabolic
Archaic-specific	GWAS	Colorectal cancer (diet interaction)	2	3.9856	0.501806503	0.910108989	digestive
Archaic-specific	GWAS	Loneliness (linear analysis)	8	12.0137	0.665906423	0.911308869	behavior
Archaic-specific	GWAS	Conotruncal heart defects	2	4.0519	0.493595597	0.911408859	cardiovascular
Archaic-specific	GWAS	Weight	6	9.5552	0.627930342	0.912708729	skeletal
Archaic-specific	GWAS	Headache	7	10.752	0.651041667	0.913908609	nervous
Archaic-specific	GWAS	Non-small cell lung cancer	3	5.5089	0.544573327	0.914008599	respiratory
Archaic-specific	GWAS	QT interval (drug interaction)	8	12.0946	0.661452218	0.914108589	cardiovascular
Archaic-specific	GWAS	Periodontitis (Mean PAL)	11	15.6772	0.701655908	0.914108589	immune
Archaic-specific	GWAS	Alopecia areata	6	9.6027	0.624824268	0.914108589	integumentary
Archaic-specific	GWAS	Periodontitis (DPAL)	1	2.488	0.40192926	0.914908509	immune
Archaic-specific	GWAS	Paclitaxel disposition in epithelial ovarian cancer	14	19.346	0.723663806	0.915008499	other
Archaic-specific	GWAS	Metabolite levels (Dihydroxy docosatrienoic acid)	2	4.1256	0.484777972	0.915608439	metabolic
Archaic-specific	GWAS	Dimensional psychopathology (Positive)	4	6.9747	0.573501369	0.916108389	behavior
Archaic-specific	GWAS	Response to cognitive-behavioural therapy in anxiety disorder	3	5.5617	0.53940342	0.916208379	other
Archaic-specific	GWAS	Essential tremor	2	4.0923	0.488722723	0.917408259	nervous
Archaic-specific	GWAS	Advanced age-related macular degeneration	5	8.3388	0.599606658	0.917708229	nervous
Archaic-specific	GWAS	Chronic obstructive pulmonary disease (moderate to severe)	1	2.4963	0.400592877	0.919108089	respiratory
Archaic-specific	GWAS	Heart rate variability traits (SDNN)	2	4.152	0.481695568	0.919308069	cardiovascular
Archaic-specific	GWAS	Response to mTOR inhibitor (everolimus)	1	2.4793	0.403339652	0.921107889	other
Archaic-specific	GWAS	Cerebrospinal fluid p-tau levels	2	4.1838	0.478034323	0.921507849	nervous
Archaic-specific	GWAS	Cough in response to angiotensin-converting enzyme inhibitor drugs	4	7.0395	0.568222175	0.921607839	other
Archaic-specific	GWAS	Congenital heart disease (inherited effect)	2	4.1858	0.477805915	0.922207779	cardiovascular
Archaic-specific	GWAS	Echocardiographic traits	1	2.5746	0.38840985	0.922207779	cardiovascular
Archaic-specific	GWAS	P wave terminal force	1	2.6015	0.384393619	0.922907709	cardiovascular
Archaic-specific	GWAS	Blood pressure traits (multi-trait analysis)	1	2.5805	0.387521798	0.922907709	hematologic
Archaic-specific	GWAS	Intraocular pressure	64	75.9801	0.84232582	0.924807519	nervous
Archaic-specific	GWAS	Response to tocilizumab in rheumatoid arthritis	2	4.2894	0.466265678	0.925507449	other
Archaic-specific	GWAS	Free thyroxine concentration	4	7.1386	0.560333959	0.925507449	endocrine
Archaic-specific	GWAS	Optic nerve measurement (disc area)	2	4.2552	0.47001316	0.925707429	nervous
Archaic-specific	GWAS	Heart rate response to recovery post exercise (50 sec)	3	5.7356	0.523049027	0.926707329	cardiovascular
Archaic-specific	GWAS	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	9	13.6272	0.660443818	0.926807319	other
Archaic-specific	GWAS	HIV-1 viral setpoint	7	11.1829	0.6259557	0.927407259	immune
Archaic-specific	GWAS	Carotid intima media thickness	3	5.7561	0.52118622	0.928007199	cardiovascular
Archaic-specific	GWAS	Cervical artery dissection	2	4.2895	0.466254808	0.928907109	cardiovascular
Archaic-specific	GWAS	Sum basophil neutrophil counts	16	22.1023	0.723906562	0.929007099	hematologic
Archaic-specific	GWAS	Pelvic organ prolapse	5	8.5888	0.582153502	0.929607039	skeletal muscle
Archaic-specific	GWAS	Acute lymphoblastic leukemia (childhood)	10	14.9363	0.669509852	0.929807019	lymphatic
Archaic-specific	GWAS	Cerebrospinal fluid t-tau levels in normal cognition	1	2.6512	0.377187689	0.929807019	nervous
Archaic-specific	GWAS	Laryngeal squamous cell carcinoma	1	2.6835	0.372647662	0.930406959	other
Archaic-specific	GWAS	Endometrial cancer	7	11.2305	0.623302613	0.930506949	reproductive
Archaic-specific	GWAS	Retinal vascular caliber	1	2.6409	0.378658791	0.930906909	nervous
Archaic-specific	GWAS	Rheumatoid arthritis	25	32.5809	0.767320731	0.931106889	immune
Archaic-specific	GWAS	Diastolic blood pressure (cigarette smoking interaction)	5	8.5596	0.584139446	0.931706829	cardiovascular
Archaic-specific	GWAS	Obesity (early onset extreme)	7	11.1676	0.626813281	0.932506749	metabolic
Archaic-specific	GWAS	Thiazide-induced adverse metabolic effects in hypertensive patients	12	17.5234	0.684798612	0.932606739	other
Archaic-specific	GWAS	Total ventricular volume (Alzheimer's disease interaction)	2	4.3567	0.459063052	0.932806719	cardiovascular
Archaic-specific	GWAS	Subiculum volume	2	4.3538	0.459368827	0.933406659	nervous
Archaic-specific	GWAS	Feeling miserable	9	13.761	0.654022237	0.933506649	behavior
Archaic-specific	GWAS	Neutrophil percentage of granulocytes	12	17.5811	0.682551149	0.933606639	lymphatic
Archaic-specific	GWAS	Type 2 diabetes and other traits	1	2.6675	0.374882849	0.933706629	metabolic
Archaic-specific	GWAS	Alcohol dependence symptom count	2	4.2882	0.466396157	0.933906609	behavior
Archaic-specific	GWAS	Placental abruption	2	4.418	0.452693526	0.934606539	reproductive
Archaic-specific	GWAS	Systolic blood pressure (cigarette smoking interaction)	6	10.0607	0.596379974	0.935506449	cardiovascular
Archaic-specific	GWAS	Lewy body disease	2	4.4801	0.446418607	0.936406359	nervous
Archaic-specific	GWAS	Attention deficit hyperactivity disorder and conduct disorder	6	10.1068	0.593659714	0.936506349	behavior
Archaic-specific	GWAS	Chronic obstructive pulmonary disease-related biomarkers	3	6.0221	0.498165092	0.937706229	respiratory
Archaic-specific	GWAS	Body mass index and waist-hip ratio (pleiotropy)	1	2.7489	0.363781876	0.938306169	metabolic
Archaic-specific	GWAS	Electrocardiographic traits	3	6.0077	0.499359156	0.938606139	cardiovascular
Archaic-specific	GWAS	Hippocampal tail volume (corrected for total hippocampal volume)	1	2.7748	0.360386334	0.939006099	nervous
Archaic-specific	GWAS	Glaucoma (primary angle closure)	2	4.4445	0.449994375	0.939206079	nervous
Archaic-specific	GWAS	Acute graft versus host disease in bone marrow transplantation (recipient effect)	3	6.1115	0.490877853	0.939306069	other
Archaic-specific	GWAS	"Allergic disease (asthma, hay fever or eczema)"	17	23.735	0.716241837	0.939406059	immune
Archaic-specific	GWAS	Gut microbiota (functional units)	10	15.2609	0.655269348	0.939406059	digestive
Archaic-specific	GWAS	Social science traits (pleiotropy) (HIPO component 1)	6	10.1239	0.59265698	0.939506049	behavior
Archaic-specific	GWAS	Response to antidepressants and depression	1	2.8181	0.354849012	0.939606039	other
Archaic-specific	GWAS	Adverse response to chemotherapy in breast cancer (alopecia) (FDC/DC)	4	7.476	0.535045479	0.939806019	other
Archaic-specific	GWAS	Response to fenofibrate	1	2.863	0.349283968	0.940405959	other
Archaic-specific	GWAS	Alzheimer's disease (survival time)	2	4.5817	0.436519196	0.942205779	nervous
Archaic-specific	GWAS	Bone mineral density (Ward's triangle area)	5	8.9354	0.559572039	0.942305769	skeletal
Archaic-specific	GWAS	Pediatric autoimmune diseases	2	4.5346	0.441053235	0.942305769	immune
Archaic-specific	GWAS	Frontotemporal dementia	1	2.8215	0.354421407	0.942305769	nervous
Archaic-specific	GWAS	Response to antipsychotic treatment in schizophrenia (working memory)	1	2.8176	0.354911982	0.942705729	other
Archaic-specific	GWAS	Age-related hearing impairment	7	11.4979	0.608806826	0.942805719	nervous
Archaic-specific	GWAS	Alanine transaminase levels	3	6.1108	0.490934084	0.943205679	other
Archaic-specific	GWAS	Hyperopia	2	4.5984	0.43493389	0.943305669	nervous
Archaic-specific	GWAS	Tuberculosis	11	16.6391	0.661093449	0.944205579	immune
Archaic-specific	GWAS	Allergic rhinitis	19	26.5386	0.715938294	0.944805519	immune
Archaic-specific	GWAS	Vertical cup-disc ratio	6	10.3105	0.581931041	0.944905509	nervous
Archaic-specific	GWAS	Diabetic kidney disease	9	14.2279	0.63255997	0.944905509	metabolic
Archaic-specific	GWAS	Magnesium levels	1	2.8705	0.348371364	0.945205479	other
Archaic-specific	GWAS	LDL peak particle diameter (total fat intake interaction)	3	6.1937	0.484363143	0.946005399	metabolic
Archaic-specific	GWAS	Fasting insulin (dietary factor interaction)	6	10.3332	0.580652654	0.946005399	metabolic
Archaic-specific	GWAS	Vein graft stenosis in coronary artery bypass grafting	1	2.907	0.343997248	0.946305369	cardiovascular
Archaic-specific	GWAS	Breast size	13	19.2626	0.674882934	0.947705229	reproductive
Archaic-specific	GWAS	Fibrinogen levels	4	7.585	0.527356625	0.948105189	hematologic
Archaic-specific	GWAS	Hippocampal atrophy	5	9.1495	0.54647795	0.948805119	nervous
Archaic-specific	GWAS	Cerebrospinal fluid AB1-42 levels	3	6.1674	0.486428641	0.948905109	nervous
Archaic-specific	GWAS	Response to cytadine analogues (cytosine arabinoside)	2	4.8088	0.415904176	0.949205079	other
Archaic-specific	GWAS	Gait speed in old age	5	9.1144	0.548582463	0.949405059	other
Archaic-specific	GWAS	Thyroid stimulating hormone	3	6.2626	0.479034267	0.949605039	endocrine
Archaic-specific	GWAS	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis	3	6.2684	0.478591028	0.949805019	other
Archaic-specific	GWAS	Erectile dysfunction	8	13.0397	0.613511047	0.949905009	reproductive
Archaic-specific	GWAS	Blood pressure	21	28.891	0.72686996	0.950005	hematologic
Archaic-specific	GWAS	Fibrinogen	2	4.7032	0.425242388	0.9510049	hematologic
Archaic-specific	GWAS	C-reactive protein levels or total cholesterol levels (pleiotropy)	1	3.0205	0.331071015	0.95110489	immune
Archaic-specific	GWAS	Regular attendance at a religious group	7	12.0439	0.581207084	0.95120488	behavior
Archaic-specific	GWAS	Resting heart rate	23	31.4	0.732484076	0.95170483	cardiovascular
Archaic-specific	GWAS	Response to radiotherapy in cancer (late toxicity)	5	9.1744	0.544994768	0.9520048	other
Archaic-specific	GWAS	Waist-to-hip ratio adjusted for BMI x sex interaction	9	14.4986	0.62074959	0.9520048	skeletal
Archaic-specific	GWAS	Forehead morphology	1	3.1233	0.320174175	0.9520048	skeletal
Archaic-specific	GWAS	Depression	19	26.8943	0.706469401	0.95220478	behavior
Archaic-specific	GWAS	Relative hand skill in reading disability	2	4.779	0.418497594	0.95220478	nervous
Archaic-specific	GWAS	Sleep duration	10	15.8215	0.632051323	0.95230477	behavior
Archaic-specific	GWAS	Response to angiotensin II receptor blocker therapy	1	3.072	0.325520833	0.95240476	other
Archaic-specific	GWAS	Fasting blood glucose (BMI interaction)	3	6.2748	0.478102888	0.95260474	metabolic
Archaic-specific	GWAS	Cutaneous squamous cell carcinoma	2	4.7205	0.423683932	0.95260474	integumentary
Archaic-specific	GWAS	Mild influenza (H1N1) infection	10	15.8207	0.632083283	0.9530047	immune
Archaic-specific	GWAS	Hypersomnia (HLA-DQB1*06:02 negative)	1	3.0751	0.325192677	0.95310469	behavior
Archaic-specific	GWAS	Asthma (moderate or severe)	3	6.4513	0.465022554	0.9540046	respiratory
Archaic-specific	GWAS	Response to statin therapy	9	14.7726	0.609236018	0.95450455	other
Archaic-specific	GWAS	Refractive error	8	13.3459	0.599435032	0.95460454	nervous
Archaic-specific	GWAS	Age-related macular degeneration	4	7.8477	0.50970348	0.95460454	nervous
Archaic-specific	GWAS	Aortic root size	4	7.9472	0.503321925	0.9550045	cardiovascular
Archaic-specific	GWAS	Gamma glutamyl transferase levels	6	10.6363	0.564105939	0.95530447	other
Archaic-specific	GWAS	C-reactive protein levels	2	4.8617	0.411378736	0.95550445	immune
Archaic-specific	GWAS	Homeostasis model assessment of insulin resistance (dietary factor interaction)	6	10.6752	0.56205036	0.95580442	metabolic
Archaic-specific	GWAS	Feeling guilty	4	7.9844	0.500976905	0.9560044	behavior
Archaic-specific	GWAS	Plasma clusterin levels	5	9.3752	0.533321956	0.95650435	other
Archaic-specific	GWAS	Urate levels in overweight individuals	8	13.3453	0.599461983	0.9570043	metabolic
Archaic-specific	GWAS	Number of children ever born	1	3.1315	0.319335782	0.95720428	reproductive
Archaic-specific	GWAS	Metabolite levels (HVA/MHPG ratio)	4	7.9684	0.501982832	0.95730427	metabolic
Archaic-specific	GWAS	Brain volume in infants (white matter)	2	4.9373	0.405079699	0.9580042	nervous
Archaic-specific	GWAS	Asthma (childhood onset)	9	14.7898	0.608527499	0.95810419	respiratory
Archaic-specific	GWAS	Scalp hair shape	1	3.1402	0.318451054	0.95820418	integumentary
Archaic-specific	GWAS	Carotid atherosclerosis in HIV infection	1	3.2126	0.311274357	0.95830417	cardiovascular
Archaic-specific	GWAS	Feeling tense	6	10.8387	0.553571923	0.95830417	behavior
Archaic-specific	GWAS	Dimensional psychopathology (Social)	1	3.1413	0.318339541	0.95830417	behavior
Archaic-specific	GWAS	Obsessive-compulsive symptoms	2	4.9161	0.40682655	0.95930407	behavior
Archaic-specific	GWAS	Irritable mood	9	14.6589	0.613961484	0.95950405	behavior
Archaic-specific	GWAS	RR interval (heart rate)	1	3.2407	0.308575308	0.96040396	cardiovascular
Archaic-specific	GWAS	Lung function (forced vital capacity)	2	5.0176	0.398596939	0.96110389	respiratory
Archaic-specific	GWAS	Early-onset Parkinson's disease	3	6.6497	0.451148172	0.96140386	nervous
Archaic-specific	GWAS	Seasonality and depression	6	10.9494	0.547975232	0.96150385	behavior
Archaic-specific	GWAS	Diverticular disease	25	34.6022	0.722497413	0.96180382	digestive
Archaic-specific	GWAS	Hypertension (SNP x SNP interaction)	2	5.0065	0.399480675	0.96180382	cardiovascular
Archaic-specific	GWAS	QT interval (ambient particulate matter interaction)	1	3.2286	0.309731772	0.96210379	cardiovascular
Archaic-specific	GWAS	Neutrophil count	22	30.7294	0.715926767	0.96210379	lymphatic
Archaic-specific	GWAS	Chronic back pain	1	3.2306	0.309540024	0.96210379	skeletal
Archaic-specific	GWAS	Response to antidepressants in depression	1	3.2921	0.30375748	0.96220378	other
Archaic-specific	GWAS	Cleft lip with or without cleft palate	1	3.2583	0.306908511	0.96220378	other
Archaic-specific	GWAS	Memory dysfunction in frontotemporal lobe dementia	1	3.3124	0.301895906	0.96230377	nervous
Archaic-specific	GWAS	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	1	3.4387	0.290807573	0.96250375	metabolic
Archaic-specific	GWAS	Mercury levels	5	9.6513	0.518064924	0.96260374	other
Archaic-specific	GWAS	Gout	13	20.2149	0.643089998	0.96280372	skeletal
Archaic-specific	GWAS	Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)	2	5.123	0.390396252	0.96280372	other
Archaic-specific	GWAS	PR segment	1	3.2416	0.308489635	0.9630037	cardiovascular
Archaic-specific	GWAS	Polycystic ovary syndrome	7	12.4651	0.561567898	0.96350365	reproductive
Archaic-specific	GWAS	Systolic blood pressure x alcohol consumption interaction (2df test)	13	19.9578	0.6513744	0.96360364	cardiovascular
Archaic-specific	GWAS	Carotid plaque burden	7	12.3215	0.568112649	0.96370363	cardiovascular
Archaic-specific	GWAS	Cleft palate	1	3.2263	0.309952577	0.96380362	other
Archaic-specific	GWAS	Response to exercise (triglyceride level interaction)	1	3.2485	0.307834385	0.9640036	other
Archaic-specific	GWAS	Brain volume in infants (grey matter)	1	3.3041	0.302654278	0.96420358	nervous
Archaic-specific	GWAS	Response to n-3 LC-PUFA supplementation (change in triglyceride levels)	1	3.298	0.303214069	0.96480352	other
Archaic-specific	GWAS	Fractional exhaled nitric oxide (childhood)	5	9.7323	0.513753172	0.96490351	respiratory
Archaic-specific	GWAS	Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma	3	6.8908	0.435363093	0.96540346	other
Archaic-specific	GWAS	Heart rate response to recovery post exercise	2	5.2208	0.383083052	0.96570343	cardiovascular
Archaic-specific	GWAS	Response to fenofibrate (total cholesterol levels)	6	10.9874	0.546080055	0.96570343	other
Archaic-specific	GWAS	Clopidogrel active metabolite levels	1	3.4669	0.288442124	0.96620338	other
Archaic-specific	GWAS	Renal function-related traits (eGRFcrea)	2	5.2297	0.382431115	0.96650335	urinary
Archaic-specific	GWAS	Waist-to-hip ratio adjusted for body mass index	17	25.201	0.674576406	0.96650335	skeletal
Archaic-specific	GWAS	Right lateral prefrontal cortical growth	1	3.4108	0.293186349	0.96660334	nervous
Archaic-specific	GWAS	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 (Grade 1 peripheral neuropathy)	1	3.4482	0.29000638	0.96670333	other
Archaic-specific	GWAS	Periodontal disease-related phenotypes	5	9.8388	0.508192056	0.96690331	immune
Archaic-specific	GWAS	Large artery stroke	1	3.4092	0.293323947	0.96710329	cardiovascular
Archaic-specific	GWAS	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	6	11.2436	0.533636913	0.96810319	endocrine
Archaic-specific	GWAS	Motion sickness	11	17.9462	0.61294313	0.96840316	nervous
Archaic-specific	GWAS	Amyotrophic lateral sclerosis (age of onset)	3	6.9152	0.433826932	0.96860314	nervous
Archaic-specific	GWAS	Renal cell carcinoma	1	3.4517	0.289712316	0.96890311	urinary
Archaic-specific	GWAS	Birth weight	7	12.7277	0.549981536	0.96910309	skeletal
Archaic-specific	GWAS	Fasting blood glucose	3	6.8504	0.437930632	0.96910309	metabolic
Archaic-specific	GWAS	Prudent dietary pattern	5	9.9353	0.503256067	0.96940306	behavior
Archaic-specific	GWAS	Homeostasis model assessment of beta-cell function	1	3.4388	0.290799116	0.96940306	metabolic
Archaic-specific	GWAS	Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	4	8.4039	0.47596949	0.96980302	cardiovascular
Archaic-specific	GWAS	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 (Grade 3 peripheral neuropathy)	1	3.4309	0.291468711	0.97040296	other
Archaic-specific	GWAS	Mean platelet volume	31	42.0577	0.737082627	0.97060294	hematologic
Archaic-specific	GWAS	Restless legs syndrome	11	18.0226	0.610344789	0.97130287	nervous
Archaic-specific	GWAS	Feeling fed-up	5	10.0076	0.499620289	0.97160284	behavior
Archaic-specific	GWAS	Urinary albumin excretion (no hypertensive medication)	2	5.3898	0.371071283	0.97160284	metabolic
Archaic-specific	GWAS	Anxiety in major depressive disorder	1	3.5333	0.283021538	0.97160284	behavior
Archaic-specific	GWAS	Contrast sensitivity	3	7.0649	0.424634461	0.97170283	nervous
Archaic-specific	GWAS	Metabolite levels  (X-11787)	8	14.158	0.565051561	0.97180282	metabolic
Archaic-specific	GWAS	Hippocampal sclerosis	2	5.3751	0.372086101	0.97230277	nervous
Archaic-specific	GWAS	Pulse pressure x alcohol consumption interaction (2df test)	7	12.8242	0.545843016	0.97250275	cardiovascular
Archaic-specific	GWAS	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	2	5.4368	0.367863449	0.97260274	other
Archaic-specific	GWAS	Response to antipsychotic treatment in schizophrenia	1	3.6607	0.273171798	0.97280272	other
Archaic-specific	GWAS	QT interval	23	32.8817	0.699477217	0.97290271	cardiovascular
Archaic-specific	GWAS	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 (Grade 2 peripheral neuropathy)	2	5.5247	0.362010607	0.97290271	other
Archaic-specific	GWAS	Chin dimples	11	18.2151	0.603894571	0.9730027	integumentary
Archaic-specific	GWAS	Nose size	5	10.3557	0.482825883	0.97360264	skeletal
Archaic-specific	GWAS	Insomnia	4	8.5937	0.465457254	0.97380262	behavior
Archaic-specific	GWAS	Mean arterial pressure x alcohol consumption interaction (2df test)	6	11.5752	0.518349575	0.97420258	cardiovascular
Archaic-specific	GWAS	Dimensional psychopathology (Negative)	4	8.6976	0.459896983	0.97480252	behavior
Archaic-specific	GWAS	Tuberculosis (SNP x SNP interaction)	2	5.5852	0.358089236	0.97480252	immune
Archaic-specific	GWAS	Breast milk fatty acid composition (infant genotype effect)	3	7.1759	0.418066027	0.97490251	reproductive
Archaic-specific	GWAS	BRCA1/2-negative high-risk breast cancer	2	5.6188	0.355947889	0.97620238	reproductive
Archaic-specific	GWAS	Cerebrospinal fluid t-tau:AB1-42 ratio	5	10.425	0.479616307	0.97660234	nervous
Archaic-specific	GWAS	Loneliness	23	33.798	0.68051364	0.97710229	behavior
Archaic-specific	GWAS	Chlamydia trachomatis seropositivity	1	3.726	0.268384326	0.97710229	immune
Archaic-specific	GWAS	Initial alcohol sensitivity	4	8.9919	0.444844805	0.97770223	other
Archaic-specific	GWAS	Hypertension	14	22.3281	0.627012598	0.97770223	cardiovascular
Archaic-specific	GWAS	Obstetric antiphospholipid syndrome	1	3.7552	0.266297401	0.97810219	immune
Archaic-specific	GWAS	Breast milk fatty acid composition (maternal genotype effect)	3	7.4382	0.403323385	0.9790021	reproductive
Archaic-specific	GWAS	Body mass index x age interaction	2	5.8292	0.343100254	0.97930207	metabolic
Archaic-specific	GWAS	Monobrow thickness	1	3.8546	0.259430291	0.97950205	integumentary
Archaic-specific	GWAS	BMI in smokers	4	9.0982	0.439647403	0.97950205	metabolic
Archaic-specific	GWAS	Periodontitis (PAL4Q3)	3	7.4985	0.400080016	0.97990201	immune
Archaic-specific	GWAS	Bone mineral density	17	26.6683	0.637460956	0.98010199	skeletal
Archaic-specific	GWAS	Migraine	13	21.4022	0.607414191	0.98020198	nervous
Archaic-specific	GWAS	Fasting plasma glucose	4	9.2432	0.432750563	0.98050195	metabolic
Archaic-specific	GWAS	Resistant hypertension	3	7.7719	0.386005996	0.98050195	cardiovascular
Archaic-specific	GWAS	Virologic severity in Herpes simplex virus type 2 infection	1	3.9213	0.255017469	0.98070193	immune
Archaic-specific	GWAS	Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)	1	3.9201	0.255095533	0.98090191	other
Archaic-specific	GWAS	Subcortical brain region volumes	3	7.4645	0.401902338	0.9810019	nervous
Archaic-specific	GWAS	Body mass index (joint analysis main effects and physical activity interaction)	20	30.1227	0.663951107	0.98110189	metabolic
Archaic-specific	GWAS	Liver enzyme levels (aspartate transaminase)	1	3.917	0.255297421	0.98110189	other
Archaic-specific	GWAS	Skin aging (microtopography measurement)	1	3.9775	0.251414205	0.98160184	integumentary
Archaic-specific	GWAS	Remission after SSRI treatment in MDD or openness	2	5.9288	0.337336392	0.98190181	other
Archaic-specific	GWAS	Bone mineral density (hip)	6	12.1918	0.492134057	0.98190181	skeletal
Archaic-specific	GWAS	Cognitive ability (MTAG)	10	17.5544	0.56965775	0.98230177	nervous
Archaic-specific	GWAS	Sense of smell	4	9.3244	0.428982026	0.98250175	nervous
Archaic-specific	GWAS	Body mass index in physically active individuals	18	27.9723	0.643493742	0.98260174	metabolic
Archaic-specific	GWAS	Axial length	6	12.2276	0.490693186	0.98260174	nervous
Archaic-specific	GWAS	Partial epilepsies	3	7.768	0.386199794	0.98270173	nervous
Archaic-specific	GWAS	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	2	5.9225	0.33769523	0.98280172	other
Archaic-specific	GWAS	Severe gingival inflammation	3	7.7974	0.384743632	0.9830017	immune
Archaic-specific	GWAS	Monobrow	9	16.5629	0.543383103	0.9830017	integumentary
Archaic-specific	GWAS	Obstructive sleep apnea trait (apnea hypopnea index)	3	7.7569	0.38675244	0.98310169	other
Archaic-specific	GWAS	Mortality in sepsis	1	4.0232	0.248558362	0.98310169	other
Archaic-specific	GWAS	Educational attainment	9	16.5141	0.544988828	0.98360164	other
Archaic-specific	GWAS	Hemostatic factors and hematological phenotypes	1	4.029	0.248200546	0.98360164	hematologic
Archaic-specific	GWAS	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	1	4.1783	0.239331786	0.98370163	behavior
Archaic-specific	GWAS	Lung cancer in ever smokers	14	23.2577	0.601951182	0.98410159	respiratory
Archaic-specific	GWAS	Pulmonary function	9	16.7792	0.536378373	0.98460154	respiratory
Archaic-specific	GWAS	Immune reponse to smallpox (secreted IL-2)	3	7.8712	0.381136294	0.98460154	immune
Archaic-specific	GWAS	Red blood cell density in sickle cell anemia	1	4.229	0.236462521	0.98470153	hematologic
Archaic-specific	GWAS	Response to fenofibrate (adiponectin levels)	6	12.4465	0.482063231	0.98480152	other
Archaic-specific	GWAS	Age at voice drop	2	6.2675	0.319106502	0.98490151	endocrine
Archaic-specific	GWAS	Asperger disorder	1	4.3453	0.230133708	0.98510149	behavior
Archaic-specific	GWAS	Multiple system atrophy (pathologically confirmed)	2	6.1734	0.323970583	0.98520148	nervous
Archaic-specific	GWAS	Nickel levels	8	15.1857	0.526811408	0.98530147	other
Archaic-specific	GWAS	Diastolic blood pressure response to hydrochlorothiazide in hypertension	1	4.1609	0.24033262	0.98540146	cardiovascular
Archaic-specific	GWAS	Cardiac structure and function	2	6.1773	0.323766047	0.9860014	cardiovascular
Archaic-specific	GWAS	Urinary albumin-to-creatinine ratio	1	4.2401	0.235843494	0.98620138	metabolic
Archaic-specific	GWAS	Aging	3	7.8348	0.38290703	0.98650135	other
Archaic-specific	GWAS	Metabolite levels (Pyroglutamine)	4	9.6387	0.414993723	0.98670133	metabolic
Archaic-specific	GWAS	Knee osteoarthritis	3	8.236	0.364254492	0.9870013	skeletal
Archaic-specific	GWAS	Attention deficit hyperactivity disorder symptom score	1	4.2513	0.235222167	0.9870013	behavior
Archaic-specific	GWAS	Emphysema-related traits	7	14.0031	0.49988931	0.9870013	respiratory
Archaic-specific	GWAS	Reaction time	5	11.3541	0.440369558	0.98720128	behavior
Archaic-specific	GWAS	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes	11	19.7203	0.557800845	0.98750125	cardiovascular
Archaic-specific	GWAS	Airway imaging phenotypes	2	6.4182	0.311613848	0.98760124	respiratory
Archaic-specific	GWAS	Western dietary pattern	3	8.0548	0.372448726	0.98760124	behavior
Archaic-specific	GWAS	Response to SSRI in MDD or openness	2	6.5248	0.306522805	0.9880012	other
Archaic-specific	GWAS	Non-response to antidepressants and depression	3	8.1814	0.366685408	0.9880012	other
Archaic-specific	GWAS	Parkinson's disease	19	30.0884	0.631472594	0.9880012	nervous
Archaic-specific	GWAS	Inflammatory skin disease	15	25.06	0.598563448	0.98830117	integumentary
Archaic-specific	GWAS	Putamen volume	2	6.2115	0.321983418	0.98840116	nervous
Archaic-specific	GWAS	Asthma and hay fever	2	6.4531	0.309928561	0.98840116	respiratory
Archaic-specific	GWAS	Recalcitrant atopic dermatitis	1	4.3829	0.228159438	0.98850115	integumentary
Archaic-specific	GWAS	Disc degeneration (lumbar)	2	6.56	0.304878049	0.98880112	skeletal
Archaic-specific	GWAS	Itch intensity from mosquito bite	5	11.5815	0.431723007	0.98920108	immune
Archaic-specific	GWAS	Lead levels	2	6.4853	0.308389743	0.98930107	other
Archaic-specific	GWAS	Clozapine-induced cytotoxicity	1	4.5358	0.220468275	0.98940106	other
Archaic-specific	GWAS	Subcutaneous adipose tissue	13	22.7312	0.571901175	0.98960104	metabolic
Archaic-specific	GWAS	Alcohol consumption	3	8.6192	0.348060145	0.98980102	behavior
Archaic-specific	GWAS	Carboplatin disposition in epthelial ovarian cancer	2	6.6505	0.300729268	0.98980102	other
Archaic-specific	GWAS	Hypothyroidism	10	18.9833	0.5267788	0.98990101	endocrine
Archaic-specific	GWAS	Chloride levels	2	6.7323	0.297075294	0.990001	other
Archaic-specific	GWAS	Pulmonary function (smoking interaction)	7	14.7057	0.476005902	0.99030097	respiratory
Archaic-specific	GWAS	Superior frontal gyrus grey matter volume	1	4.8185	0.207533465	0.99030097	nervous
Archaic-specific	GWAS	Lung cancer in never smokers	3	8.4809	0.353736042	0.99060094	respiratory
Archaic-specific	GWAS	Sodium levels	1	4.7246	0.21165813	0.99070093	other
Archaic-specific	GWAS	Cognitive ability	10	18.6831	0.535243081	0.99080092	nervous
Archaic-specific	GWAS	Migraine - clinic-based	1	4.7564	0.210243041	0.99110089	nervous
Archaic-specific	GWAS	BMI in non-smokers	11	20.0498	0.548633902	0.99110089	metabolic
Archaic-specific	GWAS	Glaucoma (primary open-angle)	13	23.3741	0.556171147	0.99130087	nervous
Archaic-specific	GWAS	Logical memory (delayed recall) in normal cognition	6	12.9994	0.461559764	0.99130087	nervous
Archaic-specific	GWAS	Mammographic density (dense area)	1	4.8523	0.206087835	0.99140086	reproductive
Archaic-specific	GWAS	Electrodermal activity	2	6.9408	0.288151222	0.99140086	integumentary
Archaic-specific	GWAS	Spherical equivalent (joint analysis main effects and education interaction)	3	8.6823	0.345530562	0.99150085	nervous
Archaic-specific	GWAS	Iris color (a* coordinate)	1	4.758	0.210172341	0.99150085	integumentary
Archaic-specific	GWAS	Multiple sclerosis	31	45.7837	0.677096871	0.99170083	nervous
Archaic-specific	GWAS	Forced expiratory volume in 1 second (occupational environmental exposures interaction)	2	6.8054	0.293884268	0.99180082	respiratory
Archaic-specific	GWAS	Waist-to-hip ratio adjusted for BMI in non-smokers	1	4.5511	0.219727099	0.99190081	skeletal
Archaic-specific	GWAS	Schizophrenia	129	157.4981	0.8190575	0.99190081	behavior
Archaic-specific	GWAS	Uterine fibroid size (maximum volume)	4	10.4091	0.38427914	0.99230077	reproductive
Archaic-specific	GWAS	Food allergy	1	4.6242	0.216253622	0.99240076	immune
Archaic-specific	GWAS	Obesity	15	26.0571	0.575658842	0.99260074	metabolic
Archaic-specific	GWAS	JT interval (sulfonylurea treatment interaction)	2	7.0858	0.28225465	0.99290071	cardiovascular
Archaic-specific	GWAS	Vigorous physical activity	1	5.1593	0.193824744	0.99330067	behavior
Archaic-specific	GWAS	Palmitic acid (16:0) levels	3	9.069	0.330797221	0.99350065	other
Archaic-specific	GWAS	Obstructive sleep apnea trait (average respiratory event duration)	4	10.4853	0.381486462	0.99350065	other
Archaic-specific	GWAS	Lung function (FEV1/FVC)	14	25.1845	0.555897477	0.99370063	respiratory
Archaic-specific	GWAS	Exhaled nitric oxide output	1	5.2129	0.191831802	0.99380062	respiratory
Archaic-specific	GWAS	Diastolic blood pressure x alcohol consumption interaction (2df test)	7	15.3143	0.457089126	0.99380062	cardiovascular
Archaic-specific	GWAS	Exhaled nitric oxide levels	1	5.2129	0.191831802	0.99380062	respiratory
Archaic-specific	GWAS	Nicotine dependence and major depression (severity of comorbidity)	6	13.8616	0.432850465	0.99380062	behavior
Archaic-specific	GWAS	Glomerular filtration rate (creatinine)	10	19.6724	0.508326386	0.99390061	hematologic
Archaic-specific	GWAS	Response to antipsychotic treatment in schizophrenia (reasoning)	1	5.1131	0.195576069	0.99390061	other
Archaic-specific	GWAS	Glomerular filtration rate in chronic kidney disease	2	7.2926	0.27425061	0.99390061	hematologic
Archaic-specific	GWAS	Gut microbiota (beta diversity)	6	13.6649	0.43908115	0.99420058	digestive
Archaic-specific	GWAS	Chronic obstructive pulmonary disease	4	10.6091	0.37703481	0.99420058	respiratory
Archaic-specific	GWAS	Osteoporosis-related phenotypes	1	5.1896	0.192693078	0.99460054	skeletal
Archaic-specific	GWAS	Cadmium levels	6	13.9541	0.429981152	0.99480052	other
Archaic-specific	GWAS	Nicotine dependence	3	8.9246	0.336149519	0.99480052	behavior
Archaic-specific	GWAS	Attention function in attention deficit hyperactive disorder	3	9.1119	0.329239785	0.99490051	behavior
Archaic-specific	GWAS	Gastroesophageal reflux disease	5	12.3854	0.403701132	0.99490051	digestive
Archaic-specific	GWAS	Molybdenum levels	2	7.8447	0.254949201	0.99520048	other
Archaic-specific	GWAS	Experiencing mood swings	10	20.0781	0.498055095	0.99520048	behavior
Archaic-specific	GWAS	Alzheimer's disease biomarkers	2	7.5651	0.264371918	0.99530047	nervous
Archaic-specific	GWAS	Periodontitis (CDC/AAP)	9	18.7206	0.480753822	0.99540046	immune
Archaic-specific	GWAS	Visceral adipose tissue/subcutaneous adipose tissue ratio	10	19.9194	0.502023153	0.99540046	metabolic
Archaic-specific	GWAS	Pursuit maintenance gain	23	36.9963	0.62168379	0.99540046	skeletal muscle
Archaic-specific	GWAS	Extraversion	1	5.3721	0.186146944	0.99550045	behavior
Archaic-specific	GWAS	Response to bupropion in depression	4	11.0451	0.362151542	0.99550045	other
Archaic-specific	GWAS	Mosquito bite size	20	33.4283	0.598295456	0.99550045	other
Archaic-specific	GWAS	Cobalt levels	3	9.4391	0.317826911	0.99550045	other
Archaic-specific	GWAS	Interleukin-6 levels	1	5.5047	0.181662943	0.99550045	immune
Archaic-specific	GWAS	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	5	12.5271	0.399134676	0.99560044	other
Archaic-specific	GWAS	Bone mineral density (femoral neck)	1	5.6	0.178571429	0.99570043	skeletal
Archaic-specific	GWAS	Energy expenditure (24h)	1	5.2758	0.189544714	0.99570043	behavior
Archaic-specific	GWAS	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)	5	12.6766	0.394427528	0.99570043	skeletal
Archaic-specific	GWAS	Toenail selenium levels	9	18.9555	0.474796233	0.99570043	other
Archaic-specific	GWAS	Body mass index (change over time)	1	5.6783	0.176109047	0.99580042	metabolic
Archaic-specific	GWAS	Myopia	18	30.8964	0.582592147	0.99590041	nervous
Archaic-specific	GWAS	Manganese levels	5	12.8946	0.387759217	0.99590041	other
Archaic-specific	GWAS	QRS interval (sulfonylurea treatment interaction)	5	13.2634	0.376977246	0.99610039	cardiovascular
Archaic-specific	GWAS	Neuroticism	15	27.9599	0.536482605	0.99610039	behavior
Archaic-specific	GWAS	Neuritic plaque	5	12.928	0.386757426	0.99620038	nervous
Archaic-specific	GWAS	Phospholipid levels (plasma)	2	7.7769	0.257171881	0.99620038	metabolic
Archaic-specific	GWAS	Alcohol consumption (maxi-drinks)	1	5.6909	0.175719131	0.99620038	behavior
Archaic-specific	GWAS	Macular thickness	26	41.9732	0.619442883	0.99640036	nervous
Archaic-specific	GWAS	Blood sugar levels	2	7.6558	0.261239844	0.99640036	metabolic
Archaic-specific	GWAS	Survival in pancreatic cancer	2	8.1151	0.246454141	0.99650035	other
Archaic-specific	GWAS	Isovolumetric relaxation time	1	5.8692	0.170380972	0.99680032	cardiovascular
Archaic-specific	GWAS	Protein quantitative trait loci	8	17.5169	0.456701814	0.99690031	other
Archaic-specific	GWAS	Feeling hurt	4	11.677	0.342553738	0.99690031	behavior
Archaic-specific	GWAS	Cardiac hypertrophy	2	7.8117	0.256026217	0.99710029	cardiovascular
Archaic-specific	GWAS	Colorectal or endometrial cancer	2	8.236	0.242836328	0.99710029	digestive
Archaic-specific	GWAS	Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)	1	5.8585	0.170692157	0.99710029	skeletal
Archaic-specific	GWAS	Blood pressure measurement (high sodium intervention)	4	11.6579	0.343114969	0.99720028	hematologic
Archaic-specific	GWAS	Aluminium levels	2	7.8182	0.255813359	0.99720028	other
Archaic-specific	GWAS	Blood pressure (smoking interaction)	12	23.9652	0.500726053	0.99740026	hematologic
Archaic-specific	GWAS	Lifetime average cigarettes per day in chronic obstructive pulmonary disease	1	5.9074	0.169279209	0.99740026	behavior
Archaic-specific	GWAS	Systemic juvenile idiopathic arthritis	4	12.326	0.324517281	0.99750025	immune
Archaic-specific	GWAS	Cognitive decline rate in late mild cognitive impairment	23	38.6762	0.594680967	0.99750025	nervous
Archaic-specific	GWAS	White matter hyperintensities in ischemic stroke	2	8.2681	0.241893543	0.99760024	nervous
Archaic-specific	GWAS	Cognitive decline (age-related)	7	16.6678	0.419971442	0.99760024	nervous
Archaic-specific	GWAS	Response to zileuton treatment in asthma (FEV1 change interaction)	2	8.1598	0.245104047	0.99760024	other
Archaic-specific	GWAS	BMI (adjusted for smoking behaviour)	13	25.1222	0.517470604	0.99760024	metabolic
Archaic-specific	GWAS	Anti-saccade response	9	19.1563	0.469819328	0.99770023	nervous
Archaic-specific	GWAS	Dental caries	8	18.6047	0.429998871	0.99770023	skeletal
Archaic-specific	GWAS	Endometrial cancer (endometrioid histology)	6	15.385	0.38999025	0.99770023	reproductive
Archaic-specific	GWAS	Body mass index (joint analysis main effects and smoking interaction)	13	25.0604	0.518746708	0.99780022	metabolic
Archaic-specific	GWAS	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	4	12.3294	0.32442779	0.99780022	other
Archaic-specific	GWAS	Adverse response to lamotrigine and phenytoin	2	8.247	0.242512429	0.99790021	other
Archaic-specific	GWAS	Coronary artery aneurysm in Kawasaki disease	14	27.6437	0.506444506	0.9980002	cardiovascular
Archaic-specific	GWAS	Orofacial clefts	3	10.411	0.288156757	0.9980002	other
Archaic-specific	GWAS	Mitochondrial DNA levels	5	13.8226	0.361726448	0.99820018	other
Archaic-specific	GWAS	Cognitive performance	12	25.1385	0.477355451	0.99820018	nervous
Archaic-specific	GWAS	Autism	2	8.771	0.228024171	0.99820018	behavior
Archaic-specific	GWAS	Serum uric acid levels in response to allopurinol in gout	2	8.5591	0.233669428	0.99830017	other
Archaic-specific	GWAS	Alzheimer's disease in APOE e4- carriers	2	9.018	0.221778665	0.99840016	nervous
Archaic-specific	GWAS	Airflow obstruction	5	13.5739	0.368353973	0.99850015	respiratory
Archaic-specific	GWAS	Alzheimer disease and age of onset	1	6.7104	0.149022413	0.99870013	nervous
Archaic-specific	GWAS	Hand grip strength	31	50.0207	0.619743426	0.99870013	skeletal muscle
Archaic-specific	GWAS	Refractive astigmatism	13	27.0627	0.480365965	0.99870013	nervous
Archaic-specific	GWAS	Anorexia nervosa	9	20.6733	0.43534414	0.99880012	behavior
Archaic-specific	GWAS	Uterine fibroids	8	18.9267	0.422683299	0.99880012	reproductive
Archaic-specific	GWAS	Cerebrospinal T-tau levels	8	19.9792	0.400416433	0.99880012	nervous
Archaic-specific	GWAS	Loneliness (multivariate analysis)	5	14.897	0.335638048	0.9990001	behavior
Archaic-specific	GWAS	Peripheral artery disease	1	6.8649	0.145668546	0.9990001	cardiovascular
Archaic-specific	GWAS	Multiple system atrophy	5	15.1664	0.329676126	0.99910009	nervous
Archaic-specific	GWAS	Itch intensity from mosquito bite adjusted by bite size	21	38.3081	0.548186937	0.99910009	immune
Archaic-specific	GWAS	Post bronchodilator FEV1 in COPD	9	21.6334	0.416023371	0.99910009	other
Archaic-specific	GWAS	Temperament	7	17.9954	0.388988297	0.99910009	behavior
Archaic-specific	GWAS	Male-pattern baldness	23	40.5491	0.567213576	0.99920008	integumentary
Archaic-specific	GWAS	Myopia (pathological)	11	24.5415	0.448220361	0.99920008	nervous
Archaic-specific	GWAS	Upper eyelid sagging severity	1	7.2782	0.137396609	0.99920008	integumentary
Archaic-specific	GWAS	Depression (quantitative trait)	3	10.9883	0.273017664	0.99920008	behavior
Archaic-specific	GWAS	Plasma parathyroid hormone levels	3	10.7348	0.279464918	0.99920008	endocrine
Archaic-specific	GWAS	Cerebrospinal P-tau181p levels	6	16.3147	0.367766493	0.99920008	nervous
Archaic-specific	GWAS	"Schizophrenia, schizoaffective disorder or bipolar disorder"	3	11.4113	0.262897304	0.99930007	behavior
Archaic-specific	GWAS	Post bronchodilator FEV1	31	51.8468	0.597915397	0.99930007	other
Archaic-specific	GWAS	Intracranial aneurysm	11	25.5584	0.430386879	0.99930007	nervous
Archaic-specific	GWAS	Immune response to measles-mumps-rubella vaccine	3	11.2918	0.26567952	0.99930007	immune
Archaic-specific	GWAS	Hip shape (DXA scan)	1	6.8106	0.146829942	0.99930007	skeletal
Archaic-specific	GWAS	Daytime sleep phenotypes	28	48.0446	0.582791823	0.99940006	behavior
Archaic-specific	GWAS	Pulmonary function decline	7	18.7504	0.373325369	0.99940006	respiratory
Archaic-specific	GWAS	Eating disorders	3	11.9377	0.25130469	0.99940006	behavior
Archaic-specific	GWAS	Methadone dose in opioid dependence	7	18.914	0.370096225	0.99950005	other
Archaic-specific	GWAS	Dementia and core Alzheimer's disease neuropathologic changes	5	14.4857	0.345167993	0.99950005	nervous
Archaic-specific	GWAS	Resting-state electroencephalogram vigilance	5	16.43	0.304321363	0.99950005	nervous
Archaic-specific	GWAS	Emphysema imaging phenotypes	6	17.5014	0.342829716	0.99950005	respiratory
Archaic-specific	GWAS	Pulse pressure	98	131.1481	0.747246815	0.99950005	cardiovascular
Archaic-specific	GWAS	Spherical equivalent or myopia (age of diagnosis)	32	56.1322	0.570082769	0.99950005	nervous
Archaic-specific	GWAS	Personality dimensions	4	15.5009	0.258049533	0.99950005	behavior
Archaic-specific	GWAS	Bronchopulmonary dysplasia	7	19.3814	0.36117102	0.99950005	respiratory
Archaic-specific	GWAS	Venous thromboembolism adjusted for sickle cell variant rs77121243-T	12	27.3502	0.438753647	0.99950005	hematologic
Archaic-specific	GWAS	Platelet aggregation	3	11.3928	0.263324205	0.99960004	hematologic
Archaic-specific	GWAS	Rosacea symptom severity	26	46.4787	0.559396024	0.99960004	integumentary
Archaic-specific	GWAS	Breast cancer	23	44.5704	0.51603755	0.99960004	reproductive
Archaic-specific	GWAS	"Type 2 diabetes (SNP x SNP interaction, 1df)"	3	12.1343	0.24723305	0.99960004	metabolic
Archaic-specific	GWAS	Angiotensin-converting enzyme inhibitor intolerance	10	22.6936	0.440652871	0.99960004	other
Archaic-specific	GWAS	Sudden cardiac arrest	5	16.1556	0.309490208	0.99960004	cardiovascular
Archaic-specific	GWAS	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes	3	12.4729	0.240521451	0.99960004	cardiovascular
Archaic-specific	GWAS	Verbal declarative memory	5	15.5603	0.321330566	0.99970003	nervous
Archaic-specific	GWAS	Eye morphology	1	7.882	0.126871352	0.99970003	nervous
Archaic-specific	GWAS	Obsessive-compulsive disorder	6	17.9472	0.334313988	0.99970003	behavior
Archaic-specific	GWAS	Major depressive disorder	31	53.4862	0.579588754	0.99970003	behavior
Archaic-specific	GWAS	Post bronchodilator FEV1/FVC ratio in COPD	9	22.8318	0.394187055	0.99970003	other
Archaic-specific	GWAS	Post-traumatic stress disorder	6	16.6382	0.360615932	0.99970003	behavior
Archaic-specific	GWAS	Response to methotrexate in juvenile idiopathic arthritis	9	23.3402	0.385600809	0.99980002	other
Archaic-specific	GWAS	Photic sneeze reflex	17	36.6213	0.464210719	0.99980002	nervous
Archaic-specific	GWAS	Osteoarthritis biomarkers	2	10.7319	0.18636029	0.99980002	skeletal
Archaic-specific	GWAS	Insulin resistance/response	4	14.7747	0.270733077	0.99980002	immune
Archaic-specific	GWAS	Neurocognitive impairment in HIV-1 infection (dichotomous)	3	14.0174	0.214019718	0.99980002	nervous
Archaic-specific	GWAS	Nasopharyngeal carcinoma (SNP x SNP interaction)	17	35.0203	0.485432735	0.99980002	other
Archaic-specific	GWAS	Bipolar disorder and schizophrenia	7	21.3359	0.328085527	0.99980002	behavior
Archaic-specific	GWAS	Multiple keratinocyte cancers	2	10.6209	0.188307959	0.99980002	integumentary
Archaic-specific	GWAS	Type 2 diabetes	66	98.7201	0.668556859	0.99980002	metabolic
Archaic-specific	GWAS	Familial squamous cell lung carcinoma	8	22.755	0.351571083	0.99990001	respiratory
Archaic-specific	GWAS	Neurociticism	20	39.6705	0.50415296	0.99990001	behavior
Archaic-specific	GWAS	Airway responsiveness in chronic obstructive pulmonary disease	4	18.5728	0.215368711	0.99990001	respiratory
Archaic-specific	GWAS	Severe influenza A (H1N1) infection	3	14.5693	0.205912432	0.99990001	immune
Archaic-specific	GWAS	Asthma	31	54.4495	0.569334888	0.99990001	respiratory
Archaic-specific	GWAS	Response to antipsychotic treatment	5	18.5478	0.26957375	0.99990001	other
Archaic-specific	GWAS	Chronic bronchitis and chronic obstructive pulmonary disease	2	12.4094	0.161168147	0.99990001	respiratory
Archaic-specific	GWAS	Eating disorders (purging via substances)	3	12.6	0.238095238	1	behavior
Archaic-specific	GWAS	Cognitive function	6	23.7074	0.253085534	1	nervous
Archaic-specific	GWAS	Aggressiveness in attention deficit hyperactivity disorder	2	12.3707	0.161672339	1	behavior
Archaic-specific	GWAS	Epstein-Barr virus copy number in lymphoblastoid cell lines	11	32.9039	0.334306875	1	immune
Archaic-specific	GWAS	Immune response to smallpox vaccine (IL-6)	8	24.5679	0.325628157	1	immune
Archaic-specific	GWAS	Alzheimer's disease (cognitive decline)	10	38.0642	0.262714046	1	nervous
Archaic-specific	GWAS	Longevity	13	42.7408	0.304159024	1	other
Archaic-specific	GWAS	Late-onset Alzheimer's disease	5	17.5673	0.28461972	1	nervous
Archaic-specific	GWAS	Night sleep phenotypes	79	116.9204	0.675673364	1	behavior
Archaic-specific	GWAS	Endometriosis	5	17.4129	0.28714344	1	reproductive
Archaic-specific	GWAS	Heel bone mineral density	143	194.7048	0.73444517	1	skeletal
Archaic-specific	GWAS	Cannabis dependence symptom count	2	15.2103	0.131489846	1	behavior
Archaic-specific	GWAS	Intelligence (MTAG)	37	77.8516	0.475263193	1	other
Archaic-specific	GWAS	Iris color (b* coordinate)	2	11.446	0.174733531	1	integumentary
Archaic-specific	GWAS	Coronary artery calcification	6	19.6119	0.305936702	1	cardiovascular
Archaic-specific	GWAS	Diisocyanate-induced asthma	33	59.5958	0.553730296	1	respiratory
Archaic-specific	GWAS	Obesity-related traits	136	253.371	0.536762297	1	metabolic
Archaic-specific	GWAS	Triptolide cytotoxicity	2	12.2127	0.163763951	1	other
Archaic-specific	GWAS	Urate levels (BMI interaction)	2	12.5276	0.159647498	1	metabolic
Archaic-specific	GWAS	Systolic blood pressure in sickle cell anemia	3	15.3072	0.195986203	1	cardiovascular
Archaic-specific	GWAS	Post bronchodilator FEV1/FVC ratio	50	95.4231	0.523982138	1	other
Archaic-specific	GWAS	Body mass index	145	228.1457	0.635558768	1	metabolic
Archaic-specific	GWAS	"Autism spectrum disorder, ADHD, bipolar disorder, MDD, and schizophrenia (combined)"	12	33.9853	0.353093838	1	behavior
Archaic-specific	GWAS	General cognitive ability	21	65.1369	0.322397903	1	nervous
Archaic-specific	GWAS	Response to amphetamines	11	29.7315	0.369977969	1	other
Archaic-specific	GWAS	Severe malaria (adjusted for sickle cell variant rs334)	2	13.0999	0.152672921	1	immune
Archaic-specific	GWAS	Severe malaria	3	15.3569	0.195351926	1	immune
Archaic-specific	GWAS	Amyotrophic lateral sclerosis (sporadic)	29	63.4873	0.45678427	1	nervous
Archaic-specific	GWAS	"Type 2 diabetes (SNP x SNP interaction, 2df)"	3	16.9093	0.177417161	1	metabolic
Archaic-specific	GWAS	Systolic blood pressure	91	158.6599	0.573553872	1	cardiovascular
Archaic-specific	GWAS	Waist-hip ratio	13	30.6504	0.424138021	1	skeletal
Archaic-specific	GWAS	Monoclonal gammopathy of undetermined significance	17	40.6395	0.418312233	1	hematologic
Archaic-specific	GWAS	Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes	10	28.6802	0.348672603	1	cardiovascular
Archaic-specific	GWAS	Attention deficit hyperactivity disorder	16	35.5369	0.450236233	1	behavior
Archaic-specific	GWAS	Urinary albumin excretion	6	22.1908	0.270382321	1	metabolic
Archaic-specific	GWAS	Visceral fat	1	14.4364	0.069269347	1	metabolic
Archaic-specific	GWAS	Menarche (age at onset)	39	79.1927	0.492469634	1	reproductive
Archaic-specific	GWAS	Cerebrospinal fluid clusterin levels	5	18.3477	0.272513721	1	nervous
Archaic-specific	GWAS	Diastolic blood pressure	94	142.7306	0.658583373	1	cardiovascular
Archaic-specific	GWAS	Presence of antiphospholipid antibodies	1	9.2259	0.108390509	1	other
Archaic-specific	GWAS	Percentage gas trapping	2	15.2195	0.131410362	1	metabolic
Archaic-specific	HPO	Abnormality of renal excretion (HP:0011036)	11	1.8874	5.828123344	1.00E-04	urinary
Archaic-specific	HPO	Generalized amyotrophy (HP:0003700)	9	1.4564	6.179620983	1.00E-04	nervous
Archaic-specific	HPO	Blindness (HP:0000618)	22	8.9239	2.46528984	1.00E-04	nervous
Archaic-specific	HPO	Type 1 muscle fiber predominance (HP:0003803)	8	1.2715	6.291781361	1.00E-04	skeletal muscle
Archaic-specific	HPO	Increased variability in muscle fiber diameter (HP:0003557)	9	1.6115	5.584858827	1.00E-04	skeletal muscle
Archaic-specific	HPO	Slender build (HP:0001533)	7	1.0012	6.991610068	1.00E-04	other
Archaic-specific	HPO	Increased connective tissue (HP:0009025)	8	1.3241	6.04183974	1.00E-04	other
Archaic-specific	HPO	Prolonged bleeding time (HP:0003010)	12	3.0561	3.926573083	1.00E-04	hematologic
Archaic-specific	HPO	Limb-girdle muscle weakness (HP:0003325)	11	2.4381	4.511709938	1.00E-04	skeletal muscle
Archaic-specific	HPO	Abnormality of skeletal muscle fiber size (HP:0012084)	9	1.6337	5.508967375	1.00E-04	skeletal muscle
Archaic-specific	HPO	Mildly elevated creatine phosphokinase (HP:0008180)	9	1.5213	5.915992901	1.00E-04	other
Archaic-specific	HPO	Abnormality of macrophages (HP:0004311)	6	0.7345	8.168822328	1.00E-04	immune
Archaic-specific	HPO	Epistaxis (HP:0000421)	15	4.7277	3.172790152	1.00E-04	other
Archaic-specific	HPO	Polyuria (HP:0000103)	10	1.3251	7.546600257	1.00E-04	urinary
Archaic-specific	HPO	Hypoventilation (HP:0002791)	8	1.2422	6.440186765	1.00E-04	respiratory
Archaic-specific	HPO	Abnormal urine output (HP:0012590)	11	1.566	7.024265645	1.00E-04	urinary
Archaic-specific	HPO	Follicular hyperkeratosis (HP:0007502)	7	0.7294	9.596928983	1.00E-04	integumentary
Archaic-specific	HPO	Spinal rigidity (HP:0003306)	12	1.886	6.362672322	1.00E-04	skeletal
Archaic-specific	HPO	Recurrent lower respiratory tract infections (HP:0002783)	13	3.9241	3.312861548	0.00019998	immune
Archaic-specific	HPO	Ankle contracture (HP:0006466)	7	1.0676	6.556762833	0.00019998	skeletal muscle
Archaic-specific	HPO	Autosomal recessive inheritance (HP:0000007)	284	227.1738	1.250144163	0.00019998	other
Archaic-specific	HPO	Ependymoma (HP:0002888)	5	0.6317	7.915149596	0.00039996	nervous
Archaic-specific	HPO	Aplasia cutis congenita (HP:0001057)	6	0.9452	6.347862886	0.00049995	integumentary
Archaic-specific	HPO	Abnormal drinking behavior (HP:0030082)	6	0.8211	7.307270734	0.00059994	behavior
Archaic-specific	HPO	Adenoma sebaceum (HP:0009720)	6	0.9949	6.03075686	0.00059994	integumentary
Archaic-specific	HPO	Polydipsia (HP:0001959)	6	0.8211	7.307270734	0.00059994	other
Archaic-specific	HPO	Angiofibromas (HP:0010615)	6	0.9949	6.03075686	0.00059994	cardiovascular
Archaic-specific	HPO	Bilateral sensorineural hearing impairment (HP:0008619)	6	0.9816	6.112469438	0.00059994	nervous
Archaic-specific	HPO	Hypermelanotic macule (HP:0001034)	17	6.235	2.726543705	0.00069993	integumentary
Archaic-specific	HPO	Skull defect (HP:0001362)	13	4.503	2.886964246	0.00079992	skeletal
Archaic-specific	HPO	Abnormal blistering of the skin (HP:0008066)	17	7.0027	2.427635055	0.00109989	integumentary
Archaic-specific	HPO	Skin nodule (HP:0200036)	7	1.3707	5.106879697	0.00109989	integumentary
Archaic-specific	HPO	Congestive heart failure (HP:0001635)	24	11.9587	2.006907105	0.00109989	cardiovascular
Archaic-specific	HPO	Pulmonary infiltrates (HP:0002113)	10	2.9843	3.350869551	0.00109989	respiratory
Archaic-specific	HPO	Pointed chin (HP:0000307)	17	7.5849	2.241295205	0.00159984	skeletal
Archaic-specific	HPO	Lymphangioma (HP:0100764)	7	1.4789	4.733247684	0.00169983	lymphatic
Archaic-specific	HPO	Stage 5 chronic kidney disease (HP:0003774)	14	5.5713	2.512878502	0.00169983	urinary
Archaic-specific	HPO	Hyperhidrosis (HP:0000975)	18	8.2482	2.182294319	0.00179982	integumentary
Archaic-specific	HPO	Atelectasis (HP:0100750)	6	1.1702	5.127328662	0.00189981	respiratory
Archaic-specific	HPO	Calf muscle hypertrophy (HP:0008981)	4	0.5696	7.02247191	0.00189981	skeletal muscle
Archaic-specific	HPO	Neonatal hypotonia (HP:0001319)	22	10.9358	2.011741253	0.00209979	skeletal muscle
Archaic-specific	HPO	Polygenic inheritance (HP:0010982)	6	1.3521	4.437541602	0.00229977	other
Archaic-specific	HPO	Vomiting (HP:0002013)	19	9.1086	2.085940759	0.00239976	digestive
Archaic-specific	HPO	Milia (HP:0001056)	7	1.6254	4.306632214	0.00249975	integumentary
Archaic-specific	HPO	Muscle hypertrophy of the lower extremities (HP:0008968)	4	0.6495	6.158583526	0.0029997	skeletal muscle
Archaic-specific	HPO	Progressive sensorineural hearing impairment (HP:0000408)	6	1.4009	4.282960954	0.0029997	nervous
Archaic-specific	HPO	Abnormality of sodium homeostasis (HP:0010931)	8	2.411	3.318125259	0.00309969	other
Archaic-specific	HPO	Lumbar hyperlordosis (HP:0002938)	15	6.4954	2.3093266	0.00309969	skeletal
Archaic-specific	HPO	Exercise-induced myalgia (HP:0003738)	4	0.5934	6.740815639	0.00329967	skeletal muscle
Archaic-specific	HPO	Premature ovarian failure (HP:0008209)	4	0.5547	7.211105102	0.00359964	reproductive
Archaic-specific	HPO	Hypopigmented skin patches (HP:0001053)	17	7.9573	2.136403051	0.00389961	integumentary
Archaic-specific	HPO	Abnormality of the lower motor neuron (HP:0002366)	4	0.6532	6.123698714	0.0039996	nervous
Archaic-specific	HPO	Oligodontia (HP:0000677)	7	2.0108	3.481201512	0.00409959	skeletal
Archaic-specific	HPO	Rimmed vacuoles (HP:0003805)	5	1.0235	4.885197851	0.00419958	skeletal muscle
Archaic-specific	HPO	Polycystic kidney dysplasia (HP:0000113)	19	9.4785	2.004536583	0.00419958	urinary
Archaic-specific	HPO	Proteinuria (HP:0000093)	22	11.7212	1.876940928	0.00479952	other
Archaic-specific	HPO	Abnormality of transition element cation homeostasis (HP:0011030)	5	1.0337	4.836993325	0.00479952	other
Archaic-specific	HPO	Cafe-au-lait spot (HP:0000957)	15	6.7474	2.223078519	0.00489951	integumentary
Archaic-specific	HPO	Renal cell carcinoma (HP:0005584)	14	6.173	2.267941034	0.00539946	urinary
Archaic-specific	HPO	Increased serum ferritin (HP:0003281)	4	0.6649	6.015942247	0.00549945	other
Archaic-specific	HPO	Nail dystrophy (HP:0008404)	9	3.1789	2.831168014	0.00559944	integumentary
Archaic-specific	HPO	Abnormal platelet volume (HP:0011876)	6	1.5913	3.770502105	0.00569943	hematologic
Archaic-specific	HPO	Increased mean platelet volume (HP:0011877)	6	1.5913	3.770502105	0.00569943	hematologic
Archaic-specific	HPO	Polyhydramnios (HP:0001561)	21	11.0963	1.892522733	0.00589941	reproductive
Archaic-specific	HPO	Hypomagnesemia (HP:0002917)	5	1.0518	4.753755467	0.00609939	other
Archaic-specific	HPO	Sacral dimple (HP:0000960)	15	7.002	2.142245073	0.00609939	integumentary
Archaic-specific	HPO	Abdominal pain (HP:0002027)	19	9.8098	1.936838672	0.00619938	other
Archaic-specific	HPO	Multifactorial inheritance (HP:0001426)	7	2.174	3.219871205	0.00649935	other
Archaic-specific	HPO	Malignant hyperthermia (HP:0002047)	6	1.6166	3.711493257	0.00719928	immune
Archaic-specific	HPO	Generalized aminoaciduria (HP:0002909)	3	0.392	7.653061224	0.00719928	urinary
Archaic-specific	HPO	Carious teeth (HP:0000670)	23	12.9475	1.776404711	0.00749925	skeletal
Archaic-specific	HPO	Neuroepithelial neoplasm (HP:0030063)	11	4.6915	2.344665885	0.00759924	nervous
Archaic-specific	HPO	Neuroectodermal neoplasm (HP:0030061)	11	4.6915	2.344665885	0.00759924	nervous
Archaic-specific	HPO	Nervous tissue neoplasm (HP:0030060)	11	4.6915	2.344665885	0.00759924	nervous
Archaic-specific	HPO	Neoplasm of the heart (HP:0100544)	4	0.8066	4.959087528	0.00769923	cardiovascular
Archaic-specific	HPO	Visceral angiomatosis (HP:0100761)	5	1.1504	4.346314325	0.00789921	skeletal
Archaic-specific	HPO	Glioma (HP:0009733)	6	1.6784	3.574833174	0.00819918	nervous
Archaic-specific	HPO	Ascites (HP:0001541)	13	6	2.166666667	0.00849915	digestive
Archaic-specific	HPO	Congenital cataract (HP:0000519)	11	4.6892	2.345815917	0.00859914	nervous
Archaic-specific	HPO	Hamartoma of the eye (HP:0010568)	5	1.2302	4.064379776	0.00879912	nervous
Archaic-specific	HPO	Hematuria (HP:0000790)	13	5.9324	2.191355944	0.0089991	urinary
Archaic-specific	HPO	Abnormality of magnesium homeostasis (HP:0004921)	5	1.1926	4.192520543	0.00919908	other
Archaic-specific	HPO	Juvenile onset (HP:0003621)	16	8.2078	1.949365238	0.00959904	other
Archaic-specific	HPO	Supranuclear gaze palsy (HP:0000605)	4	0.8185	4.886988393	0.01009899	nervous
Archaic-specific	HPO	Multicystic kidney dysplasia (HP:0000003)	25	14.6947	1.701293664	0.01029897	urinary
Archaic-specific	HPO	Generalized muscle weakness (HP:0003324)	7	2.4023	2.913874204	0.01029897	skeletal muscle
Archaic-specific	HPO	Small intestinal stenosis (HP:0012848)	10	4.1733	2.396185273	0.01049895	digestive
Archaic-specific	HPO	Megalocornea (HP:0000485)	8	2.9664	2.696871629	0.01049895	nervous
Archaic-specific	HPO	Duodenal stenosis (HP:0100867)	10	4.1733	2.396185273	0.01049895	digestive
Archaic-specific	HPO	High pitched voice (HP:0001620)	7	2.3183	3.01945391	0.01049895	other
Archaic-specific	HPO	Ectropion (HP:0000656)	6	1.8086	3.317483136	0.01079892	nervous
Archaic-specific	HPO	Retinopathy (HP:0000488)	13	6.1388	2.117677722	0.01089891	nervous
Archaic-specific	HPO	Abnormality of iron homeostasis (HP:0011031)	4	0.8255	4.845548153	0.01129887	other
Archaic-specific	HPO	Abnormality of glycosphingolipid metabolism (HP:0004343)	3	0.4549	6.594856012	0.01149885	metabolic
Archaic-specific	HPO	Abnormality of liposaccharide metabolism (HP:0010968)	3	0.4549	6.594856012	0.01149885	metabolic
Archaic-specific	HPO	Abnormality of glycolipid metabolism (HP:0010969)	3	0.4549	6.594856012	0.01149885	metabolic
Archaic-specific	HPO	Hemangiomatosis (HP:0007461)	5	1.2495	4.00160064	0.01159884	cardiovascular
Archaic-specific	HPO	Glycosuria (HP:0003076)	5	1.3086	3.820877273	0.01189881	urinary
Archaic-specific	HPO	Abnormality of urine glucose concentration (HP:0011016)	5	1.3086	3.820877273	0.01189881	urinary
Archaic-specific	HPO	Abnormality of chromosome stability (HP:0003220)	7	2.387	2.93255132	0.01209879	other
Archaic-specific	HPO	Prolonged neonatal jaundice (HP:0006579)	4	0.8898	4.495392223	0.01249875	digestive
Archaic-specific	HPO	Psychosis (HP:0000709)	10	4.3852	2.280397701	0.01269873	nervous
Archaic-specific	HPO	Granulocytopenia (HP:0001913)	6	1.9538	3.070938684	0.01289871	immune
Archaic-specific	HPO	Cutaneous photosensitivity (HP:0000992)	8	3.1001	2.580561917	0.01309869	integumentary
Archaic-specific	HPO	Dehydration (HP:0001944)	15	7.69	1.950585176	0.01329867	other
Archaic-specific	HPO	Microcytic anemia (HP:0001935)	4	0.8938	4.475274111	0.01329867	hematologic
Archaic-specific	HPO	Chest pain (HP:0100749)	6	1.961	3.059663437	0.01409859	other
Archaic-specific	HPO	Hypophosphatemia (HP:0002148)	6	1.9253	3.116397445	0.01409859	other
Archaic-specific	HPO	Tubular atrophy (HP:0000092)	5	1.453	3.441156228	0.01439856	urinary
Archaic-specific	HPO	Astrocytoma (HP:0009592)	5	1.4351	3.484077765	0.01529847	nervous
Archaic-specific	HPO	Abnormality of the astrocytes (HP:0100707)	5	1.4351	3.484077765	0.01529847	nervous
Archaic-specific	HPO	Seborrheic dermatitis (HP:0001051)	4	0.9329	4.287705006	0.01559844	integumentary
Archaic-specific	HPO	Metabolic acidosis (HP:0001942)	13	6.4831	2.005213555	0.01609839	metabolic
Archaic-specific	HPO	Athetosis (HP:0002305)	5	1.4734	3.393511606	0.01609839	nervous
Archaic-specific	HPO	Hypermetropia (HP:0000540)	24	14.7665	1.625300511	0.01669833	nervous
Archaic-specific	HPO	Heterogeneous (HP:0001425)	28	18.0173	1.554061929	0.01809819	other
Archaic-specific	HPO	Myotonia (HP:0002486)	5	1.4703	3.400666531	0.01859814	skeletal muscle
Archaic-specific	HPO	Torticollis (HP:0000473)	7	2.67	2.621722846	0.01869813	skeletal
Archaic-specific	HPO	Muscle stiffness (HP:0003552)	4	1.0041	3.983666965	0.01909809	skeletal muscle
Archaic-specific	HPO	Hereditary nonpolyposis colorectal carcinoma (HP:0006716)	11	5.3027	2.074414921	0.019998	digestive
Archaic-specific	HPO	Hepatosplenomegaly (HP:0001433)	5	1.5148	3.300765778	0.02019798	digestive
Archaic-specific	HPO	Blepharitis (HP:0000498)	5	1.5415	3.243593902	0.02039796	nervous
Archaic-specific	HPO	Thoracic kyphosis (HP:0002942)	5	1.5779	3.168768617	0.02089791	skeletal
Archaic-specific	HPO	Pruritus (HP:0000989)	13	6.756	1.924215512	0.02089791	integumentary
Archaic-specific	HPO	High palate (HP:0000218)	34	23.2795	1.460512468	0.02109789	skeletal
Archaic-specific	HPO	Asymmetric septal hypertrophy (HP:0001670)	5	1.5118	3.307315783	0.02129787	cardiovascular
Archaic-specific	HPO	Trismus (HP:0000211)	3	0.5992	5.006675567	0.0219978	skeletal muscle
Archaic-specific	HPO	Craniofacial dystonia (HP:0012179)	7	2.7786	2.519254301	0.0219978	skeletal muscle
Archaic-specific	HPO	Abnormal biliary tract morphology (HP:0012440)	7	2.7746	2.522886182	0.02209779	digestive
Archaic-specific	HPO	Uterine neoplasm (HP:0010784)	13	6.875	1.890909091	0.02219778	reproductive
Archaic-specific	HPO	Abnormality of the gallbladder (HP:0005264)	7	2.8391	2.465570075	0.02229777	digestive
Archaic-specific	HPO	Proximal placement of thumb (HP:0009623)	5	1.5752	3.174200102	0.02229777	skeletal
Archaic-specific	HPO	Abnormality of vision evoked potentials (HP:0000649)	7	2.8051	2.495454707	0.02239776	nervous
Archaic-specific	HPO	Zonular cataract (HP:0010920)	3	0.6071	4.941525284	0.02249775	nervous
Archaic-specific	HPO	Cardiomegaly (HP:0001640)	8	3.3852	2.36322817	0.02259774	cardiovascular
Archaic-specific	HPO	Neonatal respiratory distress (HP:0002643)	3	0.5903	5.082161613	0.02269773	respiratory
Archaic-specific	HPO	Hypoplasia of the capital femoral epiphysis (HP:0003090)	3	0.6156	4.873294347	0.02309769	skeletal
Archaic-specific	HPO	Teleangiectasia of the skin (HP:0100585)	11	5.4108	2.032971095	0.02339766	cardiovascular
Archaic-specific	HPO	Abnormality of the Achilles tendon (HP:0005109)	6	2.1445	2.797854978	0.02339766	skeletal muscle
Archaic-specific	HPO	Achilles tendon contracture (HP:0001771)	6	2.1445	2.797854978	0.02339766	skeletal muscle
Archaic-specific	HPO	Myocardial infarction (HP:0001658)	5	1.6338	3.060350104	0.02419758	cardiovascular
Archaic-specific	HPO	Apathy (HP:0000741)	5	1.6027	3.119735446	0.02449755	behavior
Archaic-specific	HPO	Sudden death (HP:0001699)	9	4.1495	2.168936016	0.02469753	other
Archaic-specific	HPO	Focal dystonia (HP:0004373)	7	2.8437	2.461581742	0.02509749	nervous
Archaic-specific	HPO	Menorrhagia (HP:0000132)	6	2.1935	2.735354456	0.02509749	reproductive
Archaic-specific	HPO	Thoracolumbar scoliosis (HP:0002944)	6	2.2107	2.714072466	0.02519748	skeletal
Archaic-specific	HPO	Wide intermamillary distance (HP:0006610)	10	4.9139	2.035043448	0.02569743	reproductive
Archaic-specific	HPO	Patent ductus arteriosus (HP:0001643)	25	16.2996	1.53377997	0.02629737	cardiovascular
Archaic-specific	HPO	Hyponatremia (HP:0002902)	5	1.6856	2.9663028	0.02649735	other
Archaic-specific	HPO	Palmoplantar keratoderma (HP:0000982)	19	11.5176	1.649649232	0.02659734	integumentary
Archaic-specific	HPO	Abdominal situs inversus (HP:0003363)	3	0.6479	4.630344189	0.02689731	other
Archaic-specific	HPO	Abnormality of abdominal situs (HP:0011620)	3	0.6479	4.630344189	0.02689731	cardiovascular
Archaic-specific	HPO	Diminished motivation (HP:0000745)	5	1.6395	3.049710278	0.02689731	behavior
Archaic-specific	HPO	Hypercalciuria (HP:0002150)	7	2.8735	2.436053593	0.0269973	other
Archaic-specific	HPO	Lymphoma (HP:0002665)	12	6.2778	1.911497658	0.02729727	lymphatic
Archaic-specific	HPO	Arthrogryposis multiplex congenita (HP:0002804)	13	6.9919	1.859294326	0.02729727	skeletal muscle
Archaic-specific	HPO	Childhood onset (HP:0011463)	9	4.2258	2.129774244	0.02739726	other
Archaic-specific	HPO	Ptosis (HP:0000508)	48	35.626	1.347330601	0.02769723	skeletal muscle
Archaic-specific	HPO	Arthralgia (HP:0002829)	19	11.6083	1.636759905	0.02809719	skeletal
Archaic-specific	HPO	Neoplasm of striated muscle (HP:0009728)	6	2.274	2.638522427	0.02829717	skeletal muscle
Archaic-specific	HPO	Abnormality of the duodenum (HP:0002246)	11	5.5894	1.968010878	0.02859714	digestive
Archaic-specific	HPO	Progressive hearing impairment (HP:0001730)	6	2.2858	2.624901566	0.02859714	nervous
Archaic-specific	HPO	Sepsis (HP:0100806)	8	3.551	2.252886511	0.02869713	immune
Archaic-specific	HPO	Splenomegaly (HP:0001744)	33	22.9256	1.439438881	0.02869713	lymphatic
Archaic-specific	HPO	Benign neoplasm of the central nervous system (HP:0100835)	8	3.5366	2.262059605	0.02869713	nervous
Archaic-specific	HPO	Neoplasm of the thyroid gland (HP:0100031)	9	4.2603	2.112527287	0.02939706	endocrine
Archaic-specific	HPO	Elbow flexion contracture (HP:0002987)	10	4.936	2.025931929	0.02939706	skeletal
Archaic-specific	HPO	Abnormality of the acetabulum (HP:0003170)	10	4.9354	2.026178223	0.02959704	skeletal
Archaic-specific	HPO	Macular degeneration (HP:0000608)	7	2.9332	2.386472112	0.029997	nervous
Archaic-specific	HPO	Malignant neoplasm of the central nervous system (HP:0100836)	10	4.9975	2.0010005	0.03049695	nervous
Archaic-specific	HPO	Hypochromic anemia (HP:0001931)	2	0.2781	7.191657677	0.03139686	hematologic
Archaic-specific	HPO	High anterior hairline (HP:0009890)	4	1.1811	3.38667344	0.03139686	integumentary
Archaic-specific	HPO	Fasciculations (HP:0002380)	6	2.318	2.588438309	0.03159684	skeletal muscle
Archaic-specific	HPO	Absent epiphyses (HP:0010577)	3	0.6981	4.297378599	0.03169683	skeletal
Archaic-specific	HPO	Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003)	3	0.6981	4.297378599	0.03169683	skeletal
Archaic-specific	HPO	Abnormal urine phosphate concentration (HP:0012599)	3	0.6859	4.373815425	0.03229677	other
Archaic-specific	HPO	Centrally nucleated skeletal muscle fibers (HP:0003687)	4	1.2065	3.315375052	0.03259674	skeletal muscle
Archaic-specific	HPO	Gastrointestinal carcinoma (HP:0002672)	11	5.8068	1.894330785	0.0329967	digestive
Archaic-specific	HPO	Malignant gastrointestinal tract tumors (HP:0006749)	11	5.8068	1.894330785	0.0329967	digestive
Archaic-specific	HPO	Low anterior hairline (HP:0000294)	13	7.2705	1.78804759	0.03339666	integumentary
Archaic-specific	HPO	Insomnia (HP:0100785)	4	1.1959	3.344761268	0.03419658	behavior
Archaic-specific	HPO	Cellular immunodeficiency (HP:0005374)	11	5.846	1.881628464	0.03419658	immune
Archaic-specific	HPO	Neck muscle weakness (HP:0000467)	4	1.1947	3.348120867	0.03439656	skeletal muscle
Archaic-specific	HPO	"Intellectual disability, moderate (HP:0002342)"	6	2.4456	2.453385672	0.0349965	nervous
Archaic-specific	HPO	Leiomyosarcoma (HP:0100243)	10	5.1061	1.958441864	0.03579642	skeletal muscle
Archaic-specific	HPO	Uterine leiomyosarcoma (HP:0002891)	10	5.1061	1.958441864	0.03579642	reproductive
Archaic-specific	HPO	Ovoid vertebral bodies (HP:0003300)	6	2.4306	2.46852629	0.03669633	skeletal
Archaic-specific	HPO	Abnormality of the motor neurons (HP:0002450)	5	1.7754	2.816266757	0.03729627	nervous
Archaic-specific	HPO	Abnormal neuron morphology (HP:0012757)	5	1.7754	2.816266757	0.03729627	nervous
Archaic-specific	HPO	Hypertensive crisis (HP:0100735)	5	1.8087	2.764416432	0.03729627	cardiovascular
Archaic-specific	HPO	Meckel diverticulum (HP:0002245)	5	1.8038	2.771925934	0.03769623	digestive
Archaic-specific	HPO	Corneal erosion (HP:0200020)	8	3.7428	2.137437213	0.03779622	nervous
Archaic-specific	HPO	Basal cell carcinoma (HP:0002671)	4	1.2955	3.087610961	0.03919608	integumentary
Archaic-specific	HPO	Acne (HP:0001061)	7	3.1432	2.227029779	0.03939606	integumentary
Archaic-specific	HPO	Congenital hepatic fibrosis (HP:0002612)	11	5.8544	1.878928669	0.03939606	digestive
Archaic-specific	HPO	Macrocytic anemia (HP:0001972)	6	2.5233	2.377838545	0.03959604	hematologic
Archaic-specific	HPO	Infantile onset (HP:0003593)	43	32.2857	1.331858996	0.03969603	other
Archaic-specific	HPO	Exercise-induced muscle cramps (HP:0003710)	2	0.3116	6.418485237	0.04069593	skeletal muscle
Archaic-specific	HPO	Slow progression (HP:0003677)	18	11.3975	1.579293705	0.04209579	other
Archaic-specific	HPO	Gingivitis (HP:0000230)	6	2.5082	2.392153736	0.04309569	other
Archaic-specific	HPO	Prominent occiput (HP:0000269)	8	3.8575	2.073882048	0.04329567	skeletal
Archaic-specific	HPO	Mask-like facies (HP:0000298)	6	2.5357	2.366210514	0.04409559	other
Archaic-specific	HPO	Vertebral clefting (HP:0008428)	4	1.3035	3.068661297	0.04449555	skeletal
Archaic-specific	HPO	Adducted thumb (HP:0001181)	9	4.6221	1.947166872	0.04589541	skeletal
Archaic-specific	HPO	Bronchitis (HP:0012387)	5	1.916	2.60960334	0.0459954	respiratory
Archaic-specific	HPO	Severe Myopia (HP:0011003)	6	2.574	2.331002331	0.04609539	nervous
Archaic-specific	HPO	Attention deficit hyperactivity disorder (HP:0007018)	20	13.2479	1.509673231	0.04679532	behavior
Archaic-specific	HPO	Pustule (HP:0200039)	3	0.8057	3.723470274	0.04739526	integumentary
Archaic-specific	HPO	Xanthomatosis (HP:0000991)	3	0.8216	3.651411879	0.04809519	metabolic
Archaic-specific	HPO	Intrauterine growth retardation (HP:0001511)	52	40.6793	1.278291416	0.04849515	other
Archaic-specific	HPO	Intestinal malrotation (HP:0002566)	12	6.9141	1.735583807	0.04879512	digestive
Archaic-specific	HPO	Elfin facies (HP:0004428)	4	1.3627	2.93534894	0.04939506	other
Archaic-specific	HPO	Gastrointestinal atresia (HP:0002589)	6	2.6073	2.301231159	0.04939506	digestive
Archaic-specific	HPO	Nephrocalcinosis (HP:0000121)	8	3.9748	2.012679883	0.04949505	urinary
Archaic-specific	HPO	Respiratory insufficiency due to muscle weakness (HP:0002747)	12	6.9822	1.718656011	0.051394861	respiratory
Archaic-specific	HPO	Paralysis (HP:0003470)	3	0.8312	3.609239654	0.051594841	nervous
Archaic-specific	HPO	Shoulder girdle muscle weakness (HP:0003547)	3	0.8426	3.56040826	0.051894811	skeletal muscle
Archaic-specific	HPO	Alkalosis (HP:0001948)	5	1.9992	2.5010004	0.051894811	other
Archaic-specific	HPO	Transitional cell carcinoma of the bladder (HP:0006740)	10	5.5078	1.815606957	0.052194781	urinary
Archaic-specific	HPO	Bladder neoplasm (HP:0009725)	10	5.5078	1.815606957	0.052194781	urinary
Archaic-specific	HPO	Bladder carcinoma (HP:0002862)	10	5.5078	1.815606957	0.052194781	urinary
Archaic-specific	HPO	Clonus (HP:0002169)	6	2.7273	2.199978	0.054594541	nervous
Archaic-specific	HPO	Pyloric stenosis (HP:0002021)	14	8.5159	1.643983607	0.054694531	digestive
Archaic-specific	HPO	Tetany (HP:0001281)	3	0.8553	3.507541214	0.054794521	endocrine
Archaic-specific	HPO	Hypokalemic alkalosis (HP:0001949)	3	0.845	3.550295858	0.054894511	other
Archaic-specific	HPO	Renovascular hypertension (HP:0100817)	5	2.0222	2.472554643	0.055294471	cardiovascular
Archaic-specific	HPO	Deviation of the thumb (HP:0009603)	5	2.034	2.458210423	0.055394461	skeletal
Archaic-specific	HPO	Recurrent bronchitis (HP:0002837)	3	0.8461	3.54568018	0.056094391	respiratory
Archaic-specific	HPO	Progressive microcephaly (HP:0000253)	3	0.8646	3.46981263	0.056594341	nervous
Archaic-specific	HPO	Severe visual impairment (HP:0001141)	3	0.865	3.468208092	0.056694331	nervous
Archaic-specific	HPO	Coxa vara (HP:0002812)	5	2.0507	2.438191837	0.056694331	skeletal
Archaic-specific	HPO	Renal salt wasting (HP:0000127)	3	0.8599	3.488777765	0.057894211	urinary
Archaic-specific	HPO	Distal upper limb amyotrophy (HP:0007149)	3	0.8625	3.47826087	0.058994101	nervous
Archaic-specific	HPO	Upper limb amyotrophy (HP:0009129)	3	0.8625	3.47826087	0.058994101	nervous
Archaic-specific	HPO	Everted lower lip vermilion (HP:0000232)	16	10.241	1.562347427	0.059894011	integumentary
Archaic-specific	HPO	Hypoproteinemia (HP:0003075)	3	0.8735	3.434459073	0.059994001	other
Archaic-specific	HPO	Cerebral cortical atrophy (HP:0002120)	28	20.3414	1.376503092	0.060093991	nervous
Archaic-specific	HPO	Male infertility (HP:0003251)	3	0.8895	3.372681282	0.060393961	reproductive
Archaic-specific	HPO	Emphysema (HP:0002097)	7	3.4391	2.035416243	0.060593941	respiratory
Archaic-specific	HPO	Telecanthus (HP:0000506)	19	12.7324	1.492255977	0.060793921	skeletal
Archaic-specific	HPO	Selective tooth agenesis (HP:0001592)	3	0.8793	3.411804845	0.061493851	skeletal
Archaic-specific	HPO	Hydrocephalus (HP:0000238)	36	27.2045	1.323310482	0.062193781	nervous
Archaic-specific	HPO	Bruising susceptibility (HP:0000978)	15	9.5817	1.565484204	0.063093691	other
Archaic-specific	HPO	Kyphoscoliosis (HP:0002751)	15	9.5313	1.573762236	0.063293671	skeletal
Archaic-specific	HPO	Macroglossia (HP:0000158)	10	5.628	1.776830135	0.063393661	other
Archaic-specific	HPO	Stroke (HP:0001297)	9	4.9279	1.826335762	0.064193581	cardiovascular
Archaic-specific	HPO	Hypoparathyroidism (HP:0000829)	3	0.9251	3.24289266	0.065293471	endocrine
Archaic-specific	HPO	Abnormal number of erythroid precursors (HP:0012131)	1	0.0679	14.7275405	0.065793421	hematologic
Archaic-specific	HPO	Weight loss (HP:0001824)	18	12.0777	1.490349984	0.065893411	metabolic
Archaic-specific	HPO	Abnormality of the thoracic spine (HP:0100711)	7	3.5395	1.977680463	0.066593341	skeletal
Archaic-specific	HPO	Bronchomalacia (HP:0002780)	4	1.4878	2.688533405	0.067693231	respiratory
Archaic-specific	HPO	Long philtrum (HP:0000343)	39	30.1233	1.29467887	0.067893211	integumentary
Archaic-specific	HPO	Skin ulcer (HP:0200042)	16	10.528	1.519756839	0.069293071	integumentary
Archaic-specific	HPO	Blepharophimosis (HP:0000581)	26	18.9723	1.370418979	0.069693031	integumentary
Archaic-specific	HPO	Recurrent urinary tract infections (HP:0000010)	16	10.5771	1.512701969	0.069993001	immune
Archaic-specific	HPO	Systemic lupus erythematosus (HP:0002725)	3	0.9687	3.096934035	0.070192981	immune
Archaic-specific	HPO	Hepatomegaly (HP:0002240)	37	28.536	1.296607794	0.070492951	digestive
Archaic-specific	HPO	Neoplasm of the rectum (HP:0100743)	4	1.5405	2.596559559	0.070692931	digestive
Archaic-specific	HPO	Loss of speech (HP:0002371)	4	1.5926	2.511616225	0.073192681	other
Archaic-specific	HPO	Increased intracranial pressure (HP:0002516)	7	3.5659	1.963038784	0.074292571	nervous
Archaic-specific	HPO	Abnormality of intracranial pressure (HP:0012640)	7	3.5659	1.963038784	0.074292571	nervous
Archaic-specific	HPO	Hypercholesterolemia (HP:0003124)	4	1.5606	2.56311675	0.074492551	metabolic
Archaic-specific	HPO	Neonatal onset (HP:0003623)	4	1.5913	2.51366807	0.074792521	other
Archaic-specific	HPO	Abnormality of the pericardium (HP:0001697)	7	3.5982	1.945417153	0.074992501	cardiovascular
Archaic-specific	HPO	Dyschromatopsia (HP:0007641)	2	0.4613	4.33557338	0.076092391	nervous
Archaic-specific	HPO	Lymphedema (HP:0001004)	9	5.1122	1.760494503	0.076992301	lymphatic
Archaic-specific	HPO	Vertebral arch anomaly (HP:0008438)	3	0.9969	3.00932892	0.077592241	skeletal
Archaic-specific	HPO	Abnormality of the pleura (HP:0002103)	7	3.6812	1.901553841	0.077692231	respiratory
Archaic-specific	HPO	Abnormality of Sharpey fibers (HP:0100685)	8	4.4373	1.802898159	0.079692031	skeletal muscle
Archaic-specific	HPO	Chondrocalcinosis (HP:0000934)	8	4.4373	1.802898159	0.079692031	skeletal
Archaic-specific	HPO	Hypotrichosis (HP:0001006)	4	1.6231	2.464419937	0.079692031	integumentary
Archaic-specific	HPO	Abnormality of the calf musculature (HP:0001430)	5	2.2281	2.24406445	0.080491951	skeletal muscle
Archaic-specific	HPO	Proximal amyotrophy (HP:0007126)	5	2.3014	2.172590597	0.080491951	nervous
Archaic-specific	HPO	Acrocyanosis (HP:0001063)	7	3.731	1.876172608	0.081091891	integumentary
Archaic-specific	HPO	Optic disc pallor (HP:0000543)	8	4.4968	1.779042875	0.082091791	nervous
Archaic-specific	HPO	Microdontia (HP:0000691)	15	9.9685	1.504739931	0.082591741	skeletal
Archaic-specific	HPO	Calcaneovalgus deformity (HP:0001848)	2	0.4851	4.122861266	0.082891711	skeletal
Archaic-specific	HPO	Impaired platelet aggregation (HP:0003540)	4	1.6616	2.407318247	0.082991701	hematologic
Archaic-specific	HPO	Abnormal platelet function (HP:0011869)	4	1.6616	2.407318247	0.082991701	hematologic
Archaic-specific	HPO	Rapidly progressive (HP:0003678)	5	2.2802	2.192790106	0.083491651	other
Archaic-specific	HPO	Hypokalemia (HP:0002900)	5	2.2923	2.181215373	0.083591641	other
Archaic-specific	HPO	Hyperlipoproteinemia (HP:0010980)	2	0.48	4.166666667	0.084191581	metabolic
Archaic-specific	HPO	Recurrent pneumonia (HP:0006532)	6	3.0336	1.977848101	0.084291571	immune
Archaic-specific	HPO	Pancytopenia (HP:0001876)	5	2.307	2.167316862	0.085091491	hematologic
Archaic-specific	HPO	Fragile nails (HP:0001808)	3	1.0383	2.889338342	0.085191481	integumentary
Archaic-specific	HPO	Abnormal spermatogenesis (HP:0008669)	4	1.6397	2.439470635	0.085591441	reproductive
Archaic-specific	HPO	Fibroma (HP:0010614)	7	3.7948	1.844629493	0.085991401	reproductive
Archaic-specific	HPO	Cerebral hypomyelination (HP:0006808)	2	0.4827	4.143360265	0.085991401	nervous
Archaic-specific	HPO	Hip contracture (HP:0003273)	5	2.3249	2.150630135	0.086091391	skeletal muscle
Archaic-specific	HPO	Tetralogy of Fallot (HP:0001636)	16	10.9128	1.466168169	0.087291271	cardiovascular
Archaic-specific	HPO	Hypertriglyceridemia (HP:0002155)	5	2.3525	2.125398512	0.088191181	metabolic
Archaic-specific	HPO	Colitis (HP:0002583)	4	1.67	2.395209581	0.088391161	digestive
Archaic-specific	HPO	Autism (HP:0000717)	25	18.6595	1.339800102	0.088591141	nervous
Archaic-specific	HPO	Precocious puberty (HP:0000826)	9	5.3165	1.692843036	0.088691131	endocrine
Archaic-specific	HPO	Abnormality of DNA repair (HP:0003254)	3	1.0467	2.86615076	0.089691031	other
Archaic-specific	HPO	Exostoses (HP:0100777)	6	3.1198	1.923200205	0.089791021	skeletal
Archaic-specific	HPO	Inflammation of the large intestine (HP:0002037)	5	2.3453	2.131923421	0.090090991	digestive
Archaic-specific	HPO	Deformed tarsal bones (HP:0008119)	2	0.5069	3.945551391	0.090390961	skeletal
Archaic-specific	HPO	Nephritis (HP:0000123)	6	3.0758	1.95071201	0.090590941	urinary
Archaic-specific	HPO	Neuronal loss in central nervous system (HP:0002529)	4	1.703	2.348796242	0.090690931	nervous
Archaic-specific	HPO	Fragile skin (HP:0001030)	5	2.3651	2.114075515	0.090690931	integumentary
Archaic-specific	HPO	Hypochromic microcytic anemia (HP:0004840)	1	0.0972	10.28806584	0.092090791	hematologic
Archaic-specific	HPO	Hemoptysis (HP:0002105)	4	1.6611	2.408042863	0.092190781	other
Archaic-specific	HPO	Gonadotropin excess (HP:0000837)	3	1.0614	2.826455625	0.092390761	endocrine
Archaic-specific	HPO	Decreased electroretinogram (ERG) amplitude (HP:0000654)	4	1.6976	2.356267672	0.092790721	nervous
Archaic-specific	HPO	Gastrointestinal inflammation (HP:0004386)	5	2.3734	2.106682397	0.093190681	digestive
Archaic-specific	HPO	Fibrous tissue neoplasm (HP:0012316)	7	3.8676	1.809907953	0.093390661	other
Archaic-specific	HPO	Abnormality of the ileum (HP:0001549)	5	2.3659	2.113360666	0.093790621	digestive
Archaic-specific	HPO	Hypophosphatemic rickets (HP:0004912)	2	0.5132	3.897116134	0.093890611	skeletal
Archaic-specific	HPO	Retinitis pigmentosa (HP:0000510)	22	16.1764	1.360005935	0.094190581	integumentary
Archaic-specific	HPO	Wrist flexion contracture (HP:0001239)	2	0.5127	3.900916715	0.094790521	skeletal
Archaic-specific	HPO	Abnormality of the carotid arteries (HP:0005344)	6	3.095	1.938610662	0.094890511	cardiovascular
Archaic-specific	HPO	Prominent nose (HP:0000448)	7	3.8529	1.816813309	0.095290471	skeletal
Archaic-specific	HPO	EMG: neuropathic changes (HP:0003445)	4	1.7181	2.328153192	0.095290471	nervous
Archaic-specific	HPO	Nephronophthisis (HP:0000090)	7	3.8797	1.804263216	0.095790421	urinary
Archaic-specific	HPO	Abnormality of the corticospinal tract (HP:0002492)	3	1.0725	2.797202797	0.096190381	nervous
Archaic-specific	HPO	Keratitis (HP:0000491)	4	1.7215	2.323555039	0.096190381	nervous
Archaic-specific	HPO	Mesangial abnormality (HP:0001966)	3	1.0724	2.797463633	0.096690331	urinary
Archaic-specific	HPO	Specific learning disability (HP:0001328)	9	5.4266	1.658497033	0.097190281	other
Archaic-specific	HPO	Cerebral ischemia (HP:0002637)	10	6.1478	1.626598133	0.097690231	nervous
Archaic-specific	HPO	Highly arched eyebrow (HP:0002553)	17	11.9459	1.423082396	0.098490151	integumentary
Archaic-specific	HPO	Narrow mouth (HP:0000160)	23	17.1202	1.34344225	0.098790121	skeletal
Archaic-specific	HPO	Abnormality of cells of the erythroid lineage (HP:0012130)	1	0.1045	9.56937799	0.099690031	hematologic
Archaic-specific	HPO	Neoplasm of the pancreas (HP:0002894)	7	3.9148	1.788086237	0.099990001	digestive
Archaic-specific	HPO	Thyroid carcinoma (HP:0002890)	6	3.1705	1.892445986	0.100389961	endocrine
Archaic-specific	HPO	Morphological abnormality of the pyramidal tract (HP:0002062)	6	3.1931	1.879051705	0.100589941	nervous
Archaic-specific	HPO	Neoplasm of the colon (HP:0100273)	6	3.1586	1.899575761	0.101189881	digestive
Archaic-specific	HPO	Obsessive-compulsive behavior (HP:0000722)	10	6.174	1.619695497	0.102589741	behavior
Archaic-specific	HPO	Congenital onset (HP:0003577)	29	22.4985	1.288974821	0.102789721	other
Archaic-specific	HPO	White forelock (HP:0002211)	3	1.1069	2.710271931	0.103089691	integumentary
Archaic-specific	HPO	Diastasis recti (HP:0001540)	2	0.5468	3.657644477	0.104089591	skeletal muscle
Archaic-specific	HPO	Variable expressivity (HP:0003828)	20	14.606	1.369300288	0.105089491	other
Archaic-specific	HPO	Episodic fever (HP:0001954)	3	1.1311	2.652285386	0.105389461	other
Archaic-specific	HPO	Difficulty climbing stairs (HP:0003551)	3	1.1231	2.671177989	0.105989401	other
Archaic-specific	HPO	Autosomal dominant inheritance (HP:0000006)	193	175.802	1.097825963	0.106689331	other
Archaic-specific	HPO	Long face (HP:0000276)	18	12.9581	1.389092537	0.107089291	skeletal
Archaic-specific	HPO	Synophrys (HP:0000664)	12	7.9483	1.509756803	0.107989201	integumentary
Archaic-specific	HPO	Esophageal atresia (HP:0002032)	4	1.7767	2.25136489	0.108289171	digestive
Archaic-specific	HPO	Patchy hypopigmentation of hair (HP:0011365)	3	1.1333	2.64713668	0.108689131	integumentary
Archaic-specific	HPO	Dementia (HP:0000726)	11	7.1605	1.536205572	0.108789121	nervous
Archaic-specific	HPO	Infertility (HP:0000789)	6	3.2602	1.840377891	0.109089091	reproductive
Archaic-specific	HPO	Methylmalonic aciduria (HP:0012120)	3	1.1263	2.663588742	0.109189081	urinary
Archaic-specific	HPO	Pulmonary hypertension (HP:0002092)	11	7.1148	1.546072975	0.110588941	cardiovascular
Archaic-specific	HPO	Developmental regression (HP:0002376)	15	10.4965	1.429047778	0.110588941	behavior
Archaic-specific	HPO	Truncus arteriosus (HP:0001660)	3	1.1597	2.586875916	0.111988801	cardiovascular
Archaic-specific	HPO	Urinary incontinence (HP:0000020)	7	4.025	1.739130435	0.112488751	urinary
Archaic-specific	HPO	Vesicoureteral reflux (HP:0000076)	18	13.0549	1.378792637	0.113288671	urinary
Archaic-specific	HPO	Papillary thyroid carcinoma (HP:0002895)	4	1.83	2.18579235	0.113388661	endocrine
Archaic-specific	HPO	Large hands (HP:0001176)	4	1.8334	2.181738846	0.114088591	skeletal
Archaic-specific	HPO	Abnormality of the common coagulation pathway (HP:0010990)	3	1.1857	2.530150966	0.114788521	hematologic
Archaic-specific	HPO	Lethargy (HP:0001254)	13	8.8914	1.46208696	0.116288371	behavior
Archaic-specific	HPO	Downturned corners of mouth (HP:0002714)	16	11.4217	1.400842256	0.116888311	skeletal muscle
Archaic-specific	HPO	Waddling gait (HP:0002515)	6	3.3085	1.813510654	0.117588241	other
Archaic-specific	HPO	Nephropathy (HP:0000112)	10	6.4457	1.551421878	0.117788221	urinary
Archaic-specific	HPO	Dysostosis multiplex (HP:0000943)	3	1.1982	2.503755633	0.118388161	skeletal
Archaic-specific	HPO	Hyperphosphaturia (HP:0003109)	2	0.5921	3.377807803	0.118388161	urinary
Archaic-specific	HPO	Eosinophilia (HP:0001880)	4	1.8729	2.135725346	0.119988001	hematologic
Archaic-specific	HPO	Decreased central vision (HP:0007663)	3	1.1915	2.517834662	0.120087991	nervous
Archaic-specific	HPO	Gowers sign (HP:0003391)	4	1.8806	2.126980751	0.120887911	skeletal muscle
Archaic-specific	HPO	Myopathic facies (HP:0002058)	2	0.5975	3.347280335	0.121587841	skeletal muscle
Archaic-specific	HPO	Myelodysplasia (HP:0002863)	7	4.1049	1.705279057	0.123387661	hematologic
Archaic-specific	HPO	Flexion contracture of toe (HP:0005830)	8	4.9377	1.620187537	0.123787621	skeletal muscle
Archaic-specific	HPO	Joint contractures involving the joints of the feet (HP:0100492)	8	4.9377	1.620187537	0.123787621	skeletal
Archaic-specific	HPO	Epidermoid cyst (HP:0200040)	2	0.6205	3.223207091	0.126487351	integumentary
Archaic-specific	HPO	Abnormality of the renal medulla (HP:0100957)	9	5.698	1.57950158	0.126587341	urinary
Archaic-specific	HPO	Spinal muscular atrophy (HP:0007269)	2	0.6122	3.26690624	0.127687231	skeletal muscle
Archaic-specific	HPO	Lipoatrophy (HP:0100578)	10	6.5792	1.519941634	0.128087191	metabolic
Archaic-specific	HPO	Abnormality of the endocardium (HP:0004306)	6	3.4105	1.759272834	0.128687131	cardiovascular
Archaic-specific	HPO	Bone marrow hypocellularity (HP:0005528)	6	3.3742	1.778199277	0.128687131	other
Archaic-specific	HPO	Rickets (HP:0002748)	3	1.2437	2.412157273	0.129387061	skeletal
Archaic-specific	HPO	Dry hair (HP:0011359)	2	0.6268	3.190810466	0.130186981	integumentary
Archaic-specific	HPO	Hepatitis (HP:0012115)	7	4.191	1.670245765	0.130386961	immune
Archaic-specific	HPO	Abnormality of dicarboxylic acid metabolism (HP:0010995)	4	1.9244	2.078569944	0.131086891	metabolic
Archaic-specific	HPO	Dicarboxylic aciduria (HP:0003215)	4	1.9244	2.078569944	0.131086891	metabolic
Archaic-specific	HPO	Abnormality of the vocal cords (HP:0008777)	2	0.6216	3.217503218	0.131986801	other
Archaic-specific	HPO	Azoospermia (HP:0000027)	3	1.2547	2.391009803	0.132186781	reproductive
Archaic-specific	HPO	Optic atrophy (HP:0000648)	58	49.6843	1.167370779	0.132686731	nervous
Archaic-specific	HPO	IgM deficiency (HP:0002850)	4	1.9464	2.055076038	0.132986701	immune
Archaic-specific	HPO	Atresia of the external auditory canal (HP:0000413)	9	5.8157	1.54753512	0.133986601	nervous
Archaic-specific	HPO	Progressive disorder (HP:0003676)	21	16.1356	1.301470041	0.136886311	other
Archaic-specific	HPO	Abnormal auditory evoked potentials (HP:0006958)	5	2.7155	1.841281532	0.137386261	nervous
Archaic-specific	HPO	Buphthalmos (HP:0000557)	3	1.2872	2.330640149	0.137586241	nervous
Archaic-specific	HPO	Midline defect of the nose (HP:0004122)	7	4.3191	1.620708018	0.138286171	other
Archaic-specific	HPO	Abnormality of the musculature of the hand (HP:0001421)	4	1.9665	2.034070684	0.138286171	skeletal muscle
Archaic-specific	HPO	Dilated cardiomyopathy (HP:0001644)	10	6.6854	1.495796811	0.139286071	cardiovascular
Archaic-specific	HPO	Neoplasm of the small intestine (HP:0100833)	4	1.98	2.02020202	0.139686031	digestive
Archaic-specific	HPO	Polyneuropathy (HP:0001271)	6	3.476	1.726121979	0.140885911	nervous
Archaic-specific	HPO	Biliary tract neoplasm (HP:0100574)	3	1.3014	2.305209774	0.141385861	digestive
Archaic-specific	HPO	Microcornea (HP:0000482)	18	13.4617	1.337126812	0.141785821	nervous
Archaic-specific	HPO	Hypotelorism (HP:0000601)	10	6.7287	1.486171177	0.143885611	other
Archaic-specific	HPO	Premature birth (HP:0001622)	11	7.5628	1.454487756	0.143885611	reproductive
Archaic-specific	HPO	Abnormality of the thymus (HP:0000777)	10	6.7814	1.47462176	0.144185581	lymphatic
Archaic-specific	HPO	Hypoplastic toenails (HP:0001800)	7	4.3037	1.626507424	0.144785521	integumentary
Archaic-specific	HPO	Abnormal vertebral ossification (HP:0100569)	4	2.0243	1.975991701	0.146385361	skeletal
Archaic-specific	HPO	Pulmonary fibrosis (HP:0002206)	7	4.3382	1.613572449	0.146485351	respiratory
Archaic-specific	HPO	Cavernous hemangioma (HP:0001048)	3	1.3158	2.27998176	0.147885211	cardiovascular
Archaic-specific	HPO	Aplastic anemia (HP:0001915)	1	0.1618	6.180469716	0.149185081	hematologic
Archaic-specific	HPO	Facial cleft (HP:0002006)	7	4.3591	1.605836067	0.149685031	other
Archaic-specific	HPO	Muscular dystrophy (HP:0003560)	10	6.8441	1.461112491	0.151884812	skeletal muscle
Archaic-specific	HPO	Asymmetric growth (HP:0100555)	5	2.8471	1.756172948	0.151884812	other
Archaic-specific	HPO	Talipes equinovarus (HP:0001762)	25	19.9282	1.254503668	0.152084792	skeletal
Archaic-specific	HPO	Intestinal polyposis (HP:0200008)	4	2.0521	1.949222747	0.152284772	digestive
Archaic-specific	HPO	Severe muscular hypotonia (HP:0006829)	6	3.5881	1.672194197	0.152384762	skeletal muscle
Archaic-specific	HPO	Focal seizures (HP:0007359)	8	5.1964	1.539527365	0.153484652	nervous
Archaic-specific	HPO	Poikiloderma (HP:0001029)	2	0.6967	2.870676044	0.153884612	integumentary
Archaic-specific	HPO	Postnatal microcephaly (HP:0005484)	6	3.6083	1.662832913	0.154084592	skeletal
Archaic-specific	HPO	Asthma (HP:0002099)	11	7.6798	1.432328967	0.155884412	respiratory
Archaic-specific	HPO	Entropion (HP:0000621)	2	0.706	2.83286119	0.156184382	nervous
Archaic-specific	HPO	Dialeptic seizures (HP:0011146)	6	3.6162	1.659200265	0.157784222	nervous
Archaic-specific	HPO	Amyloidosis (HP:0011034)	3	1.3642	2.199091042	0.158284172	other
Archaic-specific	HPO	Broad metatarsal (HP:0001783)	3	1.3685	2.19218122	0.158484152	skeletal
Archaic-specific	HPO	Sclerocornea (HP:0000647)	5	2.833	1.764913519	0.160183982	nervous
Archaic-specific	HPO	Upper motor neuron abnormality (HP:0002127)	2	0.7124	2.807411567	0.160183982	nervous
Archaic-specific	HPO	Leukocytosis (HP:0001974)	6	3.64	1.648351648	0.162483752	immune
Archaic-specific	HPO	IgA deficiency (HP:0002720)	4	2.114	1.892147588	0.163883612	immune
Archaic-specific	HPO	Occipital encephalocele (HP:0002085)	3	1.3875	2.162162162	0.164383562	nervous
Archaic-specific	HPO	Overfolded helix (HP:0000396)	6	3.6852	1.628134158	0.164683532	integumentary
Archaic-specific	HPO	Abnormally folded helix (HP:0008544)	6	3.6852	1.628134158	0.164683532	integumentary
Archaic-specific	HPO	Cone-rod dystrophy (HP:0000548)	4	2.11	1.895734597	0.165883412	nervous
Archaic-specific	HPO	Erythroderma (HP:0001019)	2	0.74	2.702702703	0.166083392	integumentary
Archaic-specific	HPO	Hemorrhage of the eye (HP:0011885)	3	1.3918	2.155482109	0.166383362	cardiovascular
Archaic-specific	HPO	Poikilocytosis (HP:0004447)	5	2.8941	1.727652811	0.166583342	hematologic
Archaic-specific	HPO	Underdeveloped nasal alae (HP:0000430)	11	7.8058	1.409208537	0.166783322	integumentary
Archaic-specific	HPO	Absent eyelashes (HP:0000561)	5	2.9139	1.715913381	0.166883312	integumentary
Archaic-specific	HPO	Neoplasm of the adrenal cortex (HP:0100641)	2	0.7433	2.690703619	0.167683232	endocrine
Archaic-specific	HPO	Hyperacusis (HP:0010780)	3	1.4164	2.11804575	0.167783222	nervous
Archaic-specific	HPO	Abnormality of T cells (HP:0002843)	4	2.1393	1.869770486	0.167783222	immune
Archaic-specific	HPO	Pelvic girdle muscle weakness (HP:0003749)	3	1.4151	2.11999152	0.167783222	skeletal muscle
Archaic-specific	HPO	Furrowed tongue (HP:0000221)	5	2.9048	1.721288901	0.168083192	other
Archaic-specific	HPO	Hypoplasia of dental enamel (HP:0006297)	6	3.7054	1.61925838	0.168183182	skeletal
Archaic-specific	HPO	Macrotia (HP:0000400)	18	13.9419	1.291072235	0.168383162	other
Archaic-specific	HPO	Dolichocephaly (HP:0000268)	19	14.8561	1.278935925	0.168483152	skeletal
Archaic-specific	HPO	Hyperalaninemia (HP:0003348)	2	0.7324	2.730748225	0.168883112	metabolic
Archaic-specific	HPO	Abnormality of pyruvate family amino acid metabolism (HP:0010915)	2	0.7324	2.730748225	0.168883112	metabolic
Archaic-specific	HPO	Abnormality of alanine metabolism (HP:0010916)	2	0.7324	2.730748225	0.168883112	metabolic
Archaic-specific	HPO	Plantar hyperkeratosis (HP:0007556)	4	2.1524	1.858390634	0.169083092	integumentary
Archaic-specific	HPO	Protruding ear (HP:0000411)	9	6.1661	1.459593584	0.169283072	other
Archaic-specific	HPO	Petechiae (HP:0000967)	2	0.7408	2.699784017	0.169683032	integumentary
Archaic-specific	HPO	Hand muscle atrophy (HP:0009130)	2	0.7429	2.692152376	0.169683032	skeletal muscle
Archaic-specific	HPO	Abnormality of the lacrimal duct (HP:0011481)	7	4.5294	1.54545856	0.169983002	other
Archaic-specific	HPO	Overriding aorta (HP:0002623)	3	1.41	2.127659574	0.171782822	cardiovascular
Archaic-specific	HPO	Hypopigmentation of the fundus (HP:0007894)	5	2.9286	1.707300417	0.172482752	integumentary
Archaic-specific	HPO	Papilloma (HP:0012740)	4	2.1696	1.843657817	0.175782422	other
Archaic-specific	HPO	Omphalocele (HP:0001539)	11	7.9559	1.382621702	0.175782422	other
Archaic-specific	HPO	Verrucae (HP:0200043)	4	2.1696	1.843657817	0.175782422	integumentary
Archaic-specific	HPO	Unsteady gait (HP:0002317)	6	3.7876	1.584116591	0.178082192	other
Archaic-specific	HPO	Complete atrioventricular canal defect (HP:0001674)	7	4.5838	1.527117239	0.178482152	cardiovascular
Archaic-specific	HPO	Progressive muscle weakness (HP:0003323)	2	0.7648	2.615062762	0.178482152	skeletal muscle
Archaic-specific	HPO	Neurofibrillary tangles (HP:0002185)	3	1.4659	2.04652432	0.182081792	nervous
Archaic-specific	HPO	Abnormality of the hip-girdle musculature (HP:0001445)	3	1.476	2.032520325	0.182381762	skeletal muscle
Archaic-specific	HPO	Abnormality of the musculature of the pelvis (HP:0001469)	3	1.476	2.032520325	0.182381762	skeletal muscle
Archaic-specific	HPO	Pulmonary hypoplasia (HP:0002089)	13	9.7287	1.336252531	0.182681732	respiratory
Archaic-specific	HPO	Mucopolysacchariduria (HP:0008155)	3	1.4622	2.051702913	0.182781722	metabolic
Archaic-specific	HPO	Urinary glycosaminoglycan excretion (HP:0003541)	3	1.4622	2.051702913	0.182781722	metabolic
Archaic-specific	HPO	Abnormality of mucopolysaccharide metabolism (HP:0011020)	3	1.4663	2.045966037	0.183681632	metabolic
Archaic-specific	HPO	Abnormality of polysaccharide metabolism (HP:0011012)	3	1.4663	2.045966037	0.183681632	metabolic
Archaic-specific	HPO	Abnormality of glycosaminoglycan metabolism (HP:0004371)	3	1.4663	2.045966037	0.183681632	metabolic
Archaic-specific	HPO	Neonatal death (HP:0003811)	5	2.9859	1.674536991	0.185581442	other
Archaic-specific	HPO	Status epilepticus (HP:0002133)	4	2.242	1.78412132	0.185881412	nervous
Archaic-specific	HPO	Chronic hepatic failure (HP:0100626)	3	1.4935	2.008704386	0.186281372	digestive
Archaic-specific	HPO	Neuroblastoma (HP:0003006)	5	3.0075	1.662510391	0.186481352	nervous
Archaic-specific	HPO	Primitive neuroectodermal tumor (HP:0030065)	5	3.0075	1.662510391	0.186481352	nervous
Archaic-specific	HPO	Peripheral primitive neuroectodermal neoplasm (HP:0030067)	5	3.0075	1.662510391	0.186481352	nervous
Archaic-specific	HPO	Neuroblastic tumors (HP:0004376)	5	3.0075	1.662510391	0.186481352	nervous
Archaic-specific	HPO	Hamartoma (HP:0010566)	6	3.8098	1.574885821	0.186781322	other
Archaic-specific	HPO	Atrophy/Degeneration involving the corticospinal tracts (HP:0007372)	2	0.8017	2.494698765	0.191080892	nervous
Archaic-specific	HPO	Degeneration of the lateral corticospinal tracts (HP:0002314)	2	0.8017	2.494698765	0.191080892	nervous
Archaic-specific	HPO	Mediastinal lymphadenopathy (HP:0100721)	4	2.2836	1.751620249	0.191380862	lymphatic
Archaic-specific	HPO	Lissencephaly (HP:0001339)	8	5.5419	1.443548242	0.191580842	nervous
Archaic-specific	HPO	Absent hair (HP:0002298)	5	3.0666	1.630470228	0.192080792	integumentary
Archaic-specific	HPO	Premature graying of hair (HP:0002216)	3	1.5109	1.985571514	0.192380762	integumentary
Archaic-specific	HPO	Difficulty running (HP:0009046)	3	1.5039	1.994813485	0.192480752	other
Archaic-specific	HPO	Prominent supraorbital ridges (HP:0000336)	3	1.5213	1.971997634	0.192780722	skeletal
Archaic-specific	HPO	Freckling (HP:0001480)	7	4.6926	1.491710352	0.192980702	integumentary
Archaic-specific	HPO	Persistence of primary teeth (HP:0006335)	2	0.8031	2.490349894	0.192980702	skeletal
Archaic-specific	HPO	Abnormal autonomic nervous system physiology (HP:0012332)	3	1.5151	1.980067322	0.193180682	nervous
Archaic-specific	HPO	Spastic tetraplegia (HP:0002510)	9	6.3724	1.412340719	0.193380662	nervous
Archaic-specific	HPO	Colon cancer (HP:0003003)	2	0.812	2.463054187	0.194280572	digestive
Archaic-specific	HPO	Atrioventricular canal defect (HP:0006695)	7	4.7119	1.485600289	0.194480552	cardiovascular
Archaic-specific	HPO	Restrictive lung disease (HP:0002091)	7	4.7391	1.477073706	0.194980502	respiratory
Archaic-specific	HPO	Opacification of the corneal stroma (HP:0007759)	21	16.9966	1.235541226	0.195380462	nervous
Archaic-specific	HPO	Neoplasm of the oral cavity (HP:0100649)	3	1.5257	1.966310546	0.195480452	other
Archaic-specific	HPO	Abnormality of potassium homeostasis (HP:0011042)	7	4.7105	1.486041821	0.195880412	other
Archaic-specific	HPO	Atrophy/Degeneration involving motor neurons (HP:0007373)	3	1.5282	1.963093836	0.195980402	nervous
Archaic-specific	HPO	Enlarged penis (HP:0000040)	2	0.8147	2.454891371	0.196080392	reproductive
Archaic-specific	HPO	Abnormality of femoral epiphyses (HP:0006499)	6	3.8546	1.556581746	0.196580342	skeletal
Archaic-specific	HPO	Abnormality involving the epiphyses of the lower limbs (HP:0006500)	6	3.8546	1.556581746	0.196580342	skeletal
Archaic-specific	HPO	Congenital hip dislocation (HP:0001374)	6	3.8464	1.559900166	0.197280272	skeletal
Archaic-specific	HPO	Personality changes (HP:0000751)	3	1.5332	1.956691886	0.197980202	behavior
Archaic-specific	HPO	Hypothyroidism (HP:0000821)	22	17.9439	1.226043391	0.198780122	endocrine
Archaic-specific	HPO	Increased neuronal autofluorescent lipopigment (HP:0002074)	1	0.2227	4.490345757	0.200179982	nervous
Archaic-specific	HPO	Glomerulopathy (HP:0100820)	5	3.1044	1.610617189	0.200779922	urinary
Archaic-specific	HPO	Abnormality of the renal cortex (HP:0011035)	5	3.0944	1.61582213	0.200779922	urinary
Archaic-specific	HPO	Abnormality of the nasolacrimal system (HP:0000614)	7	4.7864	1.462477018	0.201879812	other
Archaic-specific	HPO	Abnormality of serum amino acid levels (HP:0003112)	5	3.1116	1.606890346	0.202079792	other
Archaic-specific	HPO	Hypotension (HP:0002615)	5	3.1011	1.612331108	0.202879712	cardiovascular
Archaic-specific	HPO	Respiratory distress (HP:0002098)	5	3.1213	1.601896646	0.204079592	respiratory
Archaic-specific	HPO	Memory impairment (HP:0002354)	9	6.4812	1.388631735	0.205779422	nervous
Archaic-specific	HPO	Ketosis (HP:0001946)	4	2.3193	1.724658302	0.206379362	metabolic
Archaic-specific	HPO	Woolly hair (HP:0002224)	2	0.8404	2.379819134	0.206679332	integumentary
Archaic-specific	HPO	Bladder diverticulum (HP:0000015)	4	2.335	1.713062099	0.208779122	urinary
Archaic-specific	HPO	Renal duplication (HP:0000075)	3	1.5756	1.904036558	0.209279072	urinary
Archaic-specific	HPO	Tracheoesophageal fistula (HP:0002575)	11	8.2472	1.333786012	0.209479052	respiratory
Archaic-specific	HPO	Portal hypertension (HP:0001409)	6	3.9538	1.517527442	0.209679032	cardiovascular
Archaic-specific	HPO	Abnormality of the anterior chamber (HP:0000593)	5	3.1337	1.595557967	0.210778922	nervous
Archaic-specific	HPO	CNS hypomyelination (HP:0003429)	2	0.8454	2.365744026	0.210978902	nervous
Archaic-specific	HPO	Upslanted palpebral fissure (HP:0000582)	17	13.5341	1.256086478	0.210978902	integumentary
Archaic-specific	HPO	Disproportionate tall stature (HP:0001519)	5	3.1586	1.582979801	0.211378862	skeletal
Archaic-specific	HPO	Methylmalonic acidemia (HP:0002912)	2	0.8521	2.347142354	0.211778822	metabolic
Archaic-specific	HPO	Split hand (HP:0001171)	8	5.6561	1.41440215	0.211978802	skeletal
Archaic-specific	HPO	Hyperpituitarism (HP:0010514)	5	3.2049	1.56011108	0.216478352	endocrine
Archaic-specific	HPO	Low posterior hairline (HP:0002162)	8	5.7337	1.395259605	0.216678332	integumentary
Archaic-specific	HPO	Lymphopenia (HP:0001888)	6	4.042	1.484413657	0.217478252	lymphatic
Archaic-specific	HPO	Nephrolithiasis (HP:0000787)	10	7.4557	1.341255684	0.219178082	urinary
Archaic-specific	HPO	Ectopic anus (HP:0004397)	8	5.7528	1.390627173	0.219478052	digestive
Archaic-specific	HPO	Proximal tubulopathy (HP:0000114)	2	0.8766	2.281542323	0.219678032	urinary
Archaic-specific	HPO	Subaortic stenosis (HP:0001682)	3	1.5985	1.876759462	0.219978002	cardiovascular
Archaic-specific	HPO	Abnormality of the left ventricular outflow tract (HP:0011103)	3	1.5985	1.876759462	0.219978002	cardiovascular
Archaic-specific	HPO	Joint stiffness (HP:0001387)	4	2.4144	1.656726309	0.221477852	skeletal
Archaic-specific	HPO	Intestinal polyp (HP:0005266)	4	2.4051	1.66313251	0.223077692	digestive
Archaic-specific	HPO	Facial asymmetry (HP:0000324)	12	9.2361	1.299249683	0.224277572	other
Archaic-specific	HPO	Abnormal number of incisors (HP:0011064)	3	1.6386	1.830831197	0.225777422	skeletal
Archaic-specific	HPO	Conjugated hyperbilirubinemia (HP:0002908)	2	0.8931	2.239390886	0.226177382	digestive
Archaic-specific	HPO	"Intellectual disability, mild (HP:0001256)"	12	9.2926	1.291350107	0.226577342	nervous
Archaic-specific	HPO	Melanoma (HP:0002861)	5	3.2372	1.544544668	0.228677132	integumentary
Archaic-specific	HPO	Dysphonia (HP:0001618)	2	0.9095	2.199010445	0.228777122	other
Archaic-specific	HPO	Aortic valve stenosis (HP:0001650)	4	2.4402	1.639209901	0.230876912	cardiovascular
Archaic-specific	HPO	Small for gestational age (HP:0001518)	10	7.5487	1.324731411	0.231776822	other
Archaic-specific	HPO	Neurodegeneration (HP:0002180)	2	0.9188	2.176752286	0.233076692	nervous
Archaic-specific	HPO	Short hallux (HP:0010109)	3	1.6765	1.78944229	0.233476652	skeletal
Archaic-specific	HPO	Poor coordination (HP:0002370)	5	3.2707	1.528724738	0.233476652	nervous
Archaic-specific	HPO	Iris coloboma (HP:0000612)	18	14.6847	1.225765593	0.233576642	nervous
Archaic-specific	HPO	Aggressive behavior (HP:0000718)	12	9.3448	1.284136632	0.233576642	behavior
Archaic-specific	HPO	Morphological abnormality of the middle ear (HP:0008609)	5	3.3181	1.506886471	0.234976502	skeletal
Archaic-specific	HPO	Abnormality of renal resorption (HP:0011038)	2	0.9353	2.138351331	0.235276472	urinary
Archaic-specific	HPO	Leukopenia (HP:0001882)	9	6.7483	1.33366922	0.236276372	immune
Archaic-specific	HPO	Anterior segment dysgenesis (HP:0007700)	3	1.6652	1.801585395	0.236276372	integumentary
Archaic-specific	HPO	Polar cataract (HP:0010696)	4	2.487	1.60836349	0.238176182	nervous
Archaic-specific	HPO	Nuclear cataract (HP:0100018)	1	0.274	3.649635036	0.239576042	nervous
Archaic-specific	HPO	Abnormality of the hepatic vasculature (HP:0006707)	6	4.1556	1.443834825	0.240175982	skeletal muscle
Archaic-specific	HPO	Renal tubular dysfunction (HP:0000124)	4	2.5041	1.597380296	0.240375962	urinary
Archaic-specific	HPO	Testicular atrophy (HP:0000029)	1	0.2737	3.653635367	0.240675932	reproductive
Archaic-specific	HPO	Abnormality of the calcaneus (HP:0008364)	2	0.9448	2.116850127	0.241475852	skeletal
Archaic-specific	HPO	Abnormality of the gastric mucosa (HP:0004295)	5	3.3349	1.499295331	0.242875712	digestive
Archaic-specific	HPO	Aganglionic megacolon (HP:0002251)	12	9.4216	1.273669016	0.243475652	digestive
Archaic-specific	HPO	Megaloblastic anemia (HP:0001889)	3	1.7304	1.73370319	0.246675332	hematologic
Archaic-specific	HPO	Thin bony cortex (HP:0002753)	2	0.9573	2.089209234	0.247375262	skeletal
Archaic-specific	HPO	Poor speech (HP:0002465)	4	2.5292	1.581527756	0.247775222	other
Archaic-specific	HPO	Nephrogenic diabetes insipidus (HP:0009806)	4	2.528	1.582278481	0.248375162	urinary
Archaic-specific	HPO	Increased cerebral lipofuscin (HP:0011813)	1	0.285	3.50877193	0.248775122	other
Archaic-specific	HPO	Neoplasm of the adrenal gland (HP:0100631)	2	0.965	2.07253886	0.249475052	endocrine
Archaic-specific	HPO	Abnormality of the umbilical cord (HP:0010881)	2	0.9525	2.099737533	0.249675032	reproductive
Archaic-specific	HPO	Joint laxity (HP:0001388)	10	7.6958	1.299410068	0.250074993	skeletal
Archaic-specific	HPO	Aplasia/Hypoplasia of the brainstem (HP:0007362)	7	5.0968	1.373410768	0.251374863	nervous
Archaic-specific	HPO	Self-mutilation (HP:0000742)	3	1.7274	1.736714137	0.251374863	behavior
Archaic-specific	HPO	Hypoplasia of the brainstem (HP:0002365)	7	5.0968	1.373410768	0.251374863	nervous
Archaic-specific	HPO	Severe short stature (HP:0003510)	4	2.5512	1.567889621	0.251474853	skeletal
Archaic-specific	HPO	Neutropenia (HP:0001875)	8	5.9644	1.341291664	0.251674833	immune
Archaic-specific	HPO	Choroideremia (HP:0001139)	2	0.96	2.083333333	0.252174783	nervous
Archaic-specific	HPO	Ureteral obstruction (HP:0006000)	3	1.7419	1.722257305	0.252874713	urinary
Archaic-specific	HPO	Ureteral stenosis (HP:0000071)	3	1.7419	1.722257305	0.252874713	urinary
Archaic-specific	HPO	Bundle branch block (HP:0011710)	6	4.2393	1.415328002	0.252974703	cardiovascular
Archaic-specific	HPO	Choreoathetosis (HP:0001266)	4	2.5628	1.560792883	0.254174583	nervous
Archaic-specific	HPO	Abnormality of cells of the lymphoid lineage (HP:0012140)	6	4.2627	1.40755859	0.254874513	lymphatic
Archaic-specific	HPO	Paresthesia (HP:0003401)	10	7.7952	1.282840722	0.256074393	nervous
Archaic-specific	HPO	Hypercalcemia (HP:0003072)	4	2.5759	1.552855313	0.256174383	other
Archaic-specific	HPO	Abnormal sex determination (HP:0012244)	1	0.2942	3.399048266	0.256574343	reproductive
Archaic-specific	HPO	Astigmatism (HP:0000483)	15	12.3018	1.219333756	0.256574343	nervous
Archaic-specific	HPO	Sex reversal (HP:0012245)	1	0.2942	3.399048266	0.256574343	other
Archaic-specific	HPO	Annular pancreas (HP:0001734)	3	1.7607	1.70386778	0.257874213	digestive
Archaic-specific	HPO	Hypohidrosis (HP:0000966)	6	4.2782	1.402458978	0.258274173	endocrine
Archaic-specific	HPO	Genu valgum (HP:0002857)	16	13.2865	1.204229857	0.258374163	skeletal
Archaic-specific	HPO	Patellar dislocation (HP:0002999)	7	5.1432	1.361020376	0.258374163	skeletal
Archaic-specific	HPO	Cellulitis (HP:0100658)	3	1.764	1.700680272	0.259674033	integumentary
Archaic-specific	HPO	Platyspondyly (HP:0000926)	8	6.0502	1.322270338	0.260573943	skeletal
Archaic-specific	HPO	Interstitial pulmonary disease (HP:0006530)	2	0.9964	2.007226014	0.261073893	respiratory
Archaic-specific	HPO	Autoimmune thrombocytopenia (HP:0001973)	1	0.3013	3.318951211	0.261173883	immune
Archaic-specific	HPO	Squamous cell carcinoma (HP:0002860)	2	0.997	2.006018054	0.262473753	integumentary
Archaic-specific	HPO	Subcapsular cataract (HP:0000523)	3	1.7947	1.671588566	0.262673733	nervous
Archaic-specific	HPO	Photophobia (HP:0000613)	22	18.9176	1.162938216	0.262973703	nervous
Archaic-specific	HPO	Delayed skeletal maturation (HP:0002750)	25	21.5985	1.157487789	0.263073693	skeletal
Archaic-specific	HPO	Oligohydramnios (HP:0001562)	11	8.7185	1.261684923	0.263273673	reproductive
Archaic-specific	HPO	Obstructive lung disease (HP:0006536)	2	0.998	2.004008016	0.263473653	respiratory
Archaic-specific	HPO	Chronic obstructive pulmonary disease (HP:0006510)	2	0.998	2.004008016	0.263473653	respiratory
Archaic-specific	HPO	Umbilical hernia (HP:0001537)	33	29.1796	1.130927086	0.264073593	reproductive
Archaic-specific	HPO	Atrophic scars (HP:0001075)	4	2.6102	1.532449621	0.264173583	integumentary
Archaic-specific	HPO	Lower limb muscle weakness (HP:0007340)	5	3.4524	1.448267872	0.264473553	skeletal muscle
Archaic-specific	HPO	Narrow chest (HP:0000774)	12	9.6726	1.240617828	0.264473553	skeletal
Archaic-specific	HPO	Spastic gait (HP:0002064)	4	2.5907	1.543984251	0.265473453	skeletal muscle
Archaic-specific	HPO	Subacute progressive viral hepatitis (HP:0006572)	3	1.7941	1.672147595	0.266073393	immune
Archaic-specific	HPO	Type II diabetes mellitus (HP:0005978)	17	14.2674	1.191527538	0.266273373	metabolic
Archaic-specific	HPO	Alopecia of scalp (HP:0002293)	1	0.3076	3.250975293	0.266373363	integumentary
Archaic-specific	HPO	Breast hypoplasia (HP:0003187)	2	1.0081	1.983930166	0.266673333	reproductive
Archaic-specific	HPO	Overgrowth (HP:0001548)	3	1.7894	1.676539622	0.266773323	other
Archaic-specific	HPO	Cerebral inclusion bodies (HP:0100314)	3	1.8058	1.661313545	0.268373163	nervous
Archaic-specific	HPO	Coarse hair (HP:0002208)	6	4.3488	1.379690949	0.269773023	integumentary
Archaic-specific	HPO	Focal segmental glomerulosclerosis (HP:0000097)	5	3.4645	1.443209698	0.269873013	urinary
Archaic-specific	HPO	Neonatal short-limb short stature (HP:0008921)	2	1.0228	1.955416504	0.270572943	skeletal
Archaic-specific	HPO	Deep venous thrombosis (HP:0002625)	1	0.321	3.115264798	0.272872713	hematologic
Archaic-specific	HPO	Ventricular arrhythmia (HP:0004308)	11	8.8663	1.240652809	0.275172483	cardiovascular
Archaic-specific	HPO	Cheekbone underdevelopment (HP:0010669)	12	9.7397	1.232070803	0.276872313	skeletal
Archaic-specific	HPO	High forehead (HP:0000348)	17	14.3639	1.183522581	0.277372263	skeletal
Archaic-specific	HPO	Volvulus (HP:0002580)	3	1.8354	1.634521085	0.277972203	digestive
Archaic-specific	HPO	Bilateral microphthalmos (HP:0007633)	4	2.696	1.483679525	0.278572143	nervous
Archaic-specific	HPO	Conjunctival hamartoma (HP:0100780)	1	0.3262	3.065603924	0.278772123	skeletal muscle
Archaic-specific	HPO	Aplasia/Hypoplasia of the vertebrae (HP:0008515)	3	1.8328	1.636839808	0.279072093	skeletal
Archaic-specific	HPO	Vertebral hypoplasia (HP:0008417)	3	1.8328	1.636839808	0.279072093	skeletal
Archaic-specific	HPO	Aplasia/Hypoplasia of the hallux (HP:0008362)	3	1.8573	1.615247941	0.284071593	skeletal
Archaic-specific	HPO	Limb-girdle muscle atrophy (HP:0003797)	1	0.3358	2.977963073	0.284571543	skeletal muscle
Archaic-specific	HPO	Abnormality of male internal genitalia (HP:0000022)	3	1.8674	1.606511728	0.284971503	reproductive
Archaic-specific	HPO	Tetraplegia (HP:0002445)	4	2.6958	1.483789599	0.285571443	nervous
Archaic-specific	HPO	Abnormality of the preputium (HP:0100587)	3	1.8628	1.610478849	0.286571343	reproductive
Archaic-specific	HPO	Nephrotic syndrome (HP:0000100)	11	8.9592	1.227788195	0.286771323	urinary
Archaic-specific	HPO	Abnormality of the vitreous humor (HP:0004327)	7	5.3699	1.30356245	0.287871213	nervous
Archaic-specific	HPO	Diaphragmatic weakness (HP:0009113)	2	1.0568	1.892505678	0.288371163	respiratory
Archaic-specific	HPO	Lack of skin elasticity (HP:0100679)	6	4.4645	1.343935491	0.288871113	integumentary
Archaic-specific	HPO	Nausea (HP:0002018)	2	1.076	1.858736059	0.289171083	other
Archaic-specific	HPO	Aplasia/Hypoplasia of the uvula (HP:0010293)	4	2.6912	1.486325803	0.289471053	skeletal
Archaic-specific	HPO	Abnormality of eosinophils (HP:0001879)	4	2.7011	1.480878161	0.289771023	hematologic
Archaic-specific	HPO	Skin rash (HP:0000988)	5	3.5584	1.405125899	0.290070993	immune
Archaic-specific	HPO	Abnormality of the level of lipoprotein cholesterol (HP:0010979)	4	2.7296	1.465416178	0.291170883	metabolic
Archaic-specific	HPO	Hypoplastic pelvis (HP:0008839)	2	1.0685	1.871782873	0.291170883	skeletal
Archaic-specific	HPO	Deeply set eye (HP:0000490)	19	16.3957	1.158840428	0.291470853	nervous
Archaic-specific	HPO	Chronic bronchitis (HP:0004469)	2	1.0699	1.869333583	0.292070793	respiratory
Archaic-specific	HPO	Dry skin (HP:0000958)	12	9.9397	1.207279898	0.293770623	integumentary
Archaic-specific	HPO	Renal Fanconi syndrome (HP:0001994)	1	0.3485	2.869440459	0.294270573	urinary
Archaic-specific	HPO	Renal cortical cysts (HP:0000803)	2	1.0881	1.838066354	0.295070493	urinary
Archaic-specific	HPO	Aplasia/Hypoplasia involving the vertebral column (HP:0008518)	6	4.4892	1.336541032	0.295870413	skeletal
Archaic-specific	HPO	B lymphocytopenia (HP:0010976)	1	0.3519	2.841716397	0.297470253	lymphatic
Archaic-specific	HPO	Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688)	1	0.3521	2.840102244	0.298170183	skeletal muscle
Archaic-specific	HPO	Central scotoma (HP:0000603)	2	1.093	1.829826167	0.298970103	nervous
Archaic-specific	HPO	Molar tooth sign on MRI (HP:0002419)	3	1.9283	1.555774516	0.300069993	nervous
Archaic-specific	HPO	Abnormality of midbrain morphology (HP:0002418)	3	1.9283	1.555774516	0.300069993	nervous
Archaic-specific	HPO	Long nose (HP:0003189)	2	1.1047	1.810446275	0.300169983	skeletal
Archaic-specific	HPO	Spastic paraparesis (HP:0002313)	1	0.353	2.83286119	0.300369963	skeletal muscle
Archaic-specific	HPO	Abnormality of the pulmonary veins (HP:0011718)	1	0.3607	2.772387025	0.300469953	cardiovascular
Archaic-specific	HPO	Hemiparesis (HP:0001269)	3	1.9345	1.550788317	0.301469853	skeletal muscle
Archaic-specific	HPO	Heart block (HP:0012722)	6	4.5243	1.326172005	0.301869813	cardiovascular
Archaic-specific	HPO	Abnormality of the neuromuscular junction (HP:0003398)	2	1.1089	1.803589142	0.302569743	nervous
Archaic-specific	HPO	Fatigable weakness (HP:0003473)	2	1.1089	1.803589142	0.302569743	skeletal muscle
Archaic-specific	HPO	Hypoplasia of the thymus (HP:0000778)	2	1.1008	1.816860465	0.303569643	lymphatic
Archaic-specific	HPO	Aplasia/Hypoplasia of the macula (HP:0008059)	4	2.7771	1.440351446	0.306169383	nervous
Archaic-specific	HPO	Abnormality of the vitamin B12 metabolism (HP:0004341)	3	1.9367	1.549026695	0.306469353	metabolic
Archaic-specific	HPO	Congenital glaucoma (HP:0001087)	5	3.6746	1.36069232	0.306869313	nervous
Archaic-specific	HPO	Flat cornea (HP:0007720)	3	1.9359	1.549666822	0.307869213	nervous
Archaic-specific	HPO	Sensorimotor neuropathy (HP:0007141)	2	1.1349	1.762269804	0.308269173	nervous
Archaic-specific	HPO	Urinary urgency (HP:0000012)	3	1.9481	1.539962014	0.308369163	urinary
Archaic-specific	HPO	Abnormality of vitamin B metabolism (HP:0004340)	3	1.9448	1.542575072	0.308769123	metabolic
Archaic-specific	HPO	Ankle clonus (HP:0011448)	2	1.1217	1.783007934	0.308969103	nervous
Archaic-specific	HPO	Nonprogressive disorder (HP:0003680)	2	1.1224	1.781895937	0.308969103	other
Archaic-specific	HPO	Lactic acidosis (HP:0003128)	12	10.0397	1.195254838	0.309169083	metabolic
Archaic-specific	HPO	Aplasia/Hypoplasia affecting the retina (HP:0008061)	4	2.7914	1.432972702	0.309569043	nervous
Archaic-specific	HPO	Abnormal atrioventricular conduction (HP:0005150)	6	4.5682	1.313427608	0.310068993	cardiovascular
Archaic-specific	HPO	Sloping forehead (HP:0000340)	13	11.0094	1.180809127	0.310068993	skeletal
Archaic-specific	HPO	Viral hepatitis (HP:0006562)	3	1.9557	1.533977604	0.310368963	immune
Archaic-specific	HPO	Abnormality of the septum pellucidum (HP:0007375)	2	1.1343	1.763201975	0.312168783	nervous
Archaic-specific	HPO	Complement deficiency (HP:0004431)	2	1.1286	1.772107035	0.312268773	immune
Archaic-specific	HPO	Anonychia (HP:0001798)	8	6.4121	1.247641178	0.313668633	integumentary
Archaic-specific	HPO	Glomerulosclerosis (HP:0000096)	5	3.6915	1.354462955	0.314068593	urinary
Archaic-specific	HPO	Absent eyebrow (HP:0002223)	4	2.8359	1.410486971	0.314168583	integumentary
Archaic-specific	HPO	Amyotrophic lateral sclerosis (HP:0007354)	2	1.149	1.740644038	0.316068393	nervous
Archaic-specific	HPO	Decreased testicular size (HP:0008734)	6	4.6075	1.302224634	0.316868313	reproductive
Archaic-specific	HPO	Xerostomia (HP:0000217)	4	2.8398	1.408549898	0.319868013	digestive
Archaic-specific	HPO	Pachygyria (HP:0001302)	6	4.6584	1.287995878	0.321267873	nervous
Archaic-specific	HPO	Aplasia/Hypoplasia of the thymus (HP:0010515)	5	3.7377	1.337721058	0.321767823	lymphatic
Archaic-specific	HPO	T lymphocytopenia (HP:0005403)	2	1.1529	1.734755833	0.322067793	immune
Archaic-specific	HPO	Tongue fasciculations (HP:0001308)	1	0.3907	2.559508574	0.323267673	nervous
Archaic-specific	HPO	Mucosal telangiectasiae (HP:0100579)	4	2.8618	1.397721714	0.323767623	integumentary
Archaic-specific	HPO	Redundant skin (HP:0001582)	2	1.161	1.722652885	0.324767523	integumentary
Archaic-specific	HPO	Metabolic alkalosis (HP:0200114)	2	1.1705	1.708671508	0.325567443	metabolic
Archaic-specific	HPO	Erythema (HP:0010783)	2	1.1561	1.729954156	0.325767423	integumentary
Archaic-specific	HPO	Increased circulating renin level (HP:0000848)	2	1.164	1.718213058	0.326067393	other
Archaic-specific	HPO	Elevated alkaline phosphatase (HP:0003155)	3	2.0138	1.489720926	0.327867213	other
Archaic-specific	HPO	Osteomyelitis (HP:0002754)	4	2.8997	1.379453047	0.327967203	skeletal
Archaic-specific	HPO	Bifid tongue (HP:0010297)	5	3.7553	1.331451548	0.328067193	other
Archaic-specific	HPO	Scrotal hypoplasia (HP:0000046)	7	5.5709	1.256529466	0.328267173	reproductive
Archaic-specific	HPO	Abnormality of aromatic amino acid family metabolism (HP:0004338)	1	0.3984	2.510040161	0.328767123	metabolic
Archaic-specific	HPO	Abnormality of secondary sexual hair (HP:0009888)	1	0.4021	2.486943546	0.330466953	integumentary
Archaic-specific	HPO	Abnormality of fatty-acid metabolism (HP:0004359)	2	1.1785	1.69707255	0.330466953	metabolic
Archaic-specific	HPO	Abnormality of the axillary hair (HP:0100134)	1	0.4021	2.486943546	0.330466953	integumentary
Archaic-specific	HPO	Septo-optic dysplasia (HP:0100842)	1	0.4031	2.480774001	0.331166883	nervous
Archaic-specific	HPO	Advanced eruption of teeth (HP:0006288)	4	2.9253	1.367381123	0.333266673	skeletal
Archaic-specific	HPO	Hypobetalipoproteinemia (HP:0003563)	1	0.4044	2.472799209	0.333766623	metabolic
Archaic-specific	HPO	Gastrointestinal dysmotility (HP:0002579)	2	1.1969	1.670983374	0.334566543	digestive
Archaic-specific	HPO	Medulloblastoma (HP:0002885)	2	1.1959	1.672380634	0.335466453	nervous
Archaic-specific	HPO	Micronodular cirrhosis (HP:0001413)	3	2.0471	1.465487763	0.335566443	digestive
Archaic-specific	HPO	Craniofacial hyperostosis (HP:0004493)	5	3.851	1.298364061	0.337066293	skeletal
Archaic-specific	HPO	Renal tubular acidosis (HP:0001947)	3	2.0507	1.462915102	0.338566143	urinary
Archaic-specific	HPO	Protrusio acetabuli (HP:0003179)	2	1.2137	1.647853671	0.339366063	skeletal
Archaic-specific	HPO	Prostate neoplasm (HP:0100787)	2	1.2085	1.654944146	0.340465953	reproductive
Archaic-specific	HPO	Ankyloglossia (HP:0010296)	2	1.2141	1.647310765	0.340665933	other
Archaic-specific	HPO	Cranial hyperostosis (HP:0004437)	6	4.7592	1.260716087	0.340665933	skeletal
Archaic-specific	HPO	Arachnodactyly (HP:0001166)	13	11.28	1.15248227	0.341465853	skeletal
Archaic-specific	HPO	Wide nose (HP:0000445)	6	4.7915	1.252217468	0.341765823	skeletal
Archaic-specific	HPO	Tubulointerstitial abnormality (HP:0001969)	5	3.8259	1.306882041	0.342565743	urinary
Archaic-specific	HPO	Hyporeflexia of lower limbs (HP:0002600)	2	1.2099	1.653029176	0.342865713	skeletal
Archaic-specific	HPO	Thin skin (HP:0000963)	8	6.6447	1.203967072	0.343765623	integumentary
Archaic-specific	HPO	Breech presentation (HP:0001623)	1	0.4212	2.374169041	0.347265273	reproductive
Archaic-specific	HPO	Spastic tetraparesis (HP:0001285)	2	1.2348	1.619695497	0.347365263	nervous
Archaic-specific	HPO	Pes planus (HP:0001763)	18	16.1247	1.116299838	0.347365263	skeletal
Archaic-specific	HPO	Abnormal gallbladder morphology (HP:0012437)	3	2.0772	1.444251878	0.347565243	digestive
Archaic-specific	HPO	Abnormality of the salivary glands (HP:0010286)	2	1.2259	1.631454442	0.348165183	digestive
Archaic-specific	HPO	Nasolacrimal duct obstruction (HP:0000579)	3	2.1015	1.427551749	0.348765123	other
Archaic-specific	HPO	Secondary amenorrhea (HP:0000869)	3	2.095	1.431980907	0.349465053	reproductive
Archaic-specific	HPO	Delayed myelination (HP:0012448)	4	2.9866	1.33931561	0.350164984	nervous
Archaic-specific	HPO	Chorioretinal coloboma (HP:0000567)	8	6.6691	1.19956216	0.351664834	nervous
Archaic-specific	HPO	Abnormality of the epiphysis of the femoral head (HP:0010574)	4	3.0316	1.319435282	0.352264774	skeletal
Archaic-specific	HPO	Foot dorsiflexor weakness (HP:0009027)	4	2.9924	1.33671969	0.353064694	skeletal muscle
Archaic-specific	HPO	J-shaped sella turcica (HP:0002680)	1	0.4352	2.297794118	0.354464554	skeletal
Archaic-specific	HPO	Abnormality of vitamin metabolism (HP:0100508)	3	2.1174	1.416831964	0.354464554	metabolic
Archaic-specific	HPO	Generalized hyperpigmentation (HP:0007440)	3	2.1297	1.408649106	0.354564544	integumentary
Archaic-specific	HPO	Enlarged kidneys (HP:0000105)	4	3.0163	1.326128038	0.355764424	urinary
Archaic-specific	HPO	Aplasia/Hypoplasia of the lens (HP:0008063)	7	5.7574	1.215826588	0.355864414	nervous
Archaic-specific	HPO	Parakeratosis (HP:0001036)	1	0.436	2.293577982	0.356164384	integumentary
Archaic-specific	HPO	Polymicrogyria (HP:0002126)	8	6.7253	1.189538013	0.356264374	nervous
Archaic-specific	HPO	Ulnar deviation of the wrist (HP:0003049)	1	0.4435	2.254791432	0.359364064	skeletal
Archaic-specific	HPO	Abnormality of chloride homeostasis (HP:0011422)	3	2.1454	1.398340636	0.359364064	other
Archaic-specific	HPO	Abnormal glucose tolerance (HP:0001952)	2	1.2618	1.585037248	0.359464054	metabolic
Archaic-specific	HPO	Death in childhood (HP:0003819)	3	2.15	1.395348837	0.360063994	other
Archaic-specific	HPO	Abnormality of the foot musculature (HP:0001436)	4	3.0264	1.321702353	0.360663934	skeletal muscle
Archaic-specific	HPO	Abnormality of T cell number (HP:0011839)	2	1.2639	1.582403671	0.361363864	immune
Archaic-specific	HPO	Deviation of the hallux (HP:0010051)	6	4.8917	1.226567451	0.362063794	skeletal
Archaic-specific	HPO	Abnormality of the femoral head (HP:0003368)	4	3.0728	1.301744337	0.362863714	skeletal
Archaic-specific	HPO	Stereotypic behavior (HP:0000733)	8	6.7278	1.18909599	0.363963604	behavior
Archaic-specific	HPO	Natal tooth (HP:0000695)	3	2.1776	1.377663483	0.365563444	skeletal
Archaic-specific	HPO	Abnormality of oral frenula (HP:0000190)	2	1.2859	1.555330897	0.365863414	integumentary
Archaic-specific	HPO	Anal stenosis (HP:0002025)	3	2.1557	1.391659322	0.367763224	digestive
Archaic-specific	HPO	External ophthalmoplegia (HP:0000544)	2	1.3053	1.532214817	0.367863214	nervous
Archaic-specific	HPO	Bone pain (HP:0002653)	5	3.9903	1.253038619	0.367963204	skeletal
Archaic-specific	HPO	Cerebral edema (HP:0002181)	4	3.0803	1.298574814	0.368863114	nervous
Archaic-specific	HPO	Cerebellar hypoplasia (HP:0001321)	13	11.5536	1.125190417	0.370362964	nervous
Archaic-specific	HPO	Purpura (HP:0000979)	1	0.4661	2.145462347	0.371462854	integumentary
Archaic-specific	HPO	Abnormality of glutamine family amino acid metabolism (HP:0010902)	2	1.3007	1.537633582	0.371662834	metabolic
Archaic-specific	HPO	Distal lower limb amyotrophy (HP:0008944)	1	0.4709	2.12359312	0.372762724	skeletal muscle
Archaic-specific	HPO	Bowel incontinence (HP:0002607)	4	3.1025	1.289282836	0.374762524	digestive
Archaic-specific	HPO	Abnormal large intestine physiology (HP:0012700)	4	3.1025	1.289282836	0.374762524	digestive
Archaic-specific	HPO	Abnormality of the shoulder girdle musculature (HP:0001435)	5	4.0422	1.236950176	0.374862514	skeletal muscle
Archaic-specific	HPO	Hypoplasia of the corpus callosum (HP:0002079)	18	16.3544	1.10062124	0.375062494	nervous
Archaic-specific	HPO	Sprengel anomaly (HP:0000912)	6	4.9686	1.207583625	0.378462154	skeletal
Archaic-specific	HPO	Exocrine pancreatic insufficiency (HP:0001738)	2	1.3155	1.520334474	0.378762124	digestive
Archaic-specific	HPO	Abnormality of glycine metabolism (HP:0010895)	3	2.2209	1.350803728	0.379362064	metabolic
Archaic-specific	HPO	Abnormality of serine family amino acid metabolism (HP:0010894)	3	2.2209	1.350803728	0.379362064	metabolic
Archaic-specific	HPO	Ectopia lentis (HP:0001083)	8	6.8545	1.167116493	0.380561944	nervous
Archaic-specific	HPO	Camptodactyly of finger (HP:0100490)	20	18.3785	1.088228093	0.381061894	skeletal
Archaic-specific	HPO	Abnormality of the prostate (HP:0008775)	2	1.3339	1.499362771	0.382161784	reproductive
Archaic-specific	HPO	Autoimmune hemolytic anemia (HP:0001890)	2	1.3246	1.509889778	0.382461754	immune
Archaic-specific	HPO	Dysphagia (HP:0002015)	14	12.6009	1.111031752	0.382661734	digestive
Archaic-specific	HPO	Flat acetabular roof (HP:0003180)	2	1.3273	1.506818353	0.384661534	skeletal
Archaic-specific	HPO	Epicanthus (HP:0000286)	43	40.9178	1.050887389	0.386961304	integumentary
Archaic-specific	HPO	Metaphyseal cupping (HP:0003021)	1	0.487	2.05338809	0.388361164	skeletal
Archaic-specific	HPO	11 pairs of ribs (HP:0000878)	1	0.4897	2.042066571	0.388361164	skeletal
Archaic-specific	HPO	Long toe (HP:0010511)	3	2.2364	1.341441603	0.390060994	skeletal
Archaic-specific	HPO	Urticaria (HP:0001025)	4	3.1719	1.261073804	0.390360964	immune
Archaic-specific	HPO	Hypoalbuminemia (HP:0003073)	4	3.171	1.261431725	0.391360864	other
Archaic-specific	HPO	Abnormal albumin level (HP:0012116)	4	3.171	1.261431725	0.391360864	other
Archaic-specific	HPO	Reticulocytopenia (HP:0001896)	1	0.493	2.028397566	0.391560844	hematologic
Archaic-specific	HPO	Chromsome breakage (HP:0040012)	2	1.3617	1.468752295	0.393360664	other
Archaic-specific	HPO	Abnormal lung lobation (HP:0002101)	5	4.1438	1.206621941	0.393760624	respiratory
Archaic-specific	HPO	Abnormalities of placenta or umbilical cord (HP:0001194)	2	1.36	1.470588235	0.394460554	reproductive
Archaic-specific	HPO	Aplasia/Hypoplasia of the nipples (HP:0006709)	5	4.1265	1.211680601	0.395260474	other
Archaic-specific	HPO	Large for gestational age (HP:0001520)	2	1.3771	1.452327355	0.397760224	other
Archaic-specific	HPO	Meningitis (HP:0001287)	5	4.1211	1.213268302	0.397860214	nervous
Archaic-specific	HPO	Pes cavus (HP:0001761)	13	11.813	1.100482519	0.398660134	skeletal
Archaic-specific	HPO	Amaurosis fugax (HP:0100576)	2	1.3738	1.455815985	0.398760124	nervous
Archaic-specific	HPO	Albinism (HP:0001022)	2	1.3776	1.451800232	0.399960004	integumentary
Archaic-specific	HPO	Abnormality of the pubic bones (HP:0003172)	6	5.0775	1.1816839	0.400659934	skeletal
Archaic-specific	HPO	Spastic diplegia (HP:0001264)	1	0.5119	1.953506544	0.402759724	nervous
Archaic-specific	HPO	Flared iliac wings (HP:0002869)	2	1.3759	1.453594011	0.402859714	skeletal
Archaic-specific	HPO	Neonatal hypoglycemia (HP:0001998)	2	1.4072	1.421262081	0.404959504	metabolic
Archaic-specific	HPO	IgG deficiency (HP:0004315)	2	1.392	1.436781609	0.406759324	immune
Archaic-specific	HPO	Anteriorly placed anus (HP:0001545)	2	1.4029	1.425618362	0.406959304	digestive
Archaic-specific	HPO	Absent/shortened dynein arms (HP:0200106)	1	0.5296	1.888217523	0.409659034	other
Archaic-specific	HPO	Dynein arm defect of respiratory motile cilia (HP:0012255)	1	0.5296	1.888217523	0.409659034	respiratory
Archaic-specific	HPO	Fine hair (HP:0002213)	7	6.1427	1.139564035	0.409659034	integumentary
Archaic-specific	HPO	Termporal pattern (HP:0011008)	1	0.5218	1.916443082	0.409859014	other
Archaic-specific	HPO	Insidious onset (HP:0003587)	1	0.5218	1.916443082	0.409859014	other
Archaic-specific	HPO	Abnormality of the right ventricle (HP:0001707)	3	2.323	1.291433491	0.409859014	cardiovascular
Archaic-specific	HPO	Easy fatigability (HP:0003388)	2	1.395	1.433691756	0.409959004	other
Archaic-specific	HPO	Coarse facial features (HP:0000280)	19	17.6905	1.074022781	0.410558944	integumentary
Archaic-specific	HPO	Tubulointerstitial nephritis (HP:0001970)	2	1.4015	1.427042455	0.411058894	urinary
Archaic-specific	HPO	Adrenal hypoplasia (HP:0000835)	2	1.4178	1.410636197	0.412058794	endocrine
Archaic-specific	HPO	Abnormality of the peritoneum (HP:0002585)	4	3.2638	1.225565292	0.413258674	digestive
Archaic-specific	HPO	Scapular winging (HP:0003691)	4	3.2721	1.222456526	0.414458554	skeletal
Archaic-specific	HPO	Aplasia/Hypoplasia of the sternum (HP:0006714)	5	4.2519	1.175944872	0.415058494	skeletal
Archaic-specific	HPO	Clumsiness (HP:0002312)	1	0.5327	1.87722921	0.415558444	behavior
Archaic-specific	HPO	Stridor (HP:0010307)	1	0.5369	1.862544235	0.415858414	respiratory
Archaic-specific	HPO	Abdominal distention (HP:0003270)	4	3.2815	1.218954746	0.417758224	other
Archaic-specific	HPO	Prominent nasal bridge (HP:0000426)	15	13.9207	1.077532021	0.419158084	integumentary
Archaic-specific	HPO	Wormian bones (HP:0002645)	4	3.3146	1.206782115	0.419158084	skeletal
Archaic-specific	HPO	Aplasia/Hypoplasia involving the pelvis (HP:0009103)	5	4.2609	1.173461006	0.421257874	skeletal
Archaic-specific	HPO	EMG: myopathic abnormalities (HP:0003458)	4	3.3246	1.203152259	0.422057794	nervous
Archaic-specific	HPO	Generalized myoclonic seizures (HP:0002123)	2	1.4389	1.389950657	0.422157784	nervous
Archaic-specific	HPO	Hypoplasia of the iris (HP:0007676)	3	2.3643	1.268874508	0.422657734	integumentary
Archaic-specific	HPO	Abnormality of the fetal cardiovascular system (HP:0010948)	1	0.5573	1.794365692	0.424257574	cardiovascular
Archaic-specific	HPO	Abnormal umbilical cord blood vessels (HP:0011403)	1	0.5573	1.794365692	0.424257574	cardiovascular
Archaic-specific	HPO	Single umbilical artery (HP:0001195)	1	0.5573	1.794365692	0.424257574	reproductive
Archaic-specific	HPO	Median cleft lip (HP:0000161)	2	1.4531	1.376367765	0.428457154	other
Archaic-specific	HPO	Delusions (HP:0000746)	2	1.4659	1.364349546	0.429657034	behavior
Archaic-specific	HPO	Inguinal hernia (HP:0000023)	12	11.1072	1.080380294	0.430556944	digestive
Archaic-specific	HPO	Hyperglycinemia (HP:0002154)	2	1.4551	1.374475981	0.430956904	metabolic
Archaic-specific	HPO	Birth length less than 3rd percentile (HP:0003561)	1	0.5653	1.768972227	0.431656834	skeletal
Archaic-specific	HPO	Vertigo (HP:0002321)	8	7.2295	1.106577218	0.432356764	nervous
Archaic-specific	HPO	Tracheal stenosis (HP:0002777)	5	4.3169	1.158238551	0.432956704	respiratory
Archaic-specific	HPO	Osteomalacia (HP:0002749)	1	0.5614	1.781261133	0.433256674	skeletal
Archaic-specific	HPO	Back pain (HP:0003418)	1	0.5664	1.765536723	0.436256374	skeletal
Archaic-specific	HPO	Long foot (HP:0001833)	1	0.5729	1.745505324	0.436956304	skeletal
Archaic-specific	HPO	Ridged nail (HP:0001807)	1	0.5763	1.735207357	0.438056194	integumentary
Archaic-specific	HPO	Type 2 muscle fiber atrophy (HP:0003554)	1	0.5855	1.70794193	0.441255874	skeletal muscle
Archaic-specific	HPO	Muscle fiber atrophy (HP:0100295)	1	0.5855	1.70794193	0.441255874	skeletal muscle
Archaic-specific	HPO	Tubulointerstitial fibrosis (HP:0005576)	3	2.4308	1.234161593	0.441855814	urinary
Archaic-specific	HPO	Choanal stenosis (HP:0000452)	5	4.3691	1.144400449	0.442455754	respiratory
Archaic-specific	HPO	Pathologic fracture (HP:0002756)	2	1.4924	1.340123291	0.443655634	skeletal
Archaic-specific	HPO	Abnormality of dental color (HP:0011073)	3	2.4701	1.214525728	0.445755424	skeletal
Archaic-specific	HPO	Increased serum pyruvate (HP:0003542)	1	0.5896	1.696065129	0.446755324	metabolic
Archaic-specific	HPO	Anophthalmia (HP:0000528)	6	5.3888	1.113420428	0.447255274	nervous
Archaic-specific	HPO	Amelogenesis imperfecta (HP:0000705)	2	1.5073	1.326875871	0.448855114	skeletal
Archaic-specific	HPO	Hypoplastic ischia (HP:0003175)	2	1.5108	1.323801959	0.449355064	skeletal
Archaic-specific	HPO	Round face (HP:0000311)	16	15.2114	1.051842697	0.449555044	skeletal
Archaic-specific	HPO	Increased purine levels (HP:0004368)	2	1.5167	1.318652337	0.449955004	other
Archaic-specific	HPO	Hyperuricemia (HP:0002149)	2	1.5167	1.318652337	0.449955004	other
Archaic-specific	HPO	Ulnar deviation of finger (HP:0009465)	5	4.3985	1.136751165	0.451854815	skeletal
Archaic-specific	HPO	Asplenia (HP:0001746)	1	0.604	1.655629139	0.452054795	lymphatic
Archaic-specific	HPO	Pigmentary retinal degeneration (HP:0001146)	1	0.6022	1.660577881	0.452754725	integumentary
Archaic-specific	HPO	Severe global developmental delay (HP:0011344)	3	2.4829	1.208264529	0.453054695	nervous
Archaic-specific	HPO	Meningioma (HP:0002858)	2	1.5356	1.302422506	0.454554545	nervous
Archaic-specific	HPO	Basal ganglia calcification (HP:0002135)	2	1.5342	1.303611002	0.455154485	nervous
Archaic-specific	HPO	Abnormality of the anterior horn cell (HP:0006802)	1	0.6049	1.653165813	0.456354365	nervous
Archaic-specific	HPO	Degeneration of anterior horn cells (HP:0002398)	1	0.6049	1.653165813	0.456354365	nervous
Archaic-specific	HPO	Abnormality of the diencephalon (HP:0010662)	3	2.5007	1.199664094	0.456654335	nervous
Archaic-specific	HPO	Respiratory failure (HP:0002878)	5	4.4784	1.116470168	0.459154085	respiratory
Archaic-specific	HPO	CNS demyelination (HP:0007305)	4	3.4509	1.159117911	0.460253975	nervous
Archaic-specific	HPO	Abnormality of alkaline phosphatase activity (HP:0004379)	3	2.5241	1.188542451	0.460953905	other
Archaic-specific	HPO	Lower limb asymmetry (HP:0100559)	3	2.5097	1.195361995	0.461153885	skeletal
Archaic-specific	HPO	Polycystic ovaries (HP:0000147)	9	8.3954	1.072015628	0.462353765	reproductive
Archaic-specific	HPO	Posterior embryotoxon (HP:0000627)	3	2.5461	1.178272652	0.462653735	nervous
Archaic-specific	HPO	Hoarse voice (HP:0001609)	3	2.5141	1.193269957	0.463753625	other
Archaic-specific	HPO	Short philtrum (HP:0000322)	14	13.3322	1.050089258	0.463953605	integumentary
Archaic-specific	HPO	Short palpebral fissure (HP:0012745)	2	1.577	1.268230818	0.464053595	integumentary
Archaic-specific	HPO	Impaired vibration sensation in the lower limbs (HP:0002166)	2	1.5599	1.28213347	0.465153485	nervous
Archaic-specific	HPO	Distal arthrogryposis (HP:0005684)	2	1.564	1.278772379	0.466453355	skeletal muscle
Archaic-specific	HPO	Thyroid-stimulating hormone excess (HP:0002925)	2	1.5714	1.272750414	0.466553345	endocrine
Archaic-specific	HPO	Abnormality of the pupil (HP:0000615)	4	3.5236	1.135202634	0.470852915	nervous
Archaic-specific	HPO	Broad ribs (HP:0000885)	3	2.5746	1.16522955	0.471952805	skeletal
Archaic-specific	HPO	Facial edema (HP:0000282)	9	8.4744	1.06202209	0.472352765	immune
Archaic-specific	HPO	Periorbital edema (HP:0100539)	9	8.4744	1.06202209	0.472352765	other
Archaic-specific	HPO	Nasal speech (HP:0001611)	2	1.6118	1.240848741	0.472752725	other
Archaic-specific	HPO	Recurrent gram-negative bacterial infections (HP:0005420)	1	0.6435	1.554001554	0.472952705	immune
Archaic-specific	HPO	Narrow face (HP:0000275)	6	5.4955	1.091802384	0.473052695	skeletal
Archaic-specific	HPO	Thyroiditis (HP:0100646)	2	1.5979	1.251642781	0.473552645	endocrine
Archaic-specific	HPO	Muscle abnormality related to mitochondrial dysfunction (HP:0003800)	1	0.6373	1.569119724	0.473852615	skeletal muscle
Archaic-specific	HPO	Nemaline bodies (HP:0003798)	1	0.6365	1.571091909	0.474552545	skeletal muscle
Archaic-specific	HPO	Hypoplastic scapulae (HP:0000882)	3	2.5631	1.170457649	0.476352365	skeletal
Archaic-specific	HPO	Aplasia/Hypoplasia of the scapulae (HP:0006713)	3	2.5631	1.170457649	0.476352365	skeletal
Archaic-specific	HPO	Lip pit (HP:0100267)	1	0.6475	1.544401544	0.478052195	integumentary
Archaic-specific	HPO	Abnormal pupillary function (HP:0007686)	1	0.6492	1.540357363	0.478352165	nervous
Archaic-specific	HPO	Ileus (HP:0002595)	1	0.6542	1.528584531	0.479852015	digestive
Archaic-specific	HPO	Abnormal enzyme/coenzyme activity (HP:0012379)	3	2.6019	1.153003574	0.480751925	other
Archaic-specific	HPO	Rhabdomyosarcoma (HP:0002859)	2	1.6159	1.237700353	0.481551845	other
Archaic-specific	HPO	Constricted visual fields (HP:0001133)	5	4.5755	1.092776746	0.481551845	nervous
Archaic-specific	HPO	Abnormality of complement system (HP:0005339)	2	1.6092	1.242853592	0.482051795	immune
Archaic-specific	HPO	Aplasia/Hypoplasia of the spleen (HP:0010451)	1	0.6588	1.517911354	0.482251775	lymphatic
Archaic-specific	HPO	Posterior subcapsular cataract (HP:0007787)	1	0.6573	1.521375323	0.483551645	nervous
Archaic-specific	HPO	Abnormality of glycolysis (HP:0004366)	1	0.6573	1.521375323	0.483751625	metabolic
Archaic-specific	HPO	Neoplasm of the respiratory system (HP:0100606)	7	6.5746	1.064703556	0.484851515	respiratory
Archaic-specific	HPO	Aneurysm (HP:0002617)	10	9.5392	1.048305938	0.486151385	nervous
Archaic-specific	HPO	X-linked dominant inheritance (HP:0001423)	2	1.6393	1.220032941	0.486251375	other
Archaic-specific	HPO	Acute necrotizing encephalopathy (HP:0006965)	2	1.6393	1.220032941	0.486251375	nervous
Archaic-specific	HPO	Febrile seizures (HP:0002373)	4	3.5975	1.111883252	0.486551345	other
Archaic-specific	HPO	Hepatocellular carcinoma (HP:0001402)	3	2.6393	1.136665025	0.487151285	digestive
Archaic-specific	HPO	Abnormality of the ischium (HP:0003174)	2	1.633	1.224739743	0.488551145	skeletal
Archaic-specific	HPO	Abnormal mitochondria in muscle tissue (HP:0008316)	2	1.647	1.214329083	0.488851115	skeletal muscle
Archaic-specific	HPO	Bulbous nose (HP:0000414)	8	7.6015	1.052423864	0.488851115	other
Archaic-specific	HPO	Abnormality of subcutaneous fat tissue (HP:0001001)	2	1.6428	1.21743365	0.489651035	metabolic
Archaic-specific	HPO	Migraine (HP:0002076)	9	8.655	1.039861352	0.490950905	nervous
Archaic-specific	HPO	Type I transferrin isoform profile (HP:0003642)	2	1.6567	1.207219171	0.491150885	other
Archaic-specific	HPO	Coxa valga (HP:0002673)	4	3.6543	1.094600881	0.491950805	skeletal
Archaic-specific	HPO	Palpebral edema (HP:0100540)	6	5.6256	1.066552901	0.492450755	nervous
Archaic-specific	HPO	Dyskinesia (HP:0100660)	2	1.6718	1.196315349	0.493350665	nervous
Archaic-specific	HPO	Hyperthyroidism (HP:0000836)	2	1.6594	1.205254911	0.494050595	endocrine
Archaic-specific	HPO	Oculomotor apraxia (HP:0000657)	5	4.6418	1.07716834	0.494350565	nervous
Archaic-specific	HPO	Thick eyebrow (HP:0000574)	12	11.6306	1.031761044	0.496150385	integumentary
Archaic-specific	HPO	Distal sensory impairment (HP:0002936)	6	5.6564	1.06074535	0.496850315	nervous
Archaic-specific	HPO	Choanal atresia (HP:0000453)	8	7.6788	1.041829453	0.498150185	respiratory
Archaic-specific	HPO	Esophageal varix (HP:0002040)	3	2.6747	1.121621116	0.498450155	cardiovascular
Archaic-specific	HPO	Myelomeningocele (HP:0002475)	4	3.6727	1.089116998	0.498950105	nervous
Archaic-specific	HPO	Rhinitis (HP:0012384)	2	1.6812	1.189626457	0.499750025	respiratory
Archaic-specific	HPO	Preaxial hand polydactyly (HP:0001177)	7	6.6798	1.047935567	0.499750025	skeletal
Archaic-specific	HPO	Camptodactyly of toe (HP:0001836)	5	4.6432	1.076843556	0.500549945	skeletal
Archaic-specific	HPO	Convex nasal ridge (HP:0000444)	9	8.6644	1.038733207	0.501249875	skeletal
Archaic-specific	HPO	Hyperaldosteronism (HP:0000859)	2	1.6961	1.179175756	0.501249875	endocrine
Archaic-specific	HPO	Congenital stationary night blindness (HP:0007642)	1	0.6881	1.45327714	0.502549745	nervous
Archaic-specific	HPO	Male pseudohermaphroditism (HP:0000037)	4	3.7078	1.07880684	0.503049695	reproductive
Archaic-specific	HPO	Disproportionate short-trunk short stature (HP:0003521)	3	2.7062	1.108565516	0.505749425	skeletal
Archaic-specific	HPO	Abnormality of the line of Schwalbe (HP:0008048)	3	2.7204	1.102779003	0.507149285	nervous
Archaic-specific	HPO	Decreased number of large peripheral myelinated nerve fibers (HP:0003387)	1	0.7051	1.418238548	0.507949205	nervous
Archaic-specific	HPO	Rib fusion (HP:0000902)	2	1.7081	1.170891634	0.508249175	skeletal
Archaic-specific	HPO	Neoplasm of the liver (HP:0002896)	6	5.7433	1.044695558	0.511548845	digestive
Archaic-specific	HPO	Exercise intolerance (HP:0003546)	3	2.7371	1.096050564	0.512248775	other
Archaic-specific	HPO	Absent hand (HP:0004050)	2	1.7045	1.173364623	0.512348765	skeletal
Archaic-specific	HPO	Long palpebral fissure (HP:0000637)	2	1.7059	1.172401665	0.512748725	integumentary
Archaic-specific	HPO	Hallux valgus (HP:0001822)	5	4.7463	1.053452163	0.513348665	skeletal
Archaic-specific	HPO	Megalencephaly (HP:0001355)	2	1.7153	1.165976797	0.515048495	nervous
Archaic-specific	HPO	Axonal loss (HP:0003447)	1	0.727	1.375515818	0.516548345	nervous
Archaic-specific	HPO	Venous insufficiency (HP:0005293)	3	2.7361	1.096451153	0.516648335	cardiovascular
Archaic-specific	HPO	Hydroxyprolinuria (HP:0003080)	1	0.7245	1.38026225	0.518248175	other
Archaic-specific	HPO	Abnormality of proline metabolism (HP:0010907)	1	0.7245	1.38026225	0.518248175	metabolic
Archaic-specific	HPO	Duplicated collecting system (HP:0000081)	1	0.7299	1.370050692	0.519348065	urinary
Archaic-specific	HPO	Muscle fiber cytoplasmatic inclusion bodies (HP:0100303)	1	0.7295	1.370801919	0.521447855	skeletal muscle
Archaic-specific	HPO	Acanthocytosis (HP:0001927)	1	0.7439	1.344266703	0.524147585	hematologic
Archaic-specific	HPO	Stomach cancer (HP:0012126)	1	0.7507	1.332090049	0.526147385	digestive
Archaic-specific	HPO	Pterygium (HP:0001059)	4	3.8022	1.052022513	0.526247375	integumentary
Archaic-specific	HPO	Hematochezia (HP:0002573)	1	0.7337	1.362954886	0.526447355	digestive
Archaic-specific	HPO	Muscle fibrillation (HP:0010546)	1	0.7553	1.323977228	0.527847215	skeletal muscle
Archaic-specific	HPO	Pseudobulbar signs (HP:0002200)	2	1.7661	1.132438707	0.527947205	behavior
Archaic-specific	HPO	Agammaglobulinemia (HP:0004432)	1	0.7437	1.34462821	0.528047195	immune
Archaic-specific	HPO	Hirsutism (HP:0001007)	9	8.896	1.011690647	0.528047195	integumentary
Archaic-specific	HPO	Knee flexion contracture (HP:0006380)	4	3.8184	1.047559187	0.529647035	skeletal
Archaic-specific	HPO	Scotoma (HP:0000575)	2	1.7722	1.128540797	0.531046895	nervous
Archaic-specific	HPO	Absent phalangeal crease (HP:0006109)	2	1.7628	1.134558657	0.531146885	integumentary
Archaic-specific	HPO	Ventricular tachycardia (HP:0004756)	5	4.8698	1.026736211	0.531246875	cardiovascular
Archaic-specific	HPO	Abnormality of cochlea (HP:0000375)	1	0.7579	1.319435282	0.532246775	nervous
Archaic-specific	HPO	Vitreoretinal degeneration (HP:0000655)	2	1.7755	1.126443255	0.532246775	nervous
Archaic-specific	HPO	Osteoporosis (HP:0000939)	8	7.9107	1.011288508	0.532846715	skeletal
Archaic-specific	HPO	Maternal diabetes (HP:0009800)	1	0.7533	1.327492367	0.533146685	reproductive
Archaic-specific	HPO	"Congenital, generalized hypertrichosis (HP:0004540)"	1	0.7545	1.325381047	0.533146685	integumentary
Archaic-specific	HPO	Sporadic (HP:0003745)	8	7.9112	1.011224593	0.534446555	other
Archaic-specific	HPO	Muscle fiber inclusion bodies (HP:0100299)	1	0.7599	1.315962627	0.534546545	skeletal muscle
Archaic-specific	HPO	Short femoral neck (HP:0100864)	2	1.799	1.111728738	0.535046495	skeletal
Archaic-specific	HPO	Round ear (HP:0100830)	1	0.7629	1.310787783	0.535346465	other
Archaic-specific	HPO	Abnormal respiratory epithelium morphology (HP:0012253)	1	0.7671	1.303611002	0.535446455	respiratory
Archaic-specific	HPO	Abnormal respiratory motile cilium morphology (HP:0005938)	1	0.7671	1.303611002	0.535446455	respiratory
Archaic-specific	HPO	Spinal cord compression (HP:0002176)	1	0.7661	1.305312622	0.535746425	nervous
Archaic-specific	HPO	Ventricular septal defect (HP:0001629)	29	29.1094	0.996241764	0.536346365	cardiovascular
Archaic-specific	HPO	Myoglobinuria (HP:0002913)	1	0.7658	1.305823975	0.537446255	other
Archaic-specific	HPO	Vertebral fusion (HP:0002948)	3	2.8272	1.061120543	0.538146185	skeletal
Archaic-specific	HPO	Morphological abnormality of the inner ear (HP:0011390)	1	0.7722	1.295001295	0.538346165	nervous
Archaic-specific	HPO	Ulnar deviation of the hand or of fingers of the hand (HP:0001193)	6	5.9015	1.016690672	0.540445955	skeletal
Archaic-specific	HPO	Aplasia/Hypoplasia of the pubic bone (HP:0009104)	2	1.8191	1.09944478	0.541245875	skeletal
Archaic-specific	HPO	Acute myeloid leukemia (HP:0004808)	4	3.884	1.029866117	0.542245775	lymphatic
Archaic-specific	HPO	Absence seizures (HP:0002121)	3	2.8617	1.048327917	0.542645735	nervous
Archaic-specific	HPO	Hyperkalemia (HP:0002153)	3	2.8438	1.054926507	0.543045695	other
Archaic-specific	HPO	Femoral bowing (HP:0002980)	2	1.8252	1.095770327	0.543245675	skeletal
Archaic-specific	HPO	Atrioventricular block (HP:0001678)	2	1.8297	1.093075368	0.544045595	cardiovascular
Archaic-specific	HPO	Abnormal glycosylation (HP:0012345)	2	1.8231	1.097032527	0.544545545	other
Archaic-specific	HPO	Abnormal protein N-linked glycosylation (HP:0012347)	2	1.8231	1.097032527	0.544545545	other
Archaic-specific	HPO	Abnormal protein glycosylation (HP:0012346)	2	1.8231	1.097032527	0.544545545	other
Archaic-specific	HPO	Abnormal isoelectric focusing of serum transferrin (HP:0003160)	2	1.8231	1.097032527	0.544545545	other
Archaic-specific	HPO	Sandal gap (HP:0001852)	8	7.9733	1.003348676	0.544945505	skeletal
Archaic-specific	HPO	Multiple lipomas (HP:0001012)	2	1.8469	1.082895663	0.545445455	other
Archaic-specific	HPO	Asymmetry of the thorax (HP:0001555)	1	0.7809	1.280573697	0.546245375	skeletal
Archaic-specific	HPO	Cleft eyelid (HP:0000625)	5	4.9434	1.01144961	0.546645335	integumentary
Archaic-specific	HPO	Progressive macrocephaly (HP:0004481)	2	1.828	1.094091904	0.546845315	skeletal
Archaic-specific	HPO	Joint hemorrhage (HP:0005261)	1	0.7941	1.259287243	0.547945205	skeletal
Archaic-specific	HPO	Intestinal atresia (HP:0011100)	2	1.8493	1.081490294	0.548645135	digestive
Archaic-specific	HPO	Leukodystrophy (HP:0002415)	3	2.8587	1.049428062	0.549745025	nervous
Archaic-specific	HPO	Increased CSF protein (HP:0002922)	1	0.8034	1.244709983	0.549845015	other
Archaic-specific	HPO	Arterial thrombosis (HP:0004420)	2	1.8523	1.079738703	0.550144986	cardiovascular
Archaic-specific	HPO	Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108)	2	1.8581	1.076368333	0.550444956	skeletal
Archaic-specific	HPO	Agnosia (HP:0010524)	2	1.8557	1.077760414	0.550644936	nervous
Archaic-specific	HPO	Rough bone trabeculation (HP:0100670)	1	0.8001	1.24984377	0.552744726	skeletal
Archaic-specific	HPO	Bowel diverticulosis (HP:0005222)	3	2.8923	1.037236801	0.553644636	digestive
Archaic-specific	HPO	Deep philtrum (HP:0002002)	3	2.9045	1.032880014	0.557244276	integumentary
Archaic-specific	HPO	Increased nuchal translucency (HP:0010880)	5	5.0184	0.996333493	0.560243976	other
Archaic-specific	HPO	Spina bifida occulta (HP:0003298)	5	5.0357	0.992910618	0.561043896	skeletal
Archaic-specific	HPO	Aplasia/Hypoplasia of the earlobes (HP:0009906)	5	5.017	0.996611521	0.561143886	integumentary
Archaic-specific	HPO	Recurrent sinusitis (HP:0011108)	2	1.8895	1.05848108	0.561743826	respiratory
Archaic-specific	HPO	Meningocele (HP:0002435)	6	6.075	0.987654321	0.562943706	nervous
Archaic-specific	HPO	Cerebral hemorrhage (HP:0001342)	2	1.8802	1.063716626	0.563143686	nervous
Archaic-specific	HPO	Hypoplasia of the fovea (HP:0007750)	2	1.8867	1.060051943	0.563843616	nervous
Archaic-specific	HPO	Aplasia/Hypoplasia of the fovea (HP:0008060)	2	1.8867	1.060051943	0.563843616	nervous
Archaic-specific	HPO	Patent foramen ovale (HP:0001655)	2	1.8864	1.060220526	0.564043596	cardiovascular
Archaic-specific	HPO	Optic nerve hypoplasia (HP:0000609)	4	4.0098	0.997555988	0.565543446	nervous
Archaic-specific	HPO	Overlapping toe (HP:0001845)	2	1.8919	1.057138327	0.565743426	skeletal
Archaic-specific	HPO	Shawl scrotum (HP:0000049)	1	0.8385	1.192605844	0.566343366	reproductive
Archaic-specific	HPO	True hermaphroditism (HP:0010459)	2	1.9096	1.047339757	0.567443256	reproductive
Archaic-specific	HPO	Malnutrition (HP:0004395)	1	0.8361	1.196029183	0.568343166	metabolic
Archaic-specific	HPO	Broad palm (HP:0001169)	2	1.9092	1.047559187	0.568843116	skeletal
Archaic-specific	HPO	Keratoconjunctivitis sicca (HP:0001097)	1	0.8417	1.18807176	0.569543046	integumentary
Archaic-specific	HPO	Absent toe (HP:0010760)	4	4.0377	0.990663001	0.570942906	skeletal
Archaic-specific	HPO	Constipation (HP:0002019)	23	23.5677	0.975911947	0.573042696	digestive
Archaic-specific	HPO	Sudden cardiac death (HP:0001645)	14	14.3502	0.975596159	0.575642436	cardiovascular
Archaic-specific	HPO	Right ventricular cardiomyopathy (HP:0011663)	2	1.9296	1.036484245	0.577642236	cardiovascular
Archaic-specific	HPO	Irritability (HP:0000737)	5	5.1218	0.976219298	0.578642136	behavior
Archaic-specific	HPO	Heterochromia iridis (HP:0001100)	2	1.9328	1.034768212	0.578742126	integumentary
Archaic-specific	HPO	Hypokinesia (HP:0002375)	1	0.8574	1.166316772	0.579642036	skeletal muscle
Archaic-specific	HPO	Aplasia/Hypoplasia of the optic nerve (HP:0008058)	4	4.0944	0.976944119	0.580141986	nervous
Archaic-specific	HPO	Aplasia/Hypoplasia of the sacrum (HP:0008517)	1	0.8639	1.157541382	0.580241976	skeletal
Archaic-specific	HPO	Keratoconjunctivitis (HP:0001096)	1	0.8699	1.14955742	0.581241876	integumentary
Archaic-specific	HPO	Delayed gross motor development (HP:0002194)	8	8.2417	0.970673526	0.581641836	nervous
Archaic-specific	HPO	Poor head control (HP:0002421)	1	0.8785	1.138303927	0.581741826	nervous
Archaic-specific	HPO	Abnormal finger flexion creases (HP:0006143)	2	1.9466	1.027432446	0.582641736	integumentary
Archaic-specific	HPO	Amblyopia (HP:0000646)	3	3.0235	0.992227551	0.582941706	nervous
Archaic-specific	HPO	Recurrent corneal erosions (HP:0000495)	1	0.8826	1.133016089	0.583541646	nervous
Archaic-specific	HPO	Cholelithiasis (HP:0001081)	2	1.9491	1.026114617	0.585041496	digestive
Archaic-specific	HPO	Abnormality of the intrinsic pathway (HP:0010989)	1	0.8802	1.136105431	0.585341466	hematologic
Archaic-specific	HPO	Hyperbilirubinemia (HP:0002904)	4	4.1006	0.975467005	0.586541346	digestive
Archaic-specific	HPO	Abnormality of reticulocytes (HP:0004312)	3	3.0438	0.985610093	0.586741326	immune
Archaic-specific	HPO	Lower limb amyotrophy (HP:0007210)	1	0.9049	1.105094486	0.588341166	nervous
Archaic-specific	HPO	Premature skin wrinkling (HP:0100678)	1	0.8993	1.111975981	0.589641036	integumentary
Archaic-specific	HPO	Orthostatic hypotension (HP:0001278)	1	0.8888	1.125112511	0.589841016	cardiovascular
Archaic-specific	HPO	Postaxial hand polydactyly (HP:0001162)	14	14.5379	0.963000158	0.590640936	skeletal
Archaic-specific	HPO	Hypoplasia of the maxilla (HP:0000327)	6	6.2157	0.965297553	0.590740926	skeletal
Archaic-specific	HPO	"Low-set, posteriorly rotated ears (HP:0000368)"	50	51.3339	0.974015222	0.591840816	other
Archaic-specific	HPO	Clitoromegaly (HP:0000057)	4	4.1383	0.96658048	0.592140786	reproductive
Archaic-specific	HPO	Hypoglycemic coma (HP:0001325)	1	0.9086	1.100594321	0.592440756	metabolic
Archaic-specific	HPO	Homocystinuria (HP:0002156)	1	0.8951	1.11719361	0.594240576	other
Archaic-specific	HPO	Abnormality of homocysteine metabolism (HP:0010919)	1	0.8951	1.11719361	0.594240576	metabolic
Archaic-specific	HPO	Cortical visual impairment (HP:0100704)	2	1.9813	1.009438248	0.594840516	nervous
Archaic-specific	HPO	Aplasia/Hypoplasia affecting the fundus (HP:0008057)	6	6.2804	0.955353162	0.595240476	nervous
Archaic-specific	HPO	Narrow forehead (HP:0000341)	10	10.4061	0.960974813	0.595740426	skeletal
Archaic-specific	HPO	Protuberant abdomen (HP:0001538)	2	2.0069	0.996561862	0.596040396	metabolic
Archaic-specific	HPO	Pancreatic fibrosis (HP:0100732)	2	2.0193	0.990442232	0.596840316	digestive
Archaic-specific	HPO	Dental crowding (HP:0000678)	9	9.412	0.956226094	0.596940306	skeletal
Archaic-specific	HPO	Bone cyst (HP:0012062)	1	0.9225	1.08401084	0.599940006	skeletal
Archaic-specific	HPO	Wide nasal bridge (HP:0000431)	38	39.149	0.970650591	0.600839916	integumentary
Archaic-specific	HPO	Abnormal ventriculo-arterial connection (HP:0011563)	2	2.0325	0.98400984	0.601239876	cardiovascular
Archaic-specific	HPO	Transposition of the great arteries (HP:0001669)	2	2.0325	0.98400984	0.601239876	cardiovascular
Archaic-specific	HPO	Abnormal connection of the cardiac segments (HP:0011545)	2	2.0325	0.98400984	0.601239876	cardiovascular
Archaic-specific	HPO	Steppage gait (HP:0003376)	2	2.0251	0.98760555	0.601439856	skeletal muscle
Archaic-specific	HPO	Failure to thrive in infancy (HP:0001531)	1	0.9133	1.094930472	0.601639836	other
Archaic-specific	HPO	Difficulty walking (HP:0002355)	3	3.1148	0.963143701	0.603939606	other
Archaic-specific	HPO	Generalized hypopigmentation (HP:0007513)	3	3.1202	0.961476828	0.604039596	integumentary
Archaic-specific	HPO	Chronic diarrhea (HP:0002028)	2	2.0454	0.977803853	0.604039596	digestive
Archaic-specific	HPO	Abnormal pancreas size (HP:0012094)	1	0.912	1.096491228	0.604139586	digestive
Archaic-specific	HPO	Neoplasm of the lung (HP:0100526)	6	6.3675	0.942285041	0.605039496	respiratory
Archaic-specific	HPO	Abnormality of the vertebral endplates (HP:0005106)	1	0.9328	1.072041166	0.606039396	skeletal
Archaic-specific	HPO	Abnormality of the fovea (HP:0000493)	2	2.0502	0.975514584	0.606839316	nervous
Archaic-specific	HPO	Left ventricular hypertrophy (HP:0001712)	6	6.3568	0.94387113	0.607339266	cardiovascular
Archaic-specific	HPO	Neoplasm of head and neck (HP:0012288)	1	0.9205	1.086366105	0.608239176	integumentary
Archaic-specific	HPO	Esophageal neoplasm (HP:0100751)	1	0.9205	1.086366105	0.608239176	digestive
Archaic-specific	HPO	Vaginal atresia (HP:0000148)	6	6.3675	0.942285041	0.608539146	reproductive
Archaic-specific	HPO	Mandibular prognathia (HP:0000303)	12	12.6514	0.948511627	0.609139086	skeletal
Archaic-specific	HPO	Aortic regurgitation (HP:0001659)	2	2.0572	0.972195217	0.609139086	cardiovascular
Archaic-specific	HPO	Wide cranial sutures (HP:0010537)	2	2.0532	0.974089227	0.609339066	skeletal
Archaic-specific	HPO	Flared metaphyses (HP:0003015)	2	2.0636	0.969180074	0.611238876	skeletal
Archaic-specific	HPO	Abnormality of the clitoris (HP:0000056)	5	5.3185	0.940114694	0.611938806	reproductive
Archaic-specific	HPO	Carpal bone hypoplasia (HP:0001498)	1	0.9494	1.053296819	0.612338766	skeletal
Archaic-specific	HPO	Venous abnormality (HP:0002624)	4	4.2571	0.939606775	0.612438756	cardiovascular
Archaic-specific	HPO	Cerebellar dysplasia (HP:0007033)	1	0.9462	1.056859015	0.613938606	nervous
Archaic-specific	HPO	Abnormality of the tricuspid valve (HP:0001702)	2	2.0685	0.966884216	0.614638536	cardiovascular
Archaic-specific	HPO	Radial deviation of finger (HP:0009466)	36	37.4209	0.96202924	0.614838516	skeletal
Archaic-specific	HPO	Joint swelling (HP:0001386)	2	2.09	0.956937799	0.618338166	skeletal
Archaic-specific	HPO	Type I diabetes mellitus (HP:0100651)	1	0.9637	1.037667324	0.618738126	metabolic
Archaic-specific	HPO	Genu varum (HP:0002970)	2	2.1041	0.950525165	0.619138086	skeletal
Archaic-specific	HPO	Depression (HP:0000716)	4	4.3074	0.928634443	0.619638036	behavior
Archaic-specific	HPO	Oligomenorrhea (HP:0000876)	2	2.0897	0.957075178	0.621137886	reproductive
Archaic-specific	HPO	Absent septum pellucidum (HP:0001331)	1	0.9763	1.024275325	0.621337866	nervous
Archaic-specific	HPO	Tachypnea (HP:0002789)	3	3.1893	0.940645283	0.621737826	respiratory
Archaic-specific	HPO	Polycythemia (HP:0001901)	1	0.9659	1.035303862	0.622137786	lymphatic
Archaic-specific	HPO	Recurrent viral infections (HP:0004429)	2	2.1195	0.943618778	0.624137586	immune
Archaic-specific	HPO	Depressed nasal bridge (HP:0005280)	38	39.6168	0.959189031	0.625437456	skeletal
Archaic-specific	HPO	Prenatal maternal abnormality (HP:0002686)	3	3.2144	0.933300149	0.625537446	reproductive
Archaic-specific	HPO	Abnormality of the alveolar ridges (HP:0006477)	2	2.1055	0.949893137	0.626237376	skeletal
Archaic-specific	HPO	Prominent forehead (HP:0011220)	7	7.5177	0.931135853	0.626437356	skeletal
Archaic-specific	HPO	Genital tract atresia (HP:0001827)	6	6.4823	0.925597396	0.626537346	reproductive
Archaic-specific	HPO	Humeroradial synostosis (HP:0003041)	1	0.9933	1.006745193	0.626637336	skeletal
Archaic-specific	HPO	Abnormality of purine metabolism (HP:0004352)	2	2.1057	0.949802916	0.626637336	metabolic
Archaic-specific	HPO	Synostosis involving the elbow (HP:0003938)	1	0.9933	1.006745193	0.626637336	skeletal
Archaic-specific	HPO	Abnormal trabecular bone morphology (HP:0100671)	1	0.9856	1.01461039	0.629437056	skeletal
Archaic-specific	HPO	Abnormality of the wing of the ilium (HP:0011867)	4	4.3246	0.924941035	0.629637036	skeletal
Archaic-specific	HPO	Inappropriate behavior (HP:0000719)	1	0.9789	1.021554806	0.629937006	behavior
Archaic-specific	HPO	Corneal dystrophy (HP:0001131)	5	5.3976	0.926337632	0.630136986	nervous
Archaic-specific	HPO	Fused cervical vertebrae (HP:0002949)	1	0.988	1.012145749	0.630136986	skeletal
Archaic-specific	HPO	Cutis marmorata (HP:0000965)	5	5.4254	0.921591035	0.632236776	integumentary
Archaic-specific	HPO	Generalized tonic-clonic seizures (HP:0002069)	5	5.4214	0.922271	0.634136586	nervous
Archaic-specific	HPO	Smooth philtrum (HP:0000319)	8	8.6468	0.925197761	0.636636336	integumentary
Archaic-specific	HPO	Gastroesophageal reflux (HP:0002020)	10	10.7428	0.930856015	0.636736326	digestive
Archaic-specific	HPO	Short neck (HP:0000470)	34	35.6739	0.95307774	0.636936306	skeletal
Archaic-specific	HPO	Muscle fiber splitting (HP:0003555)	1	1.0023	0.997705278	0.637036296	skeletal muscle
Archaic-specific	HPO	Hypodontia (HP:0000668)	6	6.5677	0.913561825	0.638736126	skeletal
Archaic-specific	HPO	Abnormality of the incisor (HP:0000676)	5	5.439	0.919286634	0.639136086	skeletal
Archaic-specific	HPO	Mitral stenosis (HP:0001718)	1	1.0137	0.986485153	0.639636036	cardiovascular
Archaic-specific	HPO	Glossoptosis (HP:0000162)	1	1.0118	0.988337616	0.639936006	other
Archaic-specific	HPO	Hydroureter (HP:0000072)	3	3.3074	0.907056903	0.639936006	urinary
Archaic-specific	HPO	Hypertelorism (HP:0000316)	51	53.2854	0.957110203	0.640335966	skeletal
Archaic-specific	HPO	Prolonged QT interval (HP:0001657)	4	4.4311	0.902710388	0.642135786	cardiovascular
Archaic-specific	HPO	Postaxial foot polydactyly (HP:0001830)	5	5.4936	0.910149993	0.642435756	skeletal
Archaic-specific	HPO	Bicornuate uterus (HP:0000813)	5	5.5369	0.903032383	0.643935606	reproductive
Archaic-specific	HPO	Hyperphosphatemia (HP:0002905)	1	1.0368	0.964506173	0.644535546	other
Archaic-specific	HPO	Arnold-Chiari malformation (HP:0002308)	4	4.4114	0.906741624	0.647435256	skeletal
Archaic-specific	HPO	Hemivertebrae (HP:0002937)	3	3.3631	0.892034135	0.647735226	skeletal
Archaic-specific	HPO	Aplasia/Hypoplasia of the breasts (HP:0010311)	3	3.325	0.902255639	0.647735226	reproductive
Archaic-specific	HPO	Rectovaginal fistula (HP:0000143)	1	1.0426	0.95914061	0.648135186	reproductive
Archaic-specific	HPO	Rectal fistula (HP:0100590)	1	1.0426	0.95914061	0.648135186	digestive
Archaic-specific	HPO	Hypoplastic left heart (HP:0004383)	1	1.0541	0.948676596	0.649235076	cardiovascular
Archaic-specific	HPO	Tetraparesis (HP:0002273)	1	1.0419	0.959785008	0.649535046	nervous
Archaic-specific	HPO	Glucose intolerance (HP:0000833)	1	1.0469	0.95520107	0.649635036	metabolic
Archaic-specific	HPO	Arteriovenous malformation (HP:0100026)	4	4.4313	0.902669645	0.649835016	cardiovascular
Archaic-specific	HPO	Glomerulonephritis (HP:0000099)	1	1.0534	0.949307006	0.652034797	urinary
Archaic-specific	HPO	Abnormality of renin-angiotensin system (HP:0000847)	2	2.2237	0.899401898	0.652034797	other
Archaic-specific	HPO	Macroorchidism (HP:0000053)	1	1.0369	0.964413155	0.652134787	reproductive
Archaic-specific	HPO	Rhabdomyolysis (HP:0003201)	1	1.0573	0.945805353	0.653134687	other
Archaic-specific	HPO	Broad alveolar ridges (HP:0000187)	1	1.0428	0.958956655	0.654534547	skeletal
Archaic-specific	HPO	Turricephaly (HP:0000262)	1	1.0729	0.932053313	0.656034397	skeletal
Archaic-specific	HPO	Abnormal hair whorl (HP:0010721)	1	1.077	0.928505107	0.657034297	integumentary
Archaic-specific	HPO	Hypoplastic iliac wings (HP:0002866)	3	3.3952	0.883600377	0.657834217	skeletal
Archaic-specific	HPO	Atrial fibrillation (HP:0005110)	8	8.8552	0.903423977	0.659434057	cardiovascular
Archaic-specific	HPO	Intestinal fistula (HP:0100819)	1	1.0781	0.92755774	0.659934007	digestive
Archaic-specific	HPO	Truncal obesity (HP:0001956)	8	8.9279	0.896067384	0.661733827	metabolic
Archaic-specific	HPO	Hyperparathyroidism (HP:0000843)	1	1.082	0.924214418	0.661833817	endocrine
Archaic-specific	HPO	Erectile abnormalities (HP:0100639)	2	2.2565	0.886328385	0.662133787	reproductive
Archaic-specific	HPO	Supraventricular tachycardia (HP:0004755)	8	8.8816	0.900738606	0.662433757	cardiovascular
Archaic-specific	HPO	Primary atrial arrhythmia (HP:0001692)	8	8.8816	0.900738606	0.662433757	cardiovascular
Archaic-specific	HPO	Abnormal EKG (HP:0003115)	6	6.7094	0.894267744	0.663533647	cardiovascular
Archaic-specific	HPO	Non-midline cleft lip (HP:0100335)	5	5.6694	0.881927541	0.664033597	other
Archaic-specific	HPO	Thick nail (HP:0001805)	1	1.0773	0.928246542	0.665533447	integumentary
Archaic-specific	HPO	Hypolipoproteinemia (HP:0010981)	2	2.2678	0.881911985	0.665833417	metabolic
Archaic-specific	HPO	Rocker bottom foot (HP:0001838)	5	5.6648	0.882643694	0.665833417	skeletal
Archaic-specific	HPO	Cheilitis (HP:0100825)	1	1.09	0.917431193	0.665933407	other
Archaic-specific	HPO	Long eyelashes (HP:0000527)	3	3.4465	0.870448281	0.666333367	integumentary
Archaic-specific	HPO	Hypoplastic heart (HP:0001961)	1	1.116	0.896057348	0.670032997	cardiovascular
Archaic-specific	HPO	Clinodactyly of the 5th finger (HP:0004209)	30	32.1201	0.933994602	0.670232977	skeletal
Archaic-specific	HPO	Cerebral palsy (HP:0100021)	1	1.0896	0.917767988	0.671632837	nervous
Archaic-specific	HPO	Abnormality of the lumbar spine (HP:0100712)	1	1.1076	0.902853016	0.672032797	skeletal
Archaic-specific	HPO	Acanthosis nigricans (HP:0000956)	2	2.3301	0.85833226	0.673732627	integumentary
Archaic-specific	HPO	Clubbing of toes (HP:0100760)	3	3.4903	0.859524969	0.674932507	integumentary
Archaic-specific	HPO	Menstrual irregularities (HP:0000858)	1	1.1141	0.897585495	0.674932507	reproductive
Archaic-specific	HPO	Gingival overgrowth (HP:0000212)	8	8.9801	0.890858676	0.675732427	immune
Archaic-specific	HPO	Vaginal fistula (HP:0004320)	1	1.1277	0.886760663	0.676432357	reproductive
Archaic-specific	HPO	Ureteral duplication (HP:0000073)	1	1.1189	0.893734918	0.678332167	urinary
Archaic-specific	HPO	Facial shape deformation (HP:0011334)	2	2.3589	0.847852813	0.680431957	skeletal
Archaic-specific	HPO	Potter facies (HP:0002009)	2	2.3589	0.847852813	0.680431957	other
Archaic-specific	HPO	Bicuspid aortic valve (HP:0001647)	3	3.5105	0.85457912	0.680831917	cardiovascular
Archaic-specific	HPO	Myoclonus (HP:0001336)	4	4.6447	0.861196633	0.682231777	nervous
Archaic-specific	HPO	Abnormality of the odontoid process (HP:0003310)	2	2.3338	0.856971463	0.682331767	skeletal
Archaic-specific	HPO	Hypoplasia of the odontoid process (HP:0003311)	2	2.3338	0.856971463	0.682331767	skeletal
Archaic-specific	HPO	Impulsivity (HP:0100710)	1	1.1641	0.859032729	0.682831717	behavior
Archaic-specific	HPO	Ketoacidosis (HP:0001993)	1	1.1428	0.875043752	0.683731627	metabolic
Archaic-specific	HPO	Short ribs (HP:0000773)	5	5.7665	0.867077083	0.683731627	skeletal
Archaic-specific	HPO	Tracheomalacia (HP:0002779)	3	3.5359	0.848440284	0.685331467	respiratory
Archaic-specific	HPO	Acute encephalopathy (HP:0006846)	2	2.3738	0.842530963	0.688531147	nervous
Archaic-specific	HPO	Chromosomal breakage induced by crosslinking agents (HP:0003221)	1	1.1715	0.853606487	0.688931107	other
Archaic-specific	HPO	Urinary bladder sphincter dysfunction (HP:0002839)	2	2.3878	0.837591088	0.689631037	urinary
Archaic-specific	HPO	Hip dysplasia (HP:0001385)	2	2.3665	0.845129939	0.690330967	skeletal
Archaic-specific	HPO	Cupped ribs (HP:0000887)	1	1.166	0.857632933	0.691730827	skeletal
Archaic-specific	HPO	Abnormality of the fingernails (HP:0001231)	14	15.6598	0.894008863	0.692330767	integumentary
Archaic-specific	HPO	Congenital primary aphakia (HP:0007707)	2	2.4347	0.821456442	0.695130487	nervous
Archaic-specific	HPO	Vascular calcification (HP:0004934)	1	1.1959	0.836190317	0.696330367	cardiovascular
Archaic-specific	HPO	Coronal craniosynostosis (HP:0004440)	1	1.1908	0.839771582	0.696430357	skeletal
Archaic-specific	HPO	Abnormality of primary teeth (HP:0006481)	4	4.7285	0.845934229	0.696530347	skeletal
Archaic-specific	HPO	Congenital ichthyosiform erythroderma (HP:0007431)	1	1.1931	0.838152711	0.696830317	integumentary
Archaic-specific	HPO	Abnormality of the renal collecting system (HP:0004742)	1	1.1941	0.8374508	0.698330167	urinary
Archaic-specific	HPO	Short distal phalanx of finger (HP:0009882)	8	9.1784	0.87161161	0.698430157	skeletal
Archaic-specific	HPO	Adrenal overactivity (HP:0002717)	3	3.6543	0.820950661	0.700029997	endocrine
Archaic-specific	HPO	Hyperammonemia (HP:0001987)	3	3.6087	0.8313243	0.700029997	metabolic
Archaic-specific	HPO	Blue sclerae (HP:0000592)	5	5.9079	0.846324413	0.702529747	integumentary
Archaic-specific	HPO	Paraparesis (HP:0002385)	1	1.1931	0.838152711	0.704029597	nervous
Archaic-specific	HPO	Partial agenesis of the corpus callosum (HP:0001338)	2	2.4818	0.80586671	0.704329567	nervous
Archaic-specific	HPO	Triangular face (HP:0000325)	11	12.521	0.87852408	0.704529547	other
Archaic-specific	HPO	Exotropia (HP:0000577)	1	1.2154	0.822774395	0.708129187	nervous
Archaic-specific	HPO	Thick lower lip vermilion (HP:0000179)	12	13.6098	0.881717586	0.709229077	integumentary
Archaic-specific	HPO	Flat capital femoral epiphysis (HP:0003370)	1	1.2249	0.816393175	0.710228977	skeletal
Archaic-specific	HPO	Mitochondrial inheritance (HP:0001427)	2	2.5207	0.793430396	0.711728827	other
Archaic-specific	HPO	Hepatoblastoma (HP:0002884)	1	1.2659	0.789951813	0.712428757	digestive
Archaic-specific	HPO	Short thorax (HP:0010306)	4	4.8924	0.817594637	0.716628337	skeletal
Archaic-specific	HPO	Limited hip movement (HP:0008800)	6	7.1862	0.834933623	0.718328167	other
Archaic-specific	HPO	Slender long bone (HP:0003100)	1	1.2679	0.788705734	0.718728127	skeletal
Archaic-specific	HPO	Decreased subcutaneous fat (HP:0001002)	1	1.2798	0.781372089	0.719428057	metabolic
Archaic-specific	HPO	Abnormality of the sella turcica (HP:0002679)	2	2.5308	0.790263948	0.720227977	skeletal
Archaic-specific	HPO	Spinal canal stenosis (HP:0003416)	4	4.897	0.816826629	0.720227977	skeletal
Archaic-specific	HPO	Soft skin (HP:0000977)	2	2.5281	0.791107947	0.720727927	integumentary
Archaic-specific	HPO	Abnormal hemoglobin (HP:0011902)	1	1.2866	0.777242344	0.721127887	hematologic
Archaic-specific	HPO	Aseptic necrosis (HP:0010885)	3	3.7734	0.795038957	0.721227877	skeletal
Archaic-specific	HPO	Short chin (HP:0000331)	2	2.5666	0.779241019	0.721627837	skeletal
Archaic-specific	HPO	Goiter (HP:0000853)	4	4.8827	0.819218875	0.721627837	endocrine
Archaic-specific	HPO	Supraventricular arrhythmia (HP:0005115)	8	9.4004	0.851027616	0.722127787	cardiovascular
Archaic-specific	HPO	External ear malformation (HP:0008572)	8	9.4018	0.850900891	0.723727627	other
Archaic-specific	HPO	Gingival bleeding (HP:0000225)	2	2.5668	0.779180302	0.725127487	immune
Archaic-specific	HPO	Trigonocephaly (HP:0000243)	2	2.561	0.780944943	0.725227477	skeletal
Archaic-specific	HPO	Rectal prolapse (HP:0002035)	1	1.2959	0.77166448	0.725327467	digestive
Archaic-specific	HPO	Poor eye contact (HP:0000817)	2	2.5549	0.782809503	0.725527447	nervous
Archaic-specific	HPO	Reticulocytosis (HP:0001923)	2	2.5508	0.784067743	0.725527447	hematologic
Archaic-specific	HPO	Retinal dysplasia (HP:0007973)	2	2.5711	0.777877173	0.728027197	nervous
Archaic-specific	HPO	Abnormality of the nasal septum (HP:0000419)	1	1.3039	0.766929979	0.728727127	respiratory
Archaic-specific	HPO	Brachycephaly (HP:0000248)	8	9.5431	0.838302019	0.729227077	skeletal
Archaic-specific	HPO	Palmoplantar hyperkeratosis (HP:0000972)	1	1.2979	0.770475383	0.729327067	integumentary
Archaic-specific	HPO	Nephroblastoma (Wilms tumor) (HP:0002667)	2	2.5883	0.772707955	0.729827017	urinary
Archaic-specific	HPO	Abnormality of nucleobase metabolism (HP:0010932)	4	4.9382	0.810011745	0.730226977	metabolic
Archaic-specific	HPO	Frequent falls (HP:0002359)	1	1.3077	0.764701384	0.730426957	other
Archaic-specific	HPO	Incomplete penetrance (HP:0003829)	9	10.6201	0.847449647	0.730526947	other
Archaic-specific	HPO	Delayed puberty (HP:0000823)	4	4.9787	0.80342258	0.731626837	endocrine
Archaic-specific	HPO	Arterial tortuosity (HP:0005116)	1	1.3539	0.738606987	0.731926807	cardiovascular
Archaic-specific	HPO	Cryptorchidism (HP:0000028)	56	60.4814	0.925904493	0.732626737	reproductive
Archaic-specific	HPO	Thrombophlebitis (HP:0004418)	2	2.6186	0.763766898	0.733326667	cardiovascular
Archaic-specific	HPO	Prominent metopic ridge (HP:0005487)	1	1.3105	0.763067531	0.733926607	skeletal
Archaic-specific	HPO	Areflexia of lower limbs (HP:0002522)	1	1.3211	0.75694497	0.734326567	nervous
Archaic-specific	HPO	EEG with generalized epileptiform discharges (HP:0011198)	6	7.3364	0.817839812	0.737726227	nervous
Archaic-specific	HPO	Postnatal growth retardation (HP:0008897)	9	10.6879	0.842073747	0.738726127	metabolic
Archaic-specific	HPO	Melanocytic nevus (HP:0000995)	4	5.0484	0.792330243	0.740125987	integumentary
Archaic-specific	HPO	Breast aplasia (HP:0100783)	2	2.6333	0.759503285	0.740225977	reproductive
Archaic-specific	HPO	Anal atresia (HP:0002023)	4	5.0596	0.79057633	0.740925907	digestive
Archaic-specific	HPO	Mitral valve prolapse (HP:0001634)	5	6.195	0.807102502	0.740925907	cardiovascular
Archaic-specific	HPO	Radioulnar synostosis (HP:0002974)	6	7.3435	0.817049091	0.741925807	skeletal
Archaic-specific	HPO	Urethral obstruction (HP:0000796)	2	2.6709	0.748811262	0.743025697	urinary
Archaic-specific	HPO	Open mouth (HP:0000194)	8	9.5885	0.834332794	0.743125687	other
Archaic-specific	HPO	Thickened calvaria (HP:0002684)	2	2.6559	0.753040401	0.743325667	skeletal
Archaic-specific	HPO	Chin dimple (HP:0010751)	2	2.6698	0.749119784	0.743825617	integumentary
Archaic-specific	HPO	Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026)	1	1.3678	0.731101038	0.745525447	skeletal
Archaic-specific	HPO	Short 1st metacarpal (HP:0010034)	1	1.3678	0.731101038	0.745525447	skeletal
Archaic-specific	HPO	Anxiety (HP:0000739)	4	5.0578	0.790857685	0.746625337	behavior
Archaic-specific	HPO	Epiphyseal dysplasia (HP:0002656)	2	2.667	0.749906262	0.746725327	skeletal
Archaic-specific	HPO	Pallor (HP:0000980)	3	3.9012	0.768994156	0.749225077	integumentary
Archaic-specific	HPO	Abnormality of the 1st metacarpal (HP:0010009)	1	1.391	0.718907261	0.751124888	skeletal
Archaic-specific	HPO	Abnormality of the costochondral junction (HP:0000919)	1	1.3803	0.724480185	0.751424858	skeletal
Archaic-specific	HPO	Beaking of vertebral bodies (HP:0004568)	1	1.3826	0.723274989	0.752624738	skeletal
Archaic-specific	HPO	Gait imbalance (HP:0002141)	2	2.7254	0.733837235	0.753524648	nervous
Archaic-specific	HPO	Broad foot (HP:0001769)	5	6.3316	0.78968981	0.754424558	skeletal
Archaic-specific	HPO	Micropenis (HP:0000054)	15	17.4693	0.858649173	0.755124488	reproductive
Archaic-specific	HPO	Hypocalcemia (HP:0002901)	4	5.1871	0.771143799	0.755924408	other
Archaic-specific	HPO	Cutaneous finger syndactyly (HP:0010554)	5	6.3003	0.793613003	0.756724328	integumentary
Archaic-specific	HPO	Abnormality of the middle phalanges of the toes (HP:0010183)	1	1.421	0.703729768	0.757224278	skeletal
Archaic-specific	HPO	Vascular tortuosity (HP:0004948)	1	1.4517	0.688847558	0.757824218	cardiovascular
Archaic-specific	HPO	Spastic paraplegia (HP:0001258)	2	2.7396	0.730033582	0.758024198	nervous
Archaic-specific	HPO	Blue irides (HP:0000635)	3	3.9772	0.754299507	0.758324168	integumentary
Archaic-specific	HPO	Attenuation of retinal blood vessels (HP:0007843)	5	6.3243	0.790601331	0.759024098	cardiovascular
Archaic-specific	HPO	Abnormal delivery (HP:0001787)	2	2.7521	0.726717779	0.760323968	reproductive
Archaic-specific	HPO	Metatarsus adductus (HP:0001840)	2	2.7529	0.726506593	0.760523948	skeletal
Archaic-specific	HPO	Narrow palate (HP:0000189)	5	6.3361	0.789128959	0.761823818	skeletal
Archaic-specific	HPO	Increased serum lactate (HP:0002151)	4	5.1855	0.771381738	0.763623638	other
Archaic-specific	HPO	Pancreatic cysts (HP:0001737)	2	2.7905	0.716717434	0.763623638	digestive
Archaic-specific	HPO	Cutaneous syndactyly (HP:0012725)	5	6.3616	0.785965795	0.763923608	integumentary
Archaic-specific	HPO	Preaxial foot polydactyly (HP:0001841)	3	4.0202	0.746231531	0.764123588	skeletal
Archaic-specific	HPO	Bronchiectasis (HP:0002110)	4	5.223	0.765843385	0.765223478	respiratory
Archaic-specific	HPO	Aplasia/Hypoplasia involving the carpal bones (HP:0006502)	1	1.4329	0.697885407	0.765423458	skeletal
Archaic-specific	HPO	Type II lissencephaly (HP:0007260)	2	2.7424	0.729288215	0.765423458	skeletal
Archaic-specific	HPO	Protruding tongue (HP:0010808)	5	6.3831	0.78331845	0.765423458	other
Archaic-specific	HPO	Shallow orbits (HP:0000586)	2	2.7732	0.721188519	0.766123388	skeletal
Archaic-specific	HPO	Fat malabsorption (HP:0002630)	1	1.4407	0.694107031	0.767423258	metabolic
Archaic-specific	HPO	Hyperactive renin-angiotensin system (HP:0000841)	1	1.4556	0.687001924	0.767723228	other
Archaic-specific	HPO	Progressive visual loss (HP:0000529)	2	2.8086	0.712098554	0.768523148	nervous
Archaic-specific	HPO	Heterotopia (HP:0002282)	1	1.4715	0.679578661	0.769223078	nervous
Archaic-specific	HPO	Supernumerary ribs (HP:0005815)	2	2.7867	0.717694764	0.770122988	skeletal
Archaic-specific	HPO	Female pseudohermaphroditism (HP:0010458)	7	8.7265	0.802154357	0.771022898	reproductive
Archaic-specific	HPO	Mitral regurgitation (HP:0001653)	3	4.0973	0.732189491	0.772322768	cardiovascular
Archaic-specific	HPO	Tarsal synostosis (HP:0008368)	3	4.072	0.736738703	0.772522748	skeletal
Archaic-specific	HPO	Palmar hyperkeratosis (HP:0010765)	1	1.4659	0.682174773	0.773922608	integumentary
Archaic-specific	HPO	Osteoarthritis (HP:0002758)	5	6.5055	0.768580432	0.775522448	skeletal
Archaic-specific	HPO	Supernumerary bones of the axial skeleton (HP:0009144)	2	2.8227	0.708541467	0.775822418	skeletal
Archaic-specific	HPO	Medial flaring of the eyebrow (HP:0010747)	2	2.8821	0.693938448	0.778422158	integumentary
Archaic-specific	HPO	Depressed nasal ridge (HP:0000457)	10	12.2634	0.815434545	0.778522148	skeletal
Archaic-specific	HPO	Deformed sella turcica (HP:0002681)	1	1.5044	0.664716831	0.778522148	skeletal
Archaic-specific	HPO	Abnormality of sulfur amino acid metabolism (HP:0004339)	2	2.8619	0.698836437	0.781621838	metabolic
Archaic-specific	HPO	Triphalangeal thumb (HP:0001199)	4	5.375	0.744186047	0.782321768	skeletal
Archaic-specific	HPO	Abnormality of pyrimidine metabolism (HP:0004353)	2	2.8325	0.706090026	0.782721728	metabolic
Archaic-specific	HPO	Limb dystonia (HP:0002451)	1	1.508	0.663129973	0.783421658	nervous
Archaic-specific	HPO	Paraplegia (HP:0010550)	2	2.8798	0.694492673	0.783521648	nervous
Archaic-specific	HPO	Recurrent otitis media (HP:0000403)	2	2.8668	0.69764197	0.784621538	nervous
Archaic-specific	HPO	Epileptiform EEG discharges (HP:0011182)	7	8.8986	0.786640595	0.785221478	nervous
Archaic-specific	HPO	Striae distensae (HP:0001065)	2	2.8731	0.696112213	0.785421458	integumentary
Archaic-specific	HPO	Optic nerve coloboma (HP:0000588)	1	1.5433	0.647962159	0.785421458	nervous
Archaic-specific	HPO	Metaphyseal irregularity (HP:0003025)	1	1.5571	0.642219511	0.785721428	skeletal
Archaic-specific	HPO	Single transverse palmar crease (HP:0000954)	16	19.0837	0.838411838	0.785921408	integumentary
Archaic-specific	HPO	Synostosis involving bones of the feet (HP:0009140)	3	4.1673	0.719890577	0.786821318	skeletal
Archaic-specific	HPO	Abolished electroretinogram (ERG) (HP:0000550)	4	5.3761	0.744033779	0.786821318	nervous
Archaic-specific	HPO	Synostosis involving bones of the lower limbs (HP:0009138)	3	4.1673	0.719890577	0.786821318	skeletal
Archaic-specific	HPO	Recurrent skin infections (HP:0001581)	1	1.5547	0.643210909	0.787821218	immune
Archaic-specific	HPO	Dilatation of the ascending aorta (HP:0005111)	3	4.1592	0.721292556	0.787821218	cardiovascular
Archaic-specific	HPO	Reduced subcutaneous adipose tissue (HP:0003758)	1	1.5634	0.639631572	0.788921108	metabolic
Archaic-specific	HPO	Anhidrosis (HP:0000970)	1	1.6037	0.623558022	0.791920808	integumentary
Archaic-specific	HPO	Abnormal cortical bone morphology (HP:0003103)	4	5.5074	0.72629553	0.794620538	skeletal
Archaic-specific	HPO	Gangrene (HP:0100758)	1	1.5913	0.628417018	0.795220478	other
Archaic-specific	HPO	Broad hallux (HP:0010055)	2	2.9963	0.667489904	0.797020298	skeletal
Archaic-specific	HPO	Somatic mutation (HP:0001428)	7	9.0936	0.769772147	0.798020198	other
Archaic-specific	HPO	Dysarthria (HP:0001260)	25	29.021	0.86144516	0.799120088	nervous
Archaic-specific	HPO	Acute lymphatic leukemia (HP:0006721)	1	1.6016	0.624375624	0.799320068	lymphatic
Archaic-specific	HPO	Abnormality of the parietal bone (HP:0002696)	1	1.5778	0.63379389	0.800419958	skeletal
Archaic-specific	HPO	Keratoconus (HP:0000563)	2	2.9976	0.667200427	0.800419958	nervous
Archaic-specific	HPO	Increased corneal curvature (HP:0100692)	2	2.9976	0.667200427	0.800419958	nervous
Archaic-specific	HPO	Slow saccadic eye movements (HP:0000514)	1	1.6108	0.620809536	0.801019898	nervous
Archaic-specific	HPO	Hypogonadotrophic hypogonadism (HP:0000044)	2	3.0033	0.665934139	0.803119688	endocrine
Archaic-specific	HPO	Bifid uvula (HP:0000193)	3	4.3274	0.693256921	0.803719628	other
Archaic-specific	HPO	Abnormality of the heme biosynthetic pathway (HP:0010472)	1	1.6383	0.610388818	0.804619538	other
Archaic-specific	HPO	Sleep apnea (HP:0010535)	1	1.6319	0.612782646	0.805019498	behavior
Archaic-specific	HPO	Flat face (HP:0012368)	5	6.7977	0.735542904	0.807219278	skeletal
Archaic-specific	HPO	Gastrointestinal stroma tumor (HP:0100723)	1	1.6344	0.611845326	0.807919208	digestive
Archaic-specific	HPO	Death in infancy (HP:0001522)	3	4.3151	0.695233019	0.808019198	other
Archaic-specific	HPO	Cystic liver disease (HP:0006706)	2	3.0723	0.650978095	0.809519048	digestive
Archaic-specific	HPO	Premature loss of primary teeth (HP:0006323)	1	1.6809	0.594919388	0.811118888	skeletal
Archaic-specific	HPO	Dandy-Walker malformation (HP:0001305)	10	12.6915	0.787928929	0.811518848	nervous
Archaic-specific	HPO	Pectus excavatum (HP:0000767)	15	18.3332	0.818187769	0.811818818	skeletal
Archaic-specific	HPO	Gynecomastia (HP:0000771)	3	4.3644	0.687379709	0.812218778	endocrine
Archaic-specific	HPO	Microtia (HP:0008551)	5	6.878	0.72695551	0.814418558	nervous
Archaic-specific	HPO	Decreased muscle mass (HP:0003199)	2	3.0997	0.645223731	0.814518548	skeletal muscle
Archaic-specific	HPO	"Intellectual disability, profound (HP:0002187)"	3	4.3604	0.688010274	0.814818518	nervous
Archaic-specific	HPO	Abnormality of salivation (HP:0100755)	7	9.2291	0.75847049	0.814918508	digestive
Archaic-specific	HPO	Increased CSF lactate (HP:0002490)	2	3.1388	0.637186186	0.815418458	other
Archaic-specific	HPO	Bell-shaped thorax (HP:0001591)	1	1.7008	0.587958608	0.816818318	skeletal
Archaic-specific	HPO	Syncope (HP:0001279)	5	6.8581	0.729064901	0.817618238	nervous
Archaic-specific	HPO	Widely patent fontanelles and sutures (HP:0004492)	1	1.7219	0.580753818	0.818718128	skeletal
Archaic-specific	HPO	Hyperglycinuria (HP:0003108)	1	1.7391	0.575010063	0.818918108	other
Archaic-specific	HPO	Insulin-resistant diabetes mellitus (HP:0000831)	1	1.7179	0.58210606	0.820817918	metabolic
Archaic-specific	HPO	Thin ribs (HP:0000883)	1	1.687	0.592768228	0.821317868	skeletal
Archaic-specific	HPO	Focal motor seizures (HP:0011153)	1	1.738	0.575373993	0.822917708	nervous
Archaic-specific	HPO	Abnormal ciliary motility (HP:0012262)	1	1.72	0.581395349	0.825917408	respiratory
Archaic-specific	HPO	Emotional lability (HP:0000712)	2	3.242	0.616903146	0.826817318	behavior
Archaic-specific	HPO	Skin pits (HP:0100276)	2	3.2254	0.62007813	0.828417158	integumentary
Archaic-specific	HPO	Capillary hemangiomas (HP:0005306)	1	1.7701	0.564939834	0.830816918	cardiovascular
Archaic-specific	HPO	Aplasia/hypoplasia of the femur (HP:0005613)	2	3.2358	0.618085172	0.830916908	skeletal
Archaic-specific	HPO	Hepatic necrosis (HP:0002605)	1	1.778	0.562429696	0.831016898	digestive
Archaic-specific	HPO	Retinal detachment (HP:0000541)	8	10.5978	0.754873653	0.832116788	nervous
Archaic-specific	HPO	Esotropia (HP:0000565)	3	4.531	0.662105495	0.833216678	nervous
Archaic-specific	HPO	Cardiovascular calcification (HP:0011915)	1	1.7934	0.557600089	0.833616638	cardiovascular
Archaic-specific	HPO	Submucous cleft hard palate (HP:0000176)	1	1.7941	0.557382532	0.835216478	other
Archaic-specific	HPO	Hypsarrhythmia (HP:0002521)	4	5.9161	0.676121093	0.839216078	cardiovascular
Archaic-specific	HPO	Short phalanx of the thumb (HP:0009660)	1	1.8052	0.55395524	0.839316068	skeletal
Archaic-specific	HPO	Tapered finger (HP:0001182)	4	5.8623	0.68232605	0.841115888	skeletal
Archaic-specific	HPO	Premature rupture of membranes (HP:0001788)	1	1.8184	0.549934008	0.842715728	reproductive
Archaic-specific	HPO	Patellar aplasia (HP:0006443)	2	3.3423	0.59839033	0.843015698	skeletal
Archaic-specific	HPO	Neoplasm of the peripheral nervous system (HP:0100007)	1	1.8292	0.546687076	0.843315668	nervous
Archaic-specific	HPO	Embryonal renal neoplasm (HP:0011794)	2	3.3294	0.600708836	0.844115588	urinary
Archaic-specific	HPO	Conical tooth (HP:0000698)	1	1.8461	0.541682466	0.844315568	skeletal
Archaic-specific	HPO	Diminished movement (HP:0002374)	1	1.8286	0.546866455	0.845015498	nervous
Archaic-specific	HPO	Hypoalphalipoproteinemia (HP:0003233)	1	1.8634	0.536653429	0.847415258	metabolic
Archaic-specific	HPO	Hammertoe (HP:0001765)	2	3.367	0.594000594	0.848115188	skeletal
Archaic-specific	HPO	Vasculitis (HP:0002633)	3	4.6683	0.642632222	0.848615138	cardiovascular
Archaic-specific	HPO	Adactyly (HP:0009776)	1	1.9183	0.521294897	0.848715128	skeletal
Archaic-specific	HPO	Aplasia/Hypoplasia of the patella (HP:0006498)	2	3.4025	0.587803086	0.849915008	skeletal
Archaic-specific	HPO	Renal dysplasia (HP:0000110)	2	3.3556	0.596018596	0.850714929	urinary
Archaic-specific	HPO	Small hand (HP:0200055)	2	3.3654	0.594282998	0.850914909	skeletal
Archaic-specific	HPO	Absent thumb (HP:0009777)	1	1.8755	0.533191149	0.851314869	skeletal
Archaic-specific	HPO	Broad toe (HP:0001837)	2	3.4142	0.585788765	0.853514649	skeletal
Archaic-specific	HPO	Missing ribs (HP:0000921)	1	1.899	0.526592944	0.853914609	skeletal
Archaic-specific	HPO	Hypercortisolism (HP:0001578)	1	1.9582	0.510673067	0.854714529	endocrine
Archaic-specific	HPO	Short middle phalanx of finger (HP:0005819)	1	1.945	0.514138817	0.856814319	skeletal
Archaic-specific	HPO	Increased number of teeth (HP:0011069)	2	3.4719	0.576053458	0.857314269	skeletal
Archaic-specific	HPO	Broad forehead (HP:0000337)	7	9.8374	0.71157013	0.858114189	skeletal
Archaic-specific	HPO	Toxemia of pregnancy (HP:0100603)	1	1.9802	0.504999495	0.860113989	reproductive
Archaic-specific	HPO	Anosmia (HP:0000458)	1	1.9815	0.504668181	0.861413859	nervous
Archaic-specific	HPO	Abnormal eating behavior (HP:0100738)	3	4.8562	0.617766978	0.862913709	behavior
Archaic-specific	HPO	Testicular neoplasm (HP:0010788)	3	4.9083	0.611209584	0.864313569	reproductive
Archaic-specific	HPO	"Primitive reflexes (palmomental, snout, glabellar) (HP:0002476)"	1	1.9796	0.505152556	0.864413559	nervous
Archaic-specific	HPO	Supernumerary nipples (HP:0002558)	1	1.9747	0.506406036	0.867313269	other
Archaic-specific	HPO	Bulbar palsy (HP:0001283)	1	2.047	0.488519785	0.869713029	nervous
Archaic-specific	HPO	Abnormality of the humerus (HP:0003063)	5	7.5904	0.658726813	0.873212679	skeletal
Archaic-specific	HPO	Ocular albinism (HP:0001107)	3	4.8839	0.614263191	0.873812619	nervous
Archaic-specific	HPO	Hypospadias (HP:0000047)	10	13.6838	0.730791155	0.874012599	urinary
Archaic-specific	HPO	Hypoplastic ilia (HP:0000946)	3	4.9672	0.603961991	0.874612539	skeletal
Archaic-specific	HPO	Laryngomalacia (HP:0001601)	5	7.6299	0.655316583	0.875112489	other
Archaic-specific	HPO	Cubitus valgus (HP:0002967)	3	5.0314	0.596255515	0.876312369	skeletal
Archaic-specific	HPO	Abnormal respiratory motile cilium physiology (HP:0012261)	1	2.0829	0.480099861	0.878512149	respiratory
Archaic-specific	HPO	Pulmonary embolism (HP:0002204)	1	2.1198	0.471742617	0.879012099	respiratory
Archaic-specific	HPO	Short nose (HP:0003196)	16	20.6807	0.773668203	0.879712029	skeletal
Archaic-specific	HPO	Recurrent fungal infections (HP:0002841)	1	2.1173	0.472299627	0.880511949	immune
Archaic-specific	HPO	Abnormality of the basal ganglia (HP:0002134)	2	3.6417	0.549194058	0.880711929	nervous
Archaic-specific	HPO	Hydronephrosis (HP:0000126)	6	8.9877	0.667579025	0.881511849	urinary
Archaic-specific	HPO	Micromelia (HP:0002983)	14	18.434	0.759466204	0.881711829	skeletal
Archaic-specific	HPO	Porencephaly (HP:0002132)	1	2.1246	0.470676833	0.882511749	nervous
Archaic-specific	HPO	Aplasia/Hypoplasia of the tongue (HP:0010295)	3	5.099	0.588350657	0.883911609	other
Archaic-specific	HPO	Primary amenorrhea (HP:0000786)	5	7.7505	0.64511967	0.884211579	reproductive
Archaic-specific	HPO	Abnormality of incisor morphology (HP:0011063)	2	3.7588	0.532084708	0.885811419	skeletal
Archaic-specific	HPO	Tibial bowing (HP:0002982)	1	2.1936	0.455871627	0.886311369	skeletal
Archaic-specific	HPO	Abnormality of the upper arm (HP:0001454)	5	7.8203	0.639361661	0.888511149	skeletal
Archaic-specific	HPO	Palpitations (HP:0001962)	1	2.2033	0.453864658	0.889311069	cardiovascular
Archaic-specific	HPO	Ovarian neoplasm (HP:0100615)	7	10.365	0.675349735	0.889711029	reproductive
Archaic-specific	HPO	Abnormality of chromosome segregation (HP:0002916)	3	5.1378	0.583907509	0.890110989	other
Archaic-specific	HPO	Hypoplasia of the pons (HP:0012110)	1	2.2183	0.450795654	0.891110889	nervous
Archaic-specific	HPO	Abnormality of the pons (HP:0007361)	1	2.2183	0.450795654	0.891110889	nervous
Archaic-specific	HPO	Chorioretinal atrophy (HP:0000533)	1	2.2283	0.448772607	0.891710829	nervous
Archaic-specific	HPO	Renal hypoplasia (HP:0000089)	5	7.797	0.641272284	0.892210779	urinary
Archaic-specific	HPO	Iris hypopigmentation (HP:0007730)	3	5.158	0.581620783	0.894810519	integumentary
Archaic-specific	HPO	Abnormality of the dental root (HP:0006486)	1	2.2721	0.440121474	0.896610339	skeletal
Archaic-specific	HPO	Abnormality of permanent molar morphology (HP:0011071)	1	2.2721	0.440121474	0.896610339	skeletal
Archaic-specific	HPO	Taurodontia (HP:0000679)	1	2.2721	0.440121474	0.896610339	skeletal
Archaic-specific	HPO	Renal agenesis (HP:0000104)	3	5.2864	0.567493947	0.898610139	urinary
Archaic-specific	HPO	Progressive neurologic deterioration (HP:0002344)	5	7.9442	0.629389995	0.899910009	nervous
Archaic-specific	HPO	Synostosis of carpal bones (HP:0005048)	2	3.9005	0.512754775	0.902609739	skeletal
Archaic-specific	HPO	Abnormality of methionine metabolism (HP:0010901)	1	2.3247	0.430163032	0.902809719	metabolic
Archaic-specific	HPO	Pancreatitis (HP:0001733)	2	3.9373	0.507962309	0.902909709	digestive
Archaic-specific	HPO	Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658)	1	2.3361	0.428063867	0.902909709	skeletal
Archaic-specific	HPO	Aqueductal stenosis (HP:0002410)	1	2.3311	0.428982026	0.903009699	nervous
Archaic-specific	HPO	Breast carcinoma (HP:0003002)	3	5.3311	0.562735646	0.904209579	reproductive
Archaic-specific	HPO	Hyperextensible skin (HP:0000974)	4	6.7456	0.592979127	0.904509549	integumentary
Archaic-specific	HPO	Congenital sensorineural hearing impairment (HP:0008527)	3	5.3486	0.56089444	0.905409459	nervous
Archaic-specific	HPO	Impaired vibratory sensation (HP:0002495)	2	3.8995	0.512886267	0.906309369	nervous
Archaic-specific	HPO	Abnormality of the dental pulp (HP:0006479)	1	2.385	0.419287212	0.908009199	other
Archaic-specific	HPO	Hyperglycemia (HP:0003074)	1	2.3728	0.421443021	0.908309169	metabolic
Archaic-specific	HPO	Anencephaly (HP:0002323)	2	4.0342	0.495761241	0.908709129	nervous
Archaic-specific	HPO	Wide anterior fontanel (HP:0000260)	3	5.464	0.549048316	0.910508949	skeletal
Archaic-specific	HPO	Genetic anticipation (HP:0003743)	1	2.3928	0.417920428	0.910508949	other
Archaic-specific	HPO	Abnormality of skull ossification (HP:0002703)	2	4.0563	0.493060178	0.911008899	skeletal
Archaic-specific	HPO	Alveolar cell carcinoma (HP:0006519)	2	3.9674	0.504108484	0.911608839	respiratory
Archaic-specific	HPO	Malar flattening (HP:0000272)	23	29.7783	0.772374514	0.911808819	skeletal
Archaic-specific	HPO	Hypergonadotropic hypogonadism (HP:0000815)	2	4.055	0.493218249	0.911908809	endocrine
Archaic-specific	HPO	Bradycardia (HP:0001662)	2	4.1011	0.487674039	0.913408659	cardiovascular
Archaic-specific	HPO	Downslanted palpebral fissures (HP:0000494)	22	28.797	0.763968469	0.914808519	integumentary
Archaic-specific	HPO	Dysmetria (HP:0001310)	6	9.542	0.628798994	0.916008399	nervous
Archaic-specific	HPO	Short metatarsal (HP:0010743)	5	8.4067	0.5947637	0.916408359	skeletal
Archaic-specific	HPO	Intention tremor (HP:0002080)	1	2.4526	0.407730572	0.916608339	nervous
Archaic-specific	HPO	Plagiocephaly (HP:0001357)	2	4.091	0.488878025	0.917108289	skeletal
Archaic-specific	HPO	Abnormality of saccadic eye movements (HP:0000570)	3	5.5265	0.542839048	0.917508249	nervous
Archaic-specific	HPO	Abnormality of the epiphyses of the phalanges of the hand (HP:0005920)	2	4.103	0.487448209	0.917908209	skeletal
Archaic-specific	HPO	Stillbirth (HP:0003826)	1	2.444	0.409165303	0.918708129	reproductive
Archaic-specific	HPO	Broad nasal tip (HP:0000455)	2	4.1336	0.483839752	0.919108089	integumentary
Archaic-specific	HPO	Neoplasm of the tracheobronchial system (HP:0100552)	2	4.0828	0.4898599	0.919908009	respiratory
Archaic-specific	HPO	Congenital diaphragmatic hernia (HP:0000776)	5	8.3369	0.59974331	0.921507849	respiratory
Archaic-specific	HPO	Preauricular pit (HP:0004467)	1	2.5844	0.386937007	0.921707829	nervous
Archaic-specific	HPO	Periauricular skin pits (HP:0100277)	1	2.5844	0.386937007	0.921707829	integumentary
Archaic-specific	HPO	Holoprosencephaly (HP:0001360)	5	8.4297	0.593140918	0.922207779	nervous
Archaic-specific	HPO	Abnormality of macular pigmentation (HP:0008002)	1	2.5441	0.39306631	0.922307769	integumentary
Archaic-specific	HPO	Elevated hepatic transaminases (HP:0002910)	6	9.7965	0.612463635	0.922907709	digestive
Archaic-specific	HPO	Sparse scalp hair (HP:0002209)	1	2.5709	0.388968844	0.924207579	integumentary
Archaic-specific	HPO	Scanning speech (HP:0002168)	1	2.5277	0.395616568	0.925707429	nervous
Archaic-specific	HPO	Thin upper lip vermilion (HP:0000219)	5	8.5352	0.585809354	0.926207379	integumentary
Archaic-specific	HPO	Insulin resistance (HP:0000855)	1	2.629	0.380372765	0.926807319	metabolic
Archaic-specific	HPO	Short thumb (HP:0009778)	2	4.3141	0.463596115	0.927307269	skeletal
Archaic-specific	HPO	Full cheeks (HP:0000293)	4	7.1657	0.558214829	0.927607239	other
Archaic-specific	HPO	Abnormality of ocular smooth pursuit (HP:0000617)	3	5.8147	0.515933754	0.928807119	nervous
Archaic-specific	HPO	Aortic dissection (HP:0002647)	1	2.6295	0.380300437	0.929407059	cardiovascular
Archaic-specific	HPO	Frontal bossing (HP:0002007)	24	31.5734	0.76013353	0.930206979	skeletal
Archaic-specific	HPO	Preauricular skin tag (HP:0000384)	5	8.6096	0.580747073	0.930506949	integumentary
Archaic-specific	HPO	Abnormality of the epiphyses of the hand (HP:0005924)	2	4.3306	0.46182977	0.930506949	skeletal
Archaic-specific	HPO	Bifid scrotum (HP:0000048)	1	2.654	0.376789751	0.931106889	reproductive
Archaic-specific	HPO	Osteopenia (HP:0000938)	5	8.6355	0.579005269	0.932406759	skeletal
Archaic-specific	HPO	Abnormality involving the epiphyses of the upper limbs (HP:0003839)	2	4.3819	0.456423013	0.933006699	skeletal
Archaic-specific	HPO	Agitation (HP:0000713)	1	2.7097	0.369044544	0.935406459	behavior
Archaic-specific	HPO	Aplasia/Hypoplasia of the middle phalanges of the hand (HP:0009843)	1	2.739	0.365096751	0.936306369	skeletal
Archaic-specific	HPO	Cone-shaped epiphyses of the phalanges of the hand (HP:0010230)	1	2.7505	0.36357026	0.936306369	skeletal
Archaic-specific	HPO	Aplasia/Hypoplasia of metatarsal bones (HP:0001964)	5	8.8448	0.565303907	0.936706329	skeletal
Archaic-specific	HPO	Muscular hypotonia of the trunk (HP:0008936)	3	5.9769	0.50193244	0.937206279	skeletal muscle
Archaic-specific	HPO	Decreased lacrimation (HP:0000633)	1	2.7253	0.366932081	0.938706129	other
Archaic-specific	HPO	Carpal synostosis (HP:0009702)	2	4.4888	0.445553377	0.939206079	skeletal
Archaic-specific	HPO	Abnormality of aspartate family amino acid metabolism (HP:0010899)	1	2.7296	0.366354045	0.939406059	metabolic
Archaic-specific	HPO	Horizontal nystagmus (HP:0000666)	2	4.5717	0.437474025	0.942005799	nervous
Archaic-specific	HPO	Recurrent fractures (HP:0002757)	9	14.0405	0.641002813	0.942105789	skeletal
Archaic-specific	HPO	Postural tremor (HP:0002174)	1	2.8915	0.345841259	0.943105689	nervous
Archaic-specific	HPO	Polyphagia (HP:0002591)	1	2.8523	0.350594257	0.943505649	behavior
Archaic-specific	HPO	Embryonal neoplasm (HP:0002898)	2	4.5581	0.438779316	0.944105589	other
Archaic-specific	HPO	Abnormality of the metopic suture (HP:0005556)	1	2.8509	0.350766425	0.945205479	skeletal
Archaic-specific	HPO	Abnormality of molar morphology (HP:0011070)	1	2.9664	0.337108954	0.946205379	skeletal
Archaic-specific	HPO	Abnormality of molar (HP:0011077)	1	2.9664	0.337108954	0.946205379	skeletal
Archaic-specific	HPO	Impaired smooth pursuit (HP:0007772)	2	4.6376	0.431257547	0.946805319	nervous
Archaic-specific	HPO	Onion bulb formation (HP:0003383)	1	3.0112	0.332093518	0.948005199	nervous
Archaic-specific	HPO	Cupped ear (HP:0000378)	4	7.7249	0.517806056	0.949205079	other
Archaic-specific	HPO	Fair hair (HP:0002286)	1	2.9818	0.335367899	0.949705029	integumentary
Archaic-specific	HPO	2-3 toe syndactyly (HP:0004691)	1	3.0402	0.328925729	0.95060494	skeletal
Archaic-specific	HPO	Abnormality of the antihelix (HP:0009738)	2	4.7645	0.419771225	0.95070493	other
Archaic-specific	HPO	Skin tags (HP:0010609)	5	9.1981	0.543590524	0.9510049	integumentary
Archaic-specific	HPO	Synostosis involving bones of the hand (HP:0004278)	2	4.7925	0.417318727	0.95140486	skeletal
Archaic-specific	HPO	Drooling (HP:0002307)	3	6.3167	0.474931531	0.95220478	other
Archaic-specific	HPO	Brachydactyly syndrome (HP:0001156)	24	32.8988	0.729509891	0.9530047	skeletal
Archaic-specific	HPO	Germ cell neoplasia (HP:0100728)	2	4.848	0.412541254	0.95380462	reproductive
Archaic-specific	HPO	Excessive salivation (HP:0003781)	3	6.3893	0.469535004	0.95440456	digestive
Archaic-specific	HPO	Hemiplegia (HP:0002301)	1	3.0761	0.325086961	0.95470453	nervous
Archaic-specific	HPO	Restlessness (HP:0000711)	1	3.0987	0.322715978	0.9570043	behavior
Archaic-specific	HPO	Down-sloping shoulders (HP:0200021)	1	3.2215	0.310414403	0.95730427	skeletal
Archaic-specific	HPO	Impaired social interactions (HP:0000735)	5	9.4105	0.531321396	0.95960404	behavior
Archaic-specific	HPO	Abnormal social behavior (HP:0012433)	5	9.4105	0.531321396	0.95960404	behavior
Archaic-specific	HPO	Growth hormone deficiency (HP:0000824)	3	6.6242	0.452884877	0.96040396	endocrine
Archaic-specific	HPO	Abnormality of hair growth rate (HP:0011363)	1	3.1914	0.313342107	0.96060394	integumentary
Archaic-specific	HPO	Slow-growing hair (HP:0002217)	1	3.1914	0.313342107	0.96060394	integumentary
Archaic-specific	HPO	"Intellectual disability, severe (HP:0010864)"	5	9.5941	0.521153626	0.96070393	nervous
Archaic-specific	HPO	Abnormality of the periventricular white matter (HP:0002518)	1	3.2746	0.30538081	0.96170383	nervous
Archaic-specific	HPO	Fibular hypoplasia (HP:0003038)	2	5.1602	0.387581877	0.9620038	skeletal
Archaic-specific	HPO	Bradykinesia (HP:0002067)	3	6.7308	0.445712248	0.96370363	nervous
Archaic-specific	HPO	Babinski sign (HP:0003487)	9	15	0.6	0.9650035	nervous
Archaic-specific	HPO	Ventricular fibrillation (HP:0001663)	1	3.341	0.299311583	0.9660034	cardiovascular
Archaic-specific	HPO	Thickened nuchal skin fold (HP:0000474)	1	3.4299	0.29155369	0.96660334	integumentary
Archaic-specific	HPO	Decreased number of peripheral myelinated nerve fibers (HP:0003380)	1	3.3909	0.294906957	0.96660334	nervous
Archaic-specific	HPO	Broad phalanges of the hand (HP:0009768)	2	5.2666	0.379751642	0.96790321	skeletal
Archaic-specific	HPO	Broad finger (HP:0001500)	2	5.2783	0.378909876	0.96810319	skeletal
Archaic-specific	HPO	Rigidity (HP:0002063)	4	8.4632	0.472634465	0.96970303	skeletal muscle
Archaic-specific	HPO	Dysdiadochokinesis (HP:0002075)	2	5.3136	0.376392653	0.97020298	nervous
Archaic-specific	HPO	Gonadal dysgenesis (HP:0000133)	2	5.5989	0.357213024	0.97250275	other
Archaic-specific	HPO	Impaired pain sensation (HP:0007328)	1	3.5984	0.277901289	0.97310269	nervous
Archaic-specific	HPO	Abnormality of pain sensation (HP:0010832)	1	3.5984	0.277901289	0.97310269	nervous
Archaic-specific	HPO	Cerebellar atrophy (HP:0001272)	14	21.9988	0.636398349	0.97450255	nervous
Archaic-specific	HPO	Progressive cerebellar ataxia (HP:0002073)	1	3.6161	0.276541025	0.97480252	nervous
Archaic-specific	HPO	Generalized hypopigmentation of hair (HP:0011358)	1	3.6924	0.270826563	0.9770023	integumentary
Archaic-specific	HPO	Delayed eruption of teeth (HP:0000684)	6	11.9957	0.500179231	0.97780222	skeletal
Archaic-specific	HPO	Peripheral demyelination (HP:0011096)	1	3.8066	0.262701623	0.97850215	nervous
Archaic-specific	HPO	Genu recurvatum (HP:0002816)	1	3.7685	0.265357569	0.97880212	skeletal muscle
Archaic-specific	HPO	Pulmonary artery stenosis (HP:0004415)	1	3.9723	0.251743323	0.98030197	cardiovascular
Archaic-specific	HPO	Decreased skull ossification (HP:0004331)	1	3.8706	0.258357877	0.98180182	skeletal
Archaic-specific	HPO	Dental malocclusion (HP:0000689)	9	16.0898	0.559360589	0.98250175	skeletal
Archaic-specific	HPO	Rhizomelia (HP:0008905)	2	5.9396	0.336723012	0.98280172	skeletal muscle
Archaic-specific	HPO	Short foot (HP:0001773)	5	10.8001	0.462958676	0.98420158	skeletal
Archaic-specific	HPO	Broad phalanx (HP:0006009)	2	6.1473	0.325346087	0.98550145	skeletal
Archaic-specific	HPO	Aplasia/Hypoplasia of the abdominal wall musculature (HP:0010318)	4	9.6953	0.41257104	0.9860014	skeletal muscle
Archaic-specific	HPO	Hypoplasia of the ulna (HP:0003022)	1	4.263	0.234576589	0.98640136	skeletal
Archaic-specific	HPO	Bony spicule pigmentary retinopathy (HP:0007737)	2	6.1834	0.323446647	0.98640136	nervous
Archaic-specific	HPO	Truncal ataxia (HP:0002078)	2	6.257	0.319642001	0.98650135	nervous
Archaic-specific	HPO	Broad thumb (HP:0011304)	1	4.2857	0.233334111	0.98660134	skeletal
Archaic-specific	HPO	Hypoplastic female external genitalia (HP:0012815)	1	4.1886	0.238743256	0.98720128	reproductive
Archaic-specific	HPO	Broad long bones (HP:0005622)	2	6.3138	0.316766448	0.98770123	skeletal
Archaic-specific	HPO	Pulmonic stenosis (HP:0001642)	5	11.2443	0.444669744	0.98780122	cardiovascular
Archaic-specific	HPO	Abnormality of the middle phalanges of the hand (HP:0009833)	1	4.4452	0.224961757	0.9880012	skeletal
Archaic-specific	HPO	Midface retrusion (HP:0011800)	4	9.8701	0.405264384	0.98820118	skeletal
Archaic-specific	HPO	Pectus carinatum (HP:0000768)	7	14.4173	0.485527803	0.98950105	skeletal
Archaic-specific	HPO	Gliosis (HP:0002171)	3	8.3099	0.361015175	0.990001	nervous
Archaic-specific	HPO	Aplasia/Hypoplasia of the fibula (HP:0006492)	2	6.808	0.293772033	0.99040096	skeletal
Archaic-specific	HPO	Aortic aneurysm (HP:0004942)	1	4.6063	0.21709398	0.99050095	cardiovascular
Archaic-specific	HPO	Decreased motor nerve conduction velocity (HP:0003431)	1	4.6078	0.217023308	0.99070093	nervous
Archaic-specific	HPO	Webbed neck (HP:0000465)	1	4.9191	0.20328922	0.99150085	integumentary
Archaic-specific	HPO	Accelerated skeletal maturation (HP:0005616)	3	8.8637	0.338459108	0.99240076	skeletal
Archaic-specific	HPO	Postural instability (HP:0002172)	1	4.6272	0.216113416	0.99260074	other
Archaic-specific	HPO	Primary adrenal insufficiency (HP:0008207)	2	7.1165	0.281037027	0.99290071	endocrine
Archaic-specific	HPO	Widely spaced teeth (HP:0000687)	1	5.038	0.198491465	0.99320068	skeletal
Archaic-specific	HPO	Aplasia/Hypoplasia of the ulna (HP:0006495)	1	5.0829	0.196738083	0.99440056	skeletal
Archaic-specific	HPO	Forearm undergrowth (HP:0009821)	1	5.3223	0.187888695	0.99510049	skeletal
Archaic-specific	HPO	Abnormality of the humeroradial joint (HP:0100744)	1	5.7724	0.173238168	0.99580042	skeletal
Archaic-specific	HPO	Short palm (HP:0004279)	5	12.6146	0.396366115	0.9960004	skeletal
Archaic-specific	HPO	Epileptic encephalopathy (HP:0200134)	2	7.6111	0.262774106	0.99660034	nervous
Archaic-specific	HPO	Underdeveloped supraorbital ridges (HP:0009891)	1	5.5874	0.17897412	0.99680032	skeletal
Archaic-specific	HPO	Abnormality of the fibula (HP:0002991)	2	8.3278	0.240159466	0.99690031	skeletal
Archaic-specific	HPO	Limb ataxia (HP:0002070)	3	10.1915	0.29436295	0.99760024	nervous
Archaic-specific	HPO	Wide mouth (HP:0000154)	7	17.3888	0.402557968	0.99850015	skeletal
Archaic-specific	HPO	Broad-based gait (HP:0002136)	1	7.0799	0.141244933	0.99930007	other
Archaic-specific	HPO	Gait ataxia (HP:0002066)	3	11.7761	0.254753271	0.99930007	nervous
Archaic-specific	HPO	Gaze-evoked nystagmus (HP:0000640)	1	10.0134	0.099866179	1	nervous
Browning et al. 2018 Introgressed	GWAS	Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)	3	0.0809	37.08281829	1.00E-04	metabolic
Browning et al. 2018 Introgressed	GWAS	Systemic sclerosis (anti-topoisomerase-positive)	4	0.1099	36.39672429	1.00E-04	other
Browning et al. 2018 Introgressed	GWAS	Helicobacter pylori serologic status	3	0.1355	22.1402214	0.00039996	immune
Browning et al. 2018 Introgressed	GWAS	Asthma and hay fever	4	0.3868	10.34126163	0.00069993	respiratory
Browning et al. 2018 Introgressed	GWAS	Soluble interleukin-2 receptor subunit alpha	3	0.3132	9.578544061	0.00279972	immune
Browning et al. 2018 Introgressed	GWAS	Metabolic syndrome (multivariate analysis)	2	0.0811	24.66091245	0.00349965	metabolic
Browning et al. 2018 Introgressed	GWAS	P wave terminal force	2	0.1006	19.88071571	0.00409959	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Sjogren's syndrome	6	1.5475	3.877221325	0.00419958	immune
Browning et al. 2018 Introgressed	GWAS	Prostate cancer	13	5.4645	2.378991674	0.00429957	reproductive
Browning et al. 2018 Introgressed	GWAS	Serum albumin level	3	0.3874	7.743933918	0.00679932	other
Browning et al. 2018 Introgressed	GWAS	Limited cutaneous systemic scleroderma	3	0.3977	7.543374403	0.0079992	integumentary
Browning et al. 2018 Introgressed	GWAS	Two-hour glucose challenge	2	0.1537	13.01236174	0.00829917	metabolic
Browning et al. 2018 Introgressed	GWAS	Allergy	3	0.4208	7.129277567	0.00939906	immune
Browning et al. 2018 Introgressed	GWAS	Self-reported allergy	3	0.4632	6.476683938	0.01129887	immune
Browning et al. 2018 Introgressed	GWAS	Asthma (bronchodilator response)	2	0.174	11.49425287	0.01389861	respiratory
Browning et al. 2018 Introgressed	GWAS	Palmitic acid (16:0) levels	3	0.5386	5.569996287	0.01569843	other
Browning et al. 2018 Introgressed	GWAS	Serum alkaline phosphatase levels	3	0.5586	5.37056928	0.0189981	other
Browning et al. 2018 Introgressed	GWAS	Delta-5 desaturase activity response to n3-polyunsaturated fat supplement	1	0.0195	51.28205128	0.01939806	other
Browning et al. 2018 Introgressed	GWAS	Peripheral arterial disease (traffic-related air pollution interaction)	6	2.0908	2.869714942	0.01969803	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Response to quetiapine in schizophrenia	2	0.2101	9.519276535	0.02069793	other
Browning et al. 2018 Introgressed	GWAS	Alcohol consumption	5	1.6174	3.091381229	0.02269773	behavior
Browning et al. 2018 Introgressed	GWAS	Brain imaging	2	0.245	8.163265306	0.02369763	nervous
Browning et al. 2018 Introgressed	GWAS	Low tan response	3	0.6046	4.96195832	0.02409759	integumentary
Browning et al. 2018 Introgressed	GWAS	Hypertriglyceridemia	2	0.2524	7.923930269	0.02709729	metabolic
Browning et al. 2018 Introgressed	GWAS	Protein C levels	1	0.0279	35.84229391	0.02779722	other
Browning et al. 2018 Introgressed	GWAS	Allergic sensitization	3	0.622	4.823151125	0.02809719	immune
Browning et al. 2018 Introgressed	GWAS	Liver enzyme levels (gamma-glutamyl transferase)	4	1.1676	3.425830764	0.02889711	other
Browning et al. 2018 Introgressed	GWAS	Vigorous physical activity	2	0.264	7.575757576	0.02979702	behavior
Browning et al. 2018 Introgressed	GWAS	Glioblastoma (age-stratified)	1	0.0306	32.67973856	0.03029697	nervous
Browning et al. 2018 Introgressed	GWAS	Serum sulfate level	2	0.2787	7.176175099	0.03079692	other
Browning et al. 2018 Introgressed	GWAS	Hemoglobin A1c levels	3	0.7144	4.199328108	0.03569643	hematologic
Browning et al. 2018 Introgressed	GWAS	Alcohol consumption in current drinkers	1	0.0395	25.3164557	0.03929607	behavior
Browning et al. 2018 Introgressed	GWAS	Primary biliary cholangitis	4	1.2614	3.171079753	0.04049595	digestive
Browning et al. 2018 Introgressed	GWAS	Cerebrospinal AB1-42 levels in normal cognition	4	1.3095	3.054600993	0.04429557	nervous
Browning et al. 2018 Introgressed	GWAS	Coagulation factor levels	1	0.0449	22.27171492	0.04459554	hematologic
Browning et al. 2018 Introgressed	GWAS	Atopic dermatitis	3	0.8116	3.696402169	0.04649535	integumentary
Browning et al. 2018 Introgressed	GWAS	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)	2	0.3421	5.846243788	0.04769523	other
Browning et al. 2018 Introgressed	GWAS	White blood cell count (monocyte)	1	0.0522	19.15708812	0.050894911	immune
Browning et al. 2018 Introgressed	GWAS	Drinking behavior	1	0.0532	18.79699248	0.051394861	behavior
Browning et al. 2018 Introgressed	GWAS	Pediatric autoimmune diseases	3	0.8294	3.617072583	0.053294671	immune
Browning et al. 2018 Introgressed	GWAS	Triglycerides-Blood Pressure (TG-BP)	1	0.0551	18.14882033	0.053594641	metabolic
Browning et al. 2018 Introgressed	GWAS	Otitis media	1	0.0567	17.6366843	0.054794521	other
Browning et al. 2018 Introgressed	GWAS	Otitis media (chronic)	1	0.0567	17.6366843	0.054794521	other
Browning et al. 2018 Introgressed	GWAS	Otitis media (recurrent)	1	0.0567	17.6366843	0.054794521	other
Browning et al. 2018 Introgressed	GWAS	Hair color	4	1.4404	2.777006387	0.056594341	integumentary
Browning et al. 2018 Introgressed	GWAS	Blood osmolality (transformed sodium)	3	0.8972	3.343736068	0.062693731	hematologic
Browning et al. 2018 Introgressed	GWAS	Dermatomyositis	1	0.0659	15.17450683	0.063593641	integumentary
Browning et al. 2018 Introgressed	GWAS	Branched-chain amino acid levels (Isoleucine)	1	0.0649	15.40832049	0.063593641	other
Browning et al. 2018 Introgressed	GWAS	Carotid plaque burden (smoking interaction)	1	0.0659	15.17450683	0.064093591	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Neutrophil count	6	2.8446	2.10925965	0.065093491	lymphatic
Browning et al. 2018 Introgressed	GWAS	Staphylococcus aureus nasal carriage (persistent)	2	0.4321	4.628558204	0.069193081	immune
Browning et al. 2018 Introgressed	GWAS	Sum neutrophil eosinophil counts	5	2.2215	2.250731488	0.070192981	hematologic
Browning et al. 2018 Introgressed	GWAS	Waist Circumference - Triglycerides (WC-TG)	1	0.074	13.51351351	0.071092891	skeletal
Browning et al. 2018 Introgressed	GWAS	Hair morphology	2	0.4522	4.42282176	0.073092691	integumentary
Browning et al. 2018 Introgressed	GWAS	Neonatal lupus	2	0.464	4.310344828	0.077592241	immune
Browning et al. 2018 Introgressed	GWAS	Palmitoleic acid (16:1n-7) levels	1	0.083	12.04819277	0.080191981	other
Browning et al. 2018 Introgressed	GWAS	Alcohol consumption (drinkers vs non-drinkers)	1	0.0855	11.69590643	0.081391861	behavior
Browning et al. 2018 Introgressed	GWAS	Homocysteine levels	2	0.4813	4.155412425	0.084791521	other
Browning et al. 2018 Introgressed	GWAS	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)	1	0.0911	10.97694841	0.086291371	immune
Browning et al. 2018 Introgressed	GWAS	Response to inhaled corticosteroid treatment in asthma (change in FEV1)	1	0.0909	11.00110011	0.087391261	other
Browning et al. 2018 Introgressed	GWAS	Caffeine metabolism (plasma paraxanthine caffeine ratio)	1	0.0907	11.02535832	0.088191181	metabolic
Browning et al. 2018 Introgressed	GWAS	S-phenylmercapturic acid levels in smokers	1	0.0938	10.66098081	0.088191181	other
Browning et al. 2018 Introgressed	GWAS	Narcolepsy	1	0.092	10.86956522	0.088291171	behavior
Browning et al. 2018 Introgressed	GWAS	C-reactive protein levels or triglyceride levels (pleiotropy)	1	0.0944	10.59322034	0.090290971	immune
Browning et al. 2018 Introgressed	GWAS	Brain structure	2	0.5114	3.910833007	0.091590841	nervous
Browning et al. 2018 Introgressed	GWAS	Alcohol use disorder (total score)	1	0.0969	10.31991744	0.092990701	behavior
Browning et al. 2018 Introgressed	GWAS	Alcohol use disorder (consumption score)	1	0.0969	10.31991744	0.092990701	behavior
Browning et al. 2018 Introgressed	GWAS	Sphingolipid levels	1	0.0992	10.08064516	0.094490551	metabolic
Browning et al. 2018 Introgressed	GWAS	Chemerin levels	1	0.1036	9.652509653	0.099190081	other
Browning et al. 2018 Introgressed	GWAS	Myasthenia gravis	1	0.1073	9.319664492	0.101889811	skeletal muscle
Browning et al. 2018 Introgressed	GWAS	Nonalcoholic fatty liver disease	1	0.1115	8.968609865	0.106389361	digestive
Browning et al. 2018 Introgressed	GWAS	Response to fenofibrate	2	0.56	3.571428571	0.106889311	other
Browning et al. 2018 Introgressed	GWAS	circulating leptin levels adjusted for BMI	1	0.1127	8.873114463	0.107089291	metabolic
Browning et al. 2018 Introgressed	GWAS	circulating leptin levels	1	0.1127	8.873114463	0.107089291	metabolic
Browning et al. 2018 Introgressed	GWAS	Polymyositis	1	0.1138	8.787346221	0.108689131	skeletal muscle
Browning et al. 2018 Introgressed	GWAS	Chronic hepatitis C infection	1	0.1156	8.650519031	0.109289071	immune
Browning et al. 2018 Introgressed	GWAS	Glaucoma (primary angle closure)	1	0.1167	8.568980291	0.110388961	nervous
Browning et al. 2018 Introgressed	GWAS	"Allergic disease (asthma, hay fever or eczema)"	7	4.0284	1.737662596	0.112188781	immune
Browning et al. 2018 Introgressed	GWAS	Glycemic traits (pregnancy)	1	0.12	8.333333333	0.113888611	metabolic
Browning et al. 2018 Introgressed	GWAS	Red blood cell density in sickle cell anemia	2	0.5966	3.352329869	0.122087791	hematologic
Browning et al. 2018 Introgressed	GWAS	Midgestational circulating levels of PCBs	2	0.6032	3.315649867	0.123387661	reproductive
Browning et al. 2018 Introgressed	GWAS	Proinsulin levels	1	0.1307	7.651109411	0.123787621	metabolic
Browning et al. 2018 Introgressed	GWAS	Red vs. brown/black hair color	2	0.6073	3.293265273	0.124487551	integumentary
Browning et al. 2018 Introgressed	GWAS	Chronic myeloid leukemia	2	0.6208	3.221649485	0.126087391	lymphatic
Browning et al. 2018 Introgressed	GWAS	Response to taxane treatment (placlitaxel)	1	0.1363	7.336757153	0.128287171	other
Browning et al. 2018 Introgressed	GWAS	Systemic sclerosis (anti-centromere-positive)	1	0.1389	7.199424046	0.129587041	other
Browning et al. 2018 Introgressed	GWAS	Response to platinum-based chemotherapy (carboplatin)	2	0.6299	3.17510716	0.131286871	other
Browning et al. 2018 Introgressed	GWAS	Systemic juvenile idiopathic arthritis	4	1.9763	2.023984213	0.132686731	immune
Browning et al. 2018 Introgressed	GWAS	Antineutrophil cytoplasmic antibody-associated vasculitis	1	0.1443	6.93000693	0.133986601	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Preterm birth (maternal effect)	1	0.1446	6.915629322	0.134086591	reproductive
Browning et al. 2018 Introgressed	GWAS	Diffuse cutaneous systemic sclerosis	1	0.1448	6.906077348	0.134586541	immune
Browning et al. 2018 Introgressed	GWAS	Systemic lupus erythematosus or rheumatoid arthritis	1	0.1472	6.793478261	0.138286171	immune
Browning et al. 2018 Introgressed	GWAS	Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid)	1	0.1515	6.600660066	0.141485851	other
Browning et al. 2018 Introgressed	GWAS	Selective IgA deficiency	3	1.313	2.284843869	0.143485651	immune
Browning et al. 2018 Introgressed	GWAS	Response to treatment for acute lymphoblastic leukemia	3	1.3305	2.254791432	0.150184982	other
Browning et al. 2018 Introgressed	GWAS	Hippocampal tail volume	3	1.338	2.242152466	0.150384962	nervous
Browning et al. 2018 Introgressed	GWAS	Worry too long after an embarrassing experience	2	0.6908	2.895193978	0.152884712	behavior
Browning et al. 2018 Introgressed	GWAS	Lipid traits	2	0.6855	2.91757841	0.152984702	metabolic
Browning et al. 2018 Introgressed	GWAS	Fat distribution (HIV)	2	0.6972	2.868617326	0.157584242	metabolic
Browning et al. 2018 Introgressed	GWAS	Skin pigmentation	1	0.1724	5.800464037	0.159084092	integumentary
Browning et al. 2018 Introgressed	GWAS	Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)	1	0.1733	5.77034045	0.159384062	immune
Browning et al. 2018 Introgressed	GWAS	Eosinophilic esophagitis	1	0.1716	5.827505828	0.159684032	immune
Browning et al. 2018 Introgressed	GWAS	Fibrinogen levels	2	0.7166	2.790957298	0.159884012	hematologic
Browning et al. 2018 Introgressed	GWAS	Blood metabolite ratios	2	0.7134	2.803476311	0.162183782	metabolic
Browning et al. 2018 Introgressed	GWAS	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes	5	2.8381	1.76174201	0.162483752	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Dentate gyrus molecular layer volume	2	0.7252	2.757859901	0.162783722	nervous
Browning et al. 2018 Introgressed	GWAS	Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)	3	1.3772	2.178332849	0.162883712	other
Browning et al. 2018 Introgressed	GWAS	Spontaneous preterm birth (preterm birth)	1	0.1815	5.509641873	0.165783422	reproductive
Browning et al. 2018 Introgressed	GWAS	Glomerular filtration rate in non diabetics (creatinine)	3	1.4148	2.120441052	0.168983102	hematologic
Browning et al. 2018 Introgressed	GWAS	Prostate cancer (early onset)	1	0.1876	5.330490405	0.170382962	reproductive
Browning et al. 2018 Introgressed	GWAS	Paget's disease	1	0.1871	5.344735436	0.170582942	skeletal
Browning et al. 2018 Introgressed	GWAS	Lipoprotein-associated phospholipase A2 activity and mass	1	0.189	5.291005291	0.170882912	metabolic
Browning et al. 2018 Introgressed	GWAS	Initial pursuit acceleration in psychotic disorders	1	0.1854	5.393743258	0.172482752	nervous
Browning et al. 2018 Introgressed	GWAS	Total hippocampal volume	3	1.4322	2.094679514	0.173082692	nervous
Browning et al. 2018 Introgressed	GWAS	Emphysema distribution in smoking	1	0.1929	5.184033178	0.175882412	respiratory
Browning et al. 2018 Introgressed	GWAS	Alopecia areata	3	1.4403	2.082899396	0.178482152	integumentary
Browning et al. 2018 Introgressed	GWAS	Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction)	1	0.2013	4.967709886	0.181281872	nervous
Browning et al. 2018 Introgressed	GWAS	Regular attendance at a pub or social club	3	1.4713	2.039013118	0.181581842	behavior
Browning et al. 2018 Introgressed	GWAS	Diastolic blood pressure night-to-day ratio in hypertension	1	0.2016	4.96031746	0.181781822	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Pulse pressure x alcohol consumption interaction (2df test)	2	0.7695	2.599090318	0.181881812	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Sex hormone-binding globulin levels	1	0.1983	5.042864347	0.182581742	endocrine
Browning et al. 2018 Introgressed	GWAS	Cutaneous malignant melanoma	1	0.2038	4.906771344	0.184081592	integumentary
Browning et al. 2018 Introgressed	GWAS	Response to antineoplastic agents	1	0.2021	4.948045522	0.184281572	other
Browning et al. 2018 Introgressed	GWAS	Non-glioblastoma glioma	2	0.7707	2.595043467	0.185681432	nervous
Browning et al. 2018 Introgressed	GWAS	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	1	0.2076	4.816955684	0.188381162	other
Browning et al. 2018 Introgressed	GWAS	Moderate to vigorous physical activity levels	1	0.2122	4.712535344	0.190580942	behavior
Browning et al. 2018 Introgressed	GWAS	Graves' disease	2	0.7903	2.53068455	0.190880912	endocrine
Browning et al. 2018 Introgressed	GWAS	C-reactive protein	1	0.2197	4.551661356	0.196980302	immune
Browning et al. 2018 Introgressed	GWAS	Inflammatory bowel disease	12	9.0292	1.329021397	0.197180282	digestive
Browning et al. 2018 Introgressed	GWAS	Advanced age-related macular degeneration	4	2.309	1.732351667	0.198280172	nervous
Browning et al. 2018 Introgressed	GWAS	Exudative age-related macular degeneration	1	0.2193	4.55996352	0.199180082	nervous
Browning et al. 2018 Introgressed	GWAS	Gamma glutamyl transferase levels	3	1.5242	1.968245637	0.200179982	other
Browning et al. 2018 Introgressed	GWAS	Alzheimer's disease (age of onset)	1	0.2223	4.498425551	0.200879912	nervous
Browning et al. 2018 Introgressed	GWAS	Glioblastoma	1	0.2304	4.340277778	0.206179382	nervous
Browning et al. 2018 Introgressed	GWAS	Lipid metabolism phenotypes	1	0.2335	4.282655246	0.209179082	metabolic
Browning et al. 2018 Introgressed	GWAS	Resistin levels	1	0.233	4.291845494	0.209279072	other
Browning et al. 2018 Introgressed	GWAS	Fasting blood glucose (BMI interaction)	2	0.8664	2.308402585	0.210478952	metabolic
Browning et al. 2018 Introgressed	GWAS	Creatine kinase levels	2	0.8742	2.287805994	0.212278772	other
Browning et al. 2018 Introgressed	GWAS	Hippocampal tail volume (corrected for total hippocampal volume)	2	0.86	2.325581395	0.213278672	nervous
Browning et al. 2018 Introgressed	GWAS	Multiple myeloma and monoclonal gammopathy	1	0.2389	4.185851821	0.214178582	immune
Browning et al. 2018 Introgressed	GWAS	Endometrial endometrioid carcinoma	1	0.2433	4.110152076	0.216278372	reproductive
Browning et al. 2018 Introgressed	GWAS	"Cholesterol, total"	3	1.6038	1.870557426	0.216978302	metabolic
Browning et al. 2018 Introgressed	GWAS	IgA nephropathy	1	0.2497	4.004805767	0.219878012	immune
Browning et al. 2018 Introgressed	GWAS	Calcium levels	4	2.3908	1.673080141	0.220277972	other
Browning et al. 2018 Introgressed	GWAS	High light scatter reticulocyte percentage of red cells	5	3.2252	1.550291455	0.221277872	metabolic
Browning et al. 2018 Introgressed	GWAS	Joint mobility (Beighton score)	2	0.8875	2.253521127	0.221377862	skeletal
Browning et al. 2018 Introgressed	GWAS	Circulating fibroblast growth factor 23 levels	1	0.2515	3.976143141	0.221777822	other
Browning et al. 2018 Introgressed	GWAS	Liver enzyme levels	1	0.2527	3.957261575	0.225077492	other
Browning et al. 2018 Introgressed	GWAS	Urinary metabolite concentrations in chronic kidney disease	2	0.8961	2.231893762	0.225177482	metabolic
Browning et al. 2018 Introgressed	GWAS	Mean corpuscular hemoglobin concentration	4	2.4293	1.646564854	0.226177382	hematologic
Browning et al. 2018 Introgressed	GWAS	Tuberculosis	4	2.4061	1.662441295	0.226577342	immune
Browning et al. 2018 Introgressed	GWAS	Autism spectrum disorder or schizophrenia	12	9.3011	1.29016998	0.226877312	behavior
Browning et al. 2018 Introgressed	GWAS	Birdshot chorioretinopathy	1	0.2569	3.8925652	0.228077192	immune
Browning et al. 2018 Introgressed	GWAS	Infant length	1	0.2604	3.840245776	0.229377062	skeletal
Browning et al. 2018 Introgressed	GWAS	Large artery stroke	1	0.2635	3.795066414	0.229677032	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Response to antidepressants	1	0.2596	3.852080123	0.229677032	other
Browning et al. 2018 Introgressed	GWAS	Coronary heart disease	2	0.9011	2.219509488	0.229777022	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Idiopathic inflammatory myopathy	1	0.262	3.816793893	0.230976902	skeletal muscle
Browning et al. 2018 Introgressed	GWAS	Coffee consumption (cups per day)	1	0.2643	3.783579266	0.231076892	behavior
Browning et al. 2018 Introgressed	GWAS	Response to cognitive-behavioural therapy in anxiety disorder	2	0.9161	2.183167776	0.231776822	other
Browning et al. 2018 Introgressed	GWAS	Cerebrospinal fluid p-tau levels	2	0.9088	2.200704225	0.232376762	nervous
Browning et al. 2018 Introgressed	GWAS	Aspartate aminotransferase levels	2	0.9237	2.165205153	0.234276572	other
Browning et al. 2018 Introgressed	GWAS	Renal overload gout	1	0.2659	3.760812335	0.235276472	urinary
Browning et al. 2018 Introgressed	GWAS	Bone mineral density (Ward's triangle area)	4	2.4766	1.6151175	0.239976002	skeletal
Browning et al. 2018 Introgressed	GWAS	Hair shape	1	0.2734	3.657644477	0.240575942	integumentary
Browning et al. 2018 Introgressed	GWAS	Response to hepatitis B vaccine	1	0.2781	3.595828839	0.241075892	other
Browning et al. 2018 Introgressed	GWAS	Subiculum volume	2	0.9474	2.111040743	0.241675832	nervous
Browning et al. 2018 Introgressed	GWAS	Ulcerative colitis	7	5.0038	1.398936808	0.241775822	digestive
Browning et al. 2018 Introgressed	GWAS	Cardiac structure and function	3	1.7005	1.764187004	0.244275572	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Stearic acid (18:0) levels	2	0.9496	2.106149958	0.244975502	other
Browning et al. 2018 Introgressed	GWAS	Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)	1	0.2837	3.524850194	0.246375362	other
Browning et al. 2018 Introgressed	GWAS	Parkinson's disease	8	5.946	1.345442314	0.246575342	nervous
Browning et al. 2018 Introgressed	GWAS	Allergic rhinitis	5	3.3639	1.486369987	0.247075292	immune
Browning et al. 2018 Introgressed	GWAS	Age at smoking initiation in chronic obstructive pulmonary disease	2	0.9487	2.108147992	0.247075292	respiratory
Browning et al. 2018 Introgressed	GWAS	Fibrinogen	1	0.2835	3.527336861	0.247775222	hematologic
Browning et al. 2018 Introgressed	GWAS	Crohn's disease (time to surgery)	1	0.2863	3.492839679	0.248575142	immune
Browning et al. 2018 Introgressed	GWAS	Renal underexcretion gout	1	0.2865	3.490401396	0.250774923	urinary
Browning et al. 2018 Introgressed	GWAS	Cystic fibrosis severity	1	0.291	3.436426117	0.251774823	respiratory
Browning et al. 2018 Introgressed	GWAS	Blood sugar levels	2	0.9822	2.036245164	0.253074693	metabolic
Browning et al. 2018 Introgressed	GWAS	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis	1	0.2899	3.449465333	0.253774623	other
Browning et al. 2018 Introgressed	GWAS	Alanine transaminase levels	2	0.9742	2.052966537	0.254774523	other
Browning et al. 2018 Introgressed	GWAS	Wegener's granulomatosis	1	0.294	3.401360544	0.256474353	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Fasting blood insulin (BMI interaction)	2	0.9866	2.027163998	0.258674133	metabolic
Browning et al. 2018 Introgressed	GWAS	Phospholipid levels (plasma)	4	2.5857	1.546969873	0.259874013	metabolic
Browning et al. 2018 Introgressed	GWAS	Peanut allergy (parent-of-origin effect)	1	0.3069	3.258390355	0.265373463	immune
Browning et al. 2018 Introgressed	GWAS	Waist-to-hip ratio adjusted for BMI	5	3.5495	1.408649106	0.276072393	skeletal
Browning et al. 2018 Introgressed	GWAS	Suicide risk	1	0.3267	3.060912152	0.280671933	behavior
Browning et al. 2018 Introgressed	GWAS	Chronic obstructive pulmonary disease-related biomarkers	2	1.0475	1.909307876	0.281571843	respiratory
Browning et al. 2018 Introgressed	GWAS	Fasting blood glucose	2	1.0533	1.898794266	0.283071693	metabolic
Browning et al. 2018 Introgressed	GWAS	Reticulocyte fraction of red cells	6	4.4234	1.356422661	0.285071493	immune
Browning et al. 2018 Introgressed	GWAS	Bone mineral density	4	2.7078	1.477213974	0.287571243	skeletal
Browning et al. 2018 Introgressed	GWAS	Serum thyroid-stimulating hormone levels	3	1.8668	1.607028069	0.288971103	endocrine
Browning et al. 2018 Introgressed	GWAS	Gallstone disease	1	0.3386	2.953337271	0.289171083	digestive
Browning et al. 2018 Introgressed	GWAS	Serum 25-Hydroxyvitamin D levels	1	0.344	2.906976744	0.290370963	other
Browning et al. 2018 Introgressed	GWAS	Cardiovascular disease risk factors	1	0.3441	2.906131938	0.293870613	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Plasma amyloid beta peptide concentrations (ABx-42)	1	0.3519	2.841716397	0.295270473	nervous
Browning et al. 2018 Introgressed	GWAS	Uric acid levels	3	1.8877	1.589235578	0.295970403	metabolic
Browning et al. 2018 Introgressed	GWAS	Feeling lonely	2	1.097	1.823154057	0.302069793	behavior
Browning et al. 2018 Introgressed	GWAS	Systolic blood pressure x smoking status (ever vs never) interaction (2df test)	2	1.1106	1.800828381	0.306669333	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Endometrial cancer (endometrioid histology)	2	1.1345	1.762891141	0.309369063	reproductive
Browning et al. 2018 Introgressed	GWAS	Cerebrospinal fluid t-tau levels	1	0.3704	2.699784017	0.311568843	nervous
Browning et al. 2018 Introgressed	GWAS	Reticulocyte count	5	3.6986	1.351862867	0.312168783	immune
Browning et al. 2018 Introgressed	GWAS	Ability to confide in someone	1	0.38	2.631578947	0.313668633	behavior
Browning et al. 2018 Introgressed	GWAS	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 (Grade 3 peripheral neuropathy)	1	0.3719	2.688894864	0.313868613	other
Browning et al. 2018 Introgressed	GWAS	Reading disability or specific language impairment (pleiotropy)	1	0.3802	2.630194634	0.315868413	other
Browning et al. 2018 Introgressed	GWAS	Lactate dehydrogenase levels	1	0.3896	2.566735113	0.323767623	metabolic
Browning et al. 2018 Introgressed	GWAS	Beard thickness	2	1.1638	1.718508335	0.323967603	integumentary
Browning et al. 2018 Introgressed	GWAS	GIP levels in response to oral glucose tolerance test (120 minutes)	1	0.3977	2.514458134	0.327467253	metabolic
Browning et al. 2018 Introgressed	GWAS	N-glycan levels	1	0.4017	2.489419965	0.329267073	endocrine
Browning et al. 2018 Introgressed	GWAS	Iron status biomarkers (transferrin saturation)	2	1.1935	1.675743611	0.332166783	other
Browning et al. 2018 Introgressed	GWAS	Acne (severe)	4	2.8947	1.381835769	0.333366663	integumentary
Browning et al. 2018 Introgressed	GWAS	Angiotensin-converting enzyme inhibitor intolerance	3	2.0325	1.47601476	0.333666633	other
Browning et al. 2018 Introgressed	GWAS	Colorectal cancer	6	4.7153	1.272453502	0.333766623	digestive
Browning et al. 2018 Introgressed	GWAS	Sum basophil neutrophil counts	3	2.0313	1.476886723	0.335466453	hematologic
Browning et al. 2018 Introgressed	GWAS	LDL cholesterol	3	2.0327	1.475869533	0.336066393	metabolic
Browning et al. 2018 Introgressed	GWAS	Bone mineral density (spine)	2	1.2063	1.657962364	0.339466053	skeletal
Browning et al. 2018 Introgressed	GWAS	Psychosis in Alzheimer's disease	1	0.413	2.421307506	0.340665933	behavior
Browning et al. 2018 Introgressed	GWAS	Metabolite levels (small molecules and protein measures)	1	0.417	2.398081535	0.342965703	metabolic
Browning et al. 2018 Introgressed	GWAS	Glioma	1	0.4234	2.361832782	0.343065693	nervous
Browning et al. 2018 Introgressed	GWAS	Cutaneous squamous cell carcinoma	1	0.4152	2.408477842	0.343265673	integumentary
Browning et al. 2018 Introgressed	GWAS	Cytomegalovirus antibody response	2	1.2233	1.634921932	0.345465453	immune
Browning et al. 2018 Introgressed	GWAS	Periodontitis (PAL4Q3)	1	0.4304	2.323420074	0.348965103	immune
Browning et al. 2018 Introgressed	GWAS	Optic nerve measurement (cup area)	1	0.4282	2.33535731	0.349465053	nervous
Browning et al. 2018 Introgressed	GWAS	CSF tryptophan concentration in tuberculous meningitis	1	0.4286	2.333177788	0.350264974	nervous
Browning et al. 2018 Introgressed	GWAS	Clozapine-induced cytotoxicity	2	1.2453	1.606038706	0.350964904	other
Browning et al. 2018 Introgressed	GWAS	Insulin-like growth factors	1	0.43	2.325581395	0.351564844	immune
Browning et al. 2018 Introgressed	GWAS	Feeling worry	2	1.2484	1.602050625	0.355864414	behavior
Browning et al. 2018 Introgressed	GWAS	Anxiety in major depressive disorder	1	0.4446	2.249212776	0.356364364	behavior
Browning et al. 2018 Introgressed	GWAS	Glucocorticoid-induced osteonecrosis (age 10 years and older)	1	0.4416	2.264492754	0.356564344	other
Browning et al. 2018 Introgressed	GWAS	"Bone mineral density (paediatric, skull)"	1	0.4477	2.233638597	0.361863814	skeletal
Browning et al. 2018 Introgressed	GWAS	Breast Cancer in BRCA1 mutation carriers	1	0.452	2.212389381	0.364463554	reproductive
Browning et al. 2018 Introgressed	GWAS	Loneliness (multivariate analysis)	3	2.1446	1.398862259	0.367563244	behavior
Browning et al. 2018 Introgressed	GWAS	Myeloid white cell count	3	2.168	1.383763838	0.367863214	immune
Browning et al. 2018 Introgressed	GWAS	Brain volume in infants (white matter)	2	1.3002	1.538224888	0.372462754	nervous
Browning et al. 2018 Introgressed	GWAS	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	2	1.2946	1.544878727	0.372662734	immune
Browning et al. 2018 Introgressed	GWAS	Neutrophil percentage of white cells	3	2.166	1.385041551	0.373262674	lymphatic
Browning et al. 2018 Introgressed	GWAS	Response to antipsychotic treatment in schizophrenia (reasoning)	2	1.3138	1.52230172	0.379662034	other
Browning et al. 2018 Introgressed	GWAS	Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)	1	0.4794	2.085940759	0.380861914	endocrine
Browning et al. 2018 Introgressed	GWAS	Lung function (forced vital capacity)	2	1.3305	1.503194288	0.381661834	respiratory
Browning et al. 2018 Introgressed	GWAS	Acute graft versus host disease in bone marrow transplantation (recipient effect)	2	1.3255	1.508864579	0.381861814	other
Browning et al. 2018 Introgressed	GWAS	Sedentary behaviour duration	1	0.4805	2.081165453	0.383361664	behavior
Browning et al. 2018 Introgressed	GWAS	Tanning	1	0.4872	2.052545156	0.384361564	integumentary
Browning et al. 2018 Introgressed	GWAS	Cerebrospinal fluid p-tau levels in mild cognitive impairment	1	0.482	2.074688797	0.385461454	nervous
Browning et al. 2018 Introgressed	GWAS	Preeclampsia	1	0.4874	2.051702913	0.386161384	reproductive
Browning et al. 2018 Introgressed	GWAS	Papillary thyroid cancer	2	1.3572	1.473622163	0.386961304	endocrine
Browning et al. 2018 Introgressed	GWAS	Differentiated thyroid cancer	2	1.3572	1.473622163	0.386961304	endocrine
Browning et al. 2018 Introgressed	GWAS	Rheumatoid arthritis (ACPA-positive)	2	1.3408	1.491646778	0.387961204	immune
Browning et al. 2018 Introgressed	GWAS	Headache	2	1.3499	1.481591229	0.388461154	nervous
Browning et al. 2018 Introgressed	GWAS	Hippocampal volume in mild cognitive impairment	1	0.4877	2.050440845	0.388961104	nervous
Browning et al. 2018 Introgressed	GWAS	Crohn's disease	10	8.8321	1.132233557	0.391360864	immune
Browning et al. 2018 Introgressed	GWAS	Weight	1	0.5007	1.997203915	0.393860614	skeletal
Browning et al. 2018 Introgressed	GWAS	Idiopathic dilated cardiomyopathy	4	3.1873	1.254980705	0.394760524	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Systolic blood pressure change trajectories	1	0.5012	1.995211492	0.396260374	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Body mass index (age>50)	1	0.5039	1.984520738	0.398560144	metabolic
Browning et al. 2018 Introgressed	GWAS	Multiple sclerosis (severity)	1	0.5094	1.963093836	0.400659934	nervous
Browning et al. 2018 Introgressed	GWAS	White matter integrity	1	0.5254	1.903311762	0.406859314	nervous
Browning et al. 2018 Introgressed	GWAS	Corneal astigmatism	4	3.2484	1.231375446	0.407659234	nervous
Browning et al. 2018 Introgressed	GWAS	Granulocyte percentage of myeloid white cells	3	2.3254	1.290100628	0.409059094	immune
Browning et al. 2018 Introgressed	GWAS	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	1	0.5272	1.896813354	0.409259074	other
Browning et al. 2018 Introgressed	GWAS	Seborrheic dermatitis	1	0.5342	1.871958068	0.413958604	integumentary
Browning et al. 2018 Introgressed	GWAS	Metabolic traits	1	0.5385	1.857010214	0.418258174	metabolic
Browning et al. 2018 Introgressed	GWAS	Mean arterial pressure	3	2.3568	1.272912424	0.422057794	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Alcoholic chronic pancreatitis	3	2.358	1.272264631	0.423457654	endocrine
Browning et al. 2018 Introgressed	GWAS	Inflammatory biomarkers	1	0.5575	1.793721973	0.427257274	immune
Browning et al. 2018 Introgressed	GWAS	Rhegmatogenous retinal detachment	1	0.5487	1.822489521	0.427457254	nervous
Browning et al. 2018 Introgressed	GWAS	Type 2 diabetes	18	16.886	1.065971811	0.428557144	metabolic
Browning et al. 2018 Introgressed	GWAS	Granulocyte count	3	2.3822	1.259340106	0.429957004	immune
Browning et al. 2018 Introgressed	GWAS	Waist-to-hip ratio adjusted for BMI (age <50)	2	1.4698	1.360729351	0.431356864	skeletal
Browning et al. 2018 Introgressed	GWAS	C-reactive protein levels or LDL-cholesterol levels (pleiotropy)	1	0.5595	1.787310098	0.431856814	immune
Browning et al. 2018 Introgressed	GWAS	Chronic lymphocytic leukemia	2	1.4714	1.359249694	0.433156684	lymphatic
Browning et al. 2018 Introgressed	GWAS	Low vWF levels	1	0.5722	1.747640685	0.433256674	hematologic
Browning et al. 2018 Introgressed	GWAS	Metabolite levels (5-HIAA)	2	1.4898	1.342462075	0.436056394	metabolic
Browning et al. 2018 Introgressed	GWAS	Cerebrospinal fluid t-tau levels in normal cognition	1	0.575	1.739130435	0.437956204	nervous
Browning et al. 2018 Introgressed	GWAS	Triglycerides	4	3.4008	1.176193837	0.439556044	metabolic
Browning et al. 2018 Introgressed	GWAS	C-reactive protein levels or total cholesterol levels (pleiotropy)	1	0.5743	1.741250218	0.440355964	immune
Browning et al. 2018 Introgressed	GWAS	Hematological and biochemical traits	1	0.5733	1.744287459	0.440355964	hematologic
Browning et al. 2018 Introgressed	GWAS	Huntington's disease progression	2	1.4904	1.341921632	0.440655934	nervous
Browning et al. 2018 Introgressed	GWAS	Daytime sleep phenotypes	11	10.1737	1.081219222	0.440955904	behavior
Browning et al. 2018 Introgressed	GWAS	Electroencephalogram traits	1	0.5758	1.736714137	0.441155884	nervous
Browning et al. 2018 Introgressed	GWAS	"Coronary artery disease (myocardial infarction, PTCA, CABG, angina or CIHD)"	3	2.4359	1.231577651	0.441555844	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Cerebrospinal fluid t-tau levels in Alzheimer's disease dementia	1	0.5901	1.694628029	0.443255674	nervous
Browning et al. 2018 Introgressed	GWAS	Upper eyelid sagging severity	2	1.5024	1.331203408	0.444155584	integumentary
Browning et al. 2018 Introgressed	GWAS	Metabolite levels (lipoprotein measures)	1	0.59	1.694915254	0.447555244	metabolic
Browning et al. 2018 Introgressed	GWAS	Heart rate response to recovery post exercise (30 sec)	1	0.5966	1.676164935	0.448255174	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Blood protein levels	30	28.9562	1.036047548	0.450954905	other
Browning et al. 2018 Introgressed	GWAS	Body mass index x sex x age interaction (4df test)	2	1.5182	1.317349493	0.451454855	metabolic
Browning et al. 2018 Introgressed	GWAS	Periodontitis (DPAL)	1	0.6041	1.655355074	0.452454755	immune
Browning et al. 2018 Introgressed	GWAS	Bone properties (heel)	1	0.607	1.647446458	0.454554545	skeletal
Browning et al. 2018 Introgressed	GWAS	Mammographic density (dense area)	2	1.5526	1.288161793	0.457354265	reproductive
Browning et al. 2018 Introgressed	GWAS	Albumin-globulin ratio	2	1.5337	1.304035991	0.460253975	other
Browning et al. 2018 Introgressed	GWAS	Upper eyelid morphology	1	0.6237	1.603334937	0.464753525	integumentary
Browning et al. 2018 Introgressed	GWAS	LDL cholesterol levels	1	0.6238	1.60307791	0.465153485	metabolic
Browning et al. 2018 Introgressed	GWAS	Conotruncal heart defects (inherited effects)	1	0.6265	1.596169194	0.465653435	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	1	0.6422	1.557147306	0.470452955	metabolic
Browning et al. 2018 Introgressed	GWAS	Morning vs. evening chronotype	1	0.6344	1.57629256	0.471852815	behavior
Browning et al. 2018 Introgressed	GWAS	Thyroid cancer	1	0.6291	1.589572405	0.473052695	endocrine
Browning et al. 2018 Introgressed	GWAS	C-reactive protein levels	1	0.655	1.526717557	0.477052295	immune
Browning et al. 2018 Introgressed	GWAS	Systemic lupus erythematosus	8	7.5198	1.063858081	0.477452255	immune
Browning et al. 2018 Introgressed	GWAS	vWF and FVIII levels	1	0.6469	1.545833977	0.478052195	hematologic
Browning et al. 2018 Introgressed	GWAS	Generalized epilepsy	1	0.655	1.526717557	0.479052095	nervous
Browning et al. 2018 Introgressed	GWAS	Breast cancer (estrogen-receptor negative)	1	0.6558	1.524855139	0.479652035	reproductive
Browning et al. 2018 Introgressed	GWAS	Lower body strength	1	0.6519	1.533977604	0.480151985	skeletal muscle
Browning et al. 2018 Introgressed	GWAS	Chronotype	1	0.6518	1.534212949	0.480551945	behavior
Browning et al. 2018 Introgressed	GWAS	Early-onset Parkinson's disease	2	1.6244	1.231223836	0.482851715	nervous
Browning et al. 2018 Introgressed	GWAS	Heart rate response to recovery post exercise (40 sec)	1	0.6662	1.501050736	0.484951505	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Fasting blood insulin	1	0.6709	1.490535102	0.486651335	metabolic
Browning et al. 2018 Introgressed	GWAS	Cerebrospinal fluid AB1-42 levels	2	1.6574	1.206709304	0.491650835	nervous
Browning et al. 2018 Introgressed	GWAS	Heart rate response to recovery post exercise (10 sec)	1	0.687	1.455604076	0.492950705	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Pulmonary function (smoking interaction)	3	2.6339	1.138995406	0.493050695	respiratory
Browning et al. 2018 Introgressed	GWAS	Left ventricular obstructive tract defect (maternal effect)	1	0.6761	1.479071143	0.493150685	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Diverticular disease	7	6.6281	1.056109594	0.494350565	digestive
Browning et al. 2018 Introgressed	GWAS	Urinary albumin excretion (no hypertensive medication)	1	0.6685	1.495886313	0.494350565	metabolic
Browning et al. 2018 Introgressed	GWAS	Plasma amyloid beta peptide concentrations (ABx-40)	1	0.6774	1.476232654	0.495750425	nervous
Browning et al. 2018 Introgressed	GWAS	Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)	2	1.6736	1.195028681	0.500949905	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Hemoglobin	1	0.6884	1.452643812	0.501849815	hematologic
Browning et al. 2018 Introgressed	GWAS	Systemic lupus erythematosus and Systemic sclerosis	1	0.7001	1.428367376	0.501849815	immune
Browning et al. 2018 Introgressed	GWAS	Plateletcrit	5	4.6814	1.068056564	0.501949805	hematologic
Browning et al. 2018 Introgressed	GWAS	Depressive and manic episodes in bipolar disorder	1	0.6972	1.434308663	0.503149685	behavior
Browning et al. 2018 Introgressed	GWAS	Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)	2	1.6767	1.192819228	0.504349565	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Response to platinum-based neoadjuvant chemotherapy in cervical cancer	2	1.6843	1.187436917	0.506449355	other
Browning et al. 2018 Introgressed	GWAS	Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)	6	5.7003	1.05257618	0.507349265	skeletal
Browning et al. 2018 Introgressed	GWAS	Bone ultrasound measurement (broadband ultrasound attenuation)	1	0.7052	1.418037436	0.507949205	skeletal
Browning et al. 2018 Introgressed	GWAS	Non-alcoholic fatty liver disease histology (lobular)	1	0.7188	1.391207568	0.509749025	digestive
Browning et al. 2018 Introgressed	GWAS	Non-albumin protein levels	2	1.6902	1.183291918	0.510048995	other
Browning et al. 2018 Introgressed	GWAS	Multiple system atrophy (pathologically confirmed)	1	0.7228	1.383508578	0.515448455	nervous
Browning et al. 2018 Introgressed	GWAS	Phospholipid levels in medium HDL	1	0.7492	1.334757074	0.524347565	metabolic
Browning et al. 2018 Introgressed	GWAS	Hip shape (DXA scan)	2	1.751	1.142204455	0.524947505	skeletal
Browning et al. 2018 Introgressed	GWAS	Bipolar disorder (body mass index interaction)	2	1.7548	1.139731023	0.525447455	behavior
Browning et al. 2018 Introgressed	GWAS	Mortality in sepsis	1	0.7479	1.337077149	0.525847415	other
Browning et al. 2018 Introgressed	GWAS	Response to fenofibrate (HDL cholesterol levels)	2	1.7559	1.139017028	0.526147385	other
Browning et al. 2018 Introgressed	GWAS	Eosinophil counts	4	3.8124	1.049207848	0.527347265	immune
Browning et al. 2018 Introgressed	GWAS	Rosacea symptom severity	7	6.8311	1.024725154	0.528447155	integumentary
Browning et al. 2018 Introgressed	GWAS	Prothrombin time	1	0.7681	1.301913813	0.535046495	hematologic
Browning et al. 2018 Introgressed	GWAS	Radiation response	2	1.7898	1.11744329	0.535546445	other
Browning et al. 2018 Introgressed	GWAS	Free thyroxine concentration	1	0.7866	1.271294177	0.543445655	endocrine
Browning et al. 2018 Introgressed	GWAS	Menopause (age at onset)	2	1.8325	1.091405184	0.544945505	reproductive
Browning et al. 2018 Introgressed	GWAS	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)	1	0.7804	1.281394157	0.545445455	other
Browning et al. 2018 Introgressed	GWAS	White blood cell count	3	2.8424	1.055446102	0.546045395	immune
Browning et al. 2018 Introgressed	GWAS	High light scatter reticulocyte count	4	3.8875	1.028938907	0.546945305	metabolic
Browning et al. 2018 Introgressed	GWAS	Eyebrow thickness	1	0.7959	1.256439251	0.549845015	integumentary
Browning et al. 2018 Introgressed	GWAS	Intraocular pressure	13	13.1044	0.99203321	0.550244976	nervous
Browning et al. 2018 Introgressed	GWAS	Urate levels (BMI interaction)	1	0.7976	1.253761284	0.553644636	metabolic
Browning et al. 2018 Introgressed	GWAS	Loneliness (MTAG)	2	1.8644	1.072731174	0.554844516	behavior
Browning et al. 2018 Introgressed	GWAS	Response to n-3 LC-PUFA supplementation (change in triglyceride levels)	2	1.8718	1.068490223	0.556944306	other
Browning et al. 2018 Introgressed	GWAS	Orofacial clefts	2	1.8654	1.072156106	0.557444256	other
Browning et al. 2018 Introgressed	GWAS	Total cholesterol levels	3	2.9455	1.018502801	0.559744026	metabolic
Browning et al. 2018 Introgressed	GWAS	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection	1	0.8138	1.228803146	0.563643636	skeletal muscle
Browning et al. 2018 Introgressed	GWAS	Chromium levels	1	0.8259	1.210800339	0.564243576	other
Browning et al. 2018 Introgressed	GWAS	Regular attendance at a gym or sports club	1	0.8341	1.198897015	0.567943206	behavior
Browning et al. 2018 Introgressed	GWAS	Molybdenum levels	2	1.9001	1.05257618	0.569043096	other
Browning et al. 2018 Introgressed	GWAS	Proteinuria in chronic kidney disease	1	0.8442	1.184553423	0.571642836	urinary
Browning et al. 2018 Introgressed	GWAS	Attention deficit hyperactivity disorder and conduct disorder	1	0.8486	1.178411501	0.573242676	behavior
Browning et al. 2018 Introgressed	GWAS	Triglyceride levels	2	1.9428	1.029442042	0.574042596	metabolic
Browning et al. 2018 Introgressed	GWAS	Asperger disorder	1	0.8491	1.177717583	0.574242576	behavior
Browning et al. 2018 Introgressed	GWAS	Influenza A (H1N1) severity	1	0.8664	1.154201293	0.574542546	immune
Browning et al. 2018 Introgressed	GWAS	Electrocardiographic traits	1	0.8509	1.175226231	0.576742326	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Colorectal or endometrial cancer	1	0.867	1.153402537	0.580841916	digestive
Browning et al. 2018 Introgressed	GWAS	Interleukin-6 levels	1	0.878	1.138952164	0.583441656	immune
Browning et al. 2018 Introgressed	GWAS	Chloride levels	1	0.8894	1.124353497	0.587041296	other
Browning et al. 2018 Introgressed	GWAS	Metabolite levels (HVA/5-HIAA ratio)	1	0.8888	1.125112511	0.587441256	metabolic
Browning et al. 2018 Introgressed	GWAS	Age at first birth	1	0.8886	1.125365744	0.589141086	reproductive
Browning et al. 2018 Introgressed	GWAS	Serum uric acid levels in response to allopurinol in gout	2	1.9737	1.013325227	0.592040796	other
Browning et al. 2018 Introgressed	GWAS	Pulmonary function	3	3.0816	0.973520249	0.592740726	respiratory
Browning et al. 2018 Introgressed	GWAS	Bipolar disorder and eating disorder	1	0.8931	1.119695443	0.593240676	behavior
Browning et al. 2018 Introgressed	GWAS	Testicular germ cell tumor	2	2.0183	0.990932963	0.594040596	reproductive
Browning et al. 2018 Introgressed	GWAS	Squamous cell lung carcinoma	3	3.0883	0.971408218	0.595840416	respiratory
Browning et al. 2018 Introgressed	GWAS	Primary biliary cirrhosis	1	0.9014	1.1093854	0.596640336	digestive
Browning et al. 2018 Introgressed	GWAS	Serum metabolite levels	1	0.9161	1.091583888	0.599640036	metabolic
Browning et al. 2018 Introgressed	GWAS	Response to fenofibrate (adiponectin levels)	2	2.0104	0.9948269	0.601239876	other
Browning et al. 2018 Introgressed	GWAS	PR interval	3	3.1274	0.959263286	0.602339766	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Conotruncal heart defects	1	0.9276	1.078050884	0.605139486	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Type 2 diabetes nephropathy	1	0.9367	1.067577666	0.606639336	metabolic
Browning et al. 2018 Introgressed	GWAS	Breast cancer	7	7.3867	0.947649153	0.607439256	reproductive
Browning et al. 2018 Introgressed	GWAS	Heart rate response to recovery post exercise (20 sec)	1	0.9555	1.046572475	0.608739126	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Type 2 diabetes (age of onset)	2	2.0589	0.971392491	0.608839116	metabolic
Browning et al. 2018 Introgressed	GWAS	Femoral neck bone mineral density	2	2.037	0.981836033	0.610038996	skeletal
Browning et al. 2018 Introgressed	GWAS	Phospholipid levels in large HDL	1	0.9577	1.04416832	0.611338866	metabolic
Browning et al. 2018 Introgressed	GWAS	Large HDL particle concentration	1	0.9577	1.04416832	0.611338866	metabolic
Browning et al. 2018 Introgressed	GWAS	Feeling nervous	2	2.0624	0.969743988	0.611538846	behavior
Browning et al. 2018 Introgressed	GWAS	Personality traits in bipolar disorder	1	0.9406	1.06315118	0.613038696	behavior
Browning et al. 2018 Introgressed	GWAS	Heart rate response to recovery post exercise (50 sec)	1	0.953	1.049317943	0.615238476	cardiovascular
Browning et al. 2018 Introgressed	GWAS	HIV-1 viral setpoint	1	0.9547	1.047449461	0.618538146	immune
Browning et al. 2018 Introgressed	GWAS	Bipolar disorder and schizophrenia	3	3.1947	0.93905531	0.618638136	behavior
Browning et al. 2018 Introgressed	GWAS	Height	15	15.8535	0.946163308	0.618938106	skeletal
Browning et al. 2018 Introgressed	GWAS	Asthma	7	7.4741	0.936567613	0.619238076	respiratory
Browning et al. 2018 Introgressed	GWAS	Scalp hair shape	1	0.9674	1.033698573	0.622037796	integumentary
Browning et al. 2018 Introgressed	GWAS	Electrodermal activity	2	2.0789	0.962047237	0.622237776	integumentary
Browning et al. 2018 Introgressed	GWAS	Temperament (bipolar disorder)	1	0.9764	1.024170422	0.624437556	behavior
Browning et al. 2018 Introgressed	GWAS	Osteoporosis-related phenotypes	1	0.98	1.020408163	0.624937506	skeletal
Browning et al. 2018 Introgressed	GWAS	QT interval (ambient particulate matter interaction)	1	0.9698	1.031140441	0.625137486	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Bulimia nervosa	1	0.9885	1.011633789	0.625137486	behavior
Browning et al. 2018 Introgressed	GWAS	Response to serotonin reuptake inhibitors in major depressive disorder	1	0.9783	1.022181335	0.625537446	other
Browning et al. 2018 Introgressed	GWAS	Response to fenofibrate (triglyceride levels)	2	2.1075	0.948991696	0.626237376	other
Browning et al. 2018 Introgressed	GWAS	Bipolar disorder or attention deficit hyperactivity disorder	1	0.9849	1.015331506	0.626437356	behavior
Browning et al. 2018 Introgressed	GWAS	Immune reponse to smallpox (secreted IFN-alpha)	1	0.9738	1.026904909	0.626837316	immune
Browning et al. 2018 Introgressed	GWAS	Diastolic blood pressure (cigarette smoking interaction)	1	0.9817	1.018641133	0.628637136	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Asthma (sex interaction)	1	0.9886	1.011531459	0.630636936	respiratory
Browning et al. 2018 Introgressed	GWAS	Vitiligo	3	3.2257	0.930030691	0.633236676	integumentary
Browning et al. 2018 Introgressed	GWAS	Alzheimer disease and age of onset	1	0.9965	1.003512293	0.634136586	nervous
Browning et al. 2018 Introgressed	GWAS	Body mass index and waist-hip ratio (pleiotropy)	1	1.007	0.993048659	0.634436556	metabolic
Browning et al. 2018 Introgressed	GWAS	Carotid atherosclerosis in HIV infection	1	1.0179	0.982414776	0.634536546	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Age-related hearing impairment	2	2.1711	0.921192022	0.635036496	nervous
Browning et al. 2018 Introgressed	GWAS	Body mass index (age <50)	1	1.0143	0.985901607	0.637836216	metabolic
Browning et al. 2018 Introgressed	GWAS	Chronic inflammatory diseases (pleiotropy)	3	3.2936	0.91085742	0.638436156	immune
Browning et al. 2018 Introgressed	GWAS	Alcohol consumption (maxi-drinks)	1	1.0233	0.977230529	0.640135986	behavior
Browning et al. 2018 Introgressed	GWAS	Systolic blood pressure (cigarette smoking interaction)	1	1.022	0.978473581	0.642535746	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Response to antidepressants (symptom improvement)	2	2.1787	0.917978611	0.642635736	other
Browning et al. 2018 Introgressed	GWAS	Metabolic syndrome	1	1.0232	0.977326036	0.642935706	metabolic
Browning et al. 2018 Introgressed	GWAS	Multiple myeloma	1	1.0194	0.980969198	0.643635636	immune
Browning et al. 2018 Introgressed	GWAS	Proteinuria and chronic kidney disease	1	1.0418	0.959877136	0.646735326	urinary
Browning et al. 2018 Introgressed	GWAS	ALT levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	2	2.1944	0.911410864	0.647435256	other
Browning et al. 2018 Introgressed	GWAS	Pubertal anthropometrics	1	1.0264	0.974279034	0.647735226	skeletal
Browning et al. 2018 Introgressed	GWAS	Urate levels	1	1.0292	0.971628449	0.647835216	metabolic
Browning et al. 2018 Introgressed	GWAS	Paclitaxel-induced neuropathy	1	1.0565	0.946521533	0.651134887	other
Browning et al. 2018 Introgressed	GWAS	Sudden cardiac arrest	1	1.0573	0.945805353	0.651234877	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Myocardial infarction	1	1.0365	0.964785335	0.651434857	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Lung function (FEV1)	2	2.2221	0.900049503	0.651834817	respiratory
Browning et al. 2018 Introgressed	GWAS	Response to antipsychotic treatment in schizophrenia (working memory)	1	1.0552	0.947687642	0.652434757	other
Browning et al. 2018 Introgressed	GWAS	Lumbar spine bone mineral density	1	1.0547	0.948136911	0.652834717	skeletal
Browning et al. 2018 Introgressed	GWAS	Heschl's gyrus morphology	1	1.0463	0.955748829	0.652934707	nervous
Browning et al. 2018 Introgressed	GWAS	Response to amphetamines	6	6.6564	0.901388138	0.653034697	other
Browning et al. 2018 Introgressed	GWAS	Glucocorticoid-induced osteonecrosis	1	1.0655	0.938526513	0.654334567	other
Browning et al. 2018 Introgressed	GWAS	Multiple sclerosis (age of onset)	1	1.0742	0.93092534	0.656234377	nervous
Browning et al. 2018 Introgressed	GWAS	Manganese levels	1	1.0663	0.937822376	0.658434157	other
Browning et al. 2018 Introgressed	GWAS	Response to taxane treatment (docetaxel)	1	1.083	0.923361034	0.658634137	other
Browning et al. 2018 Introgressed	GWAS	Heart rate response to recovery post exercise	1	1.0642	0.939672994	0.659734027	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Heart rate	2	2.2431	0.8916232	0.660333967	cardiovascular
Browning et al. 2018 Introgressed	GWAS	BMI in smokers	1	1.0721	0.932748811	0.660433957	metabolic
Browning et al. 2018 Introgressed	GWAS	LDL peak particle diameter (total fat intake interaction)	1	1.0902	0.917262888	0.664433557	metabolic
Browning et al. 2018 Introgressed	GWAS	Homeostasis model assessment of beta-cell function (dietary factor interaction)	2	2.3024	0.868658791	0.669833017	metabolic
Browning et al. 2018 Introgressed	GWAS	Glycated hemoglobin levels	2	2.3057	0.867415535	0.671432857	metabolic
Browning et al. 2018 Introgressed	GWAS	Acute lymphoblastic leukemia (childhood)	3	3.4655	0.865675949	0.674432557	lymphatic
Browning et al. 2018 Introgressed	GWAS	Erosive tooth wear (severe vs none or mild)	1	1.1214	0.891742465	0.675232477	skeletal
Browning et al. 2018 Introgressed	GWAS	Monocyte percentage of white cells	2	2.3351	0.856494369	0.677532247	immune
Browning et al. 2018 Introgressed	GWAS	Systemic sclerosis	2	2.3519	0.850376292	0.678932107	other
Browning et al. 2018 Introgressed	GWAS	Amyotrophic lateral sclerosis (age of onset)	2	2.3104	0.86565097	0.680731927	nervous
Browning et al. 2018 Introgressed	GWAS	Platelet count	6	6.8345	0.877898895	0.681031897	hematologic
Browning et al. 2018 Introgressed	GWAS	Rheumatoid arthritis	4	4.675	0.855614973	0.684931507	immune
Browning et al. 2018 Introgressed	GWAS	Chronic kidney disease	1	1.164	0.859106529	0.685531447	urinary
Browning et al. 2018 Introgressed	GWAS	Methadone dose in opioid dependence	5	5.8029	0.861638146	0.687531247	other
Browning et al. 2018 Introgressed	GWAS	Type 1 diabetes nephropathy	1	1.159	0.86281277	0.687631237	metabolic
Browning et al. 2018 Introgressed	GWAS	Response to citalopram treatment	1	1.1737	0.852006475	0.689731027	other
Browning et al. 2018 Introgressed	GWAS	Glomerular filtration rate (creatinine)	3	3.5653	0.841443918	0.693730627	hematologic
Browning et al. 2018 Introgressed	GWAS	Waist-to-hip ratio adjusted for BMI (age >50)	2	2.4083	0.830461321	0.694630537	skeletal
Browning et al. 2018 Introgressed	GWAS	Blond vs. brown/black hair color	4	4.7737	0.837924461	0.694730527	integumentary
Browning et al. 2018 Introgressed	GWAS	Blood metabolite levels	2	2.4068	0.830978893	0.694730527	metabolic
Browning et al. 2018 Introgressed	GWAS	Ankylosing spondylitis	1	1.1893	0.840830741	0.698430157	skeletal
Browning et al. 2018 Introgressed	GWAS	Myopia (pathological)	3	3.6168	0.829462508	0.698530147	nervous
Browning et al. 2018 Introgressed	GWAS	Hippocampal volume in Alzheimer's disease dementia	1	1.2394	0.80684202	0.707529247	nervous
Browning et al. 2018 Introgressed	GWAS	Obesity	4	4.8045	0.832552815	0.708629137	metabolic
Browning et al. 2018 Introgressed	GWAS	Irritable bowel syndrome	2	2.4698	0.809782169	0.709129087	digestive
Browning et al. 2018 Introgressed	GWAS	Cobalt levels	1	1.2287	0.813868316	0.709329067	other
Browning et al. 2018 Introgressed	GWAS	Personality dimensions	1	1.2353	0.809519955	0.710828917	behavior
Browning et al. 2018 Introgressed	GWAS	Prostate cancer (SNP x SNP interaction)	2	2.4712	0.809323406	0.711728827	reproductive
Browning et al. 2018 Introgressed	GWAS	Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes	4	4.8968	0.81685999	0.716728327	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Red blood cell traits	1	1.253	0.798084597	0.717428257	hematologic
Browning et al. 2018 Introgressed	GWAS	Lymphocyte counts	3	3.7052	0.809672892	0.718128187	lymphatic
Browning et al. 2018 Introgressed	GWAS	Lung cancer	2	2.5633	0.780244216	0.720627937	respiratory
Browning et al. 2018 Introgressed	GWAS	Alzheimer's disease progression score	1	1.2605	0.793335978	0.720927907	nervous
Browning et al. 2018 Introgressed	GWAS	Hypertension	2	2.576	0.776397516	0.724327567	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Dialysis-related mortality	1	1.2894	0.775554521	0.725127487	other
Browning et al. 2018 Introgressed	GWAS	Alzheimer's disease (late onset)	2	2.5558	0.782533845	0.725727427	nervous
Browning et al. 2018 Introgressed	GWAS	Protein quantitative trait loci	4	4.9624	0.806061583	0.726827317	other
Browning et al. 2018 Introgressed	GWAS	Thyroid hormone levels	1	1.3165	0.759589821	0.730126987	endocrine
Browning et al. 2018 Introgressed	GWAS	Delirium	1	1.3292	0.75233223	0.733426657	behavior
Browning et al. 2018 Introgressed	GWAS	Disc degeneration (lumbar)	1	1.3379	0.747440018	0.734426557	skeletal
Browning et al. 2018 Introgressed	GWAS	Hemoglobin concentration	2	2.6071	0.767135898	0.735726427	hematologic
Browning et al. 2018 Introgressed	GWAS	Presence of antiphospholipid antibodies	2	2.6196	0.76347534	0.738026197	other
Browning et al. 2018 Introgressed	GWAS	Pancreatic cancer	3	3.8527	0.778674696	0.742025797	endocrine
Browning et al. 2018 Introgressed	GWAS	Cerebrospinal fluid beta-site APP cleaving enzyme levels	1	1.3541	0.738497895	0.742125787	nervous
Browning et al. 2018 Introgressed	GWAS	Serum total protein level	1	1.3577	0.736539736	0.745125487	other
Browning et al. 2018 Introgressed	GWAS	Response to antipsychotic treatment	3	3.8657	0.776056083	0.746725327	other
Browning et al. 2018 Introgressed	GWAS	Fractures	1	1.378	0.725689405	0.748825117	skeletal
Browning et al. 2018 Introgressed	GWAS	Bone mineral density (hip)	3	3.8931	0.770594128	0.749925007	skeletal
Browning et al. 2018 Introgressed	GWAS	Glaucoma	1	1.3849	0.722073796	0.750124988	nervous
Browning et al. 2018 Introgressed	GWAS	Adverse response to chemotherapy in breast cancer (alopecia) (FDC/DC)	1	1.3702	0.729820464	0.751224878	other
Browning et al. 2018 Introgressed	GWAS	Pelvic organ prolapse	1	1.3933	0.71772052	0.752524748	skeletal muscle
Browning et al. 2018 Introgressed	GWAS	Type 1 diabetes	1	1.4198	0.704324553	0.753624638	metabolic
Browning et al. 2018 Introgressed	GWAS	BMI in non-smokers	4	5.1036	0.783760483	0.754124588	metabolic
Browning et al. 2018 Introgressed	GWAS	Knee osteoarthritis	2	2.7025	0.740055504	0.754724528	skeletal
Browning et al. 2018 Introgressed	GWAS	Non-alcoholic fatty liver disease histology (other)	1	1.39	0.71942446	0.755024498	digestive
Browning et al. 2018 Introgressed	GWAS	Nicotine dependence and major depression (severity of comorbidity)	2	2.7063	0.739016369	0.757024298	behavior
Browning et al. 2018 Introgressed	GWAS	Response to platinum-based chemotherapy in non-small-cell lung cancer	1	1.4006	0.713979723	0.757424258	other
Browning et al. 2018 Introgressed	GWAS	Sodium levels	1	1.4135	0.707463742	0.757624238	other
Browning et al. 2018 Introgressed	GWAS	Aortic root size	1	1.4028	0.712859994	0.758424158	cardiovascular
Browning et al. 2018 Introgressed	GWAS	White matter lesion progression	1	1.4092	0.709622481	0.759724028	nervous
Browning et al. 2018 Introgressed	GWAS	Refractive astigmatism	2	2.7007	0.740548747	0.759924008	nervous
Browning et al. 2018 Introgressed	GWAS	Waist circumference adjusted for BMI in active individuals	3	3.9746	0.754792935	0.761323868	skeletal
Browning et al. 2018 Introgressed	GWAS	Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)	3	3.9746	0.754792935	0.761323868	skeletal
Browning et al. 2018 Introgressed	GWAS	Itch intensity from mosquito bite adjusted by bite size	4	5.224	0.765696784	0.765723428	immune
Browning et al. 2018 Introgressed	GWAS	Carotid plaque burden	2	2.8009	0.714056196	0.767423258	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Bone ultrasound measurement (velocity of sound)	1	1.4593	0.685260056	0.767623238	skeletal
Browning et al. 2018 Introgressed	GWAS	Carboplatin disposition in epthelial ovarian cancer	1	1.4757	0.677644508	0.768323168	other
Browning et al. 2018 Introgressed	GWAS	Coronary artery calcification	3	4.1045	0.730905104	0.771222878	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Systolic blood pressure x alcohol consumption interaction (2df test)	2	2.8406	0.704076604	0.772522748	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Red blood cell count	4	5.2543	0.761281236	0.773522648	hematologic
Browning et al. 2018 Introgressed	GWAS	Central corneal thickness	2	2.8231	0.708441075	0.774522548	nervous
Browning et al. 2018 Introgressed	GWAS	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)	1	1.477	0.67704807	0.774622538	other
Browning et al. 2018 Introgressed	GWAS	Paclitaxel disposition in epithelial ovarian cancer	4	5.2826	0.757202893	0.775022498	other
Browning et al. 2018 Introgressed	GWAS	Reaction time	1	1.4834	0.674127006	0.776222378	behavior
Browning et al. 2018 Introgressed	GWAS	Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)	2	2.8223	0.708641888	0.776622338	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Post bronchodilator FEV1/FVC ratio	14	16.7345	0.836595058	0.776822318	other
Browning et al. 2018 Introgressed	GWAS	Primary sclerosing cholangitis	1	1.4892	0.671501477	0.777322268	digestive
Browning et al. 2018 Introgressed	GWAS	Obsessive-compulsive symptoms	1	1.507	0.663570007	0.777622238	behavior
Browning et al. 2018 Introgressed	GWAS	Dimensional psychopathology (Social)	1	1.5101	0.662207801	0.778322168	behavior
Browning et al. 2018 Introgressed	GWAS	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)	1	1.4752	0.677874187	0.778622138	other
Browning et al. 2018 Introgressed	GWAS	Attention function in attention deficit hyperactive disorder	2	2.8654	0.69798283	0.780521948	behavior
Browning et al. 2018 Introgressed	GWAS	Fasting plasma glucose	1	1.5162	0.659543596	0.781021898	metabolic
Browning et al. 2018 Introgressed	GWAS	Intelligence (MTAG)	11	13.5174	0.813765961	0.786621338	other
Browning et al. 2018 Introgressed	GWAS	Borderline personality disorder	1	1.5223	0.656900742	0.786721328	behavior
Browning et al. 2018 Introgressed	GWAS	Venous thromboembolism adjusted for sickle cell variant rs77121243-T	4	5.3555	0.746895715	0.788421158	hematologic
Browning et al. 2018 Introgressed	GWAS	Gout	2	2.8961	0.690583889	0.788421158	skeletal
Browning et al. 2018 Introgressed	GWAS	Feeling tense	1	1.5307	0.653295878	0.788721128	behavior
Browning et al. 2018 Introgressed	GWAS	Basophil percentage of granulocytes	1	1.5661	0.63852883	0.789221078	immune
Browning et al. 2018 Introgressed	GWAS	Basophil percentage of white cells	1	1.5859	0.630556782	0.791320868	immune
Browning et al. 2018 Introgressed	GWAS	Dimensional psychopathology (Negative)	2	2.9172	0.685588921	0.795520448	behavior
Browning et al. 2018 Introgressed	GWAS	Eye morphology	1	1.5776	0.633874239	0.797920208	nervous
Browning et al. 2018 Introgressed	GWAS	Advanced glycation end-product levels	1	1.5809	0.632551078	0.797920208	metabolic
Browning et al. 2018 Introgressed	GWAS	Dimensional psychopathology (Arousal)	1	1.5841	0.631273278	0.799420058	behavior
Browning et al. 2018 Introgressed	GWAS	Coronary artery disease	11	13.6667	0.804876086	0.801319868	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Breast size	3	4.2576	0.704622322	0.801419858	reproductive
Browning et al. 2018 Introgressed	GWAS	Body mass index (change over time)	1	1.6095	0.621310966	0.801619838	metabolic
Browning et al. 2018 Introgressed	GWAS	Middle childhood and early adolescence aggressive behavior	1	1.6341	0.611957653	0.803019698	behavior
Browning et al. 2018 Introgressed	GWAS	D-dimer levels	1	1.6083	0.621774545	0.805819418	other
Browning et al. 2018 Introgressed	GWAS	Thiazide-induced adverse metabolic effects in hypertensive patients	2	3.0595	0.653701585	0.808519148	other
Browning et al. 2018 Introgressed	GWAS	Polycystic ovary syndrome	1	1.6782	0.595876534	0.810618938	reproductive
Browning et al. 2018 Introgressed	GWAS	Glaucoma (primary open-angle)	2	3.0866	0.647962159	0.811318868	nervous
Browning et al. 2018 Introgressed	GWAS	Western dietary pattern	1	1.6894	0.591926128	0.811718828	behavior
Browning et al. 2018 Introgressed	GWAS	Resting heart rate	5	6.8571	0.729171224	0.813218678	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Total body bone mineral density	1	1.6926	0.590807042	0.813818618	skeletal
Browning et al. 2018 Introgressed	GWAS	Hippocampal sclerosis	1	1.6922	0.590946697	0.815018498	nervous
Browning et al. 2018 Introgressed	GWAS	Hypertension (SNP x SNP interaction)	1	1.6755	0.596836765	0.815518448	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Lung function (FEV1/FVC)	2	3.1429	0.636354959	0.816118388	respiratory
Browning et al. 2018 Introgressed	GWAS	Mean corpuscular volume	5	6.8994	0.724700699	0.818218178	hematologic
Browning et al. 2018 Introgressed	GWAS	Putamen volume	2	3.096	0.645994832	0.819018098	nervous
Browning et al. 2018 Introgressed	GWAS	Urinary albumin excretion	4	5.6595	0.706776217	0.819718028	metabolic
Browning et al. 2018 Introgressed	GWAS	Hip circumference adjusted for BMI	3	4.4208	0.678610206	0.820017998	skeletal
Browning et al. 2018 Introgressed	GWAS	Coronary artery aneurysm in Kawasaki disease	6	8.0712	0.743383883	0.821017898	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Waist-to-hip ratio adjusted for body mass index	2	3.1322	0.63852883	0.822417758	skeletal
Browning et al. 2018 Introgressed	GWAS	Migraine without aura	1	1.7366	0.575837844	0.825317468	nervous
Browning et al. 2018 Introgressed	GWAS	Irritable mood	1	1.7758	0.563126478	0.826717328	behavior
Browning et al. 2018 Introgressed	GWAS	Skin aging (microtopography measurement)	1	1.7477	0.57218058	0.827817218	integumentary
Browning et al. 2018 Introgressed	GWAS	Telomere length	1	1.7556	0.569605833	0.830116988	other
Browning et al. 2018 Introgressed	GWAS	Total ventricular volume	1	1.7597	0.568278684	0.830416958	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Neutrophil percentage of granulocytes	2	3.2371	0.617836953	0.834216578	lymphatic
Browning et al. 2018 Introgressed	GWAS	Copper levels	2	3.2926	0.607422705	0.834516548	other
Browning et al. 2018 Introgressed	GWAS	Coenzyme Q10 levels	1	1.7888	0.559033989	0.835416458	other
Browning et al. 2018 Introgressed	GWAS	Red cell distribution width	3	4.5959	0.652755717	0.836116388	hematologic
Browning et al. 2018 Introgressed	GWAS	Monobrow	2	3.2666	0.612257393	0.836316368	integumentary
Browning et al. 2018 Introgressed	GWAS	Waist circumference	4	5.8832	0.679902094	0.839916008	skeletal
Browning et al. 2018 Introgressed	GWAS	Adolescent idiopathic scoliosis	1	1.7851	0.560192706	0.841415858	skeletal
Browning et al. 2018 Introgressed	GWAS	Cognitive ability	1	1.8282	0.546986107	0.842015798	nervous
Browning et al. 2018 Introgressed	GWAS	Urate levels in overweight individuals	2	3.3628	0.594742477	0.844615538	metabolic
Browning et al. 2018 Introgressed	GWAS	Familial squamous cell lung carcinoma	3	4.6537	0.644648344	0.844715528	respiratory
Browning et al. 2018 Introgressed	GWAS	BRCA1/2-negative high-risk breast cancer	1	1.8386	0.543892092	0.845115488	reproductive
Browning et al. 2018 Introgressed	GWAS	Male fertility	1	1.8799	0.531943188	0.846115388	reproductive
Browning et al. 2018 Introgressed	GWAS	Systolic blood pressure	19	23.3578	0.813432772	0.846615338	cardiovascular
Browning et al. 2018 Introgressed	GWAS	High density lipoprotein cholesterol levels	1	1.8968	0.527203712	0.846815318	metabolic
Browning et al. 2018 Introgressed	GWAS	Gut microbiota (functional units)	2	3.3302	0.600564531	0.847215278	digestive
Browning et al. 2018 Introgressed	GWAS	Platelet aggregation	1	1.883	0.531067446	0.848915108	hematologic
Browning et al. 2018 Introgressed	GWAS	Waist circumference adjusted for BMI in non-smokers	2	3.3276	0.601033778	0.848915108	skeletal
Browning et al. 2018 Introgressed	GWAS	Cerebrospinal fluid t-tau:AB1-42 ratio	1	1.9131	0.522711829	0.849715028	nervous
Browning et al. 2018 Introgressed	GWAS	Neuroticism	3	4.7289	0.634397006	0.850814919	behavior
Browning et al. 2018 Introgressed	GWAS	Adverse response to lamotrigine and phenytoin	1	1.9095	0.523697303	0.852114789	other
Browning et al. 2018 Introgressed	GWAS	Diastolic blood pressure	19	23.5978	0.805159803	0.854414559	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Depression in smokers	1	1.9434	0.514562108	0.856714329	behavior
Browning et al. 2018 Introgressed	GWAS	Erectile dysfunction	2	3.4024	0.587820362	0.856914309	reproductive
Browning et al. 2018 Introgressed	GWAS	Serum metabolite concentrations in chronic kidney disease	2	3.3997	0.588287202	0.857214279	urinary
Browning et al. 2018 Introgressed	GWAS	Alzheimer's disease	1	1.9079	0.524136485	0.857514249	nervous
Browning et al. 2018 Introgressed	GWAS	Cognitive ability (MTAG)	1	1.9409	0.515224896	0.857814219	nervous
Browning et al. 2018 Introgressed	GWAS	Serum uric acid levels	1	1.969	0.507872016	0.859314069	other
Browning et al. 2018 Introgressed	GWAS	Lead levels	1	1.9867	0.503347259	0.863113689	other
Browning et al. 2018 Introgressed	GWAS	Stroke	1	1.9734	0.506739637	0.864813519	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Eosinophil percentage of white cells	2	3.4895	0.573148015	0.865413459	immune
Browning et al. 2018 Introgressed	GWAS	Body mass index (joint analysis main effects and smoking interaction)	4	6.1799	0.647259664	0.865413459	metabolic
Browning et al. 2018 Introgressed	GWAS	Extremely high intelligence	1	1.9781	0.505535615	0.867213279	other
Browning et al. 2018 Introgressed	GWAS	Activated partial thromboplastin time	1	2.0233	0.49424208	0.867413259	hematologic
Browning et al. 2018 Introgressed	GWAS	Mean platelet volume	6	8.7572	0.685150505	0.867513249	hematologic
Browning et al. 2018 Introgressed	GWAS	BMI (adjusted for smoking behaviour)	4	6.2167	0.643428185	0.869213079	metabolic
Browning et al. 2018 Introgressed	GWAS	Hematocrit	2	3.5525	0.562983814	0.869313069	hematologic
Browning et al. 2018 Introgressed	GWAS	Metabolite levels	1	2.0394	0.490340296	0.870312969	metabolic
Browning et al. 2018 Introgressed	GWAS	Multiple keratinocyte cancers	2	3.569	0.560381059	0.870512949	integumentary
Browning et al. 2018 Introgressed	GWAS	Dimensional psychopathology (Positive)	1	2.0198	0.495098525	0.872412759	behavior
Browning et al. 2018 Introgressed	GWAS	Immature fraction of reticulocytes	1	2.082	0.480307397	0.873912609	hematologic
Browning et al. 2018 Introgressed	GWAS	Multiple sclerosis	7	10.0644	0.695520846	0.874012599	nervous
Browning et al. 2018 Introgressed	GWAS	Lung cancer in ever smokers	2	3.5334	0.566027056	0.874912509	respiratory
Browning et al. 2018 Introgressed	GWAS	Common carotid intima-media thickness in HIV infection	1	2.071	0.482858522	0.875912409	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Anorexia nervosa	2	3.5996	0.555617291	0.876012399	behavior
Browning et al. 2018 Introgressed	GWAS	Chronic back pain	1	2.0716	0.482718672	0.876112389	skeletal
Browning et al. 2018 Introgressed	GWAS	Glomerular filtration rate	2	3.6713	0.544766159	0.876812319	hematologic
Browning et al. 2018 Introgressed	GWAS	Mercury levels	1	2.1017	0.4758053	0.877412259	other
Browning et al. 2018 Introgressed	GWAS	Restless legs syndrome	1	2.1102	0.473888731	0.878812119	nervous
Browning et al. 2018 Introgressed	GWAS	Gait speed in old age	1	2.0822	0.480261262	0.879712029	other
Browning et al. 2018 Introgressed	GWAS	Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma	1	2.0849	0.479639311	0.879812019	other
Browning et al. 2018 Introgressed	GWAS	Gut microbiota (beta diversity)	2	3.6722	0.544632645	0.881711829	digestive
Browning et al. 2018 Introgressed	GWAS	Glucose homeostasis traits	3	5.0834	0.590156195	0.884311569	metabolic
Browning et al. 2018 Introgressed	GWAS	Chronic obstructive pulmonary disease	1	2.1834	0.458001282	0.885711429	respiratory
Browning et al. 2018 Introgressed	GWAS	Seasonality and depression	1	2.1277	0.46999107	0.885811419	behavior
Browning et al. 2018 Introgressed	GWAS	Uterine fibroid number (single vs multiple)	1	2.1851	0.457644959	0.886311369	reproductive
Browning et al. 2018 Introgressed	GWAS	Erosive tooth wear (severe vs non-severe)	1	2.1658	0.461723151	0.886811319	skeletal
Browning et al. 2018 Introgressed	GWAS	Visceral adipose tissue adjusted for BMI	1	2.1754	0.459685575	0.887111289	metabolic
Browning et al. 2018 Introgressed	GWAS	Hippocampal atrophy	1	2.1779	0.459157904	0.887611239	nervous
Browning et al. 2018 Introgressed	GWAS	Intracranial aneurysm	2	3.7362	0.535303249	0.888711129	nervous
Browning et al. 2018 Introgressed	GWAS	Endometrial cancer	1	2.191	0.456412597	0.888811119	reproductive
Browning et al. 2018 Introgressed	GWAS	QT interval	3	5.1577	0.581654613	0.889311069	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Hippocampal volume	1	2.2106	0.452365874	0.894010599	nervous
Browning et al. 2018 Introgressed	GWAS	Age-related macular degeneration	1	2.223	0.449842555	0.894910509	nervous
Browning et al. 2018 Introgressed	GWAS	Cognitive performance	2	3.8505	0.519413063	0.895410459	nervous
Browning et al. 2018 Introgressed	GWAS	Psoriasis	1	2.2707	0.44039283	0.897710229	integumentary
Browning et al. 2018 Introgressed	GWAS	Feeling hurt	1	2.2651	0.441481612	0.899110089	behavior
Browning et al. 2018 Introgressed	GWAS	Eating disorders	1	2.3324	0.428742926	0.901509849	behavior
Browning et al. 2018 Introgressed	GWAS	Blood pressure measurement (high sodium intervention)	2	3.9484	0.506534292	0.903009699	hematologic
Browning et al. 2018 Introgressed	GWAS	Post bronchodilator FEV1	5	8.0185	0.623558022	0.904109589	other
Browning et al. 2018 Introgressed	GWAS	Post bronchodilator FEV1 in COPD	1	2.3622	0.42333418	0.904209579	other
Browning et al. 2018 Introgressed	GWAS	Cognitive decline (age-related)	1	2.4057	0.415679428	0.905309469	nervous
Browning et al. 2018 Introgressed	GWAS	Sum eosinophil basophil counts	2	3.9443	0.507060822	0.906909309	hematologic
Browning et al. 2018 Introgressed	GWAS	Pulse pressure	13	17.9025	0.726155565	0.909009099	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)	2	3.9492	0.506431682	0.910108989	skeletal
Browning et al. 2018 Introgressed	GWAS	Diisocyanate-induced asthma	8	12.0005	0.66663889	0.910208979	respiratory
Browning et al. 2018 Introgressed	GWAS	Prudent dietary pattern	1	2.401	0.416493128	0.910508949	behavior
Browning et al. 2018 Introgressed	GWAS	Waist circumference adjusted for body mass index	3	5.5048	0.544978927	0.911708829	skeletal
Browning et al. 2018 Introgressed	GWAS	Brain connectivity	1	2.4026	0.416215766	0.912808719	nervous
Browning et al. 2018 Introgressed	GWAS	Spherical equivalent or myopia (age of diagnosis)	6	9.5877	0.625801809	0.913308669	nervous
Browning et al. 2018 Introgressed	GWAS	Migraine	2	4.0891	0.489105182	0.914708529	nervous
Browning et al. 2018 Introgressed	GWAS	Subcortical brain region volumes	1	2.4607	0.406388426	0.916208379	nervous
Browning et al. 2018 Introgressed	GWAS	Resting-state electroencephalogram vigilance	1	2.4232	0.412677451	0.917508249	nervous
Browning et al. 2018 Introgressed	GWAS	Longevity	4	6.9734	0.573608283	0.918508149	other
Browning et al. 2018 Introgressed	GWAS	Hypothyroidism	1	2.4873	0.402042375	0.918808119	endocrine
Browning et al. 2018 Introgressed	GWAS	Hip circumference	1	2.5066	0.39894678	0.919108089	skeletal
Browning et al. 2018 Introgressed	GWAS	Autism	1	2.509	0.398565165	0.919408059	behavior
Browning et al. 2018 Introgressed	GWAS	Uterine fibroids	2	4.1537	0.481498423	0.922107789	reproductive
Browning et al. 2018 Introgressed	GWAS	Sleep duration	1	2.5638	0.390046025	0.922607739	behavior
Browning et al. 2018 Introgressed	GWAS	Emphysema-related traits	2	4.2539	0.470156797	0.924607539	respiratory
Browning et al. 2018 Introgressed	GWAS	White blood cell count (basophil)	1	2.6335	0.379722802	0.926807319	immune
Browning et al. 2018 Introgressed	GWAS	Birth weight	1	2.6019	0.384334525	0.927107289	skeletal
Browning et al. 2018 Introgressed	GWAS	Alcohol dependence	2	4.2867	0.466559358	0.927207279	behavior
Browning et al. 2018 Introgressed	GWAS	Metabolite levels (Pyroglutamine)	1	2.6273	0.380618886	0.927707229	metabolic
Browning et al. 2018 Introgressed	GWAS	Alzheimer's disease in APOE e4- carriers	1	2.6278	0.380546465	0.928507149	nervous
Browning et al. 2018 Introgressed	GWAS	Creatinine levels	1	2.6683	0.374770453	0.928607139	other
Browning et al. 2018 Introgressed	GWAS	Response to methotrexate in juvenile idiopathic arthritis	3	5.8882	0.509493563	0.930106989	other
Browning et al. 2018 Introgressed	GWAS	JT interval (sulfonylurea treatment interaction)	1	2.6036	0.384083577	0.930306969	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Celiac disease	1	2.6634	0.375459938	0.931806819	digestive
Browning et al. 2018 Introgressed	GWAS	Visceral fat	1	2.722	0.367376929	0.932106789	metabolic
Browning et al. 2018 Introgressed	GWAS	Feeling fed-up	1	2.7404	0.364910232	0.932306769	behavior
Browning et al. 2018 Introgressed	GWAS	Body mass index	29	37.3955	0.775494378	0.933806619	metabolic
Browning et al. 2018 Introgressed	GWAS	Waist circumference adjusted for BMI (adjusted for smoking behaviour)	2	4.3276	0.462149921	0.934206579	skeletal
Browning et al. 2018 Introgressed	GWAS	Macular thickness	3	5.9368	0.505322733	0.934406559	nervous
Browning et al. 2018 Introgressed	GWAS	Endometriosis	2	4.4367	0.450785494	0.938906109	reproductive
Browning et al. 2018 Introgressed	GWAS	Immune response to smallpox vaccine (IL-6)	3	6.0512	0.495769434	0.940505949	immune
Browning et al. 2018 Introgressed	GWAS	Lymphocyte percentage of white cells	1	2.9274	0.341600055	0.941505849	lymphatic
Browning et al. 2018 Introgressed	GWAS	Disease progression in age-related macular degeneration	2	4.6641	0.428807273	0.942905709	nervous
Browning et al. 2018 Introgressed	GWAS	Ischemic stroke	1	2.89	0.346020761	0.946105389	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Response to fenofibrate (total cholesterol levels)	1	2.9335	0.340889722	0.946405359	other
Browning et al. 2018 Introgressed	GWAS	Mild influenza (H1N1) infection	2	4.7273	0.423074482	0.947705229	immune
Browning et al. 2018 Introgressed	GWAS	Urate levels in obese individuals	1	3.0022	0.333089068	0.948005199	metabolic
Browning et al. 2018 Introgressed	GWAS	Lung function (FVC)	2	4.7488	0.42115903	0.95150485	respiratory
Browning et al. 2018 Introgressed	GWAS	Bortezomib-induced peripheral neuropathy in multiple myeloma	1	3.0137	0.331818031	0.95290471	nervous
Browning et al. 2018 Introgressed	GWAS	Bipolar disorder	3	6.4481	0.46525333	0.95310469	behavior
Browning et al. 2018 Introgressed	GWAS	Bronchopulmonary dysplasia	2	4.9717	0.402276887	0.95760424	respiratory
Browning et al. 2018 Introgressed	GWAS	Atrial fibrillation	6	10.9407	0.548410979	0.96080392	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Post-traumatic stress disorder	2	5.0123	0.399018415	0.96120388	behavior
Browning et al. 2018 Introgressed	GWAS	Anti-saccade response	2	5.0764	0.393979986	0.96190381	nervous
Browning et al. 2018 Introgressed	GWAS	Subcutaneous adipose tissue	1	3.3024	0.302810078	0.96240376	metabolic
Browning et al. 2018 Introgressed	GWAS	Epstein-Barr virus copy number in lymphoblastoid cell lines	5	9.7196	0.514424462	0.96320368	immune
Browning et al. 2018 Introgressed	GWAS	"Type 2 diabetes (SNP x SNP interaction, 2df)"	2	5.2097	0.383899265	0.96460354	metabolic
Browning et al. 2018 Introgressed	GWAS	Chronic bronchitis and chronic obstructive pulmonary disease	1	3.4378	0.290883705	0.96560344	respiratory
Browning et al. 2018 Introgressed	GWAS	Logical memory (delayed recall) in normal cognition	1	3.3426	0.299168312	0.96610339	nervous
Browning et al. 2018 Introgressed	GWAS	Triptolide cytotoxicity	1	3.448	0.290023202	0.96640336	other
Browning et al. 2018 Introgressed	GWAS	Body mass index in physically active individuals	2	5.2515	0.380843569	0.96720328	metabolic
Browning et al. 2018 Introgressed	GWAS	Iris color (b* coordinate)	1	3.4779	0.287529831	0.96730327	integumentary
Browning et al. 2018 Introgressed	GWAS	Response to bupropion in depression	1	3.4978	0.285893991	0.96730327	other
Browning et al. 2018 Introgressed	GWAS	Mean corpuscular hemoglobin	2	5.2447	0.38133735	0.96730327	hematologic
Browning et al. 2018 Introgressed	GWAS	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	1	3.496	0.28604119	0.96810319	other
Browning et al. 2018 Introgressed	GWAS	Intelligence	1	3.4593	0.289075825	0.96920308	other
Browning et al. 2018 Introgressed	GWAS	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	1	3.5195	0.284131269	0.97050295	other
Browning et al. 2018 Introgressed	GWAS	Percentage gas trapping	2	5.3795	0.371781764	0.97060294	metabolic
Browning et al. 2018 Introgressed	GWAS	Aggressiveness in attention deficit hyperactivity disorder	1	3.5762	0.279626419	0.97080292	behavior
Browning et al. 2018 Introgressed	GWAS	Adiponectin levels	1	3.5449	0.282095405	0.9720028	other
Browning et al. 2018 Introgressed	GWAS	Blood pressure	2	5.5032	0.363424916	0.97230277	hematologic
Browning et al. 2018 Introgressed	GWAS	Schizophrenia	25	35.5147	0.703933864	0.97250275	behavior
Browning et al. 2018 Introgressed	GWAS	HDL cholesterol	4	8.6787	0.460898522	0.97280272	metabolic
Browning et al. 2018 Introgressed	GWAS	Insulin resistance/response	1	3.6553	0.273575356	0.97320268	immune
Browning et al. 2018 Introgressed	GWAS	Osteoarthritis biomarkers	1	3.6456	0.27430327	0.97320268	skeletal
Browning et al. 2018 Introgressed	GWAS	Loneliness	3	7.2068	0.416273519	0.97330267	behavior
Browning et al. 2018 Introgressed	GWAS	Depression (quantitative trait)	1	3.624	0.27593819	0.97330267	behavior
Browning et al. 2018 Introgressed	GWAS	Periodontitis (Mean PAL)	1	3.6299	0.275489683	0.97350265	immune
Browning et al. 2018 Introgressed	GWAS	Body mass index (joint analysis main effects and physical activity interaction)	2	5.5556	0.35999712	0.97410259	metabolic
Browning et al. 2018 Introgressed	GWAS	Eosinophil percentage of granulocytes	1	3.7028	0.270065896	0.97530247	immune
Browning et al. 2018 Introgressed	GWAS	QRS duration	1	3.718	0.268961807	0.97550245	cardiovascular
Browning et al. 2018 Introgressed	GWAS	"Type 2 diabetes (SNP x SNP interaction, 1df)"	1	3.7586	0.26605651	0.97550245	metabolic
Browning et al. 2018 Introgressed	GWAS	Influenza A (H1N1) infection	1	3.6719	0.272338571	0.97680232	immune
Browning et al. 2018 Introgressed	GWAS	Menarche (age at onset)	8	14.4535	0.553499152	0.97740226	reproductive
Browning et al. 2018 Introgressed	GWAS	Neuritic plaque	1	3.8666	0.258625149	0.97770223	nervous
Browning et al. 2018 Introgressed	GWAS	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	1	3.8611	0.258993551	0.97790221	other
Browning et al. 2018 Introgressed	GWAS	Eating disorders (purging via substances)	1	3.8501	0.259733513	0.97940206	behavior
Browning et al. 2018 Introgressed	GWAS	Gastroesophageal reflux disease	1	3.9329	0.2542653	0.97970203	digestive
Browning et al. 2018 Introgressed	GWAS	Platelet distribution width	2	5.9277	0.337398991	0.98020198	hematologic
Browning et al. 2018 Introgressed	GWAS	QRS interval (sulfonylurea treatment interaction)	1	4.0176	0.248904819	0.98040196	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Emphysema imaging phenotypes	2	5.7547	0.347542009	0.98050195	respiratory
Browning et al. 2018 Introgressed	GWAS	Mosquito bite size	3	7.6438	0.392474947	0.98080192	other
Browning et al. 2018 Introgressed	GWAS	Cognitive function	1	3.9675	0.252047889	0.98230177	nervous
Browning et al. 2018 Introgressed	GWAS	Severe malaria (adjusted for sickle cell variant rs334)	1	4.1451	0.241248703	0.98250175	immune
Browning et al. 2018 Introgressed	GWAS	Alzheimer's disease (cognitive decline)	3	7.8193	0.383666057	0.98250175	nervous
Browning et al. 2018 Introgressed	GWAS	"Schizophrenia, schizoaffective disorder or bipolar disorder"	1	4.1367	0.241738584	0.98290171	behavior
Browning et al. 2018 Introgressed	GWAS	Severe malaria	1	4.168	0.239923225	0.9830017	immune
Browning et al. 2018 Introgressed	GWAS	Dementia and core Alzheimer's disease neuropathologic changes	1	4.1879	0.238783161	0.98370163	nervous
Browning et al. 2018 Introgressed	GWAS	Myopia	2	6.1248	0.326541275	0.98380162	nervous
Browning et al. 2018 Introgressed	GWAS	Dental caries	1	4.1482	0.241068415	0.98450155	skeletal
Browning et al. 2018 Introgressed	GWAS	Cannabis dependence symptom count	1	4.3398	0.230425365	0.98450155	behavior
Browning et al. 2018 Introgressed	GWAS	Airway responsiveness in chronic obstructive pulmonary disease	1	4.2573	0.234890658	0.98450155	respiratory
Browning et al. 2018 Introgressed	GWAS	Monoclonal gammopathy of undetermined significance	4	9.515	0.42038886	0.98460154	hematologic
Browning et al. 2018 Introgressed	GWAS	Pursuit maintenance gain	3	7.8916	0.380151047	0.98460154	skeletal muscle
Browning et al. 2018 Introgressed	GWAS	"Autism spectrum disorder, ADHD, bipolar disorder, MDD, and schizophrenia (combined)"	3	7.8543	0.381956381	0.98480152	behavior
Browning et al. 2018 Introgressed	GWAS	Major depressive disorder	4	9.5317	0.419652318	0.98530147	behavior
Browning et al. 2018 Introgressed	GWAS	Toenail selenium levels	1	4.1475	0.241109102	0.98570143	other
Browning et al. 2018 Introgressed	GWAS	Systolic blood pressure in sickle cell anemia	1	4.3924	0.227665968	0.98720128	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes	1	4.3058	0.232244879	0.98770123	cardiovascular
Browning et al. 2018 Introgressed	GWAS	Neurocognitive impairment in HIV-1 infection (dichotomous)	1	4.5755	0.218555349	0.98830117	nervous
Browning et al. 2018 Introgressed	GWAS	Attention deficit hyperactivity disorder	3	8.0738	0.371572246	0.99010099	behavior
Browning et al. 2018 Introgressed	GWAS	Cerebrospinal fluid clusterin levels	1	4.6282	0.216066721	0.9910009	nervous
Browning et al. 2018 Introgressed	GWAS	Periodontitis (CDC/AAP)	1	4.8597	0.205774019	0.99240076	immune
Browning et al. 2018 Introgressed	GWAS	Blood pressure (smoking interaction)	1	5.0969	0.196197689	0.99270073	hematologic
Browning et al. 2018 Introgressed	GWAS	General cognitive ability	4	10.2343	0.390842559	0.9930007	nervous
Browning et al. 2018 Introgressed	GWAS	Inflammatory skin disease	3	8.7355	0.343426249	0.99330067	integumentary
Browning et al. 2018 Introgressed	GWAS	Pulmonary function decline	1	5.2366	0.190963602	0.99550045	respiratory
Browning et al. 2018 Introgressed	GWAS	Amyotrophic lateral sclerosis (sporadic)	6	14.8005	0.40539171	0.99650035	nervous
Browning et al. 2018 Introgressed	GWAS	Heel bone mineral density	16	29.3317	0.545484919	0.99670033	skeletal
Browning et al. 2018 Introgressed	GWAS	Waist-hip ratio	2	8.1616	0.24504999	0.99770023	skeletal
Browning et al. 2018 Introgressed	GWAS	Nasopharyngeal carcinoma (SNP x SNP interaction)	1	6.4259	0.155620224	0.99790021	other
Browning et al. 2018 Introgressed	GWAS	Neurociticism	1	6.5643	0.152339168	0.99880012	behavior
Browning et al. 2018 Introgressed	GWAS	Photic sneeze reflex	1	6.8705	0.145549814	0.9990001	nervous
Browning et al. 2018 Introgressed	GWAS	Obesity-related traits	24	43.1487	0.556216062	0.99910009	metabolic
Browning et al. 2018 Introgressed	GWAS	Night sleep phenotypes	7	22.1867	0.315504334	0.99970003	behavior
Browning et al. 2018 Introgressed	GWAS	Hand grip strength	1	8.9889	0.111248317	0.99990001	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Abnormality of the hip-girdle musculature (HP:0001445)	3	0.2656	11.29518072	0.00229977	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Abnormality of the musculature of the pelvis (HP:0001469)	3	0.2656	11.29518072	0.00229977	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Pelvic girdle muscle weakness (HP:0003749)	3	0.2656	11.29518072	0.00229977	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Shoulder girdle muscle weakness (HP:0003547)	3	0.2656	11.29518072	0.00229977	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Neurodegeneration (HP:0002180)	2	0.0769	26.00780234	0.00319968	nervous
Browning et al. 2018 Introgressed	HPO	Glossoptosis (HP:0000162)	2	0.0977	20.47082907	0.00439956	other
Browning et al. 2018 Introgressed	HPO	Increased serum lactate (HP:0002151)	4	0.6897	5.799623025	0.00509949	other
Browning et al. 2018 Introgressed	HPO	Aplasia/Hypoplasia of the lens (HP:0008063)	2	0.1648	12.13592233	0.01149885	nervous
Browning et al. 2018 Introgressed	HPO	Rimmed vacuoles (HP:0003805)	3	0.4446	6.747638327	0.01309869	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Pallor (HP:0000980)	4	0.9257	4.321054337	0.01409859	integumentary
Browning et al. 2018 Introgressed	HPO	Abnormality of reticulocytes (HP:0004312)	4	0.9804	4.07996736	0.01629837	immune
Browning et al. 2018 Introgressed	HPO	Limb-girdle muscle weakness (HP:0003325)	3	0.5365	5.591798695	0.01739826	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Abnormal trabecular bone morphology (HP:0100671)	2	0.2118	9.442870633	0.01829817	skeletal
Browning et al. 2018 Introgressed	HPO	Trismus (HP:0000211)	2	0.2327	8.594757198	0.02079792	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Tracheoesophageal fistula (HP:0002575)	4	1.031	3.879728419	0.02119788	respiratory
Browning et al. 2018 Introgressed	HPO	Hepatosplenomegaly (HP:0001433)	2	0.2353	8.499787505	0.02309769	digestive
Browning et al. 2018 Introgressed	HPO	Biconcave vertebral bodies (HP:0004586)	1	0.0247	40.48582996	0.02439756	skeletal
Browning et al. 2018 Introgressed	HPO	Fasciculations (HP:0002380)	2	0.2451	8.159934721	0.02449755	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Decreased number of large peripheral myelinated nerve fibers (HP:0003387)	2	0.2515	7.952286282	0.0269973	nervous
Browning et al. 2018 Introgressed	HPO	Recurrent fungal infections (HP:0002841)	2	0.2595	7.707129094	0.02749725	immune
Browning et al. 2018 Introgressed	HPO	Dementia (HP:0000726)	5	1.6667	2.999940001	0.02759724	nervous
Browning et al. 2018 Introgressed	HPO	Spinal rigidity (HP:0003306)	3	0.6556	4.575960952	0.02789721	skeletal
Browning et al. 2018 Introgressed	HPO	Developmental regression (HP:0002376)	5	1.6927	2.953860696	0.02859714	behavior
Browning et al. 2018 Introgressed	HPO	Full cheeks (HP:0000293)	3	0.649	4.622496148	0.02879712	other
Browning et al. 2018 Introgressed	HPO	Astigmatism (HP:0000483)	4	1.1436	3.497726478	0.02959704	nervous
Browning et al. 2018 Introgressed	HPO	Respiratory distress (HP:0002098)	2	0.2661	7.515971439	0.02969703	respiratory
Browning et al. 2018 Introgressed	HPO	Wide nose (HP:0000445)	3	0.6961	4.309725614	0.03029697	skeletal
Browning et al. 2018 Introgressed	HPO	Breast hypoplasia (HP:0003187)	2	0.2675	7.476635514	0.03159684	reproductive
Browning et al. 2018 Introgressed	HPO	Recurrent viral infections (HP:0004429)	2	0.2753	7.264802034	0.03189681	immune
Browning et al. 2018 Introgressed	HPO	Heterogeneous (HP:0001425)	6	2.3634	2.53871541	0.03269673	other
Browning et al. 2018 Introgressed	HPO	Oligohydramnios (HP:0001562)	4	1.1927	3.353735223	0.03419658	reproductive
Browning et al. 2018 Introgressed	HPO	Prominent nasal bridge (HP:0000426)	5	1.7656	2.831898505	0.03609639	integumentary
Browning et al. 2018 Introgressed	HPO	Hepatitis (HP:0012115)	2	0.303	6.600660066	0.03729627	immune
Browning et al. 2018 Introgressed	HPO	Aplasia/Hypoplasia involving the pelvis (HP:0009103)	3	0.7461	4.020908725	0.03879612	skeletal
Browning et al. 2018 Introgressed	HPO	Panhypogammaglobulinemia (HP:0003139)	1	0.0397	25.18891688	0.03929607	immune
Browning et al. 2018 Introgressed	HPO	Respiratory insufficiency due to muscle weakness (HP:0002747)	5	1.8769	2.66396718	0.03939606	respiratory
Browning et al. 2018 Introgressed	HPO	Tubulointerstitial abnormality (HP:0001969)	2	0.3298	6.064281383	0.04359564	urinary
Browning et al. 2018 Introgressed	HPO	Pulmonary hypoplasia (HP:0002089)	4	1.3311	3.005033431	0.04509549	respiratory
Browning et al. 2018 Introgressed	HPO	Abnormality of the shoulder girdle musculature (HP:0001435)	3	0.7703	3.894586525	0.04509549	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Emphysema (HP:0002097)	2	0.341	5.865102639	0.04609539	respiratory
Browning et al. 2018 Introgressed	HPO	Loss of speech (HP:0002371)	1	0.0471	21.23142251	0.04629537	other
Browning et al. 2018 Introgressed	HPO	Difficulty climbing stairs (HP:0003551)	2	0.3459	5.782017924	0.04939506	other
Browning et al. 2018 Introgressed	HPO	Recurrent lower respiratory tract infections (HP:0002783)	3	0.8386	3.57739089	0.051094891	immune
Browning et al. 2018 Introgressed	HPO	Aplasia/Hypoplasia of the fovea (HP:0008060)	1	0.0541	18.48428835	0.052394761	nervous
Browning et al. 2018 Introgressed	HPO	Hypoplasia of the fovea (HP:0007750)	1	0.0541	18.48428835	0.052394761	nervous
Browning et al. 2018 Introgressed	HPO	Cellular immunodeficiency (HP:0005374)	2	0.3678	5.437737901	0.053494651	immune
Browning et al. 2018 Introgressed	HPO	Sloping forehead (HP:0000340)	5	2.0368	2.454831108	0.053594641	skeletal
Browning et al. 2018 Introgressed	HPO	Onion bulb formation (HP:0003383)	3	0.8726	3.438001375	0.053794621	nervous
Browning et al. 2018 Introgressed	HPO	Ventricular arrhythmia (HP:0004308)	4	1.3984	2.860411899	0.053894611	cardiovascular
Browning et al. 2018 Introgressed	HPO	Poikilocytosis (HP:0004447)	2	0.3891	5.140066821	0.054594541	hematologic
Browning et al. 2018 Introgressed	HPO	Narrow mouth (HP:0000160)	7	3.377	2.072845721	0.056794321	skeletal
Browning et al. 2018 Introgressed	HPO	Lumbar hyperlordosis (HP:0002938)	3	0.8433	3.557452864	0.056994301	skeletal
Browning et al. 2018 Introgressed	HPO	Absent epiphyses (HP:0010577)	1	0.0592	16.89189189	0.057494251	skeletal
Browning et al. 2018 Introgressed	HPO	Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003)	1	0.0592	16.89189189	0.057494251	skeletal
Browning et al. 2018 Introgressed	HPO	Aplasia/Hypoplasia affecting the retina (HP:0008061)	1	0.0603	16.58374793	0.058594141	nervous
Browning et al. 2018 Introgressed	HPO	Aplasia/Hypoplasia of the macula (HP:0008059)	1	0.0603	16.58374793	0.058594141	nervous
Browning et al. 2018 Introgressed	HPO	Limb-girdle muscle atrophy (HP:0003797)	1	0.0597	16.75041876	0.058594141	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Choanal atresia (HP:0000453)	4	1.461	2.737850787	0.059094091	respiratory
Browning et al. 2018 Introgressed	HPO	Recurrent urinary tract infections (HP:0000010)	5	2.087	2.395783421	0.060893911	immune
Browning et al. 2018 Introgressed	HPO	Vertebral clefting (HP:0008428)	2	0.3925	5.095541401	0.060893911	skeletal
Browning et al. 2018 Introgressed	HPO	Aortic valve stenosis (HP:0001650)	2	0.3978	5.027652086	0.062293771	cardiovascular
Browning et al. 2018 Introgressed	HPO	Aganglionic megacolon (HP:0002251)	4	1.4726	2.716284123	0.062393761	digestive
Browning et al. 2018 Introgressed	HPO	Tongue fasciculations (HP:0001308)	1	0.0641	15.60062402	0.062693731	nervous
Browning et al. 2018 Introgressed	HPO	High pitched voice (HP:0001620)	2	0.4123	4.850836769	0.063493651	other
Browning et al. 2018 Introgressed	HPO	Coxa valga (HP:0002673)	2	0.4109	4.867364322	0.064093591	skeletal
Browning et al. 2018 Introgressed	HPO	Bilateral microphthalmos (HP:0007633)	2	0.4185	4.778972521	0.064293571	nervous
Browning et al. 2018 Introgressed	HPO	Waddling gait (HP:0002515)	3	0.8849	3.390213583	0.065093491	other
Browning et al. 2018 Introgressed	HPO	Hypopigmented skin patches (HP:0001053)	4	1.4967	2.672546268	0.065193481	integumentary
Browning et al. 2018 Introgressed	HPO	Deformed tarsal bones (HP:0008119)	1	0.0674	14.83679525	0.065593441	skeletal
Browning et al. 2018 Introgressed	HPO	Calcaneovalgus deformity (HP:0001848)	1	0.0674	14.83679525	0.065593441	skeletal
Browning et al. 2018 Introgressed	HPO	Round ear (HP:0100830)	1	0.0674	14.83679525	0.065593441	other
Browning et al. 2018 Introgressed	HPO	Stage 5 chronic kidney disease (HP:0003774)	2	0.4249	4.70698988	0.066693331	urinary
Browning et al. 2018 Introgressed	HPO	Tubulointerstitial nephritis (HP:0001970)	1	0.0699	14.30615165	0.067493251	urinary
Browning et al. 2018 Introgressed	HPO	Multiple enchondromatosis (HP:0005701)	1	0.0703	14.22475107	0.068393161	skeletal
Browning et al. 2018 Introgressed	HPO	Hirsutism (HP:0001007)	4	1.5264	2.620545073	0.070692931	integumentary
Browning et al. 2018 Introgressed	HPO	Personality changes (HP:0000751)	2	0.4409	4.536176004	0.071292871	behavior
Browning et al. 2018 Introgressed	HPO	Hypoplastic pelvis (HP:0008839)	1	0.0747	13.38688086	0.071792821	skeletal
Browning et al. 2018 Introgressed	HPO	Elevated alkaline phosphatase (HP:0003155)	2	0.4535	4.41014333	0.073392661	other
Browning et al. 2018 Introgressed	HPO	Gait imbalance (HP:0002141)	1	0.0761	13.14060447	0.073792621	nervous
Browning et al. 2018 Introgressed	HPO	Pulmonary hypertension (HP:0002092)	2	0.4518	4.426737494	0.074892511	cardiovascular
Browning et al. 2018 Introgressed	HPO	Abnormality of alkaline phosphatase activity (HP:0004379)	2	0.4605	4.34310532	0.075192481	other
Browning et al. 2018 Introgressed	HPO	Abnormal enzyme/coenzyme activity (HP:0012379)	2	0.4605	4.34310532	0.075192481	other
Browning et al. 2018 Introgressed	HPO	Abnormality of the femoral head (HP:0003368)	2	0.4534	4.411116012	0.075892411	skeletal
Browning et al. 2018 Introgressed	HPO	Upper limb amyotrophy (HP:0009129)	1	0.08	12.5	0.076892311	nervous
Browning et al. 2018 Introgressed	HPO	Distal upper limb amyotrophy (HP:0007149)	1	0.08	12.5	0.076892311	nervous
Browning et al. 2018 Introgressed	HPO	Congenital primary aphakia (HP:0007707)	1	0.0804	12.43781095	0.077692231	nervous
Browning et al. 2018 Introgressed	HPO	Axonal loss (HP:0003447)	1	0.0823	12.15066829	0.079292071	nervous
Browning et al. 2018 Introgressed	HPO	Cleft eyelid (HP:0000625)	2	0.4756	4.205214466	0.079692031	integumentary
Browning et al. 2018 Introgressed	HPO	Skull defect (HP:0001362)	2	0.4796	4.170141785	0.080591941	skeletal
Browning et al. 2018 Introgressed	HPO	Abnormality of the renal collecting system (HP:0004742)	2	0.4763	4.199034222	0.081791821	urinary
Browning et al. 2018 Introgressed	HPO	Chromosomal breakage induced by crosslinking agents (HP:0003221)	2	0.4763	4.199034222	0.081791821	other
Browning et al. 2018 Introgressed	HPO	Duplicated collecting system (HP:0000081)	2	0.4763	4.199034222	0.081791821	urinary
Browning et al. 2018 Introgressed	HPO	Chromsome breakage (HP:0040012)	2	0.4763	4.199034222	0.081791821	other
Browning et al. 2018 Introgressed	HPO	Renal cortical cysts (HP:0000803)	1	0.0841	11.89060642	0.082091791	urinary
Browning et al. 2018 Introgressed	HPO	Birth length less than 3rd percentile (HP:0003561)	1	0.0862	11.60092807	0.082391761	skeletal
Browning et al. 2018 Introgressed	HPO	Vaginal atresia (HP:0000148)	2	0.4884	4.095004095	0.083991601	reproductive
Browning et al. 2018 Introgressed	HPO	Abnormality of DNA repair (HP:0003254)	2	0.4832	4.139072848	0.084091591	other
Browning et al. 2018 Introgressed	HPO	Reticulocytopenia (HP:0001896)	2	0.4905	4.077471967	0.084991501	hematologic
Browning et al. 2018 Introgressed	HPO	Reticulocytosis (HP:0001923)	2	0.4899	4.082465809	0.088191181	hematologic
Browning et al. 2018 Introgressed	HPO	Abnormality of the vocal cords (HP:0008777)	1	0.0929	10.76426265	0.089091091	other
Browning et al. 2018 Introgressed	HPO	Agammaglobulinemia (HP:0004432)	1	0.0994	10.06036217	0.093490651	immune
Browning et al. 2018 Introgressed	HPO	Bone marrow hypocellularity (HP:0005528)	3	1.0787	2.781125429	0.093490651	other
Browning et al. 2018 Introgressed	HPO	Chronic mucocutaneous candidiasis (HP:0002728)	1	0.0998	10.02004008	0.094590541	immune
Browning et al. 2018 Introgressed	HPO	Recurrent cutaneous fungal infections (HP:0011370)	1	0.0998	10.02004008	0.094590541	immune
Browning et al. 2018 Introgressed	HPO	Abnormality of pyrimidine metabolism (HP:0004353)	3	1.0795	2.779064382	0.095890411	metabolic
Browning et al. 2018 Introgressed	HPO	Dysostosis multiplex (HP:0000943)	1	0.1009	9.910802775	0.096490351	skeletal
Browning et al. 2018 Introgressed	HPO	Horseshoe kidney (HP:0000085)	3	1.0954	2.73872558	0.097090291	urinary
Browning et al. 2018 Introgressed	HPO	Tracheal stenosis (HP:0002777)	2	0.5219	3.832151753	0.097390261	respiratory
Browning et al. 2018 Introgressed	HPO	Female pseudohermaphroditism (HP:0010458)	4	1.7417	2.296606764	0.098190181	reproductive
Browning et al. 2018 Introgressed	HPO	Abnormality of femoral epiphyses (HP:0006499)	2	0.5298	3.775009438	0.098290171	skeletal
Browning et al. 2018 Introgressed	HPO	Abnormality involving the epiphyses of the lower limbs (HP:0006500)	2	0.5298	3.775009438	0.098290171	skeletal
Browning et al. 2018 Introgressed	HPO	External ear malformation (HP:0008572)	4	1.7365	2.30348402	0.098790121	other
Browning et al. 2018 Introgressed	HPO	Genital tract atresia (HP:0001827)	2	0.5362	3.729951511	0.098790121	reproductive
Browning et al. 2018 Introgressed	HPO	Ureteral duplication (HP:0000073)	2	0.5363	3.729256013	0.100589941	urinary
Browning et al. 2018 Introgressed	HPO	Upper limb muscle weakness (HP:0003484)	1	0.1043	9.587727709	0.100589941	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Pancytopenia (HP:0001876)	3	1.1429	2.624901566	0.100789921	hematologic
Browning et al. 2018 Introgressed	HPO	Impaired proprioception (HP:0010831)	1	0.1059	9.442870633	0.100889911	nervous
Browning et al. 2018 Introgressed	HPO	Polygenic inheritance (HP:0010982)	1	0.1088	9.191176471	0.102489751	other
Browning et al. 2018 Introgressed	HPO	Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108)	2	0.5517	3.625158601	0.102589741	skeletal
Browning et al. 2018 Introgressed	HPO	Joint stiffness (HP:0001387)	1	0.1083	9.233610342	0.102589741	skeletal
Browning et al. 2018 Introgressed	HPO	Hypomagnesemia (HP:0002917)	1	0.1084	9.225092251	0.103389661	other
Browning et al. 2018 Introgressed	HPO	Aortic regurgitation (HP:0001659)	1	0.1091	9.165902841	0.104489551	cardiovascular
Browning et al. 2018 Introgressed	HPO	Abnormal auditory evoked potentials (HP:0006958)	1	0.1106	9.04159132	0.105489451	nervous
Browning et al. 2018 Introgressed	HPO	Pes cavus (HP:0001761)	5	2.5	2	0.105589441	skeletal
Browning et al. 2018 Introgressed	HPO	Cerebral palsy (HP:0100021)	1	0.1108	9.025270758	0.105689431	nervous
Browning et al. 2018 Introgressed	HPO	Abnormality of magnesium homeostasis (HP:0004921)	1	0.1124	8.896797153	0.107089291	other
Browning et al. 2018 Introgressed	HPO	Scapular winging (HP:0003691)	2	0.5515	3.626473255	0.107489251	skeletal
Browning et al. 2018 Introgressed	HPO	Protrusio acetabuli (HP:0003179)	1	0.1142	8.756567426	0.108289171	skeletal
Browning et al. 2018 Introgressed	HPO	Increased CSF protein (HP:0002922)	1	0.1156	8.650519031	0.108389161	other
Browning et al. 2018 Introgressed	HPO	Wrist flexion contracture (HP:0001239)	1	0.1164	8.591065292	0.110388961	skeletal
Browning et al. 2018 Introgressed	HPO	Anonychia (HP:0001798)	3	1.1698	2.564540947	0.111188881	integumentary
Browning et al. 2018 Introgressed	HPO	Recurrent pneumonia (HP:0006532)	2	0.5759	3.472825143	0.112288771	immune
Browning et al. 2018 Introgressed	HPO	Abnormality of the preputium (HP:0100587)	2	0.5831	3.429943406	0.112788721	reproductive
Browning et al. 2018 Introgressed	HPO	Meckel diverticulum (HP:0002245)	2	0.5826	3.432887058	0.113788621	digestive
Browning et al. 2018 Introgressed	HPO	Distal sensory impairment (HP:0002936)	3	1.1869	2.527592889	0.114388561	nervous
Browning et al. 2018 Introgressed	HPO	Aplasia/Hypoplasia of the breasts (HP:0010311)	2	0.5778	3.461405331	0.115888411	reproductive
Browning et al. 2018 Introgressed	HPO	Vertebral compression fractures (HP:0002953)	1	0.1213	8.244023083	0.115988401	skeletal
Browning et al. 2018 Introgressed	HPO	Abnormality of chromosome stability (HP:0003220)	2	0.5953	3.359650596	0.116688331	other
Browning et al. 2018 Introgressed	HPO	Rough bone trabeculation (HP:0100670)	1	0.1245	8.032128514	0.117188281	skeletal
Browning et al. 2018 Introgressed	HPO	Abnormal delayed hypersensitivity skin test (HP:0002963)	1	0.1249	8.006405124	0.117188281	integumentary
Browning et al. 2018 Introgressed	HPO	Microtia (HP:0008551)	2	0.5989	3.339455669	0.117388261	nervous
Browning et al. 2018 Introgressed	HPO	Atresia of the external auditory canal (HP:0000413)	3	1.2046	2.490453262	0.119188081	nervous
Browning et al. 2018 Introgressed	HPO	J-shaped sella turcica (HP:0002680)	1	0.1281	7.806401249	0.120287971	skeletal
Browning et al. 2018 Introgressed	HPO	Clumsiness (HP:0002312)	1	0.1278	7.824726135	0.120687931	behavior
Browning et al. 2018 Introgressed	HPO	Multifactorial inheritance (HP:0001426)	1	0.1286	7.776049767	0.120787921	other
Browning et al. 2018 Introgressed	HPO	Abnormality of T cells (HP:0002843)	2	0.5986	3.341129302	0.122887711	immune
Browning et al. 2018 Introgressed	HPO	Neutropenia (HP:0001875)	3	1.2291	2.440810349	0.124587541	immune
Browning et al. 2018 Introgressed	HPO	Distal lower limb amyotrophy (HP:0008944)	1	0.1343	7.446016381	0.125287471	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Nephrogenic diabetes insipidus (HP:0009806)	1	0.1356	7.374631268	0.127487251	urinary
Browning et al. 2018 Introgressed	HPO	Wormian bones (HP:0002645)	2	0.6125	3.265306122	0.128587141	skeletal
Browning et al. 2018 Introgressed	HPO	Abnormality of the fovea (HP:0000493)	1	0.1401	7.137758744	0.130686931	nervous
Browning et al. 2018 Introgressed	HPO	Dilatation of the ascending aorta (HP:0005111)	2	0.6286	3.18167356	0.131586841	cardiovascular
Browning et al. 2018 Introgressed	HPO	Abnormality of the carotid arteries (HP:0005344)	2	0.638	3.134796238	0.131986801	cardiovascular
Browning et al. 2018 Introgressed	HPO	Viral hepatitis (HP:0006562)	1	0.1419	7.04721635	0.132086791	immune
Browning et al. 2018 Introgressed	HPO	Decreased testicular size (HP:0008734)	2	0.6293	3.178134435	0.132186781	reproductive
Browning et al. 2018 Introgressed	HPO	Progressive muscle weakness (HP:0003323)	1	0.1421	7.037297678	0.132286771	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Tetraparesis (HP:0002273)	1	0.1415	7.067137809	0.132586741	nervous
Browning et al. 2018 Introgressed	HPO	Ectopic kidney (HP:0000086)	3	1.2731	2.356452753	0.132786721	urinary
Browning et al. 2018 Introgressed	HPO	Generalized muscle weakness (HP:0003324)	2	0.6444	3.103662322	0.134686531	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Abnormality of the lacrimal duct (HP:0011481)	2	0.6397	3.126465531	0.135286471	other
Browning et al. 2018 Introgressed	HPO	Abnormality of the nasolacrimal system (HP:0000614)	2	0.6397	3.126465531	0.135286471	other
Browning et al. 2018 Introgressed	HPO	Short thumb (HP:0009778)	2	0.6452	3.099814011	0.135586441	skeletal
Browning et al. 2018 Introgressed	HPO	Protuberant abdomen (HP:0001538)	1	0.1483	6.743088334	0.137986201	metabolic
Browning et al. 2018 Introgressed	HPO	Abnormality of the renal cortex (HP:0011035)	1	0.147	6.802721088	0.138186181	urinary
Browning et al. 2018 Introgressed	HPO	Splenomegaly (HP:0001744)	7	4.2743	1.637695061	0.139586041	lymphatic
Browning et al. 2018 Introgressed	HPO	Ectopia lentis (HP:0001083)	2	0.6563	3.047386866	0.139786021	nervous
Browning et al. 2018 Introgressed	HPO	Oligomenorrhea (HP:0000876)	1	0.1487	6.724949563	0.140385961	reproductive
Browning et al. 2018 Introgressed	HPO	Premature ovarian failure (HP:0008209)	1	0.1533	6.523157208	0.142285771	reproductive
Browning et al. 2018 Introgressed	HPO	Colitis (HP:0002583)	1	0.1565	6.389776358	0.143285671	digestive
Browning et al. 2018 Introgressed	HPO	Ulnar deviation of the wrist (HP:0003049)	1	0.1556	6.426735219	0.145085491	skeletal
Browning et al. 2018 Introgressed	HPO	Muscle fibrillation (HP:0010546)	1	0.1557	6.422607579	0.145085491	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Abnormal pupillary function (HP:0007686)	1	0.1565	6.389776358	0.145285471	nervous
Browning et al. 2018 Introgressed	HPO	Short foot (HP:0001773)	2	0.6925	2.888086643	0.148685131	skeletal
Browning et al. 2018 Introgressed	HPO	Oligodontia (HP:0000677)	2	0.6847	2.920987294	0.148785121	skeletal
Browning et al. 2018 Introgressed	HPO	Overgrowth (HP:0001548)	1	0.1609	6.215040398	0.148985101	other
Browning et al. 2018 Introgressed	HPO	Abnormality of T cell physiology (HP:0011840)	1	0.1628	6.142506143	0.149385061	immune
Browning et al. 2018 Introgressed	HPO	Back pain (HP:0003418)	1	0.1627	6.1462815	0.149585041	skeletal
Browning et al. 2018 Introgressed	HPO	Pes planus (HP:0001763)	4	2.0635	1.938454083	0.151384862	skeletal
Browning et al. 2018 Introgressed	HPO	Interstitial pulmonary disease (HP:0006530)	1	0.1684	5.93824228	0.155284472	respiratory
Browning et al. 2018 Introgressed	HPO	Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204)	1	0.1712	5.841121495	0.157284272	other
Browning et al. 2018 Introgressed	HPO	Abnormality of proline metabolism (HP:0010907)	1	0.171	5.847953216	0.157584242	metabolic
Browning et al. 2018 Introgressed	HPO	Hydroxyprolinuria (HP:0003080)	1	0.171	5.847953216	0.157584242	other
Browning et al. 2018 Introgressed	HPO	Mucopolysacchariduria (HP:0008155)	1	0.1748	5.720823799	0.159184082	metabolic
Browning et al. 2018 Introgressed	HPO	Urinary glycosaminoglycan excretion (HP:0003541)	1	0.1748	5.720823799	0.159184082	metabolic
Browning et al. 2018 Introgressed	HPO	Increased serum ferritin (HP:0003281)	1	0.1779	5.621135469	0.163083692	other
Browning et al. 2018 Introgressed	HPO	Abnormality of the pubic bones (HP:0003172)	2	0.7318	2.732987155	0.163383662	skeletal
Browning et al. 2018 Introgressed	HPO	Increased connective tissue (HP:0009025)	1	0.1805	5.540166205	0.163983602	other
Browning et al. 2018 Introgressed	HPO	Enlarged epiphyses (HP:0010580)	1	0.1818	5.500550055	0.166483352	skeletal
Browning et al. 2018 Introgressed	HPO	Increased neuronal autofluorescent lipopigment (HP:0002074)	1	0.185	5.405405405	0.167783222	nervous
Browning et al. 2018 Introgressed	HPO	Abnormality of glycosaminoglycan metabolism (HP:0004371)	1	0.1853	5.396654074	0.168383162	metabolic
Browning et al. 2018 Introgressed	HPO	Abnormality of polysaccharide metabolism (HP:0011012)	1	0.1853	5.396654074	0.168383162	metabolic
Browning et al. 2018 Introgressed	HPO	Abnormality of mucopolysaccharide metabolism (HP:0011020)	1	0.1853	5.396654074	0.168383162	metabolic
Browning et al. 2018 Introgressed	HPO	Aplasia/Hypoplasia of the pubic bone (HP:0009104)	1	0.1877	5.327650506	0.170382962	skeletal
Browning et al. 2018 Introgressed	HPO	Abnormality of nucleobase metabolism (HP:0010932)	3	1.4252	2.104967724	0.171382862	metabolic
Browning et al. 2018 Introgressed	HPO	Facial asymmetry (HP:0000324)	3	1.4285	2.100105005	0.174082592	other
Browning et al. 2018 Introgressed	HPO	Focal segmental glomerulosclerosis (HP:0000097)	1	0.1914	5.224660397	0.174182582	urinary
Browning et al. 2018 Introgressed	HPO	Leukopenia (HP:0001882)	2	0.7627	2.622263013	0.174382562	immune
Browning et al. 2018 Introgressed	HPO	Renal agenesis (HP:0000104)	2	0.7829	2.554604675	0.178782122	urinary
Browning et al. 2018 Introgressed	HPO	Dysphagia (HP:0002015)	4	2.2099	1.810036653	0.181081892	digestive
Browning et al. 2018 Introgressed	HPO	Mitral regurgitation (HP:0001653)	2	0.7705	2.595717067	0.181381862	cardiovascular
Browning et al. 2018 Introgressed	HPO	Increased cerebral lipofuscin (HP:0011813)	1	0.203	4.926108374	0.182781722	other
Browning et al. 2018 Introgressed	HPO	Difficulty walking (HP:0002355)	2	0.7881	2.537749017	0.183781622	other
Browning et al. 2018 Introgressed	HPO	Acanthocytosis (HP:0001927)	1	0.2022	4.945598417	0.184581542	hematologic
Browning et al. 2018 Introgressed	HPO	Slender long bone (HP:0003100)	1	0.2068	4.835589942	0.185981402	skeletal
Browning et al. 2018 Introgressed	HPO	Abnormal cortical bone morphology (HP:0003103)	2	0.7776	2.572016461	0.187281272	skeletal
Browning et al. 2018 Introgressed	HPO	Nephrotic syndrome (HP:0000100)	2	0.791	2.528445006	0.187781222	urinary
Browning et al. 2018 Introgressed	HPO	Paraparesis (HP:0002385)	1	0.2093	4.777830865	0.189281072	nervous
Browning et al. 2018 Introgressed	HPO	Abnormality of transition element cation homeostasis (HP:0011030)	1	0.2098	4.766444233	0.189881012	other
Browning et al. 2018 Introgressed	HPO	Abnormality of iron homeostasis (HP:0011031)	1	0.2098	4.766444233	0.189881012	other
Browning et al. 2018 Introgressed	HPO	Hypoplastic ischia (HP:0003175)	1	0.2137	4.679457183	0.191980802	skeletal
Browning et al. 2018 Introgressed	HPO	Narrow face (HP:0000275)	1	0.2124	4.708097928	0.192180782	skeletal
Browning et al. 2018 Introgressed	HPO	Camptodactyly of finger (HP:0100490)	6	3.8731	1.549146678	0.193080692	skeletal
Browning et al. 2018 Introgressed	HPO	Elevated erythrocyte sedimentation rate (HP:0003565)	1	0.2148	4.655493482	0.194180582	hematologic
Browning et al. 2018 Introgressed	HPO	Truncus arteriosus (HP:0001660)	1	0.2135	4.683840749	0.194280572	cardiovascular
Browning et al. 2018 Introgressed	HPO	Prominent nose (HP:0000448)	1	0.217	4.608294931	0.194380562	skeletal
Browning et al. 2018 Introgressed	HPO	Cheekbone underdevelopment (HP:0010669)	3	1.5286	1.962580139	0.195480452	skeletal
Browning et al. 2018 Introgressed	HPO	Peripheral demyelination (HP:0011096)	2	0.7976	2.507522568	0.195780422	nervous
Browning et al. 2018 Introgressed	HPO	Obstructive sleep apnea (HP:0002870)	1	0.2203	4.539264639	0.196480352	behavior
Browning et al. 2018 Introgressed	HPO	IgA deficiency (HP:0002720)	1	0.2187	4.572473708	0.197680232	immune
Browning et al. 2018 Introgressed	HPO	Small for gestational age (HP:0001518)	3	1.5374	1.951346429	0.198680132	other
Browning et al. 2018 Introgressed	HPO	Progressive visual loss (HP:0000529)	2	0.8275	2.416918429	0.200479952	nervous
Browning et al. 2018 Introgressed	HPO	Hammertoe (HP:0001765)	2	0.824	2.427184466	0.200979902	skeletal
Browning et al. 2018 Introgressed	HPO	Facial cleft (HP:0002006)	2	0.8258	2.421893921	0.202379762	other
Browning et al. 2018 Introgressed	HPO	Aplasia/Hypoplasia of the uvula (HP:0010293)	2	0.8349	2.395496467	0.204279572	skeletal
Browning et al. 2018 Introgressed	HPO	Small hand (HP:0200055)	2	0.8431	2.372197841	0.205179482	skeletal
Browning et al. 2018 Introgressed	HPO	Encephalitis (HP:0002383)	1	0.2276	4.393673111	0.205379462	nervous
Browning et al. 2018 Introgressed	HPO	Clubbing of toes (HP:0100760)	2	0.8414	2.37699073	0.205679432	integumentary
Browning et al. 2018 Introgressed	HPO	Inappropriate behavior (HP:0000719)	1	0.2275	4.395604396	0.206679332	behavior
Browning et al. 2018 Introgressed	HPO	Disinhibition (HP:0000734)	1	0.2275	4.395604396	0.206679332	behavior
Browning et al. 2018 Introgressed	HPO	Aplasia/hypoplasia of the femur (HP:0005613)	2	0.8494	2.354603249	0.206779322	skeletal
Browning et al. 2018 Introgressed	HPO	Confusion (HP:0001289)	1	0.2299	4.349717268	0.206979302	nervous
Browning et al. 2018 Introgressed	HPO	Gastrointestinal inflammation (HP:0004386)	1	0.2361	4.235493435	0.208179182	digestive
Browning et al. 2018 Introgressed	HPO	Inflammation of the large intestine (HP:0002037)	1	0.2361	4.235493435	0.208179182	digestive
Browning et al. 2018 Introgressed	HPO	Duodenal stenosis (HP:0100867)	2	0.8533	2.343841556	0.208679132	digestive
Browning et al. 2018 Introgressed	HPO	Small intestinal stenosis (HP:0012848)	2	0.8533	2.343841556	0.208679132	digestive
Browning et al. 2018 Introgressed	HPO	Poor coordination (HP:0002370)	1	0.2401	4.164931279	0.211078892	nervous
Browning et al. 2018 Introgressed	HPO	Abnormal cartilage morphology (HP:0002763)	1	0.239	4.184100418	0.211078892	other
Browning et al. 2018 Introgressed	HPO	Glomerulosclerosis (HP:0000096)	1	0.2384	4.194630872	0.211478852	urinary
Browning et al. 2018 Introgressed	HPO	Chronic diarrhea (HP:0002028)	1	0.2373	4.214075011	0.212478752	digestive
Browning et al. 2018 Introgressed	HPO	Myotonia (HP:0002486)	1	0.2377	4.206983593	0.212778722	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Vascular tortuosity (HP:0004948)	1	0.2367	4.224757076	0.212878712	cardiovascular
Browning et al. 2018 Introgressed	HPO	Abnormality of the duodenum (HP:0002246)	2	0.8679	2.304412951	0.213678632	digestive
Browning et al. 2018 Introgressed	HPO	Anorexia (HP:0002039)	1	0.2414	4.142502071	0.215678432	behavior
Browning et al. 2018 Introgressed	HPO	Disproportionate tall stature (HP:0001519)	1	0.2409	4.151100042	0.216078392	skeletal
Browning et al. 2018 Introgressed	HPO	Nemaline bodies (HP:0003798)	1	0.2473	4.043671654	0.217378262	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Ulnar deviation of finger (HP:0009465)	2	0.8712	2.295684114	0.217578242	skeletal
Browning et al. 2018 Introgressed	HPO	Myopathic facies (HP:0002058)	1	0.248	4.032258065	0.217678232	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Frequent falls (HP:0002359)	1	0.2455	4.073319756	0.217878212	other
Browning et al. 2018 Introgressed	HPO	Atelectasis (HP:0100750)	1	0.2475	4.04040404	0.218678132	respiratory
Browning et al. 2018 Introgressed	HPO	Cerebral aneurysm (HP:0004944)	1	0.2494	4.009623095	0.221177882	nervous
Browning et al. 2018 Introgressed	HPO	Aneurysm (HP:0002617)	3	1.6287	1.841959845	0.222377762	nervous
Browning et al. 2018 Introgressed	HPO	Absent thumb (HP:0009777)	2	0.8897	2.247948747	0.222477752	skeletal
Browning et al. 2018 Introgressed	HPO	Recurrent skin infections (HP:0001581)	1	0.2548	3.924646782	0.226377362	immune
Browning et al. 2018 Introgressed	HPO	Drooling (HP:0002307)	1	0.2568	3.894080997	0.227277272	other
Browning et al. 2018 Introgressed	HPO	Bowel incontinence (HP:0002607)	1	0.2544	3.93081761	0.227277272	digestive
Browning et al. 2018 Introgressed	HPO	Excessive salivation (HP:0003781)	1	0.2568	3.894080997	0.227277272	digestive
Browning et al. 2018 Introgressed	HPO	Abnormal large intestine physiology (HP:0012700)	1	0.2544	3.93081761	0.227277272	digestive
Browning et al. 2018 Introgressed	HPO	Medial flaring of the eyebrow (HP:0010747)	1	0.2589	3.862495172	0.227877212	integumentary
Browning et al. 2018 Introgressed	HPO	Abnormality of the ischium (HP:0003174)	1	0.2594	3.855050116	0.228777122	skeletal
Browning et al. 2018 Introgressed	HPO	Lower limb amyotrophy (HP:0007210)	1	0.2553	3.916960439	0.229277072	nervous
Browning et al. 2018 Introgressed	HPO	Tubulointerstitial fibrosis (HP:0005576)	1	0.2599	3.847633705	0.229677032	urinary
Browning et al. 2018 Introgressed	HPO	Abnormality of glutamine family amino acid metabolism (HP:0010902)	1	0.2615	3.824091778	0.230776922	metabolic
Browning et al. 2018 Introgressed	HPO	Scrotal hypoplasia (HP:0000046)	2	0.912	2.192982456	0.231876812	reproductive
Browning et al. 2018 Introgressed	HPO	Abnormal spermatogenesis (HP:0008669)	1	0.264	3.787878788	0.232076792	reproductive
Browning et al. 2018 Introgressed	HPO	Abnormality of the calcaneus (HP:0008364)	1	0.2646	3.779289494	0.234076592	skeletal
Browning et al. 2018 Introgressed	HPO	Foot dorsiflexor weakness (HP:0009027)	2	0.9191	2.17604178	0.235576442	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Abnormality of the foot musculature (HP:0001436)	2	0.9191	2.17604178	0.235576442	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Posterior embryotoxon (HP:0000627)	1	0.2696	3.709198813	0.238176182	nervous
Browning et al. 2018 Introgressed	HPO	Ulnar claw (HP:0001178)	1	0.271	3.6900369	0.238776122	nervous
Browning et al. 2018 Introgressed	HPO	Hip contracture (HP:0003273)	1	0.2745	3.64298725	0.239076092	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Muscle fiber cytoplasmatic inclusion bodies (HP:0100303)	1	0.2765	3.616636528	0.240575942	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Acute lymphatic leukemia (HP:0006721)	1	0.2731	3.661662395	0.241775822	lymphatic
Browning et al. 2018 Introgressed	HPO	Attention deficit hyperactivity disorder (HP:0007018)	3	1.7014	1.763253791	0.242475752	behavior
Browning et al. 2018 Introgressed	HPO	Specific learning disability (HP:0001328)	1	0.2766	3.615328995	0.242975702	other
Browning et al. 2018 Introgressed	HPO	Aplasia/Hypoplasia of the thymus (HP:0010515)	1	0.2759	3.624501631	0.243475652	lymphatic
Browning et al. 2018 Introgressed	HPO	Posterior subcapsular cataract (HP:0007787)	1	0.2796	3.576537911	0.246075392	nervous
Browning et al. 2018 Introgressed	HPO	Abnormality of the thymus (HP:0000777)	2	0.9582	2.087246921	0.246775322	lymphatic
Browning et al. 2018 Introgressed	HPO	Macular degeneration (HP:0000608)	1	0.281	3.558718861	0.246875312	nervous
Browning et al. 2018 Introgressed	HPO	Hydrocephalus (HP:0000238)	6	4.2152	1.423420004	0.247175282	nervous
Browning et al. 2018 Introgressed	HPO	Arthralgia (HP:0002829)	2	0.961	2.081165453	0.248075192	skeletal
Browning et al. 2018 Introgressed	HPO	Aortic aneurysm (HP:0004942)	1	0.2821	3.544842255	0.248075192	cardiovascular
Browning et al. 2018 Introgressed	HPO	Anterior segment dysgenesis (HP:0007700)	1	0.2868	3.486750349	0.248075192	integumentary
Browning et al. 2018 Introgressed	HPO	Nail dystrophy (HP:0008404)	1	0.2831	3.532320735	0.248275172	integumentary
Browning et al. 2018 Introgressed	HPO	Duplication of thumb phalanx (HP:0009942)	2	0.9623	2.078353944	0.251474853	skeletal
Browning et al. 2018 Introgressed	HPO	Stomatitis (HP:0010280)	1	0.2888	3.462603878	0.251774823	other
Browning et al. 2018 Introgressed	HPO	Aplasia/Hypoplasia of the sternum (HP:0006714)	1	0.2889	3.461405331	0.252974703	skeletal
Browning et al. 2018 Introgressed	HPO	Morphological abnormality of the middle ear (HP:0008609)	1	0.2889	3.461405331	0.252974703	skeletal
Browning et al. 2018 Introgressed	HPO	Abnormality of the basal ganglia (HP:0002134)	1	0.2888	3.462603878	0.253974603	nervous
Browning et al. 2018 Introgressed	HPO	Redundant skin (HP:0001582)	1	0.2961	3.37723742	0.257074293	integumentary
Browning et al. 2018 Introgressed	HPO	Broad nasal tip (HP:0000455)	2	0.9837	2.033140185	0.259074093	integumentary
Browning et al. 2018 Introgressed	HPO	Muscle fiber inclusion bodies (HP:0100299)	1	0.3036	3.293807642	0.260073993	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Increased CSF lactate (HP:0002490)	1	0.3024	3.306878307	0.260273973	other
Browning et al. 2018 Introgressed	HPO	Omphalocele (HP:0001539)	2	0.9937	2.012679883	0.262273773	other
Browning et al. 2018 Introgressed	HPO	Arthrogryposis multiplex congenita (HP:0002804)	2	0.9892	2.021835827	0.262973703	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Abnormal ciliary motility (HP:0012262)	1	0.3052	3.276539974	0.265973403	respiratory
Browning et al. 2018 Introgressed	HPO	Enlarged kidneys (HP:0000105)	1	0.3081	3.245699448	0.266673333	urinary
Browning et al. 2018 Introgressed	HPO	Prolonged neonatal jaundice (HP:0006579)	1	0.3135	3.189792663	0.270072993	digestive
Browning et al. 2018 Introgressed	HPO	Severe Myopia (HP:0011003)	1	0.3132	3.19284802	0.270272973	nervous
Browning et al. 2018 Introgressed	HPO	Deformed sella turcica (HP:0002681)	1	0.3195	3.129890454	0.270472953	skeletal
Browning et al. 2018 Introgressed	HPO	Segmental peripheral demyelination/remyelination (HP:0003481)	1	0.3141	3.183699459	0.272172783	nervous
Browning et al. 2018 Introgressed	HPO	Underdeveloped nasal alae (HP:0000430)	2	1.0277	1.946093218	0.272872713	integumentary
Browning et al. 2018 Introgressed	HPO	Multicystic kidney dysplasia (HP:0000003)	3	1.8214	1.64708466	0.273272673	urinary
Browning et al. 2018 Introgressed	HPO	Oculomotor apraxia (HP:0000657)	2	1.0323	1.937421292	0.273872613	nervous
Browning et al. 2018 Introgressed	HPO	Decreased number of peripheral myelinated nerve fibers (HP:0003380)	2	1.038	1.926782274	0.274972503	nervous
Browning et al. 2018 Introgressed	HPO	Muscle fiber splitting (HP:0003555)	1	0.3229	3.096934035	0.275372463	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Breast aplasia (HP:0100783)	1	0.3228	3.097893432	0.276672333	reproductive
Browning et al. 2018 Introgressed	HPO	Subcapsular cataract (HP:0000523)	1	0.3204	3.121098627	0.276872313	nervous
Browning et al. 2018 Introgressed	HPO	Myelodysplasia (HP:0002863)	2	1.0472	1.909854851	0.281671833	hematologic
Browning et al. 2018 Introgressed	HPO	Aplasia/Hypoplasia of the sacrum (HP:0008517)	1	0.328	3.048780488	0.282771723	skeletal
Browning et al. 2018 Introgressed	HPO	Aplasia/Hypoplasia affecting the fundus (HP:0008057)	1	0.3361	2.975304969	0.285071493	nervous
Browning et al. 2018 Introgressed	HPO	Adducted thumb (HP:0001181)	1	0.3318	3.013863773	0.285471453	skeletal
Browning et al. 2018 Introgressed	HPO	Low anterior hairline (HP:0000294)	2	1.0632	1.881113619	0.285571443	integumentary
Browning et al. 2018 Introgressed	HPO	Abnormality of the clitoris (HP:0000056)	2	1.0637	1.880229388	0.285671433	reproductive
Browning et al. 2018 Introgressed	HPO	Bell-shaped thorax (HP:0001591)	1	0.3359	2.977076511	0.286171383	skeletal
Browning et al. 2018 Introgressed	HPO	EMG: myopathic abnormalities (HP:0003458)	2	1.0577	1.890895339	0.286471353	nervous
Browning et al. 2018 Introgressed	HPO	Absent phalangeal crease (HP:0006109)	1	0.3434	2.912055911	0.289971003	integumentary
Browning et al. 2018 Introgressed	HPO	Abnormal finger flexion creases (HP:0006143)	1	0.3434	2.912055911	0.289971003	integumentary
Browning et al. 2018 Introgressed	HPO	Long face (HP:0000276)	3	1.8903	1.587049675	0.290370963	skeletal
Browning et al. 2018 Introgressed	HPO	Cafe-au-lait spot (HP:0000957)	3	1.8954	1.582779361	0.292470753	integumentary
Browning et al. 2018 Introgressed	HPO	Dental crowding (HP:0000678)	2	1.078	1.85528757	0.292470753	skeletal
Browning et al. 2018 Introgressed	HPO	Flared iliac wings (HP:0002869)	1	0.3464	2.886836028	0.292470753	skeletal
Browning et al. 2018 Introgressed	HPO	Abnormal vertebral ossification (HP:0100569)	1	0.3473	2.879355024	0.293170683	skeletal
Browning et al. 2018 Introgressed	HPO	EMG: neuropathic changes (HP:0003445)	1	0.3531	2.832058907	0.295570443	nervous
Browning et al. 2018 Introgressed	HPO	Nasolacrimal duct obstruction (HP:0000579)	1	0.3508	2.850627138	0.295870413	other
Browning et al. 2018 Introgressed	HPO	Hepatomegaly (HP:0002240)	7	5.4009	1.296080283	0.297570243	digestive
Browning et al. 2018 Introgressed	HPO	Abnormal EKG (HP:0003115)	2	1.0854	1.842638659	0.297570243	cardiovascular
Browning et al. 2018 Introgressed	HPO	Flat cornea (HP:0007720)	1	0.355	2.816901408	0.297670233	nervous
Browning et al. 2018 Introgressed	HPO	Neoplasm of the oral cavity (HP:0100649)	1	0.3547	2.819283902	0.297670233	other
Browning et al. 2018 Introgressed	HPO	Mask-like facies (HP:0000298)	1	0.3558	2.810567735	0.298070193	other
Browning et al. 2018 Introgressed	HPO	Sleep apnea (HP:0010535)	1	0.3558	2.810567735	0.298470153	behavior
Browning et al. 2018 Introgressed	HPO	IgG deficiency (HP:0004315)	1	0.3598	2.779321845	0.301869813	immune
Browning et al. 2018 Introgressed	HPO	Abnormality of the sella turcica (HP:0002679)	1	0.3637	2.749518834	0.303269673	skeletal
Browning et al. 2018 Introgressed	HPO	Weight loss (HP:0001824)	4	2.7814	1.438124685	0.304069593	metabolic
Browning et al. 2018 Introgressed	HPO	Acute hepatic failure (HP:0006554)	1	0.3584	2.790178571	0.304169583	digestive
Browning et al. 2018 Introgressed	HPO	Abnormal respiratory motile cilium physiology (HP:0012261)	1	0.3618	2.763957988	0.305169483	respiratory
Browning et al. 2018 Introgressed	HPO	Centrally nucleated skeletal muscle fibers (HP:0003687)	1	0.3646	2.742731761	0.306369363	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Left ventricular hypertrophy (HP:0001712)	1	0.3653	2.737476047	0.306869313	cardiovascular
Browning et al. 2018 Introgressed	HPO	Distal arthrogryposis (HP:0005684)	1	0.3697	2.704895862	0.306869313	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Joint swelling (HP:0001386)	1	0.3659	2.732987155	0.307369263	skeletal
Browning et al. 2018 Introgressed	HPO	Broad face (HP:0000283)	1	0.3672	2.723311547	0.307469253	skeletal
Browning et al. 2018 Introgressed	HPO	Downslanted palpebral fissures (HP:0000494)	6	4.5369	1.322488924	0.308369163	integumentary
Browning et al. 2018 Introgressed	HPO	Cardiomegaly (HP:0001640)	1	0.3721	2.68744961	0.308769123	cardiovascular
Browning et al. 2018 Introgressed	HPO	Gynecomastia (HP:0000771)	2	1.1201	1.785554861	0.308869113	endocrine
Browning et al. 2018 Introgressed	HPO	Aplasia involving forearm bones (HP:0009822)	2	1.1248	1.778093883	0.309169083	skeletal
Browning et al. 2018 Introgressed	HPO	Absent forearm bone (HP:0003953)	2	1.1248	1.778093883	0.309169083	skeletal
Browning et al. 2018 Introgressed	HPO	Absent radius (HP:0003974)	2	1.1248	1.778093883	0.309169083	skeletal
Browning et al. 2018 Introgressed	HPO	Abnormality of the ileum (HP:0001549)	2	1.1248	1.778093883	0.309769023	digestive
Browning et al. 2018 Introgressed	HPO	Ankyloglossia (HP:0010296)	1	0.3703	2.700513097	0.310968903	other
Browning et al. 2018 Introgressed	HPO	Abnormality of oral frenula (HP:0000190)	1	0.3703	2.700513097	0.310968903	integumentary
Browning et al. 2018 Introgressed	HPO	Midline defect of the nose (HP:0004122)	1	0.37	2.702702703	0.311868813	other
Browning et al. 2018 Introgressed	HPO	Arteriovenous malformation (HP:0100026)	3	1.9643	1.52726162	0.312568743	cardiovascular
Browning et al. 2018 Introgressed	HPO	Hamartoma of the eye (HP:0010568)	1	0.3767	2.654632333	0.313068693	nervous
Browning et al. 2018 Introgressed	HPO	Conjunctival hamartoma (HP:0100780)	1	0.3767	2.654632333	0.313068693	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Aplasia/Hypoplasia involving the vertebral column (HP:0008518)	2	1.143	1.749781277	0.315568443	skeletal
Browning et al. 2018 Introgressed	HPO	Polar cataract (HP:0010696)	1	0.3767	2.654632333	0.318868113	nervous
Browning et al. 2018 Introgressed	HPO	Dolichocephaly (HP:0000268)	4	2.8638	1.396745583	0.319068093	skeletal
Browning et al. 2018 Introgressed	HPO	Narrow chest (HP:0000774)	3	2.0116	1.491350169	0.319768023	skeletal
Browning et al. 2018 Introgressed	HPO	Malignant hyperthermia (HP:0002047)	1	0.3878	2.578648788	0.319868013	immune
Browning et al. 2018 Introgressed	HPO	Gowers sign (HP:0003391)	1	0.387	2.583979328	0.320467953	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Hypoplastic ilia (HP:0000946)	2	1.1559	1.730253482	0.323567643	skeletal
Browning et al. 2018 Introgressed	HPO	Proteinuria (HP:0000093)	2	1.1616	1.721763085	0.323667633	other
Browning et al. 2018 Introgressed	HPO	Cervical subluxation (HP:0003308)	1	0.391	2.557544757	0.325267473	skeletal
Browning et al. 2018 Introgressed	HPO	Hyperkalemia (HP:0002153)	1	0.3919	2.551671345	0.325767423	other
Browning et al. 2018 Introgressed	HPO	Myelomeningocele (HP:0002475)	1	0.3941	2.537427049	0.327167283	nervous
Browning et al. 2018 Introgressed	HPO	Bladder diverticulum (HP:0000015)	1	0.3976	2.515090543	0.330866913	urinary
Browning et al. 2018 Introgressed	HPO	Polycystic ovaries (HP:0000147)	2	1.1896	1.681237391	0.333966603	reproductive
Browning et al. 2018 Introgressed	HPO	Generalized amyotrophy (HP:0003700)	1	0.4061	2.462447673	0.334666533	nervous
Browning et al. 2018 Introgressed	HPO	Sprengel anomaly (HP:0000912)	2	1.194	1.675041876	0.334666533	skeletal
Browning et al. 2018 Introgressed	HPO	Ulnar deviation of the hand or of fingers of the hand (HP:0001193)	2	1.1815	1.692763436	0.335066493	skeletal
Browning et al. 2018 Introgressed	HPO	Abnormality of the anterior chamber (HP:0000593)	1	0.4071	2.456398919	0.335466453	nervous
Browning et al. 2018 Introgressed	HPO	Short clavicles (HP:0000894)	1	0.406	2.463054187	0.337166283	skeletal
Browning et al. 2018 Introgressed	HPO	Aplasia/Hypoplasia of the clavicles (HP:0006710)	1	0.406	2.463054187	0.337166283	skeletal
Browning et al. 2018 Introgressed	HPO	Gingival overgrowth (HP:0000212)	3	2.0751	1.44571346	0.339166083	immune
Browning et al. 2018 Introgressed	HPO	Exotropia (HP:0000577)	1	0.4093	2.4431957	0.339366063	nervous
Browning et al. 2018 Introgressed	HPO	Hypergonadotropic hypogonadism (HP:0000815)	2	1.2031	1.662372205	0.339466053	endocrine
Browning et al. 2018 Introgressed	HPO	Sparse eyelashes (HP:0000653)	1	0.422	2.369668246	0.343365663	integumentary
Browning et al. 2018 Introgressed	HPO	Elevated hepatic transaminases (HP:0002910)	2	1.2129	1.648940556	0.345865413	digestive
Browning et al. 2018 Introgressed	HPO	Aplasia/Hypoplasia of the patella (HP:0006498)	1	0.4343	2.302555837	0.350864914	skeletal
Browning et al. 2018 Introgressed	HPO	Patellar aplasia (HP:0006443)	1	0.4343	2.302555837	0.350864914	skeletal
Browning et al. 2018 Introgressed	HPO	Self-mutilation (HP:0000742)	1	0.4329	2.31000231	0.351464854	behavior
Browning et al. 2018 Introgressed	HPO	Abnormality of the epiphysis of the femoral head (HP:0010574)	1	0.4383	2.281542323	0.355064494	skeletal
Browning et al. 2018 Introgressed	HPO	Mandibular prognathia (HP:0000303)	3	2.1253	1.411565426	0.355364464	skeletal
Browning et al. 2018 Introgressed	HPO	Abnormality of the periventricular white matter (HP:0002518)	1	0.4357	2.295157218	0.356164384	nervous
Browning et al. 2018 Introgressed	HPO	Decreased motor nerve conduction velocity (HP:0003431)	2	1.2423	1.609917089	0.356464354	nervous
Browning et al. 2018 Introgressed	HPO	"Intellectual disability, moderate (HP:0002342)"	1	0.4388	2.278942571	0.356564344	nervous
Browning et al. 2018 Introgressed	HPO	Right ventricular cardiomyopathy (HP:0011663)	1	0.4443	2.250731488	0.357164284	cardiovascular
Browning et al. 2018 Introgressed	HPO	Progressive neurologic deterioration (HP:0002344)	1	0.4459	2.242655304	0.357364264	nervous
Browning et al. 2018 Introgressed	HPO	Metatarsus adductus (HP:0001840)	1	0.4503	2.220741728	0.359564044	skeletal
Browning et al. 2018 Introgressed	HPO	Atrial fibrillation (HP:0005110)	2	1.2604	1.586797842	0.360863914	cardiovascular
Browning et al. 2018 Introgressed	HPO	Optic disc pallor (HP:0000543)	1	0.4516	2.214348981	0.362063794	nervous
Browning et al. 2018 Introgressed	HPO	Slender build (HP:0001533)	1	0.4488	2.228163993	0.363763624	other
Browning et al. 2018 Introgressed	HPO	Cholelithiasis (HP:0001081)	1	0.4505	2.219755827	0.364363564	digestive
Browning et al. 2018 Introgressed	HPO	Abnormality of the wing of the ilium (HP:0011867)	2	1.2863	1.554847236	0.364963504	skeletal
Browning et al. 2018 Introgressed	HPO	Bulbar palsy (HP:0001283)	1	0.4554	2.195871761	0.365363464	nervous
Browning et al. 2018 Introgressed	HPO	Primary atrial arrhythmia (HP:0001692)	2	1.2742	1.569612306	0.365563444	cardiovascular
Browning et al. 2018 Introgressed	HPO	Supraventricular tachycardia (HP:0004755)	2	1.2742	1.569612306	0.365563444	cardiovascular
Browning et al. 2018 Introgressed	HPO	External ophthalmoplegia (HP:0000544)	1	0.4571	2.187705097	0.366463354	nervous
Browning et al. 2018 Introgressed	HPO	Type 1 muscle fiber predominance (HP:0003803)	1	0.4616	2.166377816	0.371062894	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Pathologic fracture (HP:0002756)	1	0.4624	2.162629758	0.371562844	skeletal
Browning et al. 2018 Introgressed	HPO	Abnormal gallbladder morphology (HP:0012437)	1	0.4651	2.150075253	0.373062694	digestive
Browning et al. 2018 Introgressed	HPO	Abnormality of the pupil (HP:0000615)	2	1.3012	1.53704273	0.374862514	nervous
Browning et al. 2018 Introgressed	HPO	Multiple lipomas (HP:0001012)	1	0.4726	2.115954295	0.376762324	other
Browning et al. 2018 Introgressed	HPO	Abnormality of the salivary glands (HP:0010286)	1	0.4702	2.126754573	0.377962204	digestive
Browning et al. 2018 Introgressed	HPO	Wide mouth (HP:0000154)	2	1.3064	1.530924679	0.379062094	skeletal
Browning et al. 2018 Introgressed	HPO	Premature skin wrinkling (HP:0100678)	1	0.4833	2.069108214	0.381861814	integumentary
Browning et al. 2018 Introgressed	HPO	Lymphoma (HP:0002665)	2	1.3263	1.50795446	0.382061794	lymphatic
Browning et al. 2018 Introgressed	HPO	Supraventricular arrhythmia (HP:0005115)	2	1.331	1.502629602	0.382361764	cardiovascular
Browning et al. 2018 Introgressed	HPO	Abnormality of T cell number (HP:0011839)	1	0.4826	2.072109407	0.385461454	immune
Browning et al. 2018 Introgressed	HPO	T lymphocytopenia (HP:0005403)	1	0.4826	2.072109407	0.385461454	immune
Browning et al. 2018 Introgressed	HPO	Wide nasal bridge (HP:0000431)	9	7.8426	1.147578609	0.386061394	integumentary
Browning et al. 2018 Introgressed	HPO	Triphalangeal thumb (HP:0001199)	2	1.3398	1.492760113	0.388261174	skeletal
Browning et al. 2018 Introgressed	HPO	Congenital hepatic fibrosis (HP:0002612)	1	0.4952	2.019386107	0.390360964	digestive
Browning et al. 2018 Introgressed	HPO	Amblyopia (HP:0000646)	1	0.5009	1.996406468	0.391060894	nervous
Browning et al. 2018 Introgressed	HPO	Flared metaphyses (HP:0003015)	1	0.4922	2.031694433	0.392660734	skeletal
Browning et al. 2018 Introgressed	HPO	Bone cyst (HP:0012062)	1	0.5026	1.9896538	0.394260574	skeletal
Browning et al. 2018 Introgressed	HPO	Wide intermamillary distance (HP:0006610)	1	0.4979	2.008435429	0.396260374	reproductive
Browning et al. 2018 Introgressed	HPO	Neuronal loss in central nervous system (HP:0002529)	1	0.5092	1.963864886	0.399960004	nervous
Browning et al. 2018 Introgressed	HPO	Pointed chin (HP:0000307)	2	1.3747	1.454862879	0.401159884	skeletal
Browning et al. 2018 Introgressed	HPO	Neck muscle weakness (HP:0000467)	1	0.5161	1.937608991	0.403659634	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Inguinal hernia (HP:0000023)	3	2.314	1.296456353	0.407459254	digestive
Browning et al. 2018 Introgressed	HPO	Adenoma sebaceum (HP:0009720)	1	0.5266	1.898974554	0.408959104	integumentary
Browning et al. 2018 Introgressed	HPO	Angiofibromas (HP:0010615)	1	0.5266	1.898974554	0.408959104	cardiovascular
Browning et al. 2018 Introgressed	HPO	Muscular dystrophy (HP:0003560)	2	1.3936	1.435132032	0.409359064	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Pectus excavatum (HP:0000767)	5	4.1705	1.198897015	0.409959004	skeletal
Browning et al. 2018 Introgressed	HPO	Restlessness (HP:0000711)	1	0.5215	1.917545542	0.410358964	behavior
Browning et al. 2018 Introgressed	HPO	Mixed hearing impairment (HP:0000410)	1	0.5354	1.867762421	0.414658534	nervous
Browning et al. 2018 Introgressed	HPO	Hypogonadotrophic hypogonadism (HP:0000044)	1	0.5398	1.852537977	0.415458454	endocrine
Browning et al. 2018 Introgressed	HPO	Short femoral neck (HP:0100864)	1	0.5366	1.863585539	0.419058094	skeletal
Browning et al. 2018 Introgressed	HPO	Kyphoscoliosis (HP:0002751)	2	1.4347	1.394019656	0.419358064	skeletal
Browning et al. 2018 Introgressed	HPO	Epiphyseal dysplasia (HP:0002656)	1	0.5393	1.854255516	0.420757924	skeletal
Browning et al. 2018 Introgressed	HPO	Gonadal dysgenesis (HP:0000133)	2	1.44	1.388888889	0.421057894	other
Browning et al. 2018 Introgressed	HPO	Meningioma (HP:0002858)	1	0.5518	1.812250816	0.422757724	nervous
Browning et al. 2018 Introgressed	HPO	Mucosal telangiectasiae (HP:0100579)	1	0.5495	1.819836215	0.423757624	integumentary
Browning et al. 2018 Introgressed	HPO	Premature graying of hair (HP:0002216)	1	0.553	1.808318264	0.425957404	integumentary
Browning et al. 2018 Introgressed	HPO	Progressive disorder (HP:0003676)	3	2.3917	1.254337919	0.429057094	other
Browning et al. 2018 Introgressed	HPO	Papilloma (HP:0012740)	1	0.5607	1.78348493	0.429457054	other
Browning et al. 2018 Introgressed	HPO	Syncope (HP:0001279)	2	1.456	1.373626374	0.429457054	nervous
Browning et al. 2018 Introgressed	HPO	Verrucae (HP:0200043)	1	0.5607	1.78348493	0.429457054	integumentary
Browning et al. 2018 Introgressed	HPO	Unsteady gait (HP:0002317)	1	0.5626	1.777461785	0.429757024	other
Browning et al. 2018 Introgressed	HPO	Short distal phalanx of finger (HP:0009882)	2	1.4681	1.36230502	0.430656934	skeletal
Browning et al. 2018 Introgressed	HPO	Abnormality of the endocardium (HP:0004306)	1	0.5661	1.766472355	0.431656834	cardiovascular
Browning et al. 2018 Introgressed	HPO	Lactic acidosis (HP:0003128)	2	1.4684	1.362026696	0.431956804	metabolic
Browning et al. 2018 Introgressed	HPO	Meningitis (HP:0001287)	1	0.577	1.733102253	0.433556644	nervous
Browning et al. 2018 Introgressed	HPO	Tetraplegia (HP:0002445)	1	0.5628	1.776830135	0.433856614	nervous
Browning et al. 2018 Introgressed	HPO	Benign neoplasm of the central nervous system (HP:0100835)	2	1.4798	1.351533991	0.436456354	nervous
Browning et al. 2018 Introgressed	HPO	Choanal stenosis (HP:0000452)	1	0.571	1.751313485	0.437156284	respiratory
Browning et al. 2018 Introgressed	HPO	Abdominal distention (HP:0003270)	1	0.5728	1.745810056	0.438756124	other
Browning et al. 2018 Introgressed	HPO	Vasculitis (HP:0002633)	1	0.5755	1.737619461	0.439056094	cardiovascular
Browning et al. 2018 Introgressed	HPO	Anophthalmia (HP:0000528)	1	0.5836	1.713502399	0.442455754	nervous
Browning et al. 2018 Introgressed	HPO	Biliary tract neoplasm (HP:0100574)	1	0.5887	1.69865806	0.443255674	digestive
Browning et al. 2018 Introgressed	HPO	Mildly elevated creatine phosphokinase (HP:0008180)	1	0.5863	1.705611462	0.444355564	other
Browning et al. 2018 Introgressed	HPO	Abnormally folded helix (HP:0008544)	1	0.5908	1.692620176	0.444355564	integumentary
Browning et al. 2018 Introgressed	HPO	Overfolded helix (HP:0000396)	1	0.5908	1.692620176	0.444355564	integumentary
Browning et al. 2018 Introgressed	HPO	Platyspondyly (HP:0000926)	2	1.5062	1.327844908	0.445255474	skeletal
Browning et al. 2018 Introgressed	HPO	Supernumerary nipples (HP:0002558)	1	0.5938	1.68406871	0.447355264	other
Browning et al. 2018 Introgressed	HPO	Abnormality of the line of Schwalbe (HP:0008048)	1	0.5933	1.685487949	0.447655234	nervous
Browning et al. 2018 Introgressed	HPO	Congenital sensorineural hearing impairment (HP:0008527)	1	0.5931	1.686056314	0.448155184	nervous
Browning et al. 2018 Introgressed	HPO	Slow progression (HP:0003677)	3	2.4779	1.210702611	0.449955004	other
Browning et al. 2018 Introgressed	HPO	Congenital hip dislocation (HP:0001374)	1	0.6107	1.637465204	0.450754925	skeletal
Browning et al. 2018 Introgressed	HPO	Coronal craniosynostosis (HP:0004440)	1	0.5921	1.688903901	0.452054795	skeletal
Browning et al. 2018 Introgressed	HPO	Autosomal recessive inheritance (HP:0000007)	44	42.8663	1.026447349	0.452254775	other
Browning et al. 2018 Introgressed	HPO	Everted lower lip vermilion (HP:0000232)	2	1.5321	1.30539782	0.452854715	integumentary
Browning et al. 2018 Introgressed	HPO	Abnormality of potassium homeostasis (HP:0011042)	1	0.6033	1.657550141	0.453954605	other
Browning et al. 2018 Introgressed	HPO	Exercise intolerance (HP:0003546)	1	0.6004	1.665556296	0.455154485	other
Browning et al. 2018 Introgressed	HPO	Dyskinesia (HP:0100660)	1	0.6015	1.662510391	0.455554445	nervous
Browning et al. 2018 Introgressed	HPO	Bicornuate uterus (HP:0000813)	1	0.6032	1.657824934	0.455654435	reproductive
Browning et al. 2018 Introgressed	HPO	Acute myeloid leukemia (HP:0004808)	1	0.6091	1.641766541	0.456054395	lymphatic
Browning et al. 2018 Introgressed	HPO	Broad foot (HP:0001769)	1	0.6226	1.606167684	0.461453855	skeletal
Browning et al. 2018 Introgressed	HPO	Highly arched eyebrow (HP:0002553)	2	1.559	1.282873637	0.462953705	integumentary
Browning et al. 2018 Introgressed	HPO	Striae distensae (HP:0001065)	1	0.6134	1.630257581	0.463353665	integumentary
Browning et al. 2018 Introgressed	HPO	Clitoromegaly (HP:0000057)	1	0.6257	1.598210005	0.464753525	reproductive
Browning et al. 2018 Introgressed	HPO	Coxa vara (HP:0002812)	1	0.6253	1.599232368	0.465453455	skeletal
Browning et al. 2018 Introgressed	HPO	Ventricular fibrillation (HP:0001663)	1	0.6277	1.593117731	0.467353265	cardiovascular
Browning et al. 2018 Introgressed	HPO	Split hand (HP:0001171)	1	0.6262	1.596933887	0.467753225	skeletal
Browning et al. 2018 Introgressed	HPO	Polyneuropathy (HP:0001271)	1	0.6364	1.571338781	0.467953205	nervous
Browning et al. 2018 Introgressed	HPO	Abnormality of the renal medulla (HP:0100957)	1	0.6276	1.593371574	0.468153185	urinary
Browning et al. 2018 Introgressed	HPO	Bruising susceptibility (HP:0000978)	3	2.5522	1.175456469	0.468353165	other
Browning et al. 2018 Introgressed	HPO	Dialeptic seizures (HP:0011146)	1	0.639	1.564945227	0.470452955	nervous
Browning et al. 2018 Introgressed	HPO	Furrowed tongue (HP:0000221)	1	0.6389	1.565190171	0.471252875	other
Browning et al. 2018 Introgressed	HPO	Abnormality of cells of the lymphoid lineage (HP:0012140)	1	0.6385	1.566170713	0.471652835	lymphatic
Browning et al. 2018 Introgressed	HPO	Lymphopenia (HP:0001888)	1	0.6385	1.566170713	0.471652835	lymphatic
Browning et al. 2018 Introgressed	HPO	Cupped ear (HP:0000378)	1	0.6368	1.570351759	0.471852815	other
Browning et al. 2018 Introgressed	HPO	Bronchiectasis (HP:0002110)	1	0.6432	1.554726368	0.474952505	respiratory
Browning et al. 2018 Introgressed	HPO	Fibrous tissue neoplasm (HP:0012316)	1	0.6461	1.547748027	0.474952505	other
Browning et al. 2018 Introgressed	HPO	Fibroma (HP:0010614)	1	0.6461	1.547748027	0.474952505	reproductive
Browning et al. 2018 Introgressed	HPO	Corneal dystrophy (HP:0001131)	1	0.6569	1.52230172	0.476652335	nervous
Browning et al. 2018 Introgressed	HPO	Arachnodactyly (HP:0001166)	2	1.6015	1.248829223	0.478952105	skeletal
Browning et al. 2018 Introgressed	HPO	Testicular neoplasm (HP:0010788)	2	1.6172	1.236705417	0.479352065	reproductive
Browning et al. 2018 Introgressed	HPO	Neoplasm of the pancreas (HP:0002894)	1	0.6546	1.527650474	0.479452055	digestive
Browning et al. 2018 Introgressed	HPO	Asthma (HP:0002099)	1	0.6549	1.526950679	0.481351865	respiratory
Browning et al. 2018 Introgressed	HPO	Rectal prolapse (HP:0002035)	1	0.6555	1.525553013	0.481751825	digestive
Browning et al. 2018 Introgressed	HPO	Aseptic necrosis (HP:0010885)	1	0.6623	1.509889778	0.481851815	skeletal
Browning et al. 2018 Introgressed	HPO	Dysarthria (HP:0001260)	6	5.5749	1.076252489	0.483751625	nervous
Browning et al. 2018 Introgressed	HPO	Absent eyelashes (HP:0000561)	1	0.6685	1.495886313	0.487451255	integumentary
Browning et al. 2018 Introgressed	HPO	Hypocalcemia (HP:0002901)	1	0.6685	1.495886313	0.488451155	other
Browning et al. 2018 Introgressed	HPO	Absent eyebrow (HP:0002223)	1	0.6764	1.478415139	0.490850915	integumentary
Browning et al. 2018 Introgressed	HPO	Diaphragmatic weakness (HP:0009113)	1	0.6786	1.473622163	0.491950805	respiratory
Browning et al. 2018 Introgressed	HPO	Tachypnea (HP:0002789)	1	0.6757	1.479946722	0.493050695	respiratory
Browning et al. 2018 Introgressed	HPO	Villous atrophy (HP:0011473)	1	0.6856	1.458576429	0.495750425	digestive
Browning et al. 2018 Introgressed	HPO	Abnormality of small intestinal villus morphology (HP:0011472)	1	0.6856	1.458576429	0.495750425	digestive
Browning et al. 2018 Introgressed	HPO	Hypoplasia of the odontoid process (HP:0003311)	1	0.6917	1.44571346	0.498050195	skeletal
Browning et al. 2018 Introgressed	HPO	Abnormality of the odontoid process (HP:0003310)	1	0.6951	1.438641922	0.499650035	skeletal
Browning et al. 2018 Introgressed	HPO	Cerebellar atrophy (HP:0001272)	5	4.665	1.071811361	0.501449855	nervous
Browning et al. 2018 Introgressed	HPO	Absent hair (HP:0002298)	1	0.6989	1.43081986	0.502849715	integumentary
Browning et al. 2018 Introgressed	HPO	Bifid tongue (HP:0010297)	1	0.6983	1.432049262	0.504049595	other
Browning et al. 2018 Introgressed	HPO	Focal seizures (HP:0007359)	1	0.7079	1.412628902	0.506349365	nervous
Browning et al. 2018 Introgressed	HPO	Obsessive-compulsive behavior (HP:0000722)	1	0.7027	1.423082396	0.506949305	behavior
Browning et al. 2018 Introgressed	HPO	Neonatal death (HP:0003811)	1	0.7159	1.396843135	0.508949105	other
Browning et al. 2018 Introgressed	HPO	Primary adrenal insufficiency (HP:0008207)	2	1.7069	1.171714805	0.510648935	endocrine
Browning et al. 2018 Introgressed	HPO	Abnormality of the acetabulum (HP:0003170)	1	0.7238	1.381597126	0.511348865	skeletal
Browning et al. 2018 Introgressed	HPO	Constricted visual fields (HP:0001133)	2	1.7351	1.152671316	0.515848415	nervous
Browning et al. 2018 Introgressed	HPO	Hypoplastic female external genitalia (HP:0012815)	1	0.7327	1.364815068	0.518148185	reproductive
Browning et al. 2018 Introgressed	HPO	Bone pain (HP:0002653)	1	0.7313	1.367427868	0.523247675	skeletal
Browning et al. 2018 Introgressed	HPO	Joint contractures involving the joints of the feet (HP:0100492)	1	0.7462	1.340123291	0.524447555	skeletal
Browning et al. 2018 Introgressed	HPO	Flexion contracture of toe (HP:0005830)	1	0.7462	1.340123291	0.524447555	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Choreoathetosis (HP:0001266)	1	0.7489	1.335291761	0.525647435	nervous
Browning et al. 2018 Introgressed	HPO	Flat face (HP:0012368)	2	1.7658	1.132631102	0.526547345	skeletal
Browning et al. 2018 Introgressed	HPO	Patent ductus arteriosus (HP:0001643)	3	2.8	1.071428571	0.531946805	cardiovascular
Browning et al. 2018 Introgressed	HPO	Abnormality of salivation (HP:0100755)	1	0.7695	1.299545159	0.536446355	digestive
Browning et al. 2018 Introgressed	HPO	Meningocele (HP:0002435)	1	0.7585	1.318391562	0.536846315	nervous
Browning et al. 2018 Introgressed	HPO	Conical tooth (HP:0000698)	1	0.7557	1.323276432	0.538146185	skeletal
Browning et al. 2018 Introgressed	HPO	Postnatal growth retardation (HP:0008897)	2	1.8148	1.102049813	0.539546045	metabolic
Browning et al. 2018 Introgressed	HPO	Bowel diverticulosis (HP:0005222)	1	0.7832	1.276813075	0.541045895	digestive
Browning et al. 2018 Introgressed	HPO	Lissencephaly (HP:0001339)	1	0.7716	1.296008294	0.541645835	nervous
Browning et al. 2018 Introgressed	HPO	Prolonged QT interval (HP:0001657)	1	0.7745	1.291155584	0.542845715	cardiovascular
Browning et al. 2018 Introgressed	HPO	Infertility (HP:0000789)	1	0.7745	1.291155584	0.544245575	reproductive
Browning et al. 2018 Introgressed	HPO	Blepharophimosis (HP:0000581)	4	3.8851	1.029574528	0.544745525	integumentary
Browning et al. 2018 Introgressed	HPO	Vertigo (HP:0002321)	1	0.8008	1.248751249	0.545345465	nervous
Browning et al. 2018 Introgressed	HPO	Smooth philtrum (HP:0000319)	1	0.784	1.275510204	0.546945305	integumentary
Browning et al. 2018 Introgressed	HPO	Ptosis (HP:0000508)	8	8.0529	0.993430938	0.548245175	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Abnormal biliary tract morphology (HP:0012440)	1	0.7928	1.26135217	0.550044996	digestive
Browning et al. 2018 Introgressed	HPO	Plagiocephaly (HP:0001357)	1	0.8056	1.241310824	0.552344766	skeletal
Browning et al. 2018 Introgressed	HPO	Type II diabetes mellitus (HP:0005978)	3	2.8959	1.035947374	0.552544746	metabolic
Browning et al. 2018 Introgressed	HPO	Genu recurvatum (HP:0002816)	1	0.8054	1.241619071	0.552944706	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Hypermelanotic macule (HP:0001034)	2	1.8627	1.073710206	0.553944606	integumentary
Browning et al. 2018 Introgressed	HPO	Long eyelashes (HP:0000527)	1	0.8097	1.235025318	0.554444556	integumentary
Browning et al. 2018 Introgressed	HPO	Laryngomalacia (HP:0001601)	1	0.818	1.222493888	0.555444456	other
Browning et al. 2018 Introgressed	HPO	Cavernous hemangioma (HP:0001048)	1	0.821	1.218026797	0.556244376	cardiovascular
Browning et al. 2018 Introgressed	HPO	Short neck (HP:0000470)	5	4.9762	1.004782766	0.557044296	skeletal
Browning et al. 2018 Introgressed	HPO	Abnormal lung lobation (HP:0002101)	1	0.8195	1.220256254	0.557044296	respiratory
Browning et al. 2018 Introgressed	HPO	Retinopathy (HP:0000488)	1	0.8121	1.231375446	0.557444256	nervous
Browning et al. 2018 Introgressed	HPO	Rocker bottom foot (HP:0001838)	1	0.8156	1.226091221	0.558344166	skeletal
Browning et al. 2018 Introgressed	HPO	Abnormality of the gallbladder (HP:0005264)	1	0.8132	1.229709788	0.558444156	digestive
Browning et al. 2018 Introgressed	HPO	Melanoma (HP:0002861)	1	0.8308	1.203659124	0.560743926	integumentary
Browning et al. 2018 Introgressed	HPO	Short palm (HP:0004279)	2	1.8988	1.053296819	0.563643636	skeletal
Browning et al. 2018 Introgressed	HPO	Lack of skin elasticity (HP:0100679)	1	0.8249	1.212268154	0.563943606	integumentary
Browning et al. 2018 Introgressed	HPO	Steppage gait (HP:0003376)	1	0.8362	1.195886152	0.565043496	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Abnormal albumin level (HP:0012116)	1	0.8383	1.192890373	0.567143286	other
Browning et al. 2018 Introgressed	HPO	Hypoalbuminemia (HP:0003073)	1	0.8383	1.192890373	0.567143286	other
Browning et al. 2018 Introgressed	HPO	Sudden death (HP:0001699)	1	0.8465	1.181334908	0.570142986	other
Browning et al. 2018 Introgressed	HPO	Preauricular skin tag (HP:0000384)	1	0.8379	1.19345984	0.570842916	integumentary
Browning et al. 2018 Introgressed	HPO	Irritability (HP:0000737)	1	0.8454	1.182872013	0.571042896	behavior
Browning et al. 2018 Introgressed	HPO	Cutaneous finger syndactyly (HP:0010554)	2	1.9273	1.037721164	0.572242776	integumentary
Browning et al. 2018 Introgressed	HPO	Blindness (HP:0000618)	1	0.8449	1.18357202	0.573842616	nervous
Browning et al. 2018 Introgressed	HPO	Synostosis involving bones of the feet (HP:0009140)	1	0.8524	1.173158142	0.575642436	skeletal
Browning et al. 2018 Introgressed	HPO	Synostosis involving bones of the lower limbs (HP:0009138)	1	0.8524	1.173158142	0.575642436	skeletal
Browning et al. 2018 Introgressed	HPO	Abnormality of the pleura (HP:0002103)	1	0.8648	1.156336725	0.575642436	respiratory
Browning et al. 2018 Introgressed	HPO	Tarsal synostosis (HP:0008368)	1	0.8524	1.173158142	0.575642436	skeletal
Browning et al. 2018 Introgressed	HPO	Intestinal polyposis (HP:0200008)	1	0.8758	1.141813199	0.578242176	digestive
Browning et al. 2018 Introgressed	HPO	Intestinal polyp (HP:0005266)	1	0.8758	1.141813199	0.578242176	digestive
Browning et al. 2018 Introgressed	HPO	Ventricular septal defect (HP:0001629)	4	4.0548	0.986485153	0.579142086	cardiovascular
Browning et al. 2018 Introgressed	HPO	Vesicoureteral reflux (HP:0000076)	2	1.9711	1.014661864	0.579742026	urinary
Browning et al. 2018 Introgressed	HPO	Cutaneous syndactyly (HP:0012725)	2	1.9657	1.017449255	0.582341766	integumentary
Browning et al. 2018 Introgressed	HPO	Gaze-evoked nystagmus (HP:0000640)	2	1.9538	1.023646228	0.582641736	nervous
Browning et al. 2018 Introgressed	HPO	Umbilical hernia (HP:0001537)	7	7.2198	0.969555943	0.584541546	reproductive
Browning et al. 2018 Introgressed	HPO	Ovarian neoplasm (HP:0100615)	3	3.0221	0.992687204	0.585641436	reproductive
Browning et al. 2018 Introgressed	HPO	Optic atrophy (HP:0000648)	9	9.3027	0.96746106	0.586941306	nervous
Browning et al. 2018 Introgressed	HPO	Limited hip movement (HP:0008800)	1	0.8907	1.122712473	0.588841116	other
Browning et al. 2018 Introgressed	HPO	Goiter (HP:0000853)	1	0.871	1.148105626	0.589441056	endocrine
Browning et al. 2018 Introgressed	HPO	Hypoplastic iliac wings (HP:0002866)	1	0.8934	1.119319454	0.591840816	skeletal
Browning et al. 2018 Introgressed	HPO	Spinal canal stenosis (HP:0003416)	1	0.9058	1.103996467	0.592940706	skeletal
Browning et al. 2018 Introgressed	HPO	Esotropia (HP:0000565)	1	0.8876	1.126633619	0.593440656	nervous
Browning et al. 2018 Introgressed	HPO	Lymphangioma (HP:0100764)	1	0.8959	1.116196004	0.593540646	lymphatic
Browning et al. 2018 Introgressed	HPO	Nephrolithiasis (HP:0000787)	1	0.8989	1.112470798	0.594640536	urinary
Browning et al. 2018 Introgressed	HPO	Exostoses (HP:0100777)	1	0.9164	1.091226539	0.595140486	skeletal
Browning et al. 2018 Introgressed	HPO	Abnormality of incisor morphology (HP:0011063)	1	0.8953	1.116944041	0.597440256	skeletal
Browning et al. 2018 Introgressed	HPO	Pyloric stenosis (HP:0002021)	2	1.9915	1.00426814	0.599240076	digestive
Browning et al. 2018 Introgressed	HPO	Sandal gap (HP:0001852)	1	0.9113	1.09733348	0.599740026	skeletal
Browning et al. 2018 Introgressed	HPO	Pachygyria (HP:0001302)	1	0.9164	1.091226539	0.600839916	nervous
Browning et al. 2018 Introgressed	HPO	Generalized tonic-clonic seizures (HP:0002069)	1	0.9157	1.092060719	0.602439756	nervous
Browning et al. 2018 Introgressed	HPO	Genu valgum (HP:0002857)	2	2.05	0.975609756	0.605239476	skeletal
Browning et al. 2018 Introgressed	HPO	Ectopic anus (HP:0004397)	1	0.9217	1.08495172	0.605739426	digestive
Browning et al. 2018 Introgressed	HPO	Radial deviation of finger (HP:0009466)	6	6.3701	0.941900441	0.606339366	skeletal
Browning et al. 2018 Introgressed	HPO	Webbed neck (HP:0000465)	1	0.9285	1.077005924	0.607539246	integumentary
Browning et al. 2018 Introgressed	HPO	Thick lower lip vermilion (HP:0000179)	2	2.0825	0.960384154	0.613238676	integumentary
Browning et al. 2018 Introgressed	HPO	Short ribs (HP:0000773)	1	0.9543	1.047888505	0.616338366	skeletal
Browning et al. 2018 Introgressed	HPO	Cranial hyperostosis (HP:0004437)	1	0.9643	1.037021674	0.616438356	skeletal
Browning et al. 2018 Introgressed	HPO	Short metatarsal (HP:0010743)	1	0.9655	1.035732781	0.618738126	skeletal
Browning et al. 2018 Introgressed	HPO	Palmoplantar keratoderma (HP:0000982)	3	3.2118	0.93405567	0.621237876	integumentary
Browning et al. 2018 Introgressed	HPO	Microcornea (HP:0000482)	2	2.0934	0.955383587	0.621237876	nervous
Browning et al. 2018 Introgressed	HPO	Narrow palate (HP:0000189)	1	0.9589	1.042861612	0.621837816	skeletal
Browning et al. 2018 Introgressed	HPO	Tetralogy of Fallot (HP:0001636)	2	2.1039	0.950615524	0.621837816	cardiovascular
Browning et al. 2018 Introgressed	HPO	Iris coloboma (HP:0000612)	2	2.1093	0.948181861	0.624737526	nervous
Browning et al. 2018 Introgressed	HPO	Hypertelorism (HP:0000316)	9	9.6317	0.934414486	0.625737426	skeletal
Browning et al. 2018 Introgressed	HPO	Abnormal blistering of the skin (HP:0008066)	1	1.0141	0.986096046	0.633936606	integumentary
Browning et al. 2018 Introgressed	HPO	Cerebral cortical atrophy (HP:0002120)	4	4.3758	0.914118561	0.639936006	nervous
Browning et al. 2018 Introgressed	HPO	Dental malocclusion (HP:0000689)	2	2.1487	0.930795365	0.640035996	skeletal
Browning et al. 2018 Introgressed	HPO	Abnormality of intracranial pressure (HP:0012640)	1	1.0183	0.982028872	0.640335966	nervous
Browning et al. 2018 Introgressed	HPO	Increased intracranial pressure (HP:0002516)	1	1.0183	0.982028872	0.640335966	nervous
Browning et al. 2018 Introgressed	HPO	Memory impairment (HP:0002354)	1	1.0022	0.997804829	0.644735526	nervous
Browning et al. 2018 Introgressed	HPO	Ascites (HP:0001541)	2	2.1865	0.914703865	0.645235476	digestive
Browning et al. 2018 Introgressed	HPO	Progressive inability to walk (HP:0002505)	1	1.0275	0.97323601	0.647235276	other
Browning et al. 2018 Introgressed	HPO	Generalized hyperpigmentation (HP:0007440)	1	1.0577	0.945447669	0.649935006	integumentary
Browning et al. 2018 Introgressed	HPO	Psychosis (HP:0000709)	1	1.0398	0.961723408	0.650334967	nervous
Browning et al. 2018 Introgressed	HPO	Depressed nasal ridge (HP:0000457)	2	2.2158	0.902608539	0.652234777	skeletal
Browning et al. 2018 Introgressed	HPO	Thick eyebrow (HP:0000574)	1	1.043	0.958772771	0.652634737	integumentary
Browning et al. 2018 Introgressed	HPO	Myoclonus (HP:0001336)	1	1.0612	0.942329438	0.652734727	nervous
Browning et al. 2018 Introgressed	HPO	Macroglossia (HP:0000158)	1	1.0495	0.952834683	0.656434357	other
Browning et al. 2018 Introgressed	HPO	Narrow forehead (HP:0000341)	1	1.0858	0.920979923	0.659634037	skeletal
Browning et al. 2018 Introgressed	HPO	Photophobia (HP:0000613)	3	3.4018	0.88188606	0.659934007	nervous
Browning et al. 2018 Introgressed	HPO	Gait ataxia (HP:0002066)	2	2.2655	0.882807327	0.664233577	nervous
Browning et al. 2018 Introgressed	HPO	Juvenile onset (HP:0003621)	2	2.2867	0.874622819	0.665833417	other
Browning et al. 2018 Introgressed	HPO	Synostosis of carpal bones (HP:0005048)	1	1.102	0.907441016	0.667633237	skeletal
Browning et al. 2018 Introgressed	HPO	Recurrent fractures (HP:0002757)	3	3.4714	0.864204644	0.668933107	skeletal
Browning et al. 2018 Introgressed	HPO	Polycystic kidney dysplasia (HP:0000113)	1	1.1167	0.895495657	0.676332367	urinary
Browning et al. 2018 Introgressed	HPO	Neoplasm of the thyroid gland (HP:0100031)	1	1.1367	0.879739597	0.679732027	endocrine
Browning et al. 2018 Introgressed	HPO	Childhood onset (HP:0011463)	1	1.14	0.877192982	0.684231577	other
Browning et al. 2018 Introgressed	HPO	Abnormality of the incisor (HP:0000676)	1	1.1382	0.878580214	0.684831517	skeletal
Browning et al. 2018 Introgressed	HPO	Bulbous nose (HP:0000414)	1	1.1505	0.86918731	0.685531447	other
Browning et al. 2018 Introgressed	HPO	Micropenis (HP:0000054)	2	2.3984	0.83388926	0.687931207	reproductive
Browning et al. 2018 Introgressed	HPO	Limb ataxia (HP:0002070)	2	2.4158	0.827883103	0.694230577	nervous
Browning et al. 2018 Introgressed	HPO	Osteoarthritis (HP:0002758)	1	1.2034	0.830978893	0.698630137	skeletal
Browning et al. 2018 Introgressed	HPO	Rhizomelia (HP:0008905)	1	1.1908	0.839771582	0.698630137	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Dilated cardiomyopathy (HP:0001644)	1	1.2063	0.828981182	0.699830017	cardiovascular
Browning et al. 2018 Introgressed	HPO	Melanocytic nevus (HP:0000995)	1	1.2232	0.817527796	0.701129887	integumentary
Browning et al. 2018 Introgressed	HPO	Hypodontia (HP:0000668)	1	1.222	0.818330606	0.702829717	skeletal
Browning et al. 2018 Introgressed	HPO	Hyperhidrosis (HP:0000975)	1	1.2063	0.828981182	0.703329667	integumentary
Browning et al. 2018 Introgressed	HPO	Aplasia/Hypoplasia of metatarsal bones (HP:0001964)	1	1.22	0.819672131	0.704529547	skeletal
Browning et al. 2018 Introgressed	HPO	Teleangiectasia of the skin (HP:0100585)	1	1.2196	0.819940964	0.704529547	cardiovascular
Browning et al. 2018 Introgressed	HPO	Respiratory failure (HP:0002878)	1	1.2258	0.815793767	0.705529447	respiratory
Browning et al. 2018 Introgressed	HPO	Round face (HP:0000311)	2	2.4767	0.807526144	0.707029297	skeletal
Browning et al. 2018 Introgressed	HPO	Renal hypoplasia (HP:0000089)	1	1.2348	0.809847749	0.707329267	urinary
Browning et al. 2018 Introgressed	HPO	Skin tags (HP:0010609)	1	1.2247	0.816526496	0.707329267	integumentary
Browning et al. 2018 Introgressed	HPO	Bradykinesia (HP:0002067)	1	1.2314	0.812083807	0.707929207	nervous
Browning et al. 2018 Introgressed	HPO	Clinodactyly of the 5th finger (HP:0004209)	5	6.0196	0.830619975	0.708029197	skeletal
Browning et al. 2018 Introgressed	HPO	Abnormality of the pericardium (HP:0001697)	1	1.2268	0.81512879	0.708529147	cardiovascular
Browning et al. 2018 Introgressed	HPO	Increased number of teeth (HP:0011069)	1	1.2306	0.812611734	0.712228777	skeletal
Browning et al. 2018 Introgressed	HPO	Carpal synostosis (HP:0009702)	1	1.2635	0.791452315	0.715528447	skeletal
Browning et al. 2018 Introgressed	HPO	Synostosis involving bones of the hand (HP:0004278)	1	1.2635	0.791452315	0.715528447	skeletal
Browning et al. 2018 Introgressed	HPO	Anxiety (HP:0000739)	1	1.2366	0.808668931	0.715828417	behavior
Browning et al. 2018 Introgressed	HPO	Abdominal pain (HP:0002027)	2	2.5053	0.798307588	0.718028197	other
Browning et al. 2018 Introgressed	HPO	Death in infancy (HP:0001522)	1	1.2656	0.790139064	0.718228177	other
Browning et al. 2018 Introgressed	HPO	Sudden cardiac death (HP:0001645)	2	2.5472	0.785175879	0.720727927	cardiovascular
Browning et al. 2018 Introgressed	HPO	Premature birth (HP:0001622)	1	1.291	0.774593338	0.720927907	reproductive
Browning et al. 2018 Introgressed	HPO	Cerebellar hypoplasia (HP:0001321)	1	1.2742	0.784806153	0.723027697	nervous
Browning et al. 2018 Introgressed	HPO	Somatic mutation (HP:0001428)	1	1.2872	0.77688005	0.726927307	other
Browning et al. 2018 Introgressed	HPO	Aggressive behavior (HP:0000718)	1	1.3017	0.768226166	0.729627037	behavior
Browning et al. 2018 Introgressed	HPO	Skin ulcer (HP:0200042)	1	1.3027	0.767636447	0.732726727	integumentary
Browning et al. 2018 Introgressed	HPO	Polyhydramnios (HP:0001561)	2	2.6145	0.76496462	0.734726527	reproductive
Browning et al. 2018 Introgressed	HPO	Autism (HP:0000717)	2	2.646	0.755857899	0.735026497	nervous
Browning et al. 2018 Introgressed	HPO	Intrauterine growth retardation (HP:0001511)	5	6.1971	0.806829001	0.736926307	other
Browning et al. 2018 Introgressed	HPO	Triangular face (HP:0000325)	2	2.6829	0.745462	0.743025697	other
Browning et al. 2018 Introgressed	HPO	Pruritus (HP:0000989)	1	1.3783	0.725531452	0.746925307	integumentary
Browning et al. 2018 Introgressed	HPO	Upslanted palpebral fissure (HP:0000582)	2	2.6636	0.750863493	0.747925207	integumentary
Browning et al. 2018 Introgressed	HPO	Frontal bossing (HP:0002007)	4	5.1497	0.776744276	0.751824818	skeletal
Browning et al. 2018 Introgressed	HPO	Prominent forehead (HP:0011220)	1	1.4013	0.713623064	0.757624238	skeletal
Browning et al. 2018 Introgressed	HPO	Incomplete penetrance (HP:0003829)	2	2.7372	0.730673681	0.759824018	other
Browning et al. 2018 Introgressed	HPO	Cryptorchidism (HP:0000028)	8	9.7921	0.816985121	0.759924008	reproductive
Browning et al. 2018 Introgressed	HPO	Depression (HP:0000716)	1	1.4361	0.696330339	0.760023998	behavior
Browning et al. 2018 Introgressed	HPO	Hematuria (HP:0000790)	1	1.3984	0.715102975	0.760323968	urinary
Browning et al. 2018 Introgressed	HPO	Hypoplasia of the maxilla (HP:0000327)	1	1.435	0.696864111	0.764123588	skeletal
Browning et al. 2018 Introgressed	HPO	Primary amenorrhea (HP:0000786)	1	1.4543	0.687616035	0.764223578	reproductive
Browning et al. 2018 Introgressed	HPO	Facial edema (HP:0000282)	1	1.4275	0.700525394	0.765223478	immune
Browning et al. 2018 Introgressed	HPO	Periorbital edema (HP:0100539)	1	1.4275	0.700525394	0.765223478	other
Browning et al. 2018 Introgressed	HPO	Ventricular tachycardia (HP:0004756)	1	1.4593	0.685260056	0.766423358	cardiovascular
Browning et al. 2018 Introgressed	HPO	Inability to walk (HP:0002540)	1	1.4434	0.692808646	0.766823318	other
Browning et al. 2018 Introgressed	HPO	Metabolic acidosis (HP:0001942)	1	1.4607	0.684603272	0.768923108	metabolic
Browning et al. 2018 Introgressed	HPO	Rigidity (HP:0002063)	1	1.4661	0.682081713	0.769623038	skeletal muscle
Browning et al. 2018 Introgressed	HPO	High palate (HP:0000218)	3	4.0986	0.731957254	0.771822818	skeletal
Browning et al. 2018 Introgressed	HPO	Lymphedema (HP:0001004)	1	1.52	0.657894737	0.782721728	lymphatic
Browning et al. 2018 Introgressed	HPO	Delayed skeletal maturation (HP:0002750)	3	4.1514	0.722647781	0.783421658	skeletal
Browning et al. 2018 Introgressed	HPO	Deeply set eye (HP:0000490)	2	2.9067	0.688065504	0.783721628	nervous
Browning et al. 2018 Introgressed	HPO	Microdontia (HP:0000691)	1	1.5677	0.637877145	0.789421058	skeletal
Browning et al. 2018 Introgressed	HPO	Spina bifida occulta (HP:0003298)	1	1.5597	0.641148939	0.790020998	skeletal
Browning et al. 2018 Introgressed	HPO	Pectus carinatum (HP:0000768)	2	2.9628	0.675037127	0.793020698	skeletal
Browning et al. 2018 Introgressed	HPO	Talipes equinovarus (HP:0001762)	3	4.2705	0.702493853	0.795620438	skeletal
Browning et al. 2018 Introgressed	HPO	Hamartoma (HP:0010566)	1	1.5996	0.625156289	0.796320368	other
Browning et al. 2018 Introgressed	HPO	Brachydactyly syndrome (HP:0001156)	4	5.466	0.731796561	0.797020298	skeletal
Browning et al. 2018 Introgressed	HPO	Opacification of the corneal stroma (HP:0007759)	1	1.5865	0.630318311	0.797520248	nervous
Browning et al. 2018 Introgressed	HPO	Stereotypic behavior (HP:0000733)	1	1.6131	0.619924369	0.801919808	behavior
Browning et al. 2018 Introgressed	HPO	"Low-set, posteriorly rotated ears (HP:0000368)"	7	9.227	0.758643113	0.814318568	other
Browning et al. 2018 Introgressed	HPO	Lethargy (HP:0001254)	1	1.7074	0.585685838	0.816018398	behavior
Browning et al. 2018 Introgressed	HPO	Lipoatrophy (HP:0100578)	1	1.7144	0.583294447	0.817818218	metabolic
Browning et al. 2018 Introgressed	HPO	Joint laxity (HP:0001388)	1	1.6932	0.590597685	0.820817918	skeletal
Browning et al. 2018 Introgressed	HPO	Retinitis pigmentosa (HP:0000510)	2	3.1366	0.637633106	0.822917708	integumentary
Browning et al. 2018 Introgressed	HPO	Gliosis (HP:0002171)	1	1.7498	0.571493885	0.824217578	nervous
Browning et al. 2018 Introgressed	HPO	Midface retrusion (HP:0011800)	1	1.7413	0.574283581	0.824817518	skeletal
Browning et al. 2018 Introgressed	HPO	Babinski sign (HP:0003487)	2	3.1823	0.628476259	0.825817418	nervous
Browning et al. 2018 Introgressed	HPO	Long philtrum (HP:0000343)	4	5.8155	0.687817041	0.828117188	integumentary
Browning et al. 2018 Introgressed	HPO	Malar flattening (HP:0000272)	4	5.8542	0.683270131	0.835416458	skeletal
Browning et al. 2018 Introgressed	HPO	Broad forehead (HP:0000337)	1	1.7761	0.563031361	0.835816418	skeletal
Browning et al. 2018 Introgressed	HPO	Micromelia (HP:0002983)	2	3.2756	0.610575162	0.840715928	skeletal
Browning et al. 2018 Introgressed	HPO	Blue sclerae (HP:0000592)	1	1.883	0.531067446	0.841415858	integumentary
Browning et al. 2018 Introgressed	HPO	Attenuation of retinal blood vessels (HP:0007843)	1	1.8372	0.544306553	0.845015498	cardiovascular
Browning et al. 2018 Introgressed	HPO	Short philtrum (HP:0000322)	1	1.8773	0.532679913	0.846415358	integumentary
Browning et al. 2018 Introgressed	HPO	Hypospadias (HP:0000047)	1	1.8825	0.531208499	0.847015298	urinary
Browning et al. 2018 Introgressed	HPO	Congenital diaphragmatic hernia (HP:0000776)	1	1.9205	0.520697735	0.851014899	respiratory
Browning et al. 2018 Introgressed	HPO	Carious teeth (HP:0000670)	1	1.9284	0.518564613	0.853014699	skeletal
Browning et al. 2018 Introgressed	HPO	Hypermetropia (HP:0000540)	1	1.9675	0.508259212	0.856214379	nervous
Browning et al. 2018 Introgressed	HPO	Osteopenia (HP:0000938)	1	1.9785	0.505433409	0.859814019	skeletal
Browning et al. 2018 Introgressed	HPO	Retinal detachment (HP:0000541)	1	2.0259	0.493607779	0.863613639	nervous
Browning et al. 2018 Introgressed	HPO	Osteoporosis (HP:0000939)	1	1.9702	0.507562684	0.865013499	skeletal
Browning et al. 2018 Introgressed	HPO	Single transverse palmar crease (HP:0000954)	2	3.492	0.572737686	0.866413359	integumentary
Browning et al. 2018 Introgressed	HPO	Hydronephrosis (HP:0000126)	1	2.0737	0.482229831	0.877712229	urinary
Browning et al. 2018 Introgressed	HPO	Neonatal hypotonia (HP:0001319)	1	2.1988	0.454793524	0.891710829	skeletal muscle
Browning et al. 2018 Introgressed	HPO	Congenital onset (HP:0003577)	2	3.8452	0.520128992	0.895910409	other
Browning et al. 2018 Introgressed	HPO	Congestive heart failure (HP:0001635)	1	2.2713	0.440276494	0.897810219	cardiovascular
Browning et al. 2018 Introgressed	HPO	Hypothyroidism (HP:0000821)	1	2.2983	0.435104207	0.897810219	endocrine
Browning et al. 2018 Introgressed	HPO	Delayed eruption of teeth (HP:0000684)	1	2.2727	0.44000528	0.899510049	skeletal
Browning et al. 2018 Introgressed	HPO	Uterine neoplasm (HP:0010784)	1	2.4208	0.413086583	0.909609039	reproductive
Browning et al. 2018 Introgressed	HPO	Coarse facial features (HP:0000280)	1	2.4317	0.411234939	0.911908809	integumentary
Browning et al. 2018 Introgressed	HPO	Telecanthus (HP:0000506)	1	2.574	0.388500389	0.921107889	skeletal
Browning et al. 2018 Introgressed	HPO	Variable expressivity (HP:0003828)	1	2.5851	0.386832231	0.921907809	other
Browning et al. 2018 Introgressed	HPO	Abnormality of the fingernails (HP:0001231)	1	2.7336	0.365817969	0.938206179	integumentary
Browning et al. 2018 Introgressed	HPO	Postaxial hand polydactyly (HP:0001162)	1	2.9105	0.343583577	0.947105289	skeletal
Browning et al. 2018 Introgressed	HPO	Autosomal dominant inheritance (HP:0000006)	25	33.8054	0.739526821	0.95010499	other
Browning et al. 2018 Introgressed	HPO	Short nose (HP:0003196)	2	4.8063	0.416120508	0.95350465	skeletal
Browning et al. 2018 Introgressed	HPO	Depressed nasal bridge (HP:0005280)	4	8.1063	0.493443371	0.96090391	skeletal
Browning et al. 2018 Introgressed	HPO	Infantile onset (HP:0003593)	2	5.3232	0.375713856	0.96860314	other
Browning et al. 2018 Introgressed	HPO	Epicanthus (HP:0000286)	3	8.4178	0.356387655	0.98880112	integumentary
Chagyrskaya	GWAS	Chronotype	6	0.6451	9.300883584	0.00039996	behavior
Chagyrskaya	GWAS	Morning vs. evening chronotype	5	0.5718	8.744316194	0.00059994	behavior
Chagyrskaya	GWAS	Systolic blood pressure x smoking status (current vs non-current) interaction (1df test)	3	0.3825	7.843137255	0.00729927	cardiovascular
Chagyrskaya	GWAS	Plasma PCSK9 levels in stable coronary artery disease	2	0.1301	15.37279016	0.00809919	cardiovascular
Chagyrskaya	GWAS	Bilirubin levels	3	0.4015	7.471980075	0.00819918	digestive
Chagyrskaya	GWAS	Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)	6	1.8048	3.324468085	0.01049895	cardiovascular
Chagyrskaya	GWAS	Cholangiocarcinoma in primary sclerosing cholangitis (time to event)	2	0.1594	12.54705144	0.01329867	digestive
Chagyrskaya	GWAS	Fasting blood insulin	2	0.1892	10.57082452	0.01429857	metabolic
Chagyrskaya	GWAS	Binge eating behaviour and bipolar disorder	1	0.0147	68.02721088	0.01469853	behavior
Chagyrskaya	GWAS	Caffeine metabolism (plasma caffeine) level)	1	0.0158	63.29113924	0.01579842	metabolic
Chagyrskaya	GWAS	Response to fenofibrate (LDL cholesterol levels)	2	0.2028	9.861932939	0.01729827	other
Chagyrskaya	GWAS	Autism spectrum disorder	2	0.2036	9.823182711	0.01779822	behavior
Chagyrskaya	GWAS	Caffeine metabolism (plasma paraxanthine caffeine ratio)	1	0.0188	53.19148936	0.01869813	metabolic
Chagyrskaya	GWAS	Breastfeeding duration	2	0.2127	9.402914904	0.01879812	reproductive
Chagyrskaya	GWAS	HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	2	0.2002	9.99000999	0.0189981	metabolic
Chagyrskaya	GWAS	Menstruation quality of life impact (dysmenorrhea)	1	0.0229	43.66812227	0.02289771	reproductive
Chagyrskaya	GWAS	Pain medicine use during menstruation	1	0.0229	43.66812227	0.02289771	reproductive
Chagyrskaya	GWAS	Length of menstrual cycle	1	0.0249	40.16064257	0.02479752	reproductive
Chagyrskaya	GWAS	Caffeine consumption	1	0.0266	37.59398496	0.02649735	behavior
Chagyrskaya	GWAS	Neuritic plaques or neurofibrillary tangles (pleiotropy)	1	0.027	37.03703704	0.02659734	nervous
Chagyrskaya	GWAS	Suicide in bipolar disorder	1	0.0277	36.10108303	0.02719728	behavior
Chagyrskaya	GWAS	Dysmenorrheic pain severity	1	0.028	35.71428571	0.02779722	reproductive
Chagyrskaya	GWAS	Common carotid intima-media thickness	2	0.258	7.751937984	0.02879712	cardiovascular
Chagyrskaya	GWAS	Endometrial cancer (Non-endometrioid histology)	2	0.2608	7.668711656	0.03119688	reproductive
Chagyrskaya	GWAS	Immunoglobulin A	2	0.2785	7.181328546	0.0319968	immune
Chagyrskaya	GWAS	Systemic lupus erythematosus and Systemic sclerosis	2	0.3058	6.540222368	0.03329667	immune
Chagyrskaya	GWAS	Prostate cancer (advanced)	2	0.2944	6.793478261	0.0359964	reproductive
Chagyrskaya	GWAS	Psoriasis	3	0.7195	4.169562196	0.03639636	integumentary
Chagyrskaya	GWAS	IgE levels	1	0.0382	26.17801047	0.03759624	immune
Chagyrskaya	GWAS	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	1	0.044	22.72727273	0.04279572	other
Chagyrskaya	GWAS	Alcohol dependence	4	1.3069	3.06067794	0.04319568	behavior
Chagyrskaya	GWAS	Nonsyndromic cleft lip with cleft palate	2	0.3438	5.81733566	0.04369563	other
Chagyrskaya	GWAS	Fasting blood insulin (BMI interaction)	2	0.3589	5.572582892	0.04809519	metabolic
Chagyrskaya	GWAS	Narcolepsy	1	0.0502	19.92031873	0.04839516	behavior
Chagyrskaya	GWAS	Serum alkaline phosphatase levels	2	0.3564	5.611672278	0.050594941	other
Chagyrskaya	GWAS	Diffusing capacity of the lung for carbon monoxide traits	2	0.3738	5.350454789	0.054894511	respiratory
Chagyrskaya	GWAS	Temporomandibular joint disorder	1	0.0563	17.76198934	0.055094491	skeletal muscle
Chagyrskaya	GWAS	Eosinophil percentage of granulocytes	4	1.4065	2.843938855	0.055794421	immune
Chagyrskaya	GWAS	Systemic lupus erythematosus	8	4.1028	1.949887881	0.057994201	immune
Chagyrskaya	GWAS	C-reactive protein	1	0.0623	16.05136437	0.059594041	immune
Chagyrskaya	GWAS	Ulcerative colitis	6	2.8045	2.139418791	0.061993801	digestive
Chagyrskaya	GWAS	Response to anti-TNF therapy in rheumatoid arthritis	2	0.4048	4.940711462	0.062593741	other
Chagyrskaya	GWAS	Lipoprotein-associated phospholipase A2 activity and mass	1	0.0672	14.88095238	0.065193481	metabolic
Chagyrskaya	GWAS	Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)	1	0.0728	13.73626374	0.070292971	immune
Chagyrskaya	GWAS	HIV-1 control	1	0.0737	13.56852103	0.070892911	immune
Chagyrskaya	GWAS	HIV-1 viral setpoint	2	0.4452	4.492362983	0.073192681	immune
Chagyrskaya	GWAS	Eosinophil percentage of white cells	4	1.5853	2.523181732	0.076692331	immune
Chagyrskaya	GWAS	Cannabis dependence	1	0.0793	12.61034048	0.077092291	behavior
Chagyrskaya	GWAS	Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid)	1	0.0804	12.43781095	0.077792221	other
Chagyrskaya	GWAS	White blood cell count (basophil)	3	0.9927	3.022061046	0.078492151	immune
Chagyrskaya	GWAS	Type 1 diabetes and autoimmune thyroid diseases	1	0.0819	12.21001221	0.078692131	metabolic
Chagyrskaya	GWAS	"Functional impairment in major depressive disorder, bipolar disorder and schizophrenia"	1	0.084	11.9047619	0.081291871	nervous
Chagyrskaya	GWAS	Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)	1	0.0935	10.69518717	0.090890911	metabolic
Chagyrskaya	GWAS	Shingles	1	0.0957	10.44932079	0.091290871	immune
Chagyrskaya	GWAS	Low vWF levels	1	0.096	10.41666667	0.092290771	hematologic
Chagyrskaya	GWAS	Sum eosinophil basophil counts	4	1.6901	2.366723862	0.092490751	hematologic
Chagyrskaya	GWAS	Craniofacial microsomia	3	1.0524	2.850627138	0.092890711	skeletal
Chagyrskaya	GWAS	Alcohol consumption	2	0.5075	3.9408867	0.093390661	behavior
Chagyrskaya	GWAS	Huntington's disease progression	2	0.5126	3.901677721	0.094290571	nervous
Chagyrskaya	GWAS	Eosinophil counts	4	1.7222	2.322610614	0.095990401	immune
Chagyrskaya	GWAS	Select biomarker traits	1	0.1007	9.930486594	0.096290371	other
Chagyrskaya	GWAS	Dialysis-related mortality	2	0.5262	3.800836184	0.097190281	other
Chagyrskaya	GWAS	Periodontitis	1	0.1041	9.606147935	0.099190081	immune
Chagyrskaya	GWAS	Post bronchodilator percent predicted FEV1 in smoking	1	0.1117	8.952551477	0.104389561	other
Chagyrskaya	GWAS	Systolic blood pressure change trajectories	1	0.1161	8.613264427	0.108989101	cardiovascular
Chagyrskaya	GWAS	Psychosis and Alzheimer's disease	1	0.1155	8.658008658	0.109489051	behavior
Chagyrskaya	GWAS	Hepatocellular carcinoma	1	0.1192	8.389261745	0.112388761	digestive
Chagyrskaya	GWAS	Urate levels in obese individuals	3	1.1698	2.564540947	0.112588741	metabolic
Chagyrskaya	GWAS	Cardiovascular disease risk factors	1	0.1209	8.271298594	0.114388561	cardiovascular
Chagyrskaya	GWAS	Sense of smell	2	0.5863	3.411222923	0.115388461	nervous
Chagyrskaya	GWAS	Motion sickness	4	1.8321	2.183286938	0.115888411	nervous
Chagyrskaya	GWAS	Serum protein levels (sST2)	1	0.125	8	0.117588241	other
Chagyrskaya	GWAS	Progranulin levels	1	0.1303	7.674597084	0.120787921	nervous
Chagyrskaya	GWAS	Conotruncal heart defects (inherited effects)	1	0.1292	7.73993808	0.121087891	cardiovascular
Chagyrskaya	GWAS	Erythrocyte cadmium concentration	1	0.1295	7.722007722	0.121487851	hematologic
Chagyrskaya	GWAS	Waist-to-hip ratio adjusted for BMI (age <50)	2	0.6015	3.325020781	0.122087791	skeletal
Chagyrskaya	GWAS	Creatinine levels	3	1.2103	2.478724283	0.124687531	other
Chagyrskaya	GWAS	Hypertriglyceridemia	1	0.1415	7.067137809	0.130286971	metabolic
Chagyrskaya	GWAS	Normalized brain volume	1	0.14	7.142857143	0.131686831	nervous
Chagyrskaya	GWAS	Circulating fibroblast growth factor 23 levels	1	0.1464	6.830601093	0.135686431	other
Chagyrskaya	GWAS	Chronic venous disease	1	0.1498	6.675567423	0.137786221	cardiovascular
Chagyrskaya	GWAS	Lipid metabolism phenotypes	1	0.1553	6.439150032	0.144385561	metabolic
Chagyrskaya	GWAS	Common carotid intima-media thickness in HIV infection	2	0.6544	3.056234719	0.144485551	cardiovascular
Chagyrskaya	GWAS	Kidney function decline traits	1	0.1596	6.26566416	0.145385461	urinary
Chagyrskaya	GWAS	White blood cell count	4	2.0302	1.970249237	0.145985401	immune
Chagyrskaya	GWAS	Delirium	2	0.6708	2.981514609	0.146285371	behavior
Chagyrskaya	GWAS	Serum sulfate level	1	0.1593	6.277463905	0.148185181	other
Chagyrskaya	GWAS	Migraine without aura	2	0.6931	2.885586495	0.152284772	nervous
Chagyrskaya	GWAS	Age-related cataracts (age at onset)	1	0.1657	6.035003018	0.152684732	integumentary
Chagyrskaya	GWAS	Palmitoleic acid (16:1n-7) levels	1	0.1675	5.970149254	0.154984502	other
Chagyrskaya	GWAS	Chronic central serous retinopathy	1	0.1674	5.973715651	0.156784322	nervous
Chagyrskaya	GWAS	PR interval	3	1.3789	2.175647255	0.157484252	cardiovascular
Chagyrskaya	GWAS	Bacteremia	1	0.1751	5.711022273	0.160283972	immune
Chagyrskaya	GWAS	Hip circumference adjusted for BMI	3	1.3917	2.155636991	0.162983702	skeletal
Chagyrskaya	GWAS	End-stage coagulation	1	0.1803	5.546311703	0.165683432	hematologic
Chagyrskaya	GWAS	Obese vs. thin	1	0.183	5.464480874	0.167183282	metabolic
Chagyrskaya	GWAS	Sitting height ratio	1	0.1884	5.307855626	0.173982602	skeletal
Chagyrskaya	GWAS	Endometrial cancer	2	0.7528	2.65674814	0.177082292	reproductive
Chagyrskaya	GWAS	Carotid plaque burden	2	0.7695	2.599090318	0.180081992	cardiovascular
Chagyrskaya	GWAS	Chronic inflammatory diseases (pleiotropy)	3	1.4737	2.035692475	0.186081392	immune
Chagyrskaya	GWAS	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes	3	1.4638	2.049460309	0.186281372	cardiovascular
Chagyrskaya	GWAS	Logical memory (immediate recall) in mild cognitive impairment	1	0.208	4.807692308	0.188281172	nervous
Chagyrskaya	GWAS	Glomerular filtration rate	3	1.5011	1.998534408	0.188581142	hematologic
Chagyrskaya	GWAS	Response to antidepressants and depression	1	0.2102	4.75737393	0.191080892	other
Chagyrskaya	GWAS	Hirschsprung disease	1	0.2108	4.743833017	0.192480752	digestive
Chagyrskaya	GWAS	Mercury levels	2	0.8114	2.464875524	0.194080592	other
Chagyrskaya	GWAS	Cystic fibrosis severity	1	0.2123	4.710315591	0.194980502	respiratory
Chagyrskaya	GWAS	Activated partial thromboplastin time	1	0.2167	4.614674665	0.195580442	hematologic
Chagyrskaya	GWAS	Barrett's esophagus	1	0.2196	4.553734062	0.196280372	digestive
Chagyrskaya	GWAS	Hippocampal volume in mild cognitive impairment	1	0.2178	4.591368228	0.196380362	nervous
Chagyrskaya	GWAS	Staphylococcus aureus nasal carriage (intermittent)	1	0.215	4.651162791	0.196680332	immune
Chagyrskaya	GWAS	Neurofibrillary tangles	1	0.2204	4.537205082	0.197680232	nervous
Chagyrskaya	GWAS	Response to serotonin reuptake inhibitors in major depressive disorder	1	0.2243	4.458314757	0.200779922	other
Chagyrskaya	GWAS	Accelerated cognitive decline after conversion of MCI to Alzheimer's disease	1	0.2249	4.446420631	0.202079792	nervous
Chagyrskaya	GWAS	Blood protein levels	15	11.7544	1.276117879	0.207579242	other
Chagyrskaya	GWAS	Decline in glucose metabolism in posterior cingulate cortex	1	0.2383	4.196391104	0.210378962	nervous
Chagyrskaya	GWAS	Periodontal microbiota	2	0.8626	2.31857176	0.211578842	immune
Chagyrskaya	GWAS	Alzheimer's disease in APOE e4+ carriers	1	0.24	4.166666667	0.213878612	nervous
Chagyrskaya	GWAS	Depressive symptoms (SSRI exposure interaction)	1	0.2389	4.185851821	0.213878612	behavior
Chagyrskaya	GWAS	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	1	0.2424	4.125412541	0.215578442	other
Chagyrskaya	GWAS	CSF tryptophan concentration in tuberculous meningitis	1	0.2488	4.019292605	0.220477952	nervous
Chagyrskaya	GWAS	Breast cancer and/or colorectal cancer	1	0.2489	4.017677782	0.220877912	reproductive
Chagyrskaya	GWAS	Quantitative traits	2	0.8812	2.26963232	0.221777822	other
Chagyrskaya	GWAS	Eye color	1	0.2508	3.987240829	0.222877712	integumentary
Chagyrskaya	GWAS	Asparaginase hypersensitivity in acute lymphoblastic leukemia	1	0.2491	4.014452027	0.222977702	other
Chagyrskaya	GWAS	Mortality in sepsis	1	0.2562	3.903200625	0.225177482	other
Chagyrskaya	GWAS	Hip geometry	1	0.2587	3.865481252	0.227277272	skeletal
Chagyrskaya	GWAS	Adiposity	1	0.2627	3.806623525	0.230376962	metabolic
Chagyrskaya	GWAS	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	1	0.2691	3.716090673	0.234376562	other
Chagyrskaya	GWAS	Blood urea nitrogen levels	2	0.9217	2.169903439	0.234576542	other
Chagyrskaya	GWAS	Depression in smokers	2	0.9269	2.157730068	0.238076192	behavior
Chagyrskaya	GWAS	Self-reported risk-taking behaviour	2	0.9415	2.124269782	0.238476152	behavior
Chagyrskaya	GWAS	Disease progression in age-related macular degeneration	3	1.6972	1.767617252	0.240675932	nervous
Chagyrskaya	GWAS	Plasma factor VII activating protease levels	1	0.2752	3.63372093	0.240875912	other
Chagyrskaya	GWAS	Cerebral amyloid deposition in APOEe4 non-carriers (PET imaging)	2	0.9439	2.118868524	0.240975902	nervous
Chagyrskaya	GWAS	Immune reponse to smallpox (secreted IL-12p40)	1	0.2773	3.606202669	0.242075792	immune
Chagyrskaya	GWAS	Familial lung cancer	1	0.277	3.610108303	0.243475652	respiratory
Chagyrskaya	GWAS	Emphysema-related traits	2	0.9522	2.100399076	0.245775422	respiratory
Chagyrskaya	GWAS	White matter hyperintensity burden	1	0.2886	3.465003465	0.252174783	nervous
Chagyrskaya	GWAS	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	1	0.291	3.436426117	0.252574743	other
Chagyrskaya	GWAS	Iron status biomarkers (total iron binding capacity)	1	0.2934	3.408316292	0.254574543	other
Chagyrskaya	GWAS	Age at smoking initiation in chronic obstructive pulmonary disease	1	0.2929	3.414134517	0.255374463	respiratory
Chagyrskaya	GWAS	Response to tocilizumab in rheumatoid arthritis	1	0.2985	3.350083752	0.256374363	other
Chagyrskaya	GWAS	Body mass index (joint analysis main effects and smoking interaction)	3	1.7651	1.699620418	0.257774223	metabolic
Chagyrskaya	GWAS	Metabolic traits	1	0.3033	3.297065612	0.260873913	metabolic
Chagyrskaya	GWAS	BMI (adjusted for smoking behaviour)	3	1.7775	1.687763713	0.261273873	metabolic
Chagyrskaya	GWAS	Cardiometabolic and hematological traits	1	0.3043	3.286230693	0.261773823	cardiovascular
Chagyrskaya	GWAS	Inflammatory bowel disease	6	4.2801	1.401836406	0.262173783	digestive
Chagyrskaya	GWAS	Posterior cortical atrophy and Alzheimer's disease	1	0.3032	3.298153034	0.263273673	nervous
Chagyrskaya	GWAS	Hippocampal volume	2	1.0045	1.991040319	0.265473453	nervous
Chagyrskaya	GWAS	AIDS progression	1	0.3073	3.25414904	0.266373363	immune
Chagyrskaya	GWAS	Erosive tooth wear (severe vs none or mild)	2	0.9989	2.002202423	0.269173083	skeletal
Chagyrskaya	GWAS	Alcohol and nicotine co-dependence	1	0.3168	3.156565657	0.270572943	behavior
Chagyrskaya	GWAS	Response to lithium treatment in bipolar disorder	1	0.3144	3.180661578	0.271472853	other
Chagyrskaya	GWAS	Heart rate increase in response to exercise	1	0.3183	3.141690229	0.272072793	cardiovascular
Chagyrskaya	GWAS	Barrett's esophagus  or Esophageal adenocarcinoma	1	0.3189	3.135779241	0.273672633	digestive
Chagyrskaya	GWAS	Progressive supranuclear palsy	1	0.3181	3.143665514	0.274372563	nervous
Chagyrskaya	GWAS	Gut microbiota (bacterial taxa)	2	1.0327	1.936670863	0.276572343	digestive
Chagyrskaya	GWAS	Triglycerides	3	1.8582	1.614465612	0.281571843	metabolic
Chagyrskaya	GWAS	Brain structure	1	0.3325	3.007518797	0.283371663	nervous
Chagyrskaya	GWAS	Prostate cancer	4	2.6847	1.489924386	0.283771623	reproductive
Chagyrskaya	GWAS	Urinary albumin-to-creatinine ratio	1	0.3347	2.987750224	0.285771423	metabolic
Chagyrskaya	GWAS	Metabolite levels (HVA/MHPG ratio)	1	0.3363	2.973535534	0.287171283	metabolic
Chagyrskaya	GWAS	Heart rate response to recovery post exercise (10 sec)	1	0.3392	2.948113208	0.290570943	cardiovascular
Chagyrskaya	GWAS	Cleft lip with or without cleft palate	1	0.3419	2.924831822	0.292370763	other
Chagyrskaya	GWAS	Heart rate response to recovery post exercise (30 sec)	1	0.3445	2.90275762	0.292570743	cardiovascular
Chagyrskaya	GWAS	Remission after SSRI treatment in MDD or neuroticism	1	0.3466	2.885170225	0.294470553	other
Chagyrskaya	GWAS	Stearic acid (18:0) levels	1	0.3542	2.823263693	0.296570343	other
Chagyrskaya	GWAS	Heart rate response to recovery post exercise (40 sec)	1	0.3558	2.810567735	0.300169983	cardiovascular
Chagyrskaya	GWAS	LDL cholesterol levels	1	0.3681	2.716653083	0.306169383	metabolic
Chagyrskaya	GWAS	Renal sinus fat	1	0.3667	2.727024816	0.307369263	urinary
Chagyrskaya	GWAS	Height	8	6.4327	1.243645748	0.311368863	skeletal
Chagyrskaya	GWAS	Waist-to-hip ratio adjusted for BMI	3	1.9748	1.519141179	0.316168383	skeletal
Chagyrskaya	GWAS	HDL cholesterol	4	2.8637	1.396794357	0.322567743	metabolic
Chagyrskaya	GWAS	Metabolite levels (lipoprotein measures)	1	0.3888	2.572016461	0.322767723	metabolic
Chagyrskaya	GWAS	Alzheimer's disease	2	1.1755	1.701403658	0.327667233	nervous
Chagyrskaya	GWAS	Liver enzyme levels (gamma-glutamyl transferase)	1	0.3984	2.510040161	0.330366963	other
Chagyrskaya	GWAS	Atopic dermatitis	1	0.4066	2.459419577	0.333166683	integumentary
Chagyrskaya	GWAS	Neutrophil percentage of granulocytes	2	1.1899	1.680813514	0.334466553	lymphatic
Chagyrskaya	GWAS	Erosive tooth wear (severe vs non-severe)	2	1.1804	1.694340901	0.334866513	skeletal
Chagyrskaya	GWAS	Regular attendance at a gym or sports club	1	0.4069	2.457606291	0.334966503	behavior
Chagyrskaya	GWAS	Waist circumference	4	2.9665	1.348390359	0.344165583	skeletal
Chagyrskaya	GWAS	Liver enzyme levels (aspartate transaminase)	1	0.4187	2.388344877	0.344965503	other
Chagyrskaya	GWAS	D-dimer levels	1	0.4281	2.335902826	0.350764924	other
Chagyrskaya	GWAS	Liver fibrosis in pediatric non-alcoholic fatty acid liver disease	1	0.4412	2.266545784	0.352064794	other
Chagyrskaya	GWAS	Creatine kinase levels	1	0.4386	2.27998176	0.354364564	other
Chagyrskaya	GWAS	Idiopathic dilated cardiomyopathy	2	1.2636	1.582779361	0.356864314	cardiovascular
Chagyrskaya	GWAS	Midgestational circulating levels of PBDEs (fetal genetic effect)	1	0.4452	2.246181491	0.357664234	reproductive
Chagyrskaya	GWAS	Daytime sleep phenotypes	4	3.0366	1.317262728	0.358564144	behavior
Chagyrskaya	GWAS	Cerebrospinal fluid p-tau levels	1	0.4405	2.27014756	0.358964104	nervous
Chagyrskaya	GWAS	Obstructive sleep apnea trait (apnea hypopnea index)	1	0.4526	2.209456474	0.362463754	other
Chagyrskaya	GWAS	Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)	3	2.1717	1.381406272	0.364463554	skeletal
Chagyrskaya	GWAS	Psychosis (atypical)	1	0.4521	2.211900022	0.365863414	behavior
Chagyrskaya	GWAS	Selective IgA deficiency	1	0.4671	2.140869193	0.366863314	immune
Chagyrskaya	GWAS	Non-small cell lung cancer	1	0.4573	2.186748305	0.370162984	respiratory
Chagyrskaya	GWAS	Hip circumference	2	1.2883	1.552433439	0.370362964	skeletal
Chagyrskaya	GWAS	Response to statin therapy	2	1.3017	1.536452332	0.371462854	other
Chagyrskaya	GWAS	Low high density lipoprotein cholesterol levels	1	0.4704	2.12585034	0.372762724	metabolic
Chagyrskaya	GWAS	Smooth-surface caries	1	0.4627	2.161227577	0.373362664	skeletal
Chagyrskaya	GWAS	Serum metabolite levels	1	0.4707	2.124495432	0.377562244	metabolic
Chagyrskaya	GWAS	Resting heart rate	3	2.1944	1.367116296	0.379362064	cardiovascular
Chagyrskaya	GWAS	Heart rate response to recovery post exercise (20 sec)	1	0.4739	2.110149821	0.380261974	cardiovascular
Chagyrskaya	GWAS	Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test)	1	0.4766	2.098195552	0.382461754	cardiovascular
Chagyrskaya	GWAS	Systolic blood pressure x smoking status (ever vs never) interaction (2df test)	2	1.3205	1.514577811	0.382461754	cardiovascular
Chagyrskaya	GWAS	Hair greying	1	0.4829	2.070822116	0.382861714	integumentary
Chagyrskaya	GWAS	Myeloid white cell count	2	1.3407	1.491758037	0.387161284	immune
Chagyrskaya	GWAS	Cardiac structure and function	1	0.4906	2.038320424	0.390260974	cardiovascular
Chagyrskaya	GWAS	Heart rate response to recovery post exercise (50 sec)	1	0.5	2	0.394560544	cardiovascular
Chagyrskaya	GWAS	Periodontitis (Mean PAL)	2	1.3648	1.465416178	0.394860514	immune
Chagyrskaya	GWAS	Vitiligo	2	1.3543	1.476777671	0.395460454	integumentary
Chagyrskaya	GWAS	Sum neutrophil eosinophil counts	2	1.3752	1.454333915	0.397960204	hematologic
Chagyrskaya	GWAS	Metabolic syndrome	1	0.5129	1.949697797	0.400059994	metabolic
Chagyrskaya	GWAS	LDL peak particle diameter (total fat intake interaction)	1	0.5118	1.953888238	0.400759924	metabolic
Chagyrskaya	GWAS	Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)	2	1.3774	1.452011035	0.401459854	cardiovascular
Chagyrskaya	GWAS	Chronic lymphocytic leukemia	1	0.5175	1.93236715	0.405959404	lymphatic
Chagyrskaya	GWAS	Cannabis use	1	0.5261	1.90077932	0.407259274	behavior
Chagyrskaya	GWAS	Granulocyte count	2	1.4042	1.424298533	0.408559144	immune
Chagyrskaya	GWAS	Electrocardiographic traits	1	0.5277	1.895016108	0.409059094	cardiovascular
Chagyrskaya	GWAS	Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)	2	1.4006	1.427959446	0.410058994	cardiovascular
Chagyrskaya	GWAS	Body mass index in physically active individuals	3	2.3202	1.292991983	0.411658834	metabolic
Chagyrskaya	GWAS	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	1	0.5385	1.857010214	0.417758224	metabolic
Chagyrskaya	GWAS	Upper eyelid sagging severity	1	0.5519	1.81192245	0.420257974	integumentary
Chagyrskaya	GWAS	Body mass index (change over time)	1	0.5427	1.842638659	0.421457854	metabolic
Chagyrskaya	GWAS	Glucocorticoid-induced osteonecrosis (age 10 years and older)	1	0.5467	1.829156759	0.425357464	other
Chagyrskaya	GWAS	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 (Grade 2 peripheral neuropathy)	1	0.5558	1.799208348	0.425457454	other
Chagyrskaya	GWAS	Pancreatic cancer	2	1.4705	1.360081605	0.425757424	endocrine
Chagyrskaya	GWAS	Zinc levels	1	0.5585	1.790510295	0.429757024	other
Chagyrskaya	GWAS	Response to fenofibrate (triglyceride levels)	1	0.5588	1.789549034	0.429857014	other
Chagyrskaya	GWAS	BMI in non-smokers	2	1.4539	1.375610427	0.431256874	metabolic
Chagyrskaya	GWAS	Hand grip strength	4	3.3441	1.196136479	0.432456754	skeletal muscle
Chagyrskaya	GWAS	Spherical equivalent (joint analysis main effects and education interaction)	1	0.5874	1.702417433	0.444755524	nervous
Chagyrskaya	GWAS	Basophil percentage of white cells	1	0.5985	1.670843776	0.448855114	immune
Chagyrskaya	GWAS	Bipolar disorder (body mass index interaction)	1	0.5941	1.683218313	0.449455054	behavior
Chagyrskaya	GWAS	Hypospadias	1	0.5954	1.679543164	0.450554945	urinary
Chagyrskaya	GWAS	QT interval	3	2.4869	1.206321123	0.451254875	cardiovascular
Chagyrskaya	GWAS	Cerebrospinal fluid beta-site APP cleaving enzyme levels	1	0.6001	1.666388935	0.453454655	nervous
Chagyrskaya	GWAS	Paclitaxel disposition in epithelial ovarian cancer	2	1.5443	1.295085152	0.454054595	other
Chagyrskaya	GWAS	Western dietary pattern	1	0.615	1.62601626	0.458054195	behavior
Chagyrskaya	GWAS	Uterine fibroid number (single vs multiple)	1	0.6138	1.629195178	0.458154185	reproductive
Chagyrskaya	GWAS	Erectile dysfunction and prostate cancer treatment	1	0.6205	1.611603546	0.462053795	reproductive
Chagyrskaya	GWAS	Phospholipid levels (plasma)	1	0.6144	1.627604167	0.464153585	metabolic
Chagyrskaya	GWAS	Hemoglobin	1	0.6223	1.606941989	0.466253375	hematologic
Chagyrskaya	GWAS	Weight	1	0.6284	1.591343094	0.466553345	skeletal
Chagyrskaya	GWAS	Tonsillectomy	1	0.6256	1.598465473	0.467753225	lymphatic
Chagyrskaya	GWAS	Age-related macular degeneration	1	0.6298	1.587805653	0.467853215	nervous
Chagyrskaya	GWAS	Urate levels in lean individuals	1	0.6313	1.584032948	0.468053195	metabolic
Chagyrskaya	GWAS	Migraine	2	1.5912	1.256913022	0.470052995	nervous
Chagyrskaya	GWAS	Borderline personality disorder	1	0.6382	1.566906926	0.470852915	behavior
Chagyrskaya	GWAS	Radiation response	1	0.6419	1.557875058	0.474552545	other
Chagyrskaya	GWAS	Bipolar disorder and schizophrenia	2	1.602	1.248439451	0.474852515	behavior
Chagyrskaya	GWAS	Knee osteoarthritis	1	0.6501	1.538224888	0.476652335	skeletal
Chagyrskaya	GWAS	Atrial fibrillation	5	4.5442	1.100303684	0.476952305	cardiovascular
Chagyrskaya	GWAS	Feeling fed-up	1	0.6571	1.521838381	0.479152085	behavior
Chagyrskaya	GWAS	Crohn's disease	5	4.5576	1.097068633	0.481951805	immune
Chagyrskaya	GWAS	Dimensional psychopathology (Cognitive)	1	0.6672	1.498800959	0.485051495	behavior
Chagyrskaya	GWAS	Body mass index (joint analysis main effects and physical activity interaction)	3	2.6041	1.152029492	0.486951305	metabolic
Chagyrskaya	GWAS	Testicular germ cell tumor	1	0.6691	1.494544911	0.489851015	reproductive
Chagyrskaya	GWAS	Aluminium levels	1	0.674	1.483679525	0.491250875	other
Chagyrskaya	GWAS	Response to methotrexate in juvenile idiopathic arthritis	2	1.6567	1.207219171	0.493850615	other
Chagyrskaya	GWAS	ALT levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	1	0.6789	1.472970982	0.495550445	other
Chagyrskaya	GWAS	Homeostasis model assessment of beta-cell function (dietary factor interaction)	1	0.6924	1.444251878	0.496550345	metabolic
Chagyrskaya	GWAS	Autism	1	0.689	1.45137881	0.496850315	behavior
Chagyrskaya	GWAS	Mood instability	1	0.679	1.47275405	0.496950305	behavior
Chagyrskaya	GWAS	Lung cancer in never smokers	1	0.6939	1.441129846	0.501849815	respiratory
Chagyrskaya	GWAS	Bulimia nervosa	1	0.696	1.436781609	0.502349765	behavior
Chagyrskaya	GWAS	Alzheimer's disease in APOE e4- carriers	1	0.6994	1.429796969	0.503249675	nervous
Chagyrskaya	GWAS	Systemic sclerosis	1	0.6954	1.438021283	0.504449555	other
Chagyrskaya	GWAS	Joint mobility (Beighton score)	1	0.7011	1.426330053	0.504749525	skeletal
Chagyrskaya	GWAS	Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	1	0.7101	1.408252359	0.510348965	cardiovascular
Chagyrskaya	GWAS	Liver enzyme levels (alanine transaminase)	1	0.7123	1.40390285	0.512448755	other
Chagyrskaya	GWAS	Serum metabolite concentrations in chronic kidney disease	1	0.7268	1.375894331	0.514048595	urinary
Chagyrskaya	GWAS	Serum uric acid levels	1	0.7286	1.372495196	0.520947905	other
Chagyrskaya	GWAS	Melanoma	1	0.7414	1.348799568	0.522947705	integumentary
Chagyrskaya	GWAS	Dupuytren's disease	1	0.7457	1.341021859	0.524547545	integumentary
Chagyrskaya	GWAS	Uterine fibroid size (maximum volume)	1	0.7613	1.313542624	0.531846815	reproductive
Chagyrskaya	GWAS	Attention deficit hyperactivity disorder	3	2.8103	1.06750169	0.533446655	behavior
Chagyrskaya	GWAS	Platelet aggregation	1	0.7643	1.308386759	0.537246275	hematologic
Chagyrskaya	GWAS	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	1	0.7909	1.264382349	0.546345365	endocrine
Chagyrskaya	GWAS	Headache	1	0.7955	1.257071025	0.547645235	nervous
Chagyrskaya	GWAS	Myopia (pathological)	2	1.8387	1.087725023	0.548745125	nervous
Chagyrskaya	GWAS	Bone mineral density (Ward's triangle area)	1	0.7888	1.267748479	0.549845015	skeletal
Chagyrskaya	GWAS	Red cell distribution width	2	1.8404	1.086720278	0.550244976	hematologic
Chagyrskaya	GWAS	Refractive error	1	0.83	1.204819277	0.556944306	nervous
Chagyrskaya	GWAS	Body mass index	16	16.3061	0.981227884	0.562543746	metabolic
Chagyrskaya	GWAS	Pulse pressure x alcohol consumption interaction (2df test)	1	0.8456	1.182592242	0.566343366	cardiovascular
Chagyrskaya	GWAS	Extremely high intelligence	1	0.8543	1.170548987	0.576342366	other
Chagyrskaya	GWAS	"Cholesterol, total"	1	0.8686	1.151277918	0.576742326	metabolic
Chagyrskaya	GWAS	Nose size	1	0.8744	1.143641354	0.578542146	skeletal
Chagyrskaya	GWAS	Plateletcrit	3	3.017	0.994365264	0.579142086	hematologic
Chagyrskaya	GWAS	Obesity (early onset extreme)	1	0.8806	1.135589371	0.580341966	metabolic
Chagyrskaya	GWAS	Coronary artery disease	6	6.1669	0.972936159	0.580541946	cardiovascular
Chagyrskaya	GWAS	Logical memory (delayed recall) in normal cognition	1	0.8666	1.153934918	0.580641936	nervous
Chagyrskaya	GWAS	Rosacea symptom severity	3	3.0111	0.99631364	0.581741826	integumentary
Chagyrskaya	GWAS	Social science traits (pleiotropy) (HIPO component 1)	1	0.8836	1.131733816	0.585741426	behavior
Chagyrskaya	GWAS	Waist circumference adjusted for BMI in non-smokers	1	0.8691	1.150615579	0.587241276	skeletal
Chagyrskaya	GWAS	Cerebrospinal fluid t-tau:AB1-42 ratio	1	0.8735	1.144819691	0.588241176	nervous
Chagyrskaya	GWAS	Pelvic organ prolapse (moderate/severe)	1	0.8895	1.124227094	0.588641136	skeletal muscle
Chagyrskaya	GWAS	Intelligence	1	0.897	1.114827202	0.592740726	other
Chagyrskaya	GWAS	Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes	2	1.9948	1.002606778	0.593340666	cardiovascular
Chagyrskaya	GWAS	Calcium levels	1	0.9023	1.108278843	0.594740526	other
Chagyrskaya	GWAS	Endometrial cancer (endometrioid histology)	1	0.9545	1.047668937	0.610538946	reproductive
Chagyrskaya	GWAS	Glucose homeostasis traits	2	2.0832	0.960061444	0.618238176	metabolic
Chagyrskaya	GWAS	High density lipoprotein cholesterol levels	1	0.9702	1.030715316	0.621737826	metabolic
Chagyrskaya	GWAS	Immature fraction of reticulocytes	1	0.9991	1.000900811	0.627037296	hematologic
Chagyrskaya	GWAS	Total body bone mineral density	1	0.9783	1.022181335	0.627437256	skeletal
Chagyrskaya	GWAS	Mean arterial pressure	1	1.0059	0.994134606	0.631436856	cardiovascular
Chagyrskaya	GWAS	Waist circumference adjusted for BMI in active individuals	1	0.995	1.005025126	0.632336766	skeletal
Chagyrskaya	GWAS	Rheumatoid arthritis	2	2.1556	0.927815921	0.634836516	immune
Chagyrskaya	GWAS	Seasonality and depression	1	1.0096	0.990491284	0.637036296	behavior
Chagyrskaya	GWAS	Erectile dysfunction	1	1.016	0.984251969	0.638036196	reproductive
Chagyrskaya	GWAS	Obesity	2	2.1741	0.919920887	0.639136086	metabolic
Chagyrskaya	GWAS	Photic sneeze reflex	3	3.3378	0.898795614	0.645335466	nervous
Chagyrskaya	GWAS	Feeling worry	1	1.0347	0.966463709	0.646235376	behavior
Chagyrskaya	GWAS	Autism spectrum disorder or schizophrenia	3	3.2943	0.910663874	0.647635236	behavior
Chagyrskaya	GWAS	Influenza A (H1N1) infection	1	1.0459	0.956114351	0.649735026	immune
Chagyrskaya	GWAS	Triglyceride levels	1	1.0403	0.961261175	0.653634637	metabolic
Chagyrskaya	GWAS	Response to amphetamines	2	2.2337	0.895375386	0.654634537	other
Chagyrskaya	GWAS	Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)	1	1.0646	0.939319932	0.658734127	skeletal
Chagyrskaya	GWAS	Irritable mood	1	1.0851	0.921574048	0.660733927	behavior
Chagyrskaya	GWAS	Small cell lung carcinoma	1	1.0803	0.925668796	0.660833917	respiratory
Chagyrskaya	GWAS	Dementia and core Alzheimer's disease neuropathologic changes	1	1.0701	0.934492104	0.661333867	nervous
Chagyrskaya	GWAS	Acute lymphoblastic leukemia (childhood)	1	1.0778	0.927815921	0.662333767	lymphatic
Chagyrskaya	GWAS	Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)	1	1.0866	0.920301859	0.664633537	skeletal
Chagyrskaya	GWAS	Metabolite levels	1	1.0885	0.918695452	0.666033397	metabolic
Chagyrskaya	GWAS	Post-traumatic stress disorder	1	1.072	0.932835821	0.666033397	behavior
Chagyrskaya	GWAS	Neuroticism	2	2.2839	0.875695083	0.667233277	behavior
Chagyrskaya	GWAS	Verbal declarative memory	1	1.1149	0.89694143	0.671232877	nervous
Chagyrskaya	GWAS	Corneal astigmatism	1	1.114	0.897666068	0.674932507	nervous
Chagyrskaya	GWAS	Glaucoma	1	1.1309	0.884251481	0.677032297	nervous
Chagyrskaya	GWAS	Lung cancer	1	1.1177	0.894694462	0.677732227	respiratory
Chagyrskaya	GWAS	Asthma (childhood onset)	1	1.1406	0.876731545	0.681331867	respiratory
Chagyrskaya	GWAS	Type 2 diabetes (age of onset)	1	1.154	0.866551127	0.689831017	metabolic
Chagyrskaya	GWAS	Cognitive decline (age-related)	1	1.184	0.844594595	0.692830717	nervous
Chagyrskaya	GWAS	Waist circumference adjusted for BMI (adjusted for smoking behaviour)	1	1.1793	0.847960655	0.695130487	skeletal
Chagyrskaya	GWAS	Cognitive ability (MTAG)	1	1.2062	0.829049909	0.700429957	nervous
Chagyrskaya	GWAS	Mild influenza (H1N1) infection	1	1.1994	0.833750208	0.700529947	immune
Chagyrskaya	GWAS	Uterine fibroids	1	1.2518	0.798849656	0.710428957	reproductive
Chagyrskaya	GWAS	Diastolic blood pressure x alcohol consumption interaction (2df test)	1	1.267	0.789265983	0.718628137	cardiovascular
Chagyrskaya	GWAS	Platelet count	3	3.7695	0.79586152	0.728627137	hematologic
Chagyrskaya	GWAS	Thiazide-induced adverse metabolic effects in hypertensive patients	1	1.3012	0.768521365	0.729527047	other
Chagyrskaya	GWAS	Granulocyte percentage of myeloid white cells	1	1.309	0.76394194	0.730526947	immune
Chagyrskaya	GWAS	"Coronary artery disease (myocardial infarction, PTCA, CABG, angina or CIHD)"	1	1.3098	0.76347534	0.730626937	cardiovascular
Chagyrskaya	GWAS	Squamous cell lung carcinoma	1	1.3005	0.768935025	0.732526747	respiratory
Chagyrskaya	GWAS	Anorexia nervosa	1	1.3587	0.735997645	0.738426157	behavior
Chagyrskaya	GWAS	Educational attainment	1	1.3449	0.743549706	0.739026097	other
Chagyrskaya	GWAS	Pulmonary function	1	1.3456	0.743162901	0.739526047	respiratory
Chagyrskaya	GWAS	Chin dimples	1	1.3438	0.744158357	0.740925907	integumentary
Chagyrskaya	GWAS	Cerebrospinal T-tau levels	1	1.3443	0.743881574	0.742325767	nervous
Chagyrskaya	GWAS	Monocyte percentage of white cells	1	1.3604	0.735077918	0.745325467	immune
Chagyrskaya	GWAS	Asthma	3	3.9932	0.751277171	0.759624038	respiratory
Chagyrskaya	GWAS	Schizophrenia	9	10.8971	0.82590781	0.759824018	behavior
Chagyrskaya	GWAS	Acne (severe)	1	1.4557	0.68695473	0.766323368	integumentary
Chagyrskaya	GWAS	Celiac disease	1	1.4579	0.685918101	0.769923008	digestive
Chagyrskaya	GWAS	QRS duration	1	1.4665	0.68189567	0.769923008	cardiovascular
Chagyrskaya	GWAS	High light scatter reticulocyte percentage of red cells	1	1.5093	0.662558802	0.774922508	metabolic
Chagyrskaya	GWAS	Lung cancer in ever smokers	1	1.4735	0.678656261	0.778622138	respiratory
Chagyrskaya	GWAS	Alzheimer's disease (late onset)	1	1.509	0.662690524	0.778822118	nervous
Chagyrskaya	GWAS	Systolic blood pressure x alcohol consumption interaction (2df test)	1	1.5234	0.656426415	0.781021898	cardiovascular
Chagyrskaya	GWAS	Sum basophil neutrophil counts	1	1.5337	0.652017996	0.784621538	hematologic
Chagyrskaya	GWAS	Platelet distribution width	2	2.8832	0.693673696	0.785221478	hematologic
Chagyrskaya	GWAS	Neurociticism	2	2.9301	0.682570561	0.788121188	behavior
Chagyrskaya	GWAS	Hypertension	1	1.5644	0.639222705	0.789421058	cardiovascular
Chagyrskaya	GWAS	Spherical equivalent or myopia (age of diagnosis)	3	4.2422	0.707180237	0.790320968	nervous
Chagyrskaya	GWAS	LDL cholesterol	1	1.5544	0.643335049	0.791120888	metabolic
Chagyrskaya	GWAS	Visceral adipose tissue/subcutaneous adipose tissue ratio	1	1.5861	0.630477271	0.796020398	metabolic
Chagyrskaya	GWAS	Reticulocyte count	1	1.6125	0.620155039	0.796320368	immune
Chagyrskaya	GWAS	Mean corpuscular volume	2	2.9576	0.676223965	0.796520348	hematologic
Chagyrskaya	GWAS	Blood pressure (smoking interaction)	1	1.6187	0.6177797	0.804419558	hematologic
Chagyrskaya	GWAS	Night sleep phenotypes	7	9.1226	0.767325105	0.804819518	behavior
Chagyrskaya	GWAS	Reticulocyte fraction of red cells	1	1.649	0.606428138	0.805319468	immune
Chagyrskaya	GWAS	Monocyte count	1	1.6244	0.615611918	0.807619238	immune
Chagyrskaya	GWAS	Methadone dose in opioid dependence	1	1.6816	0.594671741	0.808919108	other
Chagyrskaya	GWAS	General cognitive ability	3	4.3921	0.683044557	0.809319068	nervous
Chagyrskaya	GWAS	Cognitive performance	1	1.6711	0.598408234	0.810118988	nervous
Chagyrskaya	GWAS	Waist circumference adjusted for body mass index	1	1.6749	0.59705057	0.810218978	skeletal
Chagyrskaya	GWAS	Alzheimer's disease (cognitive decline)	2	3.068	0.651890482	0.810718928	nervous
Chagyrskaya	GWAS	Colorectal cancer	1	1.6741	0.597335882	0.813218678	digestive
Chagyrskaya	GWAS	Familial squamous cell lung carcinoma	1	1.664	0.600961538	0.813818618	respiratory
Chagyrskaya	GWAS	Macular thickness	2	3.105	0.644122383	0.815418458	nervous
Chagyrskaya	GWAS	Intraocular pressure	4	5.7846	0.691491201	0.829617038	nervous
Chagyrskaya	GWAS	Glomerular filtration rate (creatinine)	1	1.7451	0.573033064	0.832516748	hematologic
Chagyrskaya	GWAS	Glaucoma (primary open-angle)	1	1.7974	0.556359185	0.836416358	nervous
Chagyrskaya	GWAS	Allergic rhinitis	1	1.8389	0.543803361	0.843415658	immune
Chagyrskaya	GWAS	Diisocyanate-induced asthma	3	4.6867	0.640109245	0.844315568	respiratory
Chagyrskaya	GWAS	Total cholesterol levels	1	1.8462	0.541653125	0.846515348	metabolic
Chagyrskaya	GWAS	High light scatter reticulocyte count	1	1.9178	0.521430806	0.850114989	metabolic
Chagyrskaya	GWAS	Coronary artery aneurysm in Kawasaki disease	1	1.8889	0.529408651	0.854214579	cardiovascular
Chagyrskaya	GWAS	Post bronchodilator FEV1/FVC ratio	5	7.3982	0.675840069	0.860213979	other
Chagyrskaya	GWAS	Depression	1	1.9808	0.504846527	0.862813719	behavior
Chagyrskaya	GWAS	Mean platelet volume	2	3.4858	0.573756383	0.863013699	hematologic
Chagyrskaya	GWAS	Intracranial aneurysm	1	2.0094	0.497660993	0.867113289	nervous
Chagyrskaya	GWAS	"Autism spectrum disorder, ADHD, bipolar disorder, MDD, and schizophrenia (combined)"	1	2.0418	0.489763934	0.868413159	behavior
Chagyrskaya	GWAS	Hematocrit	1	2.0423	0.489644029	0.874112589	hematologic
Chagyrskaya	GWAS	Lung function (FEV1/FVC)	1	2.1268	0.470189957	0.880711929	respiratory
Chagyrskaya	GWAS	Intelligence (MTAG)	3	5.1199	0.585948944	0.882911709	other
Chagyrskaya	GWAS	Venous thromboembolism adjusted for sickle cell variant rs77121243-T	1	2.2617	0.442145289	0.891810819	hematologic
Chagyrskaya	GWAS	Diverticular disease	1	2.325	0.430107527	0.901509849	digestive
Chagyrskaya	GWAS	Neutrophil count	1	2.3456	0.42633015	0.907009299	lymphatic
Chagyrskaya	GWAS	Mean corpuscular hemoglobin	1	2.5645	0.389939559	0.921107889	hematologic
Chagyrskaya	GWAS	Nasopharyngeal carcinoma (SNP x SNP interaction)	1	2.618	0.38197097	0.925607439	other
Chagyrskaya	GWAS	Myopia	1	2.6703	0.374489758	0.926607339	nervous
Chagyrskaya	GWAS	Obesity-related traits	13	18.6527	0.696950039	0.932306769	metabolic
Chagyrskaya	GWAS	Type 2 diabetes	4	7.4415	0.537526036	0.935806419	metabolic
Chagyrskaya	GWAS	Pulse pressure	5	8.8388	0.56568765	0.938406159	cardiovascular
Chagyrskaya	GWAS	Mosquito bite size	1	2.8487	0.351037315	0.940705929	other
Chagyrskaya	GWAS	Male-pattern baldness	1	2.8232	0.354207991	0.941105889	integumentary
Chagyrskaya	GWAS	Blond vs. brown/black hair color	1	2.8388	0.352261519	0.943205679	integumentary
Chagyrskaya	GWAS	Red blood cell count	1	3.036	0.329380764	0.95460454	hematologic
Chagyrskaya	GWAS	Cognitive decline rate in late mild cognitive impairment	1	3.1289	0.319601138	0.95840416	nervous
Chagyrskaya	GWAS	Multiple sclerosis	1	3.4849	0.28695228	0.96880312	nervous
Chagyrskaya	GWAS	Major depressive disorder	1	3.6448	0.274363477	0.97440256	behavior
Chagyrskaya	GWAS	Post bronchodilator FEV1	1	3.787	0.264061262	0.97920208	other
Chagyrskaya	GWAS	Menarche (age at onset)	2	5.7817	0.34591902	0.98220178	reproductive
Chagyrskaya	GWAS	Diastolic blood pressure	4	10.0998	0.396047446	0.99030097	cardiovascular
Chagyrskaya	GWAS	Systolic blood pressure	5	11.8322	0.422575683	0.99090091	cardiovascular
Chagyrskaya	GWAS	Heel bone mineral density	7	14.8872	0.47020259	0.99120088	skeletal
Chagyrskaya	GWAS	Amyotrophic lateral sclerosis (sporadic)	1	5.0571	0.197741789	0.9930007	nervous
Chagyrskaya	HPO	Abnormality of iron homeostasis (HP:0011031)	3	0.0691	43.41534009	1.00E-04	other
Chagyrskaya	HPO	Increased serum ferritin (HP:0003281)	3	0.0624	48.07692308	1.00E-04	other
Chagyrskaya	HPO	Abnormality of transition element cation homeostasis (HP:0011030)	3	0.1047	28.65329513	0.00019998	other
Chagyrskaya	HPO	Gingivitis (HP:0000230)	3	0.1645	18.23708207	0.00069993	other
Chagyrskaya	HPO	Abnormality of the pericardium (HP:0001697)	4	0.3828	10.44932079	0.00089991	cardiovascular
Chagyrskaya	HPO	Skin nodule (HP:0200036)	3	0.1663	18.03968731	0.00089991	integumentary
Chagyrskaya	HPO	Abnormality of macrophages (HP:0004311)	2	0.0501	39.92015968	0.0009999	immune
Chagyrskaya	HPO	Cafe-au-lait spot (HP:0000957)	4	0.4883	8.191685439	0.00119988	integumentary
Chagyrskaya	HPO	Precocious puberty (HP:0000826)	3	0.2547	11.77856302	0.00179982	endocrine
Chagyrskaya	HPO	Ascites (HP:0001541)	4	0.5219	7.664303506	0.00229977	digestive
Chagyrskaya	HPO	Generalized amyotrophy (HP:0003700)	2	0.0852	23.4741784	0.00329967	nervous
Chagyrskaya	HPO	Focal seizures (HP:0007359)	3	0.3296	9.101941748	0.00439956	nervous
Chagyrskaya	HPO	Hamartoma of the eye (HP:0010568)	2	0.1199	16.68056714	0.00609939	nervous
Chagyrskaya	HPO	Prominent occiput (HP:0000269)	3	0.3786	7.923930269	0.00649935	skeletal
Chagyrskaya	HPO	Specific learning disability (HP:0001328)	3	0.3595	8.344923505	0.00649935	other
Chagyrskaya	HPO	Ependymoma (HP:0002888)	2	0.1212	16.50165017	0.00669933	nervous
Chagyrskaya	HPO	Angiofibromas (HP:0010615)	2	0.1305	15.3256705	0.0069993	cardiovascular
Chagyrskaya	HPO	Adenoma sebaceum (HP:0009720)	2	0.1305	15.3256705	0.0069993	integumentary
Chagyrskaya	HPO	Neoplasm of the heart (HP:0100544)	2	0.128	15.625	0.00729927	cardiovascular
Chagyrskaya	HPO	Hemangiomatosis (HP:0007461)	2	0.1389	14.39884809	0.00809919	cardiovascular
Chagyrskaya	HPO	Visceral angiomatosis (HP:0100761)	2	0.1389	14.39884809	0.00809919	skeletal
Chagyrskaya	HPO	Dialeptic seizures (HP:0011146)	3	0.4272	7.02247191	0.00869913	nervous
Chagyrskaya	HPO	Abnormality of the astrocytes (HP:0100707)	2	0.1394	14.3472023	0.00869913	nervous
Chagyrskaya	HPO	Astrocytoma (HP:0009592)	2	0.1394	14.3472023	0.00869913	nervous
Chagyrskaya	HPO	Aneurysm (HP:0002617)	4	0.8235	4.857316333	0.00979902	nervous
Chagyrskaya	HPO	Lymphangioma (HP:0100764)	2	0.1629	12.27747084	0.01189881	lymphatic
Chagyrskaya	HPO	Glioma (HP:0009733)	2	0.1603	12.47660636	0.01229877	nervous
Chagyrskaya	HPO	Atelectasis (HP:0100750)	2	0.1611	12.41464929	0.01319868	respiratory
Chagyrskaya	HPO	High pitched voice (HP:0001620)	2	0.1607	12.44555072	0.01339866	other
Chagyrskaya	HPO	Hemiparesis (HP:0001269)	2	0.1815	11.01928375	0.01339866	skeletal muscle
Chagyrskaya	HPO	Abnormal number of erythroid precursors (HP:0012131)	1	0.0134	74.62686567	0.01349865	hematologic
Chagyrskaya	HPO	Hemoptysis (HP:0002105)	2	0.18	11.11111111	0.01359864	other
Chagyrskaya	HPO	Hypochromic anemia (HP:0001931)	1	0.0137	72.99270073	0.01369863	hematologic
Chagyrskaya	HPO	Renal cell carcinoma (HP:0005584)	3	0.5201	5.768121515	0.01489851	urinary
Chagyrskaya	HPO	Coxa vara (HP:0002812)	2	0.1864	10.72961373	0.01579842	skeletal
Chagyrskaya	HPO	Osteoarthritis (HP:0002758)	3	0.5487	5.467468562	0.01669833	skeletal
Chagyrskaya	HPO	Hypermelanotic macule (HP:0001034)	3	0.5281	5.680742284	0.01679832	integumentary
Chagyrskaya	HPO	Hypopigmented skin patches (HP:0001053)	3	0.532	5.639097744	0.01719828	integumentary
Chagyrskaya	HPO	Abnormality of cells of the erythroid lineage (HP:0012130)	1	0.0172	58.13953488	0.01729827	hematologic
Chagyrskaya	HPO	Juvenile onset (HP:0003621)	3	0.5181	5.790387956	0.01729827	other
Chagyrskaya	HPO	Chest pain (HP:0100749)	2	0.196	10.20408163	0.01739826	other
Chagyrskaya	HPO	Nail dystrophy (HP:0008404)	2	0.1979	10.1061142	0.01759824	integumentary
Chagyrskaya	HPO	Sporadic (HP:0003745)	3	0.5887	5.09597418	0.02169783	other
Chagyrskaya	HPO	Diastasis recti (HP:0001540)	1	0.0226	44.24778761	0.02219778	skeletal muscle
Chagyrskaya	HPO	Neoplasm of striated muscle (HP:0009728)	2	0.2359	8.478168716	0.02429757	skeletal muscle
Chagyrskaya	HPO	Neoplasm of the adrenal cortex (HP:0100641)	1	0.0249	40.16064257	0.02489751	endocrine
Chagyrskaya	HPO	Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688)	1	0.0282	35.46099291	0.02779722	skeletal muscle
Chagyrskaya	HPO	Long foot (HP:0001833)	1	0.0283	35.33568905	0.02809719	skeletal
Chagyrskaya	HPO	Exostoses (HP:0100777)	2	0.2635	7.590132827	0.02849715	skeletal
Chagyrskaya	HPO	Pulmonary infiltrates (HP:0002113)	2	0.2574	7.77000777	0.02939706	respiratory
Chagyrskaya	HPO	Pallor (HP:0000980)	2	0.2746	7.283321194	0.03219678	integumentary
Chagyrskaya	HPO	Hepatoblastoma (HP:0002884)	1	0.0335	29.85074627	0.03329667	digestive
Chagyrskaya	HPO	Muscle abnormality related to mitochondrial dysfunction (HP:0003800)	1	0.0348	28.73563218	0.03409659	skeletal muscle
Chagyrskaya	HPO	Aseptic necrosis (HP:0010885)	2	0.2934	6.816632584	0.03449655	skeletal
Chagyrskaya	HPO	Increased number of teeth (HP:0011069)	2	0.2935	6.814310051	0.03509649	skeletal
Chagyrskaya	HPO	Hamartoma (HP:0010566)	2	0.29	6.896551724	0.03539646	other
Chagyrskaya	HPO	Waddling gait (HP:0002515)	2	0.2971	6.731740155	0.03739626	other
Chagyrskaya	HPO	Epidermoid cyst (HP:0200040)	1	0.038	26.31578947	0.03749625	integumentary
Chagyrskaya	HPO	Abnormality of Sharpey fibers (HP:0100685)	2	0.3105	6.441223833	0.03759624	skeletal muscle
Chagyrskaya	HPO	Chondrocalcinosis (HP:0000934)	2	0.3105	6.441223833	0.03759624	skeletal
Chagyrskaya	HPO	Hypoplasia of the capital femoral epiphysis (HP:0003090)	1	0.0382	26.17801047	0.03779622	skeletal
Chagyrskaya	HPO	Polycystic kidney dysplasia (HP:0000113)	3	0.73	4.109589041	0.03829617	urinary
Chagyrskaya	HPO	Hypopigmentation of the fundus (HP:0007894)	2	0.3106	6.439150032	0.03879612	integumentary
Chagyrskaya	HPO	Progressive muscle weakness (HP:0003323)	1	0.0401	24.93765586	0.03909609	skeletal muscle
Chagyrskaya	HPO	Abnormality of intracranial pressure (HP:0012640)	2	0.3165	6.319115324	0.03939606	nervous
Chagyrskaya	HPO	Increased intracranial pressure (HP:0002516)	2	0.3165	6.319115324	0.03939606	nervous
Chagyrskaya	HPO	Hypobetalipoproteinemia (HP:0003563)	1	0.041	24.3902439	0.04049595	metabolic
Chagyrskaya	HPO	Hyperparathyroidism (HP:0000843)	1	0.0428	23.36448598	0.04229577	endocrine
Chagyrskaya	HPO	Abnormality of the pleura (HP:0002103)	2	0.3246	6.161429452	0.04329567	respiratory
Chagyrskaya	HPO	Benign neoplasm of the central nervous system (HP:0100835)	2	0.3272	6.112469438	0.04339566	nervous
Chagyrskaya	HPO	Type II diabetes mellitus (HP:0005978)	3	0.7447	4.028467839	0.04349565	metabolic
Chagyrskaya	HPO	Supranuclear gaze palsy (HP:0000605)	1	0.0455	21.97802198	0.04479552	nervous
Chagyrskaya	HPO	Abnormal pancreas size (HP:0012094)	1	0.0458	21.83406114	0.0449955	digestive
Chagyrskaya	HPO	Xanthomatosis (HP:0000991)	1	0.0463	21.59827214	0.04509549	metabolic
Chagyrskaya	HPO	Abnormal glucose tolerance (HP:0001952)	1	0.0457	21.88183807	0.04529547	metabolic
Chagyrskaya	HPO	Keratoconjunctivitis sicca (HP:0001097)	1	0.0464	21.55172414	0.04529547	integumentary
Chagyrskaya	HPO	Cerebral ischemia (HP:0002637)	2	0.3466	5.77034045	0.04639536	nervous
Chagyrskaya	HPO	Prolonged neonatal jaundice (HP:0006579)	1	0.0486	20.57613169	0.04809519	digestive
Chagyrskaya	HPO	Absent epiphyses (HP:0010577)	1	0.0505	19.8019802	0.04959504	skeletal
Chagyrskaya	HPO	Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003)	1	0.0505	19.8019802	0.04959504	skeletal
Chagyrskaya	HPO	Keratoconjunctivitis (HP:0001096)	1	0.0514	19.45525292	0.050094991	integumentary
Chagyrskaya	HPO	Gastrointestinal dysmotility (HP:0002579)	1	0.0518	19.30501931	0.050594941	digestive
Chagyrskaya	HPO	Fibroma (HP:0010614)	2	0.3496	5.720823799	0.051094891	reproductive
Chagyrskaya	HPO	Recurrent urinary tract infections (HP:0000010)	3	0.8495	3.531489111	0.051994801	immune
Chagyrskaya	HPO	Fibrous tissue neoplasm (HP:0012316)	2	0.3542	5.646527386	0.051994801	other
Chagyrskaya	HPO	Abnormality of chromosome segregation (HP:0002916)	2	0.3541	5.648121999	0.052094791	other
Chagyrskaya	HPO	Lack of skin elasticity (HP:0100679)	2	0.3646	5.485463522	0.052394761	integumentary
Chagyrskaya	HPO	Vesicoureteral reflux (HP:0000076)	3	0.8586	3.494060098	0.054694531	urinary
Chagyrskaya	HPO	Fine hair (HP:0002213)	2	0.3737	5.35188654	0.055994401	integumentary
Chagyrskaya	HPO	Loss of speech (HP:0002371)	1	0.0574	17.42160279	0.056294371	other
Chagyrskaya	HPO	Dysphonia (HP:0001618)	1	0.0574	17.42160279	0.056294371	other
Chagyrskaya	HPO	Aplasia cutis congenita (HP:0001057)	1	0.0587	17.03577513	0.057194281	integumentary
Chagyrskaya	HPO	Muscle fiber splitting (HP:0003555)	1	0.0589	16.97792869	0.057694231	skeletal muscle
Chagyrskaya	HPO	Bone pain (HP:0002653)	2	0.3965	5.044136192	0.058994101	skeletal
Chagyrskaya	HPO	Neoplasm of the adrenal gland (HP:0100631)	1	0.0615	16.2601626	0.059794021	endocrine
Chagyrskaya	HPO	Erythroderma (HP:0001019)	1	0.0626	15.97444089	0.061193881	integumentary
Chagyrskaya	HPO	Retinitis pigmentosa (HP:0000510)	3	0.8899	3.371165299	0.061793821	integumentary
Chagyrskaya	HPO	Morphological abnormality of the inner ear (HP:0011390)	1	0.0635	15.7480315	0.061893811	nervous
Chagyrskaya	HPO	Abnormality of cochlea (HP:0000375)	1	0.0635	15.7480315	0.061893811	nervous
Chagyrskaya	HPO	Neuroepithelial neoplasm (HP:0030063)	2	0.3992	5.01002004	0.062493751	nervous
Chagyrskaya	HPO	Nervous tissue neoplasm (HP:0030060)	2	0.3992	5.01002004	0.062493751	nervous
Chagyrskaya	HPO	Neuroectodermal neoplasm (HP:0030061)	2	0.3992	5.01002004	0.062493751	nervous
Chagyrskaya	HPO	Acanthocytosis (HP:0001927)	1	0.0642	15.57632399	0.062593741	hematologic
Chagyrskaya	HPO	Hypercholesterolemia (HP:0003124)	1	0.0664	15.06024096	0.064293571	metabolic
Chagyrskaya	HPO	Delayed skeletal maturation (HP:0002750)	4	1.5067	2.654808522	0.064493551	skeletal
Chagyrskaya	HPO	Absent hand (HP:0004050)	1	0.0661	15.12859304	0.064693531	skeletal
Chagyrskaya	HPO	Duplicated collecting system (HP:0000081)	1	0.067	14.92537313	0.065493451	urinary
Chagyrskaya	HPO	Keratitis (HP:0000491)	1	0.0692	14.45086705	0.067593241	nervous
Chagyrskaya	HPO	Central scotoma (HP:0000603)	1	0.0724	13.8121547	0.069793021	nervous
Chagyrskaya	HPO	Malignant neoplasm of the central nervous system (HP:0100836)	2	0.426	4.694835681	0.070392961	nervous
Chagyrskaya	HPO	Neonatal hypoglycemia (HP:0001998)	1	0.0726	13.77410468	0.070492951	metabolic
Chagyrskaya	HPO	Premature ovarian failure (HP:0008209)	1	0.0746	13.40482574	0.071292871	reproductive
Chagyrskaya	HPO	Vertigo (HP:0002321)	2	0.4403	4.542357484	0.074992501	nervous
Chagyrskaya	HPO	Cerebral hypomyelination (HP:0006808)	1	0.0787	12.7064803	0.075392461	nervous
Chagyrskaya	HPO	Ureteral duplication (HP:0000073)	1	0.078	12.82051282	0.075492451	urinary
Chagyrskaya	HPO	Squamous cell carcinoma (HP:0002860)	1	0.0791	12.64222503	0.075492451	integumentary
Chagyrskaya	HPO	Hepatosplenomegaly (HP:0001433)	1	0.0779	12.83697047	0.075592441	digestive
Chagyrskaya	HPO	Emphysema (HP:0002097)	2	0.4584	4.363001745	0.077792221	respiratory
Chagyrskaya	HPO	Lymphedema (HP:0001004)	2	0.4718	4.239084358	0.080691931	lymphatic
Chagyrskaya	HPO	Azoospermia (HP:0000027)	1	0.0863	11.58748552	0.083191681	reproductive
Chagyrskaya	HPO	Genu valgum (HP:0002857)	3	1.0274	2.919992213	0.083691631	skeletal
Chagyrskaya	HPO	Cavernous hemangioma (HP:0001048)	1	0.0875	11.42857143	0.083791621	cardiovascular
Chagyrskaya	HPO	Splenomegaly (HP:0001744)	4	1.6363	2.44453951	0.084591541	lymphatic
Chagyrskaya	HPO	Overgrowth (HP:0001548)	1	0.0901	11.09877913	0.085991401	other
Chagyrskaya	HPO	Abnormality of the septum pellucidum (HP:0007375)	1	0.0921	10.8577633	0.088091191	nervous
Chagyrskaya	HPO	Neurofibrillary tangles (HP:0002185)	1	0.0958	10.43841336	0.091690831	nervous
Chagyrskaya	HPO	High anterior hairline (HP:0009890)	1	0.0957	10.44932079	0.092390761	integumentary
Chagyrskaya	HPO	Joint laxity (HP:0001388)	2	0.511	3.913894325	0.092890711	skeletal
Chagyrskaya	HPO	Scotoma (HP:0000575)	1	0.0999	10.01001001	0.095390461	nervous
Chagyrskaya	HPO	Buphthalmos (HP:0000557)	1	0.101	9.900990099	0.095890411	nervous
Chagyrskaya	HPO	Hypertriglyceridemia (HP:0002155)	1	0.1044	9.578544061	0.097790221	metabolic
Chagyrskaya	HPO	Autosomal recessive inheritance (HP:0000007)	22	16.147	1.362482195	0.098590141	other
Chagyrskaya	HPO	Centrally nucleated skeletal muscle fibers (HP:0003687)	1	0.1032	9.689922481	0.099390061	skeletal muscle
Chagyrskaya	HPO	Abnormality of macular pigmentation (HP:0008002)	1	0.1051	9.514747859	0.099590041	integumentary
Chagyrskaya	HPO	Abnormality of the renal collecting system (HP:0004742)	1	0.105	9.523809524	0.099890011	urinary
Chagyrskaya	HPO	IgG deficiency (HP:0004315)	1	0.1048	9.541984733	0.100389961	immune
Chagyrskaya	HPO	Proximal amyotrophy (HP:0007126)	1	0.1045	9.56937799	0.100489951	nervous
Chagyrskaya	HPO	Increased connective tissue (HP:0009025)	1	0.106	9.433962264	0.101389861	other
Chagyrskaya	HPO	Thoracic kyphosis (HP:0002942)	1	0.1068	9.36329588	0.102189781	skeletal
Chagyrskaya	HPO	Ventricular arrhythmia (HP:0004308)	2	0.5363	3.729256013	0.102889711	cardiovascular
Chagyrskaya	HPO	CNS hypomyelination (HP:0003429)	1	0.11	9.090909091	0.102989701	nervous
Chagyrskaya	HPO	Congenital ichthyosiform erythroderma (HP:0007431)	1	0.115	8.695652174	0.108689131	integumentary
Chagyrskaya	HPO	Large hands (HP:0001176)	1	0.115	8.695652174	0.108889111	skeletal
Chagyrskaya	HPO	Hypercortisolism (HP:0001578)	1	0.1172	8.532423208	0.110088991	endocrine
Chagyrskaya	HPO	Cone-rod dystrophy (HP:0000548)	1	0.1196	8.361204013	0.112388761	nervous
Chagyrskaya	HPO	Episodic fever (HP:0001954)	1	0.1194	8.37520938	0.112788721	other
Chagyrskaya	HPO	Neuronal loss in central nervous system (HP:0002529)	1	0.12	8.333333333	0.113688631	nervous
Chagyrskaya	HPO	Lymphoma (HP:0002665)	2	0.5758	3.473428274	0.113788621	lymphatic
Chagyrskaya	HPO	Soft skin (HP:0000977)	1	0.1191	8.396305626	0.115088491	integumentary
Chagyrskaya	HPO	Selective tooth agenesis (HP:0001592)	1	0.1234	8.103727715	0.115588441	skeletal
Chagyrskaya	HPO	Abnormal spermatogenesis (HP:0008669)	1	0.1241	8.058017728	0.116388361	reproductive
Chagyrskaya	HPO	Thyroid-stimulating hormone excess (HP:0002925)	1	0.1251	7.993605116	0.117588241	endocrine
Chagyrskaya	HPO	Gangrene (HP:0100758)	1	0.1268	7.886435331	0.118188181	other
Chagyrskaya	HPO	Porencephaly (HP:0002132)	1	0.1261	7.930214116	0.118288171	nervous
Chagyrskaya	HPO	Restrictive lung disease (HP:0002091)	2	0.5857	3.414717432	0.119788021	respiratory
Chagyrskaya	HPO	Infantile onset (HP:0003593)	4	1.8763	2.131855247	0.120787921	other
Chagyrskaya	HPO	Fat malabsorption (HP:0002630)	1	0.1298	7.704160247	0.122087791	metabolic
Chagyrskaya	HPO	Abnormality of the right ventricle (HP:0001707)	1	0.1313	7.61614623	0.122587741	cardiovascular
Chagyrskaya	HPO	Nephroblastoma (Wilms tumor) (HP:0002667)	1	0.1329	7.524454477	0.123587641	urinary
Chagyrskaya	HPO	Exercise intolerance (HP:0003546)	1	0.1343	7.446016381	0.126087391	other
Chagyrskaya	HPO	Hematuria (HP:0000790)	2	0.61	3.278688525	0.126687331	urinary
Chagyrskaya	HPO	Microdontia (HP:0000691)	2	0.6198	3.22684737	0.126987301	skeletal
Chagyrskaya	HPO	Bruising susceptibility (HP:0000978)	2	0.6344	3.15258512	0.130186981	other
Chagyrskaya	HPO	"Intellectual disability, mild (HP:0001256)"	2	0.6321	3.16405632	0.132686731	nervous
Chagyrskaya	HPO	Adactyly (HP:0009776)	1	0.1438	6.954102921	0.134086591	skeletal
Chagyrskaya	HPO	Hypotrichosis (HP:0001006)	1	0.1445	6.920415225	0.134386561	integumentary
Chagyrskaya	HPO	Abdominal pain (HP:0002027)	2	0.6403	3.123535843	0.136386361	other
Chagyrskaya	HPO	Wormian bones (HP:0002645)	1	0.1483	6.743088334	0.137986201	skeletal
Chagyrskaya	HPO	Personality changes (HP:0000751)	1	0.1501	6.662225183	0.138986101	behavior
Chagyrskaya	HPO	Poor coordination (HP:0002370)	1	0.1503	6.653359947	0.140085991	nervous
Chagyrskaya	HPO	Cutaneous photosensitivity (HP:0000992)	1	0.1535	6.51465798	0.141685831	integumentary
Chagyrskaya	HPO	Anterior segment dysgenesis (HP:0007700)	1	0.1529	6.540222368	0.141785821	integumentary
Chagyrskaya	HPO	Abnormality of chromosome stability (HP:0003220)	1	0.1517	6.591957811	0.142285771	other
Chagyrskaya	HPO	Microcytic anemia (HP:0001935)	1	0.1566	6.385696041	0.144585541	hematologic
Chagyrskaya	HPO	Cerebral inclusion bodies (HP:0100314)	1	0.1582	6.321112516	0.146085391	nervous
Chagyrskaya	HPO	Ectropion (HP:0000656)	1	0.1602	6.242197253	0.146985301	nervous
Chagyrskaya	HPO	Genu varum (HP:0002970)	1	0.1593	6.277463905	0.147285271	skeletal
Chagyrskaya	HPO	Hypolipoproteinemia (HP:0010981)	1	0.1603	6.238303182	0.149685031	metabolic
Chagyrskaya	HPO	Abnormality of T cells (HP:0002843)	1	0.1638	6.105006105	0.151784822	immune
Chagyrskaya	HPO	Gowers sign (HP:0003391)	1	0.1674	5.973715651	0.152684732	skeletal muscle
Chagyrskaya	HPO	Abnormal number of incisors (HP:0011064)	1	0.1688	5.924170616	0.155284472	skeletal
Chagyrskaya	HPO	Sclerocornea (HP:0000647)	1	0.1674	5.973715651	0.155484452	nervous
Chagyrskaya	HPO	Abnormality of the humerus (HP:0003063)	2	0.7039	2.841312686	0.156584342	skeletal
Chagyrskaya	HPO	Thick eyebrow (HP:0000574)	2	0.7138	2.801905296	0.157584242	integumentary
Chagyrskaya	HPO	Delusions (HP:0000746)	1	0.172	5.813953488	0.157584242	behavior
Chagyrskaya	HPO	Esophageal varix (HP:0002040)	1	0.1729	5.783689994	0.158584142	cardiovascular
Chagyrskaya	HPO	Long philtrum (HP:0000343)	4	2.0847	1.918741306	0.158884112	integumentary
Chagyrskaya	HPO	Congestive heart failure (HP:0001635)	2	0.7152	2.796420582	0.159484052	cardiovascular
Chagyrskaya	HPO	Poikilocytosis (HP:0004447)	1	0.1758	5.688282139	0.161283872	hematologic
Chagyrskaya	HPO	Advanced eruption of teeth (HP:0006288)	1	0.1773	5.640157924	0.162983702	skeletal
Chagyrskaya	HPO	Abnormality of the epiphysis of the femoral head (HP:0010574)	1	0.1775	5.633802817	0.163883612	skeletal
Chagyrskaya	HPO	Abnormality of the level of lipoprotein cholesterol (HP:0010979)	1	0.1782	5.611672278	0.164383562	metabolic
Chagyrskaya	HPO	Cardiomegaly (HP:0001640)	1	0.1796	5.567928731	0.165583442	cardiovascular
Chagyrskaya	HPO	Embryonal renal neoplasm (HP:0011794)	1	0.185	5.405405405	0.168183182	urinary
Chagyrskaya	HPO	Abnormality of the upper arm (HP:0001454)	2	0.7405	2.700877785	0.168483152	skeletal
Chagyrskaya	HPO	Abnormality of the femoral head (HP:0003368)	1	0.1838	5.440696409	0.169183082	skeletal
Chagyrskaya	HPO	Venous insufficiency (HP:0005293)	1	0.1849	5.408328826	0.169683032	cardiovascular
Chagyrskaya	HPO	Portal hypertension (HP:0001409)	1	0.1872	5.341880342	0.171382862	cardiovascular
Chagyrskaya	HPO	Macular degeneration (HP:0000608)	1	0.1933	5.173305742	0.175582442	nervous
Chagyrskaya	HPO	Pes cavus (HP:0001761)	2	0.7629	2.621575567	0.177482252	skeletal
Chagyrskaya	HPO	Prolonged bleeding time (HP:0003010)	1	0.1939	5.157297576	0.178782122	hematologic
Chagyrskaya	HPO	Hypothyroidism (HP:0000821)	3	1.4476	2.072395689	0.180081992	endocrine
Chagyrskaya	HPO	Abnormality of the hepatic vasculature (HP:0006707)	1	0.2003	4.992511233	0.181781822	skeletal muscle
Chagyrskaya	HPO	Aplasia/Hypoplasia of the abdominal wall musculature (HP:0010318)	2	0.7726	2.588661662	0.181981802	skeletal muscle
Chagyrskaya	HPO	EMG: myopathic abnormalities (HP:0003458)	1	0.2046	4.887585533	0.186281372	nervous
Chagyrskaya	HPO	Scapular winging (HP:0003691)	1	0.2078	4.812319538	0.187281272	skeletal
Chagyrskaya	HPO	Attention deficit hyperactivity disorder (HP:0007018)	2	0.7901	2.531325149	0.188281172	behavior
Chagyrskaya	HPO	Embryonal neoplasm (HP:0002898)	1	0.2102	4.75737393	0.190880912	other
Chagyrskaya	HPO	Thyroid carcinoma (HP:0002890)	1	0.2144	4.664179104	0.191880812	endocrine
Chagyrskaya	HPO	Enlarged kidneys (HP:0000105)	1	0.2133	4.688232536	0.192780722	urinary
Chagyrskaya	HPO	Secondary amenorrhea (HP:0000869)	1	0.2152	4.646840149	0.193080692	reproductive
Chagyrskaya	HPO	Striae distensae (HP:0001065)	1	0.2215	4.514672686	0.196780322	integumentary
Chagyrskaya	HPO	Ovoid vertebral bodies (HP:0003300)	1	0.2254	4.436557232	0.202179782	skeletal
Chagyrskaya	HPO	Deep philtrum (HP:0002002)	1	0.2278	4.389815628	0.204079592	integumentary
Chagyrskaya	HPO	Disproportionate short-trunk short stature (HP:0003521)	1	0.2325	4.301075269	0.208079192	skeletal
Chagyrskaya	HPO	Abnormality of femoral epiphyses (HP:0006499)	1	0.2342	4.269854825	0.210678932	skeletal
Chagyrskaya	HPO	Abnormality involving the epiphyses of the lower limbs (HP:0006500)	1	0.2342	4.269854825	0.210678932	skeletal
Chagyrskaya	HPO	IgA deficiency (HP:0002720)	1	0.2365	4.22832981	0.211778822	immune
Chagyrskaya	HPO	Hyperpituitarism (HP:0010514)	1	0.243	4.115226337	0.214978502	endocrine
Chagyrskaya	HPO	Partial agenesis of the corpus callosum (HP:0001338)	1	0.2489	4.017677782	0.221777822	nervous
Chagyrskaya	HPO	Abnormality of the shoulder girdle musculature (HP:0001435)	1	0.2521	3.966679889	0.222377762	skeletal muscle
Chagyrskaya	HPO	Germ cell neoplasia (HP:0100728)	1	0.252	3.968253968	0.222377762	reproductive
Chagyrskaya	HPO	Congenital sensorineural hearing impairment (HP:0008527)	1	0.2615	3.824091778	0.228277172	nervous
Chagyrskaya	HPO	Myelodysplasia (HP:0002863)	1	0.2601	3.844675125	0.228977102	hematologic
Chagyrskaya	HPO	Bicuspid aortic valve (HP:0001647)	1	0.2621	3.815337657	0.230176982	cardiovascular
Chagyrskaya	HPO	Hypermetropia (HP:0000540)	2	0.9149	2.18603126	0.230676932	nervous
Chagyrskaya	HPO	Asymmetric growth (HP:0100555)	1	0.2627	3.806623525	0.231076892	other
Chagyrskaya	HPO	High forehead (HP:0000348)	2	0.9125	2.191780822	0.231876812	skeletal
Chagyrskaya	HPO	IgM deficiency (HP:0002850)	1	0.2638	3.790750569	0.232376762	immune
Chagyrskaya	HPO	Adrenal overactivity (HP:0002717)	1	0.2655	3.766478343	0.234676532	endocrine
Chagyrskaya	HPO	Emotional lability (HP:0000712)	1	0.2654	3.767897513	0.234976502	behavior
Chagyrskaya	HPO	Abnormality of the anterior chamber (HP:0000593)	1	0.2694	3.711952487	0.236676332	nervous
Chagyrskaya	HPO	High palate (HP:0000218)	3	1.6826	1.782954951	0.237976202	skeletal
Chagyrskaya	HPO	Focal segmental glomerulosclerosis (HP:0000097)	1	0.2764	3.617945007	0.242275772	urinary
Chagyrskaya	HPO	Acute myeloid leukemia (HP:0004808)	1	0.2776	3.602305476	0.244175582	lymphatic
Chagyrskaya	HPO	Sepsis (HP:0100806)	1	0.2794	3.579098067	0.244475552	immune
Chagyrskaya	HPO	Psychosis (HP:0000709)	1	0.2846	3.513703443	0.246775322	nervous
Chagyrskaya	HPO	CNS demyelination (HP:0007305)	1	0.2828	3.536067893	0.247875212	nervous
Chagyrskaya	HPO	Optic atrophy (HP:0000648)	5	3.3622	1.487121528	0.249075092	nervous
Chagyrskaya	HPO	Neoplasm of the liver (HP:0002896)	1	0.2825	3.539823009	0.249275072	digestive
Chagyrskaya	HPO	Dilatation of the ascending aorta (HP:0005111)	1	0.2849	3.51000351	0.249475052	cardiovascular
Chagyrskaya	HPO	Abnormality of the thoracic spine (HP:0100711)	1	0.2867	3.487966516	0.250974903	skeletal
Chagyrskaya	HPO	Prominent nose (HP:0000448)	1	0.2969	3.36813742	0.255874413	skeletal
Chagyrskaya	HPO	Hypoplastic toenails (HP:0001800)	1	0.3	3.333333333	0.257274273	integumentary
Chagyrskaya	HPO	Venous abnormality (HP:0002624)	1	0.2984	3.351206434	0.258674133	cardiovascular
Chagyrskaya	HPO	Postnatal microcephaly (HP:0005484)	1	0.2994	3.34001336	0.260473953	skeletal
Chagyrskaya	HPO	Neonatal hypotonia (HP:0001319)	2	0.988	2.024291498	0.261773823	skeletal muscle
Chagyrskaya	HPO	Cutis marmorata (HP:0000965)	1	0.3035	3.294892916	0.262473753	integumentary
Chagyrskaya	HPO	Glomerulopathy (HP:0100820)	1	0.3082	3.244646334	0.263173683	urinary
Chagyrskaya	HPO	Delayed puberty (HP:0000823)	1	0.3056	3.272251309	0.264473553	endocrine
Chagyrskaya	HPO	Acrocyanosis (HP:0001063)	1	0.3097	3.228931224	0.264973503	integumentary
Chagyrskaya	HPO	Goiter (HP:0000853)	1	0.3077	3.249918752	0.265173483	endocrine
Chagyrskaya	HPO	Unsteady gait (HP:0002317)	1	0.3164	3.160556258	0.267573243	other
Chagyrskaya	HPO	Glomerulosclerosis (HP:0000096)	1	0.3119	3.206155819	0.269873013	urinary
Chagyrskaya	HPO	Spina bifida occulta (HP:0003298)	1	0.3128	3.196930946	0.270272973	skeletal
Chagyrskaya	HPO	Dolichocephaly (HP:0000268)	2	1.0113	1.977652526	0.270772923	skeletal
Chagyrskaya	HPO	Stroke (HP:0001297)	1	0.3195	3.129890454	0.275872413	cardiovascular
Chagyrskaya	HPO	Neoplasm of the thyroid gland (HP:0100031)	1	0.325	3.076923077	0.276172383	endocrine
Chagyrskaya	HPO	Absence seizures (HP:0002121)	1	0.3311	3.020235578	0.281071893	nervous
Chagyrskaya	HPO	Photophobia (HP:0000613)	2	1.0412	1.920860546	0.281571843	nervous
Chagyrskaya	HPO	Narrow face (HP:0000275)	1	0.3265	3.062787136	0.281871813	skeletal
Chagyrskaya	HPO	Split hand (HP:0001171)	1	0.3353	2.982403817	0.284571543	skeletal
Chagyrskaya	HPO	Absent toe (HP:0010760)	1	0.3387	2.952465309	0.286771323	skeletal
Chagyrskaya	HPO	Coarse facial features (HP:0000280)	2	1.0805	1.85099491	0.290070993	integumentary
Chagyrskaya	HPO	Multicystic kidney dysplasia (HP:0000003)	2	1.0673	1.873887379	0.290770923	urinary
Chagyrskaya	HPO	Epistaxis (HP:0000421)	1	0.3479	2.874389192	0.294170583	other
Chagyrskaya	HPO	Memory impairment (HP:0002354)	1	0.3463	2.887669651	0.295070493	nervous
Chagyrskaya	HPO	Lymphopenia (HP:0001888)	1	0.3552	2.815315315	0.298870113	lymphatic
Chagyrskaya	HPO	Congenital glaucoma (HP:0001087)	1	0.358	2.793296089	0.300869913	nervous
Chagyrskaya	HPO	Abnormality of cells of the lymphoid lineage (HP:0012140)	1	0.3588	2.787068004	0.301469853	lymphatic
Chagyrskaya	HPO	Attenuation of retinal blood vessels (HP:0007843)	1	0.3625	2.75862069	0.303269673	cardiovascular
Chagyrskaya	HPO	Pulmonary hypertension (HP:0002092)	1	0.3655	2.735978112	0.303469653	cardiovascular
Chagyrskaya	HPO	Iris coloboma (HP:0000612)	2	1.0942	1.827819411	0.303669633	nervous
Chagyrskaya	HPO	Sacral dimple (HP:0000960)	1	0.3606	2.773155851	0.303769623	integumentary
Chagyrskaya	HPO	Corneal erosion (HP:0200020)	1	0.3608	2.771618625	0.304969503	nervous
Chagyrskaya	HPO	Macroglossia (HP:0000158)	1	0.3575	2.797202797	0.305769423	other
Chagyrskaya	HPO	Bony spicule pigmentary retinopathy (HP:0007737)	1	0.3683	2.715177844	0.307169283	nervous
Chagyrskaya	HPO	Hydrocephalus (HP:0000238)	3	1.9524	1.536570375	0.310068993	nervous
Chagyrskaya	HPO	Abnormality of the acetabulum (HP:0003170)	1	0.3701	2.70197244	0.310168983	skeletal
Chagyrskaya	HPO	Protruding ear (HP:0000411)	1	0.3724	2.68528464	0.310468953	other
Chagyrskaya	HPO	Hepatomegaly (HP:0002240)	3	1.9664	1.525630594	0.313768623	digestive
Chagyrskaya	HPO	Opacification of the corneal stroma (HP:0007759)	2	1.1409	1.753002016	0.314868513	nervous
Chagyrskaya	HPO	Pes planus (HP:0001763)	2	1.1359	1.760718373	0.315668433	skeletal
Chagyrskaya	HPO	Skull defect (HP:0001362)	1	0.378	2.645502646	0.316268373	skeletal
Chagyrskaya	HPO	Hypohidrosis (HP:0000966)	1	0.3846	2.600104004	0.319668033	endocrine
Chagyrskaya	HPO	Teleangiectasia of the skin (HP:0100585)	1	0.3939	2.53871541	0.323967603	cardiovascular
Chagyrskaya	HPO	Recurrent fractures (HP:0002757)	2	1.1591	1.725476663	0.324067593	skeletal
Chagyrskaya	HPO	Increased serum lactate (HP:0002151)	1	0.3899	2.564760195	0.324867513	other
Chagyrskaya	HPO	Premature birth (HP:0001622)	1	0.3968	2.52016129	0.327067293	reproductive
Chagyrskaya	HPO	Anonychia (HP:0001798)	1	0.3972	2.517623364	0.329767023	integumentary
Chagyrskaya	HPO	Congenital hepatic fibrosis (HP:0002612)	1	0.4009	2.494387628	0.332866713	digestive
Chagyrskaya	HPO	Dysarthria (HP:0001260)	3	2.0288	1.478706625	0.335166483	nervous
Chagyrskaya	HPO	Leiomyosarcoma (HP:0100243)	1	0.4098	2.440214739	0.338266173	skeletal muscle
Chagyrskaya	HPO	Uterine leiomyosarcoma (HP:0002891)	1	0.4098	2.440214739	0.338266173	reproductive
Chagyrskaya	HPO	Coarse hair (HP:0002208)	1	0.4099	2.439619419	0.339866013	integumentary
Chagyrskaya	HPO	Neutropenia (HP:0001875)	1	0.4184	2.390057361	0.340965903	immune
Chagyrskaya	HPO	Autism (HP:0000717)	2	1.2104	1.652346332	0.344565543	nervous
Chagyrskaya	HPO	Bladder neoplasm (HP:0009725)	1	0.4215	2.372479241	0.346565343	urinary
Chagyrskaya	HPO	Transitional cell carcinoma of the bladder (HP:0006740)	1	0.4215	2.372479241	0.346565343	urinary
Chagyrskaya	HPO	Bladder carcinoma (HP:0002862)	1	0.4215	2.372479241	0.346565343	urinary
Chagyrskaya	HPO	Single transverse palmar crease (HP:0000954)	2	1.2324	1.622849724	0.350364964	integumentary
Chagyrskaya	HPO	Nephropathy (HP:0000112)	1	0.433	2.309468822	0.350564944	urinary
Chagyrskaya	HPO	Cellular immunodeficiency (HP:0005374)	1	0.4387	2.279462047	0.356164384	immune
Chagyrskaya	HPO	Broad foot (HP:0001769)	1	0.4388	2.278942571	0.358564144	skeletal
Chagyrskaya	HPO	Thin skin (HP:0000963)	1	0.4502	2.221235007	0.365663434	integumentary
Chagyrskaya	HPO	Hyperextensible skin (HP:0000974)	1	0.458	2.183406114	0.367663234	integumentary
Chagyrskaya	HPO	Hereditary nonpolyposis colorectal carcinoma (HP:0006716)	1	0.4556	2.194907814	0.368063194	digestive
Chagyrskaya	HPO	Bronchiectasis (HP:0002110)	1	0.4609	2.169668041	0.373862614	respiratory
Chagyrskaya	HPO	Pruritus (HP:0000989)	1	0.4678	2.137665669	0.374062594	integumentary
Chagyrskaya	HPO	Lumbar hyperlordosis (HP:0002938)	1	0.4716	2.120441052	0.377362264	skeletal
Chagyrskaya	HPO	Dehydration (HP:0001944)	1	0.4809	2.079434394	0.380761924	other
Chagyrskaya	HPO	Bicornuate uterus (HP:0000813)	1	0.4848	2.062706271	0.384861514	reproductive
Chagyrskaya	HPO	Tracheal stenosis (HP:0002777)	1	0.4846	2.063557573	0.385961404	respiratory
Chagyrskaya	HPO	Narrow palate (HP:0000189)	1	0.4959	2.016535592	0.388161184	skeletal
Chagyrskaya	HPO	Respiratory insufficiency due to muscle weakness (HP:0002747)	1	0.49	2.040816327	0.390460954	respiratory
Chagyrskaya	HPO	Mitral valve prolapse (HP:0001634)	1	0.4929	2.028809089	0.390560944	cardiovascular
Chagyrskaya	HPO	Gastrointestinal carcinoma (HP:0002672)	1	0.4945	2.022244692	0.392060794	digestive
Chagyrskaya	HPO	Malignant gastrointestinal tract tumors (HP:0006749)	1	0.4945	2.022244692	0.392060794	digestive
Chagyrskaya	HPO	Dementia (HP:0000726)	1	0.5038	1.984914649	0.397960204	nervous
Chagyrskaya	HPO	Sandal gap (HP:0001852)	1	0.5152	1.940993789	0.401659834	skeletal
Chagyrskaya	HPO	Micromelia (HP:0002983)	2	1.3793	1.450010875	0.401959804	skeletal
Chagyrskaya	HPO	Platyspondyly (HP:0000926)	1	0.5118	1.953888238	0.402359764	skeletal
Chagyrskaya	HPO	Abnormality of the incisor (HP:0000676)	1	0.5232	1.911314985	0.405459454	skeletal
Chagyrskaya	HPO	Accelerated skeletal maturation (HP:0005616)	1	0.5263	1.900057002	0.410558944	skeletal
Chagyrskaya	HPO	Hyperhidrosis (HP:0000975)	1	0.5288	1.89107413	0.411658834	integumentary
Chagyrskaya	HPO	Bulbous nose (HP:0000414)	1	0.5306	1.884658877	0.414258574	other
Chagyrskaya	HPO	Ptosis (HP:0000508)	3	2.3632	1.269465132	0.422157784	skeletal muscle
Chagyrskaya	HPO	Melanocytic nevus (HP:0000995)	1	0.5497	1.819174095	0.422257774	integumentary
Chagyrskaya	HPO	Short distal phalanx of finger (HP:0009882)	1	0.5605	1.78412132	0.428657134	skeletal
Chagyrskaya	HPO	Delayed gross motor development (HP:0002194)	1	0.5712	1.75070028	0.429557044	nervous
Chagyrskaya	HPO	Uterine neoplasm (HP:0010784)	1	0.5585	1.790510295	0.430756924	reproductive
Chagyrskaya	HPO	Pointed chin (HP:0000307)	1	0.5673	1.762735766	0.433956604	skeletal
Chagyrskaya	HPO	Leukopenia (HP:0001882)	1	0.5625	1.777777778	0.435456454	immune
Chagyrskaya	HPO	Everted lower lip vermilion (HP:0000232)	1	0.5918	1.689760054	0.439456054	integumentary
Chagyrskaya	HPO	Pulmonic stenosis (HP:0001642)	1	0.5773	1.732201628	0.439456054	cardiovascular
Chagyrskaya	HPO	Vomiting (HP:0002013)	1	0.5768	1.73370319	0.440855914	digestive
Chagyrskaya	HPO	Paresthesia (HP:0003401)	1	0.5711	1.751006829	0.441155884	nervous
Chagyrskaya	HPO	Dry skin (HP:0000958)	1	0.5775	1.731601732	0.443455654	integumentary
Chagyrskaya	HPO	Brachydactyly syndrome (HP:0001156)	3	2.4629	1.218076252	0.446655334	skeletal
Chagyrskaya	HPO	Highly arched eyebrow (HP:0002553)	1	0.6068	1.647989453	0.454154585	integumentary
Chagyrskaya	HPO	Postnatal growth retardation (HP:0008897)	1	0.5941	1.683218313	0.454454555	metabolic
Chagyrskaya	HPO	Developmental regression (HP:0002376)	1	0.613	1.63132137	0.455054495	behavior
Chagyrskaya	HPO	Lethargy (HP:0001254)	1	0.615	1.62601626	0.459754025	behavior
Chagyrskaya	HPO	Lactic acidosis (HP:0003128)	1	0.622	1.607717042	0.466753325	metabolic
Chagyrskaya	HPO	Short nose (HP:0003196)	2	1.5837	1.262865442	0.470452955	skeletal
Chagyrskaya	HPO	Osteopenia (HP:0000938)	1	0.6421	1.557389815	0.472152785	skeletal
Chagyrskaya	HPO	Gingival overgrowth (HP:0000212)	1	0.6395	1.563721658	0.473252675	immune
Chagyrskaya	HPO	Constipation (HP:0002019)	2	1.5974	1.252034556	0.475052495	digestive
Chagyrskaya	HPO	Broad forehead (HP:0000337)	1	0.6474	1.544640099	0.479352065	skeletal
Chagyrskaya	HPO	Migraine (HP:0002076)	1	0.6679	1.497230124	0.486551345	nervous
Chagyrskaya	HPO	Nephrotic syndrome (HP:0000100)	1	0.6671	1.499025633	0.487751225	urinary
Chagyrskaya	HPO	Inguinal hernia (HP:0000023)	1	0.6985	1.431639227	0.504649535	digestive
Chagyrskaya	HPO	Blindness (HP:0000618)	1	0.7065	1.415428167	0.508349165	nervous
Chagyrskaya	HPO	Astigmatism (HP:0000483)	1	0.7097	1.409046076	0.512148785	nervous
Chagyrskaya	HPO	Cheekbone underdevelopment (HP:0010669)	1	0.7251	1.379120121	0.519048095	skeletal
Chagyrskaya	HPO	Tetralogy of Fallot (HP:0001636)	1	0.7474	1.337971635	0.531246875	cardiovascular
Chagyrskaya	HPO	Dandy-Walker malformation (HP:0001305)	1	0.7559	1.322926313	0.537946205	nervous
Chagyrskaya	HPO	Macrotia (HP:0000400)	1	0.7767	1.287498391	0.538246175	other
Chagyrskaya	HPO	Omphalocele (HP:0001539)	1	0.7701	1.298532658	0.542645735	other
Chagyrskaya	HPO	Palmoplantar keratoderma (HP:0000982)	1	0.781	1.280409731	0.544445555	integumentary
Chagyrskaya	HPO	Long face (HP:0000276)	1	0.8421	1.187507422	0.566943306	skeletal
Chagyrskaya	HPO	Microcornea (HP:0000482)	1	0.8754	1.142334933	0.579742026	nervous
Chagyrskaya	HPO	Mandibular prognathia (HP:0000303)	1	0.8962	1.115822361	0.593340666	skeletal
Chagyrskaya	HPO	Arthralgia (HP:0002829)	1	0.9369	1.067349771	0.605739426	skeletal
Chagyrskaya	HPO	Proteinuria (HP:0000093)	1	0.9263	1.079563856	0.606039396	other
Chagyrskaya	HPO	Umbilical hernia (HP:0001537)	2	2.024	0.988142292	0.606039396	reproductive
Chagyrskaya	HPO	Dysphagia (HP:0002015)	1	0.9423	1.061233153	0.607339266	digestive
Chagyrskaya	HPO	Depressed nasal ridge (HP:0000457)	1	0.9308	1.07434465	0.608839116	skeletal
Chagyrskaya	HPO	Downslanted palpebral fissures (HP:0000494)	2	2.042	0.979431929	0.609539046	integumentary
Chagyrskaya	HPO	Abnormality of the fingernails (HP:0001231)	1	0.9666	1.034554107	0.614838516	integumentary
Chagyrskaya	HPO	Variable expressivity (HP:0003828)	1	1.0112	0.988924051	0.632836716	other
Chagyrskaya	HPO	Heterogeneous (HP:0001425)	1	1.0749	0.930319099	0.657734227	other
Chagyrskaya	HPO	Round face (HP:0000311)	1	1.1378	0.878889084	0.681231877	skeletal
Chagyrskaya	HPO	"Low-set, posteriorly rotated ears (HP:0000368)"	3	3.56	0.842696629	0.694530547	other
Chagyrskaya	HPO	Patent ductus arteriosus (HP:0001643)	1	1.2135	0.824062629	0.706429357	cardiovascular
Chagyrskaya	HPO	Camptodactyly of finger (HP:0100490)	1	1.2594	0.794028903	0.714128587	skeletal
Chagyrskaya	HPO	Cerebral cortical atrophy (HP:0002120)	1	1.2745	0.78462142	0.720227977	nervous
Chagyrskaya	HPO	Wide nasal bridge (HP:0000431)	2	2.6691	0.749316249	0.746725327	integumentary
Chagyrskaya	HPO	Intrauterine growth retardation (HP:0001511)	2	2.8219	0.708742337	0.774622538	other
Chagyrskaya	HPO	Talipes equinovarus (HP:0001762)	1	1.509	0.662690524	0.778822118	skeletal
Chagyrskaya	HPO	Autosomal dominant inheritance (HP:0000006)	9	12.5377	0.71783501	0.878012199	other
Chagyrskaya	HPO	Clinodactyly of the 5th finger (HP:0004209)	1	2.1511	0.464878434	0.886311369	skeletal
Chagyrskaya	HPO	Ventricular septal defect (HP:0001629)	1	2.1525	0.464576074	0.887511249	cardiovascular
Chagyrskaya	HPO	Malar flattening (HP:0000272)	1	2.2711	0.440315266	0.894610539	skeletal
Chagyrskaya	HPO	Short neck (HP:0000470)	1	2.275	0.43956044	0.901709829	skeletal
Chagyrskaya	HPO	Frontal bossing (HP:0002007)	1	2.363	0.423190859	0.902709729	skeletal
Chagyrskaya	HPO	Radial deviation of finger (HP:0009466)	1	2.4239	0.412558274	0.916308369	skeletal
Chagyrskaya	HPO	Cryptorchidism (HP:0000028)	2	4.1665	0.480019201	0.919908009	reproductive
Chagyrskaya	HPO	Epicanthus (HP:0000286)	1	2.8176	0.354911982	0.939606039	integumentary
Chagyrskaya	HPO	Depressed nasal bridge (HP:0005280)	1	3.2451	0.308156914	0.96250375	skeletal
Chagyrskaya	HPO	Hypertelorism (HP:0000316)	1	3.6073	0.277215646	0.97410259	skeletal
Denisovan	GWAS	Basophil percentage of white cells	10	3.5781	2.794779352	0.00349965	immune
Denisovan	GWAS	IgA nephropathy	6	1.4145	4.241781548	0.00359964	immune
Denisovan	GWAS	"Thyroid cancer (Papillary, radiation-related)"	2	0.1006	19.88071571	0.00549945	endocrine
Denisovan	GWAS	Liver enzyme levels	6	1.5954	3.760812335	0.00629937	other
Denisovan	GWAS	Aspartate aminotransferase levels	7	2.1204	3.301263912	0.00639936	other
Denisovan	GWAS	PCA3 expression level	1	0.0138	72.46376812	0.01389861	other
Denisovan	GWAS	Factor VII	2	0.1888	10.59322034	0.0169983	hematologic
Denisovan	GWAS	Graves' disease	5	1.5532	3.219160443	0.019998	endocrine
Denisovan	GWAS	Fuchs's corneal dystrophy	3	0.5832	5.144032922	0.02319768	nervous
Denisovan	GWAS	Inflammatory bowel disease	39	27.7845	1.403660314	0.02579742	digestive
Denisovan	GWAS	Osteoprotegerin levels	2	0.2571	7.77907429	0.02689731	skeletal
Denisovan	GWAS	Hematological parameters	2	0.2546	7.855459544	0.02709729	hematologic
Denisovan	GWAS	Lumbar spine bone mineral density (trabecular)	6	2.2894	2.620774002	0.03139686	skeletal
Denisovan	GWAS	Food allergy (parent-of-origin effect)	2	0.3026	6.609385327	0.0359964	immune
Denisovan	GWAS	Schizophrenia or bipolar disorder	4	1.2365	3.234937323	0.03719628	behavior
Denisovan	GWAS	Hair shape	3	0.7369	4.071108699	0.03779622	integumentary
Denisovan	GWAS	Leprosy	4	1.2794	3.126465531	0.039996	immune
Denisovan	GWAS	Hypertriglyceridemia	3	0.7824	3.834355828	0.04719528	metabolic
Denisovan	GWAS	Lower body strength	3	0.8156	3.678273664	0.050494951	skeletal muscle
Denisovan	GWAS	Urate levels	9	4.7161	1.908356481	0.051494851	metabolic
Denisovan	GWAS	Systemic sclerosis (anti-centromere-positive)	2	0.3674	5.443658138	0.054494551	other
Denisovan	GWAS	Nonsyndromic cleft lip with cleft palate	4	1.4062	2.844545584	0.054694531	other
Denisovan	GWAS	Pulmonary function in asthmatics	2	0.3871	5.166623611	0.057394261	respiratory
Denisovan	GWAS	Metabolite levels (lipid measures)	2	0.4093	4.8863914	0.063393661	metabolic
Denisovan	GWAS	Hair morphology	3	0.9106	3.294531078	0.063693631	integumentary
Denisovan	GWAS	Nephrolithiasis	2	0.4048	4.940711462	0.064593541	urinary
Denisovan	GWAS	Subclinical trait of interstitial lung disease (basilar peel-core ratio of HAA on CT scan)	3	0.9182	3.267262034	0.065493451	respiratory
Denisovan	GWAS	Iron status biomarkers (ferritin levels)	2	0.4349	4.598758335	0.069493051	other
Denisovan	GWAS	Electroencephalogram traits	5	2.1839	2.289482119	0.071992801	nervous
Denisovan	GWAS	Hearing function	3	0.9866	3.040745996	0.076592341	nervous
Denisovan	GWAS	Hair color	8	4.3909	1.821949942	0.078892111	integumentary
Denisovan	GWAS	Urinary bladder cancer	1	0.0834	11.99040767	0.079392061	metabolic
Denisovan	GWAS	Chronic lymphocytic leukemia	7	3.6783	1.903053041	0.079892011	lymphatic
Denisovan	GWAS	Waist-to-hip ratio adjusted for BMI (age <50)	8	4.4563	1.795211274	0.080491951	skeletal
Denisovan	GWAS	Left ventricular obstructive tract defect (maternal effect)	3	1.0126	2.962670354	0.081091891	cardiovascular
Denisovan	GWAS	Febrile seizures	2	0.474	4.219409283	0.081891811	nervous
Denisovan	GWAS	HDL cholesterol	26	19.3415	1.344259752	0.084791521	metabolic
Denisovan	GWAS	Proinsulin levels	2	0.4979	4.016870858	0.089391061	metabolic
Denisovan	GWAS	Beta-2 microglubulin plasma levels	1	0.0995	10.05025126	0.094790521	immune
Denisovan	GWAS	Hematological and biochemical traits	5	2.4021	2.08151201	0.095590441	hematologic
Denisovan	GWAS	Sphingolipid levels	3	1.0854	2.763957988	0.097590241	metabolic
Denisovan	GWAS	Lung cancer	14	9.4833	1.476279354	0.097690231	respiratory
Denisovan	GWAS	Event free survival in diffuse large B-cell lymphoma treated with immunochemotherapy	1	0.1038	9.633911368	0.097890211	other
Denisovan	GWAS	Febrile seizures (MMR vaccine-related)	2	0.535	3.738317757	0.098190181	nervous
Denisovan	GWAS	Cingulate cortical amyloid beta load	1	0.1043	9.587727709	0.099290071	nervous
Denisovan	GWAS	Nonalcoholic fatty liver disease	2	0.5303	3.771450123	0.100189981	digestive
Denisovan	GWAS	DNA methylation (variation)	3	1.0929	2.744990393	0.101789821	other
Denisovan	GWAS	Osteoarthritis (hip)	6	3.1709	1.89220726	0.102889711	skeletal
Denisovan	GWAS	Red blood cell traits	8	4.7743	1.675638313	0.108289171	hematologic
Denisovan	GWAS	Branched-chain amino acid levels (Isoleucine)	1	0.1149	8.703220191	0.108789121	other
Denisovan	GWAS	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	2	0.5581	3.583587171	0.108989101	other
Denisovan	GWAS	Non-glioblastoma glioma	5	2.504	1.996805112	0.109589041	nervous
Denisovan	GWAS	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	1	0.1169	8.554319932	0.110988901	nervous
Denisovan	GWAS	Type 1 diabetes in high risk HLA genotype individuals (time to event)	1	0.1181	8.467400508	0.111388861	metabolic
Denisovan	GWAS	White blood cell count (basophil)	10	6.3671	1.570573731	0.112488751	immune
Denisovan	GWAS	Blood pressure measurement (high sodium and potassium intervention)	1	0.1208	8.278145695	0.113988601	hematologic
Denisovan	GWAS	Cerebrospinal AB1-42 levels in normal cognition	6	3.2721	1.83368479	0.114888511	nervous
Denisovan	GWAS	Mumps	1	0.1224	8.169934641	0.115188481	immune
Denisovan	GWAS	Complement C3 and C4 levels	1	0.1234	8.103727715	0.116088391	immune
Denisovan	GWAS	Blood metabolite levels	11	7.2322	1.520975637	0.116288371	metabolic
Denisovan	GWAS	Basophil percentage of granulocytes	7	4.0699	1.719943979	0.116388361	immune
Denisovan	GWAS	S-phenylmercapturic acid levels in smokers	1	0.1235	8.097165992	0.116688331	other
Denisovan	GWAS	Systemic sclerosis (anti-topoisomerase-positive)	1	0.126	7.936507937	0.117688231	other
Denisovan	GWAS	Mean arterial pressure (long-term average)	1	0.1244	8.038585209	0.118088191	cardiovascular
Denisovan	GWAS	Chronic hepatitis B infection	1	0.1272	7.86163522	0.119588041	immune
Denisovan	GWAS	Bone ultrasound measurement (broadband ultrasound attenuation)	5	2.6239	1.905560425	0.119988001	skeletal
Denisovan	GWAS	Delirium	6	3.3406	1.796084536	0.122487751	behavior
Denisovan	GWAS	Amyotrophic lateral sclerosis	9	5.7336	1.569694433	0.124187581	nervous
Denisovan	GWAS	Egg allergy	2	0.5993	3.337226765	0.124487551	immune
Denisovan	GWAS	Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)	1	0.1327	7.535795026	0.125987401	other
Denisovan	GWAS	Systemic lupus erythematosus and Systemic sclerosis	4	1.9152	2.08855472	0.131686831	immune
Denisovan	GWAS	Plasma homocysteine levels (post-methionine load test)	1	0.1414	7.072135785	0.132086791	other
Denisovan	GWAS	Economic and political preferences	3	1.2436	2.412351238	0.132586741	other
Denisovan	GWAS	Chronic hepatitis C infection	1	0.1477	6.770480704	0.138086191	immune
Denisovan	GWAS	Cancer	3	1.2966	2.313743637	0.143585641	other
Denisovan	GWAS	Erosive tooth wear (severe vs none or mild)	8	5.1542	1.552132242	0.145885411	skeletal
Denisovan	GWAS	GIP levels in response to oral glucose tolerance test (120 minutes)	2	0.6754	2.961208173	0.147485251	metabolic
Denisovan	GWAS	Glioma	3	1.3142	2.282757571	0.148385161	nervous
Denisovan	GWAS	Premature menopause in childhood cancer survivors	2	0.6807	2.938151902	0.151484852	other
Denisovan	GWAS	Limited cutaneous systemic scleroderma	2	0.69	2.898550725	0.152484752	integumentary
Denisovan	GWAS	Circulating myeloperoxidase levels (plasma)	1	0.1751	5.711022273	0.157984202	other
Denisovan	GWAS	Coffee consumption	4	2.0749	1.92780375	0.157984202	behavior
Denisovan	GWAS	Hippocampal volume in Alzheimer's disease dementia	5	2.8304	1.766534765	0.158884112	nervous
Denisovan	GWAS	Logical memory (immediate recall) in Alzheimer's disease dementia	1	0.1722	5.807200929	0.159284072	nervous
Denisovan	GWAS	Body mass index (age>50)	7	4.4284	1.58070635	0.159684032	metabolic
Denisovan	GWAS	Cerebral amyloid deposition (PET imaging)	5	2.8651	1.745139786	0.160283972	nervous
Denisovan	GWAS	Waist-to-hip ratio adjusted for BMI in inactive individuals	2	0.7201	2.777392029	0.164283572	skeletal
Denisovan	GWAS	Age-related macular degeneration (choroidal neovascularisation)	1	0.183	5.464480874	0.167483252	nervous
Denisovan	GWAS	Sporadic pituitary adenoma	3	1.418	2.115655853	0.167483252	nervous
Denisovan	GWAS	Lung disease severity in cystic fibrosis	1	0.1845	5.420054201	0.167683232	respiratory
Denisovan	GWAS	Smoking initiation	3	1.4143	2.121190695	0.168383162	behavior
Denisovan	GWAS	Cold sores	1	0.1852	5.399568035	0.170282972	immune
Denisovan	GWAS	Urinary metabolites	2	0.7417	2.696508022	0.170582942	metabolic
Denisovan	GWAS	Psychosis in Alzheimer's disease	2	0.7549	2.649357531	0.173682632	behavior
Denisovan	GWAS	Yu-Zhi constitution type in type 2 diabetes	2	0.7497	2.66773376	0.175582442	hematologic
Denisovan	GWAS	Polymyositis	2	0.7605	2.629848784	0.177182282	skeletal muscle
Denisovan	GWAS	Bipolar disorder	18	14.0778	1.278608874	0.178682132	behavior
Denisovan	GWAS	Coffee consumption (cups per day)	2	0.7784	2.569373073	0.184181582	behavior
Denisovan	GWAS	Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)	2	0.7852	2.547121752	0.185481452	endocrine
Denisovan	GWAS	White blood cell count (monocyte)	1	0.205	4.87804878	0.186381362	immune
Denisovan	GWAS	Central corneal thickness	9	6.2936	1.430024152	0.186481352	nervous
Denisovan	GWAS	Pediatric non-alcoholic fatty liver disease activity score	3	1.4978	2.002937642	0.189781022	digestive
Denisovan	GWAS	Plasma omega-3 polyunsaturated fatty acid level (eicosapentaenoic acid)	2	0.8239	2.427479063	0.192580742	other
Denisovan	GWAS	Hematology traits	2	0.8111	2.465787203	0.193480652	hematologic
Denisovan	GWAS	Pneumococcal bacteremia	2	0.8053	2.483546504	0.194880512	respiratory
Denisovan	GWAS	"B-cell malignancies (CLL, Hodgkin lymphoma or multiple myeloma) (pleiotropy)"	3	1.531	1.959503592	0.195180482	immune
Denisovan	GWAS	Lipid traits	3	1.5416	1.946030099	0.198080192	metabolic
Denisovan	GWAS	Liver enzyme levels (alkaline phosphatase)	3	1.5491	1.936608353	0.200879912	other
Denisovan	GWAS	Eye color traits	1	0.2225	4.494382022	0.201379862	integumentary
Denisovan	GWAS	Plantar warts	1	0.225	4.444444444	0.202479752	integumentary
Denisovan	GWAS	Lumbar spine bone mineral density	6	3.9107	1.53425218	0.203079692	skeletal
Denisovan	GWAS	Parent of origin effect on language impairment (paternal)	1	0.2264	4.416961131	0.204179582	nervous
Denisovan	GWAS	Macular telangiectasia type 2	1	0.2319	4.312203536	0.206279372	nervous
Denisovan	GWAS	Total bilirubin levels	3	1.5652	1.916687963	0.206979302	digestive
Denisovan	GWAS	Facial pigmentation	1	0.2355	4.246284501	0.209679032	integumentary
Denisovan	GWAS	Waist-to-hip ratio adjusted for BMI	16	12.6864	1.261193089	0.210878912	skeletal
Denisovan	GWAS	Oropharynx cancer	4	2.3457	1.7052479	0.212078792	other
Denisovan	GWAS	Body mass index (change over time) in chronic obstructive pulmonary disease	4	2.3691	1.688404879	0.213978602	metabolic
Denisovan	GWAS	Metabolite levels (5-HIAA/ MHPG Ratio)	2	0.8746	2.286759662	0.215478452	metabolic
Denisovan	GWAS	Cytomegalovirus antibody response	3	1.6031	1.871374212	0.216578342	immune
Denisovan	GWAS	Sexual dysfunction (SSRI/SNRI-related)	2	0.8774	2.279462047	0.216578342	reproductive
Denisovan	GWAS	Bone ultrasound measurement (velocity of sound)	4	2.3867	1.675954246	0.219678032	skeletal
Denisovan	GWAS	Basal cell carcinoma	5	3.199	1.562988434	0.219778022	integumentary
Denisovan	GWAS	Serum uric acid levels	7	4.8996	1.428688056	0.220077992	other
Denisovan	GWAS	Autism spectrum disorder or schizophrenia	29	24.8224	1.1682996	0.221877812	behavior
Denisovan	GWAS	Strep throat	1	0.2507	3.988831272	0.222677732	immune
Denisovan	GWAS	Immature fraction of reticulocytes	9	6.6682	1.349689571	0.223077692	hematologic
Denisovan	GWAS	Mean corpuscular hemoglobin concentration	8	5.7678	1.387010645	0.223677632	hematologic
Denisovan	GWAS	Lipid metabolism phenotypes	2	0.8992	2.224199288	0.225577442	metabolic
Denisovan	GWAS	Clinical laboratory measurements	1	0.2533	3.94788788	0.227777222	other
Denisovan	GWAS	Serum alkaline phosphatase levels	4	2.423	1.650846059	0.228077192	other
Denisovan	GWAS	Serum prostate-specific antigen levels	1	0.2645	3.780718336	0.231976802	reproductive
Denisovan	GWAS	Crohn's disease	33	28.6983	1.149893896	0.232176782	immune
Denisovan	GWAS	Age-related macular degeneration (geographic atrophy)	1	0.2667	3.749531309	0.233176682	nervous
Denisovan	GWAS	Esophageal adenocarcinoma	2	0.9218	2.169668041	0.233876612	digestive
Denisovan	GWAS	Acylcarnitine levels	1	0.2638	3.790750569	0.235576442	other
Denisovan	GWAS	Neutrophil percentage of white cells	8	5.8758	1.36151673	0.239676032	lymphatic
Denisovan	GWAS	IgE levels	1	0.2739	3.650967506	0.240275972	immune
Denisovan	GWAS	Glioblastoma (age-stratified)	1	0.2831	3.532320735	0.245475452	nervous
Denisovan	GWAS	Bipolar disorder (inflammation and infection response interaction)	2	0.9413	2.12472113	0.245575442	behavior
Denisovan	GWAS	Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)	18	14.998	1.200160021	0.247575242	skeletal
Denisovan	GWAS	Hair greying	4	2.5411	1.574121443	0.248475152	integumentary
Denisovan	GWAS	Systemic lupus erythematosus or rheumatoid arthritis	2	0.9584	2.086811352	0.248475152	immune
Denisovan	GWAS	Esophageal cancer (squamous cell)	1	0.2848	3.511235955	0.248675132	digestive
Denisovan	GWAS	Esophageal squamous cell carcinoma	3	1.7246	1.739533805	0.248875112	digestive
Denisovan	GWAS	Multiple sclerosis--Brain Glutamate Levels	1	0.2893	3.456619426	0.249575042	nervous
Denisovan	GWAS	Metabolic syndrome	4	2.5552	1.565435191	0.250674933	metabolic
Denisovan	GWAS	Gastric adenocarcinoma (histologically verified)	1	0.2907	3.43997248	0.250874913	digestive
Denisovan	GWAS	Thiopurine-induced alopecia in inflammatory bowel disease	1	0.2933	3.40947835	0.252474753	other
Denisovan	GWAS	Response to fenofibrate (LDL cholesterol levels)	2	0.9848	2.030869212	0.254174583	other
Denisovan	GWAS	Caffeine consumption	1	0.2971	3.365870077	0.254974503	behavior
Denisovan	GWAS	Excessive hairiness	1	0.2953	3.386386725	0.256274373	integumentary
Denisovan	GWAS	Type 1 diabetes and autoimmune thyroid diseases	1	0.2954	3.385240352	0.257274273	metabolic
Denisovan	GWAS	Barrett's esophagus  or Esophageal adenocarcinoma	4	2.5932	1.542495758	0.262373763	digestive
Denisovan	GWAS	Paclitaxel-induced neuropathy	3	1.7823	1.683218313	0.264473553	other
Denisovan	GWAS	Body mass index (alcohol intake interaction)	1	0.3105	3.220611916	0.264873513	metabolic
Denisovan	GWAS	Lumbar spine bone mineral density (integral)	4	2.6149	1.529695208	0.268273173	skeletal
Denisovan	GWAS	Bone properties (heel)	2	1.0262	1.948937829	0.268773123	skeletal
Denisovan	GWAS	Suicide behavior	1	0.3151	3.173595684	0.270972903	behavior
Denisovan	GWAS	Mean corpuscular volume	21	17.9929	1.167127033	0.271672833	hematologic
Denisovan	GWAS	Blond vs. brown/black hair color	18	15.2437	1.180815681	0.272072793	integumentary
Denisovan	GWAS	Vitiligo	10	7.9314	1.260811458	0.273272673	integumentary
Denisovan	GWAS	Immunoglobulin A	4	2.6314	1.520103367	0.275472453	immune
Denisovan	GWAS	Glioblastoma	2	1.0251	1.951029168	0.276772323	nervous
Denisovan	GWAS	Facial morphology	1	0.3282	3.046922608	0.278972103	skeletal
Denisovan	GWAS	Lentiform nucleus volume	1	0.3272	3.056234719	0.280271973	nervous
Denisovan	GWAS	HIV-1 control	1	0.3344	2.990430622	0.282171783	immune
Denisovan	GWAS	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	3	1.8465	1.62469537	0.284071593	metabolic
Denisovan	GWAS	IgG fucosylation phenotypes (multivariate analysis)	1	0.3311	3.020235578	0.284971503	immune
Denisovan	GWAS	Response to selective serotonin reuptake inhibitors and depression	3	1.855	1.617250674	0.286471353	other
Denisovan	GWAS	Blood pressure measurement (low sodium intervention)	1	0.34	2.941176471	0.286471353	hematologic
Denisovan	GWAS	Heart failure	2	1.056	1.893939394	0.287371263	cardiovascular
Denisovan	GWAS	Amino acid levels	1	0.3356	2.979737783	0.288571143	other
Denisovan	GWAS	"1,5-anhydroglucitol levels"	1	0.3479	2.874389192	0.290070993	other
Denisovan	GWAS	Pit-and-Fissure caries	7	5.3672	1.304218214	0.291070893	skeletal
Denisovan	GWAS	Dimensional psychopathology (Cognitive)	4	2.7436	1.457938475	0.292270773	behavior
Denisovan	GWAS	Metabolite levels (small molecules and protein measures)	3	1.8917	1.585875139	0.293970603	metabolic
Denisovan	GWAS	middle facial morphology traits (quantitative measurement)	2	1.0846	1.843997787	0.295970403	skeletal
Denisovan	GWAS	IgG monogalactosylation phenotypes (multivariate analysis)	1	0.3476	2.876869965	0.297770223	immune
Denisovan	GWAS	Sulfasalazine-induced agranulocytosis	2	1.1182	1.788588803	0.304969503	hematologic
Denisovan	GWAS	Facial emotion recognition (sad faces)	2	1.13	1.769911504	0.305369463	nervous
Denisovan	GWAS	Serum folate levels	3	1.9373	1.548546947	0.305369463	other
Denisovan	GWAS	Blood trace element (Se levels)	1	0.367	2.72479564	0.306369363	other
Denisovan	GWAS	Cisplatin-induced ototoxicity	1	0.3739	2.674511902	0.309069093	other
Denisovan	GWAS	Attention deficit hyperactivity disorder and conduct disorder	6	4.5569	1.316684588	0.309369063	behavior
Denisovan	GWAS	Spontaneous preterm birth (preterm birth)	1	0.3696	2.705627706	0.309969003	reproductive
Denisovan	GWAS	Vitamin B levels in ischemic stroke	2	1.1349	1.762269804	0.313668633	other
Denisovan	GWAS	Erectile dysfunction in type 1 diabetes	1	0.3744	2.670940171	0.314468553	reproductive
Denisovan	GWAS	Resistin levels	1	0.3768	2.653927813	0.314868513	other
Denisovan	GWAS	Temporomandibular joint disorder	1	0.3787	2.640612622	0.315468453	skeletal muscle
Denisovan	GWAS	IgG digalactosylation phenotypes (multivariate analysis)	1	0.3822	2.616431188	0.320867913	immune
Denisovan	GWAS	IgG sialylation phenotypes (multivariate analysis)	1	0.3822	2.616431188	0.320867913	immune
Denisovan	GWAS	Rapid functional decline in sporadic amyotrophic lateral sclerosis	1	0.3862	2.589331952	0.321767823	nervous
Denisovan	GWAS	Total ventricular volume	4	2.8718	1.392854656	0.325967403	cardiovascular
Denisovan	GWAS	Platelet count	24	21.6078	1.110710021	0.327367263	hematologic
Denisovan	GWAS	Diffuse cutaneous systemic sclerosis	1	0.4054	2.466699556	0.330666933	immune
Denisovan	GWAS	Survival in sporadic amyotrophic lateral sclerosis	2	1.1819	1.692190541	0.331766823	other
Denisovan	GWAS	Iron status biomarkers (transferrin levels)	1	0.3986	2.508780733	0.331866813	other
Denisovan	GWAS	Waist-to-hip ratio adjusted for BMI (age >50)	9	7.47	1.204819277	0.334666533	skeletal
Denisovan	GWAS	Paget's disease	1	0.4079	2.45158127	0.336066393	skeletal
Denisovan	GWAS	Thrombin-activatable fibrinolysis inhibitor activation peptide	4	2.9468	1.357404642	0.336166383	hematologic
Denisovan	GWAS	Preeclampsia	3	2.0603	1.456098626	0.336966303	reproductive
Denisovan	GWAS	Depressive symptoms (SSRI exposure interaction)	2	1.21	1.652892562	0.338366163	behavior
Denisovan	GWAS	Reticulocyte fraction of red cells	12	10.3392	1.160631383	0.339766023	immune
Denisovan	GWAS	Sex hormone levels	1	0.4139	2.416042522	0.340365963	endocrine
Denisovan	GWAS	IgG N-glycosylation phenotypes (multivariate analysis)	1	0.4106	2.435460302	0.340865913	immune
Denisovan	GWAS	Lupus nephritis in systemic lupus erythematosus	2	1.212	1.650165017	0.340965903	urinary
Denisovan	GWAS	Glomerular filtration rate in non diabetics (creatinine)	5	3.8377	1.302863694	0.341665833	hematologic
Denisovan	GWAS	IgG galactosylation phenotypes (multivariate analysis)	1	0.4151	2.409058058	0.343965603	immune
Denisovan	GWAS	High density lipoprotein cholesterol levels	8	6.6303	1.206581904	0.344065593	metabolic
Denisovan	GWAS	Hemoglobin concentration	11	9.4767	1.160741608	0.346965303	hematologic
Denisovan	GWAS	Nephropathy	1	0.4281	2.335902826	0.349965003	urinary
Denisovan	GWAS	Erosive tooth wear (severe vs non-severe)	8	6.6284	1.206927765	0.351364864	skeletal
Denisovan	GWAS	Non-obstructive azoospermia	1	0.4442	2.251238181	0.356464354	reproductive
Denisovan	GWAS	Perioperative myocardial infarction in coronary artery bypass surgery	2	1.2528	1.59642401	0.358464154	cardiovascular
Denisovan	GWAS	Ossification of the posterior longitudinal ligament of the spine	2	1.2649	1.58115266	0.360063994	skeletal
Denisovan	GWAS	Sporadic neuroblastoma	1	0.4436	2.254283138	0.360463954	nervous
Denisovan	GWAS	Barrett's esophagus	2	1.268	1.577287066	0.360963904	digestive
Denisovan	GWAS	Psoriasis	6	4.9044	1.223391241	0.364963504	integumentary
Denisovan	GWAS	Prostate cancer (early onset)	1	0.4533	2.206044562	0.365763424	reproductive
Denisovan	GWAS	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)	1	0.455	2.197802198	0.365763424	other
Denisovan	GWAS	Inflammatory bowel disease (early onset)	1	0.4539	2.203128442	0.367063294	digestive
Denisovan	GWAS	Skin sensitivity to sun	1	0.4668	2.142245073	0.367563244	integumentary
Denisovan	GWAS	White matter integrity (bipolar disorder risk interaction)	1	0.4575	2.18579235	0.368963104	nervous
Denisovan	GWAS	Thyroid cancer	2	1.2919	1.548107439	0.370162984	endocrine
Denisovan	GWAS	Food antigen IgG levels	1	0.4677	2.138122728	0.373262674	immune
Denisovan	GWAS	Disease progression in age-related macular degeneration	13	11.5452	1.126009077	0.376662334	nervous
Denisovan	GWAS	Atopic dermatitis	3	2.1859	1.372432408	0.379362064	integumentary
Denisovan	GWAS	Renal function-related traits (BUN)	2	1.3201	1.51503674	0.379462054	urinary
Denisovan	GWAS	Shingles	1	0.4786	2.089427497	0.380061994	immune
Denisovan	GWAS	Iron status biomarkers (transferrin saturation)	4	3.1543	1.268110199	0.381661834	other
Denisovan	GWAS	Peanut allergy (parent-of-origin effect)	1	0.4852	2.061005771	0.382461754	immune
Denisovan	GWAS	Aging (time to event)	2	1.3308	1.502855425	0.383361664	other
Denisovan	GWAS	Hemoglobin A1c levels	3	2.2293	1.345713901	0.386061394	hematologic
Denisovan	GWAS	Bone mineral density (total hip)	3	2.2469	1.335172905	0.386961304	skeletal
Denisovan	GWAS	Metabolite levels (HVA-5-HIAA Factor score)	1	0.4854	2.060156572	0.387261274	metabolic
Denisovan	GWAS	Moyamoya disease	3	2.2263	1.347527287	0.387361264	cardiovascular
Denisovan	GWAS	Conduct disorder (maternal expressed emotions interaction)	1	0.4898	2.041649653	0.388161184	behavior
Denisovan	GWAS	Loneliness (MTAG)	5	4.0915	1.222045705	0.389361064	behavior
Denisovan	GWAS	IgG glycosylation	2	1.3617	1.468752295	0.390160984	immune
Denisovan	GWAS	Hepcidin levels	2	1.3552	1.47579693	0.393360664	digestive
Denisovan	GWAS	Liver enzyme levels (alanine transaminase)	4	3.1822	1.256992018	0.394860514	other
Denisovan	GWAS	Reticulocyte count	11	9.8521	1.116513231	0.396060394	immune
Denisovan	GWAS	Corneal curvature	2	1.3673	1.462736781	0.396360364	nervous
Denisovan	GWAS	Generalized epilepsy	2	1.368	1.461988304	0.398160184	nervous
Denisovan	GWAS	Neurocognitive impairment in HIV-1 infection (continuous)	1	0.5049	1.980590216	0.398660134	nervous
Denisovan	GWAS	Cerebrospinal fluid t-tau levels in mild cognitive impairment	1	0.5121	1.952743605	0.404059594	nervous
Denisovan	GWAS	Cholesterol efflux capacity (ABCA-1 dependent assay)	1	0.5177	1.93162063	0.406059394	metabolic
Denisovan	GWAS	Bone mineral density (spine)	3	2.3249	1.290378081	0.407459254	skeletal
Denisovan	GWAS	Tourette's syndrome or obsessive-compulsive disorder	4	3.2687	1.223728088	0.409859014	behavior
Denisovan	GWAS	Dialysis-related mortality	5	4.1823	1.19551443	0.411258874	other
Denisovan	GWAS	Blood metabolite ratios	3	2.3445	1.279590531	0.413558644	metabolic
Denisovan	GWAS	Urate levels in lean individuals	5	4.2305	1.181893393	0.417658234	metabolic
Denisovan	GWAS	Beard thickness	3	2.3736	1.263902932	0.418458154	integumentary
Denisovan	GWAS	Lobe attachment (rater-scored or self-reported)	1	0.541	1.848428835	0.418558144	integumentary
Denisovan	GWAS	Corneal structure	4	3.3125	1.20754717	0.419458054	nervous
Denisovan	GWAS	CSF tryptophan concentration in tuberculous meningitis	2	1.4416	1.387347392	0.420357964	nervous
Denisovan	GWAS	Diabetic retinopathy	5	4.2666	1.171893311	0.423857614	metabolic
Denisovan	GWAS	Visceral adipose tissue	1	0.5542	1.804402743	0.424957504	metabolic
Denisovan	GWAS	Epilepsy and lamotrigine-induced maculopapular eruptions	3	2.3815	1.259710267	0.426957304	nervous
Denisovan	GWAS	Psychosis (atypical)	3	2.4059	1.246934619	0.428057194	behavior
Denisovan	GWAS	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease	1	0.5601	1.785395465	0.429157084	metabolic
Denisovan	GWAS	Body mass index (recreational physical activity interaction)	1	0.5631	1.775883502	0.430656934	metabolic
Denisovan	GWAS	LDL cholesterol levels	3	2.3844	1.258178158	0.432456754	metabolic
Denisovan	GWAS	LDL cholesterol	10	9.1469	1.093266571	0.434356564	metabolic
Denisovan	GWAS	Loneliness (linear analysis)	6	5.2909	1.134022567	0.435856414	behavior
Denisovan	GWAS	"Cholesterol, total"	6	5.257	1.141335362	0.435856414	metabolic
Denisovan	GWAS	Cough in response to angiotensin-converting enzyme inhibitor drugs	4	3.3513	1.193566676	0.438956104	other
Denisovan	GWAS	Heschl's gyrus morphology	5	4.3475	1.150086256	0.439656034	nervous
Denisovan	GWAS	Hematocrit	11	10.1966	1.07879097	0.441255874	hematologic
Denisovan	GWAS	Primary sclerosing cholangitis	4	3.3799	1.183466966	0.441755824	digestive
Denisovan	GWAS	Neonatal cytokine/chemokine levels (fetal genetic effect)	1	0.5886	1.698946653	0.442655734	other
Denisovan	GWAS	Depressive and manic episodes in bipolar disorder	2	1.5103	1.324240217	0.443455654	behavior
Denisovan	GWAS	Age at smoking initiation in chronic obstructive pulmonary disease	2	1.4933	1.33931561	0.443855614	respiratory
Denisovan	GWAS	Bronchopulmonary dysplasia in preterm infants	2	1.5057	1.328285847	0.446055394	respiratory
Denisovan	GWAS	Non-alcoholic fatty liver disease histology (lobular)	2	1.5104	1.324152542	0.447655234	digestive
Denisovan	GWAS	Glucose homeostasis traits	13	12.2274	1.063185959	0.448355164	metabolic
Denisovan	GWAS	Decline in glucose metabolism in posterior cingulate cortex	2	1.5204	1.315443304	0.448455154	nervous
Denisovan	GWAS	Primary biliary cholangitis	6	5.3951	1.112120257	0.449455054	digestive
Denisovan	GWAS	Bipolar disorder lithium response (categorical) or schizophrenia	1	0.5995	1.668056714	0.451254875	behavior
Denisovan	GWAS	Metabolite levels (HVA)	1	0.5993	1.668613382	0.451654835	metabolic
Denisovan	GWAS	Electroencephalographic traits in alcoholism	1	0.6105	1.638001638	0.454954505	nervous
Denisovan	GWAS	Diffuse large B cell lymphoma	1	0.6034	1.657275439	0.456654335	lymphatic
Denisovan	GWAS	Idiopathic intracranial hypertension	1	0.6108	1.637197119	0.459254075	cardiovascular
Denisovan	GWAS	High light scatter reticulocyte percentage of red cells	10	9.3823	1.065836735	0.462153785	metabolic
Denisovan	GWAS	Nasopharyngeal carcinoma	1	0.6222	1.607200257	0.463253675	other
Denisovan	GWAS	Cortisol levels (saliva)	2	1.5669	1.276405642	0.465253475	endocrine
Denisovan	GWAS	Upper eyelid morphology	2	1.5661	1.277057659	0.469353065	integumentary
Denisovan	GWAS	Hemoglobin levels	3	2.5611	1.171371676	0.469953005	hematologic
Denisovan	GWAS	Egg allergy (parent-of-origin effect)	1	0.6399	1.562744179	0.473552645	immune
Denisovan	GWAS	N-glycan levels	1	0.6508	1.536570375	0.474752525	endocrine
Denisovan	GWAS	Warfarin maintenance dose	1	0.6487	1.541544628	0.474752525	hematologic
Denisovan	GWAS	Age-related macular degeneration (extreme sampling)	1	0.6446	1.551349674	0.475152485	nervous
Denisovan	GWAS	LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	1	0.64	1.5625	0.476152385	metabolic
Denisovan	GWAS	"Bone mineral density (paediatric, lower limb)"	1	0.6373	1.569119724	0.476352365	skeletal
Denisovan	GWAS	Iron status biomarkers (iron levels)	3	2.5863	1.159958242	0.478052195	other
Denisovan	GWAS	Facial emotion recognition	2	1.6121	1.240617828	0.478352165	nervous
Denisovan	GWAS	Creatinine levels	8	7.5186	1.064027878	0.480151985	other
Denisovan	GWAS	Normalized brain volume	1	0.6388	1.565435191	0.481651835	nervous
Denisovan	GWAS	Sjogren's syndrome	4	3.6078	1.108708908	0.482951705	immune
Denisovan	GWAS	Gut microbiota (bacterial taxa)	6	5.5992	1.071581655	0.483751625	digestive
Denisovan	GWAS	Progranulin levels	1	0.6568	1.522533496	0.484551545	nervous
Denisovan	GWAS	Response to anti-depressant treatment in major depressive disorder	4	3.6192	1.105216622	0.486751325	other
Denisovan	GWAS	Logical memory (immediate recall) in normal cognition	2	1.638	1.221001221	0.487051295	nervous
Denisovan	GWAS	Frontotemporal dementia (age at onset)	1	0.6652	1.503307276	0.488751125	nervous
Denisovan	GWAS	Non-albumin protein levels	6	5.6061	1.07026275	0.488951105	other
Denisovan	GWAS	Lobe attachment (rater scored)	1	0.6738	1.484119917	0.491150885	integumentary
Denisovan	GWAS	Fat distribution (HIV)	2	1.6506	1.211680601	0.491550845	metabolic
Denisovan	GWAS	White matter integrity	1	0.6822	1.465845793	0.492750725	nervous
Denisovan	GWAS	Conotruncal heart defects (inherited effects)	1	0.6795	1.471670346	0.494850515	cardiovascular
Denisovan	GWAS	Psychosis proneness (hypomanic personality scale)	1	0.6892	1.450957632	0.495350465	behavior
Denisovan	GWAS	Cystic fibrosis severity	1	0.68	1.470588235	0.495350465	respiratory
Denisovan	GWAS	Glycerophospholipid levels	1	0.6835	1.463057791	0.495450455	metabolic
Denisovan	GWAS	Nose morphology	4	3.6479	1.096521286	0.496750325	skeletal
Denisovan	GWAS	Childhood ear infection	3	2.6548	1.130028627	0.497050295	immune
Denisovan	GWAS	Total cholesterol levels	11	10.6283	1.034972667	0.497350265	metabolic
Denisovan	GWAS	Skin pigmentation	1	0.6854	1.459002043	0.498350165	integumentary
Denisovan	GWAS	Colorectal cancer	13	12.6687	1.026151065	0.500549945	digestive
Denisovan	GWAS	Type 2 diabetes (dietary heme iron intake interaction)	1	0.6992	1.43020595	0.502149785	metabolic
Denisovan	GWAS	Conduct disorder (symptom count)	1	0.6948	1.439263097	0.502549745	behavior
Denisovan	GWAS	Epilepsy	1	0.697	1.43472023	0.504349565	nervous
Denisovan	GWAS	P wave duration	2	1.6949	1.18001062	0.505049495	cardiovascular
Denisovan	GWAS	Iron status biomarkers	2	1.6856	1.18652112	0.506449355	other
Denisovan	GWAS	Brown vs. black hair color	4	3.7228	1.074460084	0.508349165	integumentary
Denisovan	GWAS	Uric acid levels	4	3.7063	1.07924345	0.509449055	metabolic
Denisovan	GWAS	Eosinophil percentage of granulocytes	9	8.7259	1.031412233	0.509849015	immune
Denisovan	GWAS	Pneumoconiosis in silica exposure	1	0.7245	1.38026225	0.511348865	respiratory
Denisovan	GWAS	Chronic kidney disease	6	5.7186	1.049207848	0.511448855	urinary
Denisovan	GWAS	Plasma PCSK9 levels in stable coronary artery disease	1	0.7208	1.387347392	0.512848715	cardiovascular
Denisovan	GWAS	Cerebrospinal fluid p-tau levels in mild cognitive impairment	1	0.7284	1.372872048	0.517748225	nervous
Denisovan	GWAS	Hippocampal volume in normal cognition	1	0.7341	1.362212233	0.517848215	nervous
Denisovan	GWAS	Skin colour saturation	1	0.7357	1.359249694	0.518548145	integumentary
Denisovan	GWAS	Gastric cancer	1	0.7437	1.34462821	0.521347865	digestive
Denisovan	GWAS	Hepcidin/transferrin saturation ratio	2	1.74	1.149425287	0.521547845	digestive
Denisovan	GWAS	Periodontitis	1	0.7391	1.352996888	0.521847815	immune
Denisovan	GWAS	Idiopathic pulmonary fibrosis	2	1.7715	1.128986734	0.525647435	respiratory
Denisovan	GWAS	Blood and toenail selenium levels	1	0.7448	1.34264232	0.526747325	other
Denisovan	GWAS	Psychosis proneness (hypomanic personality scale and revised physical anhedonia scale)	1	0.7653	1.30667712	0.527647235	behavior
Denisovan	GWAS	Type 2 diabetes nephropathy including microalbuminuria	1	0.7463	1.339943722	0.528247175	metabolic
Denisovan	GWAS	Acne (severe)	7	6.877	1.017885706	0.529847015	integumentary
Denisovan	GWAS	Response to SSRI (symptom remission)	2	1.7818	1.122460433	0.529847015	other
Denisovan	GWAS	Liver fibrosis in pediatric non-alcoholic fatty acid liver disease	2	1.7624	1.13481616	0.530046995	other
Denisovan	GWAS	Alanine transaminase levels	3	2.7803	1.07902025	0.530946905	other
Denisovan	GWAS	Bipolar disorder or attention deficit hyperactivity disorder	2	1.76	1.136363636	0.531046895	behavior
Denisovan	GWAS	Cancer (pleiotropy)	2	1.7983	1.112161486	0.531346865	other
Denisovan	GWAS	Esophageal cancer	2	1.7774	1.125239113	0.531646835	digestive
Denisovan	GWAS	Clozapine-induced agranulocytosis	3	2.8171	1.064924923	0.532546745	other
Denisovan	GWAS	Systolic blood pressure (alcohol consumption interaction)	1	0.7727	1.294163323	0.534146585	cardiovascular
Denisovan	GWAS	Response to antidepressants (symptom remission)	1	0.7665	1.304631442	0.535146485	other
Denisovan	GWAS	Gamma glutamyl transferase levels	5	4.8485	1.031246777	0.535546445	other
Denisovan	GWAS	Rheumatoid arthritis (ACPA-positive)	5	4.8818	1.024212381	0.536546345	immune
Denisovan	GWAS	Frontotemporal dementia with GRN mutation (age at onset)	1	0.771	1.297016861	0.536646335	nervous
Denisovan	GWAS	Glycated hemoglobin levels	6	5.9121	1.014867813	0.537246275	metabolic
Denisovan	GWAS	Very long-chain saturated fatty acid levels (fatty acid 20:0)	3	2.8214	1.063301907	0.537946205	metabolic
Denisovan	GWAS	Testicular germ cell tumor	4	3.8704	1.033484911	0.541045895	reproductive
Denisovan	GWAS	Periodontal disease-related phenotypes	4	3.853	1.038152089	0.541745825	immune
Denisovan	GWAS	Creatine kinase levels	3	2.8509	1.052299274	0.541845815	other
Denisovan	GWAS	Sleep quality	1	0.7772	1.286670098	0.541845815	behavior
Denisovan	GWAS	Osteosarcoma	1	0.7727	1.294163323	0.543545645	skeletal
Denisovan	GWAS	Lymphoma	1	0.7856	1.272912424	0.544745525	lymphatic
Denisovan	GWAS	Ulcerative colitis	18	18.1263	0.993032224	0.545145485	digestive
Denisovan	GWAS	Cutaneous psoriasis	1	0.7898	1.266143327	0.546145385	integumentary
Denisovan	GWAS	Blood osmolality (transformed sodium)	2	1.8295	1.093194862	0.546645335	hematologic
Denisovan	GWAS	Tonsillectomy	4	3.8867	1.029150693	0.547145285	lymphatic
Denisovan	GWAS	Telomere length	4	3.8916	1.027854867	0.547245275	other
Denisovan	GWAS	Lipid traits (pleiotropy) (HIPO component 1)	2	1.8345	1.090215318	0.548245175	metabolic
Denisovan	GWAS	Abdominal aortic aneurysm	1	0.7829	1.277302337	0.549245075	cardiovascular
Denisovan	GWAS	Interstitial lung disease	1	0.8022	1.246571927	0.549645035	respiratory
Denisovan	GWAS	Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid)	1	0.8097	1.235025318	0.552044796	other
Denisovan	GWAS	Eosinophil counts	10	10.0723	0.992821898	0.554044596	immune
Denisovan	GWAS	Body mass index in asthmatics	1	0.8095	1.235330451	0.554144586	metabolic
Denisovan	GWAS	Response to anti-TNF therapy in rheumatoid arthritis	2	1.8608	1.074806535	0.554444556	other
Denisovan	GWAS	Triglycerides	11	11.081	0.99269019	0.554644536	metabolic
Denisovan	GWAS	Thiazide-induced adverse metabolic effects in hypertensive patients	8	8.0663	0.991780618	0.556244376	other
Denisovan	GWAS	Sleep duration	7	7.0846	0.988058606	0.558544146	behavior
Denisovan	GWAS	Potassium levels	1	0.8245	1.212856277	0.561143886	other
Denisovan	GWAS	Hip geometry	2	1.8675	1.070950469	0.562343766	skeletal
Denisovan	GWAS	Palmitoleic acid (16:1n-7) levels	1	0.8291	1.206127126	0.564943506	other
Denisovan	GWAS	Intelligence	8	8.1451	0.982185609	0.565443456	other
Denisovan	GWAS	Estradiol levels	1	0.8261	1.210507203	0.565443456	endocrine
Denisovan	GWAS	HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	1	0.8321	1.201778632	0.567643236	metabolic
Denisovan	GWAS	Colorectal cancer (calcium intake interaction)	1	0.8303	1.204383958	0.567843216	digestive
Denisovan	GWAS	Household income	1	0.838	1.193317422	0.572442756	other
Denisovan	GWAS	Airway wall thickness	3	3.0112	0.996280553	0.575842416	respiratory
Denisovan	GWAS	Homocysteine levels	1	0.8448	1.183712121	0.576442356	other
Denisovan	GWAS	Systemic sclerosis	5	5.0764	0.984949965	0.576442356	other
Denisovan	GWAS	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	1	0.8595	1.163467132	0.579042096	nervous
Denisovan	GWAS	Immune reponse to smallpox (secreted IL-12p40)	1	0.8568	1.16713352	0.579442056	immune
Denisovan	GWAS	Ovarian reserve	1	0.8677	1.152472053	0.580841916	reproductive
Denisovan	GWAS	Lung function (FEV1)	6	6.1567	0.974548053	0.581141886	respiratory
Denisovan	GWAS	Blond vs. brown hair color	1	0.873	1.145475372	0.581541846	integumentary
Denisovan	GWAS	Idiopathic dilated cardiomyopathy	7	7.206	0.971412712	0.581741826	cardiovascular
Denisovan	GWAS	Response to taxane treatment (docetaxel)	2	1.9681	1.016208526	0.583641636	other
Denisovan	GWAS	Regular attendance at a pub or social club	4	4.0874	0.978617214	0.585041496	behavior
Denisovan	GWAS	Mean corpuscular hemoglobin	15	15.4769	0.969186336	0.587241276	hematologic
Denisovan	GWAS	Coenzyme Q10 levels	2	1.9803	1.009947988	0.589041096	other
Denisovan	GWAS	Middle childhood and early adolescence aggressive behavior	3	3.0677	0.977931349	0.590440956	behavior
Denisovan	GWAS	Glomerular filtration rate	9	9.3374	0.963865744	0.590440956	hematologic
Denisovan	GWAS	Eosinophilic esophagitis	1	0.8957	1.116445238	0.593640636	immune
Denisovan	GWAS	Post bronchodilator percent predicted FEV1 in smoking	1	0.9031	1.107297088	0.594740526	other
Denisovan	GWAS	Bipolar disorder with mood-incongruent psychosis	1	0.8958	1.116320607	0.595840416	behavior
Denisovan	GWAS	Hepatocellular carcinoma	1	0.9014	1.1093854	0.596140386	digestive
Denisovan	GWAS	Kidney function decline traits	1	0.8972	1.114578689	0.596440356	urinary
Denisovan	GWAS	Acute insulin response	1	0.9047	1.105338786	0.596640336	metabolic
Denisovan	GWAS	ALT levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	5	5.2265	0.956663159	0.596940306	other
Denisovan	GWAS	Calcium levels	5	5.2172	0.958368474	0.597340266	other
Denisovan	GWAS	Empathy quotient	1	0.9013	1.109508488	0.598540146	behavior
Denisovan	GWAS	Cervical cancer	3	3.1211	0.961199577	0.601239876	reproductive
Denisovan	GWAS	Erectile dysfunction and prostate cancer treatment	3	3.1151	0.963050945	0.602139786	reproductive
Denisovan	GWAS	Black vs. blond hair color	1	0.9235	1.082837033	0.604739526	integumentary
Denisovan	GWAS	Change in LVEF in response to paclitaxel and trastuzumab in HER2+ breast cancer	1	0.9273	1.078399655	0.604939506	other
Denisovan	GWAS	Emphysema distribution in smoking	1	0.9258	1.0801469	0.605739426	respiratory
Denisovan	GWAS	Ability to confide in someone	1	0.9484	1.054407423	0.609339066	behavior
Denisovan	GWAS	Response to cytadine analogues (cytosine arabinoside)	2	2.0582	0.971722865	0.610738926	other
Denisovan	GWAS	Self-reported allergy	2	2.0529	0.974231575	0.610738926	immune
Denisovan	GWAS	Low vWF levels	1	0.9517	1.050751287	0.611338866	hematologic
Denisovan	GWAS	Hepcidin/ferritin ratio	5	5.2727	0.948280767	0.611438856	digestive
Denisovan	GWAS	Albumin-globulin ratio	5	5.2789	0.947167023	0.612038796	other
Denisovan	GWAS	Social communication problems	3	3.1607	0.949156832	0.612338766	behavior
Denisovan	GWAS	Serum metabolite levels	3	3.2009	0.937236402	0.613638636	metabolic
Denisovan	GWAS	Feeling worry	5	5.3583	0.933131777	0.614338566	behavior
Denisovan	GWAS	Pubertal anthropometrics	2	2.0895	0.957166786	0.614538546	skeletal
Denisovan	GWAS	Chronic obstructive pulmonary disease-related biomarkers	2	2.0872	0.958221541	0.614838516	respiratory
Denisovan	GWAS	Logical memory (immediate recall) in mild cognitive impairment	1	0.9468	1.056189269	0.615438456	nervous
Denisovan	GWAS	Fibrinogen	2	2.0924	0.955840184	0.616438356	hematologic
Denisovan	GWAS	Huntington's disease progression	4	4.2633	0.93824033	0.616838316	nervous
Denisovan	GWAS	Reading and spelling	1	0.9697	1.031246777	0.619038096	other
Denisovan	GWAS	Response to antidepressants	1	0.9715	1.029336078	0.620737926	other
Denisovan	GWAS	Light vs. dark hair color	1	0.972	1.028806584	0.621937806	integumentary
Denisovan	GWAS	Blond vs non-blond hair color	1	0.972	1.028806584	0.621937806	integumentary
Denisovan	GWAS	Brown vs. non-brown hair color	1	0.972	1.028806584	0.621937806	integumentary
Denisovan	GWAS	Obese vs. thin	1	0.9694	1.031565917	0.622437756	metabolic
Denisovan	GWAS	Myocardial infarction (early onset)	1	0.9891	1.011020119	0.622937706	cardiovascular
Denisovan	GWAS	Allergic sensitization	2	2.0845	0.959462701	0.623237676	immune
Denisovan	GWAS	Response to iloperidone treatment (QT prolongation)	2	2.1196	0.943574259	0.625037496	other
Denisovan	GWAS	Cerebral cortical growth	1	0.9743	1.026377912	0.626237376	nervous
Denisovan	GWAS	Renal sinus fat	2	2.1212	0.942862531	0.626937306	urinary
Denisovan	GWAS	Immune reponse to smallpox (secreted IL-1beta)	1	0.9875	1.012658228	0.629037096	immune
Denisovan	GWAS	Chin dimples	7	7.5709	0.924592849	0.633136686	integumentary
Denisovan	GWAS	Smoking cessation in chronic obstructive pulmonary disease	1	1.02	0.980392157	0.634036596	respiratory
Denisovan	GWAS	Plasma factor VII activating protease levels	1	0.9935	1.006542526	0.634536546	other
Denisovan	GWAS	Response to statins (LDL cholesterol change)	1	0.9997	1.00030009	0.634736526	other
Denisovan	GWAS	Cardiac Troponin-T levels	2	2.1564	0.927471712	0.635336466	cardiovascular
Denisovan	GWAS	Serum bilirubin levels x sex interaction in metabolic syndrome	1	1.0324	0.968616815	0.637936206	digestive
Denisovan	GWAS	Headache	4	4.3947	0.910187271	0.639136086	nervous
Denisovan	GWAS	Adiposity	1	1.0351	0.966090233	0.641535846	metabolic
Denisovan	GWAS	Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	1	1.0281	0.972668028	0.641635836	other
Denisovan	GWAS	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)	3	3.3405	0.898069151	0.644435556	other
Denisovan	GWAS	Peripheral arterial disease (traffic-related air pollution interaction)	3	3.3006	0.90892565	0.647235276	cardiovascular
Denisovan	GWAS	Serum albumin level	1	1.0371	0.964227172	0.648035196	other
Denisovan	GWAS	Post bronchodilator FEV1/FVC ratio in smoking	1	1.039	0.962463908	0.648135186	other
Denisovan	GWAS	Response to serotonin reuptake inhibitors in major depressive disorder	2	2.21	0.904977376	0.648535146	other
Denisovan	GWAS	Mood instability	4	4.4719	0.894474384	0.648935106	behavior
Denisovan	GWAS	Bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder	1	1.0513	0.951203272	0.649735026	behavior
Denisovan	GWAS	Hirschsprung disease	1	1.062	0.941619586	0.650734927	digestive
Denisovan	GWAS	Acute lymphoblastic leukemia (childhood)	6	6.6358	0.904186383	0.651134887	lymphatic
Denisovan	GWAS	Bipolar disorder and eating disorder	2	2.2285	0.897464662	0.652034797	behavior
Denisovan	GWAS	Cerebrospinal fluid t-tau levels	1	1.0464	0.955657492	0.652034797	nervous
Denisovan	GWAS	Global electrical heterogeneity phenotypes	1	1.0607	0.94277364	0.652634737	cardiovascular
Denisovan	GWAS	Fasting blood insulin	1	1.065	0.938967136	0.653734627	metabolic
Denisovan	GWAS	Carotid intima media thickness	2	2.2582	0.885661146	0.655434457	cardiovascular
Denisovan	GWAS	Resistant hypertension	3	3.3904	0.884851345	0.655534447	cardiovascular
Denisovan	GWAS	"Bone mineral density (paediatric, total body less head)"	1	1.0546	0.948226816	0.656334367	skeletal
Denisovan	GWAS	Cannabis use (initiation)	1	1.0803	0.925668796	0.660033997	behavior
Denisovan	GWAS	Blood urea nitrogen levels	5	5.6059	0.891917444	0.660533947	other
Denisovan	GWAS	Urate levels in obese individuals	6	6.7001	0.895509022	0.662233777	metabolic
Denisovan	GWAS	Breastfeeding duration	1	1.0922	0.915583227	0.663133687	reproductive
Denisovan	GWAS	Breast cancer (estrogen-receptor negative)	2	2.2606	0.884720871	0.664133587	reproductive
Denisovan	GWAS	Low tan response	2	2.2917	0.872714579	0.665133487	integumentary
Denisovan	GWAS	Asthma and hay fever	2	2.2983	0.870208415	0.665733427	respiratory
Denisovan	GWAS	Metabolic traits	2	2.2856	0.875043752	0.666833317	metabolic
Denisovan	GWAS	Pursuit maintenance gain in psychotic disorders	1	1.1085	0.902119982	0.667433257	skeletal muscle
Denisovan	GWAS	Tuberculosis (SNP x SNP interaction)	2	2.2724	0.880126738	0.668933107	immune
Denisovan	GWAS	Regular attendance at a gym or sports club	2	2.298	0.870322019	0.669533047	behavior
Denisovan	GWAS	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	2	2.283	0.876040298	0.669633037	immune
Denisovan	GWAS	Type 2 diabetes nephropathy	2	2.2834	0.875886835	0.671532847	metabolic
Denisovan	GWAS	Breast cancer (survival)	1	1.1307	0.884407889	0.671532847	reproductive
Denisovan	GWAS	End-stage coagulation	1	1.1057	0.90440445	0.673832617	hematologic
Denisovan	GWAS	Response to Vitamin E supplementation	1	1.1418	0.875810124	0.673932607	other
Denisovan	GWAS	Systemic lupus erythematosus	22	23.8478	0.922516962	0.676332367	immune
Denisovan	GWAS	Red blood cell count	15	16.4443	0.912170174	0.676532347	hematologic
Denisovan	GWAS	Immune reponse to smallpox (secreted IFN-alpha)	2	2.3342	0.856824608	0.676932307	immune
Denisovan	GWAS	Prostate cancer	16	17.5372	0.912346327	0.677432257	reproductive
Denisovan	GWAS	Prostate cancer (SNP x SNP interaction)	5	5.6936	0.878179008	0.677832217	reproductive
Denisovan	GWAS	Major depressive disorder (broad)	1	1.1466	0.872143729	0.680231977	behavior
Denisovan	GWAS	Immunoglobulin light chain (AL) amyloidosis	1	1.1237	0.889917238	0.680231977	immune
Denisovan	GWAS	vWF and FVIII levels	1	1.1369	0.879584836	0.681831817	hematologic
Denisovan	GWAS	Red cell distribution width	10	11.223	0.891027355	0.682531747	hematologic
Denisovan	GWAS	Renal function-related traits (sCR)	1	1.1335	0.882223202	0.682931707	urinary
Denisovan	GWAS	Phosphorus levels	1	1.1427	0.875120329	0.685331467	other
Denisovan	GWAS	Periodontitis (DPAL)	1	1.1538	0.866701335	0.686531347	immune
Denisovan	GWAS	Granulocyte percentage of myeloid white cells	8	9.0318	0.885759206	0.686731327	immune
Denisovan	GWAS	Non-small cell lung cancer	2	2.3836	0.839066958	0.687531247	respiratory
Denisovan	GWAS	Extremely high intelligence	6	6.9198	0.867077083	0.687731227	other
Denisovan	GWAS	Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)	1	1.1664	0.85733882	0.689331067	other
Denisovan	GWAS	Eosinophil percentage of white cells	8	9.0992	0.879198171	0.689731027	immune
Denisovan	GWAS	Lung adenocarcinoma	8	9.1402	0.875254371	0.690430957	respiratory
Denisovan	GWAS	Logical memory (delayed recall) in mild cognitive impairment	1	1.1868	0.842601955	0.692530747	nervous
Denisovan	GWAS	Squamous cell carcinoma	3	3.5473	0.845713641	0.692730727	integumentary
Denisovan	GWAS	Activated partial thromboplastin time	2	2.3921	0.836085448	0.693030697	hematologic
Denisovan	GWAS	Body mass index x sex x age interaction (4df test)	7	8.0578	0.868723473	0.694430557	metabolic
Denisovan	GWAS	Thyroid stimulating hormone	2	2.3996	0.833472245	0.695030497	endocrine
Denisovan	GWAS	Fasting blood insulin (BMI interaction)	2	2.4419	0.819034358	0.697330267	metabolic
Denisovan	GWAS	Capecitabine sensitivity	1	1.1952	0.836680054	0.698130187	other
Denisovan	GWAS	Lymphocyte percentage of white cells	7	8.061	0.868378613	0.698830117	lymphatic
Denisovan	GWAS	Immune reponse to smallpox (secreted IL-2)	3	3.6563	0.8205016	0.702629737	immune
Denisovan	GWAS	Brain connectivity	3	3.6143	0.830036245	0.703429657	nervous
Denisovan	GWAS	C-reactive protein levels or total cholesterol levels (pleiotropy)	1	1.2037	0.830771787	0.705829417	immune
Denisovan	GWAS	Primary biliary cirrhosis	3	3.6625	0.819112628	0.706329367	digestive
Denisovan	GWAS	Corrected insulin response adjusted for insulin sensitivity index	1	1.2313	0.81214976	0.707629237	metabolic
Denisovan	GWAS	Corrected insulin response	1	1.2313	0.81214976	0.707629237	metabolic
Denisovan	GWAS	Cerebrospinal fluid t-tau levels in normal cognition	1	1.2098	0.826582906	0.707629237	nervous
Denisovan	GWAS	Papillary thyroid cancer	2	2.4746	0.808211428	0.708829117	endocrine
Denisovan	GWAS	Differentiated thyroid cancer	2	2.4817	0.805899182	0.710428957	endocrine
Denisovan	GWAS	Ischemic stroke (small-vessel)	1	1.24	0.806451613	0.710628937	cardiovascular
Denisovan	GWAS	Response to antidepressants in depression	1	1.2159	0.822436056	0.710928907	other
Denisovan	GWAS	Age-related nuclear cataracts	2	2.4837	0.805250232	0.711528847	nervous
Denisovan	GWAS	Anger	1	1.2665	0.789577576	0.712528747	behavior
Denisovan	GWAS	Non-response to antidepressants and depression	3	3.6805	0.815106643	0.713828617	other
Denisovan	GWAS	Cannabis use	2	2.5344	0.789141414	0.719028097	behavior
Denisovan	GWAS	Response to platinum-based chemotherapy in non-small-cell lung cancer	2	2.5444	0.786039931	0.719228077	other
Denisovan	GWAS	Lactate dehydrogenase levels	1	1.2659	0.789951813	0.720327967	metabolic
Denisovan	GWAS	Stearic acid (18:0) levels	2	2.5396	0.787525595	0.720327967	other
Denisovan	GWAS	Response to platinum-based chemotherapy (carboplatin)	1	1.2676	0.788892395	0.721027897	other
Denisovan	GWAS	Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)	4	4.9283	0.811638902	0.723427657	skeletal
Denisovan	GWAS	Bipolar disorder or major depressive disorder	1	1.2773	0.782901433	0.723727627	behavior
Denisovan	GWAS	Hemoglobin	3	3.7541	0.799126289	0.724327567	hematologic
Denisovan	GWAS	Hippocampal sclerosis	2	2.5727	0.7773934	0.726927307	nervous
Denisovan	GWAS	C-reactive protein levels or LDL-cholesterol levels (pleiotropy)	1	1.2948	0.772320049	0.727427257	immune
Denisovan	GWAS	White blood cell types	1	1.2897	0.775374118	0.728227177	immune
Denisovan	GWAS	Lung function (FVC)	7	8.3205	0.841295595	0.730126987	respiratory
Denisovan	GWAS	"Schizophrenia, bipolar disorder and depression (combined)"	1	1.3109	0.762834694	0.731226877	behavior
Denisovan	GWAS	Diffusing capacity of the lung for carbon monoxide traits	1	1.3304	0.751653638	0.732626737	respiratory
Denisovan	GWAS	Prostate cancer (advanced)	1	1.2969	0.771069473	0.733026697	reproductive
Denisovan	GWAS	Alcohol and nicotine co-dependence	1	1.3488	0.741399763	0.736826317	behavior
Denisovan	GWAS	Arthritis (juvenile idiopathic)	1	1.3581	0.736322804	0.737426257	skeletal
Denisovan	GWAS	Fasting plasma glucose	3	3.8205	0.785237534	0.739226077	metabolic
Denisovan	GWAS	Vein graft stenosis in coronary artery bypass grafting	1	1.3385	0.747104968	0.740525947	cardiovascular
Denisovan	GWAS	Prothrombin time	1	1.3649	0.732654407	0.741925807	hematologic
Denisovan	GWAS	Food addiction	1	1.3409	0.745767768	0.742025797	behavior
Denisovan	GWAS	Seborrheic dermatitis	1	1.3755	0.727008361	0.743025697	integumentary
Denisovan	GWAS	QT interval (ambient particulate matter interaction)	1	1.3836	0.722752241	0.743725627	cardiovascular
Denisovan	GWAS	Alzheimer's disease in APOE e4+ carriers	1	1.3476	0.742059958	0.743725627	nervous
Denisovan	GWAS	Non-melanoma skin cancer	1	1.3898	0.71952799	0.747925207	integumentary
Denisovan	GWAS	Monocyte count	9	10.7611	0.836345727	0.749325067	immune
Denisovan	GWAS	Clopidogrel active metabolite levels	1	1.3766	0.72642743	0.749625037	other
Denisovan	GWAS	Response to platinum-based chemotherapy (cisplatin)	1	1.3832	0.722961249	0.751824818	other
Denisovan	GWAS	Neurofibrillary tangles	1	1.3979	0.715358752	0.752624738	nervous
Denisovan	GWAS	Response to cognitive-behavioural therapy in anxiety disorder	2	2.7183	0.735753964	0.754924508	other
Denisovan	GWAS	Pelvic organ prolapse (moderate/severe)	4	5.1295	0.7798031	0.755024498	skeletal muscle
Denisovan	GWAS	Response to angiotensin II receptor blocker therapy	1	1.4093	0.709572128	0.755024498	other
Denisovan	GWAS	Metabolite levels  (X-11787)	4	5.1485	0.776925318	0.757824218	metabolic
Denisovan	GWAS	Neutrophil percentage of granulocytes	6	7.4746	0.80271854	0.758824118	lymphatic
Denisovan	GWAS	Sex hormone-binding globulin levels	1	1.4141	0.707163567	0.759124088	endocrine
Denisovan	GWAS	Serum metabolite ratios in chronic kidney disease	1	1.4477	0.690750846	0.760923908	urinary
Denisovan	GWAS	Asparaginase hypersensitivity in acute lymphoblastic leukemia	1	1.4412	0.693866223	0.762123788	other
Denisovan	GWAS	Dimensional psychopathology (Arousal)	2	2.7835	0.718519849	0.762323768	behavior
Denisovan	GWAS	"Allergic disease (asthma, hay fever or eczema)"	9	10.9182	0.8243117	0.763923608	immune
Denisovan	GWAS	Fractures	2	2.7679	0.722569457	0.764623538	skeletal
Denisovan	GWAS	Response to mTOR inhibitor (everolimus)	1	1.4306	0.699007409	0.764823518	other
Denisovan	GWAS	Severity of nausea and vomiting of pregnancy	1	1.4344	0.697155605	0.764923508	reproductive
Denisovan	GWAS	Gut microbiota (functional units)	6	7.6004	0.789432135	0.767623238	digestive
Denisovan	GWAS	Zinc levels	2	2.7733	0.721162514	0.768323168	other
Denisovan	GWAS	Brain volume in infants (grey matter)	1	1.4723	0.6792094	0.770222978	nervous
Denisovan	GWAS	Worry too long after an embarrassing experience	2	2.8046	0.71311417	0.772022798	behavior
Denisovan	GWAS	Fractional exhaled nitric oxide (childhood)	3	4.0929	0.732976618	0.773422658	respiratory
Denisovan	GWAS	Neuritic plaque	5	6.4427	0.776072144	0.773722628	nervous
Denisovan	GWAS	"Bone mineral density (paediatric, skull)"	1	1.4921	0.670196368	0.775222478	skeletal
Denisovan	GWAS	Migraine without aura	3	4.0552	0.739790886	0.775222478	nervous
Denisovan	GWAS	Cleft palate	1	1.5087	0.662822297	0.775322468	other
Denisovan	GWAS	Scalp hair shape	1	1.4751	0.677920141	0.775622438	integumentary
Denisovan	GWAS	Freckles	1	1.4874	0.672314105	0.776422358	integumentary
Denisovan	GWAS	Endometrial cancer	4	5.2644	0.759820682	0.777722228	reproductive
Denisovan	GWAS	Breast cancer and/or colorectal cancer	1	1.5065	0.663790242	0.777822218	reproductive
Denisovan	GWAS	Glucocorticoid-induced osteonecrosis (age 10 years and older)	1	1.5209	0.657505424	0.778022198	other
Denisovan	GWAS	Breast size	7	8.8513	0.790844283	0.778422158	reproductive
Denisovan	GWAS	Mitral valve prolapse	1	1.4913	0.670555891	0.778622138	cardiovascular
Denisovan	GWAS	AIDS progression	1	1.5086	0.662866234	0.779622038	immune
Denisovan	GWAS	Hippocampal tail volume (corrected for total hippocampal volume)	1	1.5296	0.65376569	0.780021998	nervous
Denisovan	GWAS	Red vs. brown/black hair color	1	1.5124	0.661200741	0.780621938	integumentary
Denisovan	GWAS	Loneliness	13	15.5891	0.833916005	0.781321868	behavior
Denisovan	GWAS	Adult asthma	1	1.5296	0.65376569	0.781721828	respiratory
Denisovan	GWAS	Bilirubin levels	1	1.5515	0.644537544	0.783021698	digestive
Denisovan	GWAS	Response to cytidine analogues (gemcitabine)	1	1.5404	0.649182031	0.783821618	other
Denisovan	GWAS	Dentate gyrus molecular layer volume	1	1.5462	0.646746863	0.787421258	nervous
Denisovan	GWAS	Gut microbiota (beta diversity)	5	6.5305	0.765638159	0.787821218	digestive
Denisovan	GWAS	High light scatter reticulocyte count	9	11.2622	0.799133384	0.788121188	metabolic
Denisovan	GWAS	Response to lithium treatment in bipolar disorder	1	1.5875	0.62992126	0.789321068	other
Denisovan	GWAS	Response to lurasidone in schizophrenia	2	2.9755	0.67215594	0.789321068	other
Denisovan	GWAS	Response to fenofibrate	1	1.5659	0.638610384	0.790720928	other
Denisovan	GWAS	Celiac disease	6	7.7772	0.771485882	0.791020898	digestive
Denisovan	GWAS	Bone fracture in osteoporosis	1	1.5689	0.637389254	0.796020398	skeletal
Denisovan	GWAS	Gestational age at birth (maternal effect)	2	2.9658	0.674354306	0.796520348	reproductive
Denisovan	GWAS	D-dimer levels	2	2.9675	0.673967987	0.798820118	other
Denisovan	GWAS	Hodgkin's lymphoma	1	1.6091	0.621465415	0.799120088	lymphatic
Denisovan	GWAS	Insulin-like growth factors	1	1.595	0.626959248	0.799220078	immune
Denisovan	GWAS	Bulimia nervosa	2	3.0059	0.665358129	0.799520048	behavior
Denisovan	GWAS	Disc degeneration (lumbar)	2	3.0214	0.661944794	0.805419458	skeletal
Denisovan	GWAS	Eyebrow thickness	2	3.0597	0.653658855	0.806319368	integumentary
Denisovan	GWAS	Obesity (extreme)	2	3.0386	0.658197854	0.806519348	metabolic
Denisovan	GWAS	Prostate-specific antigen levels	1	1.6559	0.603901202	0.807419258	reproductive
Denisovan	GWAS	Height	35	39.992	0.875175035	0.809519048	skeletal
Denisovan	GWAS	Ovarian cancer	4	5.5215	0.724440822	0.809619038	reproductive
Denisovan	GWAS	Response to platinum-based neoadjuvant chemotherapy in cervical cancer	2	3.0657	0.652379554	0.810118988	other
Denisovan	GWAS	Restless legs syndrome	6	8.0399	0.746277939	0.810918908	nervous
Denisovan	GWAS	Late-onset myasthenia gravis	1	1.689	0.592066311	0.811218878	skeletal muscle
Denisovan	GWAS	Cutaneous malignant melanoma	2	3.0476	0.656254102	0.811318868	integumentary
Denisovan	GWAS	Modified Stumvoll Insulin Sensitivity Index (BMI interaction)	2	3.0757	0.650258478	0.811718828	metabolic
Denisovan	GWAS	Eye color	1	1.6481	0.606759299	0.813118688	integumentary
Denisovan	GWAS	Carboplatin disposition in epthelial ovarian cancer	2	3.0542	0.654835964	0.813818618	other
Denisovan	GWAS	Alcoholic chronic pancreatitis	3	4.406	0.680889696	0.814018598	endocrine
Denisovan	GWAS	Hippocampal tail volume	1	1.6793	0.595486214	0.814018598	nervous
Denisovan	GWAS	BRCA1/2-negative high-risk breast cancer	2	3.0587	0.65387256	0.814418558	reproductive
Denisovan	GWAS	Bone mineral density (Ward's triangle area)	3	4.4112	0.680087051	0.815418458	skeletal
Denisovan	GWAS	Blood pressure measurement (high sodium intervention)	4	5.6338	0.710000355	0.815418458	hematologic
Denisovan	GWAS	Relative hand skill in reading disability	1	1.7239	0.580080051	0.816618338	nervous
Denisovan	GWAS	Urinary albumin-to-creatinine ratio in non-diabetics	1	1.6936	0.590458196	0.817618238	metabolic
Denisovan	GWAS	Periodontal microbiota	4	5.6825	0.70391553	0.818518148	immune
Denisovan	GWAS	Food allergy	1	1.7355	0.576202823	0.819818018	immune
Denisovan	GWAS	Right lateral prefrontal cortical growth	1	1.7141	0.583396535	0.822117788	nervous
Denisovan	GWAS	Serum bilirubin levels x Mediterranean diet adherence interaction in metabolic syndrome	1	1.7159	0.582784545	0.822917708	digestive
Denisovan	GWAS	Virologic severity in Herpes simplex virus type 2 infection	1	1.7475	0.572246066	0.823617638	immune
Denisovan	GWAS	PR interval in Tripanosoma cruzi seropositivity	1	1.719	0.581733566	0.825217478	cardiovascular
Denisovan	GWAS	Dupuytren's disease	3	4.4637	0.672088178	0.825217478	integumentary
Denisovan	GWAS	Bladder cancer	1	1.7311	0.577667379	0.825517448	urinary
Denisovan	GWAS	Feeling nervous	4	5.7312	0.697934115	0.825717428	behavior
Denisovan	GWAS	Chloride levels	2	3.1533	0.634256176	0.825917408	other
Denisovan	GWAS	Asthma exacerbations in inhaled corticosteroid treatment	1	1.7364	0.57590417	0.826017398	respiratory
Denisovan	GWAS	Mean arterial pressure (alcohol consumption interaction)	1	1.7549	0.569833039	0.826217378	cardiovascular
Denisovan	GWAS	Joint mobility (Beighton score)	2	3.1875	0.62745098	0.826817318	skeletal
Denisovan	GWAS	Reaction time	3	4.5084	0.665424541	0.826917308	behavior
Denisovan	GWAS	Refractive error	4	5.7382	0.697082709	0.827017298	nervous
Denisovan	GWAS	Personality traits in bipolar disorder	1	1.772	0.564334086	0.827017298	behavior
Denisovan	GWAS	Response to selective serotonin reuptake inhibitors in depression	1	1.7634	0.567086311	0.827817218	other
Denisovan	GWAS	Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test)	1	1.758	0.568828214	0.829017098	cardiovascular
Denisovan	GWAS	Intraocular pressure	27	31.8339	0.848152441	0.829117088	nervous
Denisovan	GWAS	Post bronchodilator FEV1 in COPD	7	9.41	0.743889479	0.829317068	other
Denisovan	GWAS	Optic disc area	2	3.1998	0.625039065	0.829517048	nervous
Denisovan	GWAS	Response to exercise (triglyceride level interaction)	1	1.7614	0.567730215	0.830416958	other
Denisovan	GWAS	Myocardial infarction	3	4.4986	0.666874139	0.831216878	cardiovascular
Denisovan	GWAS	Temperament	5	7.0467	0.709551989	0.831616838	behavior
Denisovan	GWAS	HDL cholesterol levels	4	5.8196	0.687332463	0.832516748	metabolic
Denisovan	GWAS	Fibrinogen levels	2	3.2293	0.619329266	0.833016698	hematologic
Denisovan	GWAS	Hyperopia	1	1.7878	0.559346683	0.834416558	nervous
Denisovan	GWAS	Psoriasis vulgaris	2	3.2337	0.618486563	0.835116488	integumentary
Denisovan	GWAS	Partial epilepsies	2	3.2201	0.621098724	0.835216478	nervous
Denisovan	GWAS	Takayasu arteritis	3	4.5867	0.654065014	0.835416458	cardiovascular
Denisovan	GWAS	Small cell lung carcinoma	5	7.0892	0.7052982	0.835816418	respiratory
Denisovan	GWAS	Alcohol dependence symptom count	1	1.7858	0.559973121	0.836216378	behavior
Denisovan	GWAS	Brain structure	1	1.7955	0.556947925	0.836316368	nervous
Denisovan	GWAS	Coronary artery disease or ischemic stroke	1	1.8391	0.543744223	0.837216278	cardiovascular
Denisovan	GWAS	Waist-to-hip ratio adjusted for BMI x sex interaction	5	7.1209	0.702158435	0.837316268	skeletal
Denisovan	GWAS	Dimensional psychopathology (Social)	1	1.8127	0.551663265	0.837316268	behavior
Denisovan	GWAS	Serum metabolite concentrations in chronic kidney disease	3	4.5883	0.653836933	0.837616238	urinary
Denisovan	GWAS	Homeostasis model assessment of beta-cell function (dietary factor interaction)	3	4.6066	0.651239526	0.838416158	metabolic
Denisovan	GWAS	Red blood cell density in sickle cell anemia	1	1.8365	0.544514021	0.838916108	hematologic
Denisovan	GWAS	Coronary heart disease	3	4.659	0.643915003	0.839416058	cardiovascular
Denisovan	GWAS	Obstetric antiphospholipid syndrome	1	1.8114	0.552059181	0.840215978	immune
Denisovan	GWAS	Fasting insulin (dietary factor interaction)	3	4.6439	0.646008743	0.842415758	metabolic
Denisovan	GWAS	Body mass index x age interaction	1	1.8298	0.546507815	0.845815418	metabolic
Denisovan	GWAS	Venous thromboembolism	1	1.8344	0.545137375	0.846515348	hematologic
Denisovan	GWAS	Cervical artery dissection	1	1.8769	0.532793436	0.849215078	cardiovascular
Denisovan	GWAS	Midgestational circulating levels of PBDEs (fetal genetic effect)	1	1.9112	0.523231478	0.849315068	reproductive
Denisovan	GWAS	Tuberculosis	4	6.0239	0.664021647	0.849315068	immune
Denisovan	GWAS	Response to fenofibrate (HDL cholesterol levels)	3	4.7386	0.633098383	0.849415058	other
Denisovan	GWAS	Atrial fibrillation	18	22.2401	0.809348879	0.849615038	cardiovascular
Denisovan	GWAS	Gastroesophageal reflux disease	4	6.019	0.66456222	0.851714829	digestive
Denisovan	GWAS	Smooth-surface caries	2	3.3809	0.591558461	0.851714829	skeletal
Denisovan	GWAS	Chronic back pain	1	1.933	0.517330574	0.852214779	skeletal
Denisovan	GWAS	Glomerular filtration rate (creatinine)	6	8.5345	0.703028883	0.852414759	hematologic
Denisovan	GWAS	Homeostasis model assessment of insulin resistance (dietary factor interaction)	3	4.7563	0.630742384	0.853114689	metabolic
Denisovan	GWAS	White matter hyperintensities in ischemic stroke	2	3.3905	0.589883498	0.853314669	nervous
Denisovan	GWAS	Influenza A (H1N1) infection	4	6.0622	0.659826466	0.854014599	immune
Denisovan	GWAS	Alzheimer's disease (survival time)	1	1.941	0.515198351	0.854114589	nervous
Denisovan	GWAS	Hip circumference adjusted for BMI	6	8.5498	0.701770802	0.854414559	skeletal
Denisovan	GWAS	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis	1	1.9692	0.507820435	0.854914509	other
Denisovan	GWAS	Depression in smokers	3	4.7734	0.628482842	0.855614439	behavior
Denisovan	GWAS	Common carotid intima-media thickness in HIV infection	2	3.4323	0.582699647	0.855614439	cardiovascular
Denisovan	GWAS	Multiple myeloma and monoclonal gammopathy	1	1.9236	0.519858598	0.855714429	immune
Denisovan	GWAS	Birth weight	4	6.102	0.655522779	0.855814419	skeletal
Denisovan	GWAS	Sum neutrophil eosinophil counts	6	8.613	0.696621386	0.856514349	hematologic
Denisovan	GWAS	Feeling miserable	4	6.1122	0.654428847	0.857214279	behavior
Denisovan	GWAS	Midgestational circulating levels of PBDEs	1	1.9466	0.513716223	0.857914209	reproductive
Denisovan	GWAS	Mean arterial pressure	4	6.1054	0.655157729	0.859714029	cardiovascular
Denisovan	GWAS	Total ventricular volume (Alzheimer's disease interaction)	1	1.9656	0.508750509	0.860213979	cardiovascular
Denisovan	GWAS	Serum bilirubin levels in metabolic syndrome	1	1.9722	0.507047967	0.860713929	digestive
Denisovan	GWAS	Aortic root size	2	3.4579	0.578385725	0.862013799	cardiovascular
Denisovan	GWAS	Menopause (age at onset)	2	3.4782	0.575010063	0.863513649	reproductive
Denisovan	GWAS	Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)	5	7.5105	0.665734638	0.865413459	cardiovascular
Denisovan	GWAS	Craniofacial microsomia	3	4.9076	0.611296764	0.865813419	skeletal
Denisovan	GWAS	Conotruncal heart defects	1	2.0117	0.497092012	0.866413359	cardiovascular
Denisovan	GWAS	PR interval	5	7.4995	0.666711114	0.866913309	cardiovascular
Denisovan	GWAS	Metabolite levels (Dihydroxy docosatrienoic acid)	1	1.9985	0.500375281	0.867013299	metabolic
Denisovan	GWAS	Cognitive ability	6	8.7397	0.686522421	0.868613139	nervous
Denisovan	GWAS	Urinary albumin excretion (no hypertensive medication)	1	2.0243	0.493997925	0.868613139	metabolic
Denisovan	GWAS	Peanut allergy	1	2.0492	0.487995315	0.868713129	immune
Denisovan	GWAS	"Coronary artery disease (myocardial infarction, PTCA, CABG, angina or CIHD)"	6	8.7866	0.682857988	0.869213079	cardiovascular
Denisovan	GWAS	Colorectal cancer (diet interaction)	1	2.0307	0.49244103	0.869413059	digestive
Denisovan	GWAS	Self-reported risk-taking behaviour	3	4.8995	0.612307378	0.869813019	behavior
Denisovan	GWAS	Squamous cell lung carcinoma	5	7.5172	0.665141276	0.870312969	respiratory
Denisovan	GWAS	White matter hyperintensity burden	1	2.0538	0.486902327	0.870512949	nervous
Denisovan	GWAS	Initial alcohol sensitivity	2	3.5587	0.562002979	0.871112889	other
Denisovan	GWAS	Ischemic stroke	3	4.9476	0.606354596	0.871612839	cardiovascular
Denisovan	GWAS	Plateletcrit	14	18.2511	0.767077053	0.871712829	hematologic
Denisovan	GWAS	Pediatric autoimmune diseases	1	2.0956	0.477190303	0.872012799	immune
Denisovan	GWAS	Coronary artery disease in type 1 diabetes	1	2.056	0.486381323	0.872112789	cardiovascular
Denisovan	GWAS	Migraine	7	9.9796	0.701430919	0.873812619	nervous
Denisovan	GWAS	Waist-to-hip ratio adjusted for BMI in active individuals	2	3.606	0.55463117	0.874212579	skeletal
Denisovan	GWAS	Motion sickness	6	8.8823	0.675500715	0.874812519	nervous
Denisovan	GWAS	Sum eosinophil basophil counts	7	10.0045	0.699685142	0.876112389	hematologic
Denisovan	GWAS	Asthma (childhood onset)	5	7.622	0.655995802	0.876712329	respiratory
Denisovan	GWAS	Femoral neck bone mineral density	3	5.0009	0.599892019	0.877012299	skeletal
Denisovan	GWAS	Interferon alpha levels in systemic lupus erythematosus	1	2.0914	0.478148609	0.877312269	immune
Denisovan	GWAS	Granulocyte count	6	8.9318	0.671757093	0.877712229	immune
Denisovan	GWAS	Total body bone mineral density	3	4.9366	0.607705708	0.877812219	skeletal
Denisovan	GWAS	Coronary artery disease	31	37.4628	0.827487534	0.878412159	cardiovascular
Denisovan	GWAS	Anti-saccade response	6	8.8814	0.675569167	0.879212079	nervous
Denisovan	GWAS	Renal function-related traits (eGRFcrea)	1	2.0878	0.478973082	0.880011999	urinary
Denisovan	GWAS	Gallstone disease	1	2.0683	0.483488856	0.881411859	digestive
Denisovan	GWAS	HIV-1 susceptibility	1	2.0996	0.476281196	0.882311769	immune
Denisovan	GWAS	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)	3	5.0684	0.59190277	0.882511749	other
Denisovan	GWAS	Cutaneous squamous cell carcinoma	1	2.1082	0.474338298	0.883711629	integumentary
Denisovan	GWAS	Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)	1	2.1374	0.467858145	0.884111589	other
Denisovan	GWAS	Polycystic ovary syndrome	3	5.104	0.587774295	0.885011499	reproductive
Denisovan	GWAS	Gout	6	8.9623	0.669471006	0.885711429	skeletal
Denisovan	GWAS	Obstructive sleep apnea trait (average respiratory event duration)	2	3.7523	0.533006423	0.885711429	other
Denisovan	GWAS	Skin aging (microtopography measurement)	1	2.1549	0.464058657	0.885811419	integumentary
Denisovan	GWAS	Response to radiotherapy in cancer (late toxicity)	2	3.7303	0.536149908	0.886411359	other
Denisovan	GWAS	Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)	4	6.4926	0.616086006	0.887211279	cardiovascular
Denisovan	GWAS	Congenital heart disease (inherited effect)	1	2.1764	0.459474361	0.887911209	cardiovascular
Denisovan	GWAS	Body mass index in physically inactive individuals	1	2.2344	0.44754744	0.887911209	metabolic
Denisovan	GWAS	Systolic blood pressure x smoking status (ever vs never) interaction (2df test)	3	5.1823	0.578893541	0.889411059	cardiovascular
Denisovan	GWAS	Psoriatic arthritis	1	2.2238	0.449680727	0.889811019	integumentary
Denisovan	GWAS	Palmitic acid (16:0) levels	2	3.7409	0.534630704	0.890110989	other
Denisovan	GWAS	Mild influenza (H1N1) infection	5	7.8192	0.639451606	0.890910909	immune
Denisovan	GWAS	Diverticular disease	11	15.2108	0.723170379	0.891210879	digestive
Denisovan	GWAS	Optic nerve measurement (disc area)	1	2.2157	0.451324638	0.892710729	nervous
Denisovan	GWAS	Triglyceride levels	3	5.2123	0.575561652	0.892810719	metabolic
Denisovan	GWAS	Spherical equivalent (joint analysis main effects and education interaction)	2	3.8239	0.52302623	0.892810719	nervous
Denisovan	GWAS	Migraine - clinic-based	1	2.2459	0.445255799	0.894710529	nervous
Denisovan	GWAS	Post bronchodilator FEV1/FVC ratio in COPD	6	9.2429	0.649146913	0.897510249	other
Denisovan	GWAS	Metabolite levels	5	7.9531	0.62868567	0.898810119	metabolic
Denisovan	GWAS	Borderline personality disorder	2	3.8504	0.519426553	0.899510049	behavior
Denisovan	GWAS	Alcohol consumption (maxi-drinks)	1	2.3251	0.430089028	0.900009999	behavior
Denisovan	GWAS	Toenail selenium levels	6	9.2531	0.648431337	0.900709929	other
Denisovan	GWAS	Regular attendance at a religious group	3	5.3317	0.562672318	0.901709829	behavior
Denisovan	GWAS	Bortezomib-induced peripheral neuropathy in multiple myeloma	2	3.9007	0.512728485	0.902509749	nervous
Denisovan	GWAS	Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	1	2.3565	0.424358158	0.903609639	other
Denisovan	GWAS	Logical memory (delayed recall) in normal cognition	4	6.6692	0.599772087	0.903809619	nervous
Denisovan	GWAS	Epithelial ovarian cancer	1	2.337	0.427899016	0.903809619	reproductive
Denisovan	GWAS	QRS duration	5	8.0629	0.620124273	0.905209479	cardiovascular
Denisovan	GWAS	Heart rate response to recovery post exercise (10 sec)	1	2.3889	0.418602704	0.905309469	cardiovascular
Denisovan	GWAS	Alopecia areata	2	3.9801	0.502499937	0.907009299	integumentary
Denisovan	GWAS	Response to bupropion in depression	3	5.3975	0.555812876	0.907809219	other
Denisovan	GWAS	Fasting blood glucose (BMI interaction)	1	2.3938	0.417745843	0.909309069	metabolic
Denisovan	GWAS	Adolescent idiopathic scoliosis	2	4.0233	0.497104367	0.909509049	skeletal
Denisovan	GWAS	Survival in pancreatic cancer	2	4.0065	0.499188818	0.910108989	other
Denisovan	GWAS	Obsessive-compulsive symptoms	1	2.4115	0.41467966	0.911308869	behavior
Denisovan	GWAS	Mean platelet volume	14	19.1632	0.73056692	0.911608839	hematologic
Denisovan	GWAS	Iris color (a* coordinate)	1	2.4229	0.412728548	0.913108689	integumentary
Denisovan	GWAS	Subiculum volume	1	2.4465	0.40874719	0.913308669	nervous
Denisovan	GWAS	Nickel levels	4	6.9225	0.57782593	0.913308669	other
Denisovan	GWAS	Alcohol dependence	5	8.1516	0.613376515	0.913508649	behavior
Denisovan	GWAS	Pelvic organ prolapse	2	4.1173	0.485755228	0.914408559	skeletal muscle
Denisovan	GWAS	Hypertension (SNP x SNP interaction)	1	2.4235	0.412626367	0.914908509	cardiovascular
Denisovan	GWAS	Chronotype	2	4.0593	0.492695785	0.917108289	behavior
Denisovan	GWAS	Cerebrospinal P-tau181p levels	4	6.913	0.578619991	0.917508249	nervous
Denisovan	GWAS	Advanced age-related macular degeneration	2	4.1222	0.485177818	0.917508249	nervous
Denisovan	GWAS	Periodontitis (Mean PAL)	4	7.0384	0.56831098	0.918308169	immune
Denisovan	GWAS	Sodium levels	1	2.5527	0.391742077	0.918408159	other
Denisovan	GWAS	Plasma clusterin levels	2	4.1397	0.483126797	0.919008099	other
Denisovan	GWAS	Diastolic blood pressure (cigarette smoking interaction)	2	4.1363	0.483523922	0.920807919	cardiovascular
Denisovan	GWAS	Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)	3	5.6841	0.52778804	0.922507749	cardiovascular
Denisovan	GWAS	Corneal astigmatism	5	8.4142	0.594233558	0.922807719	nervous
Denisovan	GWAS	Microalbuminuria	1	2.5872	0.386518244	0.923507649	other
Denisovan	GWAS	Immune response to measles-mumps-rubella vaccine	2	4.1745	0.479099293	0.923807619	immune
Denisovan	GWAS	Urinary metabolite concentrations in chronic kidney disease	1	2.5782	0.387867504	0.924007599	metabolic
Denisovan	GWAS	Irritable mood	3	5.7594	0.520887592	0.924907509	behavior
Denisovan	GWAS	Copper levels	4	7.1151	0.56218465	0.925607439	other
Denisovan	GWAS	Blood pressure	9	13.6573	0.658988233	0.926307369	hematologic
Denisovan	GWAS	Optic cup area	1	2.6178	0.382000153	0.926407359	nervous
Denisovan	GWAS	Dimensional psychopathology (Negative)	2	4.2812	0.467158741	0.926807319	behavior
Denisovan	GWAS	Gait speed in old age	2	4.3078	0.464274107	0.926907309	other
Denisovan	GWAS	Obsessive-compulsive disorder	4	7.1959	0.555872094	0.928107189	behavior
Denisovan	GWAS	"Schizophrenia, schizoaffective disorder or bipolar disorder"	3	5.7988	0.517348417	0.928307169	behavior
Denisovan	GWAS	Multiple myeloma	1	2.6229	0.381257387	0.928507149	immune
Denisovan	GWAS	Fasting blood glucose	1	2.6166	0.382175342	0.929007099	metabolic
Denisovan	GWAS	Exhaled nitric oxide output	1	2.6515	0.377145012	0.929207079	respiratory
Denisovan	GWAS	Exhaled nitric oxide levels	1	2.6515	0.377145012	0.929207079	respiratory
Denisovan	GWAS	Axial length	2	4.3065	0.464414258	0.929307069	nervous
Denisovan	GWAS	Contrast sensitivity	1	2.6146	0.382467681	0.929307069	nervous
Denisovan	GWAS	Response to antidepressants (symptom improvement)	3	5.8262	0.514915382	0.929507049	other
Denisovan	GWAS	Alzheimer's disease (late onset)	5	8.7653	0.570431132	0.929907009	nervous
Denisovan	GWAS	Ankylosing spondylitis	1	2.6138	0.382584743	0.930106989	skeletal
Denisovan	GWAS	Free thyroxine concentration	1	2.6651	0.375220442	0.930706929	endocrine
Denisovan	GWAS	Coronary artery disease or large artery stroke	1	2.703	0.369959304	0.931406859	cardiovascular
Denisovan	GWAS	Dementia and core Alzheimer's disease neuropathologic changes	4	7.219	0.554093365	0.932506749	nervous
Denisovan	GWAS	Inflammatory skin disease	8	12.5463	0.637638188	0.932806719	integumentary
Denisovan	GWAS	Myopia	9	13.8571	0.649486545	0.932906709	nervous
Denisovan	GWAS	Cognitive performance	7	11.3612	0.616132099	0.934006599	nervous
Denisovan	GWAS	Neutrophil count	8	12.7452	0.627687286	0.934506549	lymphatic
Denisovan	GWAS	Hippocampal volume	3	6.0352	0.497083775	0.935106489	nervous
Denisovan	GWAS	Hypertension	6	9.9741	0.601558035	0.935306469	cardiovascular
Denisovan	GWAS	Feeling fed-up	2	4.4503	0.449407905	0.936906309	behavior
Denisovan	GWAS	Vertical cup-disc ratio	2	4.4157	0.45292932	0.937406259	nervous
Denisovan	GWAS	Social science traits (pleiotropy) (HIPO component 1)	2	4.345	0.460299194	0.937706229	behavior
Denisovan	GWAS	QT interval (drug interaction)	2	4.5546	0.439116498	0.938006199	cardiovascular
Denisovan	GWAS	Multiple system atrophy (pathologically confirmed)	1	2.7885	0.358615743	0.938206179	nervous
Denisovan	GWAS	Myeloid white cell count	5	8.8209	0.566835584	0.938306169	immune
Denisovan	GWAS	Severe gingival inflammation	1	2.8291	0.353469301	0.939406059	immune
Denisovan	GWAS	Liver enzyme levels (gamma-glutamyl transferase)	1	2.8736	0.347995546	0.941805819	other
Denisovan	GWAS	Cadmium levels	3	6.0169	0.498595622	0.942005799	other
Denisovan	GWAS	Sum basophil neutrophil counts	5	9.0358	0.553354435	0.943005699	hematologic
Denisovan	GWAS	Plasma parathyroid hormone levels	2	4.5748	0.437177582	0.943005699	endocrine
Denisovan	GWAS	White blood cell count	9	14.2805	0.630230034	0.943805619	immune
Denisovan	GWAS	Systolic blood pressure (cigarette smoking interaction)	2	4.5731	0.437340098	0.944405559	cardiovascular
Denisovan	GWAS	Total hippocampal volume	1	2.9484	0.339167006	0.945205479	nervous
Denisovan	GWAS	Rheumatoid arthritis	10	15.4627	0.646717585	0.945905409	immune
Denisovan	GWAS	Body mass index (age <50)	2	4.7582	0.420327014	0.946405359	metabolic
Denisovan	GWAS	Acute graft versus host disease in bone marrow transplantation (recipient effect)	1	2.9375	0.340425532	0.947005299	other
Denisovan	GWAS	Attention function in attention deficit hyperactive disorder	2	4.6382	0.431201759	0.947105289	behavior
Denisovan	GWAS	Metabolite levels (HVA/MHPG ratio)	1	2.9292	0.341390141	0.947305269	metabolic
Denisovan	GWAS	Quantitative traits	2	4.7175	0.423953365	0.948905109	other
Denisovan	GWAS	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	3	6.2349	0.481162489	0.948905109	other
Denisovan	GWAS	Personality dimensions	3	6.2412	0.480676793	0.948905109	behavior
Denisovan	GWAS	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	2	4.7313	0.422716801	0.949205079	endocrine
Denisovan	GWAS	Lymphocyte counts	7	11.8508	0.590677423	0.949705029	lymphatic
Denisovan	GWAS	Cerebrospinal fluid beta-site APP cleaving enzyme levels	1	2.9464	0.339397231	0.95050495	nervous
Denisovan	GWAS	Blood protein levels	64	77.7506	0.823144773	0.95080492	other
Denisovan	GWAS	Monobrow	4	7.7134	0.518578059	0.95110489	integumentary
Denisovan	GWAS	HIV-1 viral setpoint	2	4.7929	0.417283899	0.95170483	immune
Denisovan	GWAS	Eating disorders (purging via substances)	3	6.3298	0.473948624	0.95170483	behavior
Denisovan	GWAS	Lifetime average cigarettes per day in chronic obstructive pulmonary disease	1	3.1019	0.322383056	0.9540046	behavior
Denisovan	GWAS	Heart rate response to recovery post exercise (20 sec)	1	3.0847	0.324180633	0.95470453	cardiovascular
Denisovan	GWAS	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	3	6.4322	0.466403408	0.95520448	other
Denisovan	GWAS	Resting heart rate	9	14.6884	0.612728412	0.95540446	cardiovascular
Denisovan	GWAS	Adverse response to chemotherapy in breast cancer (alopecia) (FDC/DC)	1	3.1792	0.31454454	0.9570043	other
Denisovan	GWAS	Serum total protein level	1	3.2059	0.311924888	0.95770423	other
Denisovan	GWAS	Childhood body mass index	1	3.1911	0.313371565	0.95830417	metabolic
Denisovan	GWAS	QRS interval (sulfonylurea treatment interaction)	3	6.5532	0.457791613	0.95850415	cardiovascular
Denisovan	GWAS	Cerebral amyloid deposition in APOEe4 non-carriers (PET imaging)	2	5.0603	0.395233484	0.96030397	nervous
Denisovan	GWAS	Visceral adipose tissue adjusted for BMI	2	5.016	0.398724083	0.96030397	metabolic
Denisovan	GWAS	Adiponectin levels	2	5.0581	0.395405389	0.96060394	other
Denisovan	GWAS	Endometrial cancer (endometrioid histology)	3	6.5975	0.454717696	0.96120388	reproductive
Denisovan	GWAS	Type 2 diabetes (age of onset)	2	5.1528	0.388138488	0.96120388	metabolic
Denisovan	GWAS	Periodontitis (CDC/AAP)	5	9.5819	0.521817176	0.96170383	immune
Denisovan	GWAS	Cognitive ability (MTAG)	4	8.1397	0.491418603	0.96220378	nervous
Denisovan	GWAS	Response to fenofibrate (total cholesterol levels)	2	5.1544	0.388018004	0.96240376	other
Denisovan	GWAS	Serum thyroid-stimulating hormone levels	2	5.1716	0.386727512	0.96240376	endocrine
Denisovan	GWAS	QT interval	8	13.7971	0.579831994	0.96340366	cardiovascular
Denisovan	GWAS	Response to fenofibrate (adiponectin levels)	2	5.1021	0.391995453	0.96360364	other
Denisovan	GWAS	Forced expiratory volume in 1 second (occupational environmental exposures interaction)	1	3.2771	0.305147844	0.96380362	respiratory
Denisovan	GWAS	Waist-to-hip ratio adjusted for body mass index	6	10.8924	0.550842789	0.9640036	skeletal
Denisovan	GWAS	Obstructive sleep apnea trait (apnea hypopnea index)	1	3.319	0.301295571	0.96430357	other
Denisovan	GWAS	Neurocognitive impairment in HIV-1 infection (dichotomous)	3	6.8831	0.435850126	0.96480352	nervous
Denisovan	GWAS	Depression	7	12.4313	0.563094769	0.96550345	behavior
Denisovan	GWAS	Chronic inflammatory diseases (pleiotropy)	5	9.7782	0.511341556	0.96550345	immune
Denisovan	GWAS	Experiencing mood swings	4	8.3161	0.480994697	0.96570343	behavior
Denisovan	GWAS	Cognitive decline rate in late mild cognitive impairment	10	16.6111	0.602007092	0.96580342	nervous
Denisovan	GWAS	Lipoprotein (a) levels	2	5.2243	0.382826407	0.96610339	metabolic
Denisovan	GWAS	Loneliness (multivariate analysis)	3	6.8844	0.435767823	0.96720328	behavior
Denisovan	GWAS	Early-onset Parkinson's disease	1	3.504	0.285388128	0.96730327	nervous
Denisovan	GWAS	Emphysema-related traits	3	6.7945	0.441533593	0.96730327	respiratory
Denisovan	GWAS	Bone mineral density	6	11.2991	0.531015745	0.96770323	skeletal
Denisovan	GWAS	Intracranial aneurysm	6	11.0441	0.543276501	0.96770323	nervous
Denisovan	GWAS	Monocyte percentage of white cells	5	9.8095	0.509709975	0.96840316	immune
Denisovan	GWAS	Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma	1	3.4691	0.288259203	0.96880312	other
Denisovan	GWAS	Pulmonary function (smoking interaction)	3	7.0112	0.42788681	0.96890311	respiratory
Denisovan	GWAS	Melanoma	2	5.373	0.372231528	0.96950305	integumentary
Denisovan	GWAS	Selective IgA deficiency	1	3.5045	0.28534741	0.96950305	immune
Denisovan	GWAS	Feeling hurt	2	5.2732	0.379276341	0.96980302	behavior
Denisovan	GWAS	Putamen volume	1	3.4222	0.29220969	0.96990301	nervous
Denisovan	GWAS	Adverse response to lamotrigine and phenytoin	1	3.4675	0.288392213	0.970003	other
Denisovan	GWAS	Osteoarthritis biomarkers	2	5.3078	0.376803949	0.970003	skeletal
Denisovan	GWAS	Verbal declarative memory	3	7.077	0.423908436	0.97070293	nervous
Denisovan	GWAS	Multiple system atrophy	2	5.4461	0.367235269	0.97070293	nervous
Denisovan	GWAS	Airway responsiveness in chronic obstructive pulmonary disease	4	8.5486	0.467912875	0.97080292	respiratory
Denisovan	GWAS	Waist circumference adjusted for BMI in active individuals	3	6.9704	0.430391369	0.97120288	skeletal
Denisovan	GWAS	Metabolite levels (5-HIAA)	1	3.4947	0.286147595	0.97130287	metabolic
Denisovan	GWAS	Age-related hearing impairment	2	5.3783	0.371864716	0.97150285	nervous
Denisovan	GWAS	Carotid plaque burden	2	5.3243	0.375636234	0.97170283	cardiovascular
Denisovan	GWAS	Multiple keratinocyte cancers	2	5.3705	0.372404804	0.97170283	integumentary
Denisovan	GWAS	Weight	1	3.5659	0.280434112	0.97270273	skeletal
Denisovan	GWAS	Platelet aggregation	2	5.4454	0.367282477	0.97270273	hematologic
Denisovan	GWAS	Resting-state electroencephalogram vigilance	3	7.1012	0.422463809	0.97310269	nervous
Denisovan	GWAS	Aging	1	3.7245	0.268492415	0.97320268	other
Denisovan	GWAS	Post-traumatic stress disorder	4	8.6294	0.463531648	0.97420258	behavior
Denisovan	GWAS	Methadone dose in opioid dependence	4	8.7146	0.458999839	0.97440256	other
Denisovan	GWAS	Cerebrospinal fluid clusterin levels	4	8.714	0.459031444	0.97470253	nervous
Denisovan	GWAS	Dimensional psychopathology (Positive)	1	3.5882	0.278691266	0.97470253	behavior
Denisovan	GWAS	Common carotid intima-media thickness in HIV negative individuals	1	3.753	0.266453504	0.97510249	cardiovascular
Denisovan	GWAS	Glomerular filtration rate in chronic kidney disease	1	3.6882	0.271134971	0.97620238	hematologic
Denisovan	GWAS	Amyotrophic lateral sclerosis (age of onset)	1	3.739	0.26745119	0.97660234	nervous
Denisovan	GWAS	Parkinson's disease	7	13.038	0.536892161	0.97710229	nervous
Denisovan	GWAS	Systolic blood pressure x alcohol consumption interaction (2df test)	4	8.849	0.452028478	0.97720228	cardiovascular
Denisovan	GWAS	Subcortical brain region volumes	1	3.7605	0.265922085	0.97730227	nervous
Denisovan	GWAS	Systemic juvenile idiopathic arthritis	2	5.7201	0.349644237	0.97740226	immune
Denisovan	GWAS	Emphysema imaging phenotypes	4	8.8488	0.452038695	0.97790221	respiratory
Denisovan	GWAS	Iris color (b* coordinate)	2	5.7205	0.349619788	0.97820218	integumentary
Denisovan	GWAS	Age-related macular degeneration	1	3.8771	0.257924738	0.97830217	nervous
Denisovan	GWAS	Multiple sclerosis	13	21.1981	0.613262509	0.97840216	nervous
Denisovan	GWAS	Post bronchodilator FEV1	15	23.8015	0.630212382	0.97890211	other
Denisovan	GWAS	Bipolar disorder (body mass index interaction)	1	3.9141	0.255486574	0.9790021	behavior
Denisovan	GWAS	Lung cancer in never smokers	1	3.8377	0.260572739	0.97920208	respiratory
Denisovan	GWAS	Coronary artery aneurysm in Kawasaki disease	7	13.3102	0.525912458	0.97940206	cardiovascular
Denisovan	GWAS	Autism	1	3.9231	0.254900461	0.97970203	behavior
Denisovan	GWAS	Feeling guilty	1	3.8277	0.261253494	0.97980202	behavior
Denisovan	GWAS	Bone mineral density (hip)	2	5.7424	0.348286431	0.97980202	skeletal
Denisovan	GWAS	Insomnia	1	3.8337	0.260844615	0.980002	behavior
Denisovan	GWAS	Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)	3	7.4349	0.403502401	0.98060194	skeletal
Denisovan	GWAS	Erectile dysfunction	2	5.9238	0.337621122	0.98080192	reproductive
Denisovan	GWAS	Uterine fibroid number (single vs multiple)	1	4.051	0.246852629	0.9810019	reproductive
Denisovan	GWAS	Glaucoma	2	5.9068	0.338592808	0.98150185	nervous
Denisovan	GWAS	Uterine fibroids	4	9.1442	0.437435752	0.98160184	reproductive
Denisovan	GWAS	Platelet distribution width	8	14.9953	0.533500497	0.98240176	hematologic
Denisovan	GWAS	Pulmonary function	3	7.6217	0.393612973	0.98250175	respiratory
Denisovan	GWAS	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes	2	5.8911	0.339495171	0.98260174	cardiovascular
Denisovan	GWAS	Aggressiveness in attention deficit hyperactivity disorder	2	5.9906	0.333856375	0.98290171	behavior
Denisovan	GWAS	Heart rate	1	4.088	0.244618395	0.98310169	cardiovascular
Denisovan	GWAS	Waist circumference adjusted for BMI in non-smokers	2	6.1282	0.326360106	0.98340166	skeletal
Denisovan	GWAS	Initial pursuit acceleration	4	9.1971	0.434919703	0.98340166	nervous
Denisovan	GWAS	Waist circumference adjusted for body mass index	5	10.8985	0.458778731	0.98440156	skeletal
Denisovan	GWAS	Feeling tense	1	4.2328	0.236250236	0.98440156	behavior
Denisovan	GWAS	Response to methotrexate in juvenile idiopathic arthritis	5	10.9286	0.457515144	0.98440156	other
Denisovan	GWAS	Hippocampal atrophy	1	4.1677	0.239940495	0.98460154	nervous
Denisovan	GWAS	Coronary artery calcification	4	9.1947	0.435033226	0.98460154	cardiovascular
Denisovan	GWAS	Airflow obstruction	2	6.0903	0.328391048	0.98510149	respiratory
Denisovan	GWAS	Radiation response	1	4.2375	0.235988201	0.98550145	other
Denisovan	GWAS	Chronic bronchitis and chronic obstructive pulmonary disease	2	6.2416	0.320430659	0.98550145	respiratory
Denisovan	GWAS	Lung function (FEV1/FVC)	5	11.223	0.445513677	0.98580142	respiratory
Denisovan	GWAS	Longevity	10	18.0316	0.554581956	0.98590141	other
Denisovan	GWAS	Major depressive disorder	15	24.7967	0.604919203	0.9860014	behavior
Denisovan	GWAS	"Type 2 diabetes (SNP x SNP interaction, 1df)"	2	6.1723	0.32402832	0.98640136	metabolic
Denisovan	GWAS	Morning vs. evening chronotype	1	4.2375	0.235988201	0.98650135	behavior
Denisovan	GWAS	Myopia (pathological)	5	11.1137	0.449895174	0.98650135	nervous
Denisovan	GWAS	Obesity (early onset extreme)	1	4.3926	0.227655603	0.98660134	metabolic
Denisovan	GWAS	Severe malaria (adjusted for sickle cell variant rs334)	2	6.5025	0.30757401	0.9880012	immune
Denisovan	GWAS	Neurociticism	9	17.0041	0.529284114	0.98850115	behavior
Denisovan	GWAS	Waist circumference	6	13.104	0.457875458	0.98890111	skeletal
Denisovan	GWAS	Cerebrospinal T-tau levels	2	6.6367	0.301354589	0.9890011	nervous
Denisovan	GWAS	Triptolide cytotoxicity	2	6.5675	0.304529882	0.98910109	other
Denisovan	GWAS	"Autism spectrum disorder, ADHD, bipolar disorder, MDD, and schizophrenia (combined)"	8	15.8894	0.503480308	0.98960104	behavior
Denisovan	GWAS	Prudent dietary pattern	1	4.5976	0.217504785	0.98960104	behavior
Denisovan	GWAS	Alzheimer's disease in APOE e4- carriers	1	4.403	0.227117874	0.98990101	nervous
Denisovan	GWAS	Type 1 diabetes	1	4.6965	0.212924518	0.990001	metabolic
Denisovan	GWAS	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	2	6.5956	0.303232458	0.99010099	other
Denisovan	GWAS	Lung cancer in ever smokers	4	10.0429	0.39829133	0.99010099	respiratory
Denisovan	GWAS	Endometriosis	3	8.5119	0.35244775	0.99030097	reproductive
Denisovan	GWAS	Nicotine dependence and major depression (severity of comorbidity)	2	6.6087	0.30263138	0.99040096	behavior
Denisovan	GWAS	Cognitive decline (age-related)	2	6.789	0.294594196	0.99050095	nervous
Denisovan	GWAS	Urinary albumin excretion	4	10.3455	0.386641535	0.9910009	metabolic
Denisovan	GWAS	Monoclonal gammopathy of undetermined significance	10	18.9203	0.528532846	0.99110089	hematologic
Denisovan	GWAS	Schizophrenia	55	73.6065	0.747216618	0.99110089	behavior
Denisovan	GWAS	Pancreatic cancer	5	11.5595	0.43254466	0.99140086	endocrine
Denisovan	GWAS	Nose size	1	4.6912	0.213165075	0.99150085	skeletal
Denisovan	GWAS	Response to statin therapy	2	6.8628	0.29142624	0.99160084	other
Denisovan	GWAS	Metabolite levels (Pyroglutamine)	1	4.6759	0.213862572	0.99180082	metabolic
Denisovan	GWAS	Immune response to smallpox vaccine (IL-6)	5	11.8624	0.421499865	0.9920008	immune
Denisovan	GWAS	Insulin resistance/response	2	6.8594	0.291570691	0.99210079	immune
Denisovan	GWAS	Seasonality and depression	1	4.8145	0.207705888	0.99210079	behavior
Denisovan	GWAS	Urate levels (BMI interaction)	1	4.8762	0.205077724	0.99230077	metabolic
Denisovan	GWAS	Hypothyroidism	2	6.9397	0.288196896	0.99240076	endocrine
Denisovan	GWAS	Mercury levels	1	5.0541	0.197859164	0.99250075	other
Denisovan	GWAS	Chronic obstructive pulmonary disease	1	4.8955	0.204269227	0.99250075	respiratory
Denisovan	GWAS	Blood pressure (smoking interaction)	5	12.0739	0.4141164	0.99260074	hematologic
Denisovan	GWAS	Severe malaria	2	7.1974	0.277878123	0.99260074	immune
Denisovan	GWAS	Eating disorders	1	4.9743	0.201033311	0.99380062	behavior
Denisovan	GWAS	Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)	2	7.2361	0.276391979	0.99390061	skeletal
Denisovan	GWAS	Manganese levels	1	5.2107	0.191912795	0.99390061	other
Denisovan	GWAS	Mean arterial pressure x alcohol consumption interaction (2df test)	1	5.3703	0.186209337	0.99420058	cardiovascular
Denisovan	GWAS	Itch intensity from mosquito bite	1	5.1434	0.194423922	0.99430057	immune
Denisovan	GWAS	Systolic blood pressure in sickle cell anemia	2	7.3133	0.273474355	0.99440056	cardiovascular
Denisovan	GWAS	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes	3	9.1964	0.326214606	0.99480052	cardiovascular
Denisovan	GWAS	Pulmonary function decline	3	9.1875	0.326530612	0.99520048	respiratory
Denisovan	GWAS	Stroke	1	5.4011	0.18514747	0.99550045	cardiovascular
Denisovan	GWAS	Depression (quantitative trait)	1	5.1791	0.19308374	0.99560044	behavior
Denisovan	GWAS	Hip circumference	2	7.7472	0.258157786	0.99580042	skeletal
Denisovan	GWAS	Waist circumference adjusted for BMI (adjusted for smoking behaviour)	2	7.7244	0.258919787	0.99610039	skeletal
Denisovan	GWAS	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)	1	5.696	0.175561798	0.99630037	skeletal
Denisovan	GWAS	Pursuit maintenance gain	8	17.7904	0.449680727	0.99650035	skeletal muscle
Denisovan	GWAS	Cannabis dependence symptom count	2	7.7294	0.258752296	0.99650035	behavior
Denisovan	GWAS	Percentage gas trapping	2	7.8799	0.253810328	0.99650035	metabolic
Denisovan	GWAS	BMI in non-smokers	3	9.7034	0.309169982	0.99650035	metabolic
Denisovan	GWAS	Paclitaxel disposition in epithelial ovarian cancer	3	9.9161	0.302538296	0.99670033	other
Denisovan	GWAS	Neuroticism	5	12.7432	0.392366125	0.99670033	behavior
Denisovan	GWAS	Angiotensin-converting enzyme inhibitor intolerance	3	9.8975	0.303106845	0.99690031	other
Denisovan	GWAS	Mitochondrial DNA levels	1	5.9362	0.168457936	0.9970003	other
Denisovan	GWAS	Itch intensity from mosquito bite adjusted by bite size	7	16.7149	0.418788027	0.9970003	immune
Denisovan	GWAS	Severe influenza A (H1N1) infection	1	6.2698	0.159494721	0.99710029	immune
Denisovan	GWAS	Response to antipsychotic treatment	2	8.697	0.229964356	0.99720028	other
Denisovan	GWAS	Mosquito bite size	6	15.1444	0.396186049	0.99720028	other
Denisovan	GWAS	Pulse pressure x alcohol consumption interaction (2df test)	1	6.1396	0.16287706	0.99730027	cardiovascular
Denisovan	GWAS	Rosacea symptom severity	10	20.9476	0.477381657	0.99740026	integumentary
Denisovan	GWAS	Spherical equivalent or myopia (age of diagnosis)	14	26.1829	0.534700129	0.99740026	nervous
Denisovan	GWAS	Refractive astigmatism	4	11.7901	0.339267691	0.99750025	nervous
Denisovan	GWAS	Subcutaneous adipose tissue	3	10.1932	0.294313856	0.99770023	metabolic
Denisovan	GWAS	Diabetic kidney disease	1	6.3072	0.15854896	0.99790021	metabolic
Denisovan	GWAS	Visceral fat	1	6.7025	0.14919806	0.99790021	metabolic
Denisovan	GWAS	Sudden cardiac arrest	1	6.4124	0.155947851	0.99810019	cardiovascular
Denisovan	GWAS	Allergic rhinitis	3	10.5008	0.285692519	0.99820018	immune
Denisovan	GWAS	"Type 2 diabetes (SNP x SNP interaction, 2df)"	2	8.5677	0.233434878	0.99820018	metabolic
Denisovan	GWAS	Heel bone mineral density	61	85.5219	0.713267596	0.99840016	skeletal
Denisovan	GWAS	Visceral adipose tissue/subcutaneous adipose tissue ratio	2	8.6899	0.230152246	0.99840016	metabolic
Denisovan	GWAS	Venous thromboembolism adjusted for sickle cell variant rs77121243-T	4	12.4286	0.321838341	0.99850015	hematologic
Denisovan	GWAS	Body mass index (joint analysis main effects and physical activity interaction)	5	14.2706	0.350370692	0.99850015	metabolic
Denisovan	GWAS	Urate levels in overweight individuals	1	6.1659	0.162182325	0.99870013	metabolic
Denisovan	GWAS	Dental caries	2	8.8282	0.226546748	0.99870013	skeletal
Denisovan	GWAS	Body mass index (joint analysis main effects and smoking interaction)	4	12.5578	0.318527131	0.99880012	metabolic
Denisovan	GWAS	BMI (adjusted for smoking behaviour)	4	12.6049	0.317336909	0.99880012	metabolic
Denisovan	GWAS	Diastolic blood pressure x alcohol consumption interaction (2df test)	1	7.0108	0.142637074	0.9990001	cardiovascular
Denisovan	GWAS	Anorexia nervosa	2	9.0003	0.222214815	0.99910009	behavior
Denisovan	GWAS	Male-pattern baldness	6	17.3768	0.34528797	0.99920008	integumentary
Denisovan	GWAS	Breast cancer	8	20.8311	0.384041169	0.99930007	reproductive
Denisovan	GWAS	Daytime sleep phenotypes	10	22.8374	0.437878217	0.99930007	behavior
Denisovan	GWAS	Alzheimer's disease (cognitive decline)	6	16.437	0.365030115	0.99950005	nervous
Denisovan	GWAS	Asthma	10	24.8493	0.402425823	0.99950005	respiratory
Denisovan	GWAS	Protein quantitative trait loci	1	7.9226	0.12622119	0.99950005	other
Denisovan	GWAS	Photic sneeze reflex	6	16.9929	0.353088643	0.99950005	nervous
Denisovan	GWAS	Obesity	3	12.519	0.239635754	0.99950005	metabolic
Denisovan	GWAS	Menarche (age at onset)	19	37.8011	0.502630876	0.99960004	reproductive
Denisovan	GWAS	Diastolic blood pressure	38	62.2999	0.609952825	0.99960004	cardiovascular
Denisovan	GWAS	Glaucoma (primary open-angle)	2	10.1452	0.197137563	0.99960004	nervous
Denisovan	GWAS	Macular thickness	7	18.2734	0.383070474	0.99960004	nervous
Denisovan	GWAS	Response to amphetamines	3	13.1038	0.228941223	0.99980002	other
Denisovan	GWAS	Body mass index in physically active individuals	3	13.2285	0.226783082	0.99980002	metabolic
Denisovan	GWAS	Diisocyanate-induced asthma	11	26.848	0.409713945	0.99980002	respiratory
Denisovan	GWAS	Attention deficit hyperactivity disorder	5	16.5444	0.302217064	0.99990001	behavior
Denisovan	GWAS	Epstein-Barr virus copy number in lymphoblastoid cell lines	4	17.0529	0.234564209	0.99990001	immune
Denisovan	GWAS	Bronchopulmonary dysplasia	1	9.2071	0.108611832	0.99990001	respiratory
Denisovan	GWAS	Type 2 diabetes	22	44.074	0.499160503	0.99990001	metabolic
Denisovan	GWAS	Post bronchodilator FEV1/FVC ratio	20	43.2682	0.462233234	1	other
Denisovan	GWAS	Systolic blood pressure	29	69.0562	0.419947811	1	cardiovascular
Denisovan	GWAS	General cognitive ability	6	29.4037	0.204055952	1	nervous
Denisovan	GWAS	Night sleep phenotypes	30	53.665	0.559023572	1	behavior
Denisovan	GWAS	Obesity-related traits	49	112.9668	0.433755758	1	metabolic
Denisovan	GWAS	Body mass index	57	99.3954	0.573467183	1	metabolic
Denisovan	GWAS	Amyotrophic lateral sclerosis (sporadic)	7	30.4218	0.230098153	1	nervous
Denisovan	GWAS	Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes	2	11.7526	0.17017511	1	cardiovascular
Denisovan	GWAS	Intelligence (MTAG)	12	35.7767	0.335413831	1	other
Denisovan	GWAS	Hand grip strength	6	21.7373	0.276023241	1	skeletal muscle
Denisovan	GWAS	Waist-hip ratio	3	14.4588	0.207486098	1	skeletal
Denisovan	GWAS	Cognitive function	1	10.7052	0.093412547	1	nervous
Denisovan	GWAS	Nasopharyngeal carcinoma (SNP x SNP interaction)	3	16.0071	0.187416834	1	other
Denisovan	GWAS	Pulse pressure	32	58.6801	0.545329677	1	cardiovascular
Denisovan	GWAS	Familial squamous cell lung carcinoma	1	10.2826	0.097251668	1	respiratory
Denisovan	HPO	Spinal rigidity (HP:0003306)	9	1.0287	8.748906387	1.00E-04	skeletal
Denisovan	HPO	Follicular hyperkeratosis (HP:0007502)	6	0.402	14.92537313	1.00E-04	integumentary
Denisovan	HPO	Abnormality of skeletal muscle fiber size (HP:0012084)	7	0.821	8.526187576	1.00E-04	skeletal muscle
Denisovan	HPO	Hypoventilation (HP:0002791)	6	0.6914	8.678044547	1.00E-04	respiratory
Denisovan	HPO	Recurrent lower respiratory tract infections (HP:0002783)	9	1.7691	5.087332542	1.00E-04	immune
Denisovan	HPO	Generalized amyotrophy (HP:0003700)	6	0.6789	8.837825895	1.00E-04	nervous
Denisovan	HPO	Limb-girdle muscle weakness (HP:0003325)	9	1.3225	6.805293006	1.00E-04	skeletal muscle
Denisovan	HPO	Increased variability in muscle fiber diameter (HP:0003557)	7	0.813	8.610086101	1.00E-04	skeletal muscle
Denisovan	HPO	Ankle contracture (HP:0006466)	6	0.5509	10.89126883	1.00E-04	skeletal muscle
Denisovan	HPO	Type 1 muscle fiber predominance (HP:0003803)	7	0.6752	10.36729858	0.00019998	skeletal muscle
Denisovan	HPO	Slender build (HP:0001533)	6	0.5648	10.62322946	0.00019998	other
Denisovan	HPO	Increased connective tissue (HP:0009025)	5	0.514	9.727626459	0.00019998	other
Denisovan	HPO	Neonatal hypotonia (HP:0001319)	15	4.9286	3.043460618	0.00029997	skeletal muscle
Denisovan	HPO	Mildly elevated creatine phosphokinase (HP:0008180)	7	0.8151	8.587903325	0.00029997	other
Denisovan	HPO	Metabolic acidosis (HP:0001942)	10	2.8988	3.449703326	0.0009999	metabolic
Denisovan	HPO	Skull defect (HP:0001362)	8	1.8333	4.363715704	0.00119988	skeletal
Denisovan	HPO	Torticollis (HP:0000473)	6	1.2661	4.738962167	0.00209979	skeletal
Denisovan	HPO	Abnormality of glycolipid metabolism (HP:0010969)	3	0.2491	12.04335608	0.00249975	metabolic
Denisovan	HPO	Abnormality of liposaccharide metabolism (HP:0010968)	3	0.2491	12.04335608	0.00249975	metabolic
Denisovan	HPO	Abnormality of glycosphingolipid metabolism (HP:0004343)	3	0.2491	12.04335608	0.00249975	metabolic
Denisovan	HPO	Craniofacial dystonia (HP:0012179)	6	1.3093	4.58260139	0.00259974	skeletal muscle
Denisovan	HPO	Thoracolumbar scoliosis (HP:0002944)	5	1.0152	4.925137904	0.00259974	skeletal
Denisovan	HPO	Blindness (HP:0000618)	11	3.8676	2.844141069	0.00259974	nervous
Denisovan	HPO	Focal dystonia (HP:0004373)	6	1.3324	4.503152207	0.00279972	nervous
Denisovan	HPO	Basal cell carcinoma (HP:0002671)	4	0.5831	6.859886812	0.0029997	integumentary
Denisovan	HPO	Elbow flexion contracture (HP:0002987)	8	2.4358	3.2843419	0.00369963	skeletal
Denisovan	HPO	Wide intermamillary distance (HP:0006610)	7	2.0751	3.373331406	0.00389961	reproductive
Denisovan	HPO	Lumbar hyperlordosis (HP:0002938)	8	2.6196	3.053901359	0.00409959	skeletal
Denisovan	HPO	Progressive microcephaly (HP:0000253)	3	0.3127	9.59385993	0.00469953	nervous
Denisovan	HPO	Abnormal biliary tract morphology (HP:0012440)	5	1.1313	4.419694157	0.00559944	digestive
Denisovan	HPO	Respiratory insufficiency due to muscle weakness (HP:0002747)	9	3.1802	2.830010691	0.00579942	respiratory
Denisovan	HPO	Impaired platelet aggregation (HP:0003540)	4	0.7347	5.444399074	0.00609939	hematologic
Denisovan	HPO	Abnormal platelet function (HP:0011869)	4	0.7347	5.444399074	0.00609939	hematologic
Denisovan	HPO	Abnormality of macrophages (HP:0004311)	3	0.3613	8.303349017	0.00629937	immune
Denisovan	HPO	Infantile onset (HP:0003593)	25	14.4849	1.725935284	0.00679932	other
Denisovan	HPO	Male infertility (HP:0003251)	3	0.389	7.712082262	0.0069993	reproductive
Denisovan	HPO	Progressive disorder (HP:0003676)	15	7.3723	2.034643191	0.00779922	other
Denisovan	HPO	Generalized aminoaciduria (HP:0002909)	2	0.1482	13.49527665	0.00919908	urinary
Denisovan	HPO	Pointed chin (HP:0000307)	8	3.0158	2.652695802	0.00989901	skeletal
Denisovan	HPO	Abnormality of the gallbladder (HP:0005264)	5	1.3349	3.745598921	0.01179882	digestive
Denisovan	HPO	Infertility (HP:0000789)	5	1.3479	3.709473997	0.01329867	reproductive
Denisovan	HPO	Neuroectodermal neoplasm (HP:0030061)	6	1.9531	3.072039322	0.01379862	nervous
Denisovan	HPO	Nervous tissue neoplasm (HP:0030060)	6	1.9531	3.072039322	0.01379862	nervous
Denisovan	HPO	Neuroepithelial neoplasm (HP:0030063)	6	1.9531	3.072039322	0.01379862	nervous
Denisovan	HPO	Rimmed vacuoles (HP:0003805)	3	0.4809	6.238303182	0.01459854	skeletal muscle
Denisovan	HPO	Oligodontia (HP:0000677)	4	0.9499	4.210969576	0.01469853	skeletal
Denisovan	HPO	Ependymoma (HP:0002888)	2	0.1977	10.11633789	0.01639836	nervous
Denisovan	HPO	Dicarboxylic aciduria (HP:0003215)	4	0.9822	4.072490328	0.01679832	metabolic
Denisovan	HPO	Abnormality of dicarboxylic acid metabolism (HP:0010995)	4	0.9822	4.072490328	0.01679832	metabolic
Denisovan	HPO	Abnormality of DNA repair (HP:0003254)	3	0.5233	5.732849226	0.0169983	other
Denisovan	HPO	Protruding ear (HP:0000411)	7	2.6322	2.659372388	0.01749825	other
Denisovan	HPO	Corneal erosion (HP:0200020)	5	1.5567	3.211922657	0.01869813	nervous
Denisovan	HPO	Abnormal autonomic nervous system physiology (HP:0012332)	3	0.565	5.309734513	0.01929807	nervous
Denisovan	HPO	Lymphoma (HP:0002665)	7	2.6507	2.640811861	0.01939806	lymphatic
Denisovan	HPO	Ascites (HP:0001541)	7	2.7069	2.585983967	0.0219978	digestive
Denisovan	HPO	Arthrogryposis multiplex congenita (HP:0002804)	7	2.7124	2.580740304	0.02239776	skeletal muscle
Denisovan	HPO	Small for gestational age (HP:0001518)	8	3.3855	2.363018756	0.02279772	other
Denisovan	HPO	Uterine neoplasm (HP:0010784)	8	3.3968	2.355157796	0.02339766	reproductive
Denisovan	HPO	Hereditary nonpolyposis colorectal carcinoma (HP:0006716)	7	2.7971	2.50259197	0.02409759	digestive
Denisovan	HPO	Neoplasm of the rectum (HP:0100743)	3	0.6105	4.914004914	0.02589741	digestive
Denisovan	HPO	Hypoplasia of the capital femoral epiphysis (HP:0003090)	2	0.2452	8.156606852	0.02659734	skeletal
Denisovan	HPO	Multifactorial inheritance (HP:0001426)	4	1.1218	3.565697985	0.02719728	other
Denisovan	HPO	Variable expressivity (HP:0003828)	13	7.0243	1.850718221	0.02789721	other
Denisovan	HPO	Fasciculations (HP:0002380)	4	1.1273	3.548301251	0.02869713	skeletal muscle
Denisovan	HPO	Intestinal malrotation (HP:0002566)	7	2.949	2.373685995	0.02879712	digestive
Denisovan	HPO	Generalized muscle weakness (HP:0003324)	4	1.1546	3.464403257	0.02909709	skeletal muscle
Denisovan	HPO	Polygenic inheritance (HP:0010982)	3	0.6482	4.628201172	0.02919708	other
Denisovan	HPO	High pitched voice (HP:0001620)	4	1.1519	3.472523657	0.02979702	other
Denisovan	HPO	"Intellectual disability, moderate (HP:0002342)"	4	1.1446	3.494670627	0.029997	nervous
Denisovan	HPO	Absent epiphyses (HP:0010577)	2	0.265	7.547169811	0.03029697	skeletal
Denisovan	HPO	Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003)	2	0.265	7.547169811	0.03029697	skeletal
Denisovan	HPO	Methylmalonic aciduria (HP:0012120)	3	0.6757	4.439840166	0.03039696	urinary
Denisovan	HPO	Kyphoscoliosis (HP:0002751)	9	4.2559	2.114711342	0.03069693	skeletal
Denisovan	HPO	Midline defect of the nose (HP:0004122)	5	1.7802	2.808673183	0.03109689	other
Denisovan	HPO	Malignant gastrointestinal tract tumors (HP:0006749)	7	2.9669	2.359364994	0.03269673	digestive
Denisovan	HPO	Gastrointestinal carcinoma (HP:0002672)	7	2.9669	2.359364994	0.03269673	digestive
Denisovan	HPO	Abnormality of abdominal situs (HP:0011620)	2	0.2913	6.865774116	0.03309669	cardiovascular
Denisovan	HPO	Abdominal situs inversus (HP:0003363)	2	0.2913	6.865774116	0.03309669	other
Denisovan	HPO	Exercise-induced myalgia (HP:0003738)	2	0.2976	6.720430108	0.03349665	skeletal muscle
Denisovan	HPO	Synophrys (HP:0000664)	7	3.1001	2.257991678	0.03479652	integumentary
Denisovan	HPO	Peripheral primitive neuroectodermal neoplasm (HP:0030067)	4	1.2249	3.2655727	0.0349965	nervous
Denisovan	HPO	Neuroblastoma (HP:0003006)	4	1.2249	3.2655727	0.0349965	nervous
Denisovan	HPO	Primitive neuroectodermal tumor (HP:0030065)	4	1.2249	3.2655727	0.0349965	nervous
Denisovan	HPO	Neuroblastic tumors (HP:0004376)	4	1.2249	3.2655727	0.0349965	nervous
Denisovan	HPO	Severe Myopia (HP:0011003)	4	1.2073	3.313178166	0.03519648	nervous
Denisovan	HPO	Asymmetric septal hypertrophy (HP:0001670)	3	0.7151	4.195217452	0.03569643	cardiovascular
Denisovan	HPO	Disproportionate tall stature (HP:0001519)	4	1.26	3.174603175	0.03609639	skeletal
Denisovan	HPO	Retinopathy (HP:0000488)	7	3.0953	2.261493232	0.0369963	nervous
Denisovan	HPO	Facial cleft (HP:0002006)	5	1.83	2.732240437	0.03819618	other
Denisovan	HPO	Abnormality of the thoracic spine (HP:0100711)	4	1.2361	3.235984144	0.03819618	skeletal
Denisovan	HPO	Supranuclear gaze palsy (HP:0000605)	2	0.3099	6.45369474	0.0389961	nervous
Denisovan	HPO	Poikiloderma (HP:0001029)	2	0.3327	6.011421701	0.03909609	integumentary
Denisovan	HPO	Athetosis (HP:0002305)	3	0.7401	4.053506283	0.03969603	nervous
Denisovan	HPO	Short philtrum (HP:0000322)	10	5.2541	1.903275537	0.04019598	integumentary
Denisovan	HPO	Renal cell carcinoma (HP:0005584)	7	3.1361	2.232071681	0.04039596	urinary
Denisovan	HPO	Respiratory distress (HP:0002098)	4	1.3014	3.073613032	0.04419558	respiratory
Denisovan	HPO	Loss of speech (HP:0002371)	3	0.7928	3.784056509	0.04449555	other
Denisovan	HPO	Sudden death (HP:0001699)	5	1.8987	2.633380734	0.04459554	other
Denisovan	HPO	Intrauterine growth retardation (HP:0001511)	26	17.99	1.44524736	0.04489551	other
Denisovan	HPO	Neoplasm of the colon (HP:0100273)	4	1.2947	3.089518807	0.04529547	digestive
Denisovan	HPO	Pancytopenia (HP:0001876)	4	1.332	3.003003003	0.04549545	hematologic
Denisovan	HPO	Calf muscle hypertrophy (HP:0008981)	2	0.3483	5.742176285	0.04759524	skeletal muscle
Denisovan	HPO	Neoplasm of the small intestine (HP:0100833)	3	0.8037	3.732736096	0.04829517	digestive
Denisovan	HPO	Neoplasm of the pancreas (HP:0002894)	5	1.9632	2.546862266	0.04839516	digestive
Denisovan	HPO	Meckel diverticulum (HP:0002245)	3	0.8204	3.656752804	0.04869513	digestive
Denisovan	HPO	Telecanthus (HP:0000506)	11	6.1329	1.793604983	0.04919508	skeletal
Denisovan	HPO	Talipes equinovarus (HP:0001762)	15	9.2332	1.624572196	0.049995	skeletal
Denisovan	HPO	Prolonged bleeding time (HP:0003010)	4	1.3894	2.87894055	0.051994801	hematologic
Denisovan	HPO	Hypochromic microcytic anemia (HP:0004840)	1	0.0547	18.28153565	0.053594641	hematologic
Denisovan	HPO	Epistaxis (HP:0000421)	5	2.0201	2.475124994	0.054294571	other
Denisovan	HPO	Adenoma sebaceum (HP:0009720)	2	0.3737	5.35188654	0.054494551	integumentary
Denisovan	HPO	Angiofibromas (HP:0010615)	2	0.3737	5.35188654	0.054494551	cardiovascular
Denisovan	HPO	Neuronal loss in central nervous system (HP:0002529)	3	0.819	3.663003663	0.054694531	nervous
Denisovan	HPO	Entropion (HP:0000621)	2	0.3792	5.274261603	0.054894511	nervous
Denisovan	HPO	Prolonged neonatal jaundice (HP:0006579)	2	0.3648	5.48245614	0.054994501	digestive
Denisovan	HPO	Delayed myelination (HP:0012448)	4	1.4079	2.841110874	0.055294471	nervous
Denisovan	HPO	Granulocytopenia (HP:0001913)	3	0.846	3.546099291	0.057394261	immune
Denisovan	HPO	Joint laxity (HP:0001388)	7	3.4647	2.020376945	0.059794021	skeletal
Denisovan	HPO	Muscle hypertrophy of the lower extremities (HP:0008968)	2	0.3942	5.073566717	0.059994001	skeletal muscle
Denisovan	HPO	Leiomyosarcoma (HP:0100243)	6	2.713	2.211573903	0.060593941	skeletal muscle
Denisovan	HPO	Uterine leiomyosarcoma (HP:0002891)	6	2.713	2.211573903	0.060593941	reproductive
Denisovan	HPO	Slow progression (HP:0003677)	10	5.6882	1.758025386	0.060693931	other
Denisovan	HPO	Lethargy (HP:0001254)	8	4.1878	1.910310903	0.060693931	behavior
Denisovan	HPO	Shoulder girdle muscle weakness (HP:0003547)	2	0.3859	5.182689816	0.060893911	skeletal muscle
Denisovan	HPO	Increased mean platelet volume (HP:0011877)	3	0.8804	3.407542026	0.060893911	hematologic
Denisovan	HPO	Abnormal platelet volume (HP:0011876)	3	0.8804	3.407542026	0.060893911	hematologic
Denisovan	HPO	Omphalocele (HP:0001539)	7	3.4688	2.01798893	0.061593841	other
Denisovan	HPO	Neutropenia (HP:0001875)	6	2.8051	2.138961178	0.064893511	immune
Denisovan	HPO	Congenital hip dislocation (HP:0001374)	4	1.499	2.66844563	0.065793421	skeletal
Denisovan	HPO	Abnormality of renal resorption (HP:0011038)	2	0.416	4.807692308	0.065893411	urinary
Denisovan	HPO	Malignant neoplasm of the central nervous system (HP:0100836)	5	2.1522	2.323204163	0.066093391	nervous
Denisovan	HPO	High palate (HP:0000218)	16	10.401	1.538313624	0.067193281	skeletal
Denisovan	HPO	Wide nose (HP:0000445)	5	2.1512	2.32428412	0.067893211	skeletal
Denisovan	HPO	Abnormality of the calf musculature (HP:0001430)	3	0.9515	3.152916448	0.069493051	skeletal muscle
Denisovan	HPO	Selective tooth agenesis (HP:0001592)	2	0.4349	4.598758335	0.070992901	skeletal
Denisovan	HPO	Complete atrioventricular canal defect (HP:0001674)	5	2.2194	2.252861134	0.073192681	cardiovascular
Denisovan	HPO	Death in childhood (HP:0003819)	3	0.9671	3.102057698	0.074192581	other
Denisovan	HPO	Multicystic kidney dysplasia (HP:0000003)	11	6.6714	1.648829331	0.075992401	urinary
Denisovan	HPO	Bladder neoplasm (HP:0009725)	6	2.9058	2.064835846	0.076292371	urinary
Denisovan	HPO	Transitional cell carcinoma of the bladder (HP:0006740)	6	2.9058	2.064835846	0.076292371	urinary
Denisovan	HPO	Bladder carcinoma (HP:0002862)	6	2.9058	2.064835846	0.076292371	urinary
Denisovan	HPO	Heterogeneous (HP:0001425)	12	7.4425	1.612361438	0.076592341	other
Denisovan	HPO	Abnormality of the acetabulum (HP:0003170)	5	2.2479	2.224298234	0.076692331	skeletal
Denisovan	HPO	Biliary tract neoplasm (HP:0100574)	2	0.4556	4.389815628	0.078092191	digestive
Denisovan	HPO	Aplastic anemia (HP:0001915)	1	0.0817	12.23990208	0.078692131	hematologic
Denisovan	HPO	Camptodactyly of finger (HP:0100490)	13	8.2955	1.567114701	0.078792121	skeletal
Denisovan	HPO	Atrioventricular canal defect (HP:0006695)	5	2.2693	2.20332261	0.079292071	cardiovascular
Denisovan	HPO	Cerebellar hypoplasia (HP:0001321)	9	5.1856	1.73557544	0.080591941	nervous
Denisovan	HPO	Hyperhidrosis (HP:0000975)	7	3.7234	1.880002149	0.081491851	integumentary
Denisovan	HPO	Sclerocornea (HP:0000647)	3	0.9951	3.014772385	0.081691831	nervous
Denisovan	HPO	Status epilepticus (HP:0002133)	3	1.026	2.923976608	0.082191781	nervous
Denisovan	HPO	Abnormality of sodium homeostasis (HP:0010931)	3	1.021	2.938295788	0.082491751	other
Denisovan	HPO	Arachnodactyly (HP:0001166)	8	4.497	1.778963754	0.083991601	skeletal
Denisovan	HPO	Lipoatrophy (HP:0100578)	6	3.041	1.973035186	0.084091591	metabolic
Denisovan	HPO	Downturned corners of mouth (HP:0002714)	9	5.2776	1.7053206	0.085291471	skeletal muscle
Denisovan	HPO	Megalocornea (HP:0000485)	3	1.038	2.89017341	0.086691331	nervous
Denisovan	HPO	Glycosuria (HP:0003076)	2	0.4812	4.156275977	0.086791321	urinary
Denisovan	HPO	Abnormality of urine glucose concentration (HP:0011016)	2	0.4812	4.156275977	0.086791321	urinary
Denisovan	HPO	Amaurosis fugax (HP:0100576)	2	0.4811	4.157139888	0.086891311	nervous
Denisovan	HPO	Coarse hair (HP:0002208)	4	1.6888	2.368545713	0.089091091	integumentary
Denisovan	HPO	Hypomagnesemia (HP:0002917)	2	0.4845	4.127966976	0.089291071	other
Denisovan	HPO	Hypoplastic pelvis (HP:0008839)	2	0.5076	3.940110323	0.092890711	skeletal
Denisovan	HPO	Methylmalonic acidemia (HP:0002912)	2	0.5201	3.845414343	0.093890611	metabolic
Denisovan	HPO	Underdeveloped nasal alae (HP:0000430)	6	3.129	1.917545542	0.094090591	integumentary
Denisovan	HPO	Abnormality of the Achilles tendon (HP:0005109)	3	1.0797	2.778549597	0.095390461	skeletal muscle
Denisovan	HPO	Achilles tendon contracture (HP:0001771)	3	1.0797	2.778549597	0.095390461	skeletal muscle
Denisovan	HPO	Abnormality of fatty-acid metabolism (HP:0004359)	2	0.5157	3.878223774	0.096590341	metabolic
Denisovan	HPO	Mask-like facies (HP:0000298)	3	1.0951	2.739475847	0.099090091	other
Denisovan	HPO	Increased neuronal autofluorescent lipopigment (HP:0002074)	1	0.104	9.615384615	0.099590041	nervous
Denisovan	HPO	Seborrheic dermatitis (HP:0001051)	2	0.523	3.824091778	0.101189881	integumentary
Denisovan	HPO	Febrile seizures (HP:0002373)	4	1.7482	2.288067727	0.101389861	other
Denisovan	HPO	Cellular immunodeficiency (HP:0005374)	5	2.4686	2.02543952	0.103189681	immune
Denisovan	HPO	Hypotension (HP:0002615)	3	1.1195	2.679767753	0.103789621	cardiovascular
Denisovan	HPO	Duodenal stenosis (HP:0100867)	4	1.7847	2.241273043	0.104589541	digestive
Denisovan	HPO	Small intestinal stenosis (HP:0012848)	4	1.7847	2.241273043	0.104589541	digestive
Denisovan	HPO	Atrophy/Degeneration involving motor neurons (HP:0007373)	2	0.5559	3.597769383	0.105289471	nervous
Denisovan	HPO	Thoracic kyphosis (HP:0002942)	2	0.5402	3.702332469	0.105289471	skeletal
Denisovan	HPO	Bifid tongue (HP:0010297)	4	1.7945	2.229033157	0.106189381	other
Denisovan	HPO	Ventricular arrhythmia (HP:0004308)	7	3.9376	1.777732629	0.106189381	cardiovascular
Denisovan	HPO	Abnormality of the ileum (HP:0001549)	3	1.1439	2.622606871	0.106489351	digestive
Denisovan	HPO	Ectopic anus (HP:0004397)	5	2.526	1.979414093	0.106589341	digestive
Denisovan	HPO	Severe muscular hypotonia (HP:0006829)	4	1.7984	2.224199288	0.107089291	skeletal muscle
Denisovan	HPO	Autosomal recessive inheritance (HP:0000007)	117	103.6955	1.128303543	0.107389261	other
Denisovan	HPO	Myelodysplasia (HP:0002863)	4	1.8198	2.198043741	0.108289171	hematologic
Denisovan	HPO	Polyuria (HP:0000103)	2	0.5628	3.55366027	0.108689131	urinary
Denisovan	HPO	High anterior hairline (HP:0009890)	2	0.5519	3.623844899	0.108889111	integumentary
Denisovan	HPO	Nephrotic syndrome (HP:0000100)	7	4.0401	1.73263038	0.109089091	urinary
Denisovan	HPO	Nonprogressive disorder (HP:0003680)	2	0.5666	3.529827038	0.110288971	other
Denisovan	HPO	Bilateral microphthalmos (HP:0007633)	3	1.1542	2.599202911	0.110588941	nervous
Denisovan	HPO	Abnormality of magnesium homeostasis (HP:0004921)	2	0.5569	3.591309032	0.110988901	other
Denisovan	HPO	Focal segmental glomerulosclerosis (HP:0000097)	4	1.8224	2.194907814	0.111188881	urinary
Denisovan	HPO	Juvenile onset (HP:0003621)	7	3.994	1.752628943	0.111388861	other
Denisovan	HPO	Dysostosis multiplex (HP:0000943)	2	0.5644	3.543586109	0.111588841	skeletal
Denisovan	HPO	Hoarse voice (HP:0001609)	3	1.1723	2.55907191	0.113988601	other
Denisovan	HPO	Hepatomegaly (HP:0002240)	18	13.0974	1.374318567	0.114788521	digestive
Denisovan	HPO	Hypochromic anemia (HP:0001931)	1	0.1223	8.176614881	0.114988501	hematologic
Denisovan	HPO	Occipital encephalocele (HP:0002085)	2	0.5789	3.454828122	0.115488451	nervous
Denisovan	HPO	Exocrine pancreatic insufficiency (HP:0001738)	2	0.5824	3.434065934	0.117388261	digestive
Denisovan	HPO	Abnormality of the astrocytes (HP:0100707)	2	0.5906	3.386386725	0.117988201	nervous
Denisovan	HPO	Astrocytoma (HP:0009592)	2	0.5906	3.386386725	0.117988201	nervous
Denisovan	HPO	Hypotelorism (HP:0000601)	5	2.6111	1.914901766	0.119988001	other
Denisovan	HPO	Absent eyebrow (HP:0002223)	3	1.1988	2.502502503	0.120187981	integumentary
Denisovan	HPO	Ovoid vertebral bodies (HP:0003300)	3	1.1971	2.506056303	0.120787921	skeletal
Denisovan	HPO	Hypoplasia of the maxilla (HP:0000327)	5	2.6321	1.899623874	0.121287871	skeletal
Denisovan	HPO	Abnormal urine output (HP:0012590)	2	0.6025	3.319502075	0.121687831	urinary
Denisovan	HPO	Atelectasis (HP:0100750)	2	0.6117	3.26957659	0.123287671	respiratory
Denisovan	HPO	Astigmatism (HP:0000483)	8	4.9164	1.627206899	0.124587541	nervous
Denisovan	HPO	Choanal stenosis (HP:0000452)	4	1.8983	2.107148501	0.124587541	respiratory
Denisovan	HPO	Sacral dimple (HP:0000960)	6	3.4271	1.750751364	0.125487451	integumentary
Denisovan	HPO	Poikilocytosis (HP:0004447)	3	1.2435	2.412545235	0.125787421	hematologic
Denisovan	HPO	Truncus arteriosus (HP:0001660)	2	0.6134	3.260515161	0.126387361	cardiovascular
Denisovan	HPO	Absent eyelashes (HP:0000561)	3	1.2284	2.442201237	0.127687231	integumentary
Denisovan	HPO	Prominent supraorbital ridges (HP:0000336)	2	0.6098	3.279763857	0.127787221	skeletal
Denisovan	HPO	Menorrhagia (HP:0000132)	2	0.6272	3.18877551	0.127987201	reproductive
Denisovan	HPO	Prominent nose (HP:0000448)	4	1.9396	2.062280883	0.128787121	skeletal
Denisovan	HPO	Breast hypoplasia (HP:0003187)	2	0.6224	3.213367609	0.129187081	reproductive
Denisovan	HPO	Glomerulosclerosis (HP:0000096)	4	1.9342	2.068038466	0.131086891	urinary
Denisovan	HPO	Hepatosplenomegaly (HP:0001433)	2	0.6333	3.158060951	0.131386861	digestive
Denisovan	HPO	Abnormality of the lacrimal duct (HP:0011481)	4	1.9213	2.081923697	0.131586841	other
Denisovan	HPO	Myotonia (HP:0002486)	2	0.6286	3.18167356	0.131786821	skeletal muscle
Denisovan	HPO	Increased cerebral lipofuscin (HP:0011813)	1	0.14	7.142857143	0.131786821	other
Denisovan	HPO	Renal Fanconi syndrome (HP:0001994)	1	0.1404	7.122507123	0.132586741	urinary
Denisovan	HPO	Morphological abnormality of the pyramidal tract (HP:0002062)	3	1.245	2.409638554	0.133886611	nervous
Denisovan	HPO	Atresia of the external auditory canal (HP:0000413)	5	2.669	1.873360809	0.134286571	nervous
Denisovan	HPO	Centrally nucleated skeletal muscle fibers (HP:0003687)	2	0.6457	3.09741366	0.134386561	skeletal muscle
Denisovan	HPO	Hypohidrosis (HP:0000966)	4	1.9421	2.059626178	0.136786321	endocrine
Denisovan	HPO	Proteinuria (HP:0000093)	8	5.0177	1.59435598	0.137086291	other
Denisovan	HPO	Ulnar deviation of the hand or of fingers of the hand (HP:0001193)	5	2.6859	1.861573402	0.137786221	skeletal
Denisovan	HPO	Cardiomegaly (HP:0001640)	3	1.2883	2.328650159	0.138386161	cardiovascular
Denisovan	HPO	Exercise-induced muscle cramps (HP:0003710)	1	0.1478	6.765899865	0.138686131	skeletal muscle
Denisovan	HPO	Neck muscle weakness (HP:0000467)	2	0.6558	3.049710278	0.139086091	skeletal muscle
Denisovan	HPO	Split hand (HP:0001171)	5	2.72	1.838235294	0.140685931	skeletal
Denisovan	HPO	Neoplasm of the oral cavity (HP:0100649)	2	0.6594	3.033060358	0.140985901	other
Denisovan	HPO	Morphological abnormality of the middle ear (HP:0008609)	3	1.2947	2.317139106	0.141585841	skeletal
Denisovan	HPO	Lymphangioma (HP:0100764)	2	0.6727	2.973093504	0.143185681	lymphatic
Denisovan	HPO	External ophthalmoplegia (HP:0000544)	2	0.6658	3.003905077	0.143285671	nervous
Denisovan	HPO	Absent hair (HP:0002298)	3	1.3053	2.298322225	0.144185581	integumentary
Denisovan	HPO	Bronchomalacia (HP:0002780)	2	0.6702	2.984183826	0.144285571	respiratory
Denisovan	HPO	Abnormal lung lobation (HP:0002101)	4	2.0078	1.992230302	0.144885511	respiratory
Denisovan	HPO	Purpura (HP:0000979)	1	0.1564	6.393861893	0.145485451	integumentary
Denisovan	HPO	Spastic paraparesis (HP:0002313)	1	0.1581	6.325110689	0.145685431	skeletal muscle
Denisovan	HPO	Recurrent pneumonia (HP:0006532)	3	1.3006	2.30662771	0.145885411	immune
Denisovan	HPO	Abnormality of the nasolacrimal system (HP:0000614)	4	2.0058	1.994216771	0.146385361	other
Denisovan	HPO	Hyponatremia (HP:0002902)	2	0.6779	2.950287653	0.146585341	other
Denisovan	HPO	Prostate neoplasm (HP:0100787)	2	0.6715	2.978406552	0.147685231	reproductive
Denisovan	HPO	Vertebral clefting (HP:0008428)	2	0.6784	2.948113208	0.147885211	skeletal
Denisovan	HPO	Aplasia/Hypoplasia of the earlobes (HP:0009906)	4	2.0568	1.944768573	0.149185081	integumentary
Denisovan	HPO	Glioma (HP:0009733)	2	0.6866	2.912904165	0.150384962	nervous
Denisovan	HPO	Malignant hyperthermia (HP:0002047)	2	0.6873	2.909937436	0.151784822	immune
Denisovan	HPO	Neonatal onset (HP:0003623)	2	0.6962	2.872737719	0.152284772	other
Denisovan	HPO	Neonatal death (HP:0003811)	3	1.3518	2.219263205	0.152984702	other
Denisovan	HPO	Severe global developmental delay (HP:0011344)	3	1.3389	2.240645306	0.153084692	nervous
Denisovan	HPO	Abnormality of the motor neurons (HP:0002450)	2	0.6954	2.876042565	0.153684632	nervous
Denisovan	HPO	Abnormal neuron morphology (HP:0012757)	2	0.6954	2.876042565	0.153684632	nervous
Denisovan	HPO	Abdominal pain (HP:0002027)	7	4.4135	1.586042823	0.156684332	other
Denisovan	HPO	Septo-optic dysplasia (HP:0100842)	1	0.1723	5.803830528	0.156884312	nervous
Denisovan	HPO	Ectropion (HP:0000656)	2	0.7037	2.842120222	0.158684132	nervous
Denisovan	HPO	Abnormality of the pulmonary veins (HP:0011718)	1	0.1702	5.875440658	0.158784122	cardiovascular
Denisovan	HPO	Cutaneous photosensitivity (HP:0000992)	3	1.3814	2.17170986	0.160283972	integumentary
Denisovan	HPO	Single umbilical artery (HP:0001195)	1	0.1727	5.790387956	0.160383962	reproductive
Denisovan	HPO	Abnormality of the fetal cardiovascular system (HP:0010948)	1	0.1727	5.790387956	0.160383962	cardiovascular
Denisovan	HPO	Abnormal umbilical cord blood vessels (HP:0011403)	1	0.1727	5.790387956	0.160383962	cardiovascular
Denisovan	HPO	Everted lower lip vermilion (HP:0000232)	7	4.4635	1.568276017	0.160883912	integumentary
Denisovan	HPO	Colitis (HP:0002583)	2	0.7143	2.799944001	0.161283872	digestive
Denisovan	HPO	Abnormality of the prostate (HP:0008775)	2	0.7181	2.78512742	0.164083592	reproductive
Denisovan	HPO	Teleangiectasia of the skin (HP:0100585)	4	2.1332	1.875117195	0.165783422	cardiovascular
Denisovan	HPO	Pyloric stenosis (HP:0002021)	6	3.6858	1.627869119	0.166483352	digestive
Denisovan	HPO	Milia (HP:0001056)	2	0.729	2.743484225	0.166783322	integumentary
Denisovan	HPO	Annular pancreas (HP:0001734)	2	0.7353	2.71997824	0.167483252	digestive
Denisovan	HPO	Knee flexion contracture (HP:0006380)	3	1.4054	2.134623595	0.167883212	skeletal
Denisovan	HPO	Blepharophimosis (HP:0000581)	12	8.7388	1.37318625	0.168283172	integumentary
Denisovan	HPO	Tubular atrophy (HP:0000092)	2	0.7403	2.701607456	0.168583142	urinary
Denisovan	HPO	Hypoplasia of the corpus callosum (HP:0002079)	10	7.0023	1.428102195	0.168583142	nervous
Denisovan	HPO	Chest pain (HP:0100749)	2	0.743	2.69179004	0.170082992	other
Denisovan	HPO	Mucopolysacchariduria (HP:0008155)	2	0.7511	2.662761283	0.171582842	metabolic
Denisovan	HPO	Urinary glycosaminoglycan excretion (HP:0003541)	2	0.7511	2.662761283	0.171582842	metabolic
Denisovan	HPO	Overlapping toe (HP:0001845)	2	0.749	2.670226969	0.171782822	skeletal
Denisovan	HPO	Abnormality of the lower motor neuron (HP:0002366)	1	0.188	5.319148936	0.172082792	nervous
Denisovan	HPO	Keratitis (HP:0000491)	2	0.7537	2.653575693	0.172282772	nervous
Denisovan	HPO	Abnormality of mucopolysaccharide metabolism (HP:0011020)	2	0.7543	2.651464934	0.172682732	metabolic
Denisovan	HPO	Abnormality of glycosaminoglycan metabolism (HP:0004371)	2	0.7543	2.651464934	0.172682732	metabolic
Denisovan	HPO	Abnormality of polysaccharide metabolism (HP:0011012)	2	0.7543	2.651464934	0.172682732	metabolic
Denisovan	HPO	Abnormality of renal excretion (HP:0011036)	2	0.7599	2.631925253	0.175182482	urinary
Denisovan	HPO	Cafe-au-lait spot (HP:0000957)	5	2.9449	1.697850521	0.175582442	integumentary
Denisovan	HPO	Abnormality of serum amino acid levels (HP:0003112)	3	1.4566	2.059590828	0.175582442	other
Denisovan	HPO	Dilated cardiomyopathy (HP:0001644)	5	2.9584	1.690102758	0.176282372	cardiovascular
Denisovan	HPO	Cleft eyelid (HP:0000625)	4	2.1785	1.836125775	0.177882212	integumentary
Denisovan	HPO	Apathy (HP:0000741)	2	0.7497	2.66773376	0.178082192	behavior
Denisovan	HPO	Dynein arm defect of respiratory motile cilia (HP:0012255)	1	0.1956	5.112474438	0.178682132	respiratory
Denisovan	HPO	Absent/shortened dynein arms (HP:0200106)	1	0.1956	5.112474438	0.178682132	other
Denisovan	HPO	Diminished motivation (HP:0000745)	2	0.7532	2.655337228	0.179382062	behavior
Denisovan	HPO	Oligomenorrhea (HP:0000876)	2	0.7611	2.627775588	0.180281972	reproductive
Denisovan	HPO	Pelvic girdle muscle weakness (HP:0003749)	2	0.7718	2.591344908	0.181081892	skeletal muscle
Denisovan	HPO	Atrioventricular block (HP:0001678)	2	0.7768	2.574665294	0.182781722	cardiovascular
Denisovan	HPO	Ulnar deviation of finger (HP:0009465)	4	2.2025	1.816118048	0.184281572	skeletal
Denisovan	HPO	Abnormality of femoral epiphyses (HP:0006499)	3	1.4765	2.031832035	0.185181482	skeletal
Denisovan	HPO	Abnormality involving the epiphyses of the lower limbs (HP:0006500)	3	1.4765	2.031832035	0.185181482	skeletal
Denisovan	HPO	Abnormality of vision evoked potentials (HP:0000649)	3	1.4749	2.034036206	0.185881412	nervous
Denisovan	HPO	Tongue fasciculations (HP:0001308)	1	0.2085	4.79616307	0.188781122	nervous
Denisovan	HPO	Abnormality of the hip-girdle musculature (HP:0001445)	2	0.7945	2.517306482	0.189081092	skeletal muscle
Denisovan	HPO	Abnormality of the musculature of the pelvis (HP:0001469)	2	0.7945	2.517306482	0.189081092	skeletal muscle
Denisovan	HPO	Abnormality of the thymus (HP:0000777)	5	3.0196	1.655848457	0.189381062	lymphatic
Denisovan	HPO	Emphysema (HP:0002097)	3	1.4957	2.005749816	0.191480852	respiratory
Denisovan	HPO	Long toe (HP:0010511)	2	0.8008	2.497502498	0.191480852	skeletal
Denisovan	HPO	Unsteady gait (HP:0002317)	3	1.4808	2.025931929	0.191580842	other
Denisovan	HPO	Eosinophilia (HP:0001880)	2	0.8093	2.471271469	0.191980802	hematologic
Denisovan	HPO	Atrial fibrillation (HP:0005110)	6	3.8596	1.55456524	0.194480552	cardiovascular
Denisovan	HPO	Postnatal microcephaly (HP:0005484)	3	1.5292	1.961810097	0.194580542	skeletal
Denisovan	HPO	Supraventricular tachycardia (HP:0004755)	6	3.8657	1.552112166	0.195280472	cardiovascular
Denisovan	HPO	Primary atrial arrhythmia (HP:0001692)	6	3.8657	1.552112166	0.195280472	cardiovascular
Denisovan	HPO	Low anterior hairline (HP:0000294)	5	3.0771	1.624906568	0.197180282	integumentary
Denisovan	HPO	Hip contracture (HP:0003273)	2	0.8211	2.435756911	0.197180282	skeletal muscle
Denisovan	HPO	Aplasia/Hypoplasia of the breasts (HP:0010311)	3	1.5349	1.954524725	0.200379962	reproductive
Denisovan	HPO	Micropenis (HP:0000054)	10	7.3497	1.360599752	0.200479952	reproductive
Denisovan	HPO	Hyperglycinemia (HP:0002154)	2	0.8444	2.368545713	0.203179682	metabolic
Denisovan	HPO	Polyneuropathy (HP:0001271)	3	1.566	1.915708812	0.204279572	nervous
Denisovan	HPO	Pulmonary hypoplasia (HP:0002089)	6	3.9274	1.527728268	0.204679532	respiratory
Denisovan	HPO	Stage 5 chronic kidney disease (HP:0003774)	4	2.3317	1.715486555	0.204679532	urinary
Denisovan	HPO	Abnormality of reticulocytes (HP:0004312)	3	1.5482	1.937734143	0.205079492	immune
Denisovan	HPO	Hypertriglyceridemia (HP:0002155)	2	0.8447	2.36770451	0.207179282	metabolic
Denisovan	HPO	J-shaped sella turcica (HP:0002680)	1	0.2357	4.242681375	0.207279272	skeletal
Denisovan	HPO	Optic atrophy (HP:0000648)	28	23.7279	1.180045432	0.210378962	nervous
Denisovan	HPO	Alkalosis (HP:0001948)	2	0.851	2.350176263	0.210378962	other
Denisovan	HPO	Birth length less than 3rd percentile (HP:0003561)	1	0.2363	4.231908591	0.210578942	skeletal
Denisovan	HPO	Myelomeningocele (HP:0002475)	3	1.5765	1.902949572	0.211378862	nervous
Denisovan	HPO	Acne (HP:0001061)	3	1.5867	1.890716582	0.212978702	integumentary
Denisovan	HPO	Abnormality of chloride homeostasis (HP:0011422)	2	0.8624	2.319109462	0.213678632	other
Denisovan	HPO	Neonatal respiratory distress (HP:0002643)	1	0.2439	4.100041	0.215678432	respiratory
Denisovan	HPO	Asthma (HP:0002099)	5	3.1773	1.573663173	0.215678432	respiratory
Denisovan	HPO	Verrucae (HP:0200043)	2	0.8711	2.295947652	0.217478252	integumentary
Denisovan	HPO	Papilloma (HP:0012740)	2	0.8711	2.295947652	0.217478252	other
Denisovan	HPO	Ptosis (HP:0000508)	20	16.4517	1.215679839	0.218878112	skeletal muscle
Denisovan	HPO	Hypophosphatemia (HP:0002148)	2	0.8857	2.258100937	0.219278072	other
Denisovan	HPO	Hypermelanotic macule (HP:0001034)	4	2.3952	1.67000668	0.220877912	integumentary
Denisovan	HPO	Wrist flexion contracture (HP:0001239)	1	0.2501	3.99840064	0.221177882	skeletal
Denisovan	HPO	Pulmonary infiltrates (HP:0002113)	2	0.8758	2.283626399	0.221477852	respiratory
Denisovan	HPO	Poor speech (HP:0002465)	2	0.8903	2.246433786	0.221577842	other
Denisovan	HPO	Upper motor neuron abnormality (HP:0002127)	1	0.2486	4.022526146	0.222577742	nervous
Denisovan	HPO	Hypophosphatemic rickets (HP:0004912)	1	0.254	3.937007874	0.224377562	skeletal
Denisovan	HPO	Benign neoplasm of the central nervous system (HP:0100835)	3	1.6442	1.824595548	0.224977502	nervous
Denisovan	HPO	Abnormality of the clitoris (HP:0000056)	4	2.4324	1.644466371	0.225777422	reproductive
Denisovan	HPO	Hypoproteinemia (HP:0003075)	1	0.2561	3.904724717	0.225777422	other
Denisovan	HPO	Distal lower limb amyotrophy (HP:0008944)	1	0.2535	3.944773176	0.226477352	skeletal muscle
Denisovan	HPO	Reticulocytopenia (HP:0001896)	1	0.2653	3.769317753	0.231176882	hematologic
Denisovan	HPO	Foot dorsiflexor weakness (HP:0009027)	3	1.6645	1.802343046	0.231376862	skeletal muscle
Denisovan	HPO	Spastic diplegia (HP:0001264)	1	0.2619	3.818251241	0.231376862	nervous
Denisovan	HPO	Abnormal spermatogenesis (HP:0008669)	2	0.9142	2.187705097	0.231476852	reproductive
Denisovan	HPO	Supraventricular arrhythmia (HP:0005115)	6	4.1058	1.461347362	0.233676632	cardiovascular
Denisovan	HPO	Short distal phalanx of finger (HP:0009882)	6	4.1235	1.455074573	0.234676532	skeletal
Denisovan	HPO	Postaxial foot polydactyly (HP:0001830)	4	2.4806	1.612513102	0.235876412	skeletal
Denisovan	HPO	Abnormality of the foot musculature (HP:0001436)	3	1.6875	1.777777778	0.236876312	skeletal muscle
Denisovan	HPO	Generalized myoclonic seizures (HP:0002123)	2	0.9287	2.15354797	0.237376262	nervous
Denisovan	HPO	Scrotal hypoplasia (HP:0000046)	4	2.4914	1.605522999	0.237476252	reproductive
Denisovan	HPO	Hyperammonemia (HP:0001987)	3	1.6799	1.785820585	0.238176182	metabolic
Denisovan	HPO	Anophthalmia (HP:0000528)	4	2.4769	1.614921878	0.238376162	nervous
Denisovan	HPO	Abnormality of male internal genitalia (HP:0000022)	2	0.9168	2.181500873	0.238976102	reproductive
Denisovan	HPO	Abnormality of the duodenum (HP:0002246)	4	2.4792	1.613423685	0.239176082	digestive
Denisovan	HPO	Dehydration (HP:0001944)	5	3.3132	1.509115055	0.239476052	other
Denisovan	HPO	Right ventricular cardiomyopathy (HP:0011663)	2	0.9386	2.130833156	0.239476052	cardiovascular
Denisovan	HPO	Orthostatic hypotension (HP:0001278)	1	0.275	3.636363636	0.239576042	cardiovascular
Denisovan	HPO	Trismus (HP:0000211)	1	0.2732	3.660322108	0.239676032	skeletal muscle
Denisovan	HPO	Vomiting (HP:0002013)	6	4.1589	1.442689173	0.240275972	digestive
Denisovan	HPO	Cheekbone underdevelopment (HP:0010669)	6	4.1524	1.4449475	0.241075892	skeletal
Denisovan	HPO	Bulbous nose (HP:0000414)	5	3.3424	1.495931067	0.241275872	other
Denisovan	HPO	Dental crowding (HP:0000678)	6	4.1671	1.439850256	0.242175782	skeletal
Denisovan	HPO	Microdontia (HP:0000691)	6	4.2083	1.425753867	0.242975702	skeletal
Denisovan	HPO	Dry hair (HP:0011359)	1	0.2769	3.611412062	0.243175682	integumentary
Denisovan	HPO	Distal upper limb amyotrophy (HP:0007149)	1	0.2776	3.602305476	0.243175682	nervous
Denisovan	HPO	Upper limb amyotrophy (HP:0009129)	1	0.2776	3.602305476	0.243175682	nervous
Denisovan	HPO	Short femoral neck (HP:0100864)	2	0.9348	2.139495079	0.243275672	skeletal
Denisovan	HPO	Fibroma (HP:0010614)	3	1.6871	1.778199277	0.243475652	reproductive
Denisovan	HPO	Dolichocephaly (HP:0000268)	9	6.8363	1.316501616	0.244775522	skeletal
Denisovan	HPO	Prominent nasal bridge (HP:0000426)	8	5.9162	1.35221933	0.245475452	integumentary
Denisovan	HPO	Cholelithiasis (HP:0001081)	2	0.9506	2.103934357	0.245875412	digestive
Denisovan	HPO	Congenital stationary night blindness (HP:0007642)	1	0.2823	3.542330854	0.246475352	nervous
Denisovan	HPO	Congestive heart failure (HP:0001635)	7	5.0575	1.384083045	0.246575342	cardiovascular
Denisovan	HPO	Pigmentary retinal degeneration (HP:0001146)	1	0.2883	3.468609088	0.246875312	integumentary
Denisovan	HPO	IgM deficiency (HP:0002850)	2	0.9488	2.107925801	0.246875312	immune
Denisovan	HPO	Hypokalemia (HP:0002900)	2	0.9563	2.091393914	0.248175182	other
Denisovan	HPO	Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108)	2	0.9557	2.092706916	0.249275072	skeletal
Denisovan	HPO	Decreased electroretinogram (ERG) amplitude (HP:0000654)	2	0.9669	2.068466232	0.251174883	nervous
Denisovan	HPO	Degeneration of the lateral corticospinal tracts (HP:0002314)	1	0.2891	3.459010723	0.251174883	nervous
Denisovan	HPO	Atrophy/Degeneration involving the corticospinal tracts (HP:0007372)	1	0.2891	3.459010723	0.251174883	nervous
Denisovan	HPO	Maternal diabetes (HP:0009800)	1	0.2895	3.454231434	0.252174783	reproductive
Denisovan	HPO	Spastic tetraplegia (HP:0002510)	4	2.5447	1.571894526	0.253274673	nervous
Denisovan	HPO	Fibrous tissue neoplasm (HP:0012316)	3	1.7269	1.737216978	0.253374663	other
Denisovan	HPO	Palpebral edema (HP:0100540)	4	2.5443	1.57214165	0.254174583	nervous
Denisovan	HPO	Diastasis recti (HP:0001540)	1	0.2912	3.434065934	0.254474553	skeletal muscle
Denisovan	HPO	Premature ovarian failure (HP:0008209)	1	0.2966	3.371544167	0.256374363	reproductive
Denisovan	HPO	Increased serum ferritin (HP:0003281)	1	0.2978	3.357958361	0.257674233	other
Denisovan	HPO	Muscular dystrophy (HP:0003560)	5	3.4113	1.465716882	0.258074193	skeletal muscle
Denisovan	HPO	Myopathic facies (HP:0002058)	1	0.2959	3.379520108	0.258374163	skeletal muscle
Denisovan	HPO	Short metatarsal (HP:0010743)	5	3.4161	1.463657387	0.258574143	skeletal
Denisovan	HPO	Erectile abnormalities (HP:0100639)	2	0.98	2.040816327	0.259074093	reproductive
Denisovan	HPO	Abnormality of the vitamin B12 metabolism (HP:0004341)	2	0.9874	2.025521572	0.259074093	metabolic
Denisovan	HPO	Cerebral hypomyelination (HP:0006808)	1	0.2983	3.352329869	0.260173983	nervous
Denisovan	HPO	Hypoglycemic coma (HP:0001325)	1	0.3031	3.299241175	0.260273973	metabolic
Denisovan	HPO	Urinary incontinence (HP:0000020)	3	1.7527	1.711644891	0.260473953	urinary
Denisovan	HPO	Abnormality of the vocal cords (HP:0008777)	1	0.303	3.300330033	0.261173883	other
Denisovan	HPO	Hematuria (HP:0000790)	4	2.5993	1.538875851	0.261573843	urinary
Denisovan	HPO	Cerebellar dysplasia (HP:0007033)	1	0.3014	3.317850033	0.261973803	nervous
Denisovan	HPO	Abnormality of vitamin B metabolism (HP:0004340)	2	0.9948	2.010454363	0.262073793	metabolic
Denisovan	HPO	Intestinal polyposis (HP:0200008)	2	1.0042	1.991635132	0.262573743	digestive
Denisovan	HPO	Clitoromegaly (HP:0000057)	3	1.7809	1.684541524	0.262773723	reproductive
Denisovan	HPO	Degeneration of anterior horn cells (HP:0002398)	1	0.3047	3.281916639	0.263273673	nervous
Denisovan	HPO	Abnormality of the anterior horn cell (HP:0006802)	1	0.3047	3.281916639	0.263273673	nervous
Denisovan	HPO	Hyperalaninemia (HP:0003348)	1	0.3033	3.297065612	0.263473653	metabolic
Denisovan	HPO	Abnormality of pyruvate family amino acid metabolism (HP:0010915)	1	0.3033	3.297065612	0.263473653	metabolic
Denisovan	HPO	Abnormality of alanine metabolism (HP:0010916)	1	0.3033	3.297065612	0.263473653	metabolic
Denisovan	HPO	Petechiae (HP:0000967)	1	0.3082	3.244646334	0.263673633	integumentary
Denisovan	HPO	Nemaline bodies (HP:0003798)	1	0.3049	3.279763857	0.264673533	skeletal muscle
Denisovan	HPO	Increased intracranial pressure (HP:0002516)	3	1.7689	1.695969246	0.265573443	nervous
Denisovan	HPO	Abnormality of intracranial pressure (HP:0012640)	3	1.7689	1.695969246	0.265573443	nervous
Denisovan	HPO	Inflammation of the large intestine (HP:0002037)	2	1.0125	1.975308642	0.266873313	digestive
Denisovan	HPO	Hypoplastic scapulae (HP:0000882)	2	0.9978	2.004409701	0.267173283	skeletal
Denisovan	HPO	Aplasia/Hypoplasia of the scapulae (HP:0006713)	2	0.9978	2.004409701	0.267173283	skeletal
Denisovan	HPO	Abnormal gallbladder morphology (HP:0012437)	2	1.01	1.98019802	0.268173183	digestive
Denisovan	HPO	Vaginal atresia (HP:0000148)	4	2.6155	1.529344294	0.268673133	reproductive
Denisovan	HPO	Abnormality of the alveolar ridges (HP:0006477)	2	1.0149	1.970637501	0.269473053	skeletal
Denisovan	HPO	IgA deficiency (HP:0002720)	2	1.006	1.988071571	0.270572943	immune
Denisovan	HPO	Joint hemorrhage (HP:0005261)	1	0.3138	3.186743149	0.270672933	skeletal
Denisovan	HPO	Polyhydramnios (HP:0001561)	7	5.1932	1.347916506	0.271172883	reproductive
Denisovan	HPO	Prominent occiput (HP:0000269)	3	1.7932	1.672986839	0.271272873	skeletal
Denisovan	HPO	Renal salt wasting (HP:0000127)	1	0.3183	3.141690229	0.271572843	urinary
Denisovan	HPO	Gastrointestinal inflammation (HP:0004386)	2	1.0249	1.951409894	0.271972803	digestive
Denisovan	HPO	Ileus (HP:0002595)	1	0.3165	3.159557662	0.272772723	digestive
Denisovan	HPO	Aplasia/Hypoplasia of the sternum (HP:0006714)	3	1.8494	1.622147724	0.275972403	skeletal
Denisovan	HPO	Colon cancer (HP:0003003)	1	0.3207	3.118178983	0.276072393	digestive
Denisovan	HPO	Volvulus (HP:0002580)	2	1.0416	1.920122888	0.276172383	digestive
Denisovan	HPO	Genital tract atresia (HP:0001827)	4	2.6551	1.506534594	0.277172283	reproductive
Denisovan	HPO	Axonal loss (HP:0003447)	1	0.3266	3.061849357	0.279072093	nervous
Denisovan	HPO	Gonadotropin excess (HP:0000837)	1	0.3299	3.031221582	0.279672033	endocrine
Denisovan	HPO	Enlarged penis (HP:0000040)	1	0.3283	3.045994517	0.281471853	reproductive
Denisovan	HPO	Lactic acidosis (HP:0003128)	6	4.4237	1.356330673	0.281571843	metabolic
Denisovan	HPO	Cutaneous finger syndactyly (HP:0010554)	4	2.6886	1.487763148	0.282371763	integumentary
Denisovan	HPO	Microcytic anemia (HP:0001935)	1	0.3306	3.024803388	0.283571643	hematologic
Denisovan	HPO	Abnormal respiratory motile cilium morphology (HP:0005938)	1	0.3324	3.008423586	0.284371563	respiratory
Denisovan	HPO	Abnormal respiratory epithelium morphology (HP:0012253)	1	0.3324	3.008423586	0.284371563	respiratory
Denisovan	HPO	Breast aplasia (HP:0100783)	2	1.0667	1.874941408	0.285871413	reproductive
Denisovan	HPO	Tracheal stenosis (HP:0002777)	3	1.8665	1.607286365	0.285971403	respiratory
Denisovan	HPO	Short ribs (HP:0000773)	4	2.7145	1.473567876	0.287171283	skeletal
Denisovan	HPO	Abnormality of eosinophils (HP:0001879)	2	1.0707	1.867936864	0.288771123	hematologic
Denisovan	HPO	Aplasia/Hypoplasia of the nipples (HP:0006709)	3	1.8901	1.587217608	0.288971103	other
Denisovan	HPO	Cutaneous syndactyly (HP:0012725)	4	2.7254	1.46767447	0.289071093	integumentary
Denisovan	HPO	Abnormality of the corticospinal tract (HP:0002492)	1	0.3432	2.913752914	0.290670933	nervous
Denisovan	HPO	Muscle fiber cytoplasmatic inclusion bodies (HP:0100303)	1	0.3407	2.935133549	0.290670933	skeletal muscle
Denisovan	HPO	Neoplasm of striated muscle (HP:0009728)	2	1.0813	1.849625451	0.290870913	skeletal muscle
Denisovan	HPO	Abnormal auditory evoked potentials (HP:0006958)	2	1.0651	1.877757957	0.291070893	nervous
Denisovan	HPO	Deeply set eye (HP:0000490)	9	7.1511	1.258547636	0.291370863	nervous
Denisovan	HPO	Amyotrophic lateral sclerosis (HP:0007354)	1	0.3463	2.887669651	0.292670733	nervous
Denisovan	HPO	Hypokalemic alkalosis (HP:0001949)	1	0.35	2.857142857	0.293070693	other
Denisovan	HPO	Long philtrum (HP:0000343)	16	13.6461	1.172496171	0.293770623	integumentary
Denisovan	HPO	Type I diabetes mellitus (HP:0100651)	1	0.3495	2.861230329	0.294170583	metabolic
Denisovan	HPO	Nephrogenic diabetes insipidus (HP:0009806)	2	1.09	1.834862385	0.294170583	urinary
Denisovan	HPO	Neonatal short-limb short stature (HP:0008921)	1	0.3473	2.879355024	0.294370563	skeletal
Denisovan	HPO	Smooth philtrum (HP:0000319)	5	3.6079	1.385847723	0.294870513	integumentary
Denisovan	HPO	Natal tooth (HP:0000695)	2	1.0864	1.840942563	0.294970503	skeletal
Denisovan	HPO	Genu valgum (HP:0002857)	7	5.4079	1.294402633	0.298270173	skeletal
Denisovan	HPO	Meningocele (HP:0002435)	4	2.7579	1.450378911	0.298970103	nervous
Denisovan	HPO	Abnormality of vitamin metabolism (HP:0100508)	2	1.0941	1.827986473	0.299470053	metabolic
Denisovan	HPO	Aplasia cutis congenita (HP:0001057)	1	0.3538	2.826455625	0.299470053	integumentary
Denisovan	HPO	Muscle fiber inclusion bodies (HP:0100299)	1	0.355	2.816901408	0.301769823	skeletal muscle
Denisovan	HPO	Aplasia/Hypoplasia of metatarsal bones (HP:0001964)	5	3.6293	1.377676136	0.301869813	skeletal
Denisovan	HPO	Recurrent corneal erosions (HP:0000495)	1	0.3632	2.753303965	0.304469553	nervous
Denisovan	HPO	Muscle fibrillation (HP:0010546)	1	0.3614	2.767017156	0.304569543	skeletal muscle
Denisovan	HPO	Pustule (HP:0200039)	1	0.3627	2.757099531	0.304769523	integumentary
Denisovan	HPO	Oligohydramnios (HP:0001562)	5	3.6705	1.362212233	0.306069393	reproductive
Denisovan	HPO	Interstitial pulmonary disease (HP:0006530)	1	0.3658	2.733734281	0.306069393	respiratory
Denisovan	HPO	Myoglobinuria (HP:0002913)	1	0.3605	2.773925104	0.306369363	other
Denisovan	HPO	Patent ductus arteriosus (HP:0001643)	9	7.2777	1.236654438	0.306769323	cardiovascular
Denisovan	HPO	Cubitus valgus (HP:0002967)	3	1.9268	1.556985676	0.308069193	skeletal
Denisovan	HPO	Absent septum pellucidum (HP:0001331)	1	0.3683	2.715177844	0.308469153	nervous
Denisovan	HPO	Neoplasm of the adrenal cortex (HP:0100641)	1	0.3712	2.693965517	0.308469153	endocrine
Denisovan	HPO	Nephropathy (HP:0000112)	4	2.8058	1.425618362	0.308969103	urinary
Denisovan	HPO	Abnormality of the right ventricle (HP:0001707)	2	1.1322	1.766472355	0.310068993	cardiovascular
Denisovan	HPO	Hypokinesia (HP:0002375)	1	0.3703	2.700513097	0.311468853	skeletal muscle
Denisovan	HPO	Abnormal EKG (HP:0003115)	4	2.812	1.422475107	0.312968703	cardiovascular
Denisovan	HPO	Abnormality of chromosome stability (HP:0003220)	2	1.1234	1.780309774	0.313068693	other
Denisovan	HPO	Vertebral arch anomaly (HP:0008438)	1	0.3765	2.656042497	0.313068693	skeletal
Denisovan	HPO	Neoplasm of the heart (HP:0100544)	1	0.3759	2.66028199	0.313068693	cardiovascular
Denisovan	HPO	Recurrent gram-negative bacterial infections (HP:0005420)	1	0.3748	2.668089648	0.313568643	immune
Denisovan	HPO	Persistence of primary teeth (HP:0006335)	1	0.3775	2.649006623	0.314368563	skeletal
Denisovan	HPO	Polydipsia (HP:0001959)	1	0.3754	2.663825253	0.314668533	other
Denisovan	HPO	Abnormal drinking behavior (HP:0030082)	1	0.3754	2.663825253	0.314668533	behavior
Denisovan	HPO	Failure to thrive in infancy (HP:0001531)	1	0.38	2.631578947	0.316068393	other
Denisovan	HPO	Stereotypic behavior (HP:0000733)	4	2.8248	1.416029453	0.316668333	behavior
Denisovan	HPO	Thickened calvaria (HP:0002684)	2	1.1443	1.747793411	0.316968303	skeletal
Denisovan	HPO	Systemic lupus erythematosus (HP:0002725)	1	0.3799	2.63227165	0.317168283	immune
Denisovan	HPO	Abnormality of the umbilical cord (HP:0010881)	1	0.3788	2.639915523	0.319268073	reproductive
Denisovan	HPO	Abnormality of the epiphysis of the femoral head (HP:0010574)	2	1.1494	1.740038281	0.320667933	skeletal
Denisovan	HPO	Wide nasal bridge (HP:0000431)	20	17.6361	1.134037571	0.321167883	integumentary
Denisovan	HPO	Developmental regression (HP:0002376)	6	4.63	1.295896328	0.321267873	behavior
Denisovan	HPO	Platyspondyly (HP:0000926)	4	2.8578	1.399678074	0.323167683	skeletal
Denisovan	HPO	Abnormality of potassium homeostasis (HP:0011042)	3	2.0082	1.493875112	0.323467653	other
Denisovan	HPO	Abnormality of the femoral head (HP:0003368)	2	1.1606	1.723246597	0.324967503	skeletal
Denisovan	HPO	Macroglossia (HP:0000158)	4	2.8851	1.386433746	0.327167283	other
Denisovan	HPO	Narrow mouth (HP:0000160)	9	7.4302	1.211272913	0.327767223	skeletal
Denisovan	HPO	Aplasia/Hypoplasia involving the pelvis (HP:0009103)	3	2.0156	1.488390554	0.327867213	skeletal
Denisovan	HPO	Pes planus (HP:0001763)	8	6.5662	1.218360696	0.328267173	skeletal
Denisovan	HPO	Nausea (HP:0002018)	1	0.3944	2.535496957	0.328367163	other
Denisovan	HPO	Long face (HP:0000276)	7	5.5914	1.251922595	0.328467153	skeletal
Denisovan	HPO	Recurrent bronchitis (HP:0002837)	1	0.3932	2.543234995	0.330266973	respiratory
Denisovan	HPO	Hypoplasia of the thymus (HP:0000778)	1	0.3998	2.501250625	0.330666933	lymphatic
Denisovan	HPO	Abnormality of iron homeostasis (HP:0011031)	1	0.4007	2.495632643	0.330766923	other
Denisovan	HPO	Aplasia/Hypoplasia of the tongue (HP:0010295)	3	2.0485	1.464486209	0.331966803	other
Denisovan	HPO	Trigonocephaly (HP:0000243)	2	1.1918	1.678133915	0.332666733	skeletal
Denisovan	HPO	Carpal bone hypoplasia (HP:0001498)	1	0.4087	2.446782481	0.333466653	skeletal
Denisovan	HPO	Paralysis (HP:0003470)	1	0.4051	2.46852629	0.334066593	nervous
Denisovan	HPO	Neoplasm of head and neck (HP:0012288)	1	0.406	2.463054187	0.335366463	integumentary
Denisovan	HPO	Esophageal neoplasm (HP:0100751)	1	0.406	2.463054187	0.335366463	digestive
Denisovan	HPO	Thrombophlebitis (HP:0004418)	2	1.1832	1.690331305	0.336466353	cardiovascular
Denisovan	HPO	Abnormality of serine family amino acid metabolism (HP:0010894)	2	1.1976	1.67000668	0.337266273	metabolic
Denisovan	HPO	Abnormality of glycine metabolism (HP:0010895)	2	1.1976	1.67000668	0.337266273	metabolic
Denisovan	HPO	Microcornea (HP:0000482)	8	6.591	1.213776362	0.337366263	nervous
Denisovan	HPO	Poor head control (HP:0002421)	1	0.411	2.433090024	0.338066193	nervous
Denisovan	HPO	Optic disc pallor (HP:0000543)	3	2.0462	1.466132343	0.338166183	nervous
Denisovan	HPO	Proximal tubulopathy (HP:0000114)	1	0.4158	2.405002405	0.340765923	urinary
Denisovan	HPO	Intestinal polyp (HP:0005266)	2	1.2212	1.637733377	0.340965903	digestive
Denisovan	HPO	Polymicrogyria (HP:0002126)	4	2.9564	1.352996888	0.342465753	nervous
Denisovan	HPO	Exostoses (HP:0100777)	2	1.2219	1.636795155	0.343765623	skeletal
Denisovan	HPO	Abnormality of the endocardium (HP:0004306)	2	1.2361	1.617992072	0.346165383	cardiovascular
Denisovan	HPO	Turricephaly (HP:0000262)	1	0.4257	2.349072117	0.347065293	skeletal
Denisovan	HPO	Tetraplegia (HP:0002445)	2	1.2332	1.621796951	0.347465253	nervous
Denisovan	HPO	White forelock (HP:0002211)	1	0.4243	2.356823003	0.348165183	integumentary
Denisovan	HPO	Bundle branch block (HP:0011710)	3	2.0882	1.436644	0.348765123	cardiovascular
Denisovan	HPO	Preaxial hand polydactyly (HP:0001177)	4	2.9739	1.345035139	0.350964904	skeletal
Denisovan	HPO	Abnormality of the pubic bones (HP:0003172)	3	2.112	1.420454545	0.351664834	skeletal
Denisovan	HPO	Tetralogy of Fallot (HP:0001636)	6	4.8083	1.247842273	0.351964804	cardiovascular
Denisovan	HPO	Patchy hypopigmentation of hair (HP:0011365)	1	0.4313	2.31857176	0.353064694	integumentary
Denisovan	HPO	Abnormality of the vertebral endplates (HP:0005106)	1	0.4331	2.308935581	0.353064694	skeletal
Denisovan	HPO	Syncope (HP:0001279)	4	3.0229	1.323232657	0.353664634	nervous
Denisovan	HPO	Delayed puberty (HP:0000823)	3	2.1149	1.418506785	0.354864514	endocrine
Denisovan	HPO	Abnormal hair whorl (HP:0010721)	1	0.4406	2.26963232	0.355364464	integumentary
Denisovan	HPO	Gastrointestinal atresia (HP:0002589)	2	1.2601	1.587175621	0.357864214	digestive
Denisovan	HPO	Hyperphosphatemia (HP:0002905)	1	0.4449	2.247696111	0.358264174	other
Denisovan	HPO	Bilateral sensorineural hearing impairment (HP:0008619)	1	0.4514	2.215330084	0.359464054	nervous
Denisovan	HPO	Rectovaginal fistula (HP:0000143)	1	0.4462	2.241147468	0.360663934	reproductive
Denisovan	HPO	Rectal fistula (HP:0100590)	1	0.4462	2.241147468	0.360663934	digestive
Denisovan	HPO	Premature skin wrinkling (HP:0100678)	1	0.4489	2.227667632	0.361463854	integumentary
Denisovan	HPO	Ketosis (HP:0001946)	2	1.2661	1.579654056	0.361563844	metabolic
Denisovan	HPO	Focal seizures (HP:0007359)	3	2.1442	1.399123216	0.361563844	nervous
Denisovan	HPO	Conjugated hyperbilirubinemia (HP:0002908)	1	0.4505	2.219755827	0.361663834	digestive
Denisovan	HPO	Asymmetric growth (HP:0100555)	2	1.2773	1.565802865	0.361863814	other
Denisovan	HPO	Cerebral edema (HP:0002181)	2	1.2601	1.587175621	0.362063794	nervous
Denisovan	HPO	Convex nasal ridge (HP:0000444)	5	3.9586	1.263072804	0.362263774	skeletal
Denisovan	HPO	Hypopigmentation of the fundus (HP:0007894)	2	1.2738	1.570105197	0.363363664	integumentary
Denisovan	HPO	Hypoplastic left heart (HP:0004383)	1	0.4465	2.239641657	0.363363664	cardiovascular
Denisovan	HPO	Impulsivity (HP:0100710)	1	0.4546	2.199736032	0.364363564	behavior
Denisovan	HPO	Glomerulonephritis (HP:0000099)	1	0.4504	2.220248668	0.365363464	urinary
Denisovan	HPO	Furrowed tongue (HP:0000221)	2	1.2849	1.556541365	0.367063294	other
Denisovan	HPO	Attention deficit hyperactivity disorder (HP:0007018)	7	5.849	1.196785775	0.367763224	behavior
Denisovan	HPO	Aplasia/Hypoplasia of the macula (HP:0008059)	2	1.2806	1.561767921	0.368363164	nervous
Denisovan	HPO	Reticulocytosis (HP:0001923)	2	1.2829	1.558967963	0.369463054	hematologic
Denisovan	HPO	Abnormality of the septum pellucidum (HP:0007375)	1	0.4649	2.151000215	0.369463054	nervous
Denisovan	HPO	Leukodystrophy (HP:0002415)	2	1.2818	1.56030582	0.369563044	nervous
Denisovan	HPO	Visceral angiomatosis (HP:0100761)	1	0.4586	2.180549498	0.370162984	skeletal
Denisovan	HPO	Congenital cataract (HP:0000519)	3	2.1757	1.378866572	0.370162984	nervous
Denisovan	HPO	Dysphonia (HP:0001618)	1	0.4567	2.189621196	0.370562944	other
Denisovan	HPO	Aplasia/Hypoplasia affecting the retina (HP:0008061)	2	1.2881	1.552674482	0.370662934	nervous
Denisovan	HPO	Keratoconus (HP:0000563)	2	1.3029	1.535037225	0.371162884	nervous
Denisovan	HPO	Increased corneal curvature (HP:0100692)	2	1.3029	1.535037225	0.371162884	nervous
Denisovan	HPO	Muscle stiffness (HP:0003552)	1	0.4627	2.161227577	0.372662734	skeletal muscle
Denisovan	HPO	Neoplasm of the respiratory system (HP:0100606)	4	3.0823	1.297732213	0.373162684	respiratory
Denisovan	HPO	Irritability (HP:0000737)	3	2.202	1.36239782	0.373462654	behavior
Denisovan	HPO	Intestinal fistula (HP:0100819)	1	0.4677	2.138122728	0.375062494	digestive
Denisovan	HPO	Neoplasm of the adrenal gland (HP:0100631)	1	0.4734	2.112378538	0.375162484	endocrine
Denisovan	HPO	Stroke (HP:0001297)	3	2.1964	1.365871426	0.375662434	cardiovascular
Denisovan	HPO	Severe short stature (HP:0003510)	2	1.3141	1.521954189	0.376162384	skeletal
Denisovan	HPO	Abnormality of transition element cation homeostasis (HP:0011030)	1	0.4762	2.099958001	0.377062294	other
Denisovan	HPO	Abnormality of the common coagulation pathway (HP:0010990)	1	0.476	2.100840336	0.377762224	hematologic
Denisovan	HPO	Psychosis (HP:0000709)	3	2.2047	1.360729351	0.378762124	nervous
Denisovan	HPO	Short thorax (HP:0010306)	3	2.2057	1.360112436	0.378862114	skeletal
Denisovan	HPO	Polycystic kidney dysplasia (HP:0000113)	5	4.0437	1.236491332	0.379962004	urinary
Denisovan	HPO	Hypospadias (HP:0000047)	7	5.9502	1.176431044	0.380861914	urinary
Denisovan	HPO	CNS hypomyelination (HP:0003429)	1	0.4749	2.105706465	0.380861914	nervous
Denisovan	HPO	Humeroradial synostosis (HP:0003041)	1	0.476	2.100840336	0.381661834	skeletal
Denisovan	HPO	Synostosis involving the elbow (HP:0003938)	1	0.476	2.100840336	0.381661834	skeletal
Denisovan	HPO	Distal arthrogryposis (HP:0005684)	1	0.4774	2.094679514	0.382461754	skeletal muscle
Denisovan	HPO	Upslanted palpebral fissure (HP:0000582)	7	5.9403	1.178391664	0.382961704	integumentary
Denisovan	HPO	Aggressive behavior (HP:0000718)	5	4.0488	1.234933808	0.383261674	behavior
Denisovan	HPO	Renal cortical cysts (HP:0000803)	1	0.4785	2.089864159	0.383461654	urinary
Denisovan	HPO	Lower limb amyotrophy (HP:0007210)	1	0.4792	2.086811352	0.383561644	nervous
Denisovan	HPO	Heart block (HP:0012722)	3	2.2184	1.352326001	0.383861614	cardiovascular
Denisovan	HPO	Aplasia/Hypoplasia of the sacrum (HP:0008517)	1	0.4823	2.0733983	0.384061594	skeletal
Denisovan	HPO	Weight loss (HP:0001824)	6	5.0186	1.195552545	0.384161584	metabolic
Denisovan	HPO	Hypoparathyroidism (HP:0000829)	1	0.4799	2.083767452	0.384261574	endocrine
Denisovan	HPO	Increased circulating renin level (HP:0000848)	1	0.491	2.036659878	0.384361564	other
Denisovan	HPO	Myoclonus (HP:0001336)	3	2.2209	1.350803728	0.385061494	nervous
Denisovan	HPO	Abnormal atrioventricular conduction (HP:0005150)	3	2.2297	1.345472485	0.386561344	cardiovascular
Denisovan	HPO	Paresthesia (HP:0003401)	4	3.1478	1.270728763	0.387161284	nervous
Denisovan	HPO	Hypoplastic heart (HP:0001961)	1	0.4846	2.063557573	0.387561244	cardiovascular
Denisovan	HPO	Hypertensive crisis (HP:0100735)	1	0.4931	2.02798621	0.388661134	cardiovascular
Denisovan	HPO	Rhabdomyolysis (HP:0003201)	1	0.4939	2.024701357	0.389861014	other
Denisovan	HPO	Obstructive lung disease (HP:0006536)	1	0.4966	2.013693113	0.390160984	respiratory
Denisovan	HPO	Chronic obstructive pulmonary disease (HP:0006510)	1	0.4966	2.013693113	0.390160984	respiratory
Denisovan	HPO	Poor coordination (HP:0002370)	2	1.3685	1.461454147	0.390760924	nervous
Denisovan	HPO	Flat acetabular roof (HP:0003180)	1	0.4997	2.00120072	0.391660834	skeletal
Denisovan	HPO	Erythema (HP:0010783)	1	0.5048	1.980982567	0.393560644	integumentary
Denisovan	HPO	Hypopigmented skin patches (HP:0001053)	4	3.1791	1.258217735	0.394360564	integumentary
Denisovan	HPO	Prominent metopic ridge (HP:0005487)	1	0.4966	2.013693113	0.395260474	skeletal
Denisovan	HPO	Abnormality of the lumbar spine (HP:0100712)	1	0.5117	1.95427008	0.397760224	skeletal
Denisovan	HPO	Progressive muscle weakness (HP:0003323)	1	0.5051	1.979805979	0.399060094	skeletal muscle
Denisovan	HPO	Abnormality of glutamine family amino acid metabolism (HP:0010902)	1	0.5136	1.947040498	0.401059894	metabolic
Denisovan	HPO	Bowel incontinence (HP:0002607)	2	1.3772	1.4522219	0.401259874	digestive
Denisovan	HPO	Abnormal large intestine physiology (HP:0012700)	2	1.3772	1.4522219	0.401259874	digestive
Denisovan	HPO	Vaginal fistula (HP:0004320)	1	0.5112	1.956181534	0.401659834	reproductive
Denisovan	HPO	Dementia (HP:0000726)	4	3.2335	1.237049637	0.403159684	nervous
Denisovan	HPO	Hyperpituitarism (HP:0010514)	2	1.3865	1.442481067	0.403859614	endocrine
Denisovan	HPO	Freckling (HP:0001480)	3	2.3065	1.300672014	0.404659534	integumentary
Denisovan	HPO	Redundant skin (HP:0001582)	1	0.5198	1.923816853	0.406359364	integumentary
Denisovan	HPO	Metabolic alkalosis (HP:0200114)	1	0.5206	1.920860546	0.407559244	metabolic
Denisovan	HPO	Hirsutism (HP:0001007)	5	4.1457	1.206068939	0.407859214	integumentary
Denisovan	HPO	Hemangiomatosis (HP:0007461)	1	0.5214	1.91791331	0.408459154	cardiovascular
Denisovan	HPO	Hyperactive renin-angiotensin system (HP:0000841)	1	0.5352	1.868460389	0.412358764	other
Denisovan	HPO	Paraparesis (HP:0002385)	1	0.5397	1.85288123	0.412858714	nervous
Denisovan	HPO	Aganglionic megacolon (HP:0002251)	5	4.2136	1.186633757	0.413258674	digestive
Denisovan	HPO	Hydroureter (HP:0000072)	2	1.4091	1.419345682	0.414258574	urinary
Denisovan	HPO	Hamartoma of the eye (HP:0010568)	1	0.5344	1.871257485	0.416358364	nervous
Denisovan	HPO	Arthralgia (HP:0002829)	5	4.2442	1.178078319	0.416758324	skeletal
Denisovan	HPO	Hydrocephalus (HP:0000238)	13	11.9056	1.091923129	0.417158284	nervous
Denisovan	HPO	Broad alveolar ridges (HP:0000187)	1	0.5372	1.861504095	0.417258274	skeletal
Denisovan	HPO	Bicornuate uterus (HP:0000813)	3	2.3511	1.275998469	0.418458154	reproductive
Denisovan	HPO	Specific learning disability (HP:0001328)	3	2.3473	1.278064159	0.420657934	other
Denisovan	HPO	Recurrent urinary tract infections (HP:0000010)	5	4.2482	1.176969069	0.420957904	immune
Denisovan	HPO	Nephrocalcinosis (HP:0000121)	2	1.4449	1.384178836	0.424257574	urinary
Denisovan	HPO	Neurofibrillary tangles (HP:0002185)	1	0.562	1.779359431	0.424857514	nervous
Denisovan	HPO	CNS demyelination (HP:0007305)	2	1.4593	1.370520112	0.425557444	nervous
Denisovan	HPO	Dysphagia (HP:0002015)	7	6.2089	1.127413874	0.425757424	digestive
Denisovan	HPO	Slender long bone (HP:0003100)	1	0.5571	1.795009873	0.426057394	skeletal
Denisovan	HPO	Congenital hepatic fibrosis (HP:0002612)	3	2.3974	1.251355635	0.427157284	digestive
Denisovan	HPO	Choreoathetosis (HP:0001266)	2	1.4585	1.371271855	0.427757224	nervous
Denisovan	HPO	Decreased subcutaneous fat (HP:0001002)	1	0.5579	1.79243592	0.429857014	metabolic
Denisovan	HPO	Progressive sensorineural hearing impairment (HP:0000408)	1	0.5538	1.805706031	0.430356964	nervous
Denisovan	HPO	Advanced eruption of teeth (HP:0006288)	2	1.4672	1.363140676	0.430356964	skeletal
Denisovan	HPO	Aplasia/Hypoplasia of the uvula (HP:0010293)	2	1.4732	1.357588922	0.432756724	skeletal
Denisovan	HPO	Prenatal maternal abnormality (HP:0002686)	2	1.4788	1.352447931	0.432956704	reproductive
Denisovan	HPO	Hypercholesterolemia (HP:0003124)	1	0.5727	1.746114894	0.434856514	metabolic
Denisovan	HPO	Thyroiditis (HP:0100646)	1	0.5639	1.773364072	0.435156484	endocrine
Denisovan	HPO	Mitral valve prolapse (HP:0001634)	3	2.4234	1.237930181	0.436056394	cardiovascular
Denisovan	HPO	Cerebral ischemia (HP:0002637)	3	2.415	1.242236025	0.436356364	nervous
Denisovan	HPO	Exotropia (HP:0000577)	1	0.575	1.739130435	0.436456354	nervous
Denisovan	HPO	Diaphragmatic weakness (HP:0009113)	1	0.5702	1.753770607	0.437456254	respiratory
Denisovan	HPO	Mesangial abnormality (HP:0001966)	1	0.5682	1.759943682	0.437556244	urinary
Denisovan	HPO	Portal hypertension (HP:0001409)	2	1.4843	1.347436502	0.437956204	cardiovascular
Denisovan	HPO	Coronal craniosynostosis (HP:0004440)	1	0.5727	1.746114894	0.438556144	skeletal
Denisovan	HPO	Sleep apnea (HP:0010535)	1	0.5832	1.714677641	0.439056094	behavior
Denisovan	HPO	Congenital onset (HP:0003577)	11	10.1995	1.078484239	0.439756024	other
Denisovan	HPO	Renal hypoplasia (HP:0000089)	4	3.4296	1.166316772	0.442655734	urinary
Denisovan	HPO	Gastrointestinal dysmotility (HP:0002579)	1	0.5834	1.714089818	0.443555644	digestive
Denisovan	HPO	Anteriorly placed anus (HP:0001545)	1	0.5815	1.719690456	0.444955504	digestive
Denisovan	HPO	Absent phalangeal crease (HP:0006109)	1	0.5873	1.702707305	0.445855414	integumentary
Denisovan	HPO	Abnormality of incisor morphology (HP:0011063)	2	1.5189	1.316742379	0.446355364	skeletal
Denisovan	HPO	Hypogonadotrophic hypogonadism (HP:0000044)	2	1.5288	1.308215594	0.446555344	endocrine
Denisovan	HPO	Tracheoesophageal fistula (HP:0002575)	4	3.4134	1.171852112	0.446855314	respiratory
Denisovan	HPO	Leukocytosis (HP:0001974)	2	1.5161	1.319174197	0.446855314	immune
Denisovan	HPO	Renal dysplasia (HP:0000110)	2	1.5122	1.322576379	0.447655234	urinary
Denisovan	HPO	Abnormality of the salivary glands (HP:0010286)	1	0.5906	1.693193363	0.448455154	digestive
Denisovan	HPO	Nephronophthisis (HP:0000090)	2	1.5298	1.307360439	0.449255074	urinary
Denisovan	HPO	Narrow chest (HP:0000774)	5	4.3965	1.137268282	0.449655034	skeletal
Denisovan	HPO	Medulloblastoma (HP:0002885)	1	0.601	1.663893511	0.450954905	nervous
Denisovan	HPO	Complement deficiency (HP:0004431)	1	0.588	1.700680272	0.451454855	immune
Denisovan	HPO	Beaking of vertebral bodies (HP:0004568)	1	0.605	1.652892562	0.451854815	skeletal
Denisovan	HPO	Protrusio acetabuli (HP:0003179)	1	0.6026	1.659475606	0.453354665	skeletal
Denisovan	HPO	Sandal gap (HP:0001852)	4	3.4799	1.149458318	0.454354565	skeletal
Denisovan	HPO	Waddling gait (HP:0002515)	2	1.5604	1.281722635	0.456454355	other
Denisovan	HPO	Spastic tetraparesis (HP:0001285)	1	0.6053	1.652073352	0.456654335	nervous
Denisovan	HPO	Abdominal distention (HP:0003270)	2	1.5541	1.286918474	0.456854315	other
Denisovan	HPO	Splenomegaly (HP:0001744)	11	10.2906	1.0689367	0.456854315	lymphatic
Denisovan	HPO	Gastroesophageal reflux (HP:0002020)	5	4.4483	1.124024908	0.458354165	digestive
Denisovan	HPO	Type I transferrin isoform profile (HP:0003642)	1	0.609	1.642036125	0.458754125	other
Denisovan	HPO	Reduced subcutaneous adipose tissue (HP:0003758)	1	0.6158	1.623903865	0.459254075	metabolic
Denisovan	HPO	Skin nodule (HP:0200036)	1	0.611	1.636661211	0.459854015	integumentary
Denisovan	HPO	Cerebral inclusion bodies (HP:0100314)	1	0.626	1.597444089	0.460353965	nervous
Denisovan	HPO	Acute necrotizing encephalopathy (HP:0006965)	1	0.621	1.610305958	0.461353865	nervous
Denisovan	HPO	X-linked dominant inheritance (HP:0001423)	1	0.621	1.610305958	0.461353865	other
Denisovan	HPO	Abnormal mitochondria in muscle tissue (HP:0008316)	1	0.621	1.610305958	0.461353865	skeletal muscle
Denisovan	HPO	Rectal prolapse (HP:0002035)	1	0.6241	1.602307323	0.461553845	digestive
Denisovan	HPO	Pachygyria (HP:0001302)	3	2.511	1.19474313	0.462753725	nervous
Denisovan	HPO	Abnormality of the hepatic vasculature (HP:0006707)	2	1.5581	1.283614659	0.464353565	skeletal muscle
Denisovan	HPO	Male pseudohermaphroditism (HP:0000037)	2	1.5631	1.279508669	0.468353165	reproductive
Denisovan	HPO	Aplasia/Hypoplasia involving the carpal bones (HP:0006502)	1	0.6289	1.590077914	0.468753125	skeletal
Denisovan	HPO	Proximal placement of thumb (HP:0009623)	1	0.6358	1.572821642	0.469553045	skeletal
Denisovan	HPO	Absent hand (HP:0004050)	1	0.6381	1.567152484	0.470752925	skeletal
Denisovan	HPO	Large for gestational age (HP:0001520)	1	0.6367	1.570598398	0.472052795	other
Denisovan	HPO	Palmoplantar keratoderma (HP:0000982)	6	5.4668	1.097534206	0.472452755	integumentary
Denisovan	HPO	Broad metatarsal (HP:0001783)	1	0.6421	1.557389815	0.472852715	skeletal
Denisovan	HPO	Hyperaldosteronism (HP:0000859)	1	0.6444	1.551831161	0.473752625	endocrine
Denisovan	HPO	Cavernous hemangioma (HP:0001048)	1	0.6332	1.579279848	0.474852515	cardiovascular
Denisovan	HPO	Aplasia/hypoplasia of the femur (HP:0005613)	2	1.5957	1.253368428	0.474852515	skeletal
Denisovan	HPO	Mandibular prognathia (HP:0000303)	6	5.5266	1.085658452	0.475452455	skeletal
Denisovan	HPO	Delusions (HP:0000746)	1	0.6458	1.548467018	0.475952405	behavior
Denisovan	HPO	Median cleft lip (HP:0000161)	1	0.6546	1.527650474	0.476652335	other
Denisovan	HPO	Neonatal hypoglycemia (HP:0001998)	1	0.6452	1.549907006	0.476852315	metabolic
Denisovan	HPO	Constipation (HP:0002019)	10	9.5174	1.050707126	0.479552045	digestive
Denisovan	HPO	Abnormality of the parietal bone (HP:0002696)	1	0.6617	1.511258879	0.480651935	skeletal
Denisovan	HPO	Hypoplastic toenails (HP:0001800)	2	1.6207	1.234034676	0.481251875	integumentary
Denisovan	HPO	Triangular face (HP:0000325)	6	5.5661	1.077954043	0.482951705	other
Denisovan	HPO	Basal ganglia calcification (HP:0002135)	1	0.6581	1.519525908	0.484651535	nervous
Denisovan	HPO	Memory impairment (HP:0002354)	3	2.5954	1.155891192	0.484851515	nervous
Denisovan	HPO	Abnormal ciliary motility (HP:0012262)	1	0.6626	1.509206158	0.485151485	respiratory
Denisovan	HPO	Generalized tonic-clonic seizures (HP:0002069)	3	2.6125	1.148325359	0.485651435	nervous
Denisovan	HPO	IgG deficiency (HP:0004315)	1	0.6704	1.491646778	0.487851215	immune
Denisovan	HPO	Abnormalities of placenta or umbilical cord (HP:0001194)	1	0.6623	1.509889778	0.489551045	reproductive
Denisovan	HPO	Truncal obesity (HP:0001956)	4	3.6375	1.099656357	0.490450955	metabolic
Denisovan	HPO	Abnormality of the costochondral junction (HP:0000919)	1	0.6792	1.472320377	0.490750925	skeletal
Denisovan	HPO	Aplasia/Hypoplasia of the brainstem (HP:0007362)	3	2.6276	1.14172629	0.491050895	nervous
Denisovan	HPO	Hypoplasia of the brainstem (HP:0002365)	3	2.6276	1.14172629	0.491050895	nervous
Denisovan	HPO	Buphthalmos (HP:0000557)	1	0.6768	1.477541371	0.491350865	nervous
Denisovan	HPO	Hepatic necrosis (HP:0002605)	1	0.6784	1.474056604	0.491550845	digestive
Denisovan	HPO	Mediastinal lymphadenopathy (HP:0100721)	1	0.6767	1.477759716	0.491850815	lymphatic
Denisovan	HPO	Abnormality of the epiphyses of the phalanges of the hand (HP:0005920)	2	1.6511	1.21131367	0.492750725	skeletal
Denisovan	HPO	Rocker bottom foot (HP:0001838)	3	2.6697	1.123721766	0.493350665	skeletal
Denisovan	HPO	Facial edema (HP:0000282)	4	3.6325	1.101169993	0.494050595	immune
Denisovan	HPO	Periorbital edema (HP:0100539)	4	3.6325	1.101169993	0.494050595	other
Denisovan	HPO	Abnormal finger flexion creases (HP:0006143)	1	0.6822	1.465845793	0.494150585	integumentary
Denisovan	HPO	Focal motor seizures (HP:0011153)	1	0.6861	1.457513482	0.494550545	nervous
Denisovan	HPO	Abnormality of the middle phalanges of the toes (HP:0010183)	1	0.6847	1.460493647	0.494950505	skeletal
Denisovan	HPO	Limb dystonia (HP:0002451)	1	0.6799	1.47080453	0.495350465	nervous
Denisovan	HPO	Submucous cleft hard palate (HP:0000176)	1	0.6855	1.458789205	0.498050195	other
Denisovan	HPO	Obsessive-compulsive behavior (HP:0000722)	3	2.6545	1.130156338	0.499850015	behavior
Denisovan	HPO	Hemoptysis (HP:0002105)	1	0.6874	1.454757056	0.500149985	other
Denisovan	HPO	Adrenal hypoplasia (HP:0000835)	1	0.6921	1.444877908	0.500449955	endocrine
Denisovan	HPO	Deformed sella turcica (HP:0002681)	1	0.6991	1.430410528	0.500549945	skeletal
Denisovan	HPO	Vesicoureteral reflux (HP:0000076)	6	5.6858	1.055260473	0.500949905	urinary
Denisovan	HPO	"Primitive reflexes (palmomental, snout, glabellar) (HP:0002476)"	1	0.6875	1.454545455	0.501949805	nervous
Denisovan	HPO	Autosomal dominant inheritance (HP:0000006)	79	78.7017	1.003790261	0.501949805	other
Denisovan	HPO	Abnormal isoelectric focusing of serum transferrin (HP:0003160)	1	0.6986	1.431434297	0.503749625	other
Denisovan	HPO	Abnormal glycosylation (HP:0012345)	1	0.6986	1.431434297	0.503749625	other
Denisovan	HPO	Abnormal protein N-linked glycosylation (HP:0012347)	1	0.6986	1.431434297	0.503749625	other
Denisovan	HPO	Abnormal protein glycosylation (HP:0012346)	1	0.6986	1.431434297	0.503749625	other
Denisovan	HPO	Rickets (HP:0002748)	1	0.6969	1.434926101	0.504049595	skeletal
Denisovan	HPO	Abnormality of the shoulder girdle musculature (HP:0001435)	2	1.6951	1.179871394	0.504849515	skeletal muscle
Denisovan	HPO	Progressive macrocephaly (HP:0004481)	1	0.7035	1.421464108	0.505249475	skeletal
Denisovan	HPO	True hermaphroditism (HP:0010459)	1	0.7066	1.415227852	0.505649435	reproductive
Denisovan	HPO	Azoospermia (HP:0000027)	1	0.7071	1.414227125	0.505749425	reproductive
Denisovan	HPO	Flared iliac wings (HP:0002869)	1	0.7108	1.406865504	0.506549345	skeletal
Denisovan	HPO	Cellulitis (HP:0100658)	1	0.7143	1.399972001	0.506549345	integumentary
Denisovan	HPO	Hypoalbuminemia (HP:0003073)	2	1.6933	1.181125613	0.506749325	other
Denisovan	HPO	Abnormal albumin level (HP:0012116)	2	1.6933	1.181125613	0.506749325	other
Denisovan	HPO	Abnormally folded helix (HP:0008544)	2	1.7122	1.16808784	0.508449155	integumentary
Denisovan	HPO	Overfolded helix (HP:0000396)	2	1.7122	1.16808784	0.508449155	integumentary
Denisovan	HPO	Coxa valga (HP:0002673)	2	1.7102	1.169453865	0.509049095	skeletal
Denisovan	HPO	Rhinitis (HP:0012384)	1	0.7098	1.408847563	0.510748925	respiratory
Denisovan	HPO	Pseudobulbar signs (HP:0002200)	1	0.7116	1.405283867	0.511948805	behavior
Denisovan	HPO	Subaortic stenosis (HP:0001682)	1	0.7208	1.387347392	0.515348465	cardiovascular
Denisovan	HPO	Abnormality of the left ventricular outflow tract (HP:0011103)	1	0.7208	1.387347392	0.515348465	cardiovascular
Denisovan	HPO	Abnormality of complement system (HP:0005339)	1	0.7118	1.404889014	0.515748425	immune
Denisovan	HPO	Melanoma (HP:0002861)	2	1.7394	1.149821778	0.516348365	integumentary
Denisovan	HPO	Bronchitis (HP:0012387)	1	0.7151	1.398405817	0.517448255	respiratory
Denisovan	HPO	Sudden cardiac death (HP:0001645)	6	5.77	1.039861352	0.517648235	cardiovascular
Denisovan	HPO	Aplasia/Hypoplasia of the thymus (HP:0010515)	2	1.7461	1.14540977	0.518448155	lymphatic
Denisovan	HPO	Osteoporosis (HP:0000939)	4	3.7762	1.059265929	0.520347965	skeletal
Denisovan	HPO	Abnormality of the epiphyses of the hand (HP:0005924)	2	1.7479	1.144230219	0.520947905	skeletal
Denisovan	HPO	Acute myeloid leukemia (HP:0004808)	2	1.7518	1.141682841	0.521747825	lymphatic
Denisovan	HPO	Gastrointestinal stroma tumor (HP:0100723)	1	0.7363	1.358142062	0.521847815	digestive
Denisovan	HPO	Abnormality of subcutaneous fat tissue (HP:0001001)	1	0.7342	1.362026696	0.522247775	metabolic
Denisovan	HPO	Hepatitis (HP:0012115)	2	1.7503	1.142661258	0.523247675	immune
Denisovan	HPO	Pancreatic fibrosis (HP:0100732)	1	0.7477	1.3374348	0.523547645	digestive
Denisovan	HPO	Leukopenia (HP:0001882)	3	2.7559	1.088573606	0.525747425	immune
Denisovan	HPO	Ventricular septal defect (HP:0001629)	13	12.8946	1.008173964	0.526347365	cardiovascular
Denisovan	HPO	Photophobia (HP:0000613)	9	8.837	1.018445174	0.526647335	nervous
Denisovan	HPO	Premature graying of hair (HP:0002216)	1	0.7475	1.337792642	0.526747325	integumentary
Denisovan	HPO	Prolonged QT interval (HP:0001657)	2	1.7707	1.129496809	0.526847315	cardiovascular
Denisovan	HPO	Amelogenesis imperfecta (HP:0000705)	1	0.7526	1.328727079	0.530546945	skeletal
Denisovan	HPO	Blepharitis (HP:0000498)	1	0.7615	1.313197636	0.530646935	nervous
Denisovan	HPO	Abnormality involving the epiphyses of the upper limbs (HP:0003839)	2	1.7802	1.123469273	0.530746925	skeletal
Denisovan	HPO	Difficulty running (HP:0009046)	1	0.7562	1.322401481	0.530746925	other
Denisovan	HPO	EMG: myopathic abnormalities (HP:0003458)	2	1.7852	1.120322653	0.532246775	nervous
Denisovan	HPO	Iris coloboma (HP:0000612)	7	6.904	1.013904983	0.533446655	nervous
Denisovan	HPO	Megalencephaly (HP:0001355)	1	0.756	1.322751323	0.533746625	nervous
Denisovan	HPO	Abnormality of the vitreous humor (HP:0004327)	3	2.7986	1.071964554	0.534046595	nervous
Denisovan	HPO	Neoplasm of the thyroid gland (HP:0100031)	2	1.7994	1.111481605	0.535246475	endocrine
Denisovan	HPO	Albinism (HP:0001022)	1	0.7644	1.308215594	0.535346465	integumentary
Denisovan	HPO	Vitreoretinal degeneration (HP:0000655)	1	0.7672	1.303441084	0.535446455	nervous
Denisovan	HPO	Recurrent sinusitis (HP:0011108)	1	0.759	1.317523057	0.536246375	respiratory
Denisovan	HPO	Flexion contracture of toe (HP:0005830)	2	1.7966	1.113213848	0.536546345	skeletal muscle
Denisovan	HPO	Joint contractures involving the joints of the feet (HP:0100492)	2	1.7966	1.113213848	0.536546345	skeletal
Denisovan	HPO	Rhabdomyosarcoma (HP:0002859)	1	0.771	1.297016861	0.539646035	other
Denisovan	HPO	Ankyloglossia (HP:0010296)	1	0.7684	1.301405518	0.540845915	other
Denisovan	HPO	Craniofacial hyperostosis (HP:0004493)	2	1.8021	1.109816325	0.540945905	skeletal
Denisovan	HPO	Hemivertebrae (HP:0002937)	2	1.813	1.10314396	0.541145885	skeletal
Denisovan	HPO	Inguinal hernia (HP:0000023)	5	4.898	1.020824826	0.542045795	digestive
Denisovan	HPO	Sloping forehead (HP:0000340)	5	4.9172	1.016838851	0.543945605	skeletal
Denisovan	HPO	Cryptorchidism (HP:0000028)	27	27.2044	0.99248651	0.544545545	reproductive
Denisovan	HPO	Arterial thrombosis (HP:0004420)	1	0.7859	1.272426517	0.546445355	cardiovascular
Denisovan	HPO	Diminished movement (HP:0002374)	1	0.7885	1.268230818	0.546645335	nervous
Denisovan	HPO	Thyroid-stimulating hormone excess (HP:0002925)	1	0.7971	1.254547736	0.547645235	endocrine
Denisovan	HPO	Postaxial hand polydactyly (HP:0001162)	7	6.9815	1.00264986	0.551144886	skeletal
Denisovan	HPO	Abnormal respiratory motile cilium physiology (HP:0012261)	1	0.8038	1.24409057	0.552644736	respiratory
Denisovan	HPO	Choanal atresia (HP:0000453)	4	3.9255	1.018978474	0.554344566	respiratory
Denisovan	HPO	Hypermetropia (HP:0000540)	6	5.9735	1.00443626	0.554744526	nervous
Denisovan	HPO	Aplasia/Hypoplasia affecting the fundus (HP:0008057)	3	2.9216	1.026834611	0.554744526	nervous
Denisovan	HPO	Round face (HP:0000311)	7	7.0538	0.992372905	0.555044496	skeletal
Denisovan	HPO	Left ventricular hypertrophy (HP:0001712)	3	2.9239	1.026026882	0.555644436	cardiovascular
Denisovan	HPO	Personality changes (HP:0000751)	1	0.817	1.223990208	0.556744326	behavior
Denisovan	HPO	Hyperbilirubinemia (HP:0002904)	2	1.8675	1.070950469	0.558344166	digestive
Denisovan	HPO	Abnormality of the pupil (HP:0000615)	2	1.8611	1.074633281	0.559144086	nervous
Denisovan	HPO	Deviation of the thumb (HP:0009603)	1	0.8189	1.221150324	0.559944006	skeletal
Denisovan	HPO	Broad palm (HP:0001169)	1	0.8218	1.216841081	0.560443956	skeletal
Denisovan	HPO	Lissencephaly (HP:0001339)	3	2.9202	1.027326895	0.561243876	nervous
Denisovan	HPO	Absent thumb (HP:0009777)	1	0.8172	1.223690651	0.561343866	skeletal
Denisovan	HPO	Abnormality of oral frenula (HP:0000190)	1	0.8154	1.226391955	0.561943806	integumentary
Denisovan	HPO	Esophageal atresia (HP:0002032)	1	0.83	1.204819277	0.563043696	digestive
Denisovan	HPO	Facial asymmetry (HP:0000324)	4	3.9788	1.00532824	0.563243676	other
Denisovan	HPO	Ectopia lentis (HP:0001083)	3	2.9243	1.025886537	0.563843616	nervous
Denisovan	HPO	Short hallux (HP:0010109)	1	0.8278	1.208021261	0.564043596	skeletal
Denisovan	HPO	Large hands (HP:0001176)	1	0.8194	1.220405175	0.564143586	skeletal
Denisovan	HPO	Renal tubular acidosis (HP:0001947)	1	0.8309	1.203514262	0.566143386	urinary
Denisovan	HPO	EMG: neuropathic changes (HP:0003445)	1	0.8352	1.197318008	0.566643336	nervous
Denisovan	HPO	Patent foramen ovale (HP:0001655)	1	0.8529	1.172470395	0.567543246	cardiovascular
Denisovan	HPO	Anhidrosis (HP:0000970)	1	0.8379	1.19345984	0.567543246	integumentary
Denisovan	HPO	Recurrent fungal infections (HP:0002841)	1	0.8342	1.198753297	0.568343166	immune
Denisovan	HPO	Pathologic fracture (HP:0002756)	1	0.8511	1.174950065	0.568743126	skeletal
Denisovan	HPO	Dilatation of the ascending aorta (HP:0005111)	2	1.9027	1.051137857	0.569043096	cardiovascular
Denisovan	HPO	Lymphopenia (HP:0001888)	2	1.9104	1.046901173	0.569343066	lymphatic
Denisovan	HPO	Holoprosencephaly (HP:0001360)	4	3.9991	1.000225051	0.569943006	nervous
Denisovan	HPO	Dry skin (HP:0000958)	4	3.9819	1.004545569	0.569943006	integumentary
Denisovan	HPO	Abnormality of the heme biosynthetic pathway (HP:0010472)	1	0.8367	1.195171507	0.572942706	other
Denisovan	HPO	Adducted thumb (HP:0001181)	2	1.9092	1.047559187	0.573442656	skeletal
Denisovan	HPO	Agnosia (HP:0010524)	1	0.8447	1.183852255	0.574142586	nervous
Denisovan	HPO	Neoplasm of the peripheral nervous system (HP:0100007)	1	0.8518	1.173984503	0.574342566	nervous
Denisovan	HPO	Clinodactyly of the 5th finger (HP:0004209)	14	14.3823	0.973418716	0.574642536	skeletal
Denisovan	HPO	Aplasia/Hypoplasia of the hallux (HP:0008362)	1	0.8526	1.172882946	0.576142386	skeletal
Denisovan	HPO	Patellar dislocation (HP:0002999)	2	1.9468	1.027326895	0.577842216	skeletal
Denisovan	HPO	Femoral bowing (HP:0002980)	1	0.8507	1.175502527	0.578542146	skeletal
Denisovan	HPO	Radial deviation of finger (HP:0009466)	16	16.5135	0.96890423	0.579942006	skeletal
Denisovan	HPO	Cupped ear (HP:0000378)	3	3.0127	0.995784512	0.580141986	other
Denisovan	HPO	Overgrowth (HP:0001548)	1	0.8656	1.155268022	0.580241976	other
Denisovan	HPO	Optic nerve hypoplasia (HP:0000609)	2	1.95	1.025641026	0.580641936	nervous
Denisovan	HPO	Abnormality of the preputium (HP:0100587)	1	0.8558	1.168497312	0.581241876	reproductive
Denisovan	HPO	Thin upper lip vermilion (HP:0000219)	4	4.0744	0.981739643	0.582841716	integumentary
Denisovan	HPO	Dyskinesia (HP:0100660)	1	0.8785	1.138303927	0.582941706	nervous
Denisovan	HPO	Neoplasm of the lung (HP:0100526)	3	3.0218	0.992785757	0.583741626	respiratory
Denisovan	HPO	Abnormality of cells of the lymphoid lineage (HP:0012140)	2	1.9649	1.017863505	0.585441456	lymphatic
Denisovan	HPO	Bladder diverticulum (HP:0000015)	1	0.8925	1.120448179	0.585941406	urinary
Denisovan	HPO	Slow saccadic eye movements (HP:0000514)	1	0.8837	1.131605749	0.588441156	nervous
Denisovan	HPO	Protuberant abdomen (HP:0001538)	1	0.8894	1.124353497	0.588641136	metabolic
Denisovan	HPO	Aplasia/Hypoplasia of the optic nerve (HP:0008058)	2	1.9843	1.00791211	0.588741126	nervous
Denisovan	HPO	Hemiparesis (HP:0001269)	1	0.9011	1.109754744	0.591240876	skeletal muscle
Denisovan	HPO	Progressive hearing impairment (HP:0001730)	1	0.8938	1.118818528	0.592840716	nervous
Denisovan	HPO	Abnormality of the wing of the ilium (HP:0011867)	2	1.9996	1.00020004	0.592940706	skeletal
Denisovan	HPO	Abnormality of renin-angiotensin system (HP:0000847)	1	0.9049	1.105094486	0.593440656	other
Denisovan	HPO	Aplasia/Hypoplasia involving the vertebral column (HP:0008518)	2	2.0068	0.996611521	0.593840616	skeletal
Denisovan	HPO	Mitochondrial inheritance (HP:0001427)	1	0.9055	1.104362231	0.594140586	other
Denisovan	HPO	Nasolacrimal duct obstruction (HP:0000579)	1	0.9089	1.100231049	0.594440556	other
Denisovan	HPO	Decreased testicular size (HP:0008734)	2	2.0137	0.993196603	0.594940506	reproductive
Denisovan	HPO	Rapidly progressive (HP:0003678)	1	0.9074	1.102049813	0.595440456	other
Denisovan	HPO	Restrictive lung disease (HP:0002091)	2	1.9949	1.002556519	0.595740426	respiratory
Denisovan	HPO	Subacute progressive viral hepatitis (HP:0006572)	1	0.9038	1.106439478	0.596240376	immune
Denisovan	HPO	Abnormality of the antihelix (HP:0009738)	2	2.0066	0.996710854	0.597440256	other
Denisovan	HPO	Toxemia of pregnancy (HP:0100603)	1	0.9047	1.105338786	0.597740226	reproductive
Denisovan	HPO	Coxa vara (HP:0002812)	1	0.9152	1.092657343	0.598240176	skeletal
Denisovan	HPO	Premature rupture of membranes (HP:0001788)	1	0.9125	1.095890411	0.598940106	reproductive
Denisovan	HPO	Highly arched eyebrow (HP:0002553)	5	5.2125	0.959232614	0.599240076	integumentary
Denisovan	HPO	Pruritus (HP:0000989)	3	3.1129	0.963731569	0.599940006	integumentary
Denisovan	HPO	Aplasia/Hypoplasia of the fovea (HP:0008060)	1	0.9266	1.079214332	0.600439956	nervous
Denisovan	HPO	Hypoplasia of the fovea (HP:0007750)	1	0.9266	1.079214332	0.600439956	nervous
Denisovan	HPO	Polar cataract (HP:0010696)	1	0.9312	1.073883162	0.603639636	nervous
Denisovan	HPO	Recurrent viral infections (HP:0004429)	1	0.9275	1.078167116	0.604139586	immune
Denisovan	HPO	Synostosis of carpal bones (HP:0005048)	2	2.0409	0.979959822	0.605439456	skeletal
Denisovan	HPO	Gowers sign (HP:0003391)	1	0.9385	1.065530101	0.605639436	skeletal muscle
Denisovan	HPO	Opacification of the corneal stroma (HP:0007759)	7	7.3957	0.946495937	0.606639336	nervous
Denisovan	HPO	Acanthosis nigricans (HP:0000956)	1	0.9291	1.076310408	0.606839316	integumentary
Denisovan	HPO	Hyperthyroidism (HP:0000836)	1	0.9366	1.067691651	0.607839216	endocrine
Denisovan	HPO	Elevated hepatic transaminases (HP:0002910)	4	4.2131	0.949419667	0.608339166	digestive
Denisovan	HPO	Pectus carinatum (HP:0000768)	6	6.3279	0.948181861	0.608539146	skeletal
Denisovan	HPO	Tarsal synostosis (HP:0008368)	2	2.0677	0.967258306	0.609439056	skeletal
Denisovan	HPO	Heterochromia iridis (HP:0001100)	1	0.9444	1.058873359	0.611638836	integumentary
Denisovan	HPO	Genu varum (HP:0002970)	1	0.947	1.055966209	0.612338766	skeletal
Denisovan	HPO	Hypertelorism (HP:0000316)	23	24.0533	0.956209751	0.612738726	skeletal
Denisovan	HPO	High forehead (HP:0000348)	6	6.4023	0.937163207	0.613538646	skeletal
Denisovan	HPO	Cone-shaped epiphyses of the phalanges of the hand (HP:0010230)	1	0.9468	1.056189269	0.616038396	skeletal
Denisovan	HPO	Chorioretinal atrophy (HP:0000533)	1	0.9734	1.027326895	0.617038296	nervous
Denisovan	HPO	Sprengel anomaly (HP:0000912)	2	2.0868	0.958405214	0.617438256	skeletal
Denisovan	HPO	Nephrolithiasis (HP:0000787)	3	3.2229	0.930838686	0.617838216	urinary
Denisovan	HPO	Aortic regurgitation (HP:0001659)	1	0.9669	1.034233116	0.618638136	cardiovascular
Denisovan	HPO	Limited hip movement (HP:0008800)	3	3.1871	0.941294594	0.618838116	other
Denisovan	HPO	External ear malformation (HP:0008572)	4	4.2779	0.93503822	0.619138086	other
Denisovan	HPO	Abnormality of skull ossification (HP:0002703)	2	2.0898	0.957029381	0.619438056	skeletal
Denisovan	HPO	Intestinal atresia (HP:0011100)	1	0.9564	1.04558762	0.619538046	digestive
Denisovan	HPO	Anosmia (HP:0000458)	1	0.9608	1.040799334	0.619938006	nervous
Denisovan	HPO	Cranial hyperostosis (HP:0004437)	2	2.0996	0.952562393	0.620237976	skeletal
Denisovan	HPO	Viral hepatitis (HP:0006562)	1	0.9633	1.038098204	0.620237976	immune
Denisovan	HPO	Synostosis involving bones of the feet (HP:0009140)	2	2.1194	0.943663301	0.622337766	skeletal
Denisovan	HPO	Synostosis involving bones of the lower limbs (HP:0009138)	2	2.1194	0.943663301	0.622337766	skeletal
Denisovan	HPO	Gingivitis (HP:0000230)	1	0.9984	1.001602564	0.625437456	other
Denisovan	HPO	Bruising susceptibility (HP:0000978)	4	4.3085	0.928397354	0.626537346	other
Denisovan	HPO	Abnormal vertebral ossification (HP:0100569)	1	0.9931	1.006947941	0.627537246	skeletal
Denisovan	HPO	Short middle phalanx of finger (HP:0005819)	1	0.9758	1.024800164	0.627637236	skeletal
Denisovan	HPO	Delayed skeletal maturation (HP:0002750)	9	9.6508	0.932565176	0.628437156	skeletal
Denisovan	HPO	Premature birth (HP:0001622)	3	3.2223	0.93101201	0.629437056	reproductive
Denisovan	HPO	Anterior segment dysgenesis (HP:0007700)	1	1.0011	0.998901209	0.630236976	integumentary
Denisovan	HPO	Childhood onset (HP:0011463)	2	2.1456	0.932140194	0.630336966	other
Denisovan	HPO	Acute encephalopathy (HP:0006846)	1	1.0027	0.99730727	0.631036896	nervous
Denisovan	HPO	Macrocytic anemia (HP:0001972)	1	0.9815	1.018848701	0.632136786	hematologic
Denisovan	HPO	Renal tubular dysfunction (HP:0000124)	1	0.9958	1.004217714	0.632336766	urinary
Denisovan	HPO	Urethral obstruction (HP:0000796)	1	1.0092	0.990883868	0.632736726	urinary
Denisovan	HPO	Tapered finger (HP:0001182)	2	2.139	0.935016363	0.633336666	skeletal
Denisovan	HPO	Cortical visual impairment (HP:0100704)	1	1.0139	0.986290561	0.635636436	nervous
Denisovan	HPO	Abnormality of the fovea (HP:0000493)	1	1.0191	0.981257973	0.635736426	nervous
Denisovan	HPO	Female pseudohermaphroditism (HP:0010458)	4	4.3731	0.914682948	0.636436356	reproductive
Denisovan	HPO	Abnormality of the incisor (HP:0000676)	2	2.1753	0.919413414	0.637436256	skeletal
Denisovan	HPO	Bulbar palsy (HP:0001283)	1	1.0128	0.987361769	0.637436256	nervous
Denisovan	HPO	Chronic diarrhea (HP:0002028)	1	1.0305	0.970402717	0.637636236	digestive
Denisovan	HPO	Abnormality of T cells (HP:0002843)	1	1.0023	0.997705278	0.638736126	immune
Denisovan	HPO	Abnormality of the odontoid process (HP:0003310)	1	1.0327	0.968335431	0.640035996	skeletal
Denisovan	HPO	Hypoplasia of the odontoid process (HP:0003311)	1	1.0327	0.968335431	0.640035996	skeletal
Denisovan	HPO	Secondary amenorrhea (HP:0000869)	1	1.0208	0.979623824	0.640435956	reproductive
Denisovan	HPO	Congenital primary aphakia (HP:0007707)	1	1.0283	0.972478849	0.641035896	nervous
Denisovan	HPO	Gingival bleeding (HP:0000225)	1	1.0124	0.987751877	0.641335866	immune
Denisovan	HPO	Chin dimple (HP:0010751)	1	1.021	0.979431929	0.641735826	integumentary
Denisovan	HPO	Breast carcinoma (HP:0003002)	2	2.1784	0.918105031	0.641935806	reproductive
Denisovan	HPO	Depressed nasal bridge (HP:0005280)	17	18.1939	0.934379105	0.642735726	skeletal
Denisovan	HPO	Laryngomalacia (HP:0001601)	3	3.3191	0.90385948	0.646035396	other
Denisovan	HPO	Metatarsus adductus (HP:0001840)	1	1.038	0.963391137	0.646035396	skeletal
Denisovan	HPO	Micronodular cirrhosis (HP:0001413)	1	1.0414	0.960245823	0.646635336	digestive
Denisovan	HPO	Pancreatic cysts (HP:0001737)	1	1.057	0.946073794	0.648335166	digestive
Denisovan	HPO	Palpitations (HP:0001962)	1	1.0315	0.969461949	0.649535046	cardiovascular
Denisovan	HPO	Vertigo (HP:0002321)	3	3.3383	0.898660995	0.651834817	nervous
Denisovan	HPO	Hypercalciuria (HP:0002150)	1	1.0525	0.950118765	0.655034497	other
Denisovan	HPO	Corneal dystrophy (HP:0001131)	2	2.2533	0.887587094	0.655934407	nervous
Denisovan	HPO	Abnormality of primary teeth (HP:0006481)	2	2.2423	0.89194131	0.656634337	skeletal
Denisovan	HPO	Lower limb asymmetry (HP:0100559)	1	1.0725	0.932400932	0.659234077	skeletal
Denisovan	HPO	Cerebral cortical atrophy (HP:0002120)	8	8.8602	0.902914155	0.661233877	nervous
Denisovan	HPO	Abnormality of the sella turcica (HP:0002679)	1	1.0812	0.924898261	0.662133787	skeletal
Denisovan	HPO	Glomerulopathy (HP:0100820)	1	1.0858	0.920979923	0.662933707	urinary
Denisovan	HPO	Wide anterior fontanel (HP:0000260)	2	2.2827	0.87615543	0.665733427	skeletal
Denisovan	HPO	Hip dysplasia (HP:0001385)	1	1.0968	0.911743253	0.665833417	skeletal
Denisovan	HPO	Aqueductal stenosis (HP:0002410)	1	1.0959	0.912492016	0.668533147	nervous
Denisovan	HPO	Xerostomia (HP:0000217)	1	1.0984	0.910415149	0.669733027	digestive
Denisovan	HPO	Thick eyebrow (HP:0000574)	4	4.574	0.874508089	0.669933007	integumentary
Denisovan	HPO	Migraine (HP:0002076)	3	3.4426	0.871434381	0.670432957	nervous
Denisovan	HPO	Increased CSF lactate (HP:0002490)	1	1.1288	0.885896527	0.672332767	other
Denisovan	HPO	Anal stenosis (HP:0002025)	1	1.1218	0.891424496	0.672732727	digestive
Denisovan	HPO	Soft skin (HP:0000977)	1	1.1262	0.887941751	0.673932607	integumentary
Denisovan	HPO	Urticaria (HP:0001025)	1	1.1281	0.886446237	0.674432557	immune
Denisovan	HPO	Esotropia (HP:0000565)	2	2.3141	0.864266886	0.674532547	nervous
Denisovan	HPO	Low posterior hairline (HP:0002162)	2	2.3553	0.849148728	0.676032397	integumentary
Denisovan	HPO	Pectus excavatum (HP:0000767)	7	7.8929	0.886873012	0.676332367	skeletal
Denisovan	HPO	Carpal synostosis (HP:0009702)	2	2.3358	0.856237692	0.677132287	skeletal
Denisovan	HPO	Disproportionate short-trunk short stature (HP:0003521)	1	1.1417	0.875886835	0.677632237	skeletal
Denisovan	HPO	Gait imbalance (HP:0002141)	1	1.1358	0.880436697	0.678632137	nervous
Denisovan	HPO	Abnormality of the tricuspid valve (HP:0001702)	1	1.1442	0.873973082	0.678732127	cardiovascular
Denisovan	HPO	Clonus (HP:0002169)	1	1.1347	0.881290209	0.679832017	nervous
Denisovan	HPO	Abnormality of sulfur amino acid metabolism (HP:0004339)	1	1.1375	0.879120879	0.682831717	metabolic
Denisovan	HPO	Steppage gait (HP:0003376)	1	1.1498	0.869716472	0.683231677	skeletal muscle
Denisovan	HPO	Dandy-Walker malformation (HP:0001305)	5	5.815	0.859845228	0.685331467	nervous
Denisovan	HPO	Shallow orbits (HP:0000586)	1	1.1612	0.861178092	0.685431457	skeletal
Denisovan	HPO	Exercise intolerance (HP:0003546)	1	1.1518	0.868206286	0.685931407	other
Denisovan	HPO	Rigidity (HP:0002063)	3	3.5333	0.849064614	0.686031397	skeletal muscle
Denisovan	HPO	Abnormality of the renal medulla (HP:0100957)	2	2.3824	0.83948959	0.687331267	urinary
Denisovan	HPO	Nephritis (HP:0000123)	1	1.1705	0.854335754	0.689831017	urinary
Denisovan	HPO	Abnormality of the carotid arteries (HP:0005344)	1	1.1617	0.860807437	0.690530947	cardiovascular
Denisovan	HPO	Increased serum lactate (HP:0002151)	2	2.3869	0.837906909	0.692130787	other
Denisovan	HPO	"Intellectual disability, profound (HP:0002187)"	2	2.4044	0.831808351	0.692830717	nervous
Denisovan	HPO	Joint stiffness (HP:0001387)	1	1.1777	0.849112677	0.694430557	skeletal
Denisovan	HPO	Fine hair (HP:0002213)	2	2.4244	0.824946378	0.695930407	integumentary
Denisovan	HPO	Progressive visual loss (HP:0000529)	1	1.1901	0.840265524	0.696830317	nervous
Denisovan	HPO	Preauricular skin tag (HP:0000384)	3	3.6144	0.83001328	0.698230177	integumentary
Denisovan	HPO	Abnormality of the pons (HP:0007361)	1	1.1918	0.839066958	0.700929907	nervous
Denisovan	HPO	Hypoplasia of the pons (HP:0012110)	1	1.1918	0.839066958	0.700929907	nervous
Denisovan	HPO	Autism (HP:0000717)	7	8.1396	0.85999312	0.701629837	nervous
Denisovan	HPO	Cystic liver disease (HP:0006706)	1	1.2232	0.817527796	0.703129687	digestive
Denisovan	HPO	Hypoplasia of the iris (HP:0007676)	1	1.2118	0.825218683	0.703929607	integumentary
Denisovan	HPO	Hepatocellular carcinoma (HP:0001402)	1	1.2285	0.814000814	0.706529347	digestive
Denisovan	HPO	Incomplete penetrance (HP:0003829)	4	4.839	0.82661707	0.706629337	other
Denisovan	HPO	Narrow palate (HP:0000189)	2	2.4787	0.806874571	0.706729327	skeletal
Denisovan	HPO	Medial flaring of the eyebrow (HP:0010747)	1	1.234	0.810372771	0.708329167	integumentary
Denisovan	HPO	Epiphyseal dysplasia (HP:0002656)	1	1.2252	0.816193275	0.709129087	skeletal
Denisovan	HPO	Hyperkalemia (HP:0002153)	1	1.2204	0.819403474	0.709729027	other
Denisovan	HPO	Abnormality of the peritoneum (HP:0002585)	1	1.2443	0.803664711	0.713228677	digestive
Denisovan	HPO	Anal atresia (HP:0002023)	2	2.5064	0.797957229	0.713228677	digestive
Denisovan	HPO	Hemiplegia (HP:0002301)	1	1.2522	0.798594474	0.713328667	nervous
Denisovan	HPO	Synostosis involving bones of the hand (HP:0004278)	2	2.4936	0.802053256	0.713428657	skeletal
Denisovan	HPO	Agitation (HP:0000713)	1	1.2311	0.812281699	0.713728627	behavior
Denisovan	HPO	Recurrent otitis media (HP:0000403)	1	1.2508	0.799488327	0.714828517	nervous
Denisovan	HPO	Ventricular tachycardia (HP:0004756)	2	2.5114	0.796368559	0.716928307	cardiovascular
Denisovan	HPO	Acrocyanosis (HP:0001063)	1	1.2485	0.800961153	0.717928207	integumentary
Denisovan	HPO	Macular degeneration (HP:0000608)	1	1.2603	0.793461874	0.718228177	nervous
Denisovan	HPO	Triphalangeal thumb (HP:0001199)	2	2.5507	0.784098483	0.722127787	skeletal
Denisovan	HPO	Abnormality of the humerus (HP:0003063)	3	3.7502	0.799957336	0.722427757	skeletal
Denisovan	HPO	Emotional lability (HP:0000712)	1	1.2848	0.778331258	0.723227677	behavior
Denisovan	HPO	Horizontal nystagmus (HP:0000666)	2	2.5502	0.784252216	0.723927607	nervous
Denisovan	HPO	Broad ribs (HP:0000885)	1	1.2959	0.77166448	0.724627537	skeletal
Denisovan	HPO	Pulmonary hypertension (HP:0002092)	2	2.58	0.775193798	0.725227477	cardiovascular
Denisovan	HPO	Osteopenia (HP:0000938)	3	3.7816	0.793314999	0.727627237	skeletal
Denisovan	HPO	Aplasia/Hypoplasia of the middle phalanges of the hand (HP:0009843)	1	1.2886	0.776036008	0.729127087	skeletal
Denisovan	HPO	Coarse facial features (HP:0000280)	6	7.255	0.827015851	0.729827017	integumentary
Denisovan	HPO	Dysarthria (HP:0001260)	12	13.8586	0.865888329	0.730326967	nervous
Denisovan	HPO	Bicuspid aortic valve (HP:0001647)	1	1.3109	0.762834694	0.731226877	cardiovascular
Denisovan	HPO	Aortic dissection (HP:0002647)	1	1.3175	0.759013283	0.731826817	cardiovascular
Denisovan	HPO	Postural tremor (HP:0002174)	1	1.3367	0.74811102	0.732726727	nervous
Denisovan	HPO	Abnormality of the metopic suture (HP:0005556)	1	1.3162	0.759762954	0.735026497	skeletal
Denisovan	HPO	Abnormal delivery (HP:0001787)	1	1.302	0.768049155	0.735126487	reproductive
Denisovan	HPO	Down-sloping shoulders (HP:0200021)	1	1.3221	0.756372438	0.735626437	skeletal
Denisovan	HPO	Abnormality of the upper arm (HP:0001454)	3	3.8403	0.78118897	0.737926207	skeletal
Denisovan	HPO	Gliosis (HP:0002171)	3	3.8274	0.783821916	0.738726127	nervous
Denisovan	HPO	Scapular winging (HP:0003691)	1	1.3401	0.746212969	0.738826117	skeletal
Denisovan	HPO	Enlarged kidneys (HP:0000105)	1	1.3584	0.736160188	0.739626037	urinary
Denisovan	HPO	Patellar aplasia (HP:0006443)	1	1.3619	0.734268302	0.740025997	skeletal
Denisovan	HPO	Poor eye contact (HP:0000817)	1	1.3471	0.742335387	0.740525947	nervous
Denisovan	HPO	Retinitis pigmentosa (HP:0000510)	6	7.3631	0.81487417	0.743725627	integumentary
Denisovan	HPO	Epicanthus (HP:0000286)	16	18.3891	0.870080646	0.744225577	integumentary
Denisovan	HPO	Aplasia/Hypoplasia of the patella (HP:0006498)	1	1.3808	0.724217845	0.744525547	skeletal
Denisovan	HPO	Downslanted palpebral fissures (HP:0000494)	11	13.0085	0.845600953	0.746125387	integumentary
Denisovan	HPO	Umbilical hernia (HP:0001537)	12	14.0893	0.851710163	0.750224978	reproductive
Denisovan	HPO	Sepsis (HP:0100806)	1	1.3793	0.725005438	0.751324868	immune
Denisovan	HPO	Skin tags (HP:0010609)	3	3.947	0.76007094	0.752124788	integumentary
Denisovan	HPO	Abnormality of the pleura (HP:0002103)	1	1.3949	0.716897269	0.752424758	respiratory
Denisovan	HPO	Venous insufficiency (HP:0005293)	1	1.4027	0.712910815	0.754024598	cardiovascular
Denisovan	HPO	Nephroblastoma (Wilms tumor) (HP:0002667)	1	1.4068	0.710833096	0.754424558	urinary
Denisovan	HPO	Distal sensory impairment (HP:0002936)	2	2.6773	0.747021253	0.754624538	nervous
Denisovan	HPO	Decreased muscle mass (HP:0003199)	1	1.4179	0.705268355	0.754924508	skeletal muscle
Denisovan	HPO	Abolished electroretinogram (ERG) (HP:0000550)	2	2.7239	0.734241345	0.755224478	nervous
Denisovan	HPO	Abnormality of pyrimidine metabolism (HP:0004353)	1	1.418	0.705218618	0.755724428	metabolic
Denisovan	HPO	Abnormality of the renal cortex (HP:0011035)	1	1.4077	0.710378632	0.757224278	urinary
Denisovan	HPO	Congenital glaucoma (HP:0001087)	1	1.4473	0.690941754	0.757224278	nervous
Denisovan	HPO	Neoplasm of the liver (HP:0002896)	2	2.7494	0.72743144	0.759024098	digestive
Denisovan	HPO	Open mouth (HP:0000194)	3	3.9976	0.75045027	0.761023898	other
Denisovan	HPO	Hypodontia (HP:0000668)	2	2.7673	0.722726123	0.761323868	skeletal
Denisovan	HPO	Skin rash (HP:0000988)	1	1.4448	0.69213732	0.762223778	immune
Denisovan	HPO	Pulmonary fibrosis (HP:0002206)	1	1.4422	0.693385106	0.763923608	respiratory
Denisovan	HPO	Full cheeks (HP:0000293)	2	2.7526	0.726585773	0.764023598	other
Denisovan	HPO	Restlessness (HP:0000711)	1	1.4245	0.702000702	0.764723528	behavior
Denisovan	HPO	Short neck (HP:0000470)	13	15.4431	0.841799898	0.769323068	skeletal
Denisovan	HPO	Broad hallux (HP:0010055)	1	1.4667	0.681802686	0.769623038	skeletal
Denisovan	HPO	Hypothyroidism (HP:0000821)	6	7.6153	0.787887542	0.769723028	endocrine
Denisovan	HPO	Hypoplastic iliac wings (HP:0002866)	1	1.4672	0.681570338	0.770522948	skeletal
Denisovan	HPO	Broad foot (HP:0001769)	2	2.7924	0.716229767	0.771022898	skeletal
Denisovan	HPO	Depressed nasal ridge (HP:0000457)	4	5.2696	0.759070897	0.772622738	skeletal
Denisovan	HPO	2-3 toe syndactyly (HP:0004691)	1	1.4937	0.669478476	0.773922608	skeletal
Denisovan	HPO	Non-midline cleft lip (HP:0100335)	2	2.8198	0.709270161	0.776222378	other
Denisovan	HPO	Anonychia (HP:0001798)	2	2.8558	0.700329155	0.776522348	integumentary
Denisovan	HPO	Meningitis (HP:0001287)	1	1.529	0.654022237	0.777222278	nervous
Denisovan	HPO	Abnormality of saccadic eye movements (HP:0000570)	2	2.879	0.694685655	0.778922108	nervous
Denisovan	HPO	Generalized hypopigmentation (HP:0007513)	1	1.5053	0.664319405	0.780021998	integumentary
Denisovan	HPO	Growth hormone deficiency (HP:0000824)	2	2.8759	0.695434473	0.780421958	endocrine
Denisovan	HPO	Decreased lacrimation (HP:0000633)	1	1.5341	0.651847989	0.780521948	other
Denisovan	HPO	Blue sclerae (HP:0000592)	2	2.895	0.690846287	0.785021498	integumentary
Denisovan	HPO	Bradykinesia (HP:0002067)	2	2.9085	0.687639677	0.786121388	nervous
Denisovan	HPO	Epileptic encephalopathy (HP:0200134)	2	2.9052	0.688420763	0.786421358	nervous
Denisovan	HPO	Congenital diaphragmatic hernia (HP:0000776)	3	4.1533	0.722317194	0.786521348	respiratory
Denisovan	HPO	Adrenal overactivity (HP:0002717)	1	1.5394	0.649603742	0.788421158	endocrine
Denisovan	HPO	Ventricular fibrillation (HP:0001663)	1	1.585	0.630914826	0.791320868	cardiovascular
Denisovan	HPO	Hypoplasia of dental enamel (HP:0006297)	1	1.587	0.630119723	0.791920808	skeletal
Denisovan	HPO	Radioulnar synostosis (HP:0002974)	2	2.9865	0.669680228	0.795120488	skeletal
Denisovan	HPO	Wormian bones (HP:0002645)	1	1.5813	0.632391071	0.795620438	skeletal
Denisovan	HPO	Small hand (HP:0200055)	1	1.5729	0.635768326	0.796220378	skeletal
Denisovan	HPO	"Intellectual disability, mild (HP:0001256)"	3	4.2576	0.704622322	0.797120288	nervous
Denisovan	HPO	Dialeptic seizures (HP:0011146)	1	1.5949	0.626998558	0.798520148	nervous
Denisovan	HPO	Clubbing of toes (HP:0100760)	1	1.5702	0.636861546	0.798620138	integumentary
Denisovan	HPO	Abnormality of the basal ganglia (HP:0002134)	1	1.6026	0.623986023	0.799020098	nervous
Denisovan	HPO	Chorioretinal coloboma (HP:0000567)	2	2.998	0.667111408	0.800519948	nervous
Denisovan	HPO	Bifid uvula (HP:0000193)	1	1.5875	0.62992126	0.802719728	other
Denisovan	HPO	"Low-set, posteriorly rotated ears (HP:0000368)"	20	23.6316	0.846324413	0.803219678	other
Denisovan	HPO	Somatic mutation (HP:0001428)	3	4.2794	0.701032855	0.803919608	other
Denisovan	HPO	Brachycephaly (HP:0000248)	3	4.3319	0.692536762	0.805519448	skeletal
Denisovan	HPO	Aneurysm (HP:0002617)	3	4.3569	0.688562969	0.805719428	nervous
Denisovan	HPO	Anencephaly (HP:0002323)	1	1.6626	0.601467581	0.805819418	nervous
Denisovan	HPO	Type II lissencephaly (HP:0007260)	1	1.6319	0.612782646	0.807319268	skeletal
Denisovan	HPO	Bone marrow hypocellularity (HP:0005528)	1	1.6306	0.613271189	0.807519248	other
Denisovan	HPO	Camptodactyly of toe (HP:0001836)	1	1.6519	0.605363521	0.807819218	skeletal
Denisovan	HPO	Arnold-Chiari malformation (HP:0002308)	1	1.6485	0.606612072	0.809119088	skeletal
Denisovan	HPO	Thin skin (HP:0000963)	2	3.0583	0.653958081	0.810318968	integumentary
Denisovan	HPO	Long eyelashes (HP:0000527)	1	1.6632	0.601250601	0.811218878	integumentary
Denisovan	HPO	Onion bulb formation (HP:0003383)	1	1.636	0.611246944	0.811618838	nervous
Denisovan	HPO	Abnormality of the pericardium (HP:0001697)	1	1.6921	0.59098162	0.818418158	cardiovascular
Denisovan	HPO	Dysmetria (HP:0001310)	3	4.454	0.673551863	0.818518148	nervous
Denisovan	HPO	Tracheomalacia (HP:0002779)	1	1.6928	0.59073724	0.820017998	respiratory
Denisovan	HPO	Embryonal renal neoplasm (HP:0011794)	1	1.7249	0.579743753	0.822217778	urinary
Denisovan	HPO	Delayed eruption of teeth (HP:0000684)	4	5.7249	0.698702161	0.826817318	skeletal
Denisovan	HPO	Genu recurvatum (HP:0002816)	1	1.7471	0.572377082	0.827017298	skeletal muscle
Denisovan	HPO	Mitral regurgitation (HP:0001653)	1	1.7581	0.568795859	0.827917208	cardiovascular
Denisovan	HPO	Broad toe (HP:0001837)	1	1.7643	0.56679703	0.828317168	skeletal
Denisovan	HPO	Hammertoe (HP:0001765)	1	1.7546	0.569930468	0.830416958	skeletal
Denisovan	HPO	Abnormality of the anterior chamber (HP:0000593)	1	1.8077	0.553189135	0.830716928	nervous
Denisovan	HPO	Macrotia (HP:0000400)	4	5.8248	0.686718857	0.832416758	other
Denisovan	HPO	Alveolar cell carcinoma (HP:0006519)	1	1.7987	0.55595708	0.832716728	respiratory
Denisovan	HPO	Micromelia (HP:0002983)	7	9.5157	0.735626386	0.839616038	skeletal
Denisovan	HPO	Flat face (HP:0012368)	2	3.2767	0.61037019	0.841215878	skeletal
Denisovan	HPO	Broad nasal tip (HP:0000455)	1	1.8248	0.548005261	0.842015798	integumentary
Denisovan	HPO	Progressive neurologic deterioration (HP:0002344)	2	3.3085	0.604503551	0.842415758	nervous
Denisovan	HPO	Delayed gross motor development (HP:0002194)	2	3.3138	0.603536725	0.842815718	nervous
Denisovan	HPO	Microtia (HP:0008551)	2	3.324	0.601684717	0.843415658	nervous
Denisovan	HPO	Neoplasm of the tracheobronchial system (HP:0100552)	1	1.8654	0.536078053	0.844815518	respiratory
Denisovan	HPO	Attenuation of retinal blood vessels (HP:0007843)	2	3.3224	0.601974476	0.846015398	cardiovascular
Denisovan	HPO	Gynecomastia (HP:0000771)	1	1.8828	0.531123858	0.846115388	endocrine
Denisovan	HPO	Preaxial foot polydactyly (HP:0001841)	1	1.9059	0.5246865	0.847215278	skeletal
Denisovan	HPO	Respiratory failure (HP:0002878)	1	1.8421	0.542858694	0.848015198	respiratory
Denisovan	HPO	Absent toe (HP:0010760)	1	1.8738	0.533674885	0.851314869	skeletal
Denisovan	HPO	Oculomotor apraxia (HP:0000657)	1	1.9335	0.517196793	0.856214379	nervous
Denisovan	HPO	Blue irides (HP:0000635)	1	1.9374	0.516155673	0.857614239	integumentary
Denisovan	HPO	Decreased skull ossification (HP:0004331)	1	1.9693	0.507794648	0.858414159	skeletal
Denisovan	HPO	Lymphedema (HP:0001004)	1	1.9217	0.520372587	0.858814119	lymphatic
Denisovan	HPO	Postural instability (HP:0002172)	1	2.0039	0.499026898	0.859314069	other
Denisovan	HPO	Hamartoma (HP:0010566)	1	1.9577	0.510803494	0.860613939	other
Denisovan	HPO	Precocious puberty (HP:0000826)	1	1.9742	0.506534292	0.860713929	endocrine
Denisovan	HPO	Primary amenorrhea (HP:0000786)	2	3.5058	0.570483199	0.862713729	reproductive
Denisovan	HPO	Abnormality of the middle phalanges of the hand (HP:0009833)	1	1.9764	0.505970451	0.865213479	skeletal
Denisovan	HPO	Short foot (HP:0001773)	3	4.8963	0.612707555	0.865913409	skeletal
Denisovan	HPO	"Intellectual disability, severe (HP:0010864)"	2	3.5341	0.565914943	0.866613339	nervous
Denisovan	HPO	Postnatal growth retardation (HP:0008897)	3	4.8507	0.618467438	0.866613339	metabolic
Denisovan	HPO	Sporadic (HP:0003745)	2	3.5109	0.569654505	0.867413259	other
Denisovan	HPO	Vasculitis (HP:0002633)	1	2.0352	0.491352201	0.867713229	cardiovascular
Denisovan	HPO	Hypoplastic ilia (HP:0000946)	1	2.028	0.493096647	0.870312969	skeletal
Denisovan	HPO	Broad thumb (HP:0011304)	1	2.0537	0.486926036	0.872612739	skeletal
Denisovan	HPO	Depression (HP:0000716)	1	2.106	0.474833808	0.877412259	behavior
Denisovan	HPO	Abnormal eating behavior (HP:0100738)	1	2.1136	0.473126419	0.878012199	behavior
Denisovan	HPO	Hypoplasia of the ulna (HP:0003022)	1	2.0931	0.47776026	0.879712029	skeletal
Denisovan	HPO	Lack of skin elasticity (HP:0100679)	1	2.1388	0.467551898	0.882211779	integumentary
Denisovan	HPO	Deviation of the hallux (HP:0010051)	1	2.1576	0.463477938	0.882911709	skeletal
Denisovan	HPO	Melanocytic nevus (HP:0000995)	1	2.1519	0.464705609	0.883711629	integumentary
Denisovan	HPO	Type II diabetes mellitus (HP:0005978)	4	6.3938	0.625606056	0.884711529	metabolic
Denisovan	HPO	Thick lower lip vermilion (HP:0000179)	3	5.1183	0.586132114	0.885711429	integumentary
Denisovan	HPO	Increased nuchal translucency (HP:0010880)	1	2.2088	0.452734516	0.887211279	other
Denisovan	HPO	Venous abnormality (HP:0002624)	1	2.1744	0.459896983	0.888511149	cardiovascular
Denisovan	HPO	Ovarian neoplasm (HP:0100615)	3	5.1469	0.582875129	0.888611139	reproductive
Denisovan	HPO	Bradycardia (HP:0001662)	1	2.2109	0.452304491	0.888711129	cardiovascular
Denisovan	HPO	Arteriovenous malformation (HP:0100026)	1	2.1822	0.458253139	0.890010999	cardiovascular
Denisovan	HPO	Ocular albinism (HP:0001107)	1	2.2172	0.451019304	0.891510849	nervous
Denisovan	HPO	Embryonal neoplasm (HP:0002898)	1	2.2058	0.453350258	0.891610839	other
Denisovan	HPO	Abnormality of nucleobase metabolism (HP:0010932)	1	2.2368	0.447067239	0.894110589	metabolic
Denisovan	HPO	Gingival overgrowth (HP:0000212)	2	3.8147	0.524287624	0.894610539	immune
Denisovan	HPO	Impaired smooth pursuit (HP:0007772)	1	2.3323	0.428761309	0.894710529	nervous
Denisovan	HPO	Spinal canal stenosis (HP:0003416)	1	2.2206	0.45032874	0.894810519	skeletal
Denisovan	HPO	Hypoplastic female external genitalia (HP:0012815)	1	2.2829	0.438039336	0.896310369	reproductive
Denisovan	HPO	Narrow face (HP:0000275)	1	2.271	0.440334654	0.898010199	skeletal
Denisovan	HPO	Single transverse palmar crease (HP:0000954)	5	7.9392	0.629786376	0.898710129	integumentary
Denisovan	HPO	Renal agenesis (HP:0000104)	1	2.2832	0.43798178	0.898710129	urinary
Denisovan	HPO	Protruding tongue (HP:0010808)	1	2.3275	0.429645542	0.899210079	other
Denisovan	HPO	Retinal detachment (HP:0000541)	3	5.3841	0.557196189	0.901209879	nervous
Denisovan	HPO	Constricted visual fields (HP:0001133)	1	2.3147	0.432021428	0.901809819	nervous
Denisovan	HPO	Hypocalcemia (HP:0002901)	1	2.3204	0.430960179	0.903409659	other
Denisovan	HPO	Bronchiectasis (HP:0002110)	1	2.3545	0.424718624	0.905509449	respiratory
Denisovan	HPO	Frontal bossing (HP:0002007)	10	14.3708	0.695855485	0.905509449	skeletal
Denisovan	HPO	Iris hypopigmentation (HP:0007730)	1	2.3594	0.423836569	0.906309369	integumentary
Denisovan	HPO	Cutis marmorata (HP:0000965)	1	2.3852	0.419252054	0.908809119	integumentary
Denisovan	HPO	Aplasia/Hypoplasia of the lens (HP:0008063)	1	2.4514	0.407930162	0.909809019	nervous
Denisovan	HPO	Fibular hypoplasia (HP:0003038)	1	2.4392	0.409970482	0.912408759	skeletal
Denisovan	HPO	Skin ulcer (HP:0200042)	2	4.1896	0.477372542	0.914608539	integumentary
Denisovan	HPO	Aplasia/Hypoplasia of the ulna (HP:0006495)	1	2.448	0.408496732	0.914808519	skeletal
Denisovan	HPO	Anxiety (HP:0000739)	1	2.4303	0.411471835	0.915408459	behavior
Denisovan	HPO	Dental malocclusion (HP:0000689)	4	6.9612	0.574613572	0.915608439	skeletal
Denisovan	HPO	Hydronephrosis (HP:0000126)	2	4.2079	0.475296466	0.917408259	urinary
Denisovan	HPO	Broad phalanges of the hand (HP:0009768)	1	2.5289	0.395428843	0.922207779	skeletal
Denisovan	HPO	Broad finger (HP:0001500)	1	2.5389	0.393871362	0.923107689	skeletal
Denisovan	HPO	Abnormality of ocular smooth pursuit (HP:0000617)	1	2.6926	0.371388249	0.925007499	nervous
Denisovan	HPO	Pes cavus (HP:0001761)	3	5.7105	0.525348043	0.925507449	skeletal
Denisovan	HPO	Narrow forehead (HP:0000341)	2	4.3024	0.464856824	0.925907409	skeletal
Denisovan	HPO	Dysdiadochokinesis (HP:0002075)	1	2.6715	0.374321542	0.929407059	nervous
Denisovan	HPO	Carious teeth (HP:0000670)	3	5.8216	0.515322248	0.931206879	skeletal
Denisovan	HPO	Forearm undergrowth (HP:0009821)	1	2.6748	0.373859728	0.931806819	skeletal
Denisovan	HPO	Rhizomelia (HP:0008905)	1	2.7237	0.36714763	0.932006799	skeletal muscle
Denisovan	HPO	Abnormality of the humeroradial joint (HP:0100744)	1	2.6623	0.37561507	0.934406559	skeletal
Denisovan	HPO	Malar flattening (HP:0000272)	9	13.8229	0.651093475	0.934706529	skeletal
Denisovan	HPO	Hypsarrhythmia (HP:0002521)	1	2.6889	0.37189929	0.936006399	cardiovascular
Denisovan	HPO	Short palm (HP:0004279)	3	5.9893	0.50089326	0.936306369	skeletal
Denisovan	HPO	Midface retrusion (HP:0011800)	2	4.5513	0.439434887	0.940405959	skeletal
Denisovan	HPO	Abnormal blistering of the skin (HP:0008066)	1	2.8824	0.346933111	0.941905809	integumentary
Denisovan	HPO	Osteoarthritis (HP:0002758)	1	2.8371	0.352472595	0.943205679	skeletal
Denisovan	HPO	Muscular hypotonia of the trunk (HP:0008936)	1	2.823	0.354233085	0.943705629	skeletal muscle
Denisovan	HPO	Broad phalanx (HP:0006009)	1	2.9104	0.343595382	0.947405259	skeletal
Denisovan	HPO	Broad long bones (HP:0005622)	1	2.9555	0.338352225	0.950005	skeletal
Denisovan	HPO	Truncal ataxia (HP:0002078)	1	3.029	0.330141961	0.95070493	nervous
Denisovan	HPO	Hyperextensible skin (HP:0000974)	1	3.0084	0.332402606	0.95340466	integumentary
Denisovan	HPO	Brachydactyly syndrome (HP:0001156)	9	14.6947	0.612465719	0.95780422	skeletal
Denisovan	HPO	Prominent forehead (HP:0011220)	1	3.2854	0.30437694	0.96010399	skeletal
Denisovan	HPO	Aplasia/Hypoplasia of the fibula (HP:0006492)	1	3.2775	0.305110603	0.96210379	skeletal
Denisovan	HPO	Polycystic ovaries (HP:0000147)	1	3.2716	0.305660839	0.96350365	reproductive
Denisovan	HPO	Bony spicule pigmentary retinopathy (HP:0007737)	1	3.2875	0.30418251	0.96450355	nervous
Denisovan	HPO	EEG with generalized epileptiform discharges (HP:0011198)	1	3.3796	0.295893005	0.96760324	nervous
Denisovan	HPO	Short nose (HP:0003196)	5	9.9252	0.503768186	0.96980302	skeletal
Denisovan	HPO	Abnormality of salivation (HP:0100755)	1	3.4958	0.286057555	0.96990301	digestive
Denisovan	HPO	Impaired social interactions (HP:0000735)	1	4.0391	0.247579906	0.98030197	behavior
Denisovan	HPO	Abnormal social behavior (HP:0012433)	1	4.0391	0.247579906	0.98030197	behavior
Denisovan	HPO	Abnormality of the fibula (HP:0002991)	1	3.9381	0.25392956	0.98220178	skeletal
Denisovan	HPO	Cerebellar atrophy (HP:0001272)	5	10.6725	0.468493792	0.98410159	nervous
Denisovan	HPO	Epileptiform EEG discharges (HP:0011182)	1	4.1154	0.242989746	0.98430157	nervous
Denisovan	HPO	Broad forehead (HP:0000337)	1	4.2444	0.235604561	0.98620138	skeletal
Denisovan	HPO	Recurrent fractures (HP:0002757)	2	6.4184	0.311604138	0.9880012	skeletal
Denisovan	HPO	Aplasia/Hypoplasia of the abdominal wall musculature (HP:0010318)	1	4.431	0.22568269	0.9890011	skeletal muscle
Denisovan	HPO	Limb ataxia (HP:0002070)	1	5.3034	0.188558283	0.99330067	nervous
Denisovan	HPO	Babinski sign (HP:0003487)	2	7.3717	0.271307839	0.99420058	nervous
Denisovan	HPO	Gait ataxia (HP:0002066)	1	5.367	0.186323831	0.99570043	nervous
Denisovan	HPO	Abnormality of the fingernails (HP:0001231)	1	6.8665	0.145634603	0.99870013	integumentary
Neanderthal	GWAS	Lipoprotein phospholipase A2 activity in cardiovascular disease	4	0.3967	10.08318629	0.00109989	metabolic
Neanderthal	GWAS	Obese vs. thin	3	0.3227	9.296560273	0.00269973	metabolic
Neanderthal	GWAS	Optic nerve measurement (rim area)	2	0.1174	17.03577513	0.0059994	nervous
Neanderthal	GWAS	Early onset atrial fibrillation	2	0.1144	17.48251748	0.00619938	cardiovascular
Neanderthal	GWAS	Multiple sclerosis--Brain Glutamate Levels	2	0.1262	15.84786054	0.00769923	nervous
Neanderthal	GWAS	Phosphorus levels	2	0.1373	14.56664239	0.00949905	other
Neanderthal	GWAS	Dietary macronutrient intake	2	0.1466	13.6425648	0.00969903	behavior
Neanderthal	GWAS	Metabolic syndrome (multivariate analysis)	1	0.0098	102.0408163	0.00979902	metabolic
Neanderthal	GWAS	Triglycerides-Blood Pressure (TG-BP)	1	0.0098	102.0408163	0.00979902	metabolic
Neanderthal	GWAS	HDL Cholesterol - Triglycerides (HDLC-TG)	1	0.0098	102.0408163	0.00979902	metabolic
Neanderthal	GWAS	ALT levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	4	0.8438	4.740459825	0.0109989	other
Neanderthal	GWAS	Response to taxane treatment (placlitaxel)	2	0.1706	11.72332943	0.0119988	other
Neanderthal	GWAS	Lupus nephritis in systemic lupus erythematosus	2	0.1683	11.8835413	0.01259874	urinary
Neanderthal	GWAS	Body mass index (adult)	3	0.5022	5.973715651	0.01269873	metabolic
Neanderthal	GWAS	Language performance in older adults (adjusted for episodic memory)	2	0.1746	11.45475372	0.01369863	nervous
Neanderthal	GWAS	Hippocampal tail volume	2	0.1843	10.85187195	0.01429857	nervous
Neanderthal	GWAS	Type 2 diabetes nephropathy including microalbuminuria	2	0.1873	10.67805659	0.01559844	metabolic
Neanderthal	GWAS	Tenofovir clearance in HIV infection	3	0.5329	5.629574029	0.01679832	other
Neanderthal	GWAS	Malaria	1	0.017	58.82352941	0.01709829	immune
Neanderthal	GWAS	Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor	1	0.0199	50.25125628	0.019998	hematologic
Neanderthal	GWAS	Serum parathyroid hormone levels	1	0.0209	47.84688995	0.02089791	endocrine
Neanderthal	GWAS	Anxiety disorder	2	0.2391	8.364700962	0.02579742	behavior
Neanderthal	GWAS	Autism spectrum disorder or schizophrenia	13	6.9124	1.880678201	0.02609739	behavior
Neanderthal	GWAS	Inflammatory bowel disease	13	6.9882	1.860278756	0.02629737	digestive
Neanderthal	GWAS	Metabolic syndrome (bivariate traits)	1	0.0359	27.8551532	0.0349965	metabolic
Neanderthal	GWAS	Hippocampal subfield CA3 volume	2	0.2934	6.816632584	0.03659634	nervous
Neanderthal	GWAS	Hippocampal subfield CA1 volume	2	0.2934	6.816632584	0.03659634	nervous
Neanderthal	GWAS	Schizophrenia (inflammation and infection response interaction)	2	0.2943	6.795786612	0.03669633	behavior
Neanderthal	GWAS	Ulcerative colitis	9	4.4107	2.040492439	0.03749625	digestive
Neanderthal	GWAS	Activated partial thromboplastin time	2	0.302	6.622516556	0.03769623	hematologic
Neanderthal	GWAS	Body fat percentage	2	0.3053	6.550933508	0.03859614	metabolic
Neanderthal	GWAS	Dentate gyrus molecular layer volume	2	0.3087	6.478781989	0.03979602	nervous
Neanderthal	GWAS	Sitting height ratio	2	0.3357	5.957700328	0.04479552	skeletal
Neanderthal	GWAS	Panic disorder	2	0.369	5.420054201	0.053194681	behavior
Neanderthal	GWAS	Dysmenorrheic pain	1	0.061	16.39344262	0.059194081	reproductive
Neanderthal	GWAS	Hippocampal subfield CA4 volume	2	0.3923	5.098139179	0.060693931	nervous
Neanderthal	GWAS	Dentate gyrus granule cell layer volume	2	0.3923	5.098139179	0.060693931	nervous
Neanderthal	GWAS	Barrett's esophagus	2	0.3978	5.027652086	0.061893811	digestive
Neanderthal	GWAS	Triglycerides	7	3.4661	2.01956089	0.065593441	metabolic
Neanderthal	GWAS	Alcoholic chronic pancreatitis	3	0.931	3.222341568	0.065593441	endocrine
Neanderthal	GWAS	Brain connectivity	2	0.406	4.926108374	0.065793421	nervous
Neanderthal	GWAS	Congenital left-sided heart lesions	1	0.0709	14.10437236	0.069193081	cardiovascular
Neanderthal	GWAS	Ischemic stroke (large artery atherosclerosis)	2	0.426	4.694835681	0.069893011	cardiovascular
Neanderthal	GWAS	Small cell lung carcinoma	3	0.9408	3.18877551	0.069993001	respiratory
Neanderthal	GWAS	QRS complex (Cornell)	1	0.072	13.88888889	0.070092991	cardiovascular
Neanderthal	GWAS	Total hippocampal volume	2	0.4339	4.609356995	0.070992901	nervous
Neanderthal	GWAS	Delta-5 desaturase activity response to n3-polyunsaturated fat supplement	1	0.076	13.15789474	0.073192681	other
Neanderthal	GWAS	Circulating fibroblast growth factor 23 levels	2	0.4515	4.429678848	0.075492451	other
Neanderthal	GWAS	Progranulin levels	1	0.0807	12.39157373	0.077492251	nervous
Neanderthal	GWAS	Cerebellum growth	1	0.0846	11.82033097	0.080491951	nervous
Neanderthal	GWAS	Neurofibrillary tangles	2	0.4772	4.191114837	0.083191681	nervous
Neanderthal	GWAS	Response to antidepressants (symptom improvement)	3	1.0291	2.915168594	0.083991601	other
Neanderthal	GWAS	Cardiovascular disease risk factors	1	0.0951	10.51524711	0.090090991	cardiovascular
Neanderthal	GWAS	Esophageal adenocarcinoma	1	0.0981	10.19367992	0.094290571	digestive
Neanderthal	GWAS	Heart rate	2	0.5151	3.882741215	0.095490451	cardiovascular
Neanderthal	GWAS	Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)	1	0.1017	9.832841691	0.096490351	other
Neanderthal	GWAS	Body mass index in physically inactive individuals	2	0.523	3.824091778	0.098290171	metabolic
Neanderthal	GWAS	White blood cell count (basophil)	4	1.7144	2.333177788	0.099090091	immune
Neanderthal	GWAS	Serum total protein level	3	1.1016	2.723311547	0.102589741	other
Neanderthal	GWAS	Macular telangiectasia type 2	1	0.1099	9.099181074	0.103889611	nervous
Neanderthal	GWAS	Albumin-globulin ratio	4	1.7677	2.262827403	0.105289471	other
Neanderthal	GWAS	Adiposity	2	0.5519	3.623844899	0.109089091	metabolic
Neanderthal	GWAS	Antibody level in response to infection	1	0.1151	8.688097307	0.110388961	immune
Neanderthal	GWAS	Waist-to-hip ratio adjusted for BMI (age >50)	5	2.5423	1.966723046	0.111288871	skeletal
Neanderthal	GWAS	Non-alcoholic fatty liver disease histology (lobular)	1	0.1196	8.361204013	0.111988801	digestive
Neanderthal	GWAS	Barrett's esophagus  or Esophageal adenocarcinoma	2	0.5819	3.43701667	0.114688531	digestive
Neanderthal	GWAS	Hip circumference	4	1.8648	2.145002145	0.116588341	skeletal
Neanderthal	GWAS	Nephrolithiasis	1	0.1233	8.110300081	0.117388261	urinary
Neanderthal	GWAS	Metabolic traits	2	0.5987	3.340571238	0.119588041	metabolic
Neanderthal	GWAS	Atrial fibrillation	7	4.1193	1.699317845	0.120287971	cardiovascular
Neanderthal	GWAS	Zinc levels	3	1.2022	2.495425054	0.122887711	other
Neanderthal	GWAS	Optic nerve measurement (cup-to-disc ratio)	1	0.1318	7.587253414	0.124187581	nervous
Neanderthal	GWAS	Metabolic syndrome	2	0.6189	3.231539829	0.124487551	metabolic
Neanderthal	GWAS	Vitamin B levels in ischemic stroke	1	0.1325	7.547169811	0.125087491	other
Neanderthal	GWAS	circulating leptin levels	1	0.1381	7.241129616	0.128987101	metabolic
Neanderthal	GWAS	Type 2 diabetes (dietary heme iron intake interaction)	1	0.1384	7.225433526	0.129387061	metabolic
Neanderthal	GWAS	Sexual dimorphism in anthropometric traits	1	0.1409	7.097232079	0.130986901	skeletal
Neanderthal	GWAS	Hip circumference adjusted for BMI	4	1.9462	2.055287226	0.132986701	skeletal
Neanderthal	GWAS	HDL cholesterol levels	4	1.9615	2.039255672	0.138386161	metabolic
Neanderthal	GWAS	Cholesterol efflux capacity	1	0.1512	6.613756614	0.140285971	metabolic
Neanderthal	GWAS	Susceptibility to persistent hepatitis B virus infection	1	0.1518	6.587615283	0.141285871	immune
Neanderthal	GWAS	Iron status biomarkers (ferritin levels)	1	0.1546	6.468305304	0.144085591	other
Neanderthal	GWAS	Body mass index in physically active individuals	5	2.7838	1.796106042	0.144385561	metabolic
Neanderthal	GWAS	Cocaine dependence	1	0.1555	6.430868167	0.144585541	behavior
Neanderthal	GWAS	Peanut allergy (parent-of-origin effect)	1	0.1612	6.203473945	0.148985101	immune
Neanderthal	GWAS	Incident atrial fibrillation	1	0.1632	6.12745098	0.149285071	cardiovascular
Neanderthal	GWAS	Body mass index (age>50)	3	1.322	2.269288956	0.151184882	metabolic
Neanderthal	GWAS	Response to quetiapine in schizophrenia	1	0.1641	6.093845216	0.151584842	other
Neanderthal	GWAS	Blood trace element (Zn levels)	1	0.1657	6.035003018	0.151784822	other
Neanderthal	GWAS	Educational attainment	3	1.3375	2.242990654	0.151884812	other
Neanderthal	GWAS	Osteoarthritis (hip)	2	0.6947	2.87894055	0.152884712	skeletal
Neanderthal	GWAS	Biomedical quantitative traits	1	0.1671	5.984440455	0.153484652	other
Neanderthal	GWAS	"Schizophrenia, bipolar disorder and depression (combined)"	1	0.1672	5.980861244	0.154184582	behavior
Neanderthal	GWAS	"Bone mineral density (paediatric, lower limb)"	1	0.1675	5.970149254	0.154384562	skeletal
Neanderthal	GWAS	Lipid traits	1	0.1676	5.966587112	0.154384562	metabolic
Neanderthal	GWAS	Age at smoking initiation in chronic obstructive pulmonary disease	1	0.1691	5.913660556	0.156784322	respiratory
Neanderthal	GWAS	HDL cholesterol	7	4.4027	1.58993345	0.160483952	metabolic
Neanderthal	GWAS	Thiopurine-induced leukopenia in inflammatory bowel disease	1	0.1738	5.753739931	0.161683832	other
Neanderthal	GWAS	Pelvic organ prolapse	2	0.724	2.762430939	0.161983802	skeletal muscle
Neanderthal	GWAS	Body mass index (joint analysis main effects and physical activity interaction)	5	2.8964	1.7262809	0.163083692	metabolic
Neanderthal	GWAS	Triglyceride levels	3	1.3967	2.147920097	0.163883612	metabolic
Neanderthal	GWAS	Kidney function decline traits	1	0.1816	5.50660793	0.165683432	urinary
Neanderthal	GWAS	Waist-to-hip ratio adjusted for BMI	7	4.4715	1.5654702	0.166083392	skeletal
Neanderthal	GWAS	Major depressive disorder (broad)	1	0.181	5.524861878	0.166483352	behavior
Neanderthal	GWAS	Anticoagulant levels	1	0.187	5.347593583	0.169983002	hematologic
Neanderthal	GWAS	Dehydroepiandrosterone sulphate levels	1	0.1879	5.321979776	0.170782922	other
Neanderthal	GWAS	Sulfasalazine-induced agranulocytosis	1	0.1902	5.257623554	0.174882512	hematologic
Neanderthal	GWAS	Longitudinal change in brain amyloid plaque burden	1	0.1963	5.094243505	0.178682132	nervous
Neanderthal	GWAS	Bone fracture in osteoporosis	1	0.1961	5.099439062	0.179082092	skeletal
Neanderthal	GWAS	High density lipoprotein cholesterol levels	3	1.4558	2.060722627	0.181881812	metabolic
Neanderthal	GWAS	Dialysis-related mortality	2	0.7809	2.561147394	0.182681732	other
Neanderthal	GWAS	Total bilirubin levels in HIV-1 infection	1	0.2045	4.88997555	0.183081692	digestive
Neanderthal	GWAS	Lipid metabolism phenotypes	1	0.2042	4.897159647	0.185181482	metabolic
Neanderthal	GWAS	Amino acid levels	1	0.2028	4.930966469	0.185381462	other
Neanderthal	GWAS	Inflammatory biomarkers	2	0.7964	2.511300854	0.191680832	immune
Neanderthal	GWAS	Initial pursuit acceleration	5	3.0652	1.631214929	0.197880212	nervous
Neanderthal	GWAS	Obesity (extreme)	2	0.8192	2.44140625	0.198080192	metabolic
Neanderthal	GWAS	Orofacial clefts	2	0.8211	2.435756911	0.198180182	other
Neanderthal	GWAS	C-reactive protein levels or triglyceride levels (pleiotropy)	1	0.2224	4.496402878	0.199480052	immune
Neanderthal	GWAS	Strenuous sports or other exercises	1	0.2227	4.490345757	0.200579942	behavior
Neanderthal	GWAS	Urinary metabolites	1	0.223	4.484304933	0.200779922	metabolic
Neanderthal	GWAS	Menopause (age at onset)	2	0.8236	2.428363283	0.201579842	reproductive
Neanderthal	GWAS	Urate levels in lean individuals	2	0.8396	2.382086708	0.205179482	metabolic
Neanderthal	GWAS	Bipolar disorder (body mass index interaction)	2	0.8474	2.360160491	0.207879212	behavior
Neanderthal	GWAS	Prevalent atrial fibrillation	1	0.2393	4.178854994	0.210978902	cardiovascular
Neanderthal	GWAS	Blood trace element (Se levels)	1	0.2386	4.191114837	0.211278872	other
Neanderthal	GWAS	Uterine fibroid number (single vs multiple)	2	0.8663	2.308669052	0.214478552	reproductive
Neanderthal	GWAS	Osteoarthritis	1	0.2431	4.113533525	0.215778422	skeletal
Neanderthal	GWAS	Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)	7	4.826	1.450476585	0.216078392	skeletal
Neanderthal	GWAS	Erosive tooth wear (severe vs none or mild)	3	1.5959	1.879817031	0.217178282	skeletal
Neanderthal	GWAS	Crohn's disease	12	9.183	1.306762496	0.217578242	immune
Neanderthal	GWAS	Bipolar disorder with mood-incongruent psychosis	1	0.2475	4.04040404	0.218778122	behavior
Neanderthal	GWAS	Body mass index (SNP x SNP interaction)	1	0.246	4.06504065	0.218978102	metabolic
Neanderthal	GWAS	Age-related cataracts	1	0.2472	4.045307443	0.220177982	integumentary
Neanderthal	GWAS	Response to fenofibrate (LDL cholesterol levels)	1	0.2504	3.993610224	0.220977902	other
Neanderthal	GWAS	Homocysteine levels	1	0.2532	3.949447077	0.223877612	other
Neanderthal	GWAS	Hypertriglyceridemia	1	0.2547	3.926187672	0.226977302	metabolic
Neanderthal	GWAS	Serum albumin level	1	0.2592	3.858024691	0.228477152	other
Neanderthal	GWAS	Ischemic stroke (cardioembolic)	1	0.2599	3.847633705	0.228877112	cardiovascular
Neanderthal	GWAS	Childhood body mass index	2	0.9187	2.176989224	0.231476852	metabolic
Neanderthal	GWAS	Glycerophospholipid levels	1	0.2627	3.806623525	0.232476752	metabolic
Neanderthal	GWAS	Local histogram emphysema pattern	1	0.2685	3.724394786	0.236776322	respiratory
Neanderthal	GWAS	Disrupted circadian rhythm (low relative amplitude of rest-activity cycles)	1	0.2695	3.710575139	0.236876312	behavior
Neanderthal	GWAS	Hyperactive-impulsive symptoms	1	0.2697	3.707823508	0.238776122	behavior
Neanderthal	GWAS	"Bone mineral density (paediatric, total body less head)"	1	0.2713	3.685956506	0.239176082	skeletal
Neanderthal	GWAS	Prostate-specific antigen levels	1	0.2754	3.631082062	0.240175982	reproductive
Neanderthal	GWAS	Depressive symptoms (SSRI exposure interaction)	1	0.2754	3.631082062	0.240675932	behavior
Neanderthal	GWAS	Lung function (forced vital capacity)	1	0.2779	3.598416697	0.242675732	respiratory
Neanderthal	GWAS	Alcohol use disorder (total score)	1	0.2817	3.549875754	0.245575442	behavior
Neanderthal	GWAS	Cerebrospinal fluid t-tau levels in mild cognitive impairment	1	0.2834	3.52858151	0.248375162	nervous
Neanderthal	GWAS	Hepatitis B	1	0.2847	3.512469266	0.248575142	immune
Neanderthal	GWAS	Chronic kidney disease	3	1.7394	1.724732666	0.251174883	urinary
Neanderthal	GWAS	Asthma exacerbations in inhaled corticosteroid treatment	1	0.2911	3.43524562	0.252074793	respiratory
Neanderthal	GWAS	Hippocampal volume in mild cognitive impairment	1	0.2994	3.34001336	0.258074193	nervous
Neanderthal	GWAS	Lewy body disease	1	0.2996	3.337783712	0.258774123	nervous
Neanderthal	GWAS	Recurrent major depressive disorder	1	0.303	3.300330033	0.260873913	behavior
Neanderthal	GWAS	Sex hormone-binding globulin levels	1	0.303	3.300330033	0.261573843	endocrine
Neanderthal	GWAS	Type 2 diabetes (age of onset)	3	1.7745	1.690617075	0.263873613	metabolic
Neanderthal	GWAS	Corneal structure	2	1.0005	1.9990005	0.264873513	nervous
Neanderthal	GWAS	Hematocrit	5	3.4613	1.444543957	0.267073293	hematologic
Neanderthal	GWAS	Iron status biomarkers	1	0.3192	3.13283208	0.273472653	other
Neanderthal	GWAS	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	1	0.3206	3.119151591	0.275372463	immune
Neanderthal	GWAS	Femoral neck bone mineral density	2	1.041	1.921229587	0.278472153	skeletal
Neanderthal	GWAS	Cardiometabolic and hematological traits	1	0.3283	3.045994517	0.278672133	cardiovascular
Neanderthal	GWAS	Lean body mass	1	0.3304	3.026634383	0.283771623	skeletal muscle
Neanderthal	GWAS	Metabolite levels (HVA)	1	0.3311	3.020235578	0.286171383	metabolic
Neanderthal	GWAS	Serum metabolite ratios in chronic kidney disease	1	0.3347	2.987750224	0.286271373	urinary
Neanderthal	GWAS	Red vs. brown/black hair color	1	0.3382	2.956830278	0.287971203	integumentary
Neanderthal	GWAS	Interstitial lung disease	1	0.3471	2.881014117	0.292170783	respiratory
Neanderthal	GWAS	Personality traits in bipolar disorder	1	0.3453	2.896032436	0.292570743	behavior
Neanderthal	GWAS	Brain volume in infants (white matter)	1	0.3458	2.891844997	0.293470653	nervous
Neanderthal	GWAS	Cerebral amyloid deposition (PET imaging)	1	0.3482	2.871912694	0.293670633	nervous
Neanderthal	GWAS	Neuritic plaques or neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	1	0.3542	2.823263693	0.295370463	nervous
Neanderthal	GWAS	Immune reponse to smallpox (secreted IL-12p40)	1	0.3548	2.81848929	0.297970203	immune
Neanderthal	GWAS	C-reactive protein levels or LDL-cholesterol levels (pleiotropy)	1	0.3533	2.830455703	0.299370063	immune
Neanderthal	GWAS	Dimensional psychopathology (Positive)	1	0.3577	2.795638803	0.303469653	behavior
Neanderthal	GWAS	Melanoma	2	1.1136	1.795977011	0.303869613	integumentary
Neanderthal	GWAS	Blood metabolite levels	3	1.9265	1.557228134	0.304469553	metabolic
Neanderthal	GWAS	Chronic inflammatory diseases (pleiotropy)	4	2.7954	1.430922229	0.305569443	immune
Neanderthal	GWAS	Large artery stroke	1	0.372	2.688172043	0.308469153	cardiovascular
Neanderthal	GWAS	Preterm birth (maternal effect)	1	0.3699	2.70343336	0.309369063	reproductive
Neanderthal	GWAS	Erosive tooth wear (severe vs non-severe)	3	1.9608	1.52998776	0.312668733	skeletal
Neanderthal	GWAS	P wave terminal force	1	0.3772	2.651113468	0.312668733	cardiovascular
Neanderthal	GWAS	Response to bupropion and depression	1	0.3858	2.592016589	0.316968303	other
Neanderthal	GWAS	Social communication problems	1	0.3787	2.640612622	0.317268273	behavior
Neanderthal	GWAS	"B-cell malignancies (CLL, Hodgkin lymphoma or multiple myeloma) (pleiotropy)"	1	0.3873	2.581977795	0.321367863	immune
Neanderthal	GWAS	Stroke (ischemic)	1	0.3936	2.540650407	0.322567743	cardiovascular
Neanderthal	GWAS	Response to antidepressants	1	0.3888	2.572016461	0.324067593	other
Neanderthal	GWAS	HIV-1 susceptibility	2	1.1629	1.719838335	0.325767423	immune
Neanderthal	GWAS	Laryngeal squamous cell carcinoma	1	0.3948	2.532928065	0.327267273	other
Neanderthal	GWAS	Mean platelet volume	6	4.7111	1.273587909	0.327967203	hematologic
Neanderthal	GWAS	Response to lithium treatment in bipolar disorder	1	0.4038	2.476473502	0.329567043	other
Neanderthal	GWAS	Diffusing capacity of the lung for carbon monoxide traits	1	0.3968	2.52016129	0.331666833	respiratory
Neanderthal	GWAS	Nicotine dependence and major depression (severity of comorbidity)	2	1.1705	1.708671508	0.331766823	behavior
Neanderthal	GWAS	Body mass index (age <50)	3	2.0343	1.474708745	0.332366763	metabolic
Neanderthal	GWAS	Male-pattern baldness	7	5.6019	1.249576037	0.334066593	integumentary
Neanderthal	GWAS	Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)	1	0.4143	2.413709872	0.335166483	other
Neanderthal	GWAS	Decline in glucose metabolism in posterior cingulate cortex	1	0.4087	2.446782481	0.337066293	nervous
Neanderthal	GWAS	Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	1	0.414	2.415458937	0.338166183	other
Neanderthal	GWAS	Plasma factor VII activating protease levels	1	0.4122	2.426006793	0.339766023	other
Neanderthal	GWAS	Sexual dysfunction (SSRI/SNRI-related)	1	0.4143	2.413709872	0.342565743	reproductive
Neanderthal	GWAS	Blood and toenail selenium levels	1	0.4186	2.388915432	0.342865713	other
Neanderthal	GWAS	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	1	0.4157	2.405580948	0.343065693	immune
Neanderthal	GWAS	Suffering from nerves	1	0.4182	2.391200383	0.344665533	behavior
Neanderthal	GWAS	Carotid plaque burden	2	1.2286	1.627869119	0.347165283	cardiovascular
Neanderthal	GWAS	Capecitabine sensitivity	1	0.4319	2.315350776	0.350164984	other
Neanderthal	GWAS	Subjective response to lithium treatment	1	0.4353	2.297266253	0.352264774	other
Neanderthal	GWAS	Common carotid intima-media thickness in HIV negative individuals	2	1.2421	1.610176314	0.352264774	cardiovascular
Neanderthal	GWAS	Osteosarcoma	1	0.4449	2.247696111	0.354764524	skeletal
Neanderthal	GWAS	Type 2 diabetes nephropathy	1	0.4418	2.263467632	0.355664434	metabolic
Neanderthal	GWAS	Schizophrenia or bipolar disorder	1	0.4541	2.202158115	0.364163584	behavior
Neanderthal	GWAS	Systolic blood pressure x smoking status (ever vs never) interaction (2df test)	3	2.1423	1.400364095	0.365963404	cardiovascular
Neanderthal	GWAS	Late-onset Alzheimer's disease	3	2.1433	1.399710726	0.368163184	nervous
Neanderthal	GWAS	Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)	3	2.1701	1.382424773	0.369963004	cardiovascular
Neanderthal	GWAS	Conotruncal heart defects (maternal effects)	1	0.4571	2.187705097	0.370762924	cardiovascular
Neanderthal	GWAS	Mosquito bite size	5	3.9943	1.251783792	0.371262874	other
Neanderthal	GWAS	Iron status biomarkers (total iron binding capacity)	1	0.4591	2.17817469	0.371762824	other
Neanderthal	GWAS	Inflammatory skin disease	3	2.1772	1.37791659	0.372962704	integumentary
Neanderthal	GWAS	Metabolite levels (lipoprotein measures)	1	0.4771	2.095996646	0.375662434	metabolic
Neanderthal	GWAS	Seborrheic dermatitis	1	0.4657	2.147305132	0.377162284	integumentary
Neanderthal	GWAS	IgG glycosylation	1	0.4757	2.10216523	0.380661934	immune
Neanderthal	GWAS	Breastfeeding duration	1	0.4808	2.079866889	0.381061894	reproductive
Neanderthal	GWAS	Cognitive decline rate in late mild cognitive impairment	6	4.9636	1.208800064	0.381361864	nervous
Neanderthal	GWAS	Blood protein levels	20	18.4182	1.085882442	0.382261774	other
Neanderthal	GWAS	Pubertal anthropometrics	1	0.4847	2.063131834	0.384761524	skeletal
Neanderthal	GWAS	Blood metabolite ratios	1	0.4905	2.038735984	0.386461354	metabolic
Neanderthal	GWAS	Number of children ever born	1	0.4941	2.023881805	0.387161284	reproductive
Neanderthal	GWAS	Waist-to-hip ratio adjusted for BMI (age <50)	2	1.3543	1.476777671	0.393460654	skeletal
Neanderthal	GWAS	Modified Stumvoll Insulin Sensitivity Index (BMI interaction)	1	0.4948	2.021018593	0.394560544	metabolic
Neanderthal	GWAS	Total ventricular volume (Alzheimer's disease interaction)	1	0.5121	1.952743605	0.401259874	cardiovascular
Neanderthal	GWAS	Primary biliary cholangitis	2	1.3872	1.441753172	0.405659434	digestive
Neanderthal	GWAS	Iris color (L* coordinate)	1	0.5308	1.883948757	0.409959004	integumentary
Neanderthal	GWAS	Retinal vascular caliber	1	0.5229	1.912411551	0.410758924	nervous
Neanderthal	GWAS	Bulimia nervosa	2	1.405	1.423487544	0.411358864	behavior
Neanderthal	GWAS	Lipoprotein (a) levels	2	1.4109	1.417534907	0.411458854	metabolic
Neanderthal	GWAS	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 (Grade 3 peripheral neuropathy)	1	0.5463	1.830496064	0.417658234	other
Neanderthal	GWAS	Prothrombin time	1	0.5377	1.859773108	0.418158184	hematologic
Neanderthal	GWAS	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)	2	1.431	1.397624039	0.419958004	other
Neanderthal	GWAS	Primary tooth development (number of teeth)	1	0.5501	1.8178513	0.423957604	skeletal
Neanderthal	GWAS	Coffee consumption	1	0.5422	1.844337883	0.424457554	behavior
Neanderthal	GWAS	Brain structure	1	0.549	1.821493625	0.425057494	nervous
Neanderthal	GWAS	Eye color	1	0.5578	1.792757261	0.426757324	integumentary
Neanderthal	GWAS	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	1	0.5628	1.776830135	0.428557144	metabolic
Neanderthal	GWAS	Remission after SSRI treatment in MDD or neuroticism	1	0.5623	1.778410101	0.429657034	other
Neanderthal	GWAS	Metabolite levels (5-HIAA)	1	0.5649	1.770224819	0.431156884	metabolic
Neanderthal	GWAS	Leprosy	1	0.5614	1.781261133	0.432056794	immune
Neanderthal	GWAS	Moyamoya disease	1	0.5779	1.730403184	0.434656534	cardiovascular
Neanderthal	GWAS	Response to Vitamin E supplementation	1	0.568	1.76056338	0.436156384	other
Neanderthal	GWAS	Lipid traits (pleiotropy) (HIPO component 1)	1	0.5732	1.744591766	0.436956304	metabolic
Neanderthal	GWAS	Bronchopulmonary dysplasia in preterm infants	1	0.5683	1.759633996	0.437056294	respiratory
Neanderthal	GWAS	Primary tooth development (time to first tooth eruption)	1	0.5789	1.727414061	0.439556044	skeletal
Neanderthal	GWAS	Periodontitis (PAL4Q3)	2	1.4974	1.335648457	0.440455954	immune
Neanderthal	GWAS	Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)	3	2.441	1.229004506	0.442255774	cardiovascular
Neanderthal	GWAS	Serum sulfate level	1	0.582	1.718213058	0.442555744	other
Neanderthal	GWAS	Breast cancer (estrogen-receptor negative)	1	0.5858	1.707067258	0.443255674	reproductive
Neanderthal	GWAS	Cervical cancer	2	1.5034	1.330317946	0.443555644	reproductive
Neanderthal	GWAS	Extremely high intelligence	2	1.516	1.319261214	0.445655434	other
Neanderthal	GWAS	Weight	2	1.5196	1.316135825	0.445955404	skeletal
Neanderthal	GWAS	Systemic sclerosis	1	0.5919	1.689474573	0.446155384	other
Neanderthal	GWAS	Regular attendance at a pub or social club	1	0.5953	1.679825298	0.448255174	behavior
Neanderthal	GWAS	Acne (severe)	2	1.5245	1.311905543	0.448655134	integumentary
Neanderthal	GWAS	Clozapine-induced agranulocytosis	1	0.5967	1.675884029	0.450054995	other
Neanderthal	GWAS	Obesity (early onset extreme)	2	1.5224	1.313715187	0.450254975	metabolic
Neanderthal	GWAS	Hematological and biochemical traits	1	0.5929	1.686625063	0.451354865	hematologic
Neanderthal	GWAS	Response to fenofibrate (triglyceride levels)	1	0.5838	1.712915382	0.451654835	other
Neanderthal	GWAS	Retinopathy in non-diabetics	1	0.6042	1.655081099	0.452154785	nervous
Neanderthal	GWAS	Feeling miserable	2	1.5275	1.309328969	0.453354665	behavior
Neanderthal	GWAS	Irritable mood	3	2.4964	1.201730492	0.454054595	behavior
Neanderthal	GWAS	Cerebrospinal fluid beta-site APP cleaving enzyme levels	1	0.6111	1.636393389	0.457554245	nervous
Neanderthal	GWAS	Erectile dysfunction and prostate cancer treatment	1	0.6135	1.62999185	0.459954005	reproductive
Neanderthal	GWAS	Serum metabolite concentrations in chronic kidney disease	1	0.6061	1.649892757	0.460253975	urinary
Neanderthal	GWAS	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)	2	1.5485	1.29157249	0.461153885	skeletal
Neanderthal	GWAS	Reticulocyte count	3	2.5208	1.190098381	0.461653835	immune
Neanderthal	GWAS	Bipolar disorder	4	3.5316	1.132631102	0.466353365	behavior
Neanderthal	GWAS	Alzheimer disease and age of onset	1	0.6332	1.579279848	0.469853015	nervous
Neanderthal	GWAS	Hemoglobin concentration	4	3.5093	1.139828456	0.470752925	hematologic
Neanderthal	GWAS	White matter hyperintensity burden	1	0.6348	1.575299307	0.472952705	nervous
Neanderthal	GWAS	Mean corpuscular hemoglobin	4	3.5653	1.121925224	0.474352565	hematologic
Neanderthal	GWAS	Multiple myeloma and monoclonal gammopathy	1	0.6436	1.553760099	0.475552445	immune
Neanderthal	GWAS	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	1	0.6468	1.546072975	0.476552345	other
Neanderthal	GWAS	BMI in non-smokers	2	1.6164	1.237317496	0.477452255	metabolic
Neanderthal	GWAS	Diabetic kidney disease	2	1.6235	1.231906375	0.482651735	metabolic
Neanderthal	GWAS	Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)	3	2.6413	1.135804339	0.489251075	cardiovascular
Neanderthal	GWAS	Bone mineral density (total hip)	1	0.6927	1.443626389	0.490150985	skeletal
Neanderthal	GWAS	Lung adenocarcinoma	3	2.6098	1.149513373	0.491550845	respiratory
Neanderthal	GWAS	Waist-to-hip ratio adjusted for BMI x sex interaction	2	1.6579	1.206345377	0.494750525	skeletal
Neanderthal	GWAS	Hippocampal atrophy	1	0.6941	1.440714594	0.496750325	nervous
Neanderthal	GWAS	Epilepsy and lamotrigine-induced maculopapular eruptions	1	0.6962	1.43636886	0.497350265	nervous
Neanderthal	GWAS	Eyebrow thickness	1	0.6883	1.45285486	0.500749925	integumentary
Neanderthal	GWAS	Alcohol and nicotine co-dependence	1	0.6973	1.434102969	0.501049895	behavior
Neanderthal	GWAS	Aging	1	0.6953	1.438228103	0.505349465	other
Neanderthal	GWAS	Response to tocilizumab in rheumatoid arthritis	1	0.7061	1.416229996	0.506849315	other
Neanderthal	GWAS	Response to platinum-based chemotherapy (cisplatin)	1	0.7023	1.423892923	0.507349265	other
Neanderthal	GWAS	Metabolite levels	2	1.711	1.168907072	0.508649135	metabolic
Neanderthal	GWAS	Telomere length	1	0.7256	1.378169791	0.509849015	other
Neanderthal	GWAS	Body mass index x sex x age interaction (4df test)	3	2.7337	1.097413762	0.515248475	metabolic
Neanderthal	GWAS	Multiple myeloma	1	0.7282	1.373249107	0.517948205	immune
Neanderthal	GWAS	Iron status biomarkers (transferrin saturation)	1	0.7345	1.361470388	0.518948105	other
Neanderthal	GWAS	Self-reported allergy	1	0.7286	1.372495196	0.521047895	immune
Neanderthal	GWAS	Chronotype	2	1.7593	1.136815779	0.526547345	behavior
Neanderthal	GWAS	Alzheimer's disease	2	1.7747	1.126951034	0.527347265	nervous
Neanderthal	GWAS	Gut microbiota (bacterial taxa)	2	1.7569	1.138368718	0.528047195	digestive
Neanderthal	GWAS	Visceral adipose tissue adjusted for BMI	1	0.7514	1.330849082	0.534446555	metabolic
Neanderthal	GWAS	Fasting insulin (dietary factor interaction)	2	1.7973	1.112780282	0.535346465	metabolic
Neanderthal	GWAS	Pulse pressure x alcohol consumption interaction (2df test)	2	1.8012	1.110370864	0.541145885	cardiovascular
Neanderthal	GWAS	Allergic sensitization	1	0.7886	1.268069997	0.545345465	immune
Neanderthal	GWAS	Cutaneous malignant melanoma	1	0.7791	1.283532281	0.545445455	integumentary
Neanderthal	GWAS	Homeostasis model assessment of insulin resistance (dietary factor interaction)	2	1.8413	1.086189106	0.548045195	metabolic
Neanderthal	GWAS	Urate levels in overweight individuals	2	1.833	1.091107474	0.551744826	metabolic
Neanderthal	GWAS	Colorectal or endometrial cancer	1	0.8007	1.248907206	0.555244476	digestive
Neanderthal	GWAS	Idiopathic pulmonary fibrosis	1	0.817	1.223990208	0.557144286	respiratory
Neanderthal	GWAS	Migraine without aura	1	0.8536	1.171508903	0.571242876	nervous
Neanderthal	GWAS	Airway imaging phenotypes	1	0.8421	1.187507422	0.572342766	respiratory
Neanderthal	GWAS	Cardiac hypertrophy	1	0.8448	1.183712121	0.573142686	cardiovascular
Neanderthal	GWAS	Night sleep phenotypes	12	12.3668	0.970339942	0.581141886	behavior
Neanderthal	GWAS	Corneal astigmatism	2	1.962	1.019367992	0.581241876	nervous
Neanderthal	GWAS	LDL cholesterol	3	3.0451	0.985189321	0.584841516	metabolic
Neanderthal	GWAS	Plasma amyloid beta peptide concentrations (ABx-40)	1	0.8766	1.140771161	0.585641436	nervous
Neanderthal	GWAS	Feeling guilty	1	0.8811	1.134944955	0.591040896	behavior
Neanderthal	GWAS	Feeling fed-up	1	0.894	1.118568233	0.591140886	behavior
Neanderthal	GWAS	Depression	3	3.0638	0.979176186	0.592040796	behavior
Neanderthal	GWAS	Urinary albumin-to-creatinine ratio in non-diabetics	1	0.9081	1.101200308	0.598940106	metabolic
Neanderthal	GWAS	Lung cancer	2	2.0076	0.996214385	0.601239876	respiratory
Neanderthal	GWAS	Cognitive ability (MTAG)	2	2.0087	0.995668841	0.601739826	nervous
Neanderthal	GWAS	Hyperopia	1	0.925	1.081081081	0.603639636	nervous
Neanderthal	GWAS	Refractive error	2	2.0379	0.981402424	0.606839316	nervous
Neanderthal	GWAS	Toenail selenium levels	2	2.0392	0.980776775	0.608339166	other
Neanderthal	GWAS	Metabolite levels (HVA/MHPG ratio)	1	0.937	1.067235859	0.608939106	metabolic
Neanderthal	GWAS	Familial squamous cell lung carcinoma	2	2.0515	0.974896417	0.609139086	respiratory
Neanderthal	GWAS	Schizophrenia	17	17.8003	0.955040084	0.610338966	behavior
Neanderthal	GWAS	Multiple system atrophy	2	2.0735	0.964552689	0.612938706	nervous
Neanderthal	GWAS	Body mass index (joint analysis main effects and smoking interaction)	2	2.0922	0.955931555	0.618338166	metabolic
Neanderthal	GWAS	BMI (adjusted for smoking behaviour)	2	2.0922	0.955931555	0.618338166	metabolic
Neanderthal	GWAS	Depression in smokers	1	0.9707	1.030184403	0.619138086	behavior
Neanderthal	GWAS	Central corneal thickness	2	2.0878	0.957946163	0.619338066	nervous
Neanderthal	GWAS	Prostate cancer (SNP x SNP interaction)	1	0.9726	1.02817191	0.622037796	reproductive
Neanderthal	GWAS	Psoriasis	1	0.9788	1.021659174	0.624137586	integumentary
Neanderthal	GWAS	Chromium levels	1	0.987	1.013171226	0.624937506	other
Neanderthal	GWAS	Chronic obstructive pulmonary disease-related biomarkers	1	0.9866	1.013581999	0.627737226	respiratory
Neanderthal	GWAS	QRS duration	2	2.1557	0.927772881	0.634436556	cardiovascular
Neanderthal	GWAS	Cardiac Troponin-T levels	1	1.0169	0.983380863	0.638536146	cardiovascular
Neanderthal	GWAS	Calcium levels	1	1.0223	0.978186442	0.640335966	other
Neanderthal	GWAS	Serum bilirubin levels in metabolic syndrome	1	1.0402	0.961353586	0.640935906	digestive
Neanderthal	GWAS	Feeling tense	2	2.1761	0.91907541	0.643935606	behavior
Neanderthal	GWAS	Carotid intima media thickness	1	1.053	0.949667616	0.647635236	cardiovascular
Neanderthal	GWAS	Mean corpuscular volume	4	4.4374	0.901428765	0.648035196	hematologic
Neanderthal	GWAS	Social science traits (pleiotropy) (HIPO component 1)	1	1.0317	0.969274014	0.650634937	behavior
Neanderthal	GWAS	Fractures	1	1.048	0.954198473	0.650634937	skeletal
Neanderthal	GWAS	Nose size	1	1.0564	0.946611132	0.654234577	skeletal
Neanderthal	GWAS	Coronary artery disease or large artery stroke	1	1.0672	0.937031484	0.655134487	cardiovascular
Neanderthal	GWAS	Blond vs. brown/black hair color	4	4.4753	0.893794829	0.657834217	integumentary
Neanderthal	GWAS	Ischemic stroke	1	1.0817	0.924470741	0.661033897	cardiovascular
Neanderthal	GWAS	Lung cancer in ever smokers	2	2.2693	0.881329044	0.664633537	respiratory
Neanderthal	GWAS	Gestational age at birth (maternal effect)	1	1.0816	0.924556213	0.665033497	reproductive
Neanderthal	GWAS	Uterine fibroids	2	2.2758	0.878811846	0.665533447	reproductive
Neanderthal	GWAS	Systemic lupus erythematosus	7	7.7775	0.900032144	0.667933207	immune
Neanderthal	GWAS	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis	1	1.1007	0.908512765	0.669133087	other
Neanderthal	GWAS	Glomerular filtration rate (creatinine)	2	2.3001	0.869527412	0.671132887	hematologic
Neanderthal	GWAS	Waist circumference	2	2.3268	0.859549596	0.675332467	skeletal
Neanderthal	GWAS	Hair greying	1	1.1293	0.885504295	0.677032297	integumentary
Neanderthal	GWAS	Feeling nervous	2	2.339	0.855066268	0.677632237	behavior
Neanderthal	GWAS	Bone mineral density	3	3.5036	0.85626213	0.678332167	skeletal
Neanderthal	GWAS	Extraversion	1	1.1489	0.870397772	0.679632037	behavior
Neanderthal	GWAS	Experiencing mood swings	2	2.3548	0.84932903	0.681331867	behavior
Neanderthal	GWAS	Diastolic blood pressure (cigarette smoking interaction)	1	1.1446	0.873667657	0.681431857	cardiovascular
Neanderthal	GWAS	Adiponectin levels	1	1.1447	0.873591334	0.682131787	other
Neanderthal	GWAS	BMI in smokers	1	1.1496	0.86986778	0.682531747	metabolic
Neanderthal	GWAS	Restless legs syndrome	2	2.364	0.846023689	0.684031597	nervous
Neanderthal	GWAS	Refractive astigmatism	3	3.5387	0.847768955	0.687031297	nervous
Neanderthal	GWAS	Heschl's gyrus morphology	1	1.1524	0.867754252	0.688331167	nervous
Neanderthal	GWAS	Red cell distribution width	2	2.4118	0.829256157	0.688731127	hematologic
Neanderthal	GWAS	Borderline personality disorder	1	1.1481	0.871004268	0.690030997	behavior
Neanderthal	GWAS	Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test)	1	1.1828	0.845451471	0.690130987	cardiovascular
Neanderthal	GWAS	Severe gingival inflammation	1	1.1803	0.847242227	0.690430957	immune
Neanderthal	GWAS	Breast milk fatty acid composition (infant genotype effect)	1	1.1636	0.859401856	0.692630737	reproductive
Neanderthal	GWAS	Response to fenofibrate (total cholesterol levels)	1	1.1758	0.850484776	0.692730727	other
Neanderthal	GWAS	Serum thyroid-stimulating hormone levels	1	1.1827	0.845522956	0.695030497	endocrine
Neanderthal	GWAS	Regular attendance at a religious group	1	1.182	0.846023689	0.695230477	behavior
Neanderthal	GWAS	Reaction time	1	1.1822	0.845880562	0.695230477	behavior
Neanderthal	GWAS	Cerebrospinal AB1-42 levels in normal cognition	1	1.1863	0.842957093	0.695230477	nervous
Neanderthal	GWAS	Colorectal cancer	2	2.4139	0.828534736	0.695930407	digestive
Neanderthal	GWAS	Joint mobility (Beighton score)	1	1.186	0.84317032	0.699630037	skeletal
Neanderthal	GWAS	Breast size	2	2.4456	0.817795224	0.701529847	reproductive
Neanderthal	GWAS	High light scatter reticulocyte percentage of red cells	2	2.4259	0.824436292	0.702229777	metabolic
Neanderthal	GWAS	Peripheral artery disease	1	1.2112	0.825627477	0.702529747	cardiovascular
Neanderthal	GWAS	Feeling worry	2	2.4586	0.813471081	0.703129687	behavior
Neanderthal	GWAS	Breast milk fatty acid composition (maternal genotype effect)	1	1.207	0.828500414	0.705229477	reproductive
Neanderthal	GWAS	Worry too long after an embarrassing experience	1	1.2303	0.812809884	0.705429457	behavior
Neanderthal	GWAS	Bone mineral density (hip)	1	1.2168	0.821827745	0.705429457	skeletal
Neanderthal	GWAS	Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes	3	3.6713	0.817149239	0.707029297	cardiovascular
Neanderthal	GWAS	Eating disorders	1	1.2428	0.804634696	0.708829117	behavior
Neanderthal	GWAS	HIV-1 viral setpoint	1	1.2118	0.825218683	0.709329067	immune
Neanderthal	GWAS	White blood cell count	4	4.8302	0.828123059	0.709529047	immune
Neanderthal	GWAS	Response to bupropion in depression	1	1.2488	0.800768738	0.710628937	other
Neanderthal	GWAS	Selective IgA deficiency	1	1.2234	0.817394147	0.711928807	immune
Neanderthal	GWAS	Manganese levels	2	2.483	0.805477245	0.712328767	other
Neanderthal	GWAS	Endometrial cancer (endometrioid histology)	2	2.5023	0.799264676	0.712928707	reproductive
Neanderthal	GWAS	Insomnia	1	1.2453	0.803019353	0.713428657	behavior
Neanderthal	GWAS	"Type 2 diabetes (SNP x SNP interaction, 1df)"	1	1.2739	0.784990973	0.720527947	metabolic
Neanderthal	GWAS	Headache	1	1.2713	0.786596397	0.724227577	nervous
Neanderthal	GWAS	Coronary artery aneurysm in Kawasaki disease	2	2.575	0.776699029	0.727427257	cardiovascular
Neanderthal	GWAS	"Coronary artery disease (myocardial infarction, PTCA, CABG, angina or CIHD)"	2	2.5891	0.772469198	0.728527147	cardiovascular
Neanderthal	GWAS	Parkinson's disease	3	3.7818	0.793273045	0.730326967	nervous
Neanderthal	GWAS	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	1	1.3096	0.763591936	0.730526947	other
Neanderthal	GWAS	Systemic juvenile idiopathic arthritis	1	1.3146	0.760687662	0.730826917	immune
Neanderthal	GWAS	Red blood cell count	4	4.95	0.808080808	0.733426657	hematologic
Neanderthal	GWAS	Diabetic retinopathy	1	1.3016	0.768285187	0.733526647	metabolic
Neanderthal	GWAS	Gastroesophageal reflux disease	1	1.3261	0.754090943	0.733926607	digestive
Neanderthal	GWAS	High light scatter reticulocyte count	2	2.6219	0.762805599	0.734526547	metabolic
Neanderthal	GWAS	Mitochondrial DNA levels	1	1.3261	0.754090943	0.738626137	other
Neanderthal	GWAS	Acute lymphoblastic leukemia (childhood)	1	1.3594	0.735618655	0.740425957	lymphatic
Neanderthal	GWAS	Sense of smell	1	1.354	0.738552437	0.742125787	nervous
Neanderthal	GWAS	Systolic blood pressure (cigarette smoking interaction)	1	1.3725	0.72859745	0.746225377	cardiovascular
Neanderthal	GWAS	Nickel levels	1	1.3684	0.730780474	0.748025197	other
Neanderthal	GWAS	Pancreatic cancer	2	2.6987	0.741097565	0.751724828	endocrine
Neanderthal	GWAS	Platelet distribution width	3	3.9608	0.757422743	0.752324768	hematologic
Neanderthal	GWAS	Copper levels	1	1.3844	0.722334585	0.753124688	other
Neanderthal	GWAS	Macular thickness	4	5.1146	0.782074845	0.754224578	nervous
Neanderthal	GWAS	Myopia	3	3.9086	0.767538249	0.754524548	nervous
Neanderthal	GWAS	Plasma clusterin levels	1	1.4014	0.713572142	0.757424258	other
Neanderthal	GWAS	Glycated hemoglobin levels	1	1.4217	0.703383274	0.760123988	metabolic
Neanderthal	GWAS	Intelligence (MTAG)	8	9.7791	0.818071193	0.761223878	other
Neanderthal	GWAS	Hemoglobin	1	1.4367	0.696039535	0.762323768	hematologic
Neanderthal	GWAS	Nasopharyngeal carcinoma (SNP x SNP interaction)	3	4.0243	0.745471262	0.763823618	other
Neanderthal	GWAS	Systolic blood pressure x alcohol consumption interaction (2df test)	2	2.7734	0.721136511	0.763923608	cardiovascular
Neanderthal	GWAS	Obstructive sleep apnea trait (average respiratory event duration)	1	1.4587	0.685541921	0.764423558	other
Neanderthal	GWAS	Neutrophil percentage of white cells	1	1.4624	0.68380744	0.765123488	lymphatic
Neanderthal	GWAS	"Type 2 diabetes (SNP x SNP interaction, 2df)"	1	1.4489	0.690178756	0.765323468	metabolic
Neanderthal	GWAS	Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	1	1.4593	0.685260056	0.765323468	cardiovascular
Neanderthal	GWAS	Self-reported risk-taking behaviour	1	1.4618	0.684088111	0.765623438	behavior
Neanderthal	GWAS	Seasonality and depression	1	1.4552	0.687190764	0.766223378	behavior
Neanderthal	GWAS	Post-traumatic stress disorder	1	1.4608	0.684556407	0.766323368	behavior
Neanderthal	GWAS	Allergic rhinitis	3	4.0384	0.742868463	0.768923108	immune
Neanderthal	GWAS	Glomerular filtration rate in non diabetics (creatinine)	1	1.4672	0.681570338	0.770122988	hematologic
Neanderthal	GWAS	Type 1 diabetes	1	1.4911	0.670645832	0.773922608	metabolic
Neanderthal	GWAS	Contrast sensitivity	1	1.5052	0.66436354	0.776622338	nervous
Neanderthal	GWAS	Remission after SSRI treatment in MDD or openness	1	1.5024	0.665601704	0.777322268	other
Neanderthal	GWAS	Paclitaxel disposition in epithelial ovarian cancer	1	1.468	0.68119891	0.777622238	other
Neanderthal	GWAS	QRS interval (sulfonylurea treatment interaction)	1	1.5187	0.658457892	0.778822118	cardiovascular
Neanderthal	GWAS	Free thyroxine concentration	1	1.493	0.669792364	0.779222078	endocrine
Neanderthal	GWAS	Response to SSRI in MDD or openness	1	1.5197	0.65802461	0.781121888	other
Neanderthal	GWAS	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	1	1.5464	0.646663218	0.785721428	endocrine
Neanderthal	GWAS	Type 2 diabetes	9	11.1792	0.805066552	0.786121388	metabolic
Neanderthal	GWAS	QT interval (drug interaction)	1	1.5636	0.639549757	0.786421358	cardiovascular
Neanderthal	GWAS	Morning vs. evening chronotype	1	1.5448	0.647332988	0.792520748	behavior
Neanderthal	GWAS	Myopia (pathological)	2	2.9536	0.677139762	0.795620438	nervous
Neanderthal	GWAS	Tuberculosis	1	1.6033	0.623713591	0.798220178	immune
Neanderthal	GWAS	Stroke	1	1.6073	0.622161389	0.799020098	cardiovascular
Neanderthal	GWAS	Mild influenza (H1N1) infection	1	1.5741	0.635283654	0.801119888	immune
Neanderthal	GWAS	Obesity	2	2.9951	0.667757337	0.805919408	metabolic
Neanderthal	GWAS	Spherical equivalent or myopia (age of diagnosis)	5	6.8027	0.735002279	0.810818918	nervous
Neanderthal	GWAS	Response to statin therapy	1	1.6738	0.597442944	0.814418558	other
Neanderthal	GWAS	Bronchopulmonary dysplasia	1	1.6698	0.598874117	0.814918508	respiratory
Neanderthal	GWAS	Response to amphetamines	2	3.0757	0.650258478	0.815518448	other
Neanderthal	GWAS	Pelvic organ prolapse (moderate/severe)	1	1.7196	0.581530589	0.817518248	skeletal muscle
Neanderthal	GWAS	Gut microbiota (beta diversity)	1	1.7052	0.586441473	0.819618038	digestive
Neanderthal	GWAS	Vitiligo	1	1.7292	0.578302105	0.820917908	integumentary
Neanderthal	GWAS	Periodontal microbiota	1	1.7258	0.579441418	0.821517848	immune
Neanderthal	GWAS	Mean arterial pressure x alcohol consumption interaction (2df test)	1	1.7206	0.581192607	0.822217778	cardiovascular
Neanderthal	GWAS	Pit-and-Fissure caries	1	1.751	0.571102227	0.823717628	skeletal
Neanderthal	GWAS	Blood urea nitrogen levels	1	1.7495	0.571591883	0.824417558	other
Neanderthal	GWAS	Neurociticism	4	5.8404	0.684884597	0.827017298	behavior
Neanderthal	GWAS	Waist-to-hip ratio adjusted for body mass index	2	3.2348	0.618276246	0.831516848	skeletal
Neanderthal	GWAS	Immature fraction of reticulocytes	1	1.7835	0.560695262	0.835516448	hematologic
Neanderthal	GWAS	Waist circumference adjusted for BMI (adjusted for smoking behaviour)	1	1.8294	0.54662731	0.838416158	skeletal
Neanderthal	GWAS	Hypertension	2	3.2987	0.606299451	0.839016098	cardiovascular
Neanderthal	GWAS	Insulin resistance/response	1	1.851	0.540248514	0.842115788	immune
Neanderthal	GWAS	Glaucoma	1	1.8857	0.530307048	0.845315468	nervous
Neanderthal	GWAS	Endometriosis	1	1.874	0.53361793	0.847015298	reproductive
Neanderthal	GWAS	Resting-state electroencephalogram vigilance	1	1.8943	0.527899488	0.849315068	nervous
Neanderthal	GWAS	Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)	1	1.8935	0.528122524	0.851314869	skeletal
Neanderthal	GWAS	Squamous cell lung carcinoma	1	1.8979	0.526898151	0.851814819	respiratory
Neanderthal	GWAS	Ovarian cancer	1	1.9141	0.522438744	0.852914709	reproductive
Neanderthal	GWAS	Intracranial aneurysm	2	3.3648	0.594388968	0.854214579	nervous
Neanderthal	GWAS	Coronary artery disease	7	9.7959	0.714584673	0.854214579	cardiovascular
Neanderthal	GWAS	Axial length	1	1.9435	0.514535632	0.854614539	nervous
Neanderthal	GWAS	Rheumatoid arthritis	2	3.3789	0.591908609	0.855714429	immune
Neanderthal	GWAS	"Cholesterol, total"	1	1.9465	0.513742615	0.856414359	metabolic
Neanderthal	GWAS	Cognitive ability	1	1.939	0.515729758	0.857514249	nervous
Neanderthal	GWAS	Intelligence	1	1.9688	0.507923608	0.860613939	other
Neanderthal	GWAS	Attention deficit hyperactivity disorder	2	3.4208	0.584658559	0.864213579	behavior
Neanderthal	GWAS	Cadmium levels	1	1.9798	0.505101525	0.864413559	other
Neanderthal	GWAS	Sleep duration	1	2.0158	0.49608096	0.865613439	behavior
Neanderthal	GWAS	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes	1	2.0061	0.498479637	0.868213179	cardiovascular
Neanderthal	GWAS	Thiazide-induced adverse metabolic effects in hypertensive patients	1	2.0768	0.481510015	0.872812719	other
Neanderthal	GWAS	Metabolite levels  (X-11787)	1	2.1152	0.472768533	0.873212679	metabolic
Neanderthal	GWAS	Plateletcrit	3	4.97	0.60362173	0.873712629	hematologic
Neanderthal	GWAS	Diverticular disease	2	3.6247	0.551769802	0.874012599	digestive
Neanderthal	GWAS	Resting heart rate	2	3.6172	0.552913856	0.876212379	cardiovascular
Neanderthal	GWAS	Platelet count	3	5.012	0.598563448	0.877712229	hematologic
Neanderthal	GWAS	Creatinine levels	1	2.091	0.478240077	0.878712129	other
Neanderthal	GWAS	Daytime sleep phenotypes	3	5.0205	0.597550045	0.879112089	behavior
Neanderthal	GWAS	Height	7	10.349	0.676393854	0.888711129	skeletal
Neanderthal	GWAS	Breast cancer	3	5.1418	0.583453265	0.893910609	reproductive
Neanderthal	GWAS	Lymphocyte percentage of white cells	1	2.2505	0.444345701	0.895810419	lymphatic
Neanderthal	GWAS	Monobrow	1	2.3318	0.428853246	0.902809719	integumentary
Neanderthal	GWAS	Waist circumference adjusted for body mass index	1	2.3546	0.424700586	0.904709529	skeletal
Neanderthal	GWAS	Diastolic blood pressure x alcohol consumption interaction (2df test)	1	2.3738	0.421265482	0.905009499	cardiovascular
Neanderthal	GWAS	Anorexia nervosa	1	2.3994	0.416770859	0.907209279	behavior
Neanderthal	GWAS	Response to methotrexate in juvenile idiopathic arthritis	1	2.4281	0.411844652	0.909109089	other
Neanderthal	GWAS	Bipolar disorder and schizophrenia	1	2.4629	0.406025417	0.911208879	behavior
Neanderthal	GWAS	Photic sneeze reflex	2	4.0375	0.495356037	0.912608739	nervous
Neanderthal	GWAS	Glucose homeostasis traits	1	2.4783	0.403502401	0.912808719	metabolic
Neanderthal	GWAS	Subcutaneous adipose tissue	1	2.4944	0.400898012	0.915008499	metabolic
Neanderthal	GWAS	Pursuit maintenance gain	2	4.1123	0.486345841	0.915408459	skeletal muscle
Neanderthal	GWAS	Cognitive performance	1	2.5267	0.395773143	0.916608339	nervous
Neanderthal	GWAS	Glomerular filtration rate	1	2.4528	0.407697326	0.917508249	hematologic
Neanderthal	GWAS	Eosinophil percentage of granulocytes	1	2.5728	0.388681592	0.919408059	immune
Neanderthal	GWAS	Reticulocyte fraction of red cells	1	2.5399	0.393716288	0.920707929	immune
Neanderthal	GWAS	Monocyte count	1	2.5031	0.399504614	0.922407759	immune
Neanderthal	GWAS	Diisocyanate-induced asthma	4	7.0479	0.567544942	0.923307669	respiratory
Neanderthal	GWAS	Sudden cardiac arrest	1	2.6109	0.38300969	0.924707529	cardiovascular
Neanderthal	GWAS	Major depressive disorder	3	5.7441	0.52227503	0.926507349	behavior
Neanderthal	GWAS	Granulocyte percentage of myeloid white cells	1	2.632	0.37993921	0.928307169	immune
Neanderthal	GWAS	Disease progression in age-related macular degeneration	1	2.6044	0.383965597	0.929007099	nervous
Neanderthal	GWAS	Alzheimer's disease (late onset)	1	2.7232	0.367215041	0.929107089	nervous
Neanderthal	GWAS	Migraine	1	2.7334	0.365844735	0.934606539	nervous
Neanderthal	GWAS	"Allergic disease (asthma, hay fever or eczema)"	1	2.7529	0.363253297	0.935106489	immune
Neanderthal	GWAS	Eosinophil percentage of white cells	1	2.8788	0.347366958	0.943405659	immune
Neanderthal	GWAS	Eosinophil counts	1	2.8539	0.350397701	0.945605439	immune
Neanderthal	GWAS	Waist-hip ratio	1	2.9431	0.339777785	0.948605139	skeletal
Neanderthal	GWAS	Multiple sclerosis	2	4.7798	0.418427549	0.95110489	nervous
Neanderthal	GWAS	Post bronchodilator FEV1	3	6.3012	0.476099791	0.95150485	other
Neanderthal	GWAS	QT interval	2	4.8213	0.414825877	0.95360464	cardiovascular
Neanderthal	GWAS	Cerebrospinal T-tau levels	1	3.0673	0.326019626	0.95420458	nervous
Neanderthal	GWAS	Hand grip strength	3	6.6284	0.452597912	0.95770423	skeletal muscle
Neanderthal	GWAS	Monocyte percentage of white cells	1	3.1695	0.315507178	0.95780422	immune
Neanderthal	GWAS	Lymphocyte counts	1	3.2669	0.306100585	0.95840416	lymphatic
Neanderthal	GWAS	Obesity-related traits	21	29.9118	0.702064068	0.96030397	metabolic
Neanderthal	GWAS	Asthma	3	6.6524	0.450965065	0.96240376	respiratory
Neanderthal	GWAS	Venous thromboembolism adjusted for sickle cell variant rs77121243-T	1	3.4229	0.292149931	0.96830317	hematologic
Neanderthal	GWAS	General cognitive ability	4	8.4702	0.472243867	0.96840316	nervous
Neanderthal	GWAS	Prostate cancer	1	3.5572	0.281119982	0.97190281	reproductive
Neanderthal	GWAS	Neuroticism	1	3.5784	0.279454505	0.97270273	behavior
Neanderthal	GWAS	Post bronchodilator FEV1/FVC ratio in COPD	1	3.6829	0.271525157	0.97290271	other
Neanderthal	GWAS	Loneliness	1	3.6426	0.274529182	0.97320268	behavior
Neanderthal	GWAS	Amyotrophic lateral sclerosis (sporadic)	3	7.1807	0.417786567	0.9740026	nervous
Neanderthal	GWAS	Total cholesterol levels	1	3.7324	0.267924124	0.97680232	metabolic
Neanderthal	GWAS	Rosacea symptom severity	2	5.7861	0.345655969	0.9790021	integumentary
Neanderthal	GWAS	Pulse pressure	10	17.4182	0.574112136	0.97980202	cardiovascular
Neanderthal	GWAS	Intraocular pressure	4	9.1243	0.438389794	0.97990201	nervous
Neanderthal	GWAS	"Autism spectrum disorder, ADHD, bipolar disorder, MDD, and schizophrenia (combined)"	1	4.4715	0.2236386	0.98870113	behavior
Neanderthal	GWAS	Menarche (age at onset)	3	8.3764	0.358149086	0.98910109	reproductive
Neanderthal	GWAS	Heel bone mineral density	14	24.8433	0.56353222	0.99110089	skeletal
Neanderthal	GWAS	Itch intensity from mosquito bite adjusted by bite size	1	4.7483	0.210601689	0.99180082	immune
Neanderthal	GWAS	Alzheimer's disease (cognitive decline)	1	4.9481	0.202097775	0.99320068	nervous
Neanderthal	GWAS	Longevity	1	5.2407	0.190814204	0.99530047	other
Neanderthal	GWAS	Monoclonal gammopathy of undetermined significance	1	5.3574	0.186657707	0.99590041	hematologic
Neanderthal	GWAS	Post bronchodilator FEV1/FVC ratio	3	9.8398	0.304884246	0.99740026	other
Neanderthal	GWAS	Systolic blood pressure	8	21.6789	0.369022413	0.99980002	cardiovascular
Neanderthal	GWAS	Diastolic blood pressure	6	19.1302	0.313640213	0.99990001	cardiovascular
Neanderthal	GWAS	Body mass index	13	28.1215	0.46227975	1	metabolic
Neanderthal	HPO	Bilateral sensorineural hearing impairment (HP:0008619)	3	0.1183	25.35925613	0.00019998	nervous
Neanderthal	HPO	Myocardial infarction (HP:0001658)	3	0.1589	18.87979862	0.00059994	cardiovascular
Neanderthal	HPO	Aplasia cutis congenita (HP:0001057)	3	0.1536	19.53125	0.00069993	integumentary
Neanderthal	HPO	Prolonged bleeding time (HP:0003010)	4	0.3679	10.87251971	0.00069993	hematologic
Neanderthal	HPO	Glycosuria (HP:0003076)	3	0.1704	17.6056338	0.00079992	urinary
Neanderthal	HPO	Abnormality of urine glucose concentration (HP:0011016)	3	0.1704	17.6056338	0.00079992	urinary
Neanderthal	HPO	Carious teeth (HP:0000670)	6	1.0588	5.666792595	0.00089991	skeletal
Neanderthal	HPO	Abnormal blistering of the skin (HP:0008066)	5	0.7111	7.031359865	0.00119988	integumentary
Neanderthal	HPO	Fragile skin (HP:0001030)	3	0.235	12.76595745	0.00149985	integumentary
Neanderthal	HPO	Milia (HP:0001056)	3	0.2911	10.30573686	0.00289971	integumentary
Neanderthal	HPO	Atrophic scars (HP:0001075)	3	0.2851	10.52262364	0.00309969	integumentary
Neanderthal	HPO	Severe visual impairment (HP:0001141)	2	0.0827	24.18379686	0.00309969	nervous
Neanderthal	HPO	Clonus (HP:0002169)	3	0.2746	10.92498179	0.00309969	nervous
Neanderthal	HPO	Bruising susceptibility (HP:0000978)	5	1.0453	4.783315795	0.00329967	other
Neanderthal	HPO	Hyperphosphaturia (HP:0003109)	2	0.099	20.2020202	0.00479952	urinary
Neanderthal	HPO	Nail dystrophy (HP:0008404)	3	0.3355	8.941877794	0.00489951	integumentary
Neanderthal	HPO	Increased mean platelet volume (HP:0011877)	2	0.1178	16.97792869	0.00539946	hematologic
Neanderthal	HPO	Abnormal platelet volume (HP:0011876)	2	0.1178	16.97792869	0.00539946	hematologic
Neanderthal	HPO	Epistaxis (HP:0000421)	4	0.7203	5.553241705	0.0059994	other
Neanderthal	HPO	Progressive sensorineural hearing impairment (HP:0000408)	2	0.116	17.24137931	0.00639936	nervous
Neanderthal	HPO	Abnormal urine phosphate concentration (HP:0012599)	2	0.1165	17.16738197	0.00649935	other
Neanderthal	HPO	Small intestinal stenosis (HP:0012848)	3	0.4078	7.356547327	0.0089991	digestive
Neanderthal	HPO	Duodenal stenosis (HP:0100867)	3	0.4078	7.356547327	0.0089991	digestive
Neanderthal	HPO	Abnormal drinking behavior (HP:0030082)	2	0.1452	13.77410468	0.01039896	behavior
Neanderthal	HPO	Polydipsia (HP:0001959)	2	0.1452	13.77410468	0.01039896	other
Neanderthal	HPO	Hypoplasia of dental enamel (HP:0006297)	3	0.4228	7.095553453	0.01049895	skeletal
Neanderthal	HPO	Hypophosphatemia (HP:0002148)	2	0.1718	11.64144354	0.01359864	other
Neanderthal	HPO	Hypercalciuria (HP:0002150)	3	0.5105	5.876591577	0.01389861	other
Neanderthal	HPO	Progressive hearing impairment (HP:0001730)	2	0.1836	10.89324619	0.01429857	nervous
Neanderthal	HPO	Pterygium (HP:0001059)	3	0.4988	6.014434643	0.01539846	integumentary
Neanderthal	HPO	Blepharitis (HP:0000498)	2	0.1988	10.06036217	0.0159984	nervous
Neanderthal	HPO	Calf muscle hypertrophy (HP:0008981)	1	0.0182	54.94505495	0.01829817	skeletal muscle
Neanderthal	HPO	Hepatosplenomegaly (HP:0001433)	2	0.1943	10.29336078	0.01839816	digestive
Neanderthal	HPO	Adducted thumb (HP:0001181)	3	0.5562	5.393743258	0.01859814	skeletal
Neanderthal	HPO	Lissencephaly (HP:0001339)	3	0.5604	5.353319058	0.01929807	nervous
Neanderthal	HPO	Esophageal atresia (HP:0002032)	2	0.2078	9.624639076	0.01929807	digestive
Neanderthal	HPO	Exercise-induced muscle cramps (HP:0003710)	1	0.0196	51.02040816	0.01969803	skeletal muscle
Neanderthal	HPO	Congenital cataract (HP:0000519)	3	0.5598	5.359056806	0.01969803	nervous
Neanderthal	HPO	Non-midline cleft lip (HP:0100335)	3	0.5555	5.400540054	0.02039796	other
Neanderthal	HPO	Gastrointestinal atresia (HP:0002589)	2	0.2161	9.254974549	0.02039796	digestive
Neanderthal	HPO	Polyhydramnios (HP:0001561)	4	1.0291	3.886891459	0.02089791	reproductive
Neanderthal	HPO	Pyloric stenosis (HP:0002021)	4	0.9868	4.053506283	0.0219978	digestive
Neanderthal	HPO	Ectropion (HP:0000656)	2	0.2353	8.499787505	0.02329767	nervous
Neanderthal	HPO	Abnormality of the duodenum (HP:0002246)	3	0.5876	5.105513955	0.02469753	digestive
Neanderthal	HPO	Fragile nails (HP:0001808)	2	0.2321	8.616975442	0.02479752	integumentary
Neanderthal	HPO	Macroglossia (HP:0000158)	3	0.6478	4.631058969	0.02529747	other
Neanderthal	HPO	Megaloblastic anemia (HP:0001889)	2	0.2471	8.093889114	0.02579742	hematologic
Neanderthal	HPO	Polyuria (HP:0000103)	2	0.2511	7.964954202	0.0279972	urinary
Neanderthal	HPO	Muscle hypertrophy of the lower extremities (HP:0008968)	1	0.0302	33.11258278	0.03019698	skeletal muscle
Neanderthal	HPO	Cerebral cortical atrophy (HP:0002120)	6	2.2687	2.644686384	0.03039696	nervous
Neanderthal	HPO	X-linked dominant inheritance (HP:0001423)	1	0.0325	30.76923077	0.0319968	other
Neanderthal	HPO	Acute necrotizing encephalopathy (HP:0006965)	1	0.0325	30.76923077	0.0319968	nervous
Neanderthal	HPO	Abnormal mitochondria in muscle tissue (HP:0008316)	1	0.0325	30.76923077	0.0319968	skeletal muscle
Neanderthal	HPO	Rickets (HP:0002748)	1	0.0324	30.86419753	0.03209679	skeletal
Neanderthal	HPO	Flared metaphyses (HP:0003015)	2	0.2835	7.054673721	0.03269673	skeletal
Neanderthal	HPO	Ureteral stenosis (HP:0000071)	2	0.3072	6.510416667	0.03389661	urinary
Neanderthal	HPO	Ureteral obstruction (HP:0006000)	2	0.3072	6.510416667	0.03389661	urinary
Neanderthal	HPO	Skin ulcer (HP:0200042)	4	1.2284	3.256268317	0.03429657	integumentary
Neanderthal	HPO	Progressive macrocephaly (HP:0004481)	1	0.0352	28.40909091	0.03459654	skeletal
Neanderthal	HPO	Congenital onset (HP:0003577)	7	3.057	2.289826627	0.03769623	other
Neanderthal	HPO	Abnormal urine output (HP:0012590)	2	0.3055	6.546644845	0.03819618	urinary
Neanderthal	HPO	Plantar hyperkeratosis (HP:0007556)	2	0.3271	6.114338123	0.0439956	integumentary
Neanderthal	HPO	Epidermoid cyst (HP:0200040)	1	0.0458	21.83406114	0.04519548	integumentary
Neanderthal	HPO	Macrocytic anemia (HP:0001972)	2	0.3373	5.929439668	0.04589541	hematologic
Neanderthal	HPO	Elevated alkaline phosphatase (HP:0003155)	2	0.3335	5.997001499	0.0459954	other
Neanderthal	HPO	Abnormality of renal excretion (HP:0011036)	2	0.3417	5.853087504	0.04639536	urinary
Neanderthal	HPO	Abnormality of alkaline phosphatase activity (HP:0004379)	2	0.3416	5.854800937	0.04739526	other
Neanderthal	HPO	Abnormal enzyme/coenzyme activity (HP:0012379)	2	0.3451	5.795421617	0.0479952	other
Neanderthal	HPO	Everted lower lip vermilion (HP:0000232)	4	1.3476	2.968239834	0.0479952	integumentary
Neanderthal	HPO	Generalized aminoaciduria (HP:0002909)	1	0.0497	20.12072435	0.04829517	urinary
Neanderthal	HPO	Abnormality of the fingernails (HP:0001231)	5	1.9716	2.536011361	0.04939506	integumentary
Neanderthal	HPO	Ankyloglossia (HP:0010296)	1	0.0523	19.12045889	0.050594941	other
Neanderthal	HPO	Abnormality of oral frenula (HP:0000190)	1	0.0523	19.12045889	0.050594941	integumentary
Neanderthal	HPO	Osteomalacia (HP:0002749)	1	0.0554	18.05054152	0.054194581	skeletal
Neanderthal	HPO	Death in infancy (HP:0001522)	2	0.3724	5.37056928	0.054394561	other
Neanderthal	HPO	Proteinuria (HP:0000093)	4	1.4049	2.847177735	0.056094391	other
Neanderthal	HPO	Abdominal pain (HP:0002027)	3	0.8662	3.463403371	0.056094391	other
Neanderthal	HPO	Hematochezia (HP:0002573)	1	0.059	16.94915254	0.056994301	digestive
Neanderthal	HPO	Anonychia (HP:0001798)	3	0.8659	3.464603303	0.057294271	integumentary
Neanderthal	HPO	Dementia (HP:0000726)	3	0.8618	3.481086099	0.057794221	nervous
Neanderthal	HPO	Nephritis (HP:0000123)	2	0.3947	5.0671396	0.060693931	urinary
Neanderthal	HPO	Neck muscle weakness (HP:0000467)	1	0.0656	15.24390244	0.063093691	skeletal muscle
Neanderthal	HPO	Malnutrition (HP:0004395)	1	0.065	15.38461538	0.063393661	metabolic
Neanderthal	HPO	Sepsis (HP:0100806)	2	0.4087	4.893564962	0.064793521	immune
Neanderthal	HPO	Abnormality of primary teeth (HP:0006481)	2	0.4169	4.797313504	0.064893511	skeletal
Neanderthal	HPO	Cortical visual impairment (HP:0100704)	1	0.0677	14.77104874	0.065493451	nervous
Neanderthal	HPO	Stage 5 chronic kidney disease (HP:0003774)	3	0.9211	3.256975356	0.066393361	urinary
Neanderthal	HPO	Deep philtrum (HP:0002002)	2	0.4183	4.781257471	0.066793321	integumentary
Neanderthal	HPO	Autosomal recessive inheritance (HP:0000007)	33	24.7673	1.332401998	0.066793321	other
Neanderthal	HPO	Squamous cell carcinoma (HP:0002860)	1	0.0732	13.66120219	0.070692931	integumentary
Neanderthal	HPO	Renal tubular dysfunction (HP:0000124)	2	0.4407	4.538234627	0.070792921	urinary
Neanderthal	HPO	Blindness (HP:0000618)	3	0.958	3.131524008	0.070992901	nervous
Neanderthal	HPO	Complement deficiency (HP:0004431)	1	0.075	13.33333333	0.071392861	immune
Neanderthal	HPO	Proximal tubulopathy (HP:0000114)	1	0.0745	13.42281879	0.071392861	urinary
Neanderthal	HPO	Nephrolithiasis (HP:0000787)	3	0.9616	3.119800333	0.071392861	urinary
Neanderthal	HPO	Hypoparathyroidism (HP:0000829)	1	0.0742	13.47708895	0.071892811	endocrine
Neanderthal	HPO	Premature loss of primary teeth (HP:0006323)	1	0.0775	12.90322581	0.075392461	skeletal
Neanderthal	HPO	Pointed chin (HP:0000307)	3	0.9743	3.079133737	0.075492451	skeletal
Neanderthal	HPO	Leukodystrophy (HP:0002415)	1	0.0815	12.26993865	0.078492151	nervous
Neanderthal	HPO	Pathologic fracture (HP:0002756)	1	0.0827	12.09189843	0.080091991	skeletal
Neanderthal	HPO	Microdontia (HP:0000691)	3	1.0385	2.888781897	0.082591741	skeletal
Neanderthal	HPO	B lymphocytopenia (HP:0010976)	1	0.0862	11.60092807	0.082791721	lymphatic
Neanderthal	HPO	Premature graying of hair (HP:0002216)	1	0.0875	11.42857143	0.083591641	integumentary
Neanderthal	HPO	Seborrheic dermatitis (HP:0001051)	1	0.0878	11.38952164	0.083891611	integumentary
Neanderthal	HPO	Patchy hypopigmentation of hair (HP:0011365)	1	0.0881	11.3507378	0.084091591	integumentary
Neanderthal	HPO	White forelock (HP:0002211)	1	0.0881	11.3507378	0.084091591	integumentary
Neanderthal	HPO	Abnormality of macrophages (HP:0004311)	1	0.0893	11.19820829	0.086391361	immune
Neanderthal	HPO	Sloping forehead (HP:0000340)	3	1.0355	2.897151135	0.089491051	skeletal
Neanderthal	HPO	Personality changes (HP:0000751)	1	0.0948	10.54852321	0.089891011	behavior
Neanderthal	HPO	Hepatitis (HP:0012115)	2	0.5072	3.943217666	0.092790721	immune
Neanderthal	HPO	Abnormality of complement system (HP:0005339)	1	0.1039	9.624639076	0.096990301	immune
Neanderthal	HPO	Aplasia/Hypoplasia of the thymus (HP:0010515)	2	0.516	3.875968992	0.097590241	lymphatic
Neanderthal	HPO	Patent ductus arteriosus (HP:0001643)	4	1.7475	2.288984263	0.098190181	cardiovascular
Neanderthal	HPO	Exercise-induced myalgia (HP:0003738)	1	0.1036	9.652509653	0.099290071	skeletal muscle
Neanderthal	HPO	Hematuria (HP:0000790)	2	0.5361	3.730647267	0.099490051	urinary
Neanderthal	HPO	Abnormality of serum amino acid levels (HP:0003112)	2	0.5332	3.750937734	0.099990001	other
Neanderthal	HPO	Adrenal hypoplasia (HP:0000835)	1	0.1062	9.416195857	0.100789921	endocrine
Neanderthal	HPO	Woolly hair (HP:0002224)	1	0.1072	9.328358209	0.102489751	integumentary
Neanderthal	HPO	Coxa vara (HP:0002812)	1	0.1116	8.960573477	0.104689531	skeletal
Neanderthal	HPO	Heterogeneous (HP:0001425)	5	2.5036	1.997124141	0.106489351	other
Neanderthal	HPO	Abnormality of transition element cation homeostasis (HP:0011030)	1	0.1128	8.865248227	0.107189281	other
Neanderthal	HPO	Albinism (HP:0001022)	1	0.1138	8.787346221	0.107689231	integumentary
Neanderthal	HPO	Natal tooth (HP:0000695)	1	0.1134	8.818342152	0.108089191	skeletal
Neanderthal	HPO	Recurrent bronchitis (HP:0002837)	1	0.1152	8.680555556	0.109689031	respiratory
Neanderthal	HPO	Palmoplantar keratoderma (HP:0000982)	2	0.5772	3.465003465	0.111488851	integumentary
Neanderthal	HPO	Homocystinuria (HP:0002156)	1	0.1182	8.460236887	0.112388761	other
Neanderthal	HPO	Abnormality of homocysteine metabolism (HP:0010919)	1	0.1182	8.460236887	0.112388761	metabolic
Neanderthal	HPO	Hyperhidrosis (HP:0000975)	2	0.5711	3.502013658	0.113488651	integumentary
Neanderthal	HPO	Ankle clonus (HP:0011448)	1	0.1217	8.216926869	0.114288571	nervous
Neanderthal	HPO	Xanthomatosis (HP:0000991)	1	0.1213	8.244023083	0.114988501	metabolic
Neanderthal	HPO	Acute encephalopathy (HP:0006846)	1	0.1243	8.045052293	0.116588341	nervous
Neanderthal	HPO	Medulloblastoma (HP:0002885)	1	0.1271	7.867820614	0.118588141	nervous
Neanderthal	HPO	Coarse facial features (HP:0000280)	5	2.5807	1.937458829	0.119188081	integumentary
Neanderthal	HPO	Developmental regression (HP:0002376)	3	1.199	2.502085071	0.120587941	behavior
Neanderthal	HPO	Menorrhagia (HP:0000132)	2	0.6028	3.317850033	0.121287871	reproductive
Neanderthal	HPO	Sudden death (HP:0001699)	2	0.6077	3.291097581	0.122087791	other
Neanderthal	HPO	Ocular albinism (HP:0001107)	2	0.6119	3.268507926	0.124987501	nervous
Neanderthal	HPO	Persistence of primary teeth (HP:0006335)	1	0.1322	7.56429652	0.125187481	skeletal
Neanderthal	HPO	Hyperlipoproteinemia (HP:0010980)	1	0.136	7.352941176	0.126787321	metabolic
Neanderthal	HPO	Congestive heart failure (HP:0001635)	3	1.2382	2.422871911	0.127887211	cardiovascular
Neanderthal	HPO	T lymphocytopenia (HP:0005403)	1	0.1391	7.18907261	0.129587041	immune
Neanderthal	HPO	Supernumerary nipples (HP:0002558)	1	0.1403	7.127583749	0.129587041	other
Neanderthal	HPO	Abnormality of T cell number (HP:0011839)	1	0.1391	7.18907261	0.129587041	immune
Neanderthal	HPO	Mitochondrial inheritance (HP:0001427)	1	0.1386	7.215007215	0.129987001	other
Neanderthal	HPO	Polygenic inheritance (HP:0010982)	1	0.1387	7.209805335	0.130386961	other
Neanderthal	HPO	Neuroectodermal neoplasm (HP:0030061)	2	0.6278	3.185727939	0.132586741	nervous
Neanderthal	HPO	Nervous tissue neoplasm (HP:0030060)	2	0.6278	3.185727939	0.132586741	nervous
Neanderthal	HPO	Neuroepithelial neoplasm (HP:0030063)	2	0.6278	3.185727939	0.132586741	nervous
Neanderthal	HPO	Abnormality of dental color (HP:0011073)	1	0.1441	6.93962526	0.134686531	skeletal
Neanderthal	HPO	Iris hypopigmentation (HP:0007730)	2	0.6497	3.078343851	0.135786421	integumentary
Neanderthal	HPO	Calcaneovalgus deformity (HP:0001848)	1	0.1473	6.788866259	0.136686331	skeletal
Neanderthal	HPO	Abnormality of the common coagulation pathway (HP:0010990)	1	0.1478	6.765899865	0.136686331	hematologic
Neanderthal	HPO	Gowers sign (HP:0003391)	1	0.1488	6.720430108	0.137486251	skeletal muscle
Neanderthal	HPO	Anterior segment dysgenesis (HP:0007700)	1	0.1477	6.770480704	0.137586241	integumentary
Neanderthal	HPO	Protruding tongue (HP:0010808)	2	0.6534	3.060912152	0.138486151	other
Neanderthal	HPO	Muscle stiffness (HP:0003552)	1	0.1467	6.816632584	0.138886111	skeletal muscle
Neanderthal	HPO	Hyperalaninemia (HP:0003348)	1	0.1501	6.662225183	0.139786021	metabolic
Neanderthal	HPO	Abnormality of pyruvate family amino acid metabolism (HP:0010915)	1	0.1501	6.662225183	0.139786021	metabolic
Neanderthal	HPO	Abnormality of alanine metabolism (HP:0010916)	1	0.1501	6.662225183	0.139786021	metabolic
Neanderthal	HPO	Deformed tarsal bones (HP:0008119)	1	0.1518	6.587615283	0.140485951	skeletal
Neanderthal	HPO	Long nose (HP:0003189)	1	0.1527	6.548788474	0.141085891	skeletal
Neanderthal	HPO	Dysphagia (HP:0002015)	3	1.3047	2.299379168	0.141285871	digestive
Neanderthal	HPO	Exercise intolerance (HP:0003546)	1	0.1541	6.489292667	0.142485751	other
Neanderthal	HPO	Hypodontia (HP:0000668)	2	0.6611	3.025260929	0.143485651	skeletal
Neanderthal	HPO	Tetralogy of Fallot (HP:0001636)	3	1.3045	2.299731698	0.145885411	cardiovascular
Neanderthal	HPO	Increased serum pyruvate (HP:0003542)	1	0.1596	6.26566416	0.146485351	metabolic
Neanderthal	HPO	Metaphyseal irregularity (HP:0003025)	1	0.1585	6.309148265	0.146785321	skeletal
Neanderthal	HPO	Abnormality of glycolysis (HP:0004366)	1	0.1628	6.142506143	0.148885111	metabolic
Neanderthal	HPO	Lip pit (HP:0100267)	1	0.1602	6.242197253	0.149585041	integumentary
Neanderthal	HPO	Upslanted palpebral fissure (HP:0000582)	3	1.327	2.260738508	0.151284872	integumentary
Neanderthal	HPO	Freckling (HP:0001480)	2	0.6824	2.930832356	0.152184782	integumentary
Neanderthal	HPO	Abnormality of the umbilical cord (HP:0010881)	1	0.1644	6.082725061	0.152684732	reproductive
Neanderthal	HPO	Nasal speech (HP:0001611)	1	0.1659	6.027727547	0.153284672	other
Neanderthal	HPO	Nausea (HP:0002018)	1	0.1669	5.991611744	0.153384662	other
Neanderthal	HPO	Bronchiectasis (HP:0002110)	2	0.6941	2.881429189	0.153384662	respiratory
Neanderthal	HPO	Arthrogryposis multiplex congenita (HP:0002804)	3	1.3425	2.234636872	0.153584642	skeletal muscle
Neanderthal	HPO	Abnormal eating behavior (HP:0100738)	2	0.6921	2.889755816	0.153784622	behavior
Neanderthal	HPO	Hypermetropia (HP:0000540)	4	2.0467	1.954365564	0.153884612	nervous
Neanderthal	HPO	Obsessive-compulsive behavior (HP:0000722)	2	0.6949	2.878111959	0.154684532	behavior
Neanderthal	HPO	Malignant neoplasm of the central nervous system (HP:0100836)	2	0.6917	2.891426919	0.155084492	nervous
Neanderthal	HPO	Advanced eruption of teeth (HP:0006288)	1	0.1672	5.980861244	0.155484452	skeletal
Neanderthal	HPO	Abnormalities of placenta or umbilical cord (HP:0001194)	1	0.1693	5.906674542	0.157084292	reproductive
Neanderthal	HPO	Intestinal malrotation (HP:0002566)	2	0.7142	2.80033604	0.157184282	digestive
Neanderthal	HPO	Patent foramen ovale (HP:0001655)	1	0.1712	5.841121495	0.157384262	cardiovascular
Neanderthal	HPO	Tubular atrophy (HP:0000092)	1	0.1739	5.750431282	0.158584142	urinary
Neanderthal	HPO	Annular pancreas (HP:0001734)	1	0.173	5.780346821	0.158684132	digestive
Neanderthal	HPO	Pruritus (HP:0000989)	2	0.7032	2.844141069	0.159184082	integumentary
Neanderthal	HPO	Arterial tortuosity (HP:0005116)	1	0.1741	5.743825388	0.160183982	cardiovascular
Neanderthal	HPO	Vascular tortuosity (HP:0004948)	1	0.1741	5.743825388	0.160183982	cardiovascular
Neanderthal	HPO	Abnormality of polysaccharide metabolism (HP:0011012)	1	0.1765	5.66572238	0.160683932	metabolic
Neanderthal	HPO	Mucopolysacchariduria (HP:0008155)	1	0.1765	5.66572238	0.160683932	metabolic
Neanderthal	HPO	Abnormality of mucopolysaccharide metabolism (HP:0011020)	1	0.1765	5.66572238	0.160683932	metabolic
Neanderthal	HPO	Abnormality of glycosaminoglycan metabolism (HP:0004371)	1	0.1765	5.66572238	0.160683932	metabolic
Neanderthal	HPO	Urinary glycosaminoglycan excretion (HP:0003541)	1	0.1765	5.66572238	0.160683932	metabolic
Neanderthal	HPO	Flared iliac wings (HP:0002869)	1	0.1747	5.724098454	0.161183882	skeletal
Neanderthal	HPO	Juvenile onset (HP:0003621)	2	0.7258	2.75558005	0.161283872	other
Neanderthal	HPO	Acute lymphatic leukemia (HP:0006721)	1	0.1763	5.672149745	0.162383762	lymphatic
Neanderthal	HPO	Insomnia (HP:0100785)	1	0.1787	5.595970901	0.163483652	behavior
Neanderthal	HPO	Dysostosis multiplex (HP:0000943)	1	0.1801	5.55247085	0.163683632	skeletal
Neanderthal	HPO	Cerebral ischemia (HP:0002637)	2	0.7172	2.788622421	0.163783622	nervous
Neanderthal	HPO	Bronchomalacia (HP:0002780)	1	0.1785	5.602240896	0.164183582	respiratory
Neanderthal	HPO	Renal duplication (HP:0000075)	1	0.1797	5.564830273	0.164183582	urinary
Neanderthal	HPO	Tetany (HP:0001281)	1	0.1806	5.53709856	0.164983502	endocrine
Neanderthal	HPO	Overriding aorta (HP:0002623)	1	0.1823	5.485463522	0.165783422	cardiovascular
Neanderthal	HPO	Renal agenesis (HP:0000104)	2	0.7321	2.731867231	0.166083392	urinary
Neanderthal	HPO	Elfin facies (HP:0004428)	1	0.1832	5.458515284	0.166983302	other
Neanderthal	HPO	Broad nasal tip (HP:0000455)	1	0.1832	5.458515284	0.167683232	integumentary
Neanderthal	HPO	Abnormality of the left ventricular outflow tract (HP:0011103)	1	0.1824	5.48245614	0.167683232	cardiovascular
Neanderthal	HPO	Subaortic stenosis (HP:0001682)	1	0.1824	5.48245614	0.167683232	cardiovascular
Neanderthal	HPO	Autoimmune hemolytic anemia (HP:0001890)	1	0.1847	5.414185165	0.170282972	immune
Neanderthal	HPO	Abnormality of the calcaneus (HP:0008364)	1	0.1877	5.327650506	0.170782922	skeletal
Neanderthal	HPO	Neurodegeneration (HP:0002180)	1	0.1925	5.194805195	0.173582642	nervous
Neanderthal	HPO	Hypoplasia of the thymus (HP:0000778)	1	0.1919	5.211047421	0.173882612	lymphatic
Neanderthal	HPO	Recurrent sinusitis (HP:0011108)	1	0.1901	5.260389269	0.174182582	respiratory
Neanderthal	HPO	Skin nodule (HP:0200036)	1	0.1882	5.313496281	0.174582542	integumentary
Neanderthal	HPO	Myotonia (HP:0002486)	1	0.1909	5.238344683	0.174982502	skeletal muscle
Neanderthal	HPO	Retinal dysplasia (HP:0007973)	1	0.1921	5.205622072	0.175782422	nervous
Neanderthal	HPO	Hypoplasia of the odontoid process (HP:0003311)	1	0.197	5.076142132	0.179382062	skeletal
Neanderthal	HPO	Abnormality of the odontoid process (HP:0003310)	1	0.197	5.076142132	0.179382062	skeletal
Neanderthal	HPO	Hydrocephalus (HP:0000238)	6	3.7708	1.591174287	0.179682032	nervous
Neanderthal	HPO	Proximal placement of thumb (HP:0009623)	1	0.2002	4.995004995	0.179982002	skeletal
Neanderthal	HPO	Cheilitis (HP:0100825)	1	0.1991	5.022601708	0.180381962	other
Neanderthal	HPO	Abnormality of vitamin B metabolism (HP:0004340)	1	0.2035	4.914004914	0.183381662	metabolic
Neanderthal	HPO	Abnormality of the vitamin B12 metabolism (HP:0004341)	1	0.2035	4.914004914	0.183381662	metabolic
Neanderthal	HPO	Pancytopenia (HP:0001876)	1	0.2055	4.866180049	0.185381462	hematologic
Neanderthal	HPO	Abnormality of T cells (HP:0002843)	1	0.2047	4.885197851	0.186881312	immune
Neanderthal	HPO	Neurofibrillary tangles (HP:0002185)	1	0.2101	4.759638267	0.189681032	nervous
Neanderthal	HPO	Asymmetric septal hypertrophy (HP:0001670)	1	0.2116	4.725897921	0.189781022	cardiovascular
Neanderthal	HPO	Tubulointerstitial fibrosis (HP:0005576)	1	0.2105	4.750593824	0.190980902	urinary
Neanderthal	HPO	Abnormality of subcutaneous fat tissue (HP:0001001)	1	0.2114	4.730368969	0.190980902	metabolic
Neanderthal	HPO	Gonadotropin excess (HP:0000837)	1	0.211	4.739336493	0.191780822	endocrine
Neanderthal	HPO	Microcornea (HP:0000482)	3	1.5135	1.982160555	0.194380562	nervous
Neanderthal	HPO	Type II lissencephaly (HP:0007260)	1	0.2172	4.604051565	0.196080392	skeletal
Neanderthal	HPO	Abnormality of vitamin metabolism (HP:0100508)	1	0.2248	4.448398577	0.201079892	metabolic
Neanderthal	HPO	Urinary urgency (HP:0000012)	1	0.228	4.385964912	0.203479652	urinary
Neanderthal	HPO	Attention deficit hyperactivity disorder (HP:0007018)	3	1.548	1.937984496	0.205279472	behavior
Neanderthal	HPO	Amyloidosis (HP:0011034)	1	0.2319	4.312203536	0.206579342	other
Neanderthal	HPO	Abnormality of the calf musculature (HP:0001430)	1	0.2312	4.325259516	0.206879312	skeletal muscle
Neanderthal	HPO	Apathy (HP:0000741)	1	0.2321	4.308487721	0.206979302	behavior
Neanderthal	HPO	Diminished motivation (HP:0000745)	1	0.2321	4.308487721	0.206979302	behavior
Neanderthal	HPO	Renovascular hypertension (HP:0100817)	1	0.2332	4.288164666	0.207279272	cardiovascular
Neanderthal	HPO	Premature birth (HP:0001622)	2	0.851	2.350176263	0.207879212	reproductive
Neanderthal	HPO	Megalencephaly (HP:0001355)	1	0.232	4.310344828	0.209479052	nervous
Neanderthal	HPO	Osteoporosis (HP:0000939)	2	0.8566	2.334812048	0.210278972	skeletal
Neanderthal	HPO	Dandy-Walker malformation (HP:0001305)	3	1.594	1.882057716	0.212478752	nervous
Neanderthal	HPO	Respiratory failure (HP:0002878)	1	0.238	4.201680672	0.212578742	respiratory
Neanderthal	HPO	Deviation of the thumb (HP:0009603)	1	0.2406	4.156275977	0.212678732	skeletal
Neanderthal	HPO	Granulocytopenia (HP:0001913)	1	0.2364	4.230118443	0.212978702	immune
Neanderthal	HPO	Splenomegaly (HP:0001744)	4	2.3528	1.700102006	0.213578642	lymphatic
Neanderthal	HPO	Flat cornea (HP:0007720)	1	0.2415	4.140786749	0.214078592	nervous
Neanderthal	HPO	Lower limb asymmetry (HP:0100559)	1	0.2433	4.110152076	0.215378462	skeletal
Neanderthal	HPO	Cerebral hemorrhage (HP:0001342)	1	0.2435	4.106776181	0.215578442	nervous
Neanderthal	HPO	Scanning speech (HP:0002168)	1	0.2412	4.145936982	0.216478352	nervous
Neanderthal	HPO	Bladder diverticulum (HP:0000015)	1	0.2492	4.012841091	0.218678132	urinary
Neanderthal	HPO	Large hands (HP:0001176)	1	0.2452	4.078303426	0.218778122	skeletal
Neanderthal	HPO	Hyperacusis (HP:0010780)	1	0.2475	4.04040404	0.219278072	nervous
Neanderthal	HPO	Abnormality of the thymus (HP:0000777)	2	0.8848	2.26039783	0.219578042	lymphatic
Neanderthal	HPO	Asymmetric growth (HP:0100555)	1	0.2483	4.027386226	0.219678032	other
Neanderthal	HPO	Joint stiffness (HP:0001387)	1	0.2478	4.03551251	0.221977802	skeletal
Neanderthal	HPO	Stillbirth (HP:0003826)	1	0.251	3.984063745	0.222977702	reproductive
Neanderthal	HPO	Bronchitis (HP:0012387)	1	0.259	3.861003861	0.227277272	respiratory
Neanderthal	HPO	Cutaneous photosensitivity (HP:0000992)	1	0.2552	3.918495298	0.227577242	integumentary
Neanderthal	HPO	Opacification of the corneal stroma (HP:0007759)	4	2.4265	1.648464867	0.228477152	nervous
Neanderthal	HPO	Rhabdomyosarcoma (HP:0002859)	1	0.2668	3.748125937	0.232876712	other
Neanderthal	HPO	Multifactorial inheritance (HP:0001426)	1	0.2642	3.785011355	0.233276672	other
Neanderthal	HPO	Disproportionate short-trunk short stature (HP:0003521)	1	0.2664	3.753753754	0.233576642	skeletal
Neanderthal	HPO	Abnormality of chromosome stability (HP:0003220)	1	0.2672	3.74251497	0.235076492	other
Neanderthal	HPO	Esophageal varix (HP:0002040)	1	0.2704	3.698224852	0.237176282	cardiovascular
Neanderthal	HPO	Inflammation of the large intestine (HP:0002037)	1	0.275	3.636363636	0.242775722	digestive
Neanderthal	HPO	Stereotypic behavior (HP:0000733)	2	0.9364	2.135839385	0.242975702	behavior
Neanderthal	HPO	Retinitis pigmentosa (HP:0000510)	3	1.6975	1.76730486	0.245675432	integumentary
Neanderthal	HPO	Gastroesophageal reflux (HP:0002020)	2	0.9508	2.103491796	0.245775422	digestive
Neanderthal	HPO	Ovoid vertebral bodies (HP:0003300)	1	0.2838	3.523608175	0.245775422	skeletal
Neanderthal	HPO	Dolichocephaly (HP:0000268)	3	1.7194	1.744794696	0.247375262	skeletal
Neanderthal	HPO	Abnormal auditory evoked potentials (HP:0006958)	1	0.2833	3.529827038	0.247775222	nervous
Neanderthal	HPO	Anal stenosis (HP:0002025)	1	0.2827	3.537318712	0.248975102	digestive
Neanderthal	HPO	Gastrointestinal inflammation (HP:0004386)	1	0.2833	3.529827038	0.249275072	digestive
Neanderthal	HPO	Chronic diarrhea (HP:0002028)	1	0.2877	3.475842892	0.249375062	digestive
Neanderthal	HPO	Increased CSF lactate (HP:0002490)	1	0.2898	3.450655625	0.249775022	other
Neanderthal	HPO	Cone-rod dystrophy (HP:0000548)	1	0.287	3.484320557	0.249975002	nervous
Neanderthal	HPO	Abnormality of vision evoked potentials (HP:0000649)	1	0.2901	3.447087211	0.251274873	nervous
Neanderthal	HPO	Abnormality of the anterior chamber (HP:0000593)	1	0.2951	3.388681803	0.255474453	nervous
Neanderthal	HPO	Dehydration (HP:0001944)	2	0.9707	2.060368806	0.257774223	other
Neanderthal	HPO	Polyneuropathy (HP:0001271)	1	0.2995	3.338898164	0.260473953	nervous
Neanderthal	HPO	Posterior embryotoxon (HP:0000627)	1	0.304	3.289473684	0.261073893	nervous
Neanderthal	HPO	Agnosia (HP:0010524)	1	0.3009	3.323363244	0.261673833	nervous
Neanderthal	HPO	Lactic acidosis (HP:0003128)	2	0.9777	2.045617265	0.262073793	metabolic
Neanderthal	HPO	Macrotia (HP:0000400)	3	1.7809	1.684541524	0.262073793	other
Neanderthal	HPO	Abnormality of the nasal septum (HP:0000419)	1	0.3018	3.313452618	0.262773723	respiratory
Neanderthal	HPO	Abnormality of the line of Schwalbe (HP:0008048)	1	0.3067	3.260515161	0.263273673	nervous
Neanderthal	HPO	Cerebral inclusion bodies (HP:0100314)	1	0.3075	3.25203252	0.263573643	nervous
Neanderthal	HPO	Polycystic kidney dysplasia (HP:0000113)	2	1.0004	1.99920032	0.263573643	urinary
Neanderthal	HPO	Babinski sign (HP:0003487)	2	1.0008	1.998401279	0.264173583	nervous
Neanderthal	HPO	Abolished electroretinogram (ERG) (HP:0000550)	1	0.3051	3.277613897	0.264673533	nervous
Neanderthal	HPO	Hypercalcemia (HP:0003072)	1	0.309	3.236245955	0.265573443	other
Neanderthal	HPO	Tracheoesophageal fistula (HP:0002575)	2	1.0036	1.992825827	0.267873213	respiratory
Neanderthal	HPO	Vomiting (HP:0002013)	2	1.0131	1.974138782	0.268773123	digestive
Neanderthal	HPO	Microtia (HP:0008551)	2	1.0291	1.943445729	0.270872913	nervous
Neanderthal	HPO	Generalized hypopigmentation (HP:0007513)	1	0.3198	3.126954346	0.271372863	integumentary
Neanderthal	HPO	Bone marrow hypocellularity (HP:0005528)	1	0.32	3.125	0.271472853	other
Neanderthal	HPO	Optic disc pallor (HP:0000543)	1	0.3151	3.173595684	0.272572743	nervous
Neanderthal	HPO	Neuroblastoma (HP:0003006)	1	0.3242	3.084515731	0.273672633	nervous
Neanderthal	HPO	Primitive neuroectodermal tumor (HP:0030065)	1	0.3242	3.084515731	0.273672633	nervous
Neanderthal	HPO	Peripheral primitive neuroectodermal neoplasm (HP:0030067)	1	0.3242	3.084515731	0.273672633	nervous
Neanderthal	HPO	Neuroblastic tumors (HP:0004376)	1	0.3242	3.084515731	0.273672633	nervous
Neanderthal	HPO	Abnormality of the diencephalon (HP:0010662)	1	0.3211	3.114294612	0.274072593	nervous
Neanderthal	HPO	Glioma (HP:0009733)	1	0.3244	3.082614057	0.275672433	nervous
Neanderthal	HPO	Genetic anticipation (HP:0003743)	1	0.3301	3.029385035	0.281871813	other
Neanderthal	HPO	Morphological abnormality of the pyramidal tract (HP:0002062)	1	0.3305	3.025718608	0.282271773	nervous
Neanderthal	HPO	Hip dysplasia (HP:0001385)	1	0.336	2.976190476	0.282471753	skeletal
Neanderthal	HPO	Cerebral edema (HP:0002181)	1	0.3329	3.003905077	0.283071693	nervous
Neanderthal	HPO	Nasolacrimal duct obstruction (HP:0000579)	1	0.3297	3.033060358	0.285871413	other
Neanderthal	HPO	Furrowed tongue (HP:0000221)	1	0.3343	2.991325157	0.286571343	other
Neanderthal	HPO	Epiphyseal dysplasia (HP:0002656)	1	0.3415	2.928257687	0.288771123	skeletal
Neanderthal	HPO	Tracheomalacia (HP:0002779)	1	0.3415	2.928257687	0.289471053	respiratory
Neanderthal	HPO	Abnormality of the carotid arteries (HP:0005344)	1	0.3449	2.899391128	0.290770923	cardiovascular
Neanderthal	HPO	Hyperpituitarism (HP:0010514)	1	0.3444	2.903600465	0.291370863	endocrine
Neanderthal	HPO	Spastic gait (HP:0002064)	1	0.347	2.88184438	0.293370663	skeletal muscle
Neanderthal	HPO	Abnormal ventriculo-arterial connection (HP:0011563)	1	0.3537	2.827254736	0.295670433	cardiovascular
Neanderthal	HPO	Abnormal connection of the cardiac segments (HP:0011545)	1	0.3537	2.827254736	0.295670433	cardiovascular
Neanderthal	HPO	Megalocornea (HP:0000485)	1	0.349	2.865329513	0.295670433	nervous
Neanderthal	HPO	Transposition of the great arteries (HP:0001669)	1	0.3537	2.827254736	0.295670433	cardiovascular
Neanderthal	HPO	Convex nasal ridge (HP:0000444)	2	1.0882	1.837897445	0.297170283	skeletal
Neanderthal	HPO	Corneal erosion (HP:0200020)	1	0.3536	2.828054299	0.297970203	nervous
Neanderthal	HPO	Renal tubular acidosis (HP:0001947)	1	0.3568	2.802690583	0.298470153	urinary
Neanderthal	HPO	Gingival bleeding (HP:0000225)	1	0.3558	2.810567735	0.298970103	immune
Neanderthal	HPO	Bowel diverticulosis (HP:0005222)	1	0.3596	2.780867631	0.299370063	digestive
Neanderthal	HPO	Pachygyria (HP:0001302)	1	0.3546	2.820078962	0.300669933	nervous
Neanderthal	HPO	Neoplasm of striated muscle (HP:0009728)	1	0.363	2.754820937	0.302969703	skeletal muscle
Neanderthal	HPO	Abnormality of the gastric mucosa (HP:0004295)	1	0.3612	2.76854928	0.303269673	digestive
Neanderthal	HPO	Hypercholesterolemia (HP:0003124)	1	0.3568	2.802690583	0.303469653	metabolic
Neanderthal	HPO	Hallux valgus (HP:0001822)	1	0.3653	2.737476047	0.303869613	skeletal
Neanderthal	HPO	Craniofacial hyperostosis (HP:0004493)	1	0.3623	2.760143527	0.306369363	skeletal
Neanderthal	HPO	Recurrent pneumonia (HP:0006532)	1	0.3702	2.701242572	0.308869113	immune
Neanderthal	HPO	Umbilical hernia (HP:0001537)	4	2.8167	1.420101537	0.310368963	reproductive
Neanderthal	HPO	Abnormality of the acetabulum (HP:0003170)	1	0.3751	2.665955745	0.312868713	skeletal
Neanderthal	HPO	Epileptiform EEG discharges (HP:0011182)	2	1.1295	1.770694998	0.313368663	nervous
Neanderthal	HPO	Deviation of the hallux (HP:0010051)	1	0.3816	2.620545073	0.315768423	skeletal
Neanderthal	HPO	Tubulointerstitial abnormality (HP:0001969)	1	0.3798	2.632964718	0.316668333	urinary
Neanderthal	HPO	Absent eyelashes (HP:0000561)	1	0.3779	2.646202699	0.317768223	integumentary
Neanderthal	HPO	Hamartoma (HP:0010566)	1	0.3854	2.594706798	0.318168183	other
Neanderthal	HPO	Partial agenesis of the corpus callosum (HP:0001338)	1	0.3866	2.586652871	0.318968103	nervous
Neanderthal	HPO	Overfolded helix (HP:0000396)	1	0.3813	2.622606871	0.319168083	integumentary
Neanderthal	HPO	Abnormally folded helix (HP:0008544)	1	0.3813	2.622606871	0.319168083	integumentary
Neanderthal	HPO	Abnormality of the renal cortex (HP:0011035)	1	0.3862	2.589331952	0.320667933	urinary
Neanderthal	HPO	Hypoplastic iliac wings (HP:0002866)	1	0.3919	2.551671345	0.324367563	skeletal
Neanderthal	HPO	Poor coordination (HP:0002370)	1	0.3906	2.56016385	0.324467553	nervous
Neanderthal	HPO	Osteomyelitis (HP:0002754)	1	0.3937	2.54000508	0.325367463	skeletal
Neanderthal	HPO	Abnormality of Sharpey fibers (HP:0100685)	1	0.3968	2.52016129	0.325567443	skeletal muscle
Neanderthal	HPO	Chondrocalcinosis (HP:0000934)	1	0.3968	2.52016129	0.325567443	skeletal
Neanderthal	HPO	Pulmonary fibrosis (HP:0002206)	1	0.3959	2.525890376	0.326767323	respiratory
Neanderthal	HPO	"Intellectual disability, profound (HP:0002187)"	1	0.3999	2.500625156	0.327567243	nervous
Neanderthal	HPO	Alveolar cell carcinoma (HP:0006519)	1	0.3971	2.518257366	0.328967103	respiratory
Neanderthal	HPO	Cardiomegaly (HP:0001640)	1	0.4021	2.486943546	0.330766923	cardiovascular
Neanderthal	HPO	Neoplasm of the tracheobronchial system (HP:0100552)	1	0.4018	2.488800398	0.332566743	respiratory
Neanderthal	HPO	Absent hair (HP:0002298)	1	0.4041	2.474634991	0.335966403	integumentary
Neanderthal	HPO	Abnormality of the periventricular white matter (HP:0002518)	1	0.4165	2.400960384	0.340665933	nervous
Neanderthal	HPO	Hypermelanotic macule (HP:0001034)	1	0.4187	2.388344877	0.342765723	integumentary
Neanderthal	HPO	Abnormality of the endocardium (HP:0004306)	1	0.4208	2.376425856	0.343165683	cardiovascular
Neanderthal	HPO	Amblyopia (HP:0000646)	1	0.4227	2.365744026	0.344165583	nervous
Neanderthal	HPO	Hypertriglyceridemia (HP:0002155)	1	0.4238	2.359603587	0.344465553	metabolic
Neanderthal	HPO	Recurrent lower respiratory tract infections (HP:0002783)	1	0.4284	2.33426704	0.348565143	immune
Neanderthal	HPO	Lymphopenia (HP:0001888)	1	0.4263	2.345765893	0.348665133	lymphatic
Neanderthal	HPO	Broad ribs (HP:0000885)	1	0.4281	2.335902826	0.348865113	skeletal
Neanderthal	HPO	Bone pain (HP:0002653)	1	0.4385	2.28050171	0.354564544	skeletal
Neanderthal	HPO	Decreased testicular size (HP:0008734)	1	0.4378	2.284148013	0.354764524	reproductive
Neanderthal	HPO	Anal atresia (HP:0002023)	1	0.4437	2.253775073	0.358264174	digestive
Neanderthal	HPO	Abnormality of cells of the lymphoid lineage (HP:0012140)	1	0.4435	2.254791432	0.359864014	lymphatic
Neanderthal	HPO	Broad forehead (HP:0000337)	2	1.2585	1.589193484	0.359864014	skeletal
Neanderthal	HPO	Cranial hyperostosis (HP:0004437)	1	0.4437	2.253775073	0.361763824	skeletal
Neanderthal	HPO	Recurrent urinary tract infections (HP:0000010)	2	1.2638	1.582528881	0.362863714	immune
Neanderthal	HPO	Lack of skin elasticity (HP:0100679)	1	0.4567	2.189621196	0.365163484	integumentary
Neanderthal	HPO	Polyphagia (HP:0002591)	1	0.4584	2.181500873	0.365863414	behavior
Neanderthal	HPO	Childhood onset (HP:0011463)	1	0.4563	2.191540653	0.367263274	other
Neanderthal	HPO	Abnormality of the wing of the ilium (HP:0011867)	1	0.4606	2.171081198	0.369763024	skeletal
Neanderthal	HPO	Depression (HP:0000716)	1	0.465	2.150537634	0.371162884	behavior
Neanderthal	HPO	Autism (HP:0000717)	3	2.1853	1.372809225	0.371862814	nervous
Neanderthal	HPO	Abnormality of the vitreous humor (HP:0004327)	1	0.4596	2.175805048	0.372662734	nervous
Neanderthal	HPO	Hypopigmented skin patches (HP:0001053)	1	0.4688	2.133105802	0.373562644	integumentary
Neanderthal	HPO	Aplasia/Hypoplasia involving the vertebral column (HP:0008518)	1	0.4661	2.145462347	0.373862614	skeletal
Neanderthal	HPO	Depressed nasal ridge (HP:0000457)	2	1.2977	1.541188256	0.373962604	skeletal
Neanderthal	HPO	Abnormality of methionine metabolism (HP:0010901)	1	0.4702	2.126754573	0.374262574	metabolic
Neanderthal	HPO	Prominent occiput (HP:0000269)	1	0.4746	2.107037505	0.375962404	skeletal
Neanderthal	HPO	Abnormality of the level of lipoprotein cholesterol (HP:0010979)	1	0.4812	2.078137988	0.381361864	metabolic
Neanderthal	HPO	Lipoatrophy (HP:0100578)	1	0.484	2.066115702	0.384761524	metabolic
Neanderthal	HPO	Elbow flexion contracture (HP:0002987)	1	0.4889	2.045408059	0.386761324	skeletal
Neanderthal	HPO	Periauricular skin pits (HP:0100277)	1	0.498	2.008032129	0.395060494	integumentary
Neanderthal	HPO	Preauricular pit (HP:0004467)	1	0.498	2.008032129	0.395060494	nervous
Neanderthal	HPO	Spinal canal stenosis (HP:0003416)	1	0.5072	1.971608833	0.396960304	skeletal
Neanderthal	HPO	Psychosis (HP:0000709)	1	0.5032	1.987281399	0.397960204	nervous
Neanderthal	HPO	Hepatomegaly (HP:0002240)	4	3.214	1.244555072	0.399060094	digestive
Neanderthal	HPO	Pallor (HP:0000980)	1	0.5122	1.952362358	0.401759824	integumentary
Neanderthal	HPO	Melanocytic nevus (HP:0000995)	1	0.5198	1.923816853	0.405059494	integumentary
Neanderthal	HPO	Teleangiectasia of the skin (HP:0100585)	1	0.5202	1.922337562	0.406459354	cardiovascular
Neanderthal	HPO	Sacral dimple (HP:0000960)	1	0.5221	1.915341889	0.407059294	integumentary
Neanderthal	HPO	Hypoplastic toenails (HP:0001800)	1	0.5256	1.902587519	0.409959004	integumentary
Neanderthal	HPO	Muscular hypotonia of the trunk (HP:0008936)	1	0.5235	1.910219675	0.410058994	skeletal muscle
Neanderthal	HPO	Abnormality of sulfur amino acid metabolism (HP:0004339)	1	0.5357	1.866716446	0.412958704	metabolic
Neanderthal	HPO	Neoplasm of the lung (HP:0100526)	1	0.5315	1.881467545	0.413258674	respiratory
Neanderthal	HPO	Increased serum lactate (HP:0002151)	1	0.5374	1.860811314	0.415258474	other
Neanderthal	HPO	Progressive cerebellar ataxia (HP:0002073)	1	0.5355	1.867413632	0.415858414	nervous
Neanderthal	HPO	Anencephaly (HP:0002323)	1	0.54	1.851851852	0.419858014	nervous
Neanderthal	HPO	Nephronophthisis (HP:0000090)	1	0.5456	1.832844575	0.421657834	urinary
Neanderthal	HPO	Neoplasm of the respiratory system (HP:0100606)	1	0.5523	1.810610176	0.425557444	respiratory
Neanderthal	HPO	Camptodactyly of finger (HP:0100490)	3	2.3946	1.252818842	0.428957104	skeletal
Neanderthal	HPO	Nephrocalcinosis (HP:0000121)	1	0.5587	1.78986934	0.429257074	urinary
Neanderthal	HPO	Abnormality of aspartate family amino acid metabolism (HP:0010899)	1	0.5649	1.770224819	0.431156884	metabolic
Neanderthal	HPO	Skin pits (HP:0100276)	1	0.5572	1.794687724	0.431256874	integumentary
Neanderthal	HPO	Restrictive lung disease (HP:0002091)	1	0.5664	1.765536723	0.431956804	respiratory
Neanderthal	HPO	Incomplete penetrance (HP:0003829)	2	1.4701	1.36045167	0.435856414	other
Neanderthal	HPO	Arnold-Chiari malformation (HP:0002308)	1	0.5836	1.713502399	0.442955704	skeletal
Neanderthal	HPO	Lower limb muscle weakness (HP:0007340)	1	0.5865	1.705029838	0.446155384	skeletal muscle
Neanderthal	HPO	Lymphoma (HP:0002665)	1	0.5961	1.677570877	0.451254875	lymphatic
Neanderthal	HPO	Osteoarthritis (HP:0002758)	1	0.6007	1.664724488	0.452954705	skeletal
Neanderthal	HPO	Drooling (HP:0002307)	1	0.6118	1.634521085	0.453854615	other
Neanderthal	HPO	Excessive salivation (HP:0003781)	1	0.6118	1.634521085	0.453854615	digestive
Neanderthal	HPO	Urinary incontinence (HP:0000020)	1	0.6089	1.642305797	0.453954605	urinary
Neanderthal	HPO	Dilated cardiomyopathy (HP:0001644)	1	0.6078	1.645278052	0.454954505	cardiovascular
Neanderthal	HPO	Memory impairment (HP:0002354)	1	0.6102	1.638806949	0.455454455	nervous
Neanderthal	HPO	Mandibular prognathia (HP:0000303)	2	1.5477	1.292240098	0.459054095	skeletal
Neanderthal	HPO	Preaxial hand polydactyly (HP:0001177)	1	0.6238	1.60307791	0.460153985	skeletal
Neanderthal	HPO	Short thumb (HP:0009778)	1	0.6174	1.619695497	0.461953805	skeletal
Neanderthal	HPO	Abnormal cortical bone morphology (HP:0003103)	1	0.6228	1.605651895	0.464453555	skeletal
Neanderthal	HPO	Precocious puberty (HP:0000826)	1	0.6249	1.600256041	0.464653535	endocrine
Neanderthal	HPO	Thin skin (HP:0000963)	1	0.6252	1.599488164	0.466353365	integumentary
Neanderthal	HPO	Hypoplasia of the brainstem (HP:0002365)	1	0.6259	1.597699313	0.468253175	nervous
Neanderthal	HPO	Aplasia/Hypoplasia of the brainstem (HP:0007362)	1	0.6259	1.597699313	0.468253175	nervous
Neanderthal	HPO	Morphological abnormality of the middle ear (HP:0008609)	1	0.625	1.6	0.468353165	skeletal
Neanderthal	HPO	Pulmonary hypertension (HP:0002092)	1	0.6289	1.590077914	0.470152985	cardiovascular
Neanderthal	HPO	Split hand (HP:0001171)	1	0.6345	1.576044129	0.471252875	skeletal
Neanderthal	HPO	Ventricular septal defect (HP:0001629)	4	3.5727	1.119601422	0.477452255	cardiovascular
Neanderthal	HPO	Pancreatitis (HP:0001733)	1	0.6522	1.533272002	0.478352165	digestive
Neanderthal	HPO	Wide intermamillary distance (HP:0006610)	1	0.6551	1.526484506	0.482051795	reproductive
Neanderthal	HPO	Abnormality of the renal medulla (HP:0100957)	1	0.6641	1.50579732	0.487151285	urinary
Neanderthal	HPO	Hypoplastic ilia (HP:0000946)	1	0.6627	1.508978422	0.487151285	skeletal
Neanderthal	HPO	Stroke (HP:0001297)	1	0.6723	1.487431206	0.488351165	cardiovascular
Neanderthal	HPO	Congenital hepatic fibrosis (HP:0002612)	1	0.6863	1.457088737	0.488751125	digestive
Neanderthal	HPO	Left ventricular hypertrophy (HP:0001712)	1	0.668	1.497005988	0.493350665	cardiovascular
Neanderthal	HPO	Broad foot (HP:0001769)	1	0.6964	1.435956347	0.498350165	skeletal
Neanderthal	HPO	Increased nuchal translucency (HP:0010880)	1	0.6868	1.456027956	0.498950105	other
Neanderthal	HPO	Dysdiadochokinesis (HP:0002075)	1	0.6946	1.439677512	0.500349965	nervous
Neanderthal	HPO	Abnormality of the lacrimal duct (HP:0011481)	1	0.6814	1.467566774	0.501349865	other
Neanderthal	HPO	Vesicoureteral reflux (HP:0000076)	2	1.6907	1.182941977	0.501449855	urinary
Neanderthal	HPO	Constipation (HP:0002019)	3	2.6972	1.112264571	0.502649735	digestive
Neanderthal	HPO	Cerebellar hypoplasia (HP:0001321)	2	1.6933	1.181125613	0.504849515	nervous
Neanderthal	HPO	Rocker bottom foot (HP:0001838)	1	0.7038	1.420858198	0.506349365	skeletal
Neanderthal	HPO	Patellar dislocation (HP:0002999)	1	0.7042	1.420051122	0.509549045	skeletal
Neanderthal	HPO	Variable expressivity (HP:0003828)	2	1.6923	1.181823554	0.511148885	other
Neanderthal	HPO	Primary amenorrhea (HP:0000786)	1	0.7288	1.372118551	0.517148285	reproductive
Neanderthal	HPO	Nephropathy (HP:0000112)	1	0.7259	1.37760022	0.517248275	urinary
Neanderthal	HPO	Genu valgum (HP:0002857)	2	1.7283	1.157206504	0.517548245	skeletal
Neanderthal	HPO	Spina bifida occulta (HP:0003298)	1	0.7302	1.369487812	0.519148085	skeletal
Neanderthal	HPO	Deeply set eye (HP:0000490)	2	1.7408	1.148897059	0.520547945	nervous
Neanderthal	HPO	Abnormality of salivation (HP:0100755)	1	0.7402	1.35098622	0.521247875	digestive
Neanderthal	HPO	Narrow face (HP:0000275)	1	0.7413	1.348981519	0.522647735	skeletal
Neanderthal	HPO	Lethargy (HP:0001254)	1	0.7495	1.334222815	0.523647635	behavior
Neanderthal	HPO	Low posterior hairline (HP:0002162)	1	0.7382	1.354646437	0.524247575	integumentary
Neanderthal	HPO	Aplasia/Hypoplasia of the lens (HP:0008063)	1	0.7405	1.350438893	0.524747525	nervous
Neanderthal	HPO	Bifid uvula (HP:0000193)	1	0.753	1.328021248	0.529247075	other
Neanderthal	HPO	Multicystic kidney dysplasia (HP:0000003)	2	1.7744	1.127141569	0.529547045	urinary
Neanderthal	HPO	Atresia of the external auditory canal (HP:0000413)	1	0.747	1.338688086	0.530046995	nervous
Neanderthal	HPO	Hypospadias (HP:0000047)	2	1.7721	1.128604481	0.530546945	urinary
Neanderthal	HPO	Choanal atresia (HP:0000453)	1	0.7618	1.312680494	0.533146685	respiratory
Neanderthal	HPO	Aplasia/Hypoplasia of the optic nerve (HP:0008058)	1	0.7659	1.30565348	0.535646435	nervous
Neanderthal	HPO	Optic nerve hypoplasia (HP:0000609)	1	0.7659	1.30565348	0.535646435	nervous
Neanderthal	HPO	Hypocalcemia (HP:0002901)	1	0.7704	1.298026999	0.535846415	other
Neanderthal	HPO	Cerebellar atrophy (HP:0001272)	2	1.8014	1.110247585	0.536246375	nervous
Neanderthal	HPO	Abnormality of the nasolacrimal system (HP:0000614)	1	0.7557	1.323276432	0.536646335	other
Neanderthal	HPO	Iris coloboma (HP:0000612)	2	1.7886	1.118193	0.537746225	nervous
Neanderthal	HPO	Cellular immunodeficiency (HP:0005374)	1	0.7674	1.303101381	0.539946005	immune
Neanderthal	HPO	Muscular dystrophy (HP:0003560)	1	0.7953	1.25738715	0.547045295	skeletal muscle
Neanderthal	HPO	Vertigo (HP:0002321)	1	0.8104	1.233958539	0.551444856	nervous
Neanderthal	HPO	Prolonged QT interval (HP:0001657)	1	0.7968	1.25502008	0.551744826	cardiovascular
Neanderthal	HPO	Cutis marmorata (HP:0000965)	1	0.8021	1.246727341	0.551844816	integumentary
Neanderthal	HPO	Anophthalmia (HP:0000528)	1	0.7957	1.256755058	0.554144586	nervous
Neanderthal	HPO	Hypsarrhythmia (HP:0002521)	1	0.8133	1.229558588	0.556944306	cardiovascular
Neanderthal	HPO	Brachycephaly (HP:0000248)	1	0.8086	1.236705417	0.556944306	skeletal
Neanderthal	HPO	Flat face (HP:0012368)	1	0.8351	1.197461382	0.566943306	skeletal
Neanderthal	HPO	Cafe-au-lait spot (HP:0000957)	1	0.8302	1.204529029	0.568943106	integumentary
Neanderthal	HPO	EEG with generalized epileptiform discharges (HP:0011198)	1	0.8494	1.177301625	0.572042796	nervous
Neanderthal	HPO	Chorioretinal coloboma (HP:0000567)	1	0.8462	1.181753723	0.574942506	nervous
Neanderthal	HPO	Thick lower lip vermilion (HP:0000179)	2	1.917	1.043296818	0.575742426	integumentary
Neanderthal	HPO	Limb ataxia (HP:0002070)	1	0.8651	1.15593573	0.581341866	nervous
Neanderthal	HPO	Optic atrophy (HP:0000648)	5	5.1631	0.968410451	0.584041596	nervous
Neanderthal	HPO	Autosomal dominant inheritance (HP:0000006)	20	20.655	0.96828855	0.585041496	other
Neanderthal	HPO	Intrauterine growth retardation (HP:0001511)	5	5.1746	0.966258262	0.588641136	other
Neanderthal	HPO	Low anterior hairline (HP:0000294)	1	0.8915	1.121704992	0.593740626	integumentary
Neanderthal	HPO	Corneal dystrophy (HP:0001131)	1	0.9179	1.089443294	0.598140186	nervous
Neanderthal	HPO	Spastic tetraplegia (HP:0002510)	1	0.9302	1.075037626	0.599940006	nervous
Neanderthal	HPO	Ectopia lentis (HP:0001083)	1	0.9213	1.085422772	0.603039696	nervous
Neanderthal	HPO	Narrow mouth (HP:0000160)	2	2.0146	0.992752904	0.604739526	skeletal
Neanderthal	HPO	Sporadic (HP:0003745)	1	0.9296	1.075731497	0.604939506	other
Neanderthal	HPO	Cryptorchidism (HP:0000028)	7	7.4513	0.939433387	0.614238576	reproductive
Neanderthal	HPO	Narrow chest (HP:0000774)	1	0.953	1.049317943	0.614538546	skeletal
Neanderthal	HPO	Aggressive behavior (HP:0000718)	1	0.9633	1.038098204	0.618038196	behavior
Neanderthal	HPO	Dental malocclusion (HP:0000689)	2	2.0672	0.96749226	0.619238076	skeletal
Neanderthal	HPO	Telecanthus (HP:0000506)	1	0.9732	1.027538019	0.620537946	skeletal
Neanderthal	HPO	"Intellectual disability, severe (HP:0010864)"	1	0.9814	1.018952517	0.624037596	nervous
Neanderthal	HPO	Paresthesia (HP:0003401)	1	0.9679	1.033164583	0.624537546	nervous
Neanderthal	HPO	Omphalocele (HP:0001539)	1	0.9704	1.030502885	0.626137386	other
Neanderthal	HPO	Short neck (HP:0000470)	4	4.3258	0.924684451	0.627537246	skeletal
Neanderthal	HPO	Lumbar hyperlordosis (HP:0002938)	1	0.9784	1.02207686	0.628437156	skeletal
Neanderthal	HPO	Retinal detachment (HP:0000541)	1	0.9917	1.008369467	0.630136986	nervous
Neanderthal	HPO	Hirsutism (HP:0001007)	1	1.0172	0.983090838	0.637536246	integumentary
Neanderthal	HPO	External ear malformation (HP:0008572)	1	1.0177	0.982607841	0.637836216	other
Neanderthal	HPO	Leukopenia (HP:0001882)	1	1.0081	0.991965083	0.639436056	immune
Neanderthal	HPO	Migraine (HP:0002076)	1	1.0119	0.988239945	0.639636036	nervous
Neanderthal	HPO	Talipes equinovarus (HP:0001762)	2	2.175	0.91954023	0.642035796	skeletal
Neanderthal	HPO	Osteopenia (HP:0000938)	1	1.022	0.978473581	0.642435756	skeletal
Neanderthal	HPO	Polycystic ovaries (HP:0000147)	1	1.027	0.973709834	0.645035496	reproductive
Neanderthal	HPO	Abnormal EKG (HP:0003115)	1	1.0334	0.967679505	0.646535346	cardiovascular
Neanderthal	HPO	Dry skin (HP:0000958)	1	1.0762	0.929195317	0.656634337	integumentary
Neanderthal	HPO	Malar flattening (HP:0000272)	3	3.4165	0.878091614	0.660933907	skeletal
Neanderthal	HPO	Pes cavus (HP:0001761)	1	1.0914	0.916254352	0.665333467	skeletal
Neanderthal	HPO	Radioulnar synostosis (HP:0002974)	1	1.1109	0.900171032	0.672332767	skeletal
Neanderthal	HPO	Gait ataxia (HP:0002066)	1	1.1109	0.900171032	0.674432557	nervous
Neanderthal	HPO	Dysmetria (HP:0001310)	1	1.1278	0.886682036	0.678032197	nervous
Neanderthal	HPO	Radial deviation of finger (HP:0009466)	4	4.6205	0.865707175	0.680231977	skeletal
Neanderthal	HPO	Primary atrial arrhythmia (HP:0001692)	1	1.1165	0.895656068	0.681331867	cardiovascular
Neanderthal	HPO	Supraventricular tachycardia (HP:0004755)	1	1.1165	0.895656068	0.681331867	cardiovascular
Neanderthal	HPO	Atrial fibrillation (HP:0005110)	1	1.1165	0.895656068	0.681331867	cardiovascular
Neanderthal	HPO	Gingival overgrowth (HP:0000212)	1	1.1214	0.891742465	0.682231777	immune
Neanderthal	HPO	Hydronephrosis (HP:0000126)	1	1.155	0.865800866	0.685631437	urinary
Neanderthal	HPO	Aplasia/Hypoplasia affecting the fundus (HP:0008057)	1	1.1712	0.853825137	0.687331267	nervous
Neanderthal	HPO	Supraventricular arrhythmia (HP:0005115)	1	1.1488	0.870473538	0.691930807	cardiovascular
Neanderthal	HPO	Hypoplasia of the corpus callosum (HP:0002079)	2	2.4326	0.822165584	0.695530447	nervous
Neanderthal	HPO	Ventricular arrhythmia (HP:0004308)	1	1.1687	0.855651579	0.698030197	cardiovascular
Neanderthal	HPO	Polymicrogyria (HP:0002126)	1	1.2176	0.821287779	0.702529747	nervous
Neanderthal	HPO	Depressed nasal bridge (HP:0005280)	4	4.8058	0.832327604	0.703829617	skeletal
Neanderthal	HPO	Cheekbone underdevelopment (HP:0010669)	1	1.2207	0.819202097	0.709329067	skeletal
Neanderthal	HPO	"Intellectual disability, mild (HP:0001256)"	1	1.2641	0.791076655	0.713428657	nervous
Neanderthal	HPO	Recurrent fractures (HP:0002757)	1	1.2778	0.782595085	0.714428557	skeletal
Neanderthal	HPO	Periorbital edema (HP:0100539)	1	1.2563	0.795988219	0.716028397	other
Neanderthal	HPO	Facial edema (HP:0000282)	1	1.2563	0.795988219	0.716028397	immune
Neanderthal	HPO	Single transverse palmar crease (HP:0000954)	2	2.5303	0.790420108	0.717728227	integumentary
Neanderthal	HPO	Hypothyroidism (HP:0000821)	2	2.5094	0.797003268	0.718028197	endocrine
Neanderthal	HPO	Postnatal growth retardation (HP:0008897)	1	1.247	0.801924619	0.718728127	metabolic
Neanderthal	HPO	Weight loss (HP:0001824)	1	1.2848	0.778331258	0.724927507	metabolic
Neanderthal	HPO	Arthralgia (HP:0002829)	1	1.2884	0.776156473	0.728427157	skeletal
Neanderthal	HPO	Frontal bossing (HP:0002007)	3	3.8031	0.788830165	0.733526647	skeletal
Neanderthal	HPO	Midface retrusion (HP:0011800)	1	1.3078	0.764642912	0.736226377	skeletal
Neanderthal	HPO	Pulmonary hypoplasia (HP:0002089)	1	1.3351	0.749007565	0.740025997	respiratory
Neanderthal	HPO	Inguinal hernia (HP:0000023)	1	1.3544	0.738334318	0.741525847	digestive
Neanderthal	HPO	Downturned corners of mouth (HP:0002714)	1	1.3704	0.729713952	0.743525647	skeletal muscle
Neanderthal	HPO	Type II diabetes mellitus (HP:0005978)	1	1.3893	0.719786943	0.744525547	metabolic
Neanderthal	HPO	Delayed eruption of teeth (HP:0000684)	1	1.402	0.713266762	0.748625137	skeletal
Neanderthal	HPO	Clinodactyly of the 5th finger (HP:0004209)	3	3.9259	0.76415599	0.749025097	skeletal
Neanderthal	HPO	Synophrys (HP:0000664)	1	1.4027	0.712910815	0.751724828	integumentary
Neanderthal	HPO	Highly arched eyebrow (HP:0002553)	1	1.5467	0.64653779	0.782121788	integumentary
Neanderthal	HPO	Sudden cardiac death (HP:0001645)	1	1.5201	0.657851457	0.786021398	cardiovascular
Neanderthal	HPO	Micromelia (HP:0002983)	1	1.6966	0.589414122	0.820717928	skeletal
Neanderthal	HPO	High forehead (HP:0000348)	1	1.7512	0.571037003	0.832016798	skeletal
Neanderthal	HPO	"Low-set, posteriorly rotated ears (HP:0000368)"	4	5.8241	0.686801394	0.833816618	other
Neanderthal	HPO	Astigmatism (HP:0000483)	1	1.8413	0.543094553	0.839016098	nervous
Neanderthal	HPO	Dysarthria (HP:0001260)	2	3.353	0.596480763	0.843615638	nervous
Neanderthal	HPO	Long philtrum (HP:0000343)	2	3.3317	0.600294144	0.844715528	integumentary
Neanderthal	HPO	Ptosis (HP:0000508)	2	3.4243	0.584060976	0.858914109	skeletal muscle
Neanderthal	HPO	Pes planus (HP:0001763)	1	1.9766	0.505919255	0.859314069	skeletal
Neanderthal	HPO	Blepharophimosis (HP:0000581)	1	1.9502	0.512767921	0.860113989	integumentary
Neanderthal	HPO	Photophobia (HP:0000613)	1	2.0113	0.497190872	0.865013499	nervous
Neanderthal	HPO	Brachydactyly syndrome (HP:0001156)	2	3.7481	0.533603693	0.889211079	skeletal
Neanderthal	HPO	Micropenis (HP:0000054)	1	2.2439	0.445652658	0.896710329	reproductive
Neanderthal	HPO	Delayed skeletal maturation (HP:0002750)	1	2.2957	0.435596986	0.901509849	skeletal
Neanderthal	HPO	Wide mouth (HP:0000154)	1	2.3231	0.4304593	0.902709729	skeletal
Neanderthal	HPO	Short nose (HP:0003196)	1	2.2707	0.44039283	0.903509649	skeletal
Neanderthal	HPO	Pectus excavatum (HP:0000767)	1	2.5345	0.394555139	0.919908009	skeletal
Neanderthal	HPO	Hypertelorism (HP:0000316)	3	6.0458	0.496212247	0.940605939	skeletal
Neanderthal	HPO	Epicanthus (HP:0000286)	2	4.5665	0.437972189	0.942205779	integumentary
Neanderthal	HPO	Infantile onset (HP:0003593)	1	3.5277	0.283470817	0.96930307	other
Neanderthal	HPO	Wide nasal bridge (HP:0000431)	1	4.5745	0.218603126	0.99120088	integumentary
Shared	GWAS	Progranulin levels	2	0.0286	69.93006993	0.00029997	nervous
Shared	GWAS	Itch intensity from mosquito bite adjusted by bite size	7	1.5499	4.516420414	0.00179982	immune
Shared	GWAS	IgE levels	2	0.0951	21.03049422	0.00379962	immune
Shared	GWAS	Graves' disease	3	0.3566	8.412787437	0.00529947	endocrine
Shared	GWAS	Psoriasis	3	0.4292	6.989748369	0.00939906	integumentary
Shared	GWAS	Blood metabolite ratios	3	0.4288	6.996268657	0.009999	metabolic
Shared	GWAS	Mumps	1	0.0124	80.64516129	0.01249875	immune
Shared	GWAS	Birdshot chorioretinopathy	1	0.0145	68.96551724	0.01449855	immune
Shared	GWAS	Macular telangiectasia type 2	1	0.0146	68.49315068	0.01449855	nervous
Shared	GWAS	Circulating fibroblast growth factor 23 levels	2	0.1984	10.08064516	0.01689831	other
Shared	GWAS	Elevated fasting plasma glucose	1	0.0173	57.80346821	0.01729827	metabolic
Shared	GWAS	Response to ziprazidone in schizophrenia	1	0.0188	53.19148936	0.01869813	other
Shared	GWAS	Vitiligo	4	0.9922	4.031445273	0.0189981	integumentary
Shared	GWAS	Depression in smokers	3	0.5622	5.336179296	0.01989801	behavior
Shared	GWAS	Lower body strength	1	0.0205	48.7804878	0.02029797	skeletal muscle
Shared	GWAS	Crohn's disease	9	4.0454	2.224749098	0.02379762	immune
Shared	GWAS	Bipolar disorder (body mass index interaction)	2	0.2608	7.668711656	0.02639736	behavior
Shared	GWAS	Paclitaxel disposition in epithelial ovarian cancer	3	0.6556	4.575960952	0.02729727	other
Shared	GWAS	Serum thyroid-stimulating hormone levels	3	0.6692	4.482964734	0.03069693	endocrine
Shared	GWAS	Cerebrospinal fluid t-tau levels in Alzheimer's disease dementia	1	0.0321	31.15264798	0.03169683	nervous
Shared	GWAS	Lipoprotein-associated phospholipase A2 activity and mass	1	0.0363	27.54820937	0.03539646	metabolic
Shared	GWAS	Age at smoking initiation in chronic obstructive pulmonary disease	1	0.0387	25.83979328	0.03839616	respiratory
Shared	GWAS	Psoriasis vulgaris	2	0.3109	6.432936636	0.04029597	integumentary
Shared	GWAS	Glomerular filtration rate (cystatin C)	1	0.0411	24.33090024	0.04069593	hematologic
Shared	GWAS	L-arginine levels	1	0.042	23.80952381	0.04139586	other
Shared	GWAS	Radiation response	2	0.334	5.988023952	0.04209579	other
Shared	GWAS	Cerebrospinal fluid beta-site APP cleaving enzyme levels	2	0.3274	6.108735492	0.04319568	nervous
Shared	GWAS	Lymphocyte counts	4	1.2936	3.092145949	0.04339566	lymphatic
Shared	GWAS	PCA3 expression level	1	0.0457	21.88183807	0.04519548	other
Shared	GWAS	Prostate cancer	6	2.5461	2.356545305	0.04619538	reproductive
Shared	GWAS	Inflammatory bowel disease	7	3.2926	2.125979469	0.04659534	digestive
Shared	GWAS	Creatine kinase levels	2	0.3341	5.986231667	0.04669533	other
Shared	GWAS	Response to fenofibrate (triglyceride levels)	2	0.3487	5.735589332	0.04809519	other
Shared	GWAS	Blood metabolite levels	4	1.3163	3.038820937	0.04859514	metabolic
Shared	GWAS	Obstructive sleep apnea during REM sleep (apnea hypopnea index)	1	0.0507	19.72386588	0.04919508	other
Shared	GWAS	Protein quantitative trait loci	3	0.8102	3.702789435	0.04919508	other
Shared	GWAS	Cerebral cortical growth	1	0.0513	19.49317739	0.049995	nervous
Shared	GWAS	Plasma homocysteine levels (post-methionine load test)	1	0.0516	19.37984496	0.050194981	other
Shared	GWAS	Platelet distribution width	4	1.4127	2.831457493	0.052594741	hematologic
Shared	GWAS	Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)	1	0.0564	17.73049645	0.054994501	endocrine
Shared	GWAS	Dehydroepiandrosterone sulphate levels	1	0.0572	17.48251748	0.055494451	other
Shared	GWAS	Response to taxane treatment (placlitaxel)	1	0.0584	17.12328767	0.056894311	other
Shared	GWAS	Complement C3 and C4 levels	1	0.059	16.94915254	0.057594241	immune
Shared	GWAS	Cancer	2	0.3914	5.109862034	0.058794121	other
Shared	GWAS	Ulcerative colitis	5	2.0627	2.424007369	0.058994101	digestive
Shared	GWAS	Thyroid cancer	1	0.062	16.12903226	0.059394061	endocrine
Shared	GWAS	Subjective response to lithium treatment in bipolar disorder	1	0.0625	16	0.061093891	other
Shared	GWAS	Systemic lupus erythematosus and Systemic sclerosis	1	0.0646	15.47987616	0.062793721	immune
Shared	GWAS	Kidney function decline traits	1	0.072	13.88888889	0.069293071	urinary
Shared	GWAS	Clinical laboratory measurements	1	0.0719	13.90820584	0.069393061	other
Shared	GWAS	Amino acid levels	1	0.0709	14.10437236	0.069793021	other
Shared	GWAS	Non-response to bupropion and depression	1	0.0725	13.79310345	0.069893011	other
Shared	GWAS	Malaria	1	0.0734	13.6239782	0.070692931	immune
Shared	GWAS	Prostate cancer (early onset)	1	0.0739	13.53179973	0.071692831	reproductive
Shared	GWAS	Tumor biomarkers	1	0.075	13.33333333	0.071992801	immune
Shared	GWAS	Optic cup area	2	0.4408	4.537205082	0.073392661	nervous
Shared	GWAS	HIV-1 control	1	0.0777	12.87001287	0.074892511	immune
Shared	GWAS	Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor	1	0.0784	12.75510204	0.075192481	hematologic
Shared	GWAS	Heart failure	1	0.0788	12.69035533	0.075292471	cardiovascular
Shared	GWAS	Allergic rhinitis	4	1.6104	2.483854943	0.079792021	immune
Shared	GWAS	Diffusing capacity of the lung for carbon monoxide traits	1	0.0842	11.87648456	0.081191881	respiratory
Shared	GWAS	Abdominal aortic aneurysm	1	0.0851	11.75088132	0.082191781	cardiovascular
Shared	GWAS	Iron status biomarkers (ferritin levels)	1	0.0871	11.48105626	0.083691631	other
Shared	GWAS	Sex hormone levels	1	0.0883	11.32502831	0.084591541	endocrine
Shared	GWAS	IgA nephropathy	2	0.4766	4.196391104	0.086791321	immune
Shared	GWAS	Lipid metabolism phenotypes	1	0.0925	10.81081081	0.088091191	metabolic
Shared	GWAS	Putamen volume	1	0.0962	10.3950104	0.092590741	nervous
Shared	GWAS	Thrombosis	1	0.098	10.20408163	0.093690631	hematologic
Shared	GWAS	Alcoholic chronic pancreatitis	3	1.0682	2.808462835	0.094990501	endocrine
Shared	GWAS	Beta-2 microglubulin plasma levels	1	0.1037	9.643201543	0.099190081	immune
Shared	GWAS	Elevated serum carcinoembryonic antigen levels	1	0.1059	9.442870633	0.100789921	other
Shared	GWAS	Serum metabolite ratios in chronic kidney disease	1	0.1076	9.293680297	0.102889711	urinary
Shared	GWAS	Serum metabolite levels	2	0.5421	3.689356207	0.102989701	metabolic
Shared	GWAS	Coagulation factor levels	1	0.1081	9.250693802	0.102989701	hematologic
Shared	GWAS	Body mass index (change over time) in chronic obstructive pulmonary disease	1	0.1088	9.191176471	0.103789621	metabolic
Shared	GWAS	Parental longevity (father's attained age)	1	0.1126	8.880994671	0.106689331	other
Shared	GWAS	Disease progression in age-related macular degeneration	3	1.123	2.67141585	0.107389261	nervous
Shared	GWAS	Accelerated cognitive decline after conversion of MCI to Alzheimer's disease	1	0.1166	8.576329331	0.109089091	nervous
Shared	GWAS	Liver enzyme levels (alkaline phosphatase)	1	0.1149	8.703220191	0.109289071	other
Shared	GWAS	Liver enzyme levels	1	0.1149	8.703220191	0.109389061	other
Shared	GWAS	Hippocampal volume in mild cognitive impairment	1	0.1243	8.045052293	0.117188281	nervous
Shared	GWAS	Lipid traits	1	0.1268	7.886435331	0.119688031	metabolic
Shared	GWAS	Survival in sporadic amyotrophic lateral sclerosis	1	0.1298	7.704160247	0.120187981	other
Shared	GWAS	GIP levels in response to oral glucose tolerance test (120 minutes)	1	0.1281	7.806401249	0.120787921	metabolic
Shared	GWAS	Hyperthyroidism	1	0.1315	7.604562738	0.124787521	endocrine
Shared	GWAS	Mitral valve prolapse	1	0.1341	7.457121551	0.125387461	cardiovascular
Shared	GWAS	Low vWF levels	1	0.1367	7.315288954	0.125687431	hematologic
Shared	GWAS	Midgestational circulating levels of PBDEs	1	0.1339	7.468259895	0.125787421	reproductive
Shared	GWAS	Total ventricular volume	1	0.1383	7.23065799	0.129187081	cardiovascular
Shared	GWAS	Corneal curvature	1	0.1415	7.067137809	0.130286971	nervous
Shared	GWAS	Electroencephalographic traits in alcoholism	1	0.14	7.142857143	0.130686931	nervous
Shared	GWAS	Bipolar disorder with mood-incongruent psychosis	1	0.141	7.092198582	0.130686931	behavior
Shared	GWAS	Midgestational circulating levels of PBDEs (fetal genetic effect)	1	0.1414	7.072135785	0.132986701	reproductive
Shared	GWAS	Nasopharyngeal carcinoma (SNP x SNP interaction)	3	1.2648	2.371916509	0.133386661	other
Shared	GWAS	Nasopharyngeal carcinoma	1	0.1476	6.775067751	0.137386261	other
Shared	GWAS	Serum alkaline phosphatase levels	1	0.1475	6.779661017	0.138186181	other
Shared	GWAS	Blood protein levels	14	10.0629	1.391249044	0.138886111	other
Shared	GWAS	Blood pressure (smoking interaction)	3	1.287	2.331002331	0.140885911	hematologic
Shared	GWAS	Metabolite levels	3	1.2956	2.315529484	0.141785821	metabolic
Shared	GWAS	Systolic blood pressure x smoking status (current vs non-current) interaction (1df test)	1	0.16	6.25	0.148085191	cardiovascular
Shared	GWAS	Clozapine-induced cytotoxicity	1	0.1622	6.165228113	0.152384762	other
Shared	GWAS	Serum prostate-specific antigen levels	1	0.1647	6.071645416	0.152484752	reproductive
Shared	GWAS	Childhood ear infection	2	0.6963	2.872325147	0.153784622	immune
Shared	GWAS	Weight loss (gastric bypass surgery)	1	0.1736	5.760368664	0.157284272	skeletal
Shared	GWAS	Small cell lung carcinoma	2	0.7064	2.831257078	0.159884012	respiratory
Shared	GWAS	Coronary artery disease in type 1 diabetes	1	0.1717	5.824111823	0.159984002	cardiovascular
Shared	GWAS	Neutrophil percentage of white cells	2	0.7213	2.772771385	0.160183982	lymphatic
Shared	GWAS	Lactate dehydrogenase levels	1	0.1808	5.530973451	0.165083492	metabolic
Shared	GWAS	Coronary heart disease	2	0.7294	2.741979709	0.165383462	cardiovascular
Shared	GWAS	"Cholesterol, total"	2	0.7243	2.76128676	0.165683432	metabolic
Shared	GWAS	Cutaneous psoriasis	1	0.186	5.376344086	0.169283072	integumentary
Shared	GWAS	Pulmonary function	2	0.7439	2.688533405	0.169983002	respiratory
Shared	GWAS	Lung function (forced vital capacity)	1	0.187	5.347593583	0.173282672	respiratory
Shared	GWAS	Cardiac structure and function	1	0.1901	5.260389269	0.173882612	cardiovascular
Shared	GWAS	Familial lung cancer	1	0.1979	5.0530571	0.178782122	respiratory
Shared	GWAS	Metabolite levels (lipoprotein measures)	1	0.2001	4.997501249	0.181581842	metabolic
Shared	GWAS	Brain volume in infants (white matter)	1	0.1984	5.040322581	0.182381762	nervous
Shared	GWAS	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	1	0.2005	4.987531172	0.182981702	immune
Shared	GWAS	Cold sores	1	0.2014	4.965243297	0.183381662	immune
Shared	GWAS	Ischemic stroke (cardioembolic)	1	0.2048	4.8828125	0.184881512	cardiovascular
Shared	GWAS	Middle childhood and early adolescence aggressive behavior	1	0.2115	4.728132388	0.188681132	behavior
Shared	GWAS	Response to antipsychotic treatment in schizophrenia (reasoning)	1	0.2072	4.826254826	0.188981102	other
Shared	GWAS	Cardiac Troponin-T levels	1	0.218	4.587155963	0.194980502	cardiovascular
Shared	GWAS	End-stage coagulation	1	0.2232	4.480286738	0.198480152	hematologic
Shared	GWAS	Aspartate aminotransferase levels	1	0.2213	4.518752824	0.199180082	other
Shared	GWAS	Venous thromboembolism	1	0.2222	4.500450045	0.200979902	hematologic
Shared	GWAS	Uterine fibroid size (maximum volume)	1	0.2293	4.361098997	0.203179682	reproductive
Shared	GWAS	Ankylosing spondylitis	1	0.2248	4.448398577	0.204679532	skeletal
Shared	GWAS	Hip shape (DXA scan)	1	0.2278	4.389815628	0.206879312	skeletal
Shared	GWAS	Heart rate increase in response to exercise	1	0.2379	4.203446826	0.211978802	cardiovascular
Shared	GWAS	Disrupted circadian rhythm (low relative amplitude of rest-activity cycles)	1	0.2384	4.194630872	0.213878612	behavior
Shared	GWAS	Plantar warts	1	0.2411	4.147656574	0.216178382	integumentary
Shared	GWAS	Heart rate variability traits (RMSSD)	1	0.2444	4.091653028	0.218178182	cardiovascular
Shared	GWAS	Response to statin therapy	2	0.8753	2.284930881	0.218278172	other
Shared	GWAS	Prostate-specific antigen levels	1	0.2441	4.096681688	0.218478152	reproductive
Shared	GWAS	Early-onset Parkinson's disease	1	0.2428	4.118616145	0.219278072	nervous
Shared	GWAS	Peripheral arterial disease (traffic-related air pollution interaction)	1	0.2475	4.04040404	0.220077992	cardiovascular
Shared	GWAS	Age-related hearing impairment	1	0.2493	4.011231448	0.220677932	nervous
Shared	GWAS	Cerebral amyloid deposition (PET imaging)	1	0.2526	3.958828187	0.223577642	nervous
Shared	GWAS	Cerebrospinal AB1-42 levels in normal cognition	1	0.2561	3.904724717	0.230576942	nervous
Shared	GWAS	Chromium levels	1	0.2592	3.858024691	0.230876912	other
Shared	GWAS	Response to radiotherapy in cancer (late toxicity)	1	0.2722	3.673769287	0.235576442	other
Shared	GWAS	Self-reported risk-taking behaviour	2	0.9362	2.136295663	0.240275972	behavior
Shared	GWAS	Attention function in attention deficit hyperactive disorder	1	0.2817	3.549875754	0.243775622	behavior
Shared	GWAS	White matter hyperintensity burden	1	0.2784	3.591954023	0.244575542	nervous
Shared	GWAS	LDL cholesterol levels	1	0.2824	3.541076487	0.246475352	metabolic
Shared	GWAS	Shingles	1	0.2821	3.544842255	0.248375162	immune
Shared	GWAS	Angiotensin-converting enzyme inhibitor intolerance	2	0.9523	2.100178515	0.248475152	other
Shared	GWAS	Decline in glucose metabolism in posterior cingulate cortex	1	0.2871	3.483106931	0.249575042	nervous
Shared	GWAS	Hematological and biochemical traits	1	0.2884	3.46740638	0.250974903	hematologic
Shared	GWAS	Myocardial infarction (early onset)	1	0.291	3.436426117	0.251274873	cardiovascular
Shared	GWAS	Response to fenofibrate (HDL cholesterol levels)	2	0.9577	2.08833664	0.251374863	other
Shared	GWAS	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	1	0.2903	3.444712367	0.251374863	other
Shared	GWAS	Stearic acid (18:0) levels	1	0.2939	3.402517863	0.251474853	other
Shared	GWAS	Heart rate variability traits (SDNN)	1	0.2906	3.441156228	0.252474753	cardiovascular
Shared	GWAS	Pulmonary function decline	2	0.9888	2.022653722	0.258574143	respiratory
Shared	GWAS	Heart rate	1	0.2995	3.338898164	0.258574143	cardiovascular
Shared	GWAS	Serum metabolite concentrations in chronic kidney disease	1	0.299	3.344481605	0.259774023	urinary
Shared	GWAS	Dimensional psychopathology (Positive)	1	0.3024	3.306878307	0.262173783	behavior
Shared	GWAS	Thyroid hormone levels	1	0.3106	3.219575016	0.266273373	endocrine
Shared	GWAS	Familial squamous cell lung carcinoma	2	1.0232	1.954652072	0.269573043	respiratory
Shared	GWAS	Cerebrospinal fluid AB1-42 levels	1	0.318	3.144654088	0.271372863	nervous
Shared	GWAS	Monocyte count	2	1.0256	1.950078003	0.272272773	immune
Shared	GWAS	Lung adenocarcinoma	2	1.0299	1.94193611	0.273572643	respiratory
Shared	GWAS	Molybdenum levels	1	0.3134	3.190810466	0.274072593	other
Shared	GWAS	Late-onset myasthenia gravis	1	0.32	3.125	0.274872513	skeletal muscle
Shared	GWAS	Body mass index (age <50)	1	0.3188	3.136762861	0.275072493	metabolic
Shared	GWAS	Cerebral amyloid deposition in APOEe4 non-carriers (PET imaging)	1	0.3209	3.116235587	0.275772423	nervous
Shared	GWAS	Tourette's syndrome or obsessive-compulsive disorder	1	0.3283	3.045994517	0.279572043	behavior
Shared	GWAS	Lead levels in blood	1	0.3285	3.04414003	0.281271873	other
Shared	GWAS	Acute graft versus host disease in bone marrow transplantation (recipient effect)	1	0.3313	3.018412315	0.281471853	other
Shared	GWAS	Red vs. brown/black hair color	1	0.3367	2.97000297	0.284371563	integumentary
Shared	GWAS	Daytime sleep phenotypes	4	2.7046	1.478961769	0.287271273	behavior
Shared	GWAS	Epithelial ovarian cancer	1	0.3429	2.916302129	0.292670733	reproductive
Shared	GWAS	Activated partial thromboplastin time	1	0.345	2.898550725	0.293770623	hematologic
Shared	GWAS	Chronic obstructive pulmonary disease	1	0.3525	2.836879433	0.294370563	respiratory
Shared	GWAS	Conotruncal heart defects	1	0.3512	2.84738041	0.297570243	cardiovascular
Shared	GWAS	Prostate cancer (SNP x SNP interaction)	2	1.0914	1.832508704	0.298570143	reproductive
Shared	GWAS	Allergy	1	0.3567	2.803476311	0.298570143	immune
Shared	GWAS	Asthma (moderate or severe)	1	0.3593	2.783189535	0.299570043	respiratory
Shared	GWAS	Migraine without aura	1	0.3563	2.806623632	0.300669933	nervous
Shared	GWAS	Emphysema distribution in smoking	1	0.3591	2.784739627	0.301069893	respiratory
Shared	GWAS	D-dimer levels	1	0.3588	2.787068004	0.301669833	other
Shared	GWAS	Bipolar disorder and schizophrenia	2	1.111	1.800180018	0.302569743	behavior
Shared	GWAS	"Parental longevity (combined parental attained age, Martingale residuals)"	1	0.3577	2.795638803	0.302769723	other
Shared	GWAS	Bone mineral density (Ward's triangle area)	1	0.3649	2.740476843	0.305469453	skeletal
Shared	GWAS	Pyoderma gangrenosum in inflammatory bowel disease	1	0.363	2.754820937	0.306569343	digestive
Shared	GWAS	Coronary artery disease or ischemic stroke	1	0.3626	2.757859901	0.306769323	cardiovascular
Shared	GWAS	Influenza A (H1N1) infection	1	0.3699	2.70343336	0.308669133	immune
Shared	GWAS	Metabolic traits	1	0.3679	2.718129927	0.309869013	metabolic
Shared	GWAS	Temperament (bipolar disorder)	1	0.3757	2.661698163	0.311768823	behavior
Shared	GWAS	Urinary albumin excretion (no hypertensive medication)	1	0.3719	2.688894864	0.314568543	metabolic
Shared	GWAS	Heart rate response to recovery post exercise (30 sec)	1	0.374	2.673796791	0.314668533	cardiovascular
Shared	GWAS	Urinary metabolites (H-NMR features)	1	0.3756	2.662406816	0.314968503	metabolic
Shared	GWAS	Fractures	1	0.3808	2.62605042	0.315868413	skeletal
Shared	GWAS	Systemic lupus erythematosus	6	4.6355	1.294358753	0.316168383	immune
Shared	GWAS	Platelet count	4	2.8406	1.408153207	0.316868313	hematologic
Shared	GWAS	C-reactive protein levels	1	0.382	2.617801047	0.318168183	immune
Shared	GWAS	LDL cholesterol	2	1.1573	1.728160373	0.321767823	metabolic
Shared	GWAS	Mortality in heart failure	1	0.3897	2.566076469	0.321867813	cardiovascular
Shared	GWAS	Heart rate response to recovery post exercise (40 sec)	1	0.3849	2.598077423	0.322567743	cardiovascular
Shared	GWAS	Low density lipoprotein cholesterol levels	1	0.3922	2.549719531	0.322667733	metabolic
Shared	GWAS	Body mass index x age interaction	1	0.3889	2.571355104	0.324067593	metabolic
Shared	GWAS	Waist-to-hip ratio adjusted for BMI	3	2.02	1.485148515	0.326167383	skeletal
Shared	GWAS	Plateletcrit	4	2.9091	1.374995703	0.331066893	hematologic
Shared	GWAS	Atopic dermatitis	1	0.4009	2.494387628	0.331166883	integumentary
Shared	GWAS	Basophil percentage of white cells	1	0.4003	2.498126405	0.331166883	immune
Shared	GWAS	Red blood cell count	3	2.0321	1.4763053	0.332866713	hematologic
Shared	GWAS	Thyroid stimulating hormone	1	0.4099	2.439619419	0.334266573	endocrine
Shared	GWAS	Superior frontal gyrus grey matter volume	1	0.4012	2.492522433	0.334266573	nervous
Shared	GWAS	Basophil percentage of granulocytes	1	0.4082	2.44977952	0.337166283	immune
Shared	GWAS	Subcortical brain region volumes	1	0.4161	2.403268445	0.341665833	nervous
Shared	GWAS	Adolescent idiopathic scoliosis	1	0.4162	2.402691014	0.342065793	skeletal
Shared	GWAS	Metabolite levels (5-HIAA)	1	0.4197	2.382654277	0.344765523	metabolic
Shared	GWAS	Pediatric non-alcoholic fatty liver disease activity score	1	0.4206	2.377555873	0.344765523	digestive
Shared	GWAS	Heart rate response to recovery post exercise (50 sec)	1	0.423	2.364066194	0.346865313	cardiovascular
Shared	GWAS	Heart rate response to recovery post exercise	1	0.421	2.375296912	0.348065193	cardiovascular
Shared	GWAS	Interleukin-6 levels	1	0.4237	2.360160491	0.348265173	immune
Shared	GWAS	Pancreatic cancer	2	1.2538	1.595150742	0.355764424	endocrine
Shared	GWAS	Pulmonary function (smoking interaction)	1	0.4332	2.308402585	0.356864314	respiratory
Shared	GWAS	Serum uric acid levels in response to allopurinol in gout	1	0.441	2.267573696	0.360763924	other
Shared	GWAS	Mean corpuscular hemoglobin	3	2.1492	1.39586823	0.364463554	hematologic
Shared	GWAS	Hemoglobin levels	1	0.4543	2.201188642	0.365263474	hematologic
Shared	GWAS	Gallstone disease	1	0.4575	2.18579235	0.367163284	digestive
Shared	GWAS	Amyotrophic lateral sclerosis	1	0.4596	2.175805048	0.369463054	nervous
Shared	GWAS	Osteoarthritis	1	0.4591	2.17817469	0.369763024	skeletal
Shared	GWAS	Quantitative traits	1	0.4718	2.119542179	0.372162784	other
Shared	GWAS	Glaucoma (primary open-angle)	2	1.3408	1.491646778	0.382261774	nervous
Shared	GWAS	Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)	3	2.2258	1.347829994	0.383461654	skeletal
Shared	GWAS	Venous thromboembolism adjusted for sickle cell variant rs77121243-T	2	1.3411	1.491313101	0.388161184	hematologic
Shared	GWAS	Selective IgA deficiency	1	0.4916	2.034174125	0.388161184	immune
Shared	GWAS	Urate levels	2	1.3547	1.476341625	0.388861114	metabolic
Shared	GWAS	Lung cancer in ever smokers	2	1.3496	1.481920569	0.390260974	respiratory
Shared	GWAS	Gout	2	1.3482	1.483459427	0.392460754	skeletal
Shared	GWAS	Response to SSRI in MDD or openness	1	0.4924	2.030869212	0.392960704	other
Shared	GWAS	Remission after SSRI treatment in MDD or openness	1	0.4924	2.030869212	0.392960704	other
Shared	GWAS	Obstructive sleep apnea trait (apnea hypopnea index)	1	0.4957	2.017349203	0.393460654	other
Shared	GWAS	Post bronchodilator FEV1	3	2.2626	1.325908247	0.394060594	other
Shared	GWAS	Mean corpuscular volume	3	2.2422	1.337971635	0.394660534	hematologic
Shared	GWAS	Phospholipid levels (plasma)	1	0.5069	1.972775695	0.397260274	metabolic
Shared	GWAS	Asthma	3	2.2908	1.309586171	0.397760224	respiratory
Shared	GWAS	Coronary artery disease	6	5.1176	1.172424574	0.405059494	cardiovascular
Shared	GWAS	Itch intensity from mosquito bite	1	0.5276	1.895375284	0.407759224	immune
Shared	GWAS	Cerebrospinal fluid t-tau:AB1-42 ratio	1	0.528	1.893939394	0.407959204	nervous
Shared	GWAS	Electrocardiographic traits	1	0.5326	1.877581675	0.412858714	cardiovascular
Shared	GWAS	Diabetic kidney disease	1	0.5312	1.88253012	0.413058694	metabolic
Shared	GWAS	Response to fenofibrate (total cholesterol levels)	1	0.5318	1.880406168	0.413158684	other
Shared	GWAS	Hemoglobin concentration	2	1.4571	1.37258939	0.424357564	hematologic
Shared	GWAS	Total body bone mineral density	1	0.5648	1.770538244	0.430356964	skeletal
Shared	GWAS	Homeostasis model assessment of beta-cell function (dietary factor interaction)	1	0.5627	1.777145904	0.433356664	metabolic
Shared	GWAS	Myopia	2	1.4982	1.334935256	0.440955904	nervous
Shared	GWAS	Obesity (extreme)	1	0.5829	1.71556013	0.443155684	metabolic
Shared	GWAS	Asthma (childhood onset)	1	0.5941	1.683218313	0.448255174	respiratory
Shared	GWAS	Blood pressure	2	1.5356	1.302422506	0.450654935	hematologic
Shared	GWAS	QT interval	2	1.5271	1.309671927	0.451054895	cardiovascular
Shared	GWAS	Response to lurasidone in schizophrenia	1	0.6141	1.628399284	0.456954305	other
Shared	GWAS	Parkinson's disease	2	1.5523	1.288410745	0.457154285	nervous
Shared	GWAS	Mild influenza (H1N1) infection	1	0.615	1.62601626	0.457854215	immune
Shared	GWAS	Periodontal microbiota	1	0.6181	1.617861188	0.459154085	immune
Shared	GWAS	Alzheimer's disease	1	0.6128	1.631853786	0.460553945	nervous
Shared	GWAS	Red blood cell traits	1	0.624	1.602564103	0.467153285	hematologic
Shared	GWAS	Serum total protein level	1	0.6403	1.561767921	0.473552645	other
Shared	GWAS	Hemoglobin	1	0.6451	1.550147264	0.478952105	hematologic
Shared	GWAS	Differentiated thyroid cancer	1	0.6474	1.544640099	0.479352065	endocrine
Shared	GWAS	Papillary thyroid cancer	1	0.6474	1.544640099	0.479352065	endocrine
Shared	GWAS	Reticulocyte count	2	1.6134	1.239618198	0.479552045	immune
Shared	GWAS	Blood urea nitrogen levels	2	1.6231	1.232209969	0.479652035	other
Shared	GWAS	Ischemic stroke	1	0.6746	1.482359917	0.491650835	cardiovascular
Shared	GWAS	Coronary artery disease or large artery stroke	1	0.6776	1.47579693	0.494950505	cardiovascular
Shared	GWAS	Immune reponse to smallpox (secreted IL-1beta)	1	0.6792	1.472320377	0.496150385	immune
Shared	GWAS	Hematocrit	2	1.6887	1.184342986	0.497850215	hematologic
Shared	GWAS	Sum eosinophil basophil counts	2	1.6669	1.199832024	0.499350065	hematologic
Shared	GWAS	Total cholesterol levels	2	1.692	1.182033097	0.503149685	metabolic
Shared	GWAS	Birth weight	1	0.7121	1.404297149	0.509949005	skeletal
Shared	GWAS	Body mass index x sex x age interaction (4df test)	1	0.7141	1.400364095	0.511648835	metabolic
Shared	GWAS	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	1	0.7144	1.399776036	0.511748825	other
Shared	GWAS	Mean corpuscular hemoglobin concentration	1	0.7155	1.397624039	0.512548745	hematologic
Shared	GWAS	Educational attainment	1	0.723	1.383125864	0.513148685	other
Shared	GWAS	Alopecia areata	1	0.7191	1.390627173	0.513448655	integumentary
Shared	GWAS	Resting heart rate	2	1.7206	1.162385214	0.513948605	cardiovascular
Shared	GWAS	Myocardial infarction	1	0.7276	1.374381528	0.521747825	cardiovascular
Shared	GWAS	Initial pursuit acceleration	1	0.7551	1.324327904	0.531746825	nervous
Shared	GWAS	Bone mineral density (hip)	1	0.7643	1.308386759	0.533146685	skeletal
Shared	GWAS	Atrial fibrillation	3	2.8229	1.062736902	0.534046595	cardiovascular
Shared	GWAS	Squamous cell lung carcinoma	1	0.757	1.321003963	0.534446555	respiratory
Shared	GWAS	Non-albumin protein levels	1	0.7728	1.293995859	0.535646435	other
Shared	GWAS	Glaucoma	1	0.7752	1.28998968	0.536046395	nervous
Shared	GWAS	Erectile dysfunction	1	0.7734	1.292991983	0.537846215	reproductive
Shared	GWAS	White blood cell count (basophil)	1	0.7641	1.308729224	0.541145885	immune
Shared	GWAS	Urate levels in overweight individuals	1	0.797	1.254705144	0.547445255	metabolic
Shared	GWAS	Alcohol dependence	1	0.802	1.246882793	0.549945005	behavior
Shared	GWAS	Emphysema-related traits	1	0.7989	1.251721117	0.552044796	respiratory
Shared	GWAS	Diastolic blood pressure	9	9.0529	0.994156569	0.552844716	cardiovascular
Shared	GWAS	Serum uric acid levels	1	0.7991	1.251407834	0.554044596	other
Shared	GWAS	Plasma clusterin levels	1	0.8189	1.221150324	0.558444156	other
Shared	GWAS	Glycated hemoglobin levels	1	0.8322	1.201634223	0.564843516	metabolic
Shared	GWAS	Morning vs. evening chronotype	1	0.8225	1.215805471	0.565243476	behavior
Shared	GWAS	Mean arterial pressure	1	0.8351	1.197461382	0.567843216	cardiovascular
Shared	GWAS	Mitochondrial DNA levels	1	0.8392	1.191611058	0.571842816	other
Shared	GWAS	HDL cholesterol	2	1.9233	1.039879374	0.575042496	metabolic
Shared	GWAS	Takayasu arteritis	1	0.869	1.150747986	0.581941806	cardiovascular
Shared	GWAS	Breast cancer	2	1.9772	1.011531459	0.586641336	reproductive
Shared	GWAS	Post bronchodilator FEV1/FVC ratio	6	6.2467	0.960507148	0.589141086	other
Shared	GWAS	Alzheimer's disease biomarkers	1	0.8938	1.118818528	0.590840916	nervous
Shared	GWAS	High light scatter reticulocyte count	1	0.9014	1.1093854	0.598240176	metabolic
Shared	GWAS	Monobrow	1	0.9172	1.090274749	0.599140086	integumentary
Shared	GWAS	Height	6	6.2839	0.954821051	0.599940006	skeletal
Shared	GWAS	Pit-and-Fissure caries	1	0.919	1.088139282	0.600639936	skeletal
Shared	GWAS	Intelligence	1	0.9101	1.098780354	0.602539746	other
Shared	GWAS	Multiple sclerosis	2	2.0161	0.992014285	0.604239576	nervous
Shared	GWAS	High density lipoprotein cholesterol levels	1	0.9304	1.074806535	0.609839016	metabolic
Shared	GWAS	Polycystic ovary syndrome	1	0.9512	1.051303616	0.609939006	reproductive
Shared	GWAS	Cognitive decline (age-related)	1	0.9493	1.053407774	0.615038496	nervous
Shared	GWAS	Lung function (FEV1/FVC)	1	0.9551	1.047010784	0.615138486	respiratory
Shared	GWAS	Tonsillectomy	1	0.9478	1.05507491	0.616738326	lymphatic
Shared	GWAS	Pelvic organ prolapse (moderate/severe)	1	0.9616	1.039933444	0.618038196	skeletal muscle
Shared	GWAS	Entorhinal cortical thickness	1	0.9676	1.033484911	0.620037996	nervous
Shared	GWAS	Loneliness (MTAG)	1	0.963	1.038421599	0.621537846	behavior
Shared	GWAS	Visceral adipose tissue/subcutaneous adipose tissue ratio	1	0.9824	1.017915309	0.622537746	metabolic
Shared	GWAS	Obesity	1	0.9922	1.007861318	0.626337366	metabolic
Shared	GWAS	Pursuit maintenance gain	2	2.1371	0.935847644	0.632836716	skeletal muscle
Shared	GWAS	Red cell distribution width	1	1.0161	0.984155103	0.637236276	hematologic
Shared	GWAS	Triglycerides	2	2.1607	0.925625955	0.637736226	metabolic
Shared	GWAS	Macular thickness	3	3.3053	0.907633195	0.638536146	nervous
Shared	GWAS	QRS interval (sulfonylurea treatment interaction)	1	1.0167	0.983574309	0.638836116	cardiovascular
Shared	GWAS	Systemic juvenile idiopathic arthritis	1	1.0174	0.982897582	0.639736026	immune
Shared	GWAS	PR interval	1	1.0296	0.971250971	0.645035496	cardiovascular
Shared	GWAS	Major depressive disorder	3	3.3541	0.894427715	0.655234477	behavior
Shared	GWAS	Lung cancer	1	1.0833	0.923105326	0.658434157	respiratory
Shared	GWAS	Monoclonal gammopathy of undetermined significance	2	2.2525	0.887902331	0.659934007	hematologic
Shared	GWAS	Heart rate response to exercise	1	1.081	0.92506938	0.663233677	cardiovascular
Shared	GWAS	Brain connectivity	1	1.0939	0.914160344	0.664833517	nervous
Shared	GWAS	Menarche (age at onset)	4	4.6112	0.867453158	0.669933007	reproductive
Shared	GWAS	Cannabis use	1	1.1116	0.899604174	0.670032997	behavior
Shared	GWAS	Bipolar disorder	1	1.1401	0.877116042	0.674332567	behavior
Shared	GWAS	Schizophrenia	7	7.8842	0.887851653	0.675232477	behavior
Shared	GWAS	Corneal astigmatism	1	1.1089	0.901794571	0.675532447	nervous
Shared	GWAS	Idiopathic dilated cardiomyopathy	1	1.1239	0.889758875	0.678832117	cardiovascular
Shared	GWAS	Common carotid intima-media thickness in HIV negative individuals	1	1.1257	0.888336146	0.678832117	cardiovascular
Shared	GWAS	Chronotype	1	1.1209	0.892140244	0.679632037	behavior
Shared	GWAS	Obesity (early onset extreme)	1	1.1362	0.880126738	0.681931807	metabolic
Shared	GWAS	Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)	1	1.1397	0.877423883	0.685231477	cardiovascular
Shared	GWAS	Alzheimer's disease (late onset)	1	1.1756	0.850629466	0.691330867	nervous
Shared	GWAS	Waist-to-hip ratio adjusted for BMI (age >50)	1	1.1922	0.838785439	0.693930607	skeletal
Shared	GWAS	Bone mineral density	1	1.1872	0.842318059	0.696330367	skeletal
Shared	GWAS	Rosacea symptom severity	2	2.4237	0.825184635	0.698730127	integumentary
Shared	GWAS	Inflammatory skin disease	1	1.1904	0.840053763	0.700829917	integumentary
Shared	GWAS	Migraine	1	1.2095	0.826787929	0.700829917	nervous
Shared	GWAS	Bronchopulmonary dysplasia	1	1.2294	0.813404913	0.705629437	respiratory
Shared	GWAS	Coronary artery calcification	1	1.2386	0.807363152	0.708129187	cardiovascular
Shared	GWAS	Diverticular disease	2	2.4887	0.803632419	0.709429057	digestive
Shared	GWAS	Autism spectrum disorder or schizophrenia	3	3.6864	0.813802083	0.710428957	behavior
Shared	GWAS	Type 2 diabetes	6	7.1055	0.844416297	0.713828617	metabolic
Shared	GWAS	Regular attendance at a religious group	1	1.2556	0.796431985	0.715528447	behavior
Shared	GWAS	Monocyte percentage of white cells	1	1.2713	0.786596397	0.720627937	immune
Shared	GWAS	Colorectal cancer	1	1.2628	0.791891036	0.721327867	digestive
Shared	GWAS	Inflammatory biomarkers	1	1.2769	0.783146683	0.724527547	immune
Shared	GWAS	Myeloid white cell count	1	1.291	0.774593338	0.725227477	immune
Shared	GWAS	Hypothyroidism	1	1.2909	0.774653343	0.726927307	endocrine
Shared	GWAS	"Coronary artery disease (myocardial infarction, PTCA, CABG, angina or CIHD)"	1	1.2838	0.778937529	0.729927007	cardiovascular
Shared	GWAS	Waist-hip ratio	2	2.5489	0.784652203	0.729927007	skeletal
Shared	GWAS	Sum neutrophil eosinophil counts	1	1.311	0.762776506	0.730026997	hematologic
Shared	GWAS	Neutrophil percentage of granulocytes	1	1.2994	0.769585963	0.730126987	lymphatic
Shared	GWAS	Granulocyte count	1	1.3123	0.762020879	0.730726927	immune
Shared	GWAS	Stroke	1	1.3466	0.74261102	0.739926007	cardiovascular
Shared	GWAS	Granulocyte percentage of myeloid white cells	1	1.3448	0.743604997	0.743825617	immune
Shared	GWAS	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)	1	1.3745	0.727537286	0.749425057	other
Shared	GWAS	"Allergic disease (asthma, hay fever or eczema)"	1	1.4094	0.709521782	0.749625037	immune
Shared	GWAS	Feeling miserable	1	1.4062	0.711136396	0.749825017	behavior
Shared	GWAS	Feeling tense	1	1.4042	0.712149266	0.751324868	behavior
Shared	GWAS	Spherical equivalent or myopia (age of diagnosis)	2	2.6849	0.7449067	0.752924708	nervous
Shared	GWAS	Feeling worry	1	1.4084	0.710025561	0.754724528	behavior
Shared	GWAS	Waist circumference	1	1.407	0.710732054	0.757124288	skeletal
Shared	GWAS	Cognitive function	1	1.4258	0.70136064	0.760823918	nervous
Shared	GWAS	QT interval (drug interaction)	1	1.433	0.697836706	0.761023898	cardiovascular
Shared	GWAS	Sum basophil neutrophil counts	1	1.4674	0.681477443	0.770122988	hematologic
Shared	GWAS	Reticulocyte fraction of red cells	1	1.4529	0.688278615	0.770322968	immune
Shared	GWAS	Temperament	1	1.4985	0.667334001	0.779522048	behavior
Shared	GWAS	Response to amphetamines	2	2.8429	0.703506982	0.780521948	other
Shared	GWAS	Social science traits (pleiotropy) (HIPO component 1)	1	1.5015	0.666000666	0.782121788	behavior
Shared	GWAS	Loneliness	2	2.9119	0.686836773	0.785521448	behavior
Shared	GWAS	Cognitive performance	1	1.556	0.642673522	0.787321268	nervous
Shared	GWAS	Chronic kidney disease	1	1.5666	0.638325035	0.787421258	urinary
Shared	GWAS	Gut microbiota (bacterial taxa)	1	1.5628	0.639877144	0.789021098	digestive
Shared	GWAS	Epstein-Barr virus copy number in lymphoblastoid cell lines	1	1.5776	0.633874239	0.794420558	immune
Shared	GWAS	White blood cell count	1	1.6402	0.609681746	0.805219478	immune
Shared	GWAS	Restless legs syndrome	1	1.6862	0.59304946	0.810818918	nervous
Shared	GWAS	Eosinophil percentage of granulocytes	1	1.6676	0.599664188	0.813918608	immune
Shared	GWAS	Cobalt levels	1	1.7235	0.580214679	0.815818418	other
Shared	GWAS	Urate levels in obese individuals	1	1.714	0.583430572	0.817118288	metabolic
Shared	GWAS	Blond vs. brown/black hair color	1	1.6797	0.595344407	0.817218278	integumentary
Shared	GWAS	Neuroticism	1	1.7288	0.578435909	0.817318268	behavior
Shared	GWAS	Eosinophil counts	1	1.6791	0.595557144	0.817818218	immune
Shared	GWAS	Mean platelet volume	1	1.7357	0.576136429	0.821717828	hematologic
Shared	GWAS	Neurociticism	2	3.1823	0.628476259	0.821817818	behavior
Shared	GWAS	Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	1	1.7548	0.569865512	0.822617738	other
Shared	GWAS	Depression	1	1.6909	0.591401029	0.822717728	behavior
Shared	GWAS	Photic sneeze reflex	1	1.7328	0.577100646	0.825017498	nervous
Shared	GWAS	Diisocyanate-induced asthma	2	3.1635	0.632211159	0.827317268	respiratory
Shared	GWAS	Eosinophil percentage of white cells	1	1.769	0.565291125	0.833716628	immune
Shared	GWAS	Intracranial aneurysm	1	1.8004	0.555432126	0.834616538	nervous
Shared	GWAS	Immune response to measles-mumps-rubella vaccine	1	1.8377	0.544158459	0.842315768	immune
Shared	GWAS	Neutrophil count	1	1.8763	0.532963812	0.846815318	lymphatic
Shared	GWAS	Anorexia nervosa	1	1.9775	0.505689001	0.863113689	behavior
Shared	GWAS	Late-onset Alzheimer's disease	1	2.0328	0.49193231	0.867113289	nervous
Shared	GWAS	Intraocular pressure	3	5.1026	0.587935562	0.878612139	nervous
Shared	GWAS	Amyotrophic lateral sclerosis (sporadic)	2	3.6184	0.552730489	0.879612039	nervous
Shared	GWAS	Hand grip strength	2	3.6162	0.553066755	0.879712029	skeletal muscle
Shared	GWAS	Experiencing mood swings	1	2.124	0.470809793	0.882511749	behavior
Shared	GWAS	Sense of smell	1	2.2171	0.451039646	0.895910409	nervous
Shared	GWAS	Metabolite levels  (X-11787)	1	2.5176	0.397203686	0.921307869	metabolic
Shared	GWAS	Axial length	1	2.528	0.39556962	0.921507849	nervous
Shared	GWAS	Pulse pressure	6	9.9752	0.601491699	0.931306869	cardiovascular
Shared	GWAS	Night sleep phenotypes	4	8.2565	0.484466784	0.96480352	behavior
Shared	GWAS	Obesity-related traits	11	17.7675	0.619107922	0.96820318	metabolic
Shared	GWAS	Body mass index	8	14.2776	0.560318261	0.97230277	metabolic
Shared	GWAS	Cognitive decline rate in late mild cognitive impairment	1	3.9633	0.25231499	0.98210179	nervous
Shared	GWAS	Systolic blood pressure	5	10.6869	0.467862523	0.98210179	cardiovascular
Shared	GWAS	Longevity	1	4.5443	0.220055894	0.98990101	other
Shared	GWAS	Heel bone mineral density	5	12.6557	0.395078897	0.99630037	skeletal
Shared	HPO	Bronchitis (HP:0012387)	3	0.2343	12.80409731	0.00139986	respiratory
Shared	HPO	Autosomal recessive inheritance (HP:0000007)	25	12.353	2.023799887	0.00149985	other
Shared	HPO	Low anterior hairline (HP:0000294)	4	0.496	8.064516129	0.00169983	integumentary
Shared	HPO	Macrotia (HP:0000400)	6	1.4347	4.182058967	0.00329967	other
Shared	HPO	Umbilical hernia (HP:0001537)	6	1.4433	4.157139888	0.00359964	reproductive
Shared	HPO	Polygenic inheritance (HP:0010982)	2	0.0856	23.36448598	0.00439956	other
Shared	HPO	Narrow mouth (HP:0000160)	5	1.0706	4.670278349	0.00539946	skeletal
Shared	HPO	Long philtrum (HP:0000343)	7	1.9891	3.519179528	0.00549945	integumentary
Shared	HPO	Multifactorial inheritance (HP:0001426)	2	0.0967	20.68252327	0.00589941	other
Shared	HPO	Hypertelorism (HP:0000316)	9	3.1184	2.886095434	0.0059994	skeletal
Shared	HPO	Pointed chin (HP:0000307)	4	0.7233	5.530208765	0.0059994	skeletal
Shared	HPO	Epicanthus (HP:0000286)	7	2.1634	3.235647592	0.0069993	integumentary
Shared	HPO	Congenital onset (HP:0003577)	5	1.189	4.205214466	0.00779922	other
Shared	HPO	Gastrointestinal atresia (HP:0002589)	2	0.1456	13.73626374	0.00839916	digestive
Shared	HPO	Chronic bronchitis (HP:0004469)	2	0.166	12.04819277	0.01209879	respiratory
Shared	HPO	Round face (HP:0000311)	4	0.9153	4.370151863	0.01359864	skeletal
Shared	HPO	"Low-set, posteriorly rotated ears (HP:0000368)"	8	3.1478	2.541457526	0.01529847	other
Shared	HPO	Skin ulcer (HP:0200042)	3	0.5124	5.854800937	0.01559844	integumentary
Shared	HPO	Short chin (HP:0000331)	2	0.1929	10.36806636	0.01669833	skeletal
Shared	HPO	Low posterior hairline (HP:0002162)	3	0.5429	5.525879536	0.01689831	integumentary
Shared	HPO	Periorbital edema (HP:0100539)	3	0.5619	5.339028297	0.01719828	other
Shared	HPO	Facial edema (HP:0000282)	3	0.5619	5.339028297	0.01719828	immune
Shared	HPO	Palpebral edema (HP:0100540)	2	0.1984	10.08064516	0.01749825	nervous
Shared	HPO	Thyroid carcinoma (HP:0002890)	2	0.1895	10.55408971	0.01779822	endocrine
Shared	HPO	Constricted visual fields (HP:0001133)	2	0.2093	9.55566173	0.01839816	nervous
Shared	HPO	Abnormality of secondary sexual hair (HP:0009888)	1	0.0199	50.25125628	0.019998	integumentary
Shared	HPO	Abnormality of the axillary hair (HP:0100134)	1	0.0199	50.25125628	0.019998	integumentary
Shared	HPO	Short nose (HP:0003196)	4	1.0212	3.916960439	0.02059794	skeletal
Shared	HPO	High palate (HP:0000218)	5	1.5486	3.228722717	0.02059794	skeletal
Shared	HPO	Vertebral arch anomaly (HP:0008438)	2	0.2228	8.976660682	0.02129787	skeletal
Shared	HPO	Milia (HP:0001056)	1	0.0215	46.51162791	0.02139786	integumentary
Shared	HPO	Abnormal number of incisors (HP:0011064)	2	0.2224	8.992805755	0.02139786	skeletal
Shared	HPO	Lymphopenia (HP:0001888)	2	0.2166	9.233610342	0.02149785	lymphatic
Shared	HPO	Central scotoma (HP:0000603)	1	0.0218	45.87155963	0.02159784	nervous
Shared	HPO	Tubulointerstitial fibrosis (HP:0005576)	2	0.214	9.345794393	0.02169783	urinary
Shared	HPO	Thoracic kyphosis (HP:0002942)	2	0.2258	8.857395926	0.02179782	skeletal
Shared	HPO	Long palpebral fissure (HP:0000637)	2	0.2252	8.880994671	0.02179782	integumentary
Shared	HPO	Dehydration (HP:0001944)	3	0.5866	5.114217525	0.02239776	other
Shared	HPO	Oligodontia (HP:0000677)	2	0.2306	8.673026886	0.02249775	skeletal
Shared	HPO	Abnormality of the thoracic spine (HP:0100711)	2	0.2377	8.413967186	0.02339766	skeletal
Shared	HPO	Systemic lupus erythematosus (HP:0002725)	1	0.0252	39.68253968	0.02529747	immune
Shared	HPO	Rib fusion (HP:0000902)	2	0.2464	8.116883117	0.02569743	skeletal
Shared	HPO	Neoplasm of the thyroid gland (HP:0100031)	2	0.2463	8.120178644	0.02769723	endocrine
Shared	HPO	Thick lower lip vermilion (HP:0000179)	5	1.6655	3.002101471	0.02889711	integumentary
Shared	HPO	Long face (HP:0000276)	3	0.6601	4.544765945	0.029997	skeletal
Shared	HPO	Telecanthus (HP:0000506)	3	0.6693	4.482294935	0.03149685	skeletal
Shared	HPO	Abnormal drinking behavior (HP:0030082)	1	0.0328	30.48780488	0.03239676	behavior
Shared	HPO	Polydipsia (HP:0001959)	1	0.0328	30.48780488	0.03239676	other
Shared	HPO	Aplasia cutis congenita (HP:0001057)	1	0.0329	30.39513678	0.03269673	integumentary
Shared	HPO	Abnormality of cells of the lymphoid lineage (HP:0012140)	2	0.2689	7.437709186	0.03359664	lymphatic
Shared	HPO	Macrocytic anemia (HP:0001972)	2	0.2986	6.697923644	0.03569643	hematologic
Shared	HPO	Polycystic kidney dysplasia (HP:0000113)	3	0.7061	4.248689987	0.03789621	urinary
Shared	HPO	Vertebral fusion (HP:0002948)	2	0.3127	6.39590662	0.03889611	skeletal
Shared	HPO	Abnormality of the renal cortex (HP:0011035)	2	0.3106	6.439150032	0.03989601	urinary
Shared	HPO	Proximal placement of thumb (HP:0009623)	2	0.3165	6.319115324	0.04159584	skeletal
Shared	HPO	Deviation of the thumb (HP:0009603)	2	0.319	6.269592476	0.04189581	skeletal
Shared	HPO	Fragile nails (HP:0001808)	1	0.0427	23.41920375	0.04209579	integumentary
Shared	HPO	Sepsis (HP:0100806)	2	0.3243	6.167129201	0.04259574	immune
Shared	HPO	Abnormality of the incisor (HP:0000676)	2	0.3312	6.038647343	0.04429557	skeletal
Shared	HPO	Supernumerary ribs (HP:0005815)	2	0.3412	5.861664713	0.04689531	skeletal
Shared	HPO	Supernumerary bones of the axial skeleton (HP:0009144)	2	0.3412	5.861664713	0.04689531	skeletal
Shared	HPO	Proximal amyotrophy (HP:0007126)	1	0.0492	20.32520325	0.04769523	nervous
Shared	HPO	Cellular immunodeficiency (HP:0005374)	2	0.351	5.698005698	0.04839516	immune
Shared	HPO	Large for gestational age (HP:0001520)	1	0.0494	20.24291498	0.04849515	other
Shared	HPO	Easy fatigability (HP:0003388)	1	0.0496	20.16129032	0.04859514	other
Shared	HPO	Thick eyebrow (HP:0000574)	3	0.8109	3.699593045	0.04889511	integumentary
Shared	HPO	Abnormality of the renal medulla (HP:0100957)	2	0.3515	5.689900427	0.04939506	urinary
Shared	HPO	Narrow chest (HP:0000774)	2	0.3634	5.503577325	0.050194981	skeletal
Shared	HPO	Postaxial hand polydactyly (HP:0001162)	3	0.8222	3.648747263	0.051794821	skeletal
Shared	HPO	Severe visual impairment (HP:0001141)	1	0.0527	18.97533207	0.051994801	nervous
Shared	HPO	Atrophic scars (HP:0001075)	1	0.0537	18.62197393	0.052794721	integumentary
Shared	HPO	Highly arched eyebrow (HP:0002553)	3	0.8447	3.551556766	0.053594641	integumentary
Shared	HPO	Hypotrichosis (HP:0001006)	1	0.0552	18.11594203	0.053894611	integumentary
Shared	HPO	"Intellectual disability, mild (HP:0001256)"	2	0.3756	5.324813632	0.056794321	nervous
Shared	HPO	Polyuria (HP:0000103)	1	0.0588	17.00680272	0.057494251	urinary
Shared	HPO	Abnormal blistering of the skin (HP:0008066)	2	0.3951	5.062009618	0.058694131	integumentary
Shared	HPO	"Congenital, generalized hypertrichosis (HP:0004540)"	1	0.0612	16.33986928	0.059694031	integumentary
Shared	HPO	Fragile skin (HP:0001030)	1	0.062	16.12903226	0.060593941	integumentary
Shared	HPO	Postnatal microcephaly (HP:0005484)	2	0.3954	5.058168943	0.060893911	skeletal
Shared	HPO	Papillary thyroid carcinoma (HP:0002895)	1	0.0641	15.60062402	0.060893911	endocrine
Shared	HPO	Scotoma (HP:0000575)	1	0.0635	15.7480315	0.061293871	nervous
Shared	HPO	Tubular atrophy (HP:0000092)	1	0.0648	15.43209877	0.062893711	urinary
Shared	HPO	Polyhydramnios (HP:0001561)	2	0.4048	4.940711462	0.063093691	reproductive
Shared	HPO	Chromsome breakage (HP:0040012)	1	0.0665	15.03759398	0.064293571	other
Shared	HPO	Redundant skin (HP:0001582)	1	0.0677	14.77104874	0.064993501	integumentary
Shared	HPO	Agammaglobulinemia (HP:0004432)	1	0.0669	14.94768311	0.065193481	immune
Shared	HPO	Recurrent bronchitis (HP:0002837)	1	0.0683	14.64128843	0.065993401	respiratory
Shared	HPO	Ovoid vertebral bodies (HP:0003300)	1	0.0686	14.57725948	0.065993401	skeletal
Shared	HPO	Coarse facial features (HP:0000280)	4	1.5411	2.595548634	0.066893311	integumentary
Shared	HPO	Abnormality of the duodenum (HP:0002246)	2	0.4192	4.770992366	0.067093291	digestive
Shared	HPO	Macular degeneration (HP:0000608)	1	0.0702	14.24501425	0.067393261	nervous
Shared	HPO	Cardiomegaly (HP:0001640)	2	0.425	4.705882353	0.069293071	cardiovascular
Shared	HPO	Depressed nasal bridge (HP:0005280)	4	1.4998	2.66702227	0.069393061	skeletal
Shared	HPO	Gonadotropin excess (HP:0000837)	1	0.0721	13.86962552	0.069593041	endocrine
Shared	HPO	Nail dystrophy (HP:0008404)	1	0.0735	13.60544218	0.071192881	integumentary
Shared	HPO	Aortic regurgitation (HP:0001659)	1	0.0737	13.56852103	0.071392861	cardiovascular
Shared	HPO	Aplasia/Hypoplasia of the pubic bone (HP:0009104)	1	0.0743	13.4589502	0.071792821	skeletal
Shared	HPO	Cellulitis (HP:0100658)	1	0.0745	13.42281879	0.071792821	integumentary
Shared	HPO	Delayed skeletal maturation (HP:0002750)	4	1.5836	2.525890376	0.072292771	skeletal
Shared	HPO	Abnormal urine output (HP:0012590)	1	0.0761	13.14060447	0.073692631	urinary
Shared	HPO	Amyloidosis (HP:0011034)	1	0.078	12.82051282	0.075392461	other
Shared	HPO	Abnormality of chromosome stability (HP:0003220)	1	0.0783	12.77139208	0.075592441	other
Shared	HPO	Abnormality of renal excretion (HP:0011036)	1	0.0795	12.57861635	0.076992301	urinary
Shared	HPO	Plantar hyperkeratosis (HP:0007556)	1	0.0807	12.39157373	0.077192281	integumentary
Shared	HPO	High forehead (HP:0000348)	3	1.0063	2.981218325	0.078492151	skeletal
Shared	HPO	Choreoathetosis (HP:0001266)	1	0.0835	11.9760479	0.080291971	nervous
Shared	HPO	Gingival overgrowth (HP:0000212)	2	0.4758	4.203446826	0.080391961	immune
Shared	HPO	Childhood onset (HP:0011463)	1	0.0855	11.69590643	0.082091791	other
Shared	HPO	Prominent supraorbital ridges (HP:0000336)	1	0.0873	11.45475372	0.083291671	skeletal
Shared	HPO	Hypoplasia of dental enamel (HP:0006297)	1	0.087	11.49425287	0.083891611	skeletal
Shared	HPO	Broad metatarsal (HP:0001783)	1	0.0908	11.01321586	0.086291371	skeletal
Shared	HPO	Termporal pattern (HP:0011008)	1	0.095	10.52631579	0.090390961	other
Shared	HPO	Insidious onset (HP:0003587)	1	0.095	10.52631579	0.090390961	other
Shared	HPO	Preauricular skin tag (HP:0000384)	2	0.5059	3.953350465	0.091390861	integumentary
Shared	HPO	Tubulointerstitial abnormality (HP:0001969)	2	0.5026	3.9793076	0.092390761	urinary
Shared	HPO	Emphysema (HP:0002097)	1	0.0973	10.27749229	0.093690631	respiratory
Shared	HPO	Posterior subcapsular cataract (HP:0007787)	1	0.0981	10.19367992	0.093890611	nervous
Shared	HPO	Hypermetropia (HP:0000540)	3	1.065	2.816901408	0.094190581	nervous
Shared	HPO	Sacral dimple (HP:0000960)	2	0.5156	3.87897595	0.095290471	integumentary
Shared	HPO	Abnormality of the ischium (HP:0003174)	1	0.1009	9.910802775	0.095690431	skeletal
Shared	HPO	Hypoplastic ischia (HP:0003175)	1	0.1009	9.910802775	0.095690431	skeletal
Shared	HPO	Skin tags (HP:0010609)	2	0.5233	3.821899484	0.097490251	integumentary
Shared	HPO	Papilloma (HP:0012740)	1	0.1033	9.68054211	0.097990201	other
Shared	HPO	Verrucae (HP:0200043)	1	0.1033	9.68054211	0.097990201	integumentary
Shared	HPO	Large hands (HP:0001176)	1	0.1066	9.380863039	0.100889911	skeletal
Shared	HPO	Congenital hepatic fibrosis (HP:0002612)	2	0.53	3.773584906	0.101789821	digestive
Shared	HPO	Short hallux (HP:0010109)	1	0.1071	9.337068161	0.101789821	skeletal
Shared	HPO	Triangular face (HP:0000325)	3	1.1297	2.655572276	0.102489751	other
Shared	HPO	Abnormal gallbladder morphology (HP:0012437)	1	0.1093	9.149130833	0.103689631	digestive
Shared	HPO	Narrow forehead (HP:0000341)	3	1.1316	2.651113468	0.104789521	skeletal
Shared	HPO	Optic atrophy (HP:0000648)	5	2.4968	2.002563281	0.106389361	nervous
Shared	HPO	Broad hallux (HP:0010055)	1	0.1118	8.944543828	0.106389361	skeletal
Shared	HPO	Anteriorly placed anus (HP:0001545)	1	0.1139	8.779631255	0.107689231	digestive
Shared	HPO	Broad toe (HP:0001837)	1	0.1147	8.718395815	0.109289071	skeletal
Shared	HPO	Atrophy/Degeneration involving the corticospinal tracts (HP:0007372)	1	0.1156	8.650519031	0.109489051	nervous
Shared	HPO	Degeneration of the lateral corticospinal tracts (HP:0002314)	1	0.1156	8.650519031	0.109489051	nervous
Shared	HPO	Abnormality of the corticospinal tract (HP:0002492)	1	0.1156	8.650519031	0.109489051	nervous
Shared	HPO	Intestinal atresia (HP:0011100)	1	0.1153	8.673026886	0.109689031	digestive
Shared	HPO	Long eyelashes (HP:0000527)	1	0.1231	8.123476848	0.116088391	integumentary
Shared	HPO	Sparse scalp hair (HP:0002209)	1	0.1273	7.855459544	0.119188081	integumentary
Shared	HPO	Underdeveloped nasal alae (HP:0000430)	2	0.5917	3.380091262	0.119288071	integumentary
Shared	HPO	Impaired vibration sensation in the lower limbs (HP:0002166)	1	0.1266	7.898894155	0.119588041	nervous
Shared	HPO	Abnormality of the gallbladder (HP:0005264)	1	0.1272	7.86163522	0.119788021	digestive
Shared	HPO	Esophageal atresia (HP:0002032)	1	0.1276	7.836990596	0.120487951	digestive
Shared	HPO	Anal stenosis (HP:0002025)	1	0.1296	7.716049383	0.121587841	digestive
Shared	HPO	Nephronophthisis (HP:0000090)	1	0.1301	7.686395081	0.122587741	urinary
Shared	HPO	Facial asymmetry (HP:0000324)	2	0.6125	3.265306122	0.123087691	other
Shared	HPO	Blepharophimosis (HP:0000581)	3	1.2367	2.425810625	0.124087591	integumentary
Shared	HPO	Cerebral ischemia (HP:0002637)	2	0.6044	3.309066843	0.125587441	nervous
Shared	HPO	Decreased muscle mass (HP:0003199)	1	0.1346	7.429420505	0.126287371	skeletal muscle
Shared	HPO	Ureteral obstruction (HP:0006000)	1	0.1482	6.747638327	0.137486251	urinary
Shared	HPO	Ureteral stenosis (HP:0000071)	1	0.1482	6.747638327	0.137486251	urinary
Shared	HPO	Aplasia/Hypoplasia of the hallux (HP:0008362)	1	0.1509	6.626905235	0.139786021	skeletal
Shared	HPO	Aortic valve stenosis (HP:0001650)	1	0.1509	6.626905235	0.139886011	cardiovascular
Shared	HPO	Hyperpituitarism (HP:0010514)	1	0.1519	6.583278473	0.140285971	endocrine
Shared	HPO	Patent ductus arteriosus (HP:0001643)	3	1.2999	2.307869836	0.142785721	cardiovascular
Shared	HPO	Neutropenia (HP:0001875)	1	0.1541	6.489292667	0.143885611	immune
Shared	HPO	Aplasia/Hypoplasia involving the pelvis (HP:0009103)	1	0.155	6.451612903	0.144485551	skeletal
Shared	HPO	Prolonged bleeding time (HP:0003010)	1	0.159	6.289308176	0.146685331	hematologic
Shared	HPO	Abnormality of vision evoked potentials (HP:0000649)	1	0.1578	6.337135615	0.146885311	nervous
Shared	HPO	Variable expressivity (HP:0003828)	2	0.6825	2.93040293	0.147785221	other
Shared	HPO	Pterygium (HP:0001059)	1	0.1605	6.230529595	0.148385161	integumentary
Shared	HPO	Babinski sign (HP:0003487)	2	0.6832	2.927400468	0.150784922	nervous
Shared	HPO	Ventricular tachycardia (HP:0004756)	1	0.1646	6.075334143	0.151584842	cardiovascular
Shared	HPO	Recurrent otitis media (HP:0000403)	1	0.164	6.097560976	0.152384762	nervous
Shared	HPO	Postnatal growth retardation (HP:0008897)	2	0.7038	2.841716397	0.153484652	metabolic
Shared	HPO	Skin rash (HP:0000988)	1	0.1662	6.016847172	0.154684532	immune
Shared	HPO	Cerebellar atrophy (HP:0001272)	3	1.3672	2.194265652	0.154884512	nervous
Shared	HPO	Lower limb muscle weakness (HP:0007340)	1	0.1693	5.906674542	0.155884412	skeletal muscle
Shared	HPO	Death in infancy (HP:0001522)	1	0.1705	5.865102639	0.156484352	other
Shared	HPO	Unsteady gait (HP:0002317)	1	0.1722	5.807200929	0.156684332	other
Shared	HPO	Abnormality of the pericardium (HP:0001697)	1	0.1755	5.698005698	0.159884012	cardiovascular
Shared	HPO	Osteomyelitis (HP:0002754)	1	0.1759	5.685048323	0.160283972	skeletal
Shared	HPO	Spastic gait (HP:0002064)	1	0.1764	5.66893424	0.162183782	skeletal muscle
Shared	HPO	Abnormality of the sella turcica (HP:0002679)	1	0.1801	5.55247085	0.163583642	skeletal
Shared	HPO	Coxa valga (HP:0002673)	1	0.1789	5.589714925	0.164483552	skeletal
Shared	HPO	Wide mouth (HP:0000154)	4	2.1307	1.877317314	0.168583142	skeletal
Shared	HPO	Dilated cardiomyopathy (HP:0001644)	2	0.743	2.69179004	0.169183082	cardiovascular
Shared	HPO	Progressive neurologic deterioration (HP:0002344)	1	0.1864	5.364806867	0.169583042	nervous
Shared	HPO	Clonus (HP:0002169)	1	0.1878	5.324813632	0.170382962	nervous
Shared	HPO	Abnormality of the pubic bones (HP:0003172)	1	0.1853	5.396654074	0.171282872	skeletal
Shared	HPO	Preaxial foot polydactyly (HP:0001841)	1	0.1889	5.293806247	0.173082692	skeletal
Shared	HPO	Hydrocephalus (HP:0000238)	3	1.4201	2.112527287	0.173182682	nervous
Shared	HPO	Enlarged kidneys (HP:0000105)	1	0.1936	5.165289256	0.174882512	urinary
Shared	HPO	Urinary bladder sphincter dysfunction (HP:0002839)	1	0.194	5.154639175	0.176282372	urinary
Shared	HPO	Abnormal biliary tract morphology (HP:0012440)	1	0.1936	5.165289256	0.176382362	digestive
Shared	HPO	Synophrys (HP:0000664)	2	0.7614	2.626740215	0.179182082	integumentary
Shared	HPO	Short neck (HP:0000470)	5	2.976	1.680107527	0.179382062	skeletal
Shared	HPO	Urinary urgency (HP:0000012)	1	0.199	5.025125628	0.181081892	urinary
Shared	HPO	Hyperglycemia (HP:0003074)	1	0.2008	4.980079681	0.182381762	metabolic
Shared	HPO	Neonatal death (HP:0003811)	1	0.2029	4.928536225	0.183081692	other
Shared	HPO	Pulmonary artery stenosis (HP:0004415)	1	0.2018	4.955401388	0.183681632	cardiovascular
Shared	HPO	Platyspondyly (HP:0000926)	1	0.2023	4.943153732	0.183981602	skeletal
Shared	HPO	Ectropion (HP:0000656)	1	0.2069	4.833252779	0.185881412	nervous
Shared	HPO	Abnormally folded helix (HP:0008544)	1	0.208	4.807692308	0.188281172	integumentary
Shared	HPO	Overfolded helix (HP:0000396)	1	0.208	4.807692308	0.188281172	integumentary
Shared	HPO	Intrauterine growth retardation (HP:0001511)	4	2.2804	1.754078232	0.193780622	other
Shared	HPO	Epistaxis (HP:0000421)	1	0.2142	4.66853408	0.195080492	other
Shared	HPO	Optic disc pallor (HP:0000543)	1	0.2187	4.572473708	0.196980302	nervous
Shared	HPO	Downturned corners of mouth (HP:0002714)	2	0.8213	2.435163765	0.199080092	skeletal muscle
Shared	HPO	Congenital cataract (HP:0000519)	1	0.227	4.405286344	0.202879712	nervous
Shared	HPO	Craniofacial hyperostosis (HP:0004493)	1	0.2256	4.432624113	0.203079692	skeletal
Shared	HPO	Delayed gross motor development (HP:0002194)	1	0.2298	4.351610096	0.204079592	nervous
Shared	HPO	Retinitis pigmentosa (HP:0000510)	2	0.8411	2.377838545	0.209279072	integumentary
Shared	HPO	Testicular neoplasm (HP:0010788)	1	0.2382	4.198152813	0.214678532	reproductive
Shared	HPO	Anal atresia (HP:0002023)	1	0.2425	4.12371134	0.215078492	digestive
Shared	HPO	Everted lower lip vermilion (HP:0000232)	2	0.8854	2.258866049	0.217478252	integumentary
Shared	HPO	Absent toe (HP:0010760)	1	0.2474	4.042037187	0.218578142	skeletal
Shared	HPO	Stroke (HP:0001297)	1	0.2514	3.977724741	0.222377762	cardiovascular
Shared	HPO	Ectopic anus (HP:0004397)	1	0.2489	4.017677782	0.222477752	digestive
Shared	HPO	Carious teeth (HP:0000670)	2	0.8842	2.26193169	0.223477652	skeletal
Shared	HPO	Ptosis (HP:0000508)	3	1.6314	1.838911364	0.225577442	skeletal muscle
Shared	HPO	Paraplegia (HP:0010550)	1	0.2688	3.720238095	0.236276372	nervous
Shared	HPO	Spastic paraplegia (HP:0001258)	1	0.2688	3.720238095	0.236276372	nervous
Shared	HPO	Impaired vibratory sensation (HP:0002495)	1	0.2728	3.66568915	0.239476052	nervous
Shared	HPO	Cerebral cortical atrophy (HP:0002120)	3	1.6822	1.783378909	0.240575942	nervous
Shared	HPO	Abnormality of the fingernails (HP:0001231)	2	0.9353	2.138351331	0.240675932	integumentary
Shared	HPO	Morphological abnormality of the pyramidal tract (HP:0002062)	1	0.2752	3.63372093	0.240875912	nervous
Shared	HPO	Autism (HP:0000717)	3	1.6961	1.768763634	0.241275872	nervous
Shared	HPO	Radial deviation of finger (HP:0009466)	4	2.5246	1.584409411	0.244075592	skeletal
Shared	HPO	Wide nasal bridge (HP:0000431)	4	2.5	1.6	0.244575542	integumentary
Shared	HPO	Stage 5 chronic kidney disease (HP:0003774)	1	0.2829	3.534817957	0.246875312	urinary
Shared	HPO	Autosomal dominant inheritance (HP:0000006)	13	10.3824	1.252118971	0.248375162	other
Shared	HPO	Palmoplantar keratoderma (HP:0000982)	2	0.9574	2.088991017	0.249575042	integumentary
Shared	HPO	Esophageal varix (HP:0002040)	1	0.2894	3.455425017	0.250174983	cardiovascular
Shared	HPO	Facial shape deformation (HP:0011334)	1	0.2949	3.390979993	0.254474553	skeletal
Shared	HPO	Potter facies (HP:0002009)	1	0.2949	3.390979993	0.254474553	other
Shared	HPO	Scrotal hypoplasia (HP:0000046)	1	0.2926	3.417634997	0.255374463	reproductive
Shared	HPO	Primary adrenal insufficiency (HP:0008207)	1	0.2934	3.408316292	0.255874413	endocrine
Shared	HPO	Urinary incontinence (HP:0000020)	1	0.2955	3.384094755	0.256474353	urinary
Shared	HPO	Duodenal stenosis (HP:0100867)	1	0.2974	3.362474781	0.257674233	digestive
Shared	HPO	Small intestinal stenosis (HP:0012848)	1	0.2974	3.362474781	0.257674233	digestive
Shared	HPO	Severe muscular hypotonia (HP:0006829)	1	0.3061	3.26690624	0.262573743	skeletal muscle
Shared	HPO	Insomnia (HP:0100785)	1	0.3063	3.264773098	0.265373463	behavior
Shared	HPO	Hip contracture (HP:0003273)	1	0.307	3.25732899	0.265873413	skeletal muscle
Shared	HPO	Renal duplication (HP:0000075)	1	0.3058	3.270111184	0.266173383	urinary
Shared	HPO	Complete atrioventricular canal defect (HP:0001674)	1	0.3078	3.248862898	0.266773323	cardiovascular
Shared	HPO	Bicuspid aortic valve (HP:0001647)	1	0.3108	3.217503218	0.266873313	cardiovascular
Shared	HPO	Gonadal dysgenesis (HP:0000133)	1	0.3101	3.224766204	0.270472953	other
Shared	HPO	Chorioretinal coloboma (HP:0000567)	1	0.3139	3.185727939	0.270772923	nervous
Shared	HPO	Furrowed tongue (HP:0000221)	1	0.3198	3.126954346	0.271672833	other
Shared	HPO	Atrioventricular canal defect (HP:0006695)	1	0.3186	3.138731952	0.274372563	cardiovascular
Shared	HPO	Overriding aorta (HP:0002623)	1	0.3186	3.138731952	0.274672533	cardiovascular
Shared	HPO	Elfin facies (HP:0004428)	1	0.3179	3.145643284	0.274972503	other
Shared	HPO	Hypercalcemia (HP:0003072)	1	0.3207	3.118178983	0.276472353	other
Shared	HPO	Flat cornea (HP:0007720)	1	0.3227	3.098853424	0.277772223	nervous
Shared	HPO	Anonychia (HP:0001798)	1	0.3236	3.090234858	0.278672133	integumentary
Shared	HPO	Osteoporosis (HP:0000939)	1	0.3304	3.026634383	0.280071993	skeletal
Shared	HPO	Bladder diverticulum (HP:0000015)	1	0.3278	3.050640635	0.282171783	urinary
Shared	HPO	Bulbous nose (HP:0000414)	1	0.3345	2.989536622	0.285571443	other
Shared	HPO	Amblyopia (HP:0000646)	1	0.3402	2.939447384	0.286771323	nervous
Shared	HPO	Hyperbilirubinemia (HP:0002904)	1	0.3421	2.923121894	0.288571143	digestive
Shared	HPO	Congestive heart failure (HP:0001635)	2	1.0608	1.885369532	0.289071093	cardiovascular
Shared	HPO	Meningitis (HP:0001287)	1	0.3375	2.962962963	0.290470953	nervous
Shared	HPO	Hyperacusis (HP:0010780)	1	0.3412	2.930832356	0.290670933	nervous
Shared	HPO	Neonatal hypotonia (HP:0001319)	1	0.3489	2.86615076	0.294270573	skeletal muscle
Shared	HPO	Abnormality of the diencephalon (HP:0010662)	1	0.3491	2.864508737	0.297370263	nervous
Shared	HPO	Posterior embryotoxon (HP:0000627)	1	0.3528	2.83446712	0.298470153	nervous
Shared	HPO	Abnormality of the gastric mucosa (HP:0004295)	1	0.358	2.793296089	0.303469653	digestive
Shared	HPO	Female pseudohermaphroditism (HP:0010458)	1	0.3572	2.799552072	0.304169583	reproductive
Shared	HPO	Spastic tetraplegia (HP:0002510)	1	0.3661	2.731494127	0.308169183	nervous
Shared	HPO	Abnormality of the line of Schwalbe (HP:0008048)	1	0.367	2.72479564	0.309269073	nervous
Shared	HPO	Heterogeneous (HP:0001425)	2	1.1205	1.784917448	0.309669033	other
Shared	HPO	Lymphedema (HP:0001004)	1	0.3739	2.674511902	0.309869013	lymphatic
Shared	HPO	Pruritus (HP:0000989)	1	0.3805	2.628120894	0.314568543	integumentary
Shared	HPO	Decreased testicular size (HP:0008734)	1	0.3782	2.644103649	0.314768523	reproductive
Shared	HPO	Subcapsular cataract (HP:0000523)	1	0.3775	2.649006623	0.315668433	nervous
Shared	HPO	Mitral regurgitation (HP:0001653)	1	0.38	2.631578947	0.317168283	cardiovascular
Shared	HPO	Bowel diverticulosis (HP:0005222)	1	0.3784	2.642706131	0.317268273	digestive
Shared	HPO	Abnormality of the carotid arteries (HP:0005344)	1	0.3797	2.633658151	0.317568243	cardiovascular
Shared	HPO	Polar cataract (HP:0010696)	1	0.3885	2.574002574	0.323367663	nervous
Shared	HPO	Ventricular septal defect (HP:0001629)	3	2.0184	1.486325803	0.325767423	cardiovascular
Shared	HPO	Aplasia/Hypoplasia of the abdominal wall musculature (HP:0010318)	1	0.3922	2.549719531	0.327167283	skeletal muscle
Shared	HPO	Hypercalciuria (HP:0002150)	1	0.3999	2.500625156	0.328167183	other
Shared	HPO	Dementia (HP:0000726)	1	0.3983	2.510670349	0.329967003	nervous
Shared	HPO	Abnormal social behavior (HP:0012433)	1	0.4006	2.496255617	0.330866913	behavior
Shared	HPO	Impaired social interactions (HP:0000735)	1	0.4006	2.496255617	0.330866913	behavior
Shared	HPO	Hyperhidrosis (HP:0000975)	1	0.4015	2.490660025	0.331766823	integumentary
Shared	HPO	Polymicrogyria (HP:0002126)	1	0.4096	2.44140625	0.335966403	nervous
Shared	HPO	Pancreatic cysts (HP:0001737)	1	0.4176	2.394636015	0.336066393	digestive
Shared	HPO	Hypodontia (HP:0000668)	1	0.4072	2.455795678	0.336866313	skeletal
Shared	HPO	Prominent forehead (HP:0011220)	1	0.4123	2.425418385	0.337566243	skeletal
Shared	HPO	Cystic liver disease (HP:0006706)	1	0.4214	2.37304224	0.338866113	digestive
Shared	HPO	Left ventricular hypertrophy (HP:0001712)	1	0.4276	2.338634238	0.346165383	cardiovascular
Shared	HPO	Type II diabetes mellitus (HP:0005978)	2	1.2344	1.62022035	0.346565343	metabolic
Shared	HPO	Hydronephrosis (HP:0000126)	1	0.4242	2.357378595	0.346665333	urinary
Shared	HPO	Megalocornea (HP:0000485)	1	0.4307	2.321801718	0.353164684	nervous
Shared	HPO	Hallux valgus (HP:0001822)	1	0.4568	2.189141856	0.369363064	skeletal
Shared	HPO	Goiter (HP:0000853)	1	0.4655	2.148227712	0.373062694	endocrine
Shared	HPO	Short philtrum (HP:0000322)	2	1.3007	1.537633582	0.373462654	integumentary
Shared	HPO	Lipoatrophy (HP:0100578)	1	0.4645	2.15285253	0.374862514	metabolic
Shared	HPO	Corneal dystrophy (HP:0001131)	1	0.4751	2.104820038	0.379562044	nervous
Shared	HPO	Deviation of the hallux (HP:0010051)	1	0.4749	2.105706465	0.379862014	skeletal
Shared	HPO	Vesicoureteral reflux (HP:0000076)	2	1.3094	1.527417138	0.383661634	urinary
Shared	HPO	Upslanted palpebral fissure (HP:0000582)	2	1.3306	1.503081317	0.384361564	integumentary
Shared	HPO	Hypoplastic toenails (HP:0001800)	1	0.4887	2.04624514	0.388761124	integumentary
Shared	HPO	Increased nuchal translucency (HP:0010880)	1	0.4952	2.019386107	0.390160984	other
Shared	HPO	Premature birth (HP:0001622)	1	0.5001	1.99960008	0.392360764	reproductive
Shared	HPO	Hypothyroidism (HP:0000821)	2	1.3575	1.473296501	0.392760724	endocrine
Shared	HPO	Arnold-Chiari malformation (HP:0002308)	1	0.5003	1.99880072	0.392760724	skeletal
Shared	HPO	Cranial hyperostosis (HP:0004437)	1	0.5049	1.980590216	0.396060394	skeletal
Shared	HPO	Pyloric stenosis (HP:0002021)	1	0.5101	1.960399922	0.399460054	digestive
Shared	HPO	Muscular dystrophy (HP:0003560)	1	0.5216	1.917177914	0.402959704	skeletal muscle
Shared	HPO	Inguinal hernia (HP:0000023)	1	0.5248	1.905487805	0.409759024	digestive
Shared	HPO	Short distal phalanx of finger (HP:0009882)	1	0.523	1.912045889	0.409759024	skeletal
Shared	HPO	Abnormality of the endocardium (HP:0004306)	1	0.5307	1.88430375	0.411858814	cardiovascular
Shared	HPO	Ovarian neoplasm (HP:0100615)	1	0.5273	1.896453632	0.412058794	reproductive
Shared	HPO	Pes cavus (HP:0001761)	1	0.5261	1.90077932	0.413158684	skeletal
Shared	HPO	Portal hypertension (HP:0001409)	1	0.5384	1.857355126	0.416158384	cardiovascular
Shared	HPO	Intestinal malrotation (HP:0002566)	1	0.5392	1.854599407	0.416658334	digestive
Shared	HPO	Atrial fibrillation (HP:0005110)	1	0.5428	1.842299189	0.418158184	cardiovascular
Shared	HPO	Limited hip movement (HP:0008800)	1	0.5447	1.835872958	0.419358064	other
Shared	HPO	Hypotelorism (HP:0000601)	1	0.5453	1.833852925	0.420457954	other
Shared	HPO	Primary atrial arrhythmia (HP:0001692)	1	0.5473	1.827151471	0.420757924	cardiovascular
Shared	HPO	Supraventricular tachycardia (HP:0004755)	1	0.5473	1.827151471	0.420757924	cardiovascular
Shared	HPO	Narrow face (HP:0000275)	1	0.5494	1.820167455	0.421957804	skeletal
Shared	HPO	Infertility (HP:0000789)	1	0.5574	1.794043775	0.425357464	reproductive
Shared	HPO	Cerebellar hypoplasia (HP:0001321)	1	0.5617	1.780309774	0.425657434	nervous
Shared	HPO	Hypoplasia of the corpus callosum (HP:0002079)	2	1.466	1.36425648	0.426057394	nervous
Shared	HPO	Abnormality of the hepatic vasculature (HP:0006707)	1	0.5635	1.774622893	0.429957004	skeletal muscle
Shared	HPO	Spina bifida occulta (HP:0003298)	1	0.5523	1.810610176	0.430656934	skeletal
Shared	HPO	Astigmatism (HP:0000483)	2	1.4667	1.363605373	0.432156784	nervous
Shared	HPO	Adducted thumb (HP:0001181)	1	0.5663	1.76584849	0.432456754	skeletal
Shared	HPO	Supraventricular arrhythmia (HP:0005115)	1	0.5686	1.758705593	0.432856714	cardiovascular
Shared	HPO	Pulmonary hypoplasia (HP:0002089)	1	0.5787	1.728011059	0.436856314	respiratory
Shared	HPO	Cryptorchidism (HP:0000028)	5	4.3357	1.15321632	0.439556044	reproductive
Shared	HPO	Renovascular hypertension (HP:0100817)	1	0.582	1.718213058	0.442955704	cardiovascular
Shared	HPO	Single transverse palmar crease (HP:0000954)	2	1.4998	1.333511135	0.443855614	integumentary
Shared	HPO	Patellar dislocation (HP:0002999)	1	0.5897	1.695777514	0.443855614	skeletal
Shared	HPO	Dysarthria (HP:0001260)	2	1.5156	1.319609396	0.445855414	nervous
Shared	HPO	Lymphoma (HP:0002665)	1	0.6049	1.653165813	0.449755024	lymphatic
Shared	HPO	External ear malformation (HP:0008572)	1	0.5997	1.667500417	0.453554645	other
Shared	HPO	Arthrogryposis multiplex congenita (HP:0002804)	1	0.6054	1.651800463	0.455554445	skeletal muscle
Shared	HPO	Nephrocalcinosis (HP:0000121)	1	0.6209	1.610565308	0.461853815	urinary
Shared	HPO	Hirsutism (HP:0001007)	1	0.6207	1.61108426	0.462453755	integumentary
Shared	HPO	Limb ataxia (HP:0002070)	1	0.6156	1.624431449	0.464753525	nervous
Shared	HPO	Cheekbone underdevelopment (HP:0010669)	1	0.6181	1.617861188	0.465753425	skeletal
Shared	HPO	Sloping forehead (HP:0000340)	1	0.6336	1.578282828	0.466653335	skeletal
Shared	HPO	Nephrolithiasis (HP:0000787)	1	0.6446	1.551349674	0.474352565	urinary
Shared	HPO	Radioulnar synostosis (HP:0002974)	1	0.6399	1.562744179	0.476352365	skeletal
Shared	HPO	Microdontia (HP:0000691)	1	0.6938	1.441337561	0.498750125	skeletal
Shared	HPO	Malar flattening (HP:0000272)	2	1.6723	1.195957663	0.499250075	skeletal
Shared	HPO	Gaze-evoked nystagmus (HP:0000640)	1	0.6933	1.442377037	0.502249775	nervous
Shared	HPO	Dysmetria (HP:0001310)	1	0.7041	1.420252805	0.504149585	nervous
Shared	HPO	Frontal bossing (HP:0002007)	2	1.7194	1.163196464	0.512248775	skeletal
Shared	HPO	Precocious puberty (HP:0000826)	1	0.7221	1.384849744	0.512448755	endocrine
Shared	HPO	Developmental regression (HP:0002376)	1	0.7168	1.395089286	0.512848715	behavior
Shared	HPO	Accelerated skeletal maturation (HP:0005616)	1	0.7214	1.386193513	0.516148385	skeletal
Shared	HPO	Pulmonic stenosis (HP:0001642)	1	0.7293	1.371177842	0.522747725	cardiovascular
Shared	HPO	Abdominal pain (HP:0002027)	1	0.7436	1.344809037	0.526947305	other
Shared	HPO	Genu valgum (HP:0002857)	1	0.7436	1.344809037	0.529647035	skeletal
Shared	HPO	Truncal obesity (HP:0001956)	1	0.7632	1.310272537	0.534746525	metabolic
Shared	HPO	Tapered finger (HP:0001182)	1	0.7721	1.29516902	0.535846415	skeletal
Shared	HPO	Oligohydramnios (HP:0001562)	1	0.7809	1.280573697	0.538646135	reproductive
Shared	HPO	Progressive disorder (HP:0003676)	1	0.78	1.282051282	0.539346065	other
Shared	HPO	Brachycephaly (HP:0000248)	1	0.8007	1.248907206	0.547845215	skeletal
Shared	HPO	Smooth philtrum (HP:0000319)	1	0.7943	1.258970162	0.549345065	integumentary
Shared	HPO	Multicystic kidney dysplasia (HP:0000003)	1	0.8092	1.235788433	0.555544446	urinary
Shared	HPO	Broad forehead (HP:0000337)	1	0.8098	1.234872808	0.560643936	skeletal
Shared	HPO	Obsessive-compulsive behavior (HP:0000722)	1	0.8281	1.207583625	0.565843416	behavior
Shared	HPO	Constipation (HP:0002019)	2	1.9205	1.04139547	0.570542946	digestive
Shared	HPO	Open mouth (HP:0000194)	1	0.8461	1.181893393	0.572742726	other
Shared	HPO	Tetralogy of Fallot (HP:0001636)	1	0.8484	1.178689298	0.574042596	cardiovascular
Shared	HPO	Tracheoesophageal fistula (HP:0002575)	1	0.8574	1.166316772	0.575442456	respiratory
Shared	HPO	Clinodactyly of the 5th finger (HP:0004209)	2	1.9232	1.039933444	0.580841916	skeletal
Shared	HPO	Recurrent urinary tract infections (HP:0000010)	1	0.8724	1.146263182	0.583241676	immune
Shared	HPO	Depressed nasal ridge (HP:0000457)	1	0.9131	1.095170299	0.593440656	skeletal
Shared	HPO	"Intellectual disability, severe (HP:0010864)"	1	0.9348	1.06974754	0.611238876	nervous
Shared	HPO	Attention deficit hyperactivity disorder (HP:0007018)	1	0.9482	1.054629825	0.613438656	behavior
Shared	HPO	Gastroesophageal reflux (HP:0002020)	1	0.9759	1.024695153	0.625337466	digestive
Shared	HPO	Pectus excavatum (HP:0000767)	1	0.972	1.028806584	0.628037196	skeletal
Shared	HPO	Brachydactyly syndrome (HP:0001156)	2	2.1425	0.933488915	0.634336566	skeletal
Shared	HPO	Camptodactyly of finger (HP:0100490)	1	1.0097	0.990393186	0.640635936	skeletal
Shared	HPO	Proteinuria (HP:0000093)	1	1.0336	0.96749226	0.650434957	other
Shared	HPO	Arthralgia (HP:0002829)	1	1.05	0.952380952	0.650834917	skeletal
Shared	HPO	Full cheeks (HP:0000293)	1	1.0509	0.951565325	0.654134587	other
Shared	HPO	Polycystic ovaries (HP:0000147)	1	1.0791	0.926698174	0.661833817	reproductive
Shared	HPO	Photophobia (HP:0000613)	1	1.0896	0.917767988	0.665633437	nervous
Shared	HPO	Microcornea (HP:0000482)	1	1.1081	0.902445628	0.668333167	nervous
Shared	HPO	Sudden cardiac death (HP:0001645)	1	1.1523	0.867829558	0.684831517	cardiovascular
Shared	HPO	Gait ataxia (HP:0002066)	1	1.2401	0.806386582	0.718328167	nervous
Shared	HPO	Opacification of the corneal stroma (HP:0007759)	1	1.3537	0.738716111	0.739926007	nervous
Shared	HPO	Dental malocclusion (HP:0000689)	1	1.3884	0.720253529	0.755024498	skeletal
Shared	HPO	Splenomegaly (HP:0001744)	1	1.452	0.688705234	0.770522948	lymphatic
Shared	HPO	Pes planus (HP:0001763)	1	1.6094	0.621349571	0.800619938	skeletal
Shared	HPO	Deeply set eye (HP:0000490)	1	1.6229	0.616180911	0.803119688	nervous
Shared	HPO	Hepatomegaly (HP:0002240)	1	1.7729	0.564047606	0.828817118	digestive
Shared	HPO	Micropenis (HP:0000054)	1	1.7894	0.558846541	0.835216478	reproductive
Shared	HPO	Infantile onset (HP:0003593)	1	2.3745	0.421141293	0.905909409	other
Vernot et al. 2016 Introgressed	GWAS	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)	2	0.0782	25.57544757	0.00309969	other
Vernot et al. 2016 Introgressed	GWAS	Serum albumin level	3	0.3692	8.12567714	0.00539946	other
Vernot et al. 2016 Introgressed	GWAS	Eosinophilic esophagitis	2	0.1226	16.3132137	0.00649935	immune
Vernot et al. 2016 Introgressed	GWAS	Hypertriglyceridemia	2	0.1363	14.67351431	0.00779922	metabolic
Vernot et al. 2016 Introgressed	GWAS	Cold medicine-related SJS/TEN with severe ocular complications	1	0.0105	95.23809524	0.01059894	other
Vernot et al. 2016 Introgressed	GWAS	Lipoprotein-associated phospholipase A2 activity and mass	1	0.0105	95.23809524	0.01059894	metabolic
Vernot et al. 2016 Introgressed	GWAS	Protein C levels	1	0.0105	95.23809524	0.01059894	other
Vernot et al. 2016 Introgressed	GWAS	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)	2	0.172	11.62790698	0.01239876	other
Vernot et al. 2016 Introgressed	GWAS	Brain imaging	2	0.1674	11.9474313	0.01429857	nervous
Vernot et al. 2016 Introgressed	GWAS	Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)	1	0.0142	70.42253521	0.01429857	immune
Vernot et al. 2016 Introgressed	GWAS	Endometrial endometrioid carcinoma	2	0.1889	10.58761249	0.01619838	reproductive
Vernot et al. 2016 Introgressed	GWAS	Ability to confide in someone	2	0.2035	9.828009828	0.01779822	behavior
Vernot et al. 2016 Introgressed	GWAS	Chemerin levels	2	0.2009	9.955201593	0.01829817	other
Vernot et al. 2016 Introgressed	GWAS	Triglycerides-Blood Pressure (TG-BP)	1	0.0204	49.01960784	0.02049795	metabolic
Vernot et al. 2016 Introgressed	GWAS	Midgestational circulating levels of PCBs	3	0.5621	5.337128625	0.02049795	reproductive
Vernot et al. 2016 Introgressed	GWAS	Branched-chain amino acid levels (Isoleucine)	1	0.0227	44.05286344	0.02269773	other
Vernot et al. 2016 Introgressed	GWAS	Creatine kinase levels	3	0.598	5.016722408	0.02269773	other
Vernot et al. 2016 Introgressed	GWAS	Glaucoma	4	1.103	3.626473255	0.02489751	nervous
Vernot et al. 2016 Introgressed	GWAS	Caffeine consumption	1	0.0256	39.0625	0.02539746	behavior
Vernot et al. 2016 Introgressed	GWAS	Carotid plaque burden (smoking interaction)	1	0.0265	37.73584906	0.02649735	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Red vs. brown/black hair color	2	0.2583	7.742934572	0.02719728	integumentary
Vernot et al. 2016 Introgressed	GWAS	Lung function (FEV1)	4	1.1258	3.553028957	0.02789721	respiratory
Vernot et al. 2016 Introgressed	GWAS	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)	1	0.032	31.25	0.03139686	immune
Vernot et al. 2016 Introgressed	GWAS	Two-hour glucose challenge	1	0.0336	29.76190476	0.03279672	metabolic
Vernot et al. 2016 Introgressed	GWAS	Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)	1	0.035	28.57142857	0.03439656	metabolic
Vernot et al. 2016 Introgressed	GWAS	C-reactive protein levels or triglyceride levels (pleiotropy)	1	0.0359	27.8551532	0.03559644	immune
Vernot et al. 2016 Introgressed	GWAS	Waist Circumference - Triglycerides (WC-TG)	1	0.0361	27.70083102	0.03589641	skeletal
Vernot et al. 2016 Introgressed	GWAS	circulating leptin levels adjusted for BMI	1	0.0382	26.17801047	0.03809619	metabolic
Vernot et al. 2016 Introgressed	GWAS	Caffeine metabolism (plasma paraxanthine caffeine ratio)	1	0.0405	24.69135802	0.03979602	metabolic
Vernot et al. 2016 Introgressed	GWAS	Low tan response	2	0.3311	6.040471157	0.0409959	integumentary
Vernot et al. 2016 Introgressed	GWAS	Feeling worry	3	0.7544	3.976670201	0.04269573	behavior
Vernot et al. 2016 Introgressed	GWAS	Metabolic syndrome (multivariate analysis)	1	0.0439	22.77904328	0.04319568	metabolic
Vernot et al. 2016 Introgressed	GWAS	Response to fenofibrate	2	0.3195	6.259780908	0.04329567	other
Vernot et al. 2016 Introgressed	GWAS	Alcohol consumption in current drinkers	1	0.0461	21.69197397	0.04539546	behavior
Vernot et al. 2016 Introgressed	GWAS	Serum alkaline phosphatase levels	2	0.3342	5.984440455	0.04579542	other
Vernot et al. 2016 Introgressed	GWAS	Paget's disease	1	0.0476	21.00840336	0.04639536	skeletal
Vernot et al. 2016 Introgressed	GWAS	Asthma and hay fever	2	0.3513	5.693139767	0.0489951	respiratory
Vernot et al. 2016 Introgressed	GWAS	Glycemic traits (pregnancy)	1	0.0507	19.72386588	0.04979502	metabolic
Vernot et al. 2016 Introgressed	GWAS	Sphingolipid levels	1	0.0505	19.8019802	0.04989501	metabolic
Vernot et al. 2016 Introgressed	GWAS	Systemic sclerosis (anti-topoisomerase-positive)	1	0.0551	18.14882033	0.053494651	other
Vernot et al. 2016 Introgressed	GWAS	Lipid traits	2	0.3828	5.224660397	0.055494451	metabolic
Vernot et al. 2016 Introgressed	GWAS	Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	2	0.3828	5.224660397	0.057894211	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	circulating leptin levels	1	0.0636	15.72327044	0.062193781	metabolic
Vernot et al. 2016 Introgressed	GWAS	White blood cell count (monocyte)	1	0.0661	15.12859304	0.063793621	immune
Vernot et al. 2016 Introgressed	GWAS	Periodontitis (DPAL)	2	0.4164	4.803073967	0.065393461	immune
Vernot et al. 2016 Introgressed	GWAS	P wave terminal force	1	0.0695	14.38848921	0.067293271	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Helicobacter pylori serologic status	1	0.0701	14.26533524	0.067993201	immune
Vernot et al. 2016 Introgressed	GWAS	Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)	3	0.955	3.141361257	0.073092691	other
Vernot et al. 2016 Introgressed	GWAS	Response to taxane treatment (placlitaxel)	1	0.0768	13.02083333	0.073592641	other
Vernot et al. 2016 Introgressed	GWAS	Mean arterial pressure	4	1.5437	2.591177042	0.073692631	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Pulse pressure x alcohol consumption interaction (2df test)	3	0.9671	3.102057698	0.074392561	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Response to treatment for acute lymphoblastic leukemia	3	1.0059	2.982403817	0.080891911	other
Vernot et al. 2016 Introgressed	GWAS	Myasthenia gravis	1	0.0845	11.83431953	0.081091891	skeletal muscle
Vernot et al. 2016 Introgressed	GWAS	Lipid metabolism phenotypes	1	0.0855	11.69590643	0.081691831	metabolic
Vernot et al. 2016 Introgressed	GWAS	Coronary atherosclerosis (increased number of diseased vessels) (traffic exposure interaction)	1	0.086	11.62790698	0.082591741	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Alzheimer's disease (age of onset)	1	0.0881	11.3507378	0.084091591	nervous
Vernot et al. 2016 Introgressed	GWAS	Alcohol use disorder (consumption score)	1	0.0885	11.29943503	0.084391561	behavior
Vernot et al. 2016 Introgressed	GWAS	Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid)	1	0.0947	10.55966209	0.090390961	other
Vernot et al. 2016 Introgressed	GWAS	Sjogren's syndrome	3	1.0566	2.839295855	0.091290871	immune
Vernot et al. 2016 Introgressed	GWAS	Palmitic acid (16:0) levels	2	0.4955	4.036326942	0.091590841	other
Vernot et al. 2016 Introgressed	GWAS	Urate levels (BMI interaction)	2	0.5043	3.965893317	0.093290671	metabolic
Vernot et al. 2016 Introgressed	GWAS	Asthma (bronchodilator response)	1	0.1003	9.970089731	0.094690531	respiratory
Vernot et al. 2016 Introgressed	GWAS	Cerebrospinal AB1-42 levels in normal cognition	3	1.0805	2.776492365	0.095590441	nervous
Vernot et al. 2016 Introgressed	GWAS	Mean arterial pressure x alcohol consumption interaction (2df test)	3	1.0921	2.74700119	0.097190281	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test)	2	0.5231	3.823360734	0.098590141	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Alcohol use disorder (total score)	1	0.1024	9.765625	0.098690131	behavior
Vernot et al. 2016 Introgressed	GWAS	Waist-to-hip ratio adjusted for body mass index	5	2.4217	2.064665318	0.099090091	skeletal
Vernot et al. 2016 Introgressed	GWAS	Pancreatic ductal adenocarcinoma	1	0.1043	9.587727709	0.099090091	endocrine
Vernot et al. 2016 Introgressed	GWAS	GIP levels in response to oral glucose tolerance test (120 minutes)	1	0.1047	9.551098376	0.100089991	metabolic
Vernot et al. 2016 Introgressed	GWAS	Chronic inflammatory diseases (pleiotropy)	4	1.7597	2.273114735	0.100989901	immune
Vernot et al. 2016 Introgressed	GWAS	Upper eyelid sagging severity	3	1.0961	2.736976553	0.102089791	integumentary
Vernot et al. 2016 Introgressed	GWAS	Granulocyte percentage of myeloid white cells	4	1.7558	2.2781638	0.103889611	immune
Vernot et al. 2016 Introgressed	GWAS	Sex hormone-binding globulin levels	1	0.1092	9.157509158	0.104089591	endocrine
Vernot et al. 2016 Introgressed	GWAS	Preterm birth (maternal effect)	1	0.1146	8.72600349	0.108489151	reproductive
Vernot et al. 2016 Introgressed	GWAS	Emphysema distribution in smoking	1	0.1176	8.503401361	0.110588941	respiratory
Vernot et al. 2016 Introgressed	GWAS	Palmitoleic acid (16:1n-7) levels	1	0.1237	8.084074373	0.115988401	other
Vernot et al. 2016 Introgressed	GWAS	Carotid atherosclerosis in HIV infection	2	0.5912	3.382949932	0.117288271	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Age at first birth	2	0.5825	3.433476395	0.118588141	reproductive
Vernot et al. 2016 Introgressed	GWAS	C-reactive protein	1	0.1265	7.90513834	0.120287971	immune
Vernot et al. 2016 Introgressed	GWAS	Spontaneous preterm birth (preterm birth)	1	0.1338	7.473841555	0.123587641	reproductive
Vernot et al. 2016 Introgressed	GWAS	Pediatric autoimmune diseases	2	0.623	3.210272873	0.125387461	immune
Vernot et al. 2016 Introgressed	GWAS	Breast cancer (estrogen-receptor negative)	2	0.6265	3.192338388	0.126687331	reproductive
Vernot et al. 2016 Introgressed	GWAS	Cardiovascular disease risk factors	1	0.1372	7.288629738	0.127987201	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Response to hepatitis B vaccine	1	0.1447	6.910850035	0.135486451	other
Vernot et al. 2016 Introgressed	GWAS	Sexual dimorphism in anthropometric traits	1	0.1468	6.811989101	0.137086291	skeletal
Vernot et al. 2016 Introgressed	GWAS	Diastolic blood pressure night-to-day ratio in hypertension	1	0.1506	6.640106242	0.139986001	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Fasting blood insulin (BMI interaction)	2	0.6581	3.039051816	0.141885811	metabolic
Vernot et al. 2016 Introgressed	GWAS	Attention deficit hyperactivity disorder and conduct disorder	2	0.6615	3.023431595	0.142985701	behavior
Vernot et al. 2016 Introgressed	GWAS	Alcohol consumption	3	1.3111	2.288154984	0.143585641	behavior
Vernot et al. 2016 Introgressed	GWAS	Coffee consumption (cups per day)	1	0.1558	6.418485237	0.144385561	behavior
Vernot et al. 2016 Introgressed	GWAS	Nonalcoholic fatty liver disease	1	0.1555	6.430868167	0.145485451	digestive
Vernot et al. 2016 Introgressed	GWAS	Red blood cell density in sickle cell anemia	1	0.155	6.451612903	0.145585441	hematologic
Vernot et al. 2016 Introgressed	GWAS	Birdshot chorioretinopathy	1	0.157	6.369426752	0.147185281	immune
Vernot et al. 2016 Introgressed	GWAS	Hearing function	1	0.1586	6.30517024	0.148385161	nervous
Vernot et al. 2016 Introgressed	GWAS	Suicide risk	1	0.1654	6.045949214	0.152384762	behavior
Vernot et al. 2016 Introgressed	GWAS	Crohn's disease (time to surgery)	1	0.1641	6.093845216	0.152784722	immune
Vernot et al. 2016 Introgressed	GWAS	Urinary metabolite concentrations in chronic kidney disease	2	0.6988	2.862049227	0.155184482	metabolic
Vernot et al. 2016 Introgressed	GWAS	Serum sulfate level	1	0.1727	5.790387956	0.158784122	other
Vernot et al. 2016 Introgressed	GWAS	Dermatomyositis	1	0.1827	5.473453749	0.168483152	integumentary
Vernot et al. 2016 Introgressed	GWAS	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis	1	0.1876	5.330490405	0.170682932	other
Vernot et al. 2016 Introgressed	GWAS	Response to antidepressants	1	0.1898	5.268703899	0.172182782	other
Vernot et al. 2016 Introgressed	GWAS	Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)	1	0.1875	5.333333333	0.173082692	other
Vernot et al. 2016 Introgressed	GWAS	Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction)	1	0.1892	5.285412262	0.173782622	nervous
Vernot et al. 2016 Introgressed	GWAS	Renal overload gout	1	0.1924	5.197505198	0.178482152	urinary
Vernot et al. 2016 Introgressed	GWAS	Renal underexcretion gout	1	0.1924	5.197505198	0.178482152	urinary
Vernot et al. 2016 Introgressed	GWAS	Systolic blood pressure x alcohol consumption interaction (2df test)	4	2.1956	1.821825469	0.178782122	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Weight loss (gastric bypass surgery)	1	0.1993	5.017561465	0.181581842	skeletal
Vernot et al. 2016 Introgressed	GWAS	Wegener's granulomatosis	1	0.2006	4.985044865	0.182281772	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	IgE grass sensitization	1	0.2015	4.962779156	0.183181682	immune
Vernot et al. 2016 Introgressed	GWAS	Resistin levels	1	0.2016	4.96031746	0.183381662	other
Vernot et al. 2016 Introgressed	GWAS	Allergic rhinitis	4	2.2049	1.814141231	0.183481652	immune
Vernot et al. 2016 Introgressed	GWAS	Asthma exacerbations in inhaled corticosteroid treatment	2	0.7881	2.537749017	0.185181482	respiratory
Vernot et al. 2016 Introgressed	GWAS	Bone mineral density	4	2.2451	1.781657833	0.187581242	skeletal
Vernot et al. 2016 Introgressed	GWAS	Serum 25-Hydroxyvitamin D levels	1	0.2054	4.868549172	0.187881212	other
Vernot et al. 2016 Introgressed	GWAS	Advanced age-related macular degeneration	3	1.4845	2.020882452	0.189881012	nervous
Vernot et al. 2016 Introgressed	GWAS	Chronic lymphocytic leukemia	2	0.7962	2.511931675	0.190680932	lymphatic
Vernot et al. 2016 Introgressed	GWAS	Response to antineoplastic agents	1	0.2099	4.764173416	0.191080892	other
Vernot et al. 2016 Introgressed	GWAS	Glaucoma (primary angle closure)	1	0.214	4.672897196	0.193380662	nervous
Vernot et al. 2016 Introgressed	GWAS	Metabolite levels (lipoprotein measures)	1	0.217	4.608294931	0.194280572	metabolic
Vernot et al. 2016 Introgressed	GWAS	Response to quetiapine in schizophrenia	1	0.2179	4.589261129	0.194680532	other
Vernot et al. 2016 Introgressed	GWAS	Staphylococcus aureus nasal carriage (persistent)	1	0.2171	4.606172271	0.196580342	immune
Vernot et al. 2016 Introgressed	GWAS	Mean platelet volume	8	5.5838	1.432716071	0.198080192	hematologic
Vernot et al. 2016 Introgressed	GWAS	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)	2	0.8139	2.457304337	0.199280072	other
Vernot et al. 2016 Introgressed	GWAS	Neonatal lupus	1	0.2219	4.506534475	0.199880012	immune
Vernot et al. 2016 Introgressed	GWAS	Response to fenofibrate (triglyceride levels)	3	1.5414	1.9462826	0.201379862	other
Vernot et al. 2016 Introgressed	GWAS	Aspartate aminotransferase levels	2	0.8251	2.423948612	0.202479752	other
Vernot et al. 2016 Introgressed	GWAS	Breast Cancer in BRCA1 mutation carriers	1	0.2267	4.411116012	0.204379562	reproductive
Vernot et al. 2016 Introgressed	GWAS	Hair shape	1	0.2286	4.374453193	0.205379462	integumentary
Vernot et al. 2016 Introgressed	GWAS	Bone mineral density (Ward's triangle area)	3	1.5813	1.897173212	0.209379062	skeletal
Vernot et al. 2016 Introgressed	GWAS	Initial pursuit acceleration in psychotic disorders	1	0.241	4.149377593	0.211478852	nervous
Vernot et al. 2016 Introgressed	GWAS	Acne (severe)	4	2.3647	1.691546496	0.212178782	integumentary
Vernot et al. 2016 Introgressed	GWAS	Tooth agenesis	1	0.2395	4.175365344	0.214178582	skeletal
Vernot et al. 2016 Introgressed	GWAS	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 (Grade 3 peripheral neuropathy)	1	0.2436	4.105090312	0.215178482	other
Vernot et al. 2016 Introgressed	GWAS	Hair color	2	0.8729	2.291213197	0.216878312	integumentary
Vernot et al. 2016 Introgressed	GWAS	Autism spectrum disorder or schizophrenia	9	6.5793	1.367926679	0.217278272	behavior
Vernot et al. 2016 Introgressed	GWAS	Extremely high intelligence	3	1.6041	1.870207593	0.217578242	other
Vernot et al. 2016 Introgressed	GWAS	Weight	1	0.2402	4.163197336	0.217778222	skeletal
Vernot et al. 2016 Introgressed	GWAS	Soluble interleukin-2 receptor subunit alpha	1	0.2531	3.951007507	0.223477652	immune
Vernot et al. 2016 Introgressed	GWAS	"Cholesterol, total"	2	0.9121	2.192742024	0.231776822	metabolic
Vernot et al. 2016 Introgressed	GWAS	Glomerular filtration rate in non diabetics (creatinine)	2	0.9038	2.212878956	0.231876812	hematologic
Vernot et al. 2016 Introgressed	GWAS	Nonsyndromic cleft lip with or without cleft palate	1	0.2609	3.832886163	0.232076792	other
Vernot et al. 2016 Introgressed	GWAS	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	2	0.9108	2.195871761	0.232276772	immune
Vernot et al. 2016 Introgressed	GWAS	Systolic blood pressure change trajectories	1	0.2709	3.69139904	0.235876412	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Endometrial cancer (endometrioid histology)	2	0.9276	2.156101768	0.236376362	reproductive
Vernot et al. 2016 Introgressed	GWAS	Response to selective serotonin reuptake inhibitors and depression	1	0.2694	3.711952487	0.237176282	other
Vernot et al. 2016 Introgressed	GWAS	Multiple myeloma and monoclonal gammopathy	1	0.2693	3.713330858	0.237276272	immune
Vernot et al. 2016 Introgressed	GWAS	Lactate dehydrogenase levels	1	0.2703	3.699593045	0.238076192	metabolic
Vernot et al. 2016 Introgressed	GWAS	Bone mineral density (spine)	2	0.9283	2.154475924	0.238176182	skeletal
Vernot et al. 2016 Introgressed	GWAS	Ossification of the posterior longitudinal ligament of the spine	1	0.274	3.649635036	0.238776122	skeletal
Vernot et al. 2016 Introgressed	GWAS	Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)	1	0.2721	3.675119441	0.238776122	endocrine
Vernot et al. 2016 Introgressed	GWAS	Selective IgA deficiency	2	0.9443	2.117970984	0.239976002	immune
Vernot et al. 2016 Introgressed	GWAS	Cerebrospinal fluid t-tau levels	1	0.2735	3.65630713	0.241575842	nervous
Vernot et al. 2016 Introgressed	GWAS	Obsessive-compulsive symptoms	2	0.9422	2.122691573	0.243775622	behavior
Vernot et al. 2016 Introgressed	GWAS	Social communication problems	2	0.959	2.085505735	0.244575542	behavior
Vernot et al. 2016 Introgressed	GWAS	N-glycan levels	1	0.2826	3.538570418	0.245175482	endocrine
Vernot et al. 2016 Introgressed	GWAS	Metabolite levels (small molecules and protein measures)	1	0.2827	3.537318712	0.246475352	metabolic
Vernot et al. 2016 Introgressed	GWAS	Response to n-3 LC-PUFA supplementation (change in triglyceride levels)	2	0.9517	2.101502574	0.246775322	other
Vernot et al. 2016 Introgressed	GWAS	Dialysis-related mortality	2	0.9737	2.054020746	0.252374763	other
Vernot et al. 2016 Introgressed	GWAS	Papillary thyroid cancer	2	0.9801	2.040608101	0.254074593	endocrine
Vernot et al. 2016 Introgressed	GWAS	Differentiated thyroid cancer	2	0.9801	2.040608101	0.254074593	endocrine
Vernot et al. 2016 Introgressed	GWAS	Triglycerides	3	1.7592	1.7053206	0.257174283	metabolic
Vernot et al. 2016 Introgressed	GWAS	Lung cancer (smoking interaction)	1	0.3017	3.314550878	0.259974003	respiratory
Vernot et al. 2016 Introgressed	GWAS	Plasma amyloid beta peptide concentrations (ABx-42)	1	0.2992	3.342245989	0.260873913	nervous
Vernot et al. 2016 Introgressed	GWAS	Infant length	1	0.3001	3.332222592	0.261373863	skeletal
Vernot et al. 2016 Introgressed	GWAS	Response to fenofibrate (LDL cholesterol levels)	1	0.3048	3.280839895	0.262673733	other
Vernot et al. 2016 Introgressed	GWAS	"Allergic disease (asthma, hay fever or eczema)"	5	3.4441	1.451758079	0.263273673	immune
Vernot et al. 2016 Introgressed	GWAS	Liver enzyme levels (gamma-glutamyl transferase)	2	0.9898	2.020610224	0.263373663	other
Vernot et al. 2016 Introgressed	GWAS	"Bone mineral density (paediatric, skull)"	1	0.3075	3.25203252	0.265073493	skeletal
Vernot et al. 2016 Introgressed	GWAS	Gallstone disease	1	0.3139	3.185727939	0.267473253	digestive
Vernot et al. 2016 Introgressed	GWAS	vWF and FVIII levels	1	0.3118	3.207184092	0.269673033	hematologic
Vernot et al. 2016 Introgressed	GWAS	Seborrheic dermatitis	1	0.3154	3.170577045	0.269773023	integumentary
Vernot et al. 2016 Introgressed	GWAS	Fibrinogen	1	0.3163	3.161555485	0.272172783	hematologic
Vernot et al. 2016 Introgressed	GWAS	Osteoarthritis	1	0.3215	3.110419907	0.272572743	skeletal
Vernot et al. 2016 Introgressed	GWAS	Hair morphology	1	0.3208	3.117206983	0.272772723	integumentary
Vernot et al. 2016 Introgressed	GWAS	Chronic myeloid leukemia	1	0.3182	3.142677561	0.274372563	lymphatic
Vernot et al. 2016 Introgressed	GWAS	Phospholipid levels (plasma)	3	1.8176	1.650528169	0.274672533	metabolic
Vernot et al. 2016 Introgressed	GWAS	Primary biliary cholangitis	2	1.0227	1.955607705	0.277072293	digestive
Vernot et al. 2016 Introgressed	GWAS	Uric acid levels	2	1.0362	1.930129319	0.277672233	metabolic
Vernot et al. 2016 Introgressed	GWAS	Homocysteine levels	1	0.3278	3.050640635	0.279072093	other
Vernot et al. 2016 Introgressed	GWAS	Blood metabolite ratios	1	0.3249	3.077870114	0.280771923	metabolic
Vernot et al. 2016 Introgressed	GWAS	Hemoglobin A1c levels	1	0.3345	2.989536622	0.284771523	hematologic
Vernot et al. 2016 Introgressed	GWAS	Cerebrospinal fluid t-tau levels in normal cognition	1	0.3394	2.946375958	0.286771323	nervous
Vernot et al. 2016 Introgressed	GWAS	Bone properties (heel)	1	0.3392	2.948113208	0.288471153	skeletal
Vernot et al. 2016 Introgressed	GWAS	Anxiety in major depressive disorder	1	0.3381	2.957704821	0.288571143	behavior
Vernot et al. 2016 Introgressed	GWAS	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	1	0.3413	2.92997363	0.288671133	other
Vernot et al. 2016 Introgressed	GWAS	Cerebrospinal fluid p-tau levels in mild cognitive impairment	1	0.3415	2.928257687	0.289671033	nervous
Vernot et al. 2016 Introgressed	GWAS	Multiple sclerosis (severity)	1	0.3499	2.857959417	0.291070893	nervous
Vernot et al. 2016 Introgressed	GWAS	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes	3	1.8886	1.588478238	0.292970703	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Pyoderma gangrenosum in inflammatory bowel disease	1	0.3491	2.864508737	0.294070593	digestive
Vernot et al. 2016 Introgressed	GWAS	Tanning	1	0.3518	2.842524161	0.295870413	integumentary
Vernot et al. 2016 Introgressed	GWAS	Metabolic traits	1	0.3526	2.836074872	0.297670233	metabolic
Vernot et al. 2016 Introgressed	GWAS	Optic nerve measurement (cup area)	1	0.3565	2.805049088	0.301969803	nervous
Vernot et al. 2016 Introgressed	GWAS	C-reactive protein levels or LDL-cholesterol levels (pleiotropy)	1	0.3598	2.779321845	0.303669633	immune
Vernot et al. 2016 Introgressed	GWAS	C-reactive protein levels or total cholesterol levels (pleiotropy)	1	0.366	2.732240437	0.308269173	immune
Vernot et al. 2016 Introgressed	GWAS	JT interval (sulfonylurea treatment interaction)	3	1.9341	1.551109043	0.309469053	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Economic and political preferences (time)	1	0.3748	2.668089648	0.310668933	other
Vernot et al. 2016 Introgressed	GWAS	Hematological and biochemical traits	1	0.3794	2.635740643	0.311068893	hematologic
Vernot et al. 2016 Introgressed	GWAS	Monocyte percentage of white cells	3	1.9658	1.526096246	0.311668833	immune
Vernot et al. 2016 Introgressed	GWAS	Total ventricular volume	2	1.1398	1.754693806	0.312768723	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Prostate cancer	5	3.69	1.35501355	0.313268673	reproductive
Vernot et al. 2016 Introgressed	GWAS	Vitiligo	3	1.9631	1.528195201	0.316068393	integumentary
Vernot et al. 2016 Introgressed	GWAS	Stroke (ischemic)	1	0.3828	2.612330199	0.317768223	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Cerebrospinal fluid t-tau levels in Alzheimer's disease dementia	1	0.3821	2.617115938	0.318168183	nervous
Vernot et al. 2016 Introgressed	GWAS	Urinary albumin excretion (no hypertensive medication)	1	0.397	2.518891688	0.328467153	metabolic
Vernot et al. 2016 Introgressed	GWAS	Prothrombin time	1	0.4009	2.494387628	0.328567143	hematologic
Vernot et al. 2016 Introgressed	GWAS	Anticoagulant levels	1	0.4034	2.478929103	0.329267073	hematologic
Vernot et al. 2016 Introgressed	GWAS	Waist circumference adjusted for BMI in non-smokers	3	2.0301	1.477759716	0.331066893	skeletal
Vernot et al. 2016 Introgressed	GWAS	LDL cholesterol levels	1	0.4123	2.425418385	0.334366563	metabolic
Vernot et al. 2016 Introgressed	GWAS	Bone ultrasound measurement (broadband ultrasound attenuation)	1	0.4066	2.459419577	0.336166383	skeletal
Vernot et al. 2016 Introgressed	GWAS	Angiotensin-converting enzyme inhibitor intolerance	3	2.05	1.463414634	0.336966303	other
Vernot et al. 2016 Introgressed	GWAS	Methadone dose in opioid dependence	5	3.8278	1.306233346	0.338666133	other
Vernot et al. 2016 Introgressed	GWAS	Allergy	1	0.4176	2.394636015	0.341465853	immune
Vernot et al. 2016 Introgressed	GWAS	Lower body strength	1	0.4181	2.391772303	0.341765823	skeletal muscle
Vernot et al. 2016 Introgressed	GWAS	Fat distribution (HIV)	1	0.4202	2.379819134	0.341765823	metabolic
Vernot et al. 2016 Introgressed	GWAS	Left ventricular obstructive tract defect (maternal effect)	1	0.4169	2.398656752	0.341965803	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	PR interval in Tripanosoma cruzi seropositivity	1	0.4209	2.37586125	0.342265773	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	White matter integrity	1	0.4195	2.383790226	0.343765623	nervous
Vernot et al. 2016 Introgressed	GWAS	Glucocorticoid-induced osteonecrosis (age 10 years and older)	1	0.4179	2.392916966	0.344065593	other
Vernot et al. 2016 Introgressed	GWAS	Fasting blood insulin	1	0.4273	2.340276153	0.348865113	metabolic
Vernot et al. 2016 Introgressed	GWAS	Cancer (pleiotropy)	1	0.427	2.341920375	0.348965103	other
Vernot et al. 2016 Introgressed	GWAS	Change in glucose in response to thiazide diuretic treatment in hypertension	1	0.4347	2.300437083	0.352464754	other
Vernot et al. 2016 Introgressed	GWAS	Electroencephalogram traits	1	0.4369	2.288853285	0.355364464	nervous
Vernot et al. 2016 Introgressed	GWAS	Diverticular disease	6	4.8459	1.238160094	0.356064394	digestive
Vernot et al. 2016 Introgressed	GWAS	Cardiac Troponin-T levels	1	0.4436	2.254283138	0.357364264	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	1	0.447	2.237136465	0.360863914	metabolic
Vernot et al. 2016 Introgressed	GWAS	Urate levels in obese individuals	3	2.1525	1.393728223	0.363263674	metabolic
Vernot et al. 2016 Introgressed	GWAS	Preeclampsia	1	0.4546	2.199736032	0.364663534	reproductive
Vernot et al. 2016 Introgressed	GWAS	PR interval	3	2.1695	1.382807098	0.365163484	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	LDL cholesterol	2	1.2812	1.561036528	0.366463354	metabolic
Vernot et al. 2016 Introgressed	GWAS	Thyroid cancer	1	0.461	2.169197397	0.367963204	endocrine
Vernot et al. 2016 Introgressed	GWAS	Intraocular pressure	11	9.6256	1.142785904	0.368063194	nervous
Vernot et al. 2016 Introgressed	GWAS	Proteinuria and chronic kidney disease	1	0.4649	2.151000215	0.370162984	urinary
Vernot et al. 2016 Introgressed	GWAS	Stearic acid (18:0) levels	1	0.4688	2.133105802	0.371862814	other
Vernot et al. 2016 Introgressed	GWAS	Brain structure	1	0.4651	2.150075253	0.373862614	nervous
Vernot et al. 2016 Introgressed	GWAS	Coffee consumption	1	0.4698	2.128565347	0.374662534	behavior
Vernot et al. 2016 Introgressed	GWAS	Red cell distribution width	4	3.1001	1.290280959	0.376362364	hematologic
Vernot et al. 2016 Introgressed	GWAS	Worry too long after an embarrassing experience	1	0.4687	2.133560913	0.376562344	behavior
Vernot et al. 2016 Introgressed	GWAS	Femoral neck bone mineral density	2	1.3286	1.505343971	0.380761924	skeletal
Vernot et al. 2016 Introgressed	GWAS	Allergic sensitization	1	0.4749	2.105706465	0.380961904	immune
Vernot et al. 2016 Introgressed	GWAS	Large artery stroke	1	0.4784	2.090301003	0.381161884	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Cortical amyloid beta load	1	0.4863	2.056343821	0.381761824	nervous
Vernot et al. 2016 Introgressed	GWAS	Cerebrospinal T-tau levels	1	0.4769	2.096875655	0.382861714	nervous
Vernot et al. 2016 Introgressed	GWAS	Ulcerative colitis	5	4.0558	1.232802406	0.384061594	digestive
Vernot et al. 2016 Introgressed	GWAS	Hemoglobin	1	0.4904	2.039151713	0.387161284	hematologic
Vernot et al. 2016 Introgressed	GWAS	Proteinuria in chronic kidney disease	1	0.4969	2.01247736	0.387761224	urinary
Vernot et al. 2016 Introgressed	GWAS	Inflammatory bowel disease	8	6.9278	1.154767747	0.391860814	digestive
Vernot et al. 2016 Introgressed	GWAS	Chromium levels	1	0.5082	1.96772924	0.395260474	other
Vernot et al. 2016 Introgressed	GWAS	Self-reported allergy	1	0.503	1.988071571	0.396560344	immune
Vernot et al. 2016 Introgressed	GWAS	Eyebrow thickness	1	0.5053	1.979022363	0.397960204	integumentary
Vernot et al. 2016 Introgressed	GWAS	Feeling nervous	2	1.3746	1.454968718	0.399060094	behavior
Vernot et al. 2016 Introgressed	GWAS	Regular attendance at a gym or sports club	1	0.5176	1.931993818	0.399660034	behavior
Vernot et al. 2016 Introgressed	GWAS	Hip minimal joint space width	1	0.5183	1.929384526	0.401559844	skeletal
Vernot et al. 2016 Introgressed	GWAS	Type 2 diabetes (age of onset)	2	1.3872	1.441753172	0.402359764	metabolic
Vernot et al. 2016 Introgressed	GWAS	Graves' disease	1	0.5205	1.921229587	0.404959504	endocrine
Vernot et al. 2016 Introgressed	GWAS	High light scatter reticulocyte percentage of red cells	3	2.3059	1.301010451	0.406059394	metabolic
Vernot et al. 2016 Introgressed	GWAS	Fibrinogen levels	1	0.5186	1.928268415	0.407459254	hematologic
Vernot et al. 2016 Introgressed	GWAS	Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)	3	2.3137	1.296624454	0.408059194	skeletal
Vernot et al. 2016 Introgressed	GWAS	Mortality in sepsis	1	0.5244	1.906941266	0.409159084	other
Vernot et al. 2016 Introgressed	GWAS	Parkinson's disease	5	4.2065	1.188636634	0.409259074	nervous
Vernot et al. 2016 Introgressed	GWAS	Diastolic blood pressure x alcohol consumption interaction (2df test)	2	1.4142	1.414227125	0.410758924	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Generalized epilepsy	1	0.5294	1.888930865	0.411158884	nervous
Vernot et al. 2016 Introgressed	GWAS	Eating disorders	2	1.4181	1.410337776	0.412358764	behavior
Vernot et al. 2016 Introgressed	GWAS	Non-glioblastoma glioma	1	0.5252	1.904036558	0.412358764	nervous
Vernot et al. 2016 Introgressed	GWAS	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)	2	1.4063	1.422171656	0.412758724	skeletal
Vernot et al. 2016 Introgressed	GWAS	Blood protein levels	21	19.7476	1.063420365	0.413558644	other
Vernot et al. 2016 Introgressed	GWAS	Protein quantitative trait loci	4	3.2844	1.217878456	0.416258374	other
Vernot et al. 2016 Introgressed	GWAS	Inflammatory biomarkers	1	0.5399	1.852194851	0.416358364	immune
Vernot et al. 2016 Introgressed	GWAS	Urate levels in overweight individuals	3	2.3591	1.2716714	0.419458054	metabolic
Vernot et al. 2016 Introgressed	GWAS	Temperament	1	0.5541	1.804728388	0.420557944	behavior
Vernot et al. 2016 Introgressed	GWAS	Scalp hair shape	1	0.5519	1.81192245	0.428457154	integumentary
Vernot et al. 2016 Introgressed	GWAS	Itch intensity from mosquito bite adjusted by bite size	5	4.3214	1.157032443	0.433256674	immune
Vernot et al. 2016 Introgressed	GWAS	Squamous cell lung carcinoma	3	2.4336	1.232741617	0.435356464	respiratory
Vernot et al. 2016 Introgressed	GWAS	Fasting blood glucose (BMI interaction)	1	0.5672	1.763046544	0.435556444	metabolic
Vernot et al. 2016 Introgressed	GWAS	Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)	1	0.5695	1.755926251	0.436056394	skeletal
Vernot et al. 2016 Introgressed	GWAS	Influenza A (H1N1) severity	1	0.5721	1.747946163	0.436356364	immune
Vernot et al. 2016 Introgressed	GWAS	middle facial morphology traits (quantitative measurement)	1	0.5807	1.722059583	0.437556244	skeletal
Vernot et al. 2016 Introgressed	GWAS	facial morphology traits (multivariate analysis)	1	0.5848	1.70998632	0.440555944	skeletal
Vernot et al. 2016 Introgressed	GWAS	Response to cognitive-behavioural therapy in anxiety disorder	1	0.5815	1.719690456	0.441755824	other
Vernot et al. 2016 Introgressed	GWAS	Glycated hemoglobin levels	2	1.5017	1.331823933	0.443255674	metabolic
Vernot et al. 2016 Introgressed	GWAS	Response to antipsychotic treatment in schizophrenia (working memory)	1	0.5873	1.702707305	0.443655634	other
Vernot et al. 2016 Introgressed	GWAS	Serum metabolite levels	1	0.5827	1.716148962	0.444355564	metabolic
Vernot et al. 2016 Introgressed	GWAS	Bone mineral density (hip)	3	2.4654	1.216841081	0.445055494	skeletal
Vernot et al. 2016 Introgressed	GWAS	Asthma (childhood onset)	2	1.4978	1.335291761	0.445955404	respiratory
Vernot et al. 2016 Introgressed	GWAS	"Coronary artery disease (myocardial infarction, PTCA, CABG, angina or CIHD)"	2	1.5222	1.313887794	0.446455354	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Waist circumference adjusted for BMI (adjusted for smoking behaviour)	3	2.4682	1.21546066	0.449455054	skeletal
Vernot et al. 2016 Introgressed	GWAS	Perceived unattractiveness to mosquitoes	1	0.596	1.677852349	0.452354765	other
Vernot et al. 2016 Introgressed	GWAS	Corneal astigmatism	3	2.5143	1.193175039	0.453754625	nervous
Vernot et al. 2016 Introgressed	GWAS	Metabolic syndrome	1	0.5973	1.674200569	0.456954305	metabolic
Vernot et al. 2016 Introgressed	GWAS	Metabolite levels (HVA/5-HIAA ratio)	1	0.618	1.618122977	0.460153985	metabolic
Vernot et al. 2016 Introgressed	GWAS	Midgestational circulating levels of PBDEs	1	0.6198	1.613423685	0.460553945	reproductive
Vernot et al. 2016 Introgressed	GWAS	Coronary heart disease	1	0.61	1.639344262	0.461153885	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Alcohol consumption (maxi-drinks)	1	0.6127	1.632120124	0.462553745	behavior
Vernot et al. 2016 Introgressed	GWAS	C-reactive protein levels	1	0.618	1.618122977	0.462853715	immune
Vernot et al. 2016 Introgressed	GWAS	Amyotrophic lateral sclerosis (age of onset)	2	1.5701	1.273804216	0.463353665	nervous
Vernot et al. 2016 Introgressed	GWAS	Endometrial cancer	2	1.5651	1.277873618	0.463353665	reproductive
Vernot et al. 2016 Introgressed	GWAS	Waist-to-hip ratio adjusted for BMI	3	2.5157	1.192511031	0.463553645	skeletal
Vernot et al. 2016 Introgressed	GWAS	Loneliness (multivariate analysis)	2	1.572	1.272264631	0.467753225	behavior
Vernot et al. 2016 Introgressed	GWAS	Erythrocyte cadmium concentration in never smokers	1	0.6379	1.567643831	0.469553045	hematologic
Vernot et al. 2016 Introgressed	GWAS	Asthma	6	5.4997	1.090968598	0.469953005	respiratory
Vernot et al. 2016 Introgressed	GWAS	Bone ultrasound measurement (velocity of sound)	1	0.6351	1.574555188	0.470152985	skeletal
Vernot et al. 2016 Introgressed	GWAS	Systolic blood pressure x smoking status (ever vs never) interaction (2df test)	1	0.6317	1.583029919	0.470252975	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Hippocampal tail volume	1	0.623	1.605136437	0.470752925	nervous
Vernot et al. 2016 Introgressed	GWAS	Disease progression in age-related macular degeneration	3	2.5636	1.170229365	0.472352765	nervous
Vernot et al. 2016 Introgressed	GWAS	Electrodermal activity	2	1.5965	1.25274037	0.473752625	integumentary
Vernot et al. 2016 Introgressed	GWAS	Plasma kynurenine levels in major depressive disorder	1	0.6439	1.553036186	0.475752425	other
Vernot et al. 2016 Introgressed	GWAS	Metabolite levels	2	1.585	1.261829653	0.476452355	metabolic
Vernot et al. 2016 Introgressed	GWAS	Tuberculosis	2	1.5945	1.254311696	0.477252275	immune
Vernot et al. 2016 Introgressed	GWAS	Cannabis use	1	0.6478	1.543686323	0.479152085	behavior
Vernot et al. 2016 Introgressed	GWAS	Waist-to-hip ratio adjusted for BMI in non-smokers	1	0.6527	1.532097441	0.479852015	skeletal
Vernot et al. 2016 Introgressed	GWAS	Birth weight	2	1.6204	1.234263145	0.480651935	skeletal
Vernot et al. 2016 Introgressed	GWAS	Cerebrospinal fluid p-tau levels	1	0.6562	1.523925632	0.481851815	nervous
Vernot et al. 2016 Introgressed	GWAS	Reticulocyte count	3	2.5969	1.155223536	0.482051795	immune
Vernot et al. 2016 Introgressed	GWAS	Liver fibrosis in pediatric non-alcoholic fatty acid liver disease	1	0.6551	1.526484506	0.482951705	other
Vernot et al. 2016 Introgressed	GWAS	Atopic dermatitis	1	0.6525	1.53256705	0.483251675	integumentary
Vernot et al. 2016 Introgressed	GWAS	Loneliness (MTAG)	2	1.6116	1.24100273	0.483751625	behavior
Vernot et al. 2016 Introgressed	GWAS	Blood sugar levels	1	0.659	1.517450683	0.483751625	metabolic
Vernot et al. 2016 Introgressed	GWAS	Temperament (bipolar disorder)	1	0.6824	1.465416178	0.490150985	behavior
Vernot et al. 2016 Introgressed	GWAS	Homeostasis model assessment of beta-cell function (dietary factor interaction)	2	1.6604	1.204529029	0.495350465	metabolic
Vernot et al. 2016 Introgressed	GWAS	Fasting blood glucose	1	0.6805	1.469507715	0.497650235	metabolic
Vernot et al. 2016 Introgressed	GWAS	Body mass index (age <50)	1	0.6892	1.450957632	0.501749825	metabolic
Vernot et al. 2016 Introgressed	GWAS	Primary sclerosing cholangitis	1	0.7005	1.427551749	0.501949805	digestive
Vernot et al. 2016 Introgressed	GWAS	High light scatter reticulocyte count	3	2.6917	1.114537281	0.502849715	metabolic
Vernot et al. 2016 Introgressed	GWAS	Non-small cell lung cancer	1	0.7071	1.414227125	0.503649635	respiratory
Vernot et al. 2016 Introgressed	GWAS	Mean arterial pressure (alcohol consumption interaction)	1	0.6878	1.453911021	0.503749625	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Asperger disorder	1	0.7099	1.408649106	0.507549245	behavior
Vernot et al. 2016 Introgressed	GWAS	Late-onset Alzheimer's disease	2	1.6992	1.177024482	0.508349165	nervous
Vernot et al. 2016 Introgressed	GWAS	Myocardial infarction	1	0.7226	1.383891503	0.512548745	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Body mass index and waist-hip ratio (pleiotropy)	1	0.7215	1.386001386	0.513348665	metabolic
Vernot et al. 2016 Introgressed	GWAS	Chloride levels	1	0.7199	1.389081817	0.514648535	other
Vernot et al. 2016 Introgressed	GWAS	Hippocampal atrophy	2	1.7289	1.156804905	0.515248475	nervous
Vernot et al. 2016 Introgressed	GWAS	Response to platinum-based chemotherapy (carboplatin)	1	0.7193	1.390240512	0.517648235	other
Vernot et al. 2016 Introgressed	GWAS	Response to taxane treatment (docetaxel)	1	0.7244	1.380452789	0.518048195	other
Vernot et al. 2016 Introgressed	GWAS	Spherical equivalent (joint analysis main effects and education interaction)	1	0.719	1.390820584	0.518448155	nervous
Vernot et al. 2016 Introgressed	GWAS	Bulimia nervosa	1	0.7222	1.384657989	0.518448155	behavior
Vernot et al. 2016 Introgressed	GWAS	Initial alcohol sensitivity	1	0.7388	1.353546291	0.520947905	other
Vernot et al. 2016 Introgressed	GWAS	Total cholesterol levels	2	1.7395	1.149755677	0.521447855	metabolic
Vernot et al. 2016 Introgressed	GWAS	Interleukin-6 levels	1	0.7371	1.356668023	0.522147785	immune
Vernot et al. 2016 Introgressed	GWAS	Conotruncal heart defects	1	0.7471	1.338508901	0.522347765	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Platelet count	5	4.7931	1.043166218	0.523447655	hematologic
Vernot et al. 2016 Introgressed	GWAS	Alcohol dependence	3	2.7826	1.078128369	0.526447355	behavior
Vernot et al. 2016 Introgressed	GWAS	Urate levels	1	0.749	1.335113485	0.531646835	metabolic
Vernot et al. 2016 Introgressed	GWAS	Waist-to-hip ratio adjusted for BMI (age >50)	2	1.7766	1.125745807	0.533046695	skeletal
Vernot et al. 2016 Introgressed	GWAS	Fractures	1	0.7666	1.304461258	0.533646635	skeletal
Vernot et al. 2016 Introgressed	GWAS	Orofacial clefts	2	1.7999	1.111172843	0.533946605	other
Vernot et al. 2016 Introgressed	GWAS	Lymphocyte counts	3	2.818	1.064584812	0.536546345	lymphatic
Vernot et al. 2016 Introgressed	GWAS	Reticulocyte fraction of red cells	3	2.8397	1.056449625	0.539946005	immune
Vernot et al. 2016 Introgressed	GWAS	Post bronchodilator FEV1 in COPD	2	1.8194	1.099263493	0.540245975	other
Vernot et al. 2016 Introgressed	GWAS	Multiple myeloma	1	0.7851	1.273723093	0.542345765	immune
Vernot et al. 2016 Introgressed	GWAS	Bipolar disorder	4	3.8939	1.027247746	0.544845515	behavior
Vernot et al. 2016 Introgressed	GWAS	Alzheimer's disease in APOE e4- carriers	2	1.8394	1.08731108	0.546745325	nervous
Vernot et al. 2016 Introgressed	GWAS	Alanine transaminase levels	1	0.805	1.242236025	0.547745225	other
Vernot et al. 2016 Introgressed	GWAS	Idiopathic dilated cardiomyopathy	2	1.8514	1.080263584	0.548045195	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Paclitaxel-induced neuropathy	1	0.8249	1.212268154	0.562043796	other
Vernot et al. 2016 Introgressed	GWAS	BMI in smokers	1	0.8405	1.189767995	0.567943206	metabolic
Vernot et al. 2016 Introgressed	GWAS	Copper levels	2	1.9216	1.040799334	0.569043096	other
Vernot et al. 2016 Introgressed	GWAS	Osteoporosis-related phenotypes	1	0.8383	1.192890373	0.570742926	skeletal
Vernot et al. 2016 Introgressed	GWAS	Presence of antiphospholipid antibodies	2	1.9225	1.040312094	0.570842916	other
Vernot et al. 2016 Introgressed	GWAS	Huntington's disease progression	1	0.8578	1.165772907	0.571142886	nervous
Vernot et al. 2016 Introgressed	GWAS	Type 2 diabetes	11	11.2762	0.975505933	0.572942706	metabolic
Vernot et al. 2016 Introgressed	GWAS	Subcortical brain region volumes	2	1.926	1.038421599	0.575542446	nervous
Vernot et al. 2016 Introgressed	GWAS	Type 2 diabetes nephropathy	1	0.8569	1.166997316	0.580041996	metabolic
Vernot et al. 2016 Introgressed	GWAS	Ankylosing spondylitis	1	0.8587	1.164551066	0.580241976	skeletal
Vernot et al. 2016 Introgressed	GWAS	Nose morphology	1	0.8681	1.151941021	0.580641936	skeletal
Vernot et al. 2016 Introgressed	GWAS	Thyroid hormone levels	1	0.8706	1.148633127	0.580741926	endocrine
Vernot et al. 2016 Introgressed	GWAS	Intracranial aneurysm	3	3.0699	0.977230529	0.585041496	nervous
Vernot et al. 2016 Introgressed	GWAS	Immune reponse to smallpox (secreted IL-2)	1	0.8809	1.135202634	0.590140986	immune
Vernot et al. 2016 Introgressed	GWAS	Lumbar spine bone mineral density	1	0.8785	1.138303927	0.590440956	skeletal
Vernot et al. 2016 Introgressed	GWAS	Alopecia areata	1	0.8869	1.127522832	0.591040896	integumentary
Vernot et al. 2016 Introgressed	GWAS	Coronary artery aneurysm in Kawasaki disease	5	5.1853	0.964264363	0.592740726	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Multiple sclerosis (age of onset)	1	0.8919	1.121201928	0.594640536	nervous
Vernot et al. 2016 Introgressed	GWAS	Total hippocampal volume	1	0.9008	1.110124334	0.595440456	nervous
Vernot et al. 2016 Introgressed	GWAS	Serum total protein level	1	0.8947	1.117693081	0.595640436	other
Vernot et al. 2016 Introgressed	GWAS	Fasting plasma glucose	1	0.906	1.103752759	0.596340366	metabolic
Vernot et al. 2016 Introgressed	GWAS	Response to platinum-based chemotherapy in non-small-cell lung cancer	1	0.9191	1.08802089	0.599940006	other
Vernot et al. 2016 Introgressed	GWAS	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	1	0.921	1.08577633	0.601039896	behavior
Vernot et al. 2016 Introgressed	GWAS	Breast cancer	5	5.2391	0.95436239	0.601139886	reproductive
Vernot et al. 2016 Introgressed	GWAS	Energy expenditure (24h)	1	0.9106	1.098177026	0.602139786	behavior
Vernot et al. 2016 Introgressed	GWAS	Primary biliary cirrhosis	1	0.9241	1.082133968	0.604639536	digestive
Vernot et al. 2016 Introgressed	GWAS	Non-alcoholic fatty liver disease histology (other)	1	0.9259	1.080030241	0.605339466	digestive
Vernot et al. 2016 Introgressed	GWAS	Serum thyroid-stimulating hormone levels	1	0.9303	1.074922068	0.606439356	endocrine
Vernot et al. 2016 Introgressed	GWAS	Eye morphology	1	0.9382	1.065870816	0.610138986	nervous
Vernot et al. 2016 Introgressed	GWAS	Waist-to-hip ratio adjusted for BMI (age <50)	1	0.9465	1.056524036	0.610638936	skeletal
Vernot et al. 2016 Introgressed	GWAS	White matter lesion progression	1	0.9375	1.066666667	0.611138886	nervous
Vernot et al. 2016 Introgressed	GWAS	Heschl's gyrus morphology	1	0.9386	1.065416578	0.613038696	nervous
Vernot et al. 2016 Introgressed	GWAS	Rosacea symptom severity	4	4.2649	0.937888344	0.613638636	integumentary
Vernot et al. 2016 Introgressed	GWAS	Bipolar disorder and eating disorder	1	0.9442	1.059097649	0.615038496	behavior
Vernot et al. 2016 Introgressed	GWAS	Glucocorticoid-induced osteonecrosis	1	0.9657	1.035518277	0.621537846	other
Vernot et al. 2016 Introgressed	GWAS	Coenzyme Q10 levels	1	0.9771	1.0234367	0.622737726	other
Vernot et al. 2016 Introgressed	GWAS	HIV-1 viral setpoint	1	0.9649	1.036376827	0.624937506	immune
Vernot et al. 2016 Introgressed	GWAS	Social science traits (pleiotropy) (HIPO component 1)	1	0.984	1.016260163	0.625937406	behavior
Vernot et al. 2016 Introgressed	GWAS	Testicular germ cell tumor	1	0.965	1.03626943	0.626637336	reproductive
Vernot et al. 2016 Introgressed	GWAS	Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)	1	0.9732	1.027538019	0.627137286	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Alzheimer disease and age of onset	1	0.9852	1.01502233	0.627237276	nervous
Vernot et al. 2016 Introgressed	GWAS	Regular attendance at a pub or social club	1	0.98	1.020408163	0.627437256	behavior
Vernot et al. 2016 Introgressed	GWAS	Aortic root size	1	0.9923	1.00775975	0.628237176	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Nicotine dependence and major depression (severity of comorbidity)	2	2.1344	0.937031484	0.629137086	behavior
Vernot et al. 2016 Introgressed	GWAS	Putamen volume	2	2.1318	0.938174313	0.631236876	nervous
Vernot et al. 2016 Introgressed	GWAS	Response to citalopram treatment	1	1.0034	0.996611521	0.631636836	other
Vernot et al. 2016 Introgressed	GWAS	Chronic kidney disease	1	0.9986	1.001401963	0.635236476	urinary
Vernot et al. 2016 Introgressed	GWAS	Albumin-globulin ratio	1	1.0183	0.982028872	0.636536346	other
Vernot et al. 2016 Introgressed	GWAS	Multiple system atrophy (pathologically confirmed)	1	1.0187	0.981643271	0.637536246	nervous
Vernot et al. 2016 Introgressed	GWAS	Sudden cardiac arrest	1	1.0202	0.980199961	0.637636236	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)	1	1.0059	0.994134606	0.637936206	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Advanced glycation end-product levels	1	1.0196	0.980776775	0.642235776	metabolic
Vernot et al. 2016 Introgressed	GWAS	Cerebrospinal fluid beta-site APP cleaving enzyme levels	1	1.0337	0.967398665	0.642735726	nervous
Vernot et al. 2016 Introgressed	GWAS	Pelvic organ prolapse	1	1.026	0.974658869	0.644935506	skeletal muscle
Vernot et al. 2016 Introgressed	GWAS	Borderline personality disorder	1	1.0505	0.951927653	0.648235176	behavior
Vernot et al. 2016 Introgressed	GWAS	Type 1 diabetes	1	1.0459	0.956114351	0.650334967	metabolic
Vernot et al. 2016 Introgressed	GWAS	Acute lymphoblastic leukemia (childhood)	2	2.2227	0.899806542	0.650334967	lymphatic
Vernot et al. 2016 Introgressed	GWAS	Body mass index x sex x age interaction (4df test)	1	1.0609	0.942595909	0.654934507	metabolic
Vernot et al. 2016 Introgressed	GWAS	Neuroticism	3	3.3702	0.890154887	0.656134387	behavior
Vernot et al. 2016 Introgressed	GWAS	Menopause (age at onset)	1	1.061	0.942507069	0.657334267	reproductive
Vernot et al. 2016 Introgressed	GWAS	Sleep duration	2	2.2366	0.894214433	0.658034197	behavior
Vernot et al. 2016 Introgressed	GWAS	Cognitive decline rate in late mild cognitive impairment	3	3.4248	0.87596356	0.662033797	nervous
Vernot et al. 2016 Introgressed	GWAS	Systemic lupus erythematosus	5	5.6383	0.886792118	0.662633737	immune
Vernot et al. 2016 Introgressed	GWAS	Triglyceride levels	1	1.1094	0.901388138	0.668433157	metabolic
Vernot et al. 2016 Introgressed	GWAS	Alzheimer's disease progression score	1	1.0804	0.925583117	0.668933107	nervous
Vernot et al. 2016 Introgressed	GWAS	Crohn's disease	6	6.7655	0.886852413	0.669133087	immune
Vernot et al. 2016 Introgressed	GWAS	Breast size	2	2.2808	0.876885303	0.669633037	reproductive
Vernot et al. 2016 Introgressed	GWAS	Hippocampal volume in Alzheimer's disease dementia	1	1.1037	0.906043309	0.669833017	nervous
Vernot et al. 2016 Introgressed	GWAS	Peripheral arterial disease (traffic-related air pollution interaction)	1	1.1204	0.892538379	0.673332667	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Polycystic ovary syndrome	1	1.1257	0.888336146	0.674232577	reproductive
Vernot et al. 2016 Introgressed	GWAS	Mammographic density (dense area)	1	1.1185	0.894054537	0.676832317	reproductive
Vernot et al. 2016 Introgressed	GWAS	Blood metabolite levels	1	1.1416	0.87596356	0.684231577	metabolic
Vernot et al. 2016 Introgressed	GWAS	Non-albumin protein levels	1	1.152	0.868055556	0.684731527	other
Vernot et al. 2016 Introgressed	GWAS	Plateletcrit	3	3.5489	0.845332357	0.687931207	hematologic
Vernot et al. 2016 Introgressed	GWAS	BRCA1/2-negative high-risk breast cancer	1	1.202	0.831946755	0.695130487	reproductive
Vernot et al. 2016 Introgressed	GWAS	Monobrow	2	2.452	0.815660685	0.699330067	integumentary
Vernot et al. 2016 Introgressed	GWAS	Glaucoma (primary open-angle)	2	2.4543	0.814896304	0.699430057	nervous
Vernot et al. 2016 Introgressed	GWAS	Waist circumference	4	4.7558	0.841078262	0.700229977	skeletal
Vernot et al. 2016 Introgressed	GWAS	Calcium levels	1	1.2116	0.825354903	0.700829917	other
Vernot et al. 2016 Introgressed	GWAS	Male fertility	1	1.2113	0.825559316	0.701829817	reproductive
Vernot et al. 2016 Introgressed	GWAS	Hypertension (SNP x SNP interaction)	1	1.2031	0.831186103	0.702029797	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Waist circumference adjusted for body mass index	3	3.6332	0.825718375	0.702629737	skeletal
Vernot et al. 2016 Introgressed	GWAS	Adverse response to lamotrigine and phenytoin	1	1.2219	0.818397578	0.703129687	other
Vernot et al. 2016 Introgressed	GWAS	Gamma glutamyl transferase levels	1	1.2245	0.816659861	0.704129587	other
Vernot et al. 2016 Introgressed	GWAS	Rheumatoid arthritis (ACPA-positive)	1	1.2284	0.814067079	0.705929407	immune
Vernot et al. 2016 Introgressed	GWAS	Subcutaneous adipose tissue	2	2.4678	0.810438447	0.707529247	metabolic
Vernot et al. 2016 Introgressed	GWAS	Quantitative traits	1	1.2213	0.81879964	0.708929107	other
Vernot et al. 2016 Introgressed	GWAS	Bone mineral density (femoral neck)	1	1.2196	0.819940964	0.709029097	skeletal
Vernot et al. 2016 Introgressed	GWAS	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)	1	1.2226	0.817929004	0.709329067	other
Vernot et al. 2016 Introgressed	GWAS	Glucose homeostasis traits	3	3.7334	0.803557079	0.719328067	metabolic
Vernot et al. 2016 Introgressed	GWAS	Irritable mood	1	1.2702	0.787277594	0.720227977	behavior
Vernot et al. 2016 Introgressed	GWAS	Chronic back pain	1	1.2856	0.77784692	0.721627837	skeletal
Vernot et al. 2016 Introgressed	GWAS	Monocyte count	2	2.5515	0.783852636	0.723627637	immune
Vernot et al. 2016 Introgressed	GWAS	Post bronchodilator FEV1/FVC ratio in COPD	1	1.2958	0.771724031	0.725527447	other
Vernot et al. 2016 Introgressed	GWAS	Dimensional psychopathology (Cognitive)	1	1.297	0.771010023	0.726327367	behavior
Vernot et al. 2016 Introgressed	GWAS	Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)	3	3.7503	0.799936005	0.726527347	skeletal
Vernot et al. 2016 Introgressed	GWAS	Regular attendance at a religious group	1	1.3235	0.755572346	0.728727127	behavior
Vernot et al. 2016 Introgressed	GWAS	Glomerular filtration rate (creatinine)	2	2.5801	0.775163753	0.731026897	hematologic
Vernot et al. 2016 Introgressed	GWAS	Total body bone mineral density	1	1.2974	0.770772314	0.731426857	skeletal
Vernot et al. 2016 Introgressed	GWAS	Neutrophil count	2	2.5929	0.771337113	0.733126687	lymphatic
Vernot et al. 2016 Introgressed	GWAS	Hip circumference adjusted for BMI	2	2.634	0.759301443	0.735226477	skeletal
Vernot et al. 2016 Introgressed	GWAS	Feeling hurt	1	1.3426	0.744823477	0.735926407	behavior
Vernot et al. 2016 Introgressed	GWAS	Dupuytren's disease	1	1.3364	0.748278958	0.740325967	integumentary
Vernot et al. 2016 Introgressed	GWAS	Cerebrospinal fluid t-tau:AB1-42 ratio	1	1.3456	0.743162901	0.740925907	nervous
Vernot et al. 2016 Introgressed	GWAS	Serum uric acid levels	1	1.3499	0.740795614	0.743525647	other
Vernot et al. 2016 Introgressed	GWAS	Cleft lip with or without cleft palate (maternal periconceptional vitamin use interaction)	1	1.3705	0.729660708	0.746125387	other
Vernot et al. 2016 Introgressed	GWAS	Myopia (pathological)	2	2.708	0.738552437	0.747925207	nervous
Vernot et al. 2016 Introgressed	GWAS	Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)	2	2.6958	0.741894799	0.748625137	skeletal
Vernot et al. 2016 Introgressed	GWAS	Waist circumference adjusted for BMI in active individuals	2	2.6958	0.741894799	0.748625137	skeletal
Vernot et al. 2016 Introgressed	GWAS	Migraine without aura	1	1.3883	0.720305409	0.752824718	nervous
Vernot et al. 2016 Introgressed	GWAS	ALT levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	1	1.3943	0.717205766	0.753324668	other
Vernot et al. 2016 Introgressed	GWAS	Migraine	2	2.6928	0.742721331	0.753824618	nervous
Vernot et al. 2016 Introgressed	GWAS	Height	9	10.83	0.831024931	0.754524548	skeletal
Vernot et al. 2016 Introgressed	GWAS	Post bronchodilator FEV1/FVC ratio	10	11.9887	0.834118795	0.757024298	other
Vernot et al. 2016 Introgressed	GWAS	Brain connectivity	1	1.4274	0.700574471	0.758724128	nervous
Vernot et al. 2016 Introgressed	GWAS	Depression in smokers	1	1.4367	0.696039535	0.765223478	behavior
Vernot et al. 2016 Introgressed	GWAS	Systolic blood pressure	14	16.4562	0.850743185	0.767323268	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Response to antipsychotic treatment	2	2.7923	0.716255417	0.769423058	other
Vernot et al. 2016 Introgressed	GWAS	Dimensional psychopathology (Positive)	1	1.4649	0.682640453	0.770022998	behavior
Vernot et al. 2016 Introgressed	GWAS	Lung function (FVC)	2	2.8073	0.712428312	0.771822818	respiratory
Vernot et al. 2016 Introgressed	GWAS	Cardiac hypertrophy	1	1.453	0.688231246	0.772422758	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Age-related macular degeneration	1	1.4907	0.670825787	0.777122288	nervous
Vernot et al. 2016 Introgressed	GWAS	Alcoholic chronic pancreatitis	1	1.5174	0.659022011	0.778522148	endocrine
Vernot et al. 2016 Introgressed	GWAS	High density lipoprotein cholesterol levels	1	1.524	0.656167979	0.783321668	metabolic
Vernot et al. 2016 Introgressed	GWAS	Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes	2	2.8958	0.690655432	0.785221478	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Common carotid intima-media thickness in HIV infection	1	1.5445	0.647458725	0.785421458	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma	1	1.5446	0.647416807	0.787421258	other
Vernot et al. 2016 Introgressed	GWAS	Mean corpuscular hemoglobin concentration	1	1.5891	0.629287018	0.791820818	hematologic
Vernot et al. 2016 Introgressed	GWAS	Irritable bowel syndrome	1	1.5704	0.636780438	0.791920808	digestive
Vernot et al. 2016 Introgressed	GWAS	Coronary artery disease	7	9.0458	0.773839793	0.794320568	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Western dietary pattern	1	1.5765	0.634316524	0.794420558	behavior
Vernot et al. 2016 Introgressed	GWAS	Chronic obstructive pulmonary disease	1	1.5703	0.63682099	0.796420358	respiratory
Vernot et al. 2016 Introgressed	GWAS	Sum basophil neutrophil counts	1	1.5745	0.635122261	0.797420258	hematologic
Vernot et al. 2016 Introgressed	GWAS	Anti-saccade response	2	2.9723	0.672879588	0.798620138	nervous
Vernot et al. 2016 Introgressed	GWAS	Spherical equivalent or myopia (age of diagnosis)	6	7.8657	0.762805599	0.799820018	nervous
Vernot et al. 2016 Introgressed	GWAS	Response to antidepressants (symptom improvement)	1	1.6286	0.614024315	0.802019798	other
Vernot et al. 2016 Introgressed	GWAS	Cognitive decline (age-related)	1	1.6222	0.616446801	0.803719628	nervous
Vernot et al. 2016 Introgressed	GWAS	Uterine fibroid number (single vs multiple)	1	1.6186	0.617817867	0.804919508	reproductive
Vernot et al. 2016 Introgressed	GWAS	Pancreatic cancer	2	3.0474	0.656297171	0.806619338	endocrine
Vernot et al. 2016 Introgressed	GWAS	Alzheimer's disease	1	1.6301	0.613459297	0.808719128	nervous
Vernot et al. 2016 Introgressed	GWAS	Pulmonary function (smoking interaction)	1	1.6616	0.601829562	0.808819118	respiratory
Vernot et al. 2016 Introgressed	GWAS	Pulmonary function	1	1.6651	0.600564531	0.810518948	respiratory
Vernot et al. 2016 Introgressed	GWAS	Eosinophil counts	2	3.0739	0.650639253	0.814418558	immune
Vernot et al. 2016 Introgressed	GWAS	Fractional exhaled nitric oxide (childhood)	1	1.6592	0.602700096	0.814718528	respiratory
Vernot et al. 2016 Introgressed	GWAS	Neurociticism	3	4.4102	0.680241259	0.815218478	behavior
Vernot et al. 2016 Introgressed	GWAS	Autism	1	1.7005	0.588062335	0.815318468	behavior
Vernot et al. 2016 Introgressed	GWAS	Sum neutrophil eosinophil counts	1	1.6653	0.600492404	0.816018398	hematologic
Vernot et al. 2016 Introgressed	GWAS	Visceral fat	1	1.7162	0.582682671	0.818318168	metabolic
Vernot et al. 2016 Introgressed	GWAS	Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)	1	1.6867	0.592873659	0.818318168	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Creatinine levels	1	1.731	0.577700751	0.821017898	other
Vernot et al. 2016 Introgressed	GWAS	Waist-to-hip ratio adjusted for BMI x sex interaction	1	1.7188	0.581801257	0.821517848	skeletal
Vernot et al. 2016 Introgressed	GWAS	Age-related hearing impairment	1	1.7402	0.574646592	0.823817618	nervous
Vernot et al. 2016 Introgressed	GWAS	Dimensional psychopathology (Negative)	1	1.7609	0.567891419	0.827617238	behavior
Vernot et al. 2016 Introgressed	GWAS	Lymphocyte percentage of white cells	1	1.7496	0.571559214	0.828017198	lymphatic
Vernot et al. 2016 Introgressed	GWAS	Motion sickness	2	3.17	0.630914826	0.828717128	nervous
Vernot et al. 2016 Introgressed	GWAS	Hypertension	1	1.791	0.558347292	0.831016898	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Alzheimer's disease (late onset)	1	1.8055	0.553863196	0.832716728	nervous
Vernot et al. 2016 Introgressed	GWAS	Myeloid white cell count	1	1.7783	0.562334814	0.832816718	immune
Vernot et al. 2016 Introgressed	GWAS	Nose size	1	1.8188	0.549813064	0.833316668	skeletal
Vernot et al. 2016 Introgressed	GWAS	Feeling miserable	1	1.7803	0.561703084	0.834116588	behavior
Vernot et al. 2016 Introgressed	GWAS	Granulocyte count	1	1.7846	0.560349658	0.835516448	immune
Vernot et al. 2016 Introgressed	GWAS	Mosquito bite size	4	5.8303	0.686071043	0.835616438	other
Vernot et al. 2016 Introgressed	GWAS	Hip circumference	1	1.832	0.545851528	0.835916408	skeletal
Vernot et al. 2016 Introgressed	GWAS	Gut microbiota (functional units)	1	1.7768	0.562809545	0.836416358	digestive
Vernot et al. 2016 Introgressed	GWAS	Intelligence (MTAG)	7	9.4628	0.739738767	0.838416158	other
Vernot et al. 2016 Introgressed	GWAS	Urinary albumin excretion	2	3.3075	0.604686319	0.844715528	metabolic
Vernot et al. 2016 Introgressed	GWAS	Metabolite levels (Pyroglutamine)	1	1.8724	0.534073916	0.844915508	metabolic
Vernot et al. 2016 Introgressed	GWAS	Attention function in attention deficit hyperactive disorder	1	1.84	0.543478261	0.845015498	behavior
Vernot et al. 2016 Introgressed	GWAS	Mean corpuscular volume	3	4.708	0.637213254	0.850114989	hematologic
Vernot et al. 2016 Introgressed	GWAS	Itch intensity from mosquito bite	1	1.89	0.529100529	0.851114889	immune
Vernot et al. 2016 Introgressed	GWAS	BMI in non-smokers	2	3.4072	0.586992252	0.854914509	metabolic
Vernot et al. 2016 Introgressed	GWAS	Knee osteoarthritis	1	1.9451	0.514112385	0.855514449	skeletal
Vernot et al. 2016 Introgressed	GWAS	Lung cancer	1	1.9621	0.509658019	0.856614339	respiratory
Vernot et al. 2016 Introgressed	GWAS	Post bronchodilator FEV1	4	6.1196	0.653637493	0.856814319	other
Vernot et al. 2016 Introgressed	GWAS	Bronchopulmonary dysplasia	2	3.434	0.582411182	0.857814219	respiratory
Vernot et al. 2016 Introgressed	GWAS	Prostate cancer (SNP x SNP interaction)	1	1.9482	0.513294323	0.859114089	reproductive
Vernot et al. 2016 Introgressed	GWAS	Mild influenza (H1N1) infection	2	3.4294	0.583192395	0.859314069	immune
Vernot et al. 2016 Introgressed	GWAS	Red blood cell count	2	3.4305	0.583005393	0.860413959	hematologic
Vernot et al. 2016 Introgressed	GWAS	Emphysema imaging phenotypes	2	3.4603	0.577984568	0.861413859	respiratory
Vernot et al. 2016 Introgressed	GWAS	Chin dimples	1	1.9733	0.506765317	0.861613839	integumentary
Vernot et al. 2016 Introgressed	GWAS	Rheumatoid arthritis	2	3.4856	0.573789305	0.862313769	immune
Vernot et al. 2016 Introgressed	GWAS	Pulse pressure	10	13.5075	0.740329447	0.863313669	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Gout	1	1.9984	0.50040032	0.863513649	skeletal
Vernot et al. 2016 Introgressed	GWAS	Paclitaxel disposition in epithelial ovarian cancer	2	3.4791	0.574861315	0.864113589	other
Vernot et al. 2016 Introgressed	GWAS	Multiple keratinocyte cancers	1	1.9807	0.504872015	0.865413459	integumentary
Vernot et al. 2016 Introgressed	GWAS	Hematocrit	1	2.0436	0.48933255	0.867513249	hematologic
Vernot et al. 2016 Introgressed	GWAS	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	1	1.9932	0.5017058	0.867713229	other
Vernot et al. 2016 Introgressed	GWAS	Blond vs. brown/black hair color	2	3.5367	0.565498911	0.868813119	integumentary
Vernot et al. 2016 Introgressed	GWAS	Diastolic blood pressure	12	15.9568	0.752030482	0.869313069	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Gut microbiota (beta diversity)	1	2.0116	0.497116723	0.869513049	digestive
Vernot et al. 2016 Introgressed	GWAS	Platelet distribution width	2	3.5745	0.559518814	0.872512749	hematologic
Vernot et al. 2016 Introgressed	GWAS	Amyotrophic lateral sclerosis	1	2.1137	0.473104036	0.874412559	nervous
Vernot et al. 2016 Introgressed	GWAS	Response to fenofibrate (total cholesterol levels)	1	2.0883	0.478858402	0.874412559	other
Vernot et al. 2016 Introgressed	GWAS	Waist-hip ratio	3	5.0786	0.590713976	0.881411859	skeletal
Vernot et al. 2016 Introgressed	GWAS	Verbal declarative memory	1	2.1941	0.455767741	0.884411559	nervous
Vernot et al. 2016 Introgressed	GWAS	Mean corpuscular hemoglobin	2	3.7803	0.52905854	0.887711229	hematologic
Vernot et al. 2016 Introgressed	GWAS	Bipolar disorder and schizophrenia	1	2.1917	0.456266825	0.890410959	behavior
Vernot et al. 2016 Introgressed	GWAS	Immune response to smallpox vaccine (IL-6)	2	3.8185	0.523765877	0.893810619	immune
Vernot et al. 2016 Introgressed	GWAS	Erectile dysfunction	1	2.2642	0.441657097	0.897410259	reproductive
Vernot et al. 2016 Introgressed	GWAS	Diisocyanate-induced asthma	5	7.9453	0.629302858	0.900509949	respiratory
Vernot et al. 2016 Introgressed	GWAS	Neutrophil percentage of granulocytes	1	2.3134	0.4322642	0.902609739	lymphatic
Vernot et al. 2016 Introgressed	GWAS	Atrial fibrillation	5	8.0825	0.618620476	0.907109289	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Lung cancer in ever smokers	1	2.4327	0.411065894	0.907509249	respiratory
Vernot et al. 2016 Introgressed	GWAS	Longevity	2	3.9472	0.506688285	0.908309169	other
Vernot et al. 2016 Introgressed	GWAS	Uterine fibroids	1	2.4015	0.416406413	0.909609039	reproductive
Vernot et al. 2016 Introgressed	GWAS	Experiencing mood swings	1	2.3788	0.420380024	0.910708929	behavior
Vernot et al. 2016 Introgressed	GWAS	Depression (quantitative trait)	1	2.4704	0.404792746	0.914808519	behavior
Vernot et al. 2016 Introgressed	GWAS	Body mass index in physically active individuals	2	4.0803	0.490160037	0.915008499	metabolic
Vernot et al. 2016 Introgressed	GWAS	Thiazide-induced adverse metabolic effects in hypertensive patients	1	2.5057	0.399090075	0.915908409	other
Vernot et al. 2016 Introgressed	GWAS	Glomerular filtration rate	1	2.4466	0.408730483	0.916808319	hematologic
Vernot et al. 2016 Introgressed	GWAS	White blood cell count	1	2.516	0.39745628	0.918408159	immune
Vernot et al. 2016 Introgressed	GWAS	Photic sneeze reflex	3	5.6211	0.533703368	0.920707929	nervous
Vernot et al. 2016 Introgressed	GWAS	Airway responsiveness in chronic obstructive pulmonary disease	1	2.5272	0.39569484	0.922007799	respiratory
Vernot et al. 2016 Introgressed	GWAS	Colorectal cancer	1	2.5507	0.392049241	0.923407659	digestive
Vernot et al. 2016 Introgressed	GWAS	Lung function (FEV1/FVC)	1	2.5626	0.390228674	0.924107589	respiratory
Vernot et al. 2016 Introgressed	GWAS	Major depressive disorder	4	7.0674	0.565979002	0.924307569	behavior
Vernot et al. 2016 Introgressed	GWAS	Body mass index (joint analysis main effects and smoking interaction)	2	4.2738	0.467967617	0.928507149	metabolic
Vernot et al. 2016 Introgressed	GWAS	Cognitive performance	1	2.6971	0.370768603	0.930206979	nervous
Vernot et al. 2016 Introgressed	GWAS	BMI (adjusted for smoking behaviour)	2	4.3193	0.463037992	0.930506949	metabolic
Vernot et al. 2016 Introgressed	GWAS	Eosinophil percentage of white cells	1	2.6636	0.375431747	0.932206779	immune
Vernot et al. 2016 Introgressed	GWAS	Eosinophil percentage of granulocytes	1	2.6822	0.372828275	0.933106689	immune
Vernot et al. 2016 Introgressed	GWAS	Cognitive function	1	2.8008	0.357040845	0.935706429	nervous
Vernot et al. 2016 Introgressed	GWAS	Endometriosis	1	2.7361	0.365483718	0.937306269	reproductive
Vernot et al. 2016 Introgressed	GWAS	Menarche (age at onset)	6	10.1057	0.593724334	0.939206079	reproductive
Vernot et al. 2016 Introgressed	GWAS	Influenza A (H1N1) infection	1	2.8139	0.355378656	0.943105689	immune
Vernot et al. 2016 Introgressed	GWAS	Coronary artery calcification	1	2.864	0.349162011	0.943605639	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Body mass index (joint analysis main effects and physical activity interaction)	2	4.6635	0.428862442	0.947305269	metabolic
Vernot et al. 2016 Introgressed	GWAS	Myopia	2	4.7364	0.422261633	0.948505149	nervous
Vernot et al. 2016 Introgressed	GWAS	Sum eosinophil basophil counts	1	2.9766	0.335953773	0.95050495	hematologic
Vernot et al. 2016 Introgressed	GWAS	"Autism spectrum disorder, ADHD, bipolar disorder, MDD, and schizophrenia (combined)"	2	4.7485	0.421185638	0.95070493	behavior
Vernot et al. 2016 Introgressed	GWAS	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes	1	3.0563	0.327193011	0.95470453	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Obesity	1	3.1084	0.321708918	0.95480452	metabolic
Vernot et al. 2016 Introgressed	GWAS	Resting heart rate	2	4.8797	0.409861262	0.95550445	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Loneliness	2	4.7926	0.41731002	0.95590441	behavior
Vernot et al. 2016 Introgressed	GWAS	Post-traumatic stress disorder	1	3.0882	0.323813225	0.95620438	behavior
Vernot et al. 2016 Introgressed	GWAS	Familial squamous cell lung carcinoma	1	3.1979	0.312705213	0.95820418	respiratory
Vernot et al. 2016 Introgressed	GWAS	Percentage gas trapping	1	3.1413	0.318339541	0.95990401	metabolic
Vernot et al. 2016 Introgressed	GWAS	Blood pressure	1	3.5162	0.28439793	0.96740326	hematologic
Vernot et al. 2016 Introgressed	GWAS	Blood pressure (smoking interaction)	1	3.4873	0.286754796	0.96810319	hematologic
Vernot et al. 2016 Introgressed	GWAS	HDL cholesterol	2	5.2093	0.383928743	0.96830317	metabolic
Vernot et al. 2016 Introgressed	GWAS	"Type 2 diabetes (SNP x SNP interaction, 2df)"	1	3.4442	0.290343186	0.96940306	metabolic
Vernot et al. 2016 Introgressed	GWAS	Venous thromboembolism adjusted for sickle cell variant rs77121243-T	1	3.3947	0.29457684	0.96970303	hematologic
Vernot et al. 2016 Introgressed	GWAS	Response to amphetamines	1	3.561	0.280819994	0.97050295	other
Vernot et al. 2016 Introgressed	GWAS	Daytime sleep phenotypes	3	7.1697	0.418427549	0.97360264	behavior
Vernot et al. 2016 Introgressed	GWAS	Attention deficit hyperactivity disorder	2	5.5146	0.36267363	0.97530247	behavior
Vernot et al. 2016 Introgressed	GWAS	Heel bone mineral density	13	21.1063	0.615929841	0.97730227	skeletal
Vernot et al. 2016 Introgressed	GWAS	General cognitive ability	3	7.3946	0.405701458	0.9780022	nervous
Vernot et al. 2016 Introgressed	GWAS	Response to methotrexate in juvenile idiopathic arthritis	1	3.6946	0.270665295	0.9780022	other
Vernot et al. 2016 Introgressed	GWAS	QT interval	1	3.9871	0.250808859	0.98260174	cardiovascular
Vernot et al. 2016 Introgressed	GWAS	Macular thickness	1	4.2287	0.236479296	0.98490151	nervous
Vernot et al. 2016 Introgressed	GWAS	Obesity-related traits	19	29.4779	0.644550663	0.98490151	metabolic
Vernot et al. 2016 Introgressed	GWAS	Male-pattern baldness	1	4.4876	0.22283626	0.98790121	integumentary
Vernot et al. 2016 Introgressed	GWAS	Epstein-Barr virus copy number in lymphoblastoid cell lines	2	6.6405	0.30118214	0.98950105	immune
Vernot et al. 2016 Introgressed	GWAS	Amyotrophic lateral sclerosis (sporadic)	4	10.4912	0.381271923	0.99260074	nervous
Vernot et al. 2016 Introgressed	GWAS	Nasopharyngeal carcinoma (SNP x SNP interaction)	1	4.9914	0.200344593	0.99350065	other
Vernot et al. 2016 Introgressed	GWAS	Pursuit maintenance gain	1	5.1276	0.195023013	0.99360064	skeletal muscle
Vernot et al. 2016 Introgressed	GWAS	Body mass index	15	25.8511	0.580246102	0.99420058	metabolic
Vernot et al. 2016 Introgressed	GWAS	Schizophrenia	12	23.314	0.51471219	0.99650035	behavior
Vernot et al. 2016 Introgressed	GWAS	Monoclonal gammopathy of undetermined significance	1	5.7538	0.173798186	0.99730027	hematologic
Vernot et al. 2016 Introgressed	GWAS	Hand grip strength	1	5.8428	0.171150818	0.99760024	skeletal muscle
Vernot et al. 2016 Introgressed	GWAS	Multiple sclerosis	1	6.3296	0.157987867	0.99820018	nervous
Vernot et al. 2016 Introgressed	GWAS	Night sleep phenotypes	5	15.8671	0.315117444	0.99960004	behavior
Vernot et al. 2016 Introgressed	HPO	Oligohydramnios (HP:0001562)	5	0.7681	6.509569067	0.00119988	reproductive
Vernot et al. 2016 Introgressed	HPO	Difficulty climbing stairs (HP:0003551)	3	0.2716	11.04565538	0.00239976	other
Vernot et al. 2016 Introgressed	HPO	Muscle fibrillation (HP:0010546)	2	0.131	15.26717557	0.00779922	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Tubulointerstitial abnormality (HP:0001969)	3	0.4745	6.322444679	0.01279872	urinary
Vernot et al. 2016 Introgressed	HPO	Recurrent viral infections (HP:0004429)	2	0.1703	11.74398121	0.01289871	immune
Vernot et al. 2016 Introgressed	HPO	Recurrent fungal infections (HP:0002841)	2	0.1796	11.13585746	0.01349865	immune
Vernot et al. 2016 Introgressed	HPO	Pelvic girdle muscle weakness (HP:0003749)	2	0.1697	11.78550383	0.01359864	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Shoulder girdle muscle weakness (HP:0003547)	2	0.1697	11.78550383	0.01359864	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Abnormality of the musculature of the pelvis (HP:0001469)	2	0.1697	11.78550383	0.01359864	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Abnormality of the hip-girdle musculature (HP:0001445)	2	0.1697	11.78550383	0.01359864	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Prominent nasal bridge (HP:0000426)	5	1.4457	3.458532199	0.01559844	integumentary
Vernot et al. 2016 Introgressed	HPO	Elevated alkaline phosphatase (HP:0003155)	2	0.2003	9.985022466	0.0179982	other
Vernot et al. 2016 Introgressed	HPO	Abnormal enzyme/coenzyme activity (HP:0012379)	2	0.2003	9.985022466	0.0179982	other
Vernot et al. 2016 Introgressed	HPO	Abnormality of alkaline phosphatase activity (HP:0004379)	2	0.2003	9.985022466	0.0179982	other
Vernot et al. 2016 Introgressed	HPO	Pulmonary hypoplasia (HP:0002089)	4	1.0257	3.899775763	0.01949805	respiratory
Vernot et al. 2016 Introgressed	HPO	Abnormality of the renal cortex (HP:0011035)	2	0.2116	9.451795841	0.01959804	urinary
Vernot et al. 2016 Introgressed	HPO	Tongue fasciculations (HP:0001308)	1	0.0219	45.66210046	0.02169783	nervous
Vernot et al. 2016 Introgressed	HPO	Fasciculations (HP:0002380)	2	0.2265	8.830022075	0.02169783	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Abnormality of the renal medulla (HP:0100957)	3	0.6057	4.952947003	0.0249975	urinary
Vernot et al. 2016 Introgressed	HPO	Muscle fiber splitting (HP:0003555)	2	0.2475	8.080808081	0.02649735	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Heterogeneous (HP:0001425)	5	1.6575	3.016591252	0.0269973	other
Vernot et al. 2016 Introgressed	HPO	Wide nose (HP:0000445)	3	0.655	4.580152672	0.02839716	skeletal
Vernot et al. 2016 Introgressed	HPO	Panhypogammaglobulinemia (HP:0003139)	1	0.0323	30.95975232	0.03189681	immune
Vernot et al. 2016 Introgressed	HPO	Limb-girdle muscle atrophy (HP:0003797)	1	0.0331	30.21148036	0.03269673	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Limb-girdle muscle weakness (HP:0003325)	2	0.2847	7.024938532	0.03289671	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Enlarged kidneys (HP:0000105)	2	0.2914	6.863417982	0.03349665	urinary
Vernot et al. 2016 Introgressed	HPO	Recurrent urinary tract infections (HP:0000010)	4	1.2108	3.303600925	0.03479652	immune
Vernot et al. 2016 Introgressed	HPO	Increased serum lactate (HP:0002151)	3	0.713	4.207573633	0.03529647	other
Vernot et al. 2016 Introgressed	HPO	Respiratory insufficiency due to muscle weakness (HP:0002747)	4	1.2139	3.295164346	0.03709629	respiratory
Vernot et al. 2016 Introgressed	HPO	Dysphagia (HP:0002015)	4	1.2888	3.103662322	0.04019598	digestive
Vernot et al. 2016 Introgressed	HPO	Recurrent lower respiratory tract infections (HP:0002783)	2	0.3335	5.997001499	0.04359564	immune
Vernot et al. 2016 Introgressed	HPO	Increased CSF lactate (HP:0002490)	2	0.3372	5.931198102	0.04389561	other
Vernot et al. 2016 Introgressed	HPO	Rimmed vacuoles (HP:0003805)	2	0.34	5.882352941	0.0439956	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Aplasia/Hypoplasia of the sternum (HP:0006714)	2	0.3332	6.00240096	0.04649535	skeletal
Vernot et al. 2016 Introgressed	HPO	Polycystic kidney dysplasia (HP:0000113)	3	0.7942	3.777386049	0.04909509	urinary
Vernot et al. 2016 Introgressed	HPO	Multicystic kidney dysplasia (HP:0000003)	4	1.3735	2.912267929	0.04909509	urinary
Vernot et al. 2016 Introgressed	HPO	Chronic mucocutaneous candidiasis (HP:0002728)	1	0.0511	19.56947162	0.050494951	immune
Vernot et al. 2016 Introgressed	HPO	Recurrent cutaneous fungal infections (HP:0011370)	1	0.0511	19.56947162	0.050494951	immune
Vernot et al. 2016 Introgressed	HPO	Stomach cancer (HP:0012126)	1	0.0516	19.37984496	0.050694931	digestive
Vernot et al. 2016 Introgressed	HPO	Renal cortical cysts (HP:0000803)	1	0.0563	17.76198934	0.054194581	urinary
Vernot et al. 2016 Introgressed	HPO	Viral hepatitis (HP:0006562)	1	0.0576	17.36111111	0.055894411	immune
Vernot et al. 2016 Introgressed	HPO	Skull defect (HP:0001362)	2	0.3768	5.307855626	0.055994401	skeletal
Vernot et al. 2016 Introgressed	HPO	Combined immunodeficiency (HP:0005387)	1	0.0592	16.89189189	0.057794221	immune
Vernot et al. 2016 Introgressed	HPO	Birth length less than 3rd percentile (HP:0003561)	1	0.0609	16.42036125	0.058894111	skeletal
Vernot et al. 2016 Introgressed	HPO	Back pain (HP:0003418)	1	0.0607	16.47446458	0.059194081	skeletal
Vernot et al. 2016 Introgressed	HPO	Tubulointerstitial nephritis (HP:0001970)	1	0.0631	15.84786054	0.060493951	urinary
Vernot et al. 2016 Introgressed	HPO	Congenital hepatic fibrosis (HP:0002612)	2	0.4081	4.900759618	0.061993801	digestive
Vernot et al. 2016 Introgressed	HPO	Hirsutism (HP:0001007)	3	0.9095	3.298515668	0.063693631	integumentary
Vernot et al. 2016 Introgressed	HPO	Decreased testicular size (HP:0008734)	2	0.4043	4.946821667	0.063693631	reproductive
Vernot et al. 2016 Introgressed	HPO	Spinal rigidity (HP:0003306)	2	0.406	4.926108374	0.064293571	skeletal
Vernot et al. 2016 Introgressed	HPO	Increased neuronal autofluorescent lipopigment (HP:0002074)	1	0.0662	15.10574018	0.064593541	nervous
Vernot et al. 2016 Introgressed	HPO	Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204)	1	0.0662	15.10574018	0.064593541	other
Vernot et al. 2016 Introgressed	HPO	Vaginal atresia (HP:0000148)	2	0.4195	4.767580453	0.065893411	reproductive
Vernot et al. 2016 Introgressed	HPO	Duodenal stenosis (HP:0100867)	2	0.4345	4.602991945	0.067293271	digestive
Vernot et al. 2016 Introgressed	HPO	Tubulointerstitial fibrosis (HP:0005576)	2	0.4114	4.861448712	0.067293271	urinary
Vernot et al. 2016 Introgressed	HPO	Small intestinal stenosis (HP:0012848)	2	0.4345	4.602991945	0.067293271	digestive
Vernot et al. 2016 Introgressed	HPO	Aganglionic megacolon (HP:0002251)	3	0.9431	3.180998834	0.067993201	digestive
Vernot et al. 2016 Introgressed	HPO	Emphysema (HP:0002097)	2	0.4475	4.469273743	0.071692831	respiratory
Vernot et al. 2016 Introgressed	HPO	Abnormality of T cells (HP:0002843)	2	0.45	4.444444444	0.071692831	immune
Vernot et al. 2016 Introgressed	HPO	Abnormality of the duodenum (HP:0002246)	2	0.4495	4.449388209	0.071692831	digestive
Vernot et al. 2016 Introgressed	HPO	Agammaglobulinemia (HP:0004432)	1	0.0761	13.14060447	0.073292671	immune
Vernot et al. 2016 Introgressed	HPO	Oligomenorrhea (HP:0000876)	1	0.0784	12.75510204	0.075792421	reproductive
Vernot et al. 2016 Introgressed	HPO	Wrist flexion contracture (HP:0001239)	1	0.0815	12.26993865	0.078392161	skeletal
Vernot et al. 2016 Introgressed	HPO	Neonatal death (HP:0003811)	2	0.4488	4.456327986	0.078492151	other
Vernot et al. 2016 Introgressed	HPO	Abnormal auditory evoked potentials (HP:0006958)	1	0.0822	12.16545012	0.078892111	nervous
Vernot et al. 2016 Introgressed	HPO	External ear malformation (HP:0008572)	3	1.002	2.994011976	0.079792021	other
Vernot et al. 2016 Introgressed	HPO	Ventricular arrhythmia (HP:0004308)	3	0.994	3.018108652	0.080591941	cardiovascular
Vernot et al. 2016 Introgressed	HPO	Increased cerebral lipofuscin (HP:0011813)	1	0.0846	11.82033097	0.081391861	other
Vernot et al. 2016 Introgressed	HPO	Upper limb muscle weakness (HP:0003484)	1	0.0859	11.64144354	0.082291771	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Tetraparesis (HP:0002273)	1	0.0873	11.45475372	0.082891711	nervous
Vernot et al. 2016 Introgressed	HPO	Congenital primary aphakia (HP:0007707)	1	0.088	11.36363636	0.084091591	nervous
Vernot et al. 2016 Introgressed	HPO	Gait imbalance (HP:0002141)	1	0.088	11.36363636	0.084091591	nervous
Vernot et al. 2016 Introgressed	HPO	Genital tract atresia (HP:0001827)	2	0.4787	4.177982035	0.084391561	reproductive
Vernot et al. 2016 Introgressed	HPO	Ependymoma (HP:0002888)	1	0.0891	11.22334456	0.086091391	nervous
Vernot et al. 2016 Introgressed	HPO	Dilatation of the ascending aorta (HP:0005111)	2	0.4976	4.019292605	0.086391361	cardiovascular
Vernot et al. 2016 Introgressed	HPO	Hepatosplenomegaly (HP:0001433)	1	0.0897	11.14827202	0.086591341	digestive
Vernot et al. 2016 Introgressed	HPO	Abnormality of proline metabolism (HP:0010907)	1	0.0924	10.82251082	0.088191181	metabolic
Vernot et al. 2016 Introgressed	HPO	Hydroxyprolinuria (HP:0003080)	1	0.0924	10.82251082	0.088191181	other
Vernot et al. 2016 Introgressed	HPO	Abnormality of the astrocytes (HP:0100707)	1	0.093	10.75268817	0.089891011	nervous
Vernot et al. 2016 Introgressed	HPO	Astrocytoma (HP:0009592)	1	0.093	10.75268817	0.089891011	nervous
Vernot et al. 2016 Introgressed	HPO	Decreased number of large peripheral myelinated nerve fibers (HP:0003387)	1	0.0972	10.28806584	0.091890811	nervous
Vernot et al. 2016 Introgressed	HPO	Slender long bone (HP:0003100)	1	0.0981	10.19367992	0.092690731	skeletal
Vernot et al. 2016 Introgressed	HPO	Polygenic inheritance (HP:0010982)	1	0.0977	10.23541453	0.093490651	other
Vernot et al. 2016 Introgressed	HPO	Interstitial pulmonary disease (HP:0006530)	1	0.0975	10.25641026	0.094190581	respiratory
Vernot et al. 2016 Introgressed	HPO	Progressive muscle weakness (HP:0003323)	1	0.0991	10.09081736	0.094590541	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Paralysis (HP:0003470)	1	0.0999	10.01001001	0.094690531	nervous
Vernot et al. 2016 Introgressed	HPO	Increased hepatocellular lipid droplets (HP:0006565)	1	0.0983	10.17293998	0.094890511	metabolic
Vernot et al. 2016 Introgressed	HPO	Progressive visual loss (HP:0000529)	2	0.5246	3.812428517	0.095190481	nervous
Vernot et al. 2016 Introgressed	HPO	Highly arched eyebrow (HP:0002553)	3	1.099	2.729754322	0.095490451	integumentary
Vernot et al. 2016 Introgressed	HPO	Abnormality of the shoulder girdle musculature (HP:0001435)	2	0.5242	3.815337657	0.095590441	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Dementia (HP:0000726)	3	1.0848	2.765486726	0.097090291	nervous
Vernot et al. 2016 Introgressed	HPO	Exercise intolerance (HP:0003546)	2	0.5214	3.835826621	0.097090291	other
Vernot et al. 2016 Introgressed	HPO	Pallor (HP:0000980)	2	0.5234	3.821169278	0.097990201	integumentary
Vernot et al. 2016 Introgressed	HPO	Abnormal delayed hypersensitivity skin test (HP:0002963)	1	0.1038	9.633911368	0.098890111	integumentary
Vernot et al. 2016 Introgressed	HPO	Full cheeks (HP:0000293)	2	0.5266	3.797949107	0.100189981	other
Vernot et al. 2016 Introgressed	HPO	Nemaline bodies (HP:0003798)	1	0.1059	9.442870633	0.100489951	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Abnormality of pyrimidine metabolism (HP:0004353)	2	0.5378	3.718854593	0.100989901	metabolic
Vernot et al. 2016 Introgressed	HPO	Lipid accumulation in hepatocytes (HP:0006561)	1	0.1058	9.451795841	0.101389861	metabolic
Vernot et al. 2016 Introgressed	HPO	Horseshoe kidney (HP:0000085)	2	0.5428	3.684598379	0.101589841	urinary
Vernot et al. 2016 Introgressed	HPO	Attention deficit hyperactivity disorder (HP:0007018)	3	1.134	2.645502646	0.102489751	behavior
Vernot et al. 2016 Introgressed	HPO	Renal Fanconi syndrome (HP:0001994)	1	0.1082	9.242144177	0.103389661	urinary
Vernot et al. 2016 Introgressed	HPO	Paraparesis (HP:0002385)	1	0.1097	9.115770283	0.103989601	nervous
Vernot et al. 2016 Introgressed	HPO	Clumsiness (HP:0002312)	1	0.11	9.090909091	0.105089491	behavior
Vernot et al. 2016 Introgressed	HPO	Focal seizures (HP:0007359)	2	0.5474	3.653635367	0.107089291	nervous
Vernot et al. 2016 Introgressed	HPO	Myopathic facies (HP:0002058)	1	0.1132	8.833922261	0.107189281	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Exertional dyspnea (HP:0002875)	1	0.1134	8.818342152	0.108389161	respiratory
Vernot et al. 2016 Introgressed	HPO	Aneurysm (HP:0002617)	3	1.1416	2.62789068	0.108689131	nervous
Vernot et al. 2016 Introgressed	HPO	Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688)	1	0.1137	8.795074758	0.108889111	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Trismus (HP:0000211)	1	0.1186	8.431703204	0.110888911	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Abnormality of potassium homeostasis (HP:0011042)	2	0.571	3.50262697	0.112388761	other
Vernot et al. 2016 Introgressed	HPO	Abnormal trabecular bone morphology (HP:0100671)	1	0.1185	8.438818565	0.112988701	skeletal
Vernot et al. 2016 Introgressed	HPO	Multifactorial inheritance (HP:0001426)	1	0.1219	8.203445447	0.114488551	other
Vernot et al. 2016 Introgressed	HPO	Wormian bones (HP:0002645)	2	0.5753	3.476447071	0.115288471	skeletal
Vernot et al. 2016 Introgressed	HPO	Muscle fiber cytoplasmatic inclusion bodies (HP:0100303)	1	0.1258	7.949125596	0.117788221	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Waddling gait (HP:0002515)	2	0.5808	3.443526171	0.118188181	other
Vernot et al. 2016 Introgressed	HPO	Lumbar hyperlordosis (HP:0002938)	2	0.5896	3.392130258	0.118588141	skeletal
Vernot et al. 2016 Introgressed	HPO	Generalized hypotonia (HP:0001290)	1	0.1263	7.917656374	0.118688131	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Glioma (HP:0009733)	1	0.1266	7.898894155	0.119288071	nervous
Vernot et al. 2016 Introgressed	HPO	Developmental regression (HP:0002376)	3	1.208	2.483443709	0.120287971	behavior
Vernot et al. 2016 Introgressed	HPO	Pancreatic cysts (HP:0001737)	1	0.1283	7.794232268	0.120587941	digestive
Vernot et al. 2016 Introgressed	HPO	Cystic liver disease (HP:0006706)	1	0.1283	7.794232268	0.120587941	digestive
Vernot et al. 2016 Introgressed	HPO	Vertebral compression fractures (HP:0002953)	1	0.1278	7.824726135	0.120687931	skeletal
Vernot et al. 2016 Introgressed	HPO	Hyperphosphaturia (HP:0003109)	1	0.1288	7.763975155	0.122087791	urinary
Vernot et al. 2016 Introgressed	HPO	Abnormal urine phosphate concentration (HP:0012599)	1	0.1288	7.763975155	0.122087791	other
Vernot et al. 2016 Introgressed	HPO	Malignant hyperthermia (HP:0002047)	1	0.1298	7.704160247	0.122087791	immune
Vernot et al. 2016 Introgressed	HPO	Redundant skin (HP:0001582)	1	0.1299	7.698229407	0.122487751	integumentary
Vernot et al. 2016 Introgressed	HPO	Acanthocytosis (HP:0001927)	1	0.1369	7.304601899	0.126987301	hematologic
Vernot et al. 2016 Introgressed	HPO	Arthrogryposis multiplex congenita (HP:0002804)	2	0.6188	3.232062056	0.127087291	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Pes planus (HP:0001763)	3	1.2271	2.444788526	0.127687231	skeletal
Vernot et al. 2016 Introgressed	HPO	Nephrogenic diabetes insipidus (HP:0009806)	1	0.138	7.246376812	0.128887111	urinary
Vernot et al. 2016 Introgressed	HPO	Myelodysplasia (HP:0002863)	2	0.6254	3.19795331	0.129387061	hematologic
Vernot et al. 2016 Introgressed	HPO	Cerebral aneurysm (HP:0004944)	1	0.1394	7.173601148	0.130286971	nervous
Vernot et al. 2016 Introgressed	HPO	Facial shape deformation (HP:0011334)	1	0.1399	7.147962831	0.130486951	skeletal
Vernot et al. 2016 Introgressed	HPO	Potter facies (HP:0002009)	1	0.1399	7.147962831	0.130486951	other
Vernot et al. 2016 Introgressed	HPO	Abnormality of renal resorption (HP:0011038)	1	0.1402	7.132667618	0.131286871	urinary
Vernot et al. 2016 Introgressed	HPO	Hip contracture (HP:0003273)	1	0.1445	6.920415225	0.133286671	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Abnormal pupillary function (HP:0007686)	1	0.141	7.092198582	0.133586641	nervous
Vernot et al. 2016 Introgressed	HPO	Narrow mouth (HP:0000160)	4	1.933	2.069322297	0.133586641	skeletal
Vernot et al. 2016 Introgressed	HPO	Generalized amyotrophy (HP:0003700)	1	0.1442	6.93481276	0.135286471	nervous
Vernot et al. 2016 Introgressed	HPO	Depressed nasal ridge (HP:0000457)	3	1.2803	2.343200812	0.136086391	skeletal
Vernot et al. 2016 Introgressed	HPO	Hepatitis (HP:0012115)	1	0.1462	6.83994528	0.136586341	immune
Vernot et al. 2016 Introgressed	HPO	Breast hypoplasia (HP:0003187)	1	0.1514	6.605019815	0.139186081	reproductive
Vernot et al. 2016 Introgressed	HPO	Increased connective tissue (HP:0009025)	1	0.1498	6.675567423	0.139486051	other
Vernot et al. 2016 Introgressed	HPO	Ascites (HP:0001541)	3	1.2958	2.315172094	0.140285971	digestive
Vernot et al. 2016 Introgressed	HPO	Muscle fiber inclusion bodies (HP:0100299)	1	0.1518	6.587615283	0.141085891	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Myotonia (HP:0002486)	1	0.1531	6.531678641	0.141485851	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Abnormal ciliary motility (HP:0012262)	1	0.1548	6.45994832	0.143085691	respiratory
Vernot et al. 2016 Introgressed	HPO	Abnormality of glutamine family amino acid metabolism (HP:0010902)	1	0.1587	6.301197227	0.144385561	metabolic
Vernot et al. 2016 Introgressed	HPO	Anorexia (HP:0002039)	1	0.1579	6.333122229	0.147685231	behavior
Vernot et al. 2016 Introgressed	HPO	Abnormal lung lobation (HP:0002101)	2	0.6789	2.945941965	0.149785021	respiratory
Vernot et al. 2016 Introgressed	HPO	Disinhibition (HP:0000734)	1	0.1652	6.053268765	0.152184782	behavior
Vernot et al. 2016 Introgressed	HPO	Neutropenia (HP:0001875)	2	0.6957	2.874802357	0.155384462	immune
Vernot et al. 2016 Introgressed	HPO	Abnormal vertebral ossification (HP:0100569)	1	0.1682	5.94530321	0.156084392	skeletal
Vernot et al. 2016 Introgressed	HPO	Subcapsular cataract (HP:0000523)	1	0.1702	5.875440658	0.156184382	nervous
Vernot et al. 2016 Introgressed	HPO	Posterior subcapsular cataract (HP:0007787)	1	0.1702	5.875440658	0.156184382	nervous
Vernot et al. 2016 Introgressed	HPO	Respiratory failure (HP:0002878)	2	0.694	2.88184438	0.156484352	respiratory
Vernot et al. 2016 Introgressed	HPO	Glycosuria (HP:0003076)	1	0.1701	5.878894768	0.157184282	urinary
Vernot et al. 2016 Introgressed	HPO	Abnormality of urine glucose concentration (HP:0011016)	1	0.1701	5.878894768	0.157184282	urinary
Vernot et al. 2016 Introgressed	HPO	Underdeveloped nasal alae (HP:0000430)	2	0.7072	2.828054299	0.157384262	integumentary
Vernot et al. 2016 Introgressed	HPO	Ectopic kidney (HP:0000086)	2	0.7145	2.799160252	0.157484252	urinary
Vernot et al. 2016 Introgressed	HPO	Acute hepatic failure (HP:0006554)	1	0.1723	5.803830528	0.157584242	digestive
Vernot et al. 2016 Introgressed	HPO	Vascular tortuosity (HP:0004948)	1	0.1699	5.885815185	0.157584242	cardiovascular
Vernot et al. 2016 Introgressed	HPO	Atelectasis (HP:0100750)	1	0.1727	5.790387956	0.158284172	respiratory
Vernot et al. 2016 Introgressed	HPO	Chromosomal breakage induced by crosslinking agents (HP:0003221)	1	0.1746	5.727376861	0.161383862	other
Vernot et al. 2016 Introgressed	HPO	Abnormality of the renal collecting system (HP:0004742)	1	0.1746	5.727376861	0.161383862	urinary
Vernot et al. 2016 Introgressed	HPO	Duplicated collecting system (HP:0000081)	1	0.1746	5.727376861	0.161383862	urinary
Vernot et al. 2016 Introgressed	HPO	Chromsome breakage (HP:0040012)	1	0.1746	5.727376861	0.161383862	other
Vernot et al. 2016 Introgressed	HPO	Coxa valga (HP:0002673)	1	0.1768	5.656108597	0.161783822	skeletal
Vernot et al. 2016 Introgressed	HPO	Poor coordination (HP:0002370)	1	0.1786	5.599104143	0.162683732	nervous
Vernot et al. 2016 Introgressed	HPO	Sloping forehead (HP:0000340)	3	1.3978	2.14622979	0.163383662	skeletal
Vernot et al. 2016 Introgressed	HPO	Frequent falls (HP:0002359)	1	0.1777	5.627462015	0.163683632	other
Vernot et al. 2016 Introgressed	HPO	Colitis (HP:0002583)	1	0.1798	5.561735261	0.163683632	digestive
Vernot et al. 2016 Introgressed	HPO	Truncus arteriosus (HP:0001660)	1	0.1777	5.627462015	0.164483552	cardiovascular
Vernot et al. 2016 Introgressed	HPO	Recurrent skin infections (HP:0001581)	1	0.178	5.617977528	0.165083492	immune
Vernot et al. 2016 Introgressed	HPO	Overgrowth (HP:0001548)	1	0.1831	5.46149645	0.166383362	other
Vernot et al. 2016 Introgressed	HPO	Abnormality of nucleobase metabolism (HP:0010932)	2	0.7405	2.700877785	0.166383362	metabolic
Vernot et al. 2016 Introgressed	HPO	Protrusio acetabuli (HP:0003179)	1	0.1841	5.431830527	0.168183182	skeletal
Vernot et al. 2016 Introgressed	HPO	Reticulocytopenia (HP:0001896)	1	0.1843	5.425935974	0.169683032	hematologic
Vernot et al. 2016 Introgressed	HPO	Choanal atresia (HP:0000453)	2	0.742	2.69541779	0.171282872	respiratory
Vernot et al. 2016 Introgressed	HPO	Mask-like facies (HP:0000298)	1	0.1883	5.310674456	0.173382662	other
Vernot et al. 2016 Introgressed	HPO	Type 1 muscle fiber predominance (HP:0003803)	1	0.1906	5.246589717	0.173682632	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Abnormal large intestine physiology (HP:0012700)	1	0.1894	5.279831045	0.173782622	digestive
Vernot et al. 2016 Introgressed	HPO	Bowel incontinence (HP:0002607)	1	0.1894	5.279831045	0.173782622	digestive
Vernot et al. 2016 Introgressed	HPO	Dialeptic seizures (HP:0011146)	2	0.7544	2.651113468	0.174082592	nervous
Vernot et al. 2016 Introgressed	HPO	Encephalitis (HP:0002383)	1	0.1913	5.227391532	0.174182582	nervous
Vernot et al. 2016 Introgressed	HPO	Bifid scrotum (HP:0000048)	1	0.1939	5.157297576	0.175982402	reproductive
Vernot et al. 2016 Introgressed	HPO	Atresia of the external auditory canal (HP:0000413)	2	0.7635	2.61951539	0.177982202	nervous
Vernot et al. 2016 Introgressed	HPO	Slender build (HP:0001533)	1	0.1991	5.022601708	0.180581942	other
Vernot et al. 2016 Introgressed	HPO	Abnormality of T cell physiology (HP:0011840)	1	0.1979	5.0530571	0.180681932	immune
Vernot et al. 2016 Introgressed	HPO	Short foot (HP:0001773)	2	0.7741	2.583645524	0.182881712	skeletal
Vernot et al. 2016 Introgressed	HPO	Abnormal respiratory motile cilium physiology (HP:0012261)	1	0.204	4.901960784	0.183681632	respiratory
Vernot et al. 2016 Introgressed	HPO	Vertebral clefting (HP:0008428)	1	0.2013	4.967709886	0.183781622	skeletal
Vernot et al. 2016 Introgressed	HPO	Polar cataract (HP:0010696)	1	0.2025	4.938271605	0.183781622	nervous
Vernot et al. 2016 Introgressed	HPO	Muscle abnormality related to mitochondrial dysfunction (HP:0003800)	1	0.2028	4.930966469	0.184081592	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Specific learning disability (HP:0001328)	1	0.2064	4.84496124	0.185481452	other
Vernot et al. 2016 Introgressed	HPO	Abnormality of DNA repair (HP:0003254)	1	0.2051	4.875670405	0.186981302	other
Vernot et al. 2016 Introgressed	HPO	Joint swelling (HP:0001386)	1	0.2101	4.759638267	0.187981202	skeletal
Vernot et al. 2016 Introgressed	HPO	Cardiomegaly (HP:0001640)	1	0.2052	4.873294347	0.188481152	cardiovascular
Vernot et al. 2016 Introgressed	HPO	Ureteral duplication (HP:0000073)	1	0.2074	4.821600771	0.189581042	urinary
Vernot et al. 2016 Introgressed	HPO	Polyhydramnios (HP:0001561)	3	1.4982	2.002402883	0.191980802	reproductive
Vernot et al. 2016 Introgressed	HPO	Portal hypertension (HP:0001409)	1	0.2132	4.69043152	0.194180582	cardiovascular
Vernot et al. 2016 Introgressed	HPO	Abnormality of the hepatic vasculature (HP:0006707)	1	0.2132	4.69043152	0.194180582	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Inappropriate behavior (HP:0000719)	1	0.2175	4.597701149	0.196380362	behavior
Vernot et al. 2016 Introgressed	HPO	Neoplasm of the oral cavity (HP:0100649)	1	0.2188	4.570383912	0.196780322	other
Vernot et al. 2016 Introgressed	HPO	Respiratory difficulties (HP:0002880)	1	0.2174	4.599816007	0.198380162	respiratory
Vernot et al. 2016 Introgressed	HPO	Bladder diverticulum (HP:0000015)	1	0.225	4.444444444	0.199680032	urinary
Vernot et al. 2016 Introgressed	HPO	Premature skin wrinkling (HP:0100678)	1	0.2239	4.466279589	0.199980002	integumentary
Vernot et al. 2016 Introgressed	HPO	Meckel diverticulum (HP:0002245)	1	0.2222	4.500450045	0.200779922	digestive
Vernot et al. 2016 Introgressed	HPO	Radial deviation of finger (HP:0009466)	6	3.9294	1.526950679	0.203079692	skeletal
Vernot et al. 2016 Introgressed	HPO	Facial asymmetry (HP:0000324)	2	0.842	2.375296912	0.204379562	other
Vernot et al. 2016 Introgressed	HPO	Abnormality of the preputium (HP:0100587)	1	0.2264	4.416961131	0.204579542	reproductive
Vernot et al. 2016 Introgressed	HPO	Breast aplasia (HP:0100783)	1	0.2294	4.359197908	0.204979502	reproductive
Vernot et al. 2016 Introgressed	HPO	Astigmatism (HP:0000483)	2	0.8483	2.357656489	0.206579342	nervous
Vernot et al. 2016 Introgressed	HPO	Respiratory distress (HP:0002098)	1	0.2352	4.25170068	0.208679132	respiratory
Vernot et al. 2016 Introgressed	HPO	Difficulty running (HP:0009046)	1	0.2347	4.260758415	0.208879112	other
Vernot et al. 2016 Introgressed	HPO	Esophageal varix (HP:0002040)	1	0.2321	4.308487721	0.210578942	cardiovascular
Vernot et al. 2016 Introgressed	HPO	Increased intramyocellular lipid droplets (HP:0012240)	1	0.2364	4.230118443	0.212178782	metabolic
Vernot et al. 2016 Introgressed	HPO	Areflexia of lower limbs (HP:0002522)	1	0.2372	4.215851602	0.212978702	nervous
Vernot et al. 2016 Introgressed	HPO	Recurrent pneumonia (HP:0006532)	1	0.2377	4.206983593	0.212978702	immune
Vernot et al. 2016 Introgressed	HPO	Abnormality of chromosome stability (HP:0003220)	1	0.2391	4.182350481	0.213678632	other
Vernot et al. 2016 Introgressed	HPO	Small for gestational age (HP:0001518)	2	0.8767	2.281282081	0.215378462	other
Vernot et al. 2016 Introgressed	HPO	Weight loss (HP:0001824)	3	1.5909	1.885725061	0.215778422	metabolic
Vernot et al. 2016 Introgressed	HPO	Acute lymphatic leukemia (HP:0006721)	1	0.2457	4.07000407	0.217778222	lymphatic
Vernot et al. 2016 Introgressed	HPO	Increased muscle lipid content (HP:0009058)	1	0.2439	4.100041	0.217878212	metabolic
Vernot et al. 2016 Introgressed	HPO	IgA deficiency (HP:0002720)	1	0.2473	4.043671654	0.219078092	immune
Vernot et al. 2016 Introgressed	HPO	EMG: myopathic abnormalities (HP:0003458)	2	0.8759	2.283365681	0.219378062	nervous
Vernot et al. 2016 Introgressed	HPO	Abnormality of the basal ganglia (HP:0002134)	1	0.2489	4.017677782	0.219478052	nervous
Vernot et al. 2016 Introgressed	HPO	Macular degeneration (HP:0000608)	1	0.2518	3.971405878	0.221077892	nervous
Vernot et al. 2016 Introgressed	HPO	Supernumerary nipples (HP:0002558)	1	0.2479	4.033884631	0.221277872	other
Vernot et al. 2016 Introgressed	HPO	Somatic mutation (HP:0001428)	2	0.893	2.239641657	0.222877712	other
Vernot et al. 2016 Introgressed	HPO	Abnormality of oral frenula (HP:0000190)	1	0.2538	3.940110323	0.223477652	integumentary
Vernot et al. 2016 Introgressed	HPO	Ankyloglossia (HP:0010296)	1	0.2538	3.940110323	0.223477652	other
Vernot et al. 2016 Introgressed	HPO	Hyporeflexia of lower limbs (HP:0002600)	1	0.251	3.984063745	0.223577642	skeletal
Vernot et al. 2016 Introgressed	HPO	Slow progression (HP:0003677)	3	1.6356	1.834189288	0.224377562	other
Vernot et al. 2016 Introgressed	HPO	Medial flaring of the eyebrow (HP:0010747)	1	0.2555	3.913894325	0.225777422	integumentary
Vernot et al. 2016 Introgressed	HPO	Hypokalemia (HP:0002900)	1	0.2598	3.849114704	0.227177282	other
Vernot et al. 2016 Introgressed	HPO	Chronic diarrhea (HP:0002028)	1	0.2596	3.852080123	0.227977202	digestive
Vernot et al. 2016 Introgressed	HPO	Abnormality of the carotid arteries (HP:0005344)	1	0.2558	3.909304144	0.228177182	cardiovascular
Vernot et al. 2016 Introgressed	HPO	Diaphragmatic weakness (HP:0009113)	1	0.2614	3.825554705	0.230076992	respiratory
Vernot et al. 2016 Introgressed	HPO	Hypogonadotrophic hypogonadism (HP:0000044)	1	0.2605	3.838771593	0.231276872	endocrine
Vernot et al. 2016 Introgressed	HPO	T lymphocytopenia (HP:0005403)	1	0.2658	3.762227239	0.234676532	immune
Vernot et al. 2016 Introgressed	HPO	Self-mutilation (HP:0000742)	1	0.272	3.676470588	0.236376362	behavior
Vernot et al. 2016 Introgressed	HPO	Generalized myoclonic seizures (HP:0002123)	1	0.2709	3.69139904	0.236776322	nervous
Vernot et al. 2016 Introgressed	HPO	Hepatic necrosis (HP:0002605)	1	0.27	3.703703704	0.238376162	digestive
Vernot et al. 2016 Introgressed	HPO	Hepatocellular necrosis (HP:0001404)	1	0.27	3.703703704	0.238376162	digestive
Vernot et al. 2016 Introgressed	HPO	Micropenis (HP:0000054)	3	1.6822	1.783378909	0.240475952	reproductive
Vernot et al. 2016 Introgressed	HPO	Aplasia/Hypoplasia of the lens (HP:0008063)	1	0.2746	3.641660597	0.241175882	nervous
Vernot et al. 2016 Introgressed	HPO	Increased variability in muscle fiber diameter (HP:0003557)	1	0.2767	3.614022407	0.243375662	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Abnormality of skeletal muscle fiber size (HP:0012084)	1	0.2767	3.614022407	0.243375662	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Drooling (HP:0002307)	1	0.2787	3.588087549	0.243675632	other
Vernot et al. 2016 Introgressed	HPO	Excessive salivation (HP:0003781)	1	0.2787	3.588087549	0.243675632	digestive
Vernot et al. 2016 Introgressed	HPO	Unsteady gait (HP:0002317)	1	0.2803	3.567606136	0.243675632	other
Vernot et al. 2016 Introgressed	HPO	Elevated hepatic transaminases (HP:0002910)	2	0.9383	2.131514441	0.244775522	digestive
Vernot et al. 2016 Introgressed	HPO	Flat face (HP:0012368)	2	0.9531	2.098415696	0.244875512	skeletal
Vernot et al. 2016 Introgressed	HPO	Generalized tonic-clonic seizures (HP:0002069)	2	0.9407	2.126076326	0.245475452	nervous
Vernot et al. 2016 Introgressed	HPO	Increased nuchal translucency (HP:0010880)	1	0.2837	3.524850194	0.246475352	other
Vernot et al. 2016 Introgressed	HPO	Gowers sign (HP:0003391)	1	0.2767	3.614022407	0.247075292	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Progressive disorder (HP:0003676)	3	1.7322	1.731901628	0.249275072	other
Vernot et al. 2016 Introgressed	HPO	Bulbar palsy (HP:0001283)	1	0.2818	3.54861604	0.249875012	nervous
Vernot et al. 2016 Introgressed	HPO	EMG: neuropathic changes (HP:0003445)	1	0.2879	3.473428274	0.250274973	nervous
Vernot et al. 2016 Introgressed	HPO	Abnormality of T cell number (HP:0011839)	1	0.2861	3.49528137	0.250374963	immune
Vernot et al. 2016 Introgressed	HPO	Right ventricular cardiomyopathy (HP:0011663)	1	0.2886	3.465003465	0.252174783	cardiovascular
Vernot et al. 2016 Introgressed	HPO	Morphological abnormality of the middle ear (HP:0008609)	1	0.2948	3.392130258	0.254274573	skeletal
Vernot et al. 2016 Introgressed	HPO	Poikilocytosis (HP:0004447)	1	0.2968	3.369272237	0.256074393	hematologic
Vernot et al. 2016 Introgressed	HPO	Pathologic fracture (HP:0002756)	1	0.2985	3.350083752	0.258974103	skeletal
Vernot et al. 2016 Introgressed	HPO	Mildly elevated creatine phosphokinase (HP:0008180)	1	0.3016	3.315649867	0.259774023	other
Vernot et al. 2016 Introgressed	HPO	Tetraplegia (HP:0002445)	1	0.3044	3.285151117	0.261173883	nervous
Vernot et al. 2016 Introgressed	HPO	Renal agenesis (HP:0000104)	1	0.302	3.311258278	0.262073793	urinary
Vernot et al. 2016 Introgressed	HPO	Cafe-au-lait spot (HP:0000957)	2	0.9935	2.013085053	0.262973703	integumentary
Vernot et al. 2016 Introgressed	HPO	Arachnodactyly (HP:0001166)	2	0.9933	2.013490386	0.264773523	skeletal
Vernot et al. 2016 Introgressed	HPO	Arteriovenous malformation (HP:0100026)	2	1.0062	1.987676406	0.266173383	cardiovascular
Vernot et al. 2016 Introgressed	HPO	Dental crowding (HP:0000678)	2	1.0041	1.991833483	0.266673333	skeletal
Vernot et al. 2016 Introgressed	HPO	Female pseudohermaphroditism (HP:0010458)	2	1.012	1.976284585	0.267573243	reproductive
Vernot et al. 2016 Introgressed	HPO	Rapidly progressive (HP:0003678)	1	0.3115	3.210272873	0.267673233	other
Vernot et al. 2016 Introgressed	HPO	Coronal craniosynostosis (HP:0004440)	1	0.3113	3.212335368	0.268173183	skeletal
Vernot et al. 2016 Introgressed	HPO	Hyperkalemia (HP:0002153)	1	0.3112	3.213367609	0.269973003	other
Vernot et al. 2016 Introgressed	HPO	Ptosis (HP:0000508)	7	5.2402	1.335826877	0.273272673	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Cellular immunodeficiency (HP:0005374)	1	0.3235	3.091190108	0.274772523	immune
Vernot et al. 2016 Introgressed	HPO	Pyloric stenosis (HP:0002021)	2	1.0344	1.933488012	0.277572243	digestive
Vernot et al. 2016 Introgressed	HPO	Restlessness (HP:0000711)	1	0.3264	3.06372549	0.278472153	behavior
Vernot et al. 2016 Introgressed	HPO	Rhabdomyosarcoma (HP:0002859)	1	0.3227	3.098853424	0.278772123	other
Vernot et al. 2016 Introgressed	HPO	Lower limb muscle weakness (HP:0007340)	1	0.3275	3.053435115	0.279972003	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Hepatomegaly (HP:0002240)	5	3.5431	1.411193588	0.282871713	digestive
Vernot et al. 2016 Introgressed	HPO	Personality changes (HP:0000751)	1	0.3342	2.992220227	0.283671633	behavior
Vernot et al. 2016 Introgressed	HPO	Aortic valve stenosis (HP:0001650)	1	0.3338	2.995805872	0.285471453	cardiovascular
Vernot et al. 2016 Introgressed	HPO	Mitochondrial inheritance (HP:0001427)	1	0.334	2.994011976	0.285771423	other
Vernot et al. 2016 Introgressed	HPO	Gastrointestinal inflammation (HP:0004386)	1	0.3398	2.942907593	0.287271273	digestive
Vernot et al. 2016 Introgressed	HPO	Inflammation of the large intestine (HP:0002037)	1	0.3398	2.942907593	0.287271273	digestive
Vernot et al. 2016 Introgressed	HPO	Biliary tract neoplasm (HP:0100574)	1	0.3366	2.970885324	0.288271173	digestive
Vernot et al. 2016 Introgressed	HPO	Autosomal recessive inheritance (HP:0000007)	32	28.6219	1.118025009	0.288771123	other
Vernot et al. 2016 Introgressed	HPO	Aplasia/Hypoplasia of the patella (HP:0006498)	1	0.3409	2.933411558	0.289971003	skeletal
Vernot et al. 2016 Introgressed	HPO	Patellar aplasia (HP:0006443)	1	0.3409	2.933411558	0.289971003	skeletal
Vernot et al. 2016 Introgressed	HPO	Abnormality of femoral epiphyses (HP:0006499)	1	0.339	2.949852507	0.290470953	skeletal
Vernot et al. 2016 Introgressed	HPO	Abnormality involving the epiphyses of the lower limbs (HP:0006500)	1	0.339	2.949852507	0.290470953	skeletal
Vernot et al. 2016 Introgressed	HPO	Polyneuropathy (HP:0001271)	1	0.3475	2.877697842	0.292070793	nervous
Vernot et al. 2016 Introgressed	HPO	Embryonal renal neoplasm (HP:0011794)	1	0.3471	2.881014117	0.294170583	urinary
Vernot et al. 2016 Introgressed	HPO	Nephroblastoma (Wilms tumor) (HP:0002667)	1	0.3471	2.881014117	0.294170583	urinary
Vernot et al. 2016 Introgressed	HPO	"Low-set, posteriorly rotated ears (HP:0000368)"	8	6.3025	1.269337564	0.296270373	other
Vernot et al. 2016 Introgressed	HPO	High pitched voice (HP:0001620)	1	0.3477	2.876042565	0.296470353	other
Vernot et al. 2016 Introgressed	HPO	Dyskinesia (HP:0100660)	1	0.3508	2.850627138	0.297470253	nervous
Vernot et al. 2016 Introgressed	HPO	Absent thumb (HP:0009777)	1	0.3547	2.819283902	0.299370063	skeletal
Vernot et al. 2016 Introgressed	HPO	Midline defect of the nose (HP:0004122)	1	0.3626	2.757859901	0.299570043	other
Vernot et al. 2016 Introgressed	HPO	Short thumb (HP:0009778)	1	0.3512	2.84738041	0.300969903	skeletal
Vernot et al. 2016 Introgressed	HPO	Neck muscle weakness (HP:0000467)	1	0.3581	2.792516057	0.302769723	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Clinodactyly of the 5th finger (HP:0004209)	5	3.6829	1.357625784	0.303069693	skeletal
Vernot et al. 2016 Introgressed	HPO	Myelomeningocele (HP:0002475)	1	0.3629	2.75558005	0.303969603	nervous
Vernot et al. 2016 Introgressed	HPO	Aplasia/Hypoplasia of the breasts (HP:0010311)	1	0.3692	2.708559047	0.306469353	reproductive
Vernot et al. 2016 Introgressed	HPO	Neoplasm of the colon (HP:0100273)	1	0.3676	2.720348205	0.308669133	digestive
Vernot et al. 2016 Introgressed	HPO	Bilateral microphthalmos (HP:0007633)	1	0.3729	2.681684098	0.309569043	nervous
Vernot et al. 2016 Introgressed	HPO	Neoplasm of striated muscle (HP:0009728)	1	0.3675	2.721088435	0.309869013	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Obsessive-compulsive behavior (HP:0000722)	1	0.3751	2.665955745	0.313068693	behavior
Vernot et al. 2016 Introgressed	HPO	Aortic aneurysm (HP:0004942)	1	0.3698	2.704164413	0.313268673	cardiovascular
Vernot et al. 2016 Introgressed	HPO	Splenomegaly (HP:0001744)	4	2.842	1.407459536	0.315868413	lymphatic
Vernot et al. 2016 Introgressed	HPO	Hydrocephalus (HP:0000238)	4	2.8564	1.400364095	0.317268273	nervous
Vernot et al. 2016 Introgressed	HPO	Oligodontia (HP:0000677)	1	0.3816	2.620545073	0.317968203	skeletal
Vernot et al. 2016 Introgressed	HPO	Bowel diverticulosis (HP:0005222)	1	0.3872	2.582644628	0.321267873	digestive
Vernot et al. 2016 Introgressed	HPO	Choanal stenosis (HP:0000452)	1	0.3893	2.568713075	0.321767823	respiratory
Vernot et al. 2016 Introgressed	HPO	Muscular dystrophy (HP:0003560)	2	1.1626	1.720282126	0.323367663	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Overfolded helix (HP:0000396)	1	0.3962	2.523977789	0.324867513	integumentary
Vernot et al. 2016 Introgressed	HPO	Abnormally folded helix (HP:0008544)	1	0.3962	2.523977789	0.324867513	integumentary
Vernot et al. 2016 Introgressed	HPO	Stage 5 chronic kidney disease (HP:0003774)	1	0.394	2.538071066	0.325367463	urinary
Vernot et al. 2016 Introgressed	HPO	Cutaneous finger syndactyly (HP:0010554)	2	1.167	1.713796058	0.326167383	integumentary
Vernot et al. 2016 Introgressed	HPO	Scapular winging (HP:0003691)	1	0.396	2.525252525	0.329867013	skeletal
Vernot et al. 2016 Introgressed	HPO	Rectal prolapse (HP:0002035)	1	0.4004	2.497502498	0.330066993	digestive
Vernot et al. 2016 Introgressed	HPO	Emotional lability (HP:0000712)	1	0.4037	2.477086946	0.333166683	behavior
Vernot et al. 2016 Introgressed	HPO	Left ventricular hypertrophy (HP:0001712)	1	0.4112	2.431906615	0.334866513	cardiovascular
Vernot et al. 2016 Introgressed	HPO	Conical tooth (HP:0000698)	1	0.4083	2.449179525	0.335166483	skeletal
Vernot et al. 2016 Introgressed	HPO	Genu recurvatum (HP:0002816)	1	0.4103	2.437241043	0.336066393	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Cleft eyelid (HP:0000625)	1	0.4119	2.427773731	0.336966303	integumentary
Vernot et al. 2016 Introgressed	HPO	Vesicoureteral reflux (HP:0000076)	2	1.1968	1.671122995	0.338666133	urinary
Vernot et al. 2016 Introgressed	HPO	Cutaneous syndactyly (HP:0012725)	2	1.2058	1.658649859	0.338966103	integumentary
Vernot et al. 2016 Introgressed	HPO	Asthma (HP:0002099)	1	0.4253	2.351281448	0.343465653	respiratory
Vernot et al. 2016 Introgressed	HPO	Abnormal biliary tract morphology (HP:0012440)	1	0.4203	2.379252915	0.343665633	digestive
Vernot et al. 2016 Introgressed	HPO	Peripheral demyelination (HP:0011096)	1	0.4201	2.380385622	0.343765623	nervous
Vernot et al. 2016 Introgressed	HPO	Broad foot (HP:0001769)	1	0.4267	2.343566909	0.345065493	skeletal
Vernot et al. 2016 Introgressed	HPO	Severe global developmental delay (HP:0011344)	1	0.4211	2.374732843	0.346565343	nervous
Vernot et al. 2016 Introgressed	HPO	Clitoromegaly (HP:0000057)	1	0.4302	2.324500232	0.347665233	reproductive
Vernot et al. 2016 Introgressed	HPO	Nephronophthisis (HP:0000090)	1	0.4273	2.340276153	0.348465153	urinary
Vernot et al. 2016 Introgressed	HPO	Generalized muscle weakness (HP:0003324)	1	0.4359	2.294104152	0.352864714	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Ectopia lentis (HP:0001083)	1	0.4381	2.282583885	0.354364564	nervous
Vernot et al. 2016 Introgressed	HPO	Congenital hip dislocation (HP:0001374)	1	0.4366	2.290426019	0.354764524	skeletal
Vernot et al. 2016 Introgressed	HPO	Clubbing of toes (HP:0100760)	1	0.4418	2.263467632	0.357664234	integumentary
Vernot et al. 2016 Introgressed	HPO	Leukopenia (HP:0001882)	1	0.4444	2.250225023	0.360763924	immune
Vernot et al. 2016 Introgressed	HPO	Optic disc pallor (HP:0000543)	1	0.4462	2.241147468	0.360863914	nervous
Vernot et al. 2016 Introgressed	HPO	Duplication of thumb phalanx (HP:0009942)	1	0.4474	2.235136343	0.361563844	skeletal
Vernot et al. 2016 Introgressed	HPO	Low anterior hairline (HP:0000294)	1	0.4548	2.19876869	0.363763624	integumentary
Vernot et al. 2016 Introgressed	HPO	Intestinal polyposis (HP:0200008)	1	0.4516	2.214348981	0.364463554	digestive
Vernot et al. 2016 Introgressed	HPO	Bone pain (HP:0002653)	1	0.4557	2.194426158	0.365463454	skeletal
Vernot et al. 2016 Introgressed	HPO	Intestinal polyp (HP:0005266)	1	0.4584	2.181500873	0.368463154	digestive
Vernot et al. 2016 Introgressed	HPO	Lymphangioma (HP:0100764)	1	0.466	2.145922747	0.372262774	lymphatic
Vernot et al. 2016 Introgressed	HPO	Postnatal growth retardation (HP:0008897)	2	1.2978	1.541069502	0.372662734	metabolic
Vernot et al. 2016 Introgressed	HPO	Tachypnea (HP:0002789)	1	0.4634	2.157962883	0.373362664	respiratory
Vernot et al. 2016 Introgressed	HPO	Renal tubular dysfunction (HP:0000124)	1	0.4721	2.118195298	0.373462654	urinary
Vernot et al. 2016 Introgressed	HPO	Infertility (HP:0000789)	1	0.4622	2.163565556	0.375262474	reproductive
Vernot et al. 2016 Introgressed	HPO	Hypocalcemia (HP:0002901)	1	0.4736	2.111486486	0.376362364	other
Vernot et al. 2016 Introgressed	HPO	Pulmonary hypertension (HP:0002092)	1	0.4697	2.129018522	0.376562344	cardiovascular
Vernot et al. 2016 Introgressed	HPO	Abnormality of the nasolacrimal system (HP:0000614)	1	0.4789	2.088118605	0.378662134	other
Vernot et al. 2016 Introgressed	HPO	Abnormality of the lacrimal duct (HP:0011481)	1	0.4789	2.088118605	0.378662134	other
Vernot et al. 2016 Introgressed	HPO	Wide intermamillary distance (HP:0006610)	1	0.4824	2.072968491	0.381361864	reproductive
Vernot et al. 2016 Introgressed	HPO	Abnormality of the ileum (HP:0001549)	1	0.4839	2.066542674	0.382061794	digestive
Vernot et al. 2016 Introgressed	HPO	Mitral regurgitation (HP:0001653)	1	0.4761	2.100399076	0.382761724	cardiovascular
Vernot et al. 2016 Introgressed	HPO	Laryngomalacia (HP:0001601)	1	0.4822	2.073828287	0.384861514	other
Vernot et al. 2016 Introgressed	HPO	Meningitis (HP:0001287)	1	0.4899	2.041232905	0.385161484	nervous
Vernot et al. 2016 Introgressed	HPO	Aplasia/Hypoplasia of the uvula (HP:0010293)	1	0.4839	2.066542674	0.385461454	skeletal
Vernot et al. 2016 Introgressed	HPO	Anophthalmia (HP:0000528)	1	0.4829	2.070822116	0.385561444	nervous
Vernot et al. 2016 Introgressed	HPO	Camptodactyly of finger (HP:0100490)	3	2.2522	1.332030903	0.386661334	skeletal
Vernot et al. 2016 Introgressed	HPO	Narrow chest (HP:0000774)	2	1.3385	1.494209936	0.387561244	skeletal
Vernot et al. 2016 Introgressed	HPO	CNS demyelination (HP:0007305)	1	0.4949	2.020610224	0.388561144	nervous
Vernot et al. 2016 Introgressed	HPO	Pectus excavatum (HP:0000767)	3	2.259	1.328021248	0.392660734	skeletal
Vernot et al. 2016 Introgressed	HPO	Bronchiectasis (HP:0002110)	1	0.4953	2.018978397	0.393360664	respiratory
Vernot et al. 2016 Introgressed	HPO	Abnormality of small intestinal villus morphology (HP:0011472)	1	0.4977	2.009242516	0.393960604	digestive
Vernot et al. 2016 Introgressed	HPO	Villous atrophy (HP:0011473)	1	0.4977	2.009242516	0.393960604	digestive
Vernot et al. 2016 Introgressed	HPO	Abnormality of reticulocytes (HP:0004312)	1	0.4991	2.003606492	0.395460454	immune
Vernot et al. 2016 Introgressed	HPO	Choreoathetosis (HP:0001266)	1	0.5051	1.979805979	0.396260374	nervous
Vernot et al. 2016 Introgressed	HPO	Inguinal hernia (HP:0000023)	2	1.3805	1.448750453	0.398160184	digestive
Vernot et al. 2016 Introgressed	HPO	Irritability (HP:0000737)	1	0.5145	1.943634597	0.401959804	behavior
Vernot et al. 2016 Introgressed	HPO	Tracheoesophageal fistula (HP:0002575)	1	0.512	1.953125	0.402759724	respiratory
Vernot et al. 2016 Introgressed	HPO	Aplasia involving forearm bones (HP:0009822)	1	0.5144	1.944012442	0.404759524	skeletal
Vernot et al. 2016 Introgressed	HPO	Absent radius (HP:0003974)	1	0.5144	1.944012442	0.404759524	skeletal
Vernot et al. 2016 Introgressed	HPO	Absent forearm bone (HP:0003953)	1	0.5144	1.944012442	0.404759524	skeletal
Vernot et al. 2016 Introgressed	HPO	Hypospadias (HP:0000047)	2	1.386	1.443001443	0.405759424	urinary
Vernot et al. 2016 Introgressed	HPO	Embryonal neoplasm (HP:0002898)	1	0.5266	1.898974554	0.406059394	other
Vernot et al. 2016 Introgressed	HPO	Absent eyelashes (HP:0000561)	1	0.5286	1.891789633	0.407259274	integumentary
Vernot et al. 2016 Introgressed	HPO	Abnormality of the acetabulum (HP:0003170)	1	0.5291	1.89000189	0.407859214	skeletal
Vernot et al. 2016 Introgressed	HPO	Absent eyebrow (HP:0002223)	1	0.5355	1.867413632	0.410158984	integumentary
Vernot et al. 2016 Introgressed	HPO	"Intellectual disability, profound (HP:0002187)"	1	0.5237	1.909490166	0.410458954	nervous
Vernot et al. 2016 Introgressed	HPO	Tracheal stenosis (HP:0002777)	1	0.538	1.858736059	0.411758824	respiratory
Vernot et al. 2016 Introgressed	HPO	Abdominal pain (HP:0002027)	2	1.4144	1.414027149	0.411958804	other
Vernot et al. 2016 Introgressed	HPO	Nephropathy (HP:0000112)	1	0.536	1.865671642	0.412758724	urinary
Vernot et al. 2016 Introgressed	HPO	Coxa vara (HP:0002812)	1	0.5355	1.867413632	0.412858714	skeletal
Vernot et al. 2016 Introgressed	HPO	Absent hair (HP:0002298)	1	0.5473	1.827151471	0.418458154	integumentary
Vernot et al. 2016 Introgressed	HPO	Long face (HP:0000276)	2	1.4332	1.395478649	0.419158084	skeletal
Vernot et al. 2016 Introgressed	HPO	Abnormality of incisor morphology (HP:0011063)	1	0.5423	1.843997787	0.421057894	skeletal
Vernot et al. 2016 Introgressed	HPO	Upslanted palpebral fissure (HP:0000582)	2	1.4298	1.398797035	0.421157884	integumentary
Vernot et al. 2016 Introgressed	HPO	Bifid tongue (HP:0010297)	1	0.5498	1.818843216	0.421157884	other
Vernot et al. 2016 Introgressed	HPO	Pancytopenia (HP:0001876)	1	0.5526	1.809627217	0.423557644	hematologic
Vernot et al. 2016 Introgressed	HPO	Broad nasal tip (HP:0000455)	1	0.5488	1.822157434	0.424757524	integumentary
Vernot et al. 2016 Introgressed	HPO	Lymphopenia (HP:0001888)	1	0.5624	1.778093883	0.426957304	lymphatic
Vernot et al. 2016 Introgressed	HPO	Onion bulb formation (HP:0003383)	1	0.5598	1.786352269	0.429257074	nervous
Vernot et al. 2016 Introgressed	HPO	Facial cleft (HP:0002006)	1	0.5696	1.755617978	0.435156484	other
Vernot et al. 2016 Introgressed	HPO	Hypodontia (HP:0000668)	1	0.5744	1.740947075	0.436756324	skeletal
Vernot et al. 2016 Introgressed	HPO	Abnormality of cells of the lymphoid lineage (HP:0012140)	1	0.5827	1.716148962	0.438056194	lymphatic
Vernot et al. 2016 Introgressed	HPO	Hypothyroidism (HP:0000821)	2	1.4846	1.347164219	0.438256174	endocrine
Vernot et al. 2016 Introgressed	HPO	Joint contractures involving the joints of the feet (HP:0100492)	1	0.5794	1.725923369	0.440455954	skeletal
Vernot et al. 2016 Introgressed	HPO	Flexion contracture of toe (HP:0005830)	1	0.5794	1.725923369	0.440455954	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Bicornuate uterus (HP:0000813)	1	0.5758	1.736714137	0.440455954	reproductive
Vernot et al. 2016 Introgressed	HPO	Smooth philtrum (HP:0000319)	1	0.5776	1.731301939	0.440855914	integumentary
Vernot et al. 2016 Introgressed	HPO	Abnormality of the pleura (HP:0002103)	1	0.5824	1.717032967	0.440955904	respiratory
Vernot et al. 2016 Introgressed	HPO	Difficulty walking (HP:0002355)	1	0.5804	1.72294969	0.441255874	other
Vernot et al. 2016 Introgressed	HPO	Bone marrow hypocellularity (HP:0005528)	1	0.5808	1.721763085	0.443055694	other
Vernot et al. 2016 Introgressed	HPO	Microtia (HP:0008551)	1	0.5754	1.737921446	0.443455654	nervous
Vernot et al. 2016 Introgressed	HPO	Microcornea (HP:0000482)	2	1.5041	1.329698823	0.445655434	nervous
Vernot et al. 2016 Introgressed	HPO	Gynecomastia (HP:0000771)	1	0.5946	1.681802893	0.448355164	endocrine
Vernot et al. 2016 Introgressed	HPO	Sudden death (HP:0001699)	1	0.5911	1.691761123	0.449055094	other
Vernot et al. 2016 Introgressed	HPO	Scrotal hypoplasia (HP:0000046)	1	0.6078	1.645278052	0.453254675	reproductive
Vernot et al. 2016 Introgressed	HPO	Dysarthria (HP:0001260)	4	3.4654	1.154267906	0.453354665	nervous
Vernot et al. 2016 Introgressed	HPO	Nephrolithiasis (HP:0000787)	1	0.6079	1.645007403	0.454454555	urinary
Vernot et al. 2016 Introgressed	HPO	Abnormality of salivation (HP:0100755)	1	0.6219	1.607975559	0.458154185	digestive
Vernot et al. 2016 Introgressed	HPO	Blepharophimosis (HP:0000581)	3	2.5358	1.183058601	0.458554145	integumentary
Vernot et al. 2016 Introgressed	HPO	Hypergonadotropic hypogonadism (HP:0000815)	1	0.6104	1.638269987	0.460453955	endocrine
Vernot et al. 2016 Introgressed	HPO	Cupped ear (HP:0000378)	1	0.6226	1.606167684	0.461553845	other
Vernot et al. 2016 Introgressed	HPO	Absence seizures (HP:0002121)	1	0.6148	1.626545218	0.463453655	nervous
Vernot et al. 2016 Introgressed	HPO	Abnormality of the thymus (HP:0000777)	1	0.6213	1.609528408	0.463853615	lymphatic
Vernot et al. 2016 Introgressed	HPO	Long eyelashes (HP:0000527)	1	0.6345	1.576044129	0.466853315	integumentary
Vernot et al. 2016 Introgressed	HPO	Ectopic anus (HP:0004397)	1	0.6299	1.58755358	0.466853315	digestive
Vernot et al. 2016 Introgressed	HPO	Vasculitis (HP:0002633)	1	0.6383	1.566661444	0.471552845	cardiovascular
Vernot et al. 2016 Introgressed	HPO	Bruising susceptibility (HP:0000978)	2	1.6099	1.242313187	0.475452455	other
Vernot et al. 2016 Introgressed	HPO	High forehead (HP:0000348)	2	1.6223	1.232817605	0.481951805	skeletal
Vernot et al. 2016 Introgressed	HPO	Cryptorchidism (HP:0000028)	7	6.5626	1.066650413	0.484151585	reproductive
Vernot et al. 2016 Introgressed	HPO	Vertigo (HP:0002321)	1	0.6747	1.48214021	0.488551145	nervous
Vernot et al. 2016 Introgressed	HPO	Abnormality of chromosome segregation (HP:0002916)	1	0.6872	1.455180442	0.492850715	other
Vernot et al. 2016 Introgressed	HPO	Small hand (HP:0200055)	1	0.6814	1.467566774	0.496850315	skeletal
Vernot et al. 2016 Introgressed	HPO	Abnormality of the incisor (HP:0000676)	1	0.6836	1.462843768	0.500349965	skeletal
Vernot et al. 2016 Introgressed	HPO	Incomplete penetrance (HP:0003829)	2	1.6685	1.19868145	0.500549945	other
Vernot et al. 2016 Introgressed	HPO	Abnormality of the clitoris (HP:0000056)	1	0.6976	1.433486239	0.500749925	reproductive
Vernot et al. 2016 Introgressed	HPO	Facial edema (HP:0000282)	1	0.6987	1.431229426	0.501149885	immune
Vernot et al. 2016 Introgressed	HPO	Periorbital edema (HP:0100539)	1	0.6987	1.431229426	0.501149885	other
Vernot et al. 2016 Introgressed	HPO	Hypopigmented skin patches (HP:0001053)	1	0.6965	1.435750179	0.501449855	integumentary
Vernot et al. 2016 Introgressed	HPO	Pointed chin (HP:0000307)	1	0.6991	1.430410528	0.502949705	skeletal
Vernot et al. 2016 Introgressed	HPO	Myoclonus (HP:0001336)	1	0.7005	1.427551749	0.504549545	nervous
Vernot et al. 2016 Introgressed	HPO	Ulnar deviation of finger (HP:0009465)	1	0.6954	1.438021283	0.504749525	skeletal
Vernot et al. 2016 Introgressed	HPO	Triphalangeal thumb (HP:0001199)	1	0.7049	1.418640942	0.505849415	skeletal
Vernot et al. 2016 Introgressed	HPO	Alveolar cell carcinoma (HP:0006519)	1	0.7084	1.411631846	0.506649335	respiratory
Vernot et al. 2016 Introgressed	HPO	Arthralgia (HP:0002829)	1	0.7099	1.408649106	0.507849215	skeletal
Vernot et al. 2016 Introgressed	HPO	Omphalocele (HP:0001539)	1	0.7184	1.391982183	0.507849215	other
Vernot et al. 2016 Introgressed	HPO	Decreased number of peripheral myelinated nerve fibers (HP:0003380)	1	0.7108	1.406865504	0.508649135	nervous
Vernot et al. 2016 Introgressed	HPO	Malignant neoplasm of the central nervous system (HP:0100836)	1	0.7177	1.393339836	0.510248975	nervous
Vernot et al. 2016 Introgressed	HPO	Hypoplastic iliac wings (HP:0002866)	1	0.7125	1.403508772	0.511348865	skeletal
Vernot et al. 2016 Introgressed	HPO	Sprengel anomaly (HP:0000912)	1	0.721	1.386962552	0.513248675	skeletal
Vernot et al. 2016 Introgressed	HPO	Psychosis (HP:0000709)	1	0.7299	1.370050692	0.516148385	nervous
Vernot et al. 2016 Introgressed	HPO	Lactic acidosis (HP:0003128)	2	1.7329	1.154134688	0.516348365	metabolic
Vernot et al. 2016 Introgressed	HPO	Umbilical hernia (HP:0001537)	5	4.737	1.055520372	0.516848315	reproductive
Vernot et al. 2016 Introgressed	HPO	Abnormality of the pubic bones (HP:0003172)	1	0.7334	1.363512408	0.517348265	skeletal
Vernot et al. 2016 Introgressed	HPO	Premature birth (HP:0001622)	1	0.7279	1.373815084	0.518248175	reproductive
Vernot et al. 2016 Introgressed	HPO	Anonychia (HP:0001798)	1	0.7297	1.370426203	0.518548145	integumentary
Vernot et al. 2016 Introgressed	HPO	Neoplasm of the tracheobronchial system (HP:0100552)	1	0.7322	1.365747064	0.518648135	respiratory
Vernot et al. 2016 Introgressed	HPO	Pruritus (HP:0000989)	1	0.7373	1.356300014	0.523547645	integumentary
Vernot et al. 2016 Introgressed	HPO	Narrow palate (HP:0000189)	1	0.7558	1.32310135	0.531346865	skeletal
Vernot et al. 2016 Introgressed	HPO	Pes cavus (HP:0001761)	2	1.7862	1.119695443	0.532746725	skeletal
Vernot et al. 2016 Introgressed	HPO	Ventricular septal defect (HP:0001629)	3	2.8287	1.060557853	0.532846715	cardiovascular
Vernot et al. 2016 Introgressed	HPO	Chorioretinal coloboma (HP:0000567)	1	0.7647	1.307702367	0.534946505	nervous
Vernot et al. 2016 Introgressed	HPO	Delayed skeletal maturation (HP:0002750)	3	2.8214	1.063301907	0.535746425	skeletal
Vernot et al. 2016 Introgressed	HPO	Meningocele (HP:0002435)	1	0.7774	1.286339079	0.537246275	nervous
Vernot et al. 2016 Introgressed	HPO	Abnormal EKG (HP:0003115)	1	0.7819	1.278935925	0.540145985	cardiovascular
Vernot et al. 2016 Introgressed	HPO	Pachygyria (HP:0001302)	1	0.7933	1.260557166	0.542845715	nervous
Vernot et al. 2016 Introgressed	HPO	Polycystic ovaries (HP:0000147)	1	0.7876	1.269680041	0.545145485	reproductive
Vernot et al. 2016 Introgressed	HPO	Memory impairment (HP:0002354)	1	0.8003	1.249531426	0.547045295	nervous
Vernot et al. 2016 Introgressed	HPO	Limited hip movement (HP:0008800)	1	0.7845	1.274697259	0.547645235	other
Vernot et al. 2016 Introgressed	HPO	Abnormal albumin level (HP:0012116)	1	0.797	1.254705144	0.551944806	other
Vernot et al. 2016 Introgressed	HPO	Hypoalbuminemia (HP:0003073)	1	0.797	1.254705144	0.551944806	other
Vernot et al. 2016 Introgressed	HPO	Benign neoplasm of the central nervous system (HP:0100835)	1	0.8038	1.24409057	0.553244676	nervous
Vernot et al. 2016 Introgressed	HPO	Distal sensory impairment (HP:0002936)	1	0.813	1.2300123	0.555544446	nervous
Vernot et al. 2016 Introgressed	HPO	Joint laxity (HP:0001388)	1	0.8169	1.224140042	0.556944306	skeletal
Vernot et al. 2016 Introgressed	HPO	Lissencephaly (HP:0001339)	1	0.824	1.213592233	0.559644036	nervous
Vernot et al. 2016 Introgressed	HPO	Nephrotic syndrome (HP:0000100)	1	0.8239	1.213739531	0.560443956	urinary
Vernot et al. 2016 Introgressed	HPO	Oculomotor apraxia (HP:0000657)	1	0.8347	1.198035222	0.561143886	nervous
Vernot et al. 2016 Introgressed	HPO	Intrauterine growth retardation (HP:0001511)	4	3.988	1.003009027	0.561143886	other
Vernot et al. 2016 Introgressed	HPO	Renal hypoplasia (HP:0000089)	1	0.8217	1.216989169	0.562443756	urinary
Vernot et al. 2016 Introgressed	HPO	Aggressive behavior (HP:0000718)	1	0.8215	1.217285453	0.564343566	behavior
Vernot et al. 2016 Introgressed	HPO	Hypertelorism (HP:0000316)	6	6.1202	0.980360119	0.569043096	skeletal
Vernot et al. 2016 Introgressed	HPO	Nervous tissue neoplasm (HP:0030060)	1	0.8486	1.178411501	0.571542846	nervous
Vernot et al. 2016 Introgressed	HPO	Neuroectodermal neoplasm (HP:0030061)	1	0.8486	1.178411501	0.571542846	nervous
Vernot et al. 2016 Introgressed	HPO	Neuroepithelial neoplasm (HP:0030063)	1	0.8486	1.178411501	0.571542846	nervous
Vernot et al. 2016 Introgressed	HPO	Cheekbone underdevelopment (HP:0010669)	1	0.8405	1.189767995	0.573642636	skeletal
Vernot et al. 2016 Introgressed	HPO	Macroglossia (HP:0000158)	1	0.8514	1.174536058	0.576842316	other
Vernot et al. 2016 Introgressed	HPO	Anxiety (HP:0000739)	1	0.8689	1.150880424	0.577442256	behavior
Vernot et al. 2016 Introgressed	HPO	Hypoplastic ilia (HP:0000946)	1	0.8543	1.170548987	0.577742226	skeletal
Vernot et al. 2016 Introgressed	HPO	Increased number of teeth (HP:0011069)	1	0.872	1.146788991	0.579542046	skeletal
Vernot et al. 2016 Introgressed	HPO	Abnormality of the pericardium (HP:0001697)	1	0.8677	1.152472053	0.582641736	cardiovascular
Vernot et al. 2016 Introgressed	HPO	Abnormality of the pupil (HP:0000615)	1	0.8762	1.141291942	0.583241676	nervous
Vernot et al. 2016 Introgressed	HPO	Ulnar deviation of the hand or of fingers of the hand (HP:0001193)	1	0.8737	1.144557628	0.586141386	skeletal
Vernot et al. 2016 Introgressed	HPO	Blindness (HP:0000618)	1	0.9081	1.101200308	0.594740526	nervous
Vernot et al. 2016 Introgressed	HPO	Cerebellar hypoplasia (HP:0001321)	1	0.9068	1.102779003	0.594840516	nervous
Vernot et al. 2016 Introgressed	HPO	Stereotypic behavior (HP:0000733)	1	0.9074	1.102049813	0.595540446	behavior
Vernot et al. 2016 Introgressed	HPO	Lymphedema (HP:0001004)	1	0.9155	1.09229929	0.597540246	lymphatic
Vernot et al. 2016 Introgressed	HPO	Metabolic acidosis (HP:0001942)	1	0.9209	1.085894234	0.601039896	metabolic
Vernot et al. 2016 Introgressed	HPO	Abnormality of the wing of the ilium (HP:0011867)	1	0.9135	1.09469075	0.601339866	skeletal
Vernot et al. 2016 Introgressed	HPO	Spina bifida occulta (HP:0003298)	1	0.9304	1.074806535	0.602139786	skeletal
Vernot et al. 2016 Introgressed	HPO	Sandal gap (HP:0001852)	1	0.9225	1.08401084	0.602539746	skeletal
Vernot et al. 2016 Introgressed	HPO	Downslanted palpebral fissures (HP:0000494)	3	3.1656	0.947687642	0.608039196	integumentary
Vernot et al. 2016 Introgressed	HPO	Decreased motor nerve conduction velocity (HP:0003431)	1	0.9357	1.068718606	0.608439156	nervous
Vernot et al. 2016 Introgressed	HPO	Kyphoscoliosis (HP:0002751)	1	0.9474	1.055520372	0.612838716	skeletal
Vernot et al. 2016 Introgressed	HPO	Dilated cardiomyopathy (HP:0001644)	1	0.9431	1.060332945	0.612938706	cardiovascular
Vernot et al. 2016 Introgressed	HPO	Everted lower lip vermilion (HP:0000232)	1	0.9592	1.042535446	0.615238476	integumentary
Vernot et al. 2016 Introgressed	HPO	Brachycephaly (HP:0000248)	1	0.95	1.052631579	0.615338466	skeletal
Vernot et al. 2016 Introgressed	HPO	Syncope (HP:0001279)	1	0.9558	1.046243984	0.618438156	nervous
Vernot et al. 2016 Introgressed	HPO	Short distal phalanx of finger (HP:0009882)	1	0.9818	1.01853738	0.624037596	skeletal
Vernot et al. 2016 Introgressed	HPO	Uterine leiomyosarcoma (HP:0002891)	1	0.9769	1.023646228	0.627337266	reproductive
Vernot et al. 2016 Introgressed	HPO	Leiomyosarcoma (HP:0100243)	1	0.9769	1.023646228	0.627337266	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Atrial fibrillation (HP:0005110)	1	0.9997	1.00030009	0.631736826	cardiovascular
Vernot et al. 2016 Introgressed	HPO	Short neck (HP:0000470)	3	3.252	0.922509225	0.633236676	skeletal
Vernot et al. 2016 Introgressed	HPO	Ventricular tachycardia (HP:0004756)	1	1.005	0.995024876	0.633536646	cardiovascular
Vernot et al. 2016 Introgressed	HPO	Tetralogy of Fallot (HP:0001636)	1	1.0008	0.999200639	0.634036596	cardiovascular
Vernot et al. 2016 Introgressed	HPO	Renal cell carcinoma (HP:0005584)	1	0.997	1.003009027	0.634236576	urinary
Vernot et al. 2016 Introgressed	HPO	Primary atrial arrhythmia (HP:0001692)	1	1.019	0.981354269	0.638536146	cardiovascular
Vernot et al. 2016 Introgressed	HPO	Supraventricular tachycardia (HP:0004755)	1	1.019	0.981354269	0.638536146	cardiovascular
Vernot et al. 2016 Introgressed	HPO	Hypoplasia of the maxilla (HP:0000327)	1	1.018	0.982318271	0.639136086	skeletal
Vernot et al. 2016 Introgressed	HPO	Primary amenorrhea (HP:0000786)	1	1.0272	0.973520249	0.643435656	reproductive
Vernot et al. 2016 Introgressed	HPO	Hereditary nonpolyposis colorectal carcinoma (HP:0006716)	1	1.0277	0.973046609	0.645435456	digestive
Vernot et al. 2016 Introgressed	HPO	Supraventricular arrhythmia (HP:0005115)	1	1.0392	0.962278676	0.646335366	cardiovascular
Vernot et al. 2016 Introgressed	HPO	Narrow forehead (HP:0000341)	1	1.0429	0.958864704	0.649035096	skeletal
Vernot et al. 2016 Introgressed	HPO	Gingival overgrowth (HP:0000212)	1	1.0517	0.950841495	0.651034897	immune
Vernot et al. 2016 Introgressed	HPO	Platyspondyly (HP:0000926)	1	1.0543	0.948496633	0.652034797	skeletal
Vernot et al. 2016 Introgressed	HPO	Recurrent fractures (HP:0002757)	2	2.2706	0.880824452	0.660533947	skeletal
Vernot et al. 2016 Introgressed	HPO	Holoprosencephaly (HP:0001360)	1	1.0836	0.92284976	0.661733827	nervous
Vernot et al. 2016 Introgressed	HPO	Midface retrusion (HP:0011800)	1	1.0886	0.91861106	0.664533547	skeletal
Vernot et al. 2016 Introgressed	HPO	Blue sclerae (HP:0000592)	1	1.1213	0.891821992	0.672032797	integumentary
Vernot et al. 2016 Introgressed	HPO	Proteinuria (HP:0000093)	1	1.1256	0.888415068	0.672232777	other
Vernot et al. 2016 Introgressed	HPO	Hypoplasia of the corpus callosum (HP:0002079)	1	1.1336	0.882145378	0.676232377	nervous
Vernot et al. 2016 Introgressed	HPO	Dandy-Walker malformation (HP:0001305)	1	1.142	0.875656743	0.679632037	nervous
Vernot et al. 2016 Introgressed	HPO	Short palm (HP:0004279)	1	1.174	0.851788756	0.682431757	skeletal
Vernot et al. 2016 Introgressed	HPO	Long philtrum (HP:0000343)	3	3.5226	0.851643672	0.685231477	integumentary
Vernot et al. 2016 Introgressed	HPO	Broad forehead (HP:0000337)	1	1.1686	0.855724799	0.686631337	skeletal
Vernot et al. 2016 Introgressed	HPO	Congenital diaphragmatic hernia (HP:0000776)	1	1.1957	0.836330183	0.694130587	respiratory
Vernot et al. 2016 Introgressed	HPO	Osteopenia (HP:0000938)	1	1.2002	0.833194468	0.694730527	skeletal
Vernot et al. 2016 Introgressed	HPO	Malar flattening (HP:0000272)	3	3.6483	0.822300798	0.705829417	skeletal
Vernot et al. 2016 Introgressed	HPO	Lipoatrophy (HP:0100578)	1	1.2111	0.825695649	0.706829317	metabolic
Vernot et al. 2016 Introgressed	HPO	Gastrointestinal carcinoma (HP:0002672)	1	1.2093	0.826924667	0.707329267	digestive
Vernot et al. 2016 Introgressed	HPO	Malignant gastrointestinal tract tumors (HP:0006749)	1	1.2093	0.826924667	0.707329267	digestive
Vernot et al. 2016 Introgressed	HPO	Thick lower lip vermilion (HP:0000179)	1	1.2456	0.802825947	0.708229177	integumentary
Vernot et al. 2016 Introgressed	HPO	Hydronephrosis (HP:0000126)	1	1.2332	0.810898476	0.710528947	urinary
Vernot et al. 2016 Introgressed	HPO	Opacification of the corneal stroma (HP:0007759)	1	1.2799	0.78131104	0.719428057	nervous
Vernot et al. 2016 Introgressed	HPO	Bladder carcinoma (HP:0002862)	1	1.2702	0.787277594	0.721027897	urinary
Vernot et al. 2016 Introgressed	HPO	Bladder neoplasm (HP:0009725)	1	1.2702	0.787277594	0.721027897	urinary
Vernot et al. 2016 Introgressed	HPO	Transitional cell carcinoma of the bladder (HP:0006740)	1	1.2702	0.787277594	0.721027897	urinary
Vernot et al. 2016 Introgressed	HPO	Talipes equinovarus (HP:0001762)	2	2.5531	0.783361404	0.721127887	skeletal
Vernot et al. 2016 Introgressed	HPO	Dehydration (HP:0001944)	1	1.2569	0.795608243	0.722127787	other
Vernot et al. 2016 Introgressed	HPO	Gliosis (HP:0002171)	1	1.2786	0.782105428	0.724627537	nervous
Vernot et al. 2016 Introgressed	HPO	Short philtrum (HP:0000322)	1	1.3099	0.763417055	0.726327367	integumentary
Vernot et al. 2016 Introgressed	HPO	Neonatal hypotonia (HP:0001319)	1	1.3058	0.76581406	0.726927307	skeletal muscle
Vernot et al. 2016 Introgressed	HPO	Congestive heart failure (HP:0001635)	1	1.3076	0.764759865	0.735626437	cardiovascular
Vernot et al. 2016 Introgressed	HPO	Osteoporosis (HP:0000939)	1	1.3649	0.732654407	0.743025697	skeletal
Vernot et al. 2016 Introgressed	HPO	Uterine neoplasm (HP:0010784)	1	1.3553	0.73784402	0.745125487	reproductive
Vernot et al. 2016 Introgressed	HPO	High palate (HP:0000218)	2	2.6904	0.743383883	0.750924908	skeletal
Vernot et al. 2016 Introgressed	HPO	Wide nasal bridge (HP:0000431)	4	5.173	0.773245699	0.761723828	integumentary
Vernot et al. 2016 Introgressed	HPO	Optic atrophy (HP:0000648)	5	6.3837	0.783244827	0.763123688	nervous
Vernot et al. 2016 Introgressed	HPO	Genu valgum (HP:0002857)	1	1.4383	0.695265244	0.763623638	skeletal
Vernot et al. 2016 Introgressed	HPO	Neoplasm of the lung (HP:0100526)	1	1.4392	0.694830461	0.764223578	respiratory
Vernot et al. 2016 Introgressed	HPO	Attenuation of retinal blood vessels (HP:0007843)	1	1.4656	0.68231441	0.768223178	cardiovascular
Vernot et al. 2016 Introgressed	HPO	Autism (HP:0000717)	1	1.4818	0.674854906	0.775022498	nervous
Vernot et al. 2016 Introgressed	HPO	Ovarian neoplasm (HP:0100615)	1	1.5138	0.660589246	0.778322168	reproductive
Vernot et al. 2016 Introgressed	HPO	Neoplasm of the respiratory system (HP:0100606)	1	1.5146	0.660240327	0.781321868	respiratory
Vernot et al. 2016 Introgressed	HPO	Lethargy (HP:0001254)	1	1.546	0.64683053	0.784121588	behavior
Vernot et al. 2016 Introgressed	HPO	Delayed eruption of teeth (HP:0000684)	1	1.5434	0.647920176	0.786021398	skeletal
Vernot et al. 2016 Introgressed	HPO	Cerebellar atrophy (HP:0001272)	2	2.8869	0.692784648	0.788321168	nervous
Vernot et al. 2016 Introgressed	HPO	Short nose (HP:0003196)	2	2.9427	0.679647942	0.791820818	skeletal
Vernot et al. 2016 Introgressed	HPO	Dolichocephaly (HP:0000268)	1	1.5835	0.631512472	0.797220278	skeletal
Vernot et al. 2016 Introgressed	HPO	Macrotia (HP:0000400)	1	1.6036	0.623596907	0.801919808	other
Vernot et al. 2016 Introgressed	HPO	Cerebral cortical atrophy (HP:0002120)	2	3.0736	0.650702759	0.807319268	nervous
Vernot et al. 2016 Introgressed	HPO	Dental malocclusion (HP:0000689)	1	1.6906	0.591505974	0.810418958	skeletal
Vernot et al. 2016 Introgressed	HPO	Sudden cardiac death (HP:0001645)	1	1.7284	0.578569776	0.824817518	cardiovascular
Vernot et al. 2016 Introgressed	HPO	Patent ductus arteriosus (HP:0001643)	1	1.7417	0.574151691	0.825517448	cardiovascular
Vernot et al. 2016 Introgressed	HPO	Triangular face (HP:0000325)	1	1.7324	0.577233895	0.826817318	other
Vernot et al. 2016 Introgressed	HPO	Frontal bossing (HP:0002007)	2	3.1913	0.626703851	0.827817218	skeletal
Vernot et al. 2016 Introgressed	HPO	Iris coloboma (HP:0000612)	1	1.7817	0.561261716	0.830016998	nervous
Vernot et al. 2016 Introgressed	HPO	Deeply set eye (HP:0000490)	1	1.8062	0.553648544	0.838516148	nervous
Vernot et al. 2016 Introgressed	HPO	Postaxial hand polydactyly (HP:0001162)	1	1.8232	0.548486178	0.841315868	skeletal
Vernot et al. 2016 Introgressed	HPO	Single transverse palmar crease (HP:0000954)	1	1.8214	0.54902822	0.842015798	integumentary
Vernot et al. 2016 Introgressed	HPO	Telecanthus (HP:0000506)	1	1.8503	0.5404529	0.845015498	skeletal
Vernot et al. 2016 Introgressed	HPO	Pectus carinatum (HP:0000768)	1	1.902	0.525762355	0.848015198	skeletal
Vernot et al. 2016 Introgressed	HPO	Depressed nasal bridge (HP:0005280)	3	4.723	0.635189498	0.853514649	skeletal
Vernot et al. 2016 Introgressed	HPO	Palmoplantar keratoderma (HP:0000982)	1	1.9807	0.504872015	0.865113489	integumentary
Vernot et al. 2016 Introgressed	HPO	Type II diabetes mellitus (HP:0005978)	1	2.0311	0.49234405	0.870012999	metabolic
Vernot et al. 2016 Introgressed	HPO	Epicanthus (HP:0000286)	3	5.0827	0.590237472	0.882011799	integumentary
Vernot et al. 2016 Introgressed	HPO	Brachydactyly syndrome (HP:0001156)	2	3.6923	0.541667795	0.885411459	skeletal
Vernot et al. 2016 Introgressed	HPO	Congenital onset (HP:0003577)	1	2.1942	0.455746969	0.888711129	other
Vernot et al. 2016 Introgressed	HPO	Retinitis pigmentosa (HP:0000510)	1	2.2228	0.44988303	0.893010699	integumentary
Vernot et al. 2016 Introgressed	HPO	Infantile onset (HP:0003593)	2	3.8974	0.513162621	0.902609739	other
Vernot et al. 2016 Introgressed	HPO	Micromelia (HP:0002983)	1	2.4524	0.407763823	0.913208679	skeletal
Vernot et al. 2016 Introgressed	HPO	Photophobia (HP:0000613)	1	2.5852	0.386817268	0.925507449	nervous
Vernot et al. 2016 Introgressed	HPO	Autosomal dominant inheritance (HP:0000006)	14	22.1257	0.632748342	0.9740026	other
Vindija	GWAS	Pancreatic ductal adenocarcinoma	3	0.0876	34.2465753	1.00E-04	endocrine
Vindija	GWAS	Blood metabolite levels	8	1.3458	5.94441968	0.00019998	metabolic
Vindija	GWAS	Lead levels in blood	4	0.5419	7.38143569	0.00239976	other
Vindija	GWAS	Type 1 diabetes	5	1.1077	4.51385754	0.00589941	metabolic
Vindija	GWAS	Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)	1	0.0086	116.27907	0.00859914	integumentary
Vindija	GWAS	Inflammatory bowel disease	12	5.4974	2.18285007	0.00979902	digestive
Vindija	GWAS	Temporomandibular joint disorder	2	0.1556	12.8534704	0.01029897	skeletal muscle
Vindija	GWAS	Intrinsic epigenetic age acceleration	2	0.1399	14.2959257	0.01029897	other
Vindija	GWAS	Urate levels in obese individuals	5	1.3434	3.72189966	0.01209879	metabolic
Vindija	GWAS	Plateletcrit	9	3.6024	2.49833444	0.01239876	hematologic
Vindija	GWAS	Delta-5 desaturase activity response to n3-polyunsaturated fat supplement	1	0.0125	80	0.01259874	other
Vindija	GWAS	Crohn's disease (time to surgery)	1	0.0143	69.9300699	0.01429857	immune
Vindija	GWAS	Ulcerative colitis	9	3.8586	2.33245218	0.01639836	digestive
Vindija	GWAS	Subjective response to lithium treatment	2	0.1845	10.8401084	0.01639836	other
Vindija	GWAS	Egg allergy (maternal genetic effects)	1	0.02	50	0.01959804	immune
Vindija	GWAS	Optic disc area	3	0.5779	5.19120955	0.01959804	nervous
Vindija	GWAS	Suicide risk	2	0.2214	9.03342367	0.02249775	behavior
Vindija	GWAS	Serum metabolite levels	3	0.5962	5.0318685	0.02389761	metabolic
Vindija	GWAS	Chronic lymphocytic leukemia	3	0.6372	4.70809793	0.0269973	lymphatic
Vindija	GWAS	Celiac disease or Rheumatoid arthritis	2	0.2617	7.64233856	0.02809719	digestive
Vindija	GWAS	Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor	1	0.029	34.4827586	0.02859714	hematologic
Vindija	GWAS	EGFR mutation-positive lung adenocarcinoma	1	0.0345	28.9855072	0.03379662	respiratory
Vindija	GWAS	Idiopathic membranous nephropathy	1	0.0345	28.9855072	0.03389661	urinary
Vindija	GWAS	Glioblastoma (age-stratified)	1	0.0372	26.8817204	0.03709629	nervous
Vindija	GWAS	IgA nephropathy	2	0.3092	6.4683053	0.03779622	immune
Vindija	GWAS	Circulating phylloquinone levels	1	0.0433	23.0946882	0.04269573	other
Vindija	GWAS	Advanced age-related macular degeneration	3	0.7868	3.81291307	0.04519548	nervous
Vindija	GWAS	Factor VII	1	0.0468	21.3675214	0.04609539	hematologic
Vindija	GWAS	Resting metabolic rate	1	0.0523	19.1204589	0.05069493	metabolic
Vindija	GWAS	LDL cholesterol	5	1.9794	2.52601799	0.05109489	metabolic
Vindija	GWAS	Sitting height ratio	2	0.3645	5.48696845	0.05119488	skeletal
Vindija	GWAS	Chronic hepatitis B infection	1	0.0529	18.9035917	0.05189481	immune
Vindija	GWAS	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	1	0.0531	18.8323917	0.05209479	nervous
Vindija	GWAS	Vascular brain injury	2	0.3704	5.39956803	0.05489451	cardiovascular
Vindija	GWAS	Psoriasis	3	0.8451	3.54987575	0.05529447	integumentary
Vindija	GWAS	Response to antineoplastic agents	1	0.0587	17.0357751	0.05719428	other
Vindija	GWAS	Serum prostate-specific antigen levels	1	0.0589	16.9779287	0.05719428	reproductive
Vindija	GWAS	Food allergy (parent-of-origin effect)	1	0.0604	16.5562914	0.05849415	immune
Vindija	GWAS	Testicular germ cell cancer	1	0.0604	16.5562914	0.05889411	reproductive
Vindija	GWAS	Metabolic traits	2	0.4027	4.96647629	0.06359364	metabolic
Vindija	GWAS	Blood metabolite ratios	2	0.4172	4.79386385	0.06479352	metabolic
Vindija	GWAS	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy	1	0.0687	14.5560408	0.0659934	metabolic
Vindija	GWAS	Melanoma	3	0.9141	3.28191664	0.06659334	integumentary
Vindija	GWAS	Crohn's disease	10	5.8099	1.72120002	0.06709329	immune
Vindija	GWAS	Corneal astigmatism	4	1.4981	2.67004873	0.06849315	nervous
Vindija	GWAS	Breast Cancer in BRCA1 mutation carriers	1	0.0721	13.8696255	0.06969303	reproductive
Vindija	GWAS	Rhegmatogenous retinal detachment	1	0.0725	13.7931034	0.06979302	nervous
Vindija	GWAS	Pubertal anthropometrics	2	0.4361	4.5861041	0.07109289	skeletal
Vindija	GWAS	Lymphocyte percentage of white cells	4	1.5488	2.58264463	0.07389261	lymphatic
Vindija	GWAS	Pancreatic cancer	5	2.1861	2.28717808	0.07549245	endocrine
Vindija	GWAS	Intraocular pressure	12	7.4216	1.61690202	0.07579242	nervous
Vindija	GWAS	Hepatitis B vaccine response	1	0.0802	12.4688279	0.0769923	immune
Vindija	GWAS	Reticulocyte count	5	2.2609	2.21150869	0.0779922	immune
Vindija	GWAS	Gallstone disease	2	0.4646	4.3047783	0.07969203	digestive
Vindija	GWAS	Cold sores	1	0.0834	11.9904077	0.07979202	immune
Vindija	GWAS	Esophageal cancer (squamous cell)	1	0.0827	12.0918984	0.07989201	digestive
Vindija	GWAS	Adult asthma	2	0.4602	4.34593655	0.07989201	respiratory
Vindija	GWAS	Iron status biomarkers (total iron binding capacity)	2	0.4701	4.25441395	0.08029197	other
Vindija	GWAS	Hematological and biochemical traits	2	0.4688	4.2662116	0.08169183	hematologic
Vindija	GWAS	Pulmonary function in asthmatics	1	0.0877	11.4025086	0.08369163	respiratory
Vindija	GWAS	Apolipoprotein A1 levels	1	0.0875	11.4285714	0.08379162	metabolic
Vindija	GWAS	Axial length	2	0.4711	4.24538315	0.0839916	nervous
Vindija	GWAS	Low density lipoprotein cholesterol levels	2	0.4839	4.13308535	0.08419158	metabolic
Vindija	GWAS	Response to serotonin reuptake inhibitors in MDD (plasma drug and metabolite levels)	1	0.089	11.2359551	0.08489151	other
Vindija	GWAS	Childhood steroid-sensitive nephrotic syndrome	1	0.0895	11.1731844	0.08509149	other
Vindija	GWAS	Alcoholic chronic pancreatitis	3	1.0294	2.91431902	0.08779122	endocrine
Vindija	GWAS	Total cholesterol levels in HDL	1	0.0977	10.2354145	0.09269073	metabolic
Vindija	GWAS	Rheumatoid arthritis (rheumatoid factor and/or anti-CCP seropositive)	1	0.0983	10.17294	0.09349065	immune
Vindija	GWAS	Epstein-Barr virus immune response (EBNA-1)	1	0.0995	10.0502513	0.09429057	immune
Vindija	GWAS	Neuromyelitis optica	1	0.1024	9.765625	0.09639036	nervous
Vindija	GWAS	Plantar warts	1	0.1024	9.765625	0.09639036	integumentary
Vindija	GWAS	Pneumonia	1	0.1024	9.765625	0.09639036	respiratory
Vindija	GWAS	Neuromyelitis optica (AQP4-IgG-positive)	1	0.1024	9.765625	0.09639036	nervous
Vindija	GWAS	Pursuit maintenance gain in psychotic disorders	1	0.1019	9.81354269	0.09729027	skeletal muscle
Vindija	GWAS	Atopic dermatitis	2	0.5178	3.86249517	0.09749025	integumentary
Vindija	GWAS	Autism spectrum disorder or schizophrenia	9	5.3756	1.67423171	0.09839016	behavior
Vindija	GWAS	Corticobasal degeneration	1	0.1046	9.56022945	0.09939006	nervous
Vindija	GWAS	Plasma trimethylamine N-oxide levels	1	0.1041	9.60614793	0.09969003	other
Vindija	GWAS	Esophageal adenocarcinoma	1	0.1048	9.54198473	0.10038996	digestive
Vindija	GWAS	Iris characteristics	1	0.1054	9.48766603	0.10048995	integumentary
Vindija	GWAS	Giant cell arteritis	1	0.107	9.34579439	0.10068993	cardiovascular
Vindija	GWAS	Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)	1	0.1062	9.41619586	0.1009899	other
Vindija	GWAS	LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	1	0.1055	9.47867299	0.10148985	metabolic
Vindija	GWAS	Myasthenia gravis	1	0.1089	9.18273646	0.10248975	skeletal muscle
Vindija	GWAS	Lung adenocarcinoma	4	1.7577	2.2757012	0.10278972	respiratory
Vindija	GWAS	Strep throat	1	0.1101	9.08265213	0.10348965	immune
Vindija	GWAS	Phospholipid levels in medium HDL	1	0.11	9.09090909	0.10448955	metabolic
Vindija	GWAS	Lymphocyte counts	5	2.4496	2.04114958	0.10538946	lymphatic
Vindija	GWAS	Parental lifespan	1	0.1128	8.86524823	0.1059894	other
Vindija	GWAS	Yeast infection	1	0.1139	8.77963126	0.10648935	immune
Vindija	GWAS	Disrupted circadian rhythm (low relative amplitude of rest-activity cycles)	1	0.1158	8.63557858	0.10988901	behavior
Vindija	GWAS	Vogt-Koyanagi-Harada syndrome	1	0.1176	8.50340136	0.11128887	integumentary
Vindija	GWAS	Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test)	2	0.5761	3.47161951	0.11178882	cardiovascular
Vindija	GWAS	Myositis	1	0.12	8.33333333	0.11248875	skeletal muscle
Vindija	GWAS	Asthma (moderate or severe)	2	0.5707	3.5044682	0.11328867	respiratory
Vindija	GWAS	Height	13	8.9125	1.45862553	0.11428857	skeletal
Vindija	GWAS	Peanut allergy (parent-of-origin effect)	1	0.1225	8.16326531	0.11558844	immune
Vindija	GWAS	Glaucoma	3	1.1888	2.52355316	0.11748825	nervous
Vindija	GWAS	Visceral adipose tissue	1	0.1257	7.95544948	0.11858814	metabolic
Vindija	GWAS	Left superior temporal gyrus thickness (schizophrenia interaction)	1	0.1313	7.61614623	0.12248775	nervous
Vindija	GWAS	Nasopharyngeal carcinoma	1	0.1309	7.6394194	0.12328767	other
Vindija	GWAS	Alzheimer's disease (APOE e4 interaction)	1	0.1312	7.62195122	0.12328767	nervous
Vindija	GWAS	Glioblastoma	1	0.1338	7.47384155	0.12508749	nervous
Vindija	GWAS	Abdominal aortic aneurysm	1	0.1332	7.50750751	0.12588741	cardiovascular
Vindija	GWAS	Shingles	1	0.135	7.40740741	0.12648735	immune
Vindija	GWAS	Atopic march	1	0.1342	7.45156483	0.12738726	immune
Vindija	GWAS	Staphylococcus aureus nasal carriage (persistent)	1	0.1374	7.27802038	0.12778722	immune
Vindija	GWAS	Nephropathy	1	0.1369	7.3046019	0.1279872	urinary
Vindija	GWAS	Blood and toenail selenium levels	1	0.1377	7.26216412	0.12868713	other
Vindija	GWAS	Reading disability or specific language impairment (pleiotropy)	1	0.1394	7.17360115	0.12948705	other
Vindija	GWAS	Neutrophil percentage of white cells	3	1.2625	2.37623762	0.13428657	lymphatic
Vindija	GWAS	Endometrial endometrioid carcinoma	1	0.1439	6.94927033	0.13448655	reproductive
Vindija	GWAS	Response to quetiapine in schizophrenia	1	0.1473	6.78886626	0.13728627	other
Vindija	GWAS	Obsessive-compulsive disorder or autism spectrum disorder	1	0.152	6.57894737	0.13908609	behavior
Vindija	GWAS	Response to antipsychotic therapy (extrapyramidal side effects)	1	0.154	6.49350649	0.14348565	other
Vindija	GWAS	Interstitial lung disease	1	0.1535	6.51465798	0.14458554	respiratory
Vindija	GWAS	Mean diameter of HDL particles	1	0.1583	6.31711939	0.14508549	metabolic
Vindija	GWAS	Cancer (pleiotropy)	1	0.1579	6.33312223	0.14578542	other
Vindija	GWAS	Neonatal lupus	1	0.1574	6.35324015	0.14668533	immune
Vindija	GWAS	Bulimia nervosa	2	0.6848	2.92056075	0.14888511	behavior
Vindija	GWAS	Parental longevity (mother's attained age)	1	0.163	6.13496933	0.14978502	other
Vindija	GWAS	Rheumatoid arthritis (ACPA-negative)	1	0.1655	6.04229607	0.15118488	immune
Vindija	GWAS	Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	1	0.1639	6.10128127	0.15168483	other
Vindija	GWAS	Anthropometric traits	1	0.1647	6.07164542	0.15328467	skeletal
Vindija	GWAS	Amyotrophic lateral sclerosis in C9orf72 mutation negative individuals	1	0.1732	5.77367206	0.15808419	nervous
Vindija	GWAS	Premature menopause in childhood cancer survivors	1	0.1735	5.76368876	0.15808419	other
Vindija	GWAS	Celiac disease	3	1.3715	2.18738607	0.15838416	digestive
Vindija	GWAS	Eosinophil counts	4	2.097	1.90748689	0.15958404	immune
Vindija	GWAS	Ossification of the posterior longitudinal ligament of the spine	1	0.174	5.74712644	0.16228377	skeletal
Vindija	GWAS	Cancer	1	0.1762	5.6753689	0.16318368	other
Vindija	GWAS	Heart rate response to exercise	2	0.7262	2.75406224	0.16328367	cardiovascular
Vindija	GWAS	Response to fenofibrate (HDL cholesterol levels)	2	0.7209	2.77430989	0.16468353	other
Vindija	GWAS	Large HDL particle concentration	1	0.1808	5.53097345	0.16488351	metabolic
Vindija	GWAS	Chronic obstructive pulmonary disease (moderate to severe)	1	0.1806	5.53709856	0.16548345	respiratory
Vindija	GWAS	Triglycerides	4	2.1339	1.87450209	0.16568343	metabolic
Vindija	GWAS	Total cholesterol levels	4	2.1525	1.8583043	0.16848315	metabolic
Vindija	GWAS	HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	1	0.1845	5.4200542	0.16958304	metabolic
Vindija	GWAS	Tonsillectomy	2	0.7408	2.69978402	0.169983	lymphatic
Vindija	GWAS	Phospholipid levels in large HDL	1	0.191	5.23560209	0.17268273	metabolic
Vindija	GWAS	Tourette syndrome	1	0.19	5.26315789	0.17348265	behavior
Vindija	GWAS	Menopause (age at onset)	2	0.7637	2.61882938	0.17418258	reproductive
Vindija	GWAS	Response to bupropion and depression	1	0.1935	5.16795866	0.17418258	other
Vindija	GWAS	Childhood ear infection	2	0.7541	2.65216815	0.17508249	immune
Vindija	GWAS	Cervical artery dissection	1	0.1942	5.14933059	0.17668233	cardiovascular
Vindija	GWAS	Bacteremia	1	0.1991	5.02260171	0.18018198	immune
Vindija	GWAS	Echocardiographic traits	1	0.2007	4.98256104	0.18068193	cardiovascular
Vindija	GWAS	Staphylococcus aureus nasal carriage (intermittent)	1	0.201	4.97512438	0.18208179	immune
Vindija	GWAS	"Schizophrenia, bipolar disorder and depression (combined)"	1	0.202	4.95049505	0.18228177	behavior
Vindija	GWAS	Hepatocellular carcinoma	1	0.2047	4.88519785	0.18438156	digestive
Vindija	GWAS	Bipolar disorder with mood-incongruent psychosis	1	0.206	4.85436893	0.18768123	behavior
Vindija	GWAS	Alzheimer's disease	3	1.4854	2.019658	0.18788121	nervous
Vindija	GWAS	Smooth-surface caries	2	0.8018	2.49438763	0.19008099	skeletal
Vindija	GWAS	Amyotrophic lateral sclerosis	2	0.8009	2.49719066	0.19018098	nervous
Vindija	GWAS	Serum bilirubin levels x sex interaction in metabolic syndrome	1	0.2133	4.68823254	0.19138086	digestive
Vindija	GWAS	Peanut allergy	2	0.8107	2.46700382	0.19338066	immune
Vindija	GWAS	Hip minimal joint space width	1	0.214	4.6728972	0.19488051	skeletal
Vindija	GWAS	Glaucoma (primary open-angle)	4	2.279	1.75515577	0.19778022	nervous
Vindija	GWAS	Bladder cancer	1	0.2239	4.46627959	0.19978002	urinary
Vindija	GWAS	Cardiometabolic and hematological traits	1	0.2265	4.41501104	0.20357964	cardiovascular
Vindija	GWAS	Staphylococcus aureus infection	1	0.23	4.34782609	0.20567943	immune
Vindija	GWAS	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	2	0.8461	2.36378679	0.20647935	endocrine
Vindija	GWAS	Neutrophil count	4	2.3353	1.71284203	0.20827917	lymphatic
Vindija	GWAS	Lymphoma	1	0.2343	4.26803244	0.20857914	lymphatic
Vindija	GWAS	Alopecia areata	2	0.8491	2.35543517	0.21037896	integumentary
Vindija	GWAS	Glioma	1	0.2361	4.23549343	0.21057894	nervous
Vindija	GWAS	Response to antidepressants (symptom remission)	1	0.2432	4.11184211	0.21477852	other
Vindija	GWAS	Obese vs. thin	1	0.2391	4.18235048	0.2159784	metabolic
Vindija	GWAS	Testicular germ cell tumor	2	0.8684	2.30308614	0.21737826	reproductive
Vindija	GWAS	Red vs. brown/black hair color	1	0.2447	4.0866367	0.21887811	integumentary
Vindija	GWAS	Platelet distribution width	5	3.205	1.5600624	0.21917808	hematologic
Vindija	GWAS	Bone mineral density (femoral neck) in inflammatory bowel disease	1	0.251	3.98406375	0.22107789	skeletal
Vindija	GWAS	Chronic inflammatory diseases (pleiotropy)	3	1.6311	1.83924959	0.2229777	immune
Vindija	GWAS	Takayasu arteritis	2	0.8998	2.22271616	0.22747725	cardiovascular
Vindija	GWAS	Systemic sclerosis	2	0.9044	2.21141088	0.22977702	other
Vindija	GWAS	Prudent dietary pattern	2	0.9174	2.18007412	0.23007699	behavior
Vindija	GWAS	Cholangiocarcinoma in primary sclerosing cholangitis (time to event)	1	0.2673	3.74111485	0.23477652	digestive
Vindija	GWAS	Iron status biomarkers	1	0.2712	3.68731563	0.23537646	other
Vindija	GWAS	Asparaginase hypersensitivity in acute lymphoblastic leukemia	1	0.2693	3.71333086	0.23577642	other
Vindija	GWAS	Multiple sclerosis (OCB status)	1	0.2682	3.72856078	0.23617638	nervous
Vindija	GWAS	Pelvic organ prolapse (moderate/severe)	2	0.9288	2.15331611	0.23687631	skeletal muscle
Vindija	GWAS	Nodular sclerosis Hodgkin lymphoma	1	0.272	3.67647059	0.23707629	lymphatic
Vindija	GWAS	High light scatter reticulocyte count	4	2.4779	1.61427015	0.23777622	metabolic
Vindija	GWAS	Neurofibrillary tangles	1	0.2756	3.62844702	0.23867613	nervous
Vindija	GWAS	Red blood cell traits	2	0.9463	2.11349466	0.24507549	hematologic
Vindija	GWAS	Urate levels in overweight individuals	2	0.9531	2.0984157	0.24627537	metabolic
Vindija	GWAS	Hyperthyroidism	1	0.2852	3.50631136	0.24847515	endocrine
Vindija	GWAS	Systolic blood pressure x alcohol consumption interaction (2df test)	3	1.7176	1.7466232	0.24857514	cardiovascular
Vindija	GWAS	Serum albumin level	1	0.2914	3.43170899	0.25317468	other
Vindija	GWAS	ALT levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	2	0.9759	2.04939031	0.25477452	other
Vindija	GWAS	Response to n-3 LC-PUFA supplementation (change in triglyceride levels)	1	0.2976	3.36021505	0.25547445	other
Vindija	GWAS	Immune reponse to smallpox (secreted IL-1beta)	1	0.2955	3.38409475	0.25747425	immune
Vindija	GWAS	Platelet count	6	4.2529	1.41080204	0.25787421	hematologic
Vindija	GWAS	Arthritis (juvenile idiopathic)	1	0.2979	3.35683115	0.25937406	skeletal
Vindija	GWAS	Systemic lupus erythematosus	7	5.1712	1.35365099	0.26017398	immune
Vindija	GWAS	Prostate cancer	5	3.4141	1.46451481	0.26047395	reproductive
Vindija	GWAS	Mean arterial pressure x alcohol consumption interaction (2df test)	2	0.9935	2.01308505	0.26427357	cardiovascular
Vindija	GWAS	Sex hormone-binding globulin levels	1	0.3085	3.24149109	0.26787321	endocrine
Vindija	GWAS	Periodontal microbiota	2	1.0228	1.9554165	0.269973	immune
Vindija	GWAS	Liver enzyme levels (alkaline phosphatase)	1	0.3154	3.17057705	0.27087291	other
Vindija	GWAS	Thyroid cancer	1	0.3236	3.09023486	0.27687231	endocrine
Vindija	GWAS	PR segment	1	0.3229	3.09693404	0.27767223	cardiovascular
Vindija	GWAS	Response to serotonin reuptake inhibitors in major depressive disorder	1	0.3326	3.00661455	0.27917208	other
Vindija	GWAS	Psoriatic arthritis	1	0.3254	3.07314075	0.27927207	integumentary
Vindija	GWAS	Prostate-specific antigen levels	1	0.3282	3.04692261	0.28057194	reproductive
Vindija	GWAS	Response to fenofibrate (LDL cholesterol levels)	1	0.3327	3.00571085	0.28207179	other
Vindija	GWAS	Squamous cell lung carcinoma	3	1.8634	1.60996029	0.28227177	respiratory
Vindija	GWAS	Iris color (L* coordinate)	1	0.3351	2.98418383	0.28337166	integumentary
Vindija	GWAS	Body mass index (adult)	1	0.3282	3.04692261	0.28487151	metabolic
Vindija	GWAS	Cerebrospinal T-tau levels	2	1.0692	1.87055743	0.28767123	nervous
Vindija	GWAS	Huntington's disease progression	2	1.0617	1.88377131	0.28977102	nervous
Vindija	GWAS	Cytomegalovirus antibody response	1	0.3443	2.9044438	0.29167083	immune
Vindija	GWAS	Dimensional psychopathology (Cognitive)	1	0.3451	2.89771081	0.29177082	behavior
Vindija	GWAS	Logical memory (delayed recall) in mild cognitive impairment	1	0.3459	2.89100896	0.29407059	nervous
Vindija	GWAS	"Parental longevity (combined parental attained age, Martingale residuals)"	1	0.3482	2.87191269	0.29417058	other
Vindija	GWAS	Macular thickness	5	3.6228	1.38014795	0.29937006	nervous
Vindija	GWAS	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 (Grade 1 peripheral neuropathy)	1	0.3528	2.83446712	0.30086991	other
Vindija	GWAS	Midgestational circulating levels of PBDEs (fetal genetic effect)	1	0.3708	2.69687163	0.30806919	reproductive
Vindija	GWAS	Total bilirubin levels	1	0.3742	2.67236772	0.30986901	digestive
Vindija	GWAS	Essential tremor	1	0.3694	2.70709258	0.3109689	nervous
Vindija	GWAS	Preeclampsia	1	0.3809	2.62536099	0.319968	reproductive
Vindija	GWAS	D-dimer levels	1	0.3878	2.57864879	0.32166783	other
Vindija	GWAS	Waist circumference adjusted for BMI in non-smokers	2	1.1709	1.7080878	0.32216778	skeletal
Vindija	GWAS	Aspartate aminotransferase levels	1	0.3866	2.58665287	0.32226777	other
Vindija	GWAS	PR interval in Tripanosoma cruzi seropositivity	1	0.3868	2.58531541	0.32326767	cardiovascular
Vindija	GWAS	Bone mineral density (total hip)	1	0.3927	2.54647313	0.32466753	skeletal
Vindija	GWAS	Eosinophil percentage of granulocytes	3	2.011	1.49179513	0.329967	immune
Vindija	GWAS	Cerebral amyloid deposition (PET imaging)	1	0.4026	2.48385494	0.3309669	nervous
Vindija	GWAS	Problematic alcohol use in trauma-exposed individuals	1	0.4051	2.46852629	0.33146685	behavior
Vindija	GWAS	Epithelial ovarian cancer	1	0.4064	2.46062992	0.3329667	reproductive
Vindija	GWAS	Glucocorticoid-induced osteonecrosis (age 10 years and older)	1	0.4032	2.48015873	0.33426657	other
Vindija	GWAS	Urinary metabolite concentrations in chronic kidney disease	1	0.4092	2.44379277	0.33546645	metabolic
Vindija	GWAS	Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	1	0.4082	2.44977952	0.33586641	cardiovascular
Vindija	GWAS	Interferon alpha levels in systemic lupus erythematosus	1	0.4152	2.40847784	0.33666633	immune
Vindija	GWAS	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	1	0.4114	2.43072436	0.33916608	behavior
Vindija	GWAS	Inflammatory biomarkers	1	0.4139	2.41604252	0.34036596	immune
Vindija	GWAS	Retinopathy in non-diabetics	1	0.4143	2.41370987	0.34206579	nervous
Vindija	GWAS	Eosinophil percentage of white cells	3	2.0535	1.46092038	0.34366563	immune
Vindija	GWAS	Breast cancer (estrogen-receptor negative)	1	0.4206	2.37755587	0.34466553	reproductive
Vindija	GWAS	Non-alcoholic fatty liver disease histology (lobular)	1	0.4205	2.37812128	0.34486551	digestive
Vindija	GWAS	Feeling nervous	2	1.2085	1.65494415	0.34626537	behavior
Vindija	GWAS	Immunoglobulin A	1	0.4282	2.33535731	0.34636536	immune
Vindija	GWAS	Barrett's esophagus  or Esophageal adenocarcinoma	1	0.4255	2.35017626	0.34976502	digestive
Vindija	GWAS	Copper levels	2	1.2643	1.58190303	0.35646435	other
Vindija	GWAS	Airflow obstruction	2	1.2764	1.56690693	0.35726427	respiratory
Vindija	GWAS	Metabolite levels (Dihydroxy docosatrienoic acid)	1	0.4474	2.23513634	0.35876412	metabolic
Vindija	GWAS	Systolic blood pressure x smoking status (current vs non-current) interaction (1df test)	1	0.4503	2.22074173	0.36186381	cardiovascular
Vindija	GWAS	Response to taxane treatment (docetaxel)	1	0.4508	2.21827862	0.36266373	other
Vindija	GWAS	Immune response to anthrax vaccine	1	0.4444	2.25022502	0.36316368	immune
Vindija	GWAS	Blood protein levels	17	15.4101	1.10317259	0.3689631	other
Vindija	GWAS	Lung function (FEV1)	2	1.2984	1.54035736	0.369963	respiratory
Vindija	GWAS	Response to SSRI (symptom remission)	1	0.4676	2.13857998	0.37156284	other
Vindija	GWAS	Idiopathic pulmonary fibrosis	1	0.4647	2.15192597	0.37166283	respiratory
Vindija	GWAS	High light scatter reticulocyte percentage of red cells	3	2.1793	1.37658881	0.37176282	metabolic
Vindija	GWAS	Plasma amyloid beta peptide concentrations (ABx-40)	1	0.4654	2.1486893	0.37556244	nervous
Vindija	GWAS	Response to cognitive-behavioural therapy in anxiety disorder	1	0.4787	2.08899102	0.38156184	other
Vindija	GWAS	Non-glioblastoma glioma	1	0.4851	2.06143063	0.38456154	nervous
Vindija	GWAS	Pulmonary function	2	1.3589	1.47177864	0.38846115	respiratory
Vindija	GWAS	Rheumatoid arthritis	4	3.1621	1.26498213	0.38966103	immune
Vindija	GWAS	Waist circumference adjusted for body mass index	3	2.2687	1.32234319	0.38986101	skeletal
Vindija	GWAS	Mitochondrial DNA levels	2	1.3239	1.51068812	0.39056094	other
Vindija	GWAS	Alcohol dependence	2	1.3492	1.48235992	0.39126087	behavior
Vindija	GWAS	Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)	2	1.3713	1.45847006	0.39546045	skeletal
Vindija	GWAS	Ankylosing spondylitis	1	0.4958	2.01694232	0.39546045	skeletal
Vindija	GWAS	Body mass index in physically inactive individuals	1	0.5043	1.98294666	0.39736026	metabolic
Vindija	GWAS	C-reactive protein levels	1	0.5169	1.93461018	0.40025997	immune
Vindija	GWAS	Multiple myeloma	1	0.5197	1.92418703	0.40385961	immune
Vindija	GWAS	Late-onset myasthenia gravis	1	0.5214	1.91791331	0.40715928	skeletal muscle
Vindija	GWAS	Pursuit maintenance gain	4	3.2571	1.22808633	0.40725927	skeletal muscle
Vindija	GWAS	Waist-to-hip ratio adjusted for BMI (age >50)	2	1.4074	1.42106011	0.40955904	skeletal
Vindija	GWAS	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	1	0.5268	1.89825361	0.41135886	immune
Vindija	GWAS	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	1	0.5213	1.91828122	0.41145885	other
Vindija	GWAS	Chromium levels	1	0.5271	1.89717321	0.41305869	other
Vindija	GWAS	Diastolic blood pressure x alcohol consumption interaction (2df test)	2	1.4127	1.41572875	0.41415858	cardiovascular
Vindija	GWAS	LDL cholesterol levels	1	0.5416	1.84638109	0.41465853	metabolic
Vindija	GWAS	Modified Stumvoll Insulin Sensitivity Index (BMI interaction)	1	0.5565	1.79694519	0.42445755	metabolic
Vindija	GWAS	Protein quantitative trait loci	2	1.4636	1.36649358	0.42615738	other
Vindija	GWAS	Waist circumference adjusted for BMI (adjusted for smoking behaviour)	2	1.4679	1.36249063	0.42785721	skeletal
Vindija	GWAS	Energy expenditure (24h)	1	0.5623	1.7784101	0.43185681	behavior
Vindija	GWAS	Breast milk fatty acid composition (infant genotype effect)	1	0.579	1.72711572	0.43475652	reproductive
Vindija	GWAS	Reticulocyte fraction of red cells	3	2.393	1.2536565	0.43475652	immune
Vindija	GWAS	Prostate cancer (SNP x SNP interaction)	2	1.4745	1.356392	0.43505649	reproductive
Vindija	GWAS	Osteoarthritis (hip)	1	0.5714	1.7500875	0.43575642	skeletal
Vindija	GWAS	Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)	2	1.481	1.35043889	0.43635636	skeletal
Vindija	GWAS	Obsessive-compulsive symptoms	1	0.5662	1.76616037	0.43875612	behavior
Vindija	GWAS	Microalbuminuria	1	0.5841	1.71203561	0.44085591	other
Vindija	GWAS	Response to lurasidone in schizophrenia	1	0.5875	1.70212766	0.4429557	other
Vindija	GWAS	Acne (severe)	2	1.5129	1.32196444	0.44615538	integumentary
Vindija	GWAS	Creatinine levels	2	1.5117	1.32301383	0.44705529	other
Vindija	GWAS	Iron status biomarkers (iron levels)	1	0.5869	1.70386778	0.44735526	other
Vindija	GWAS	Breast milk fatty acid composition (maternal genotype effect)	1	0.6027	1.65920027	0.44755524	reproductive
Vindija	GWAS	Optic cup area	1	0.5962	1.6772895	0.44855514	nervous
Vindija	GWAS	Age-related macular degeneration	1	0.5982	1.67168171	0.44935506	nervous
Vindija	GWAS	Diastolic blood pressure	14	13.2091	1.05987539	0.45345465	cardiovascular
Vindija	GWAS	Gestational age at birth (maternal effect)	1	0.6104	1.63826999	0.45515448	reproductive
Vindija	GWAS	Vitiligo	2	1.5489	1.29123894	0.45745425	integumentary
Vindija	GWAS	QT interval	4	3.4716	1.15220648	0.4589541	cardiovascular
Vindija	GWAS	Hemoglobin levels	1	0.6136	1.62972621	0.45925407	hematologic
Vindija	GWAS	Electrocardiographic traits	1	0.6222	1.60720026	0.46205379	cardiovascular
Vindija	GWAS	Colorectal cancer	3	2.533	1.18436636	0.46325367	digestive
Vindija	GWAS	Bone mineral density (femoral neck)	1	0.6251	1.59974404	0.46435356	skeletal
Vindija	GWAS	Response to selective serotonin reuptake inhibitors in depression	1	0.6238	1.60307791	0.46715328	other
Vindija	GWAS	Primary sclerosing cholangitis	1	0.6331	1.5795293	0.46735326	digestive
Vindija	GWAS	Cervical cancer	1	0.6382	1.56690693	0.47055294	reproductive
Vindija	GWAS	Mercury levels	1	0.6357	1.57306906	0.47135286	other
Vindija	GWAS	Mean corpuscular volume	4	3.5473	1.12761819	0.4729527	hematologic
Vindija	GWAS	Metabolite levels  (X-11787)	1	0.6418	1.55811779	0.47375262	metabolic
Vindija	GWAS	Coronary artery disease	8	7.4679	1.07125162	0.47705229	cardiovascular
Vindija	GWAS	Mood instability	1	0.6435	1.55400155	0.47705229	behavior
Vindija	GWAS	Dental caries	2	1.6014	1.24890721	0.47705229	skeletal
Vindija	GWAS	Selective IgA deficiency	1	0.6646	1.50466446	0.48345165	immune
Vindija	GWAS	Brown vs. black hair color	1	0.6622	1.51011779	0.48585141	integumentary
Vindija	GWAS	Cobalt levels	1	0.6694	1.49387511	0.48935106	other
Vindija	GWAS	Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)	2	1.6338	1.22414004	0.49005099	cardiovascular
Vindija	GWAS	Aortic root size	1	0.6748	1.48192057	0.49025097	cardiovascular
Vindija	GWAS	Iron status biomarkers (transferrin saturation)	1	0.6778	1.47536146	0.49035096	other
Vindija	GWAS	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes	2	1.6637	1.20213981	0.49145085	cardiovascular
Vindija	GWAS	Chronic obstructive pulmonary disease	1	0.6774	1.47623265	0.49205079	respiratory
Vindija	GWAS	QRS duration	2	1.6514	1.21109362	0.4939506	cardiovascular
Vindija	GWAS	Basal cell carcinoma	1	0.6814	1.46756677	0.49585041	integumentary
Vindija	GWAS	Heschl's gyrus morphology	1	0.6819	1.46649069	0.49605039	nervous
Vindija	GWAS	Lung function (FVC)	2	1.6518	1.21080034	0.4969503	respiratory
Vindija	GWAS	PR interval	2	1.6708	1.19703136	0.50064994	cardiovascular
Vindija	GWAS	Lung cancer in never smokers	1	0.6954	1.43802128	0.50224978	respiratory
Vindija	GWAS	Red blood cell count	4	3.6824	1.0862481	0.50294971	hematologic
Vindija	GWAS	Worry too long after an embarrassing experience	1	0.6955	1.43781452	0.50424958	behavior
Vindija	GWAS	Fibrinogen levels	1	0.7005	1.42755175	0.50534947	hematologic
Vindija	GWAS	Initial alcohol sensitivity	1	0.7111	1.40627197	0.51114889	other
Vindija	GWAS	Eyebrow thickness	1	0.7073	1.41382723	0.51184882	integumentary
Vindija	GWAS	Waist-to-hip ratio adjusted for BMI in active individuals	1	0.7238	1.38159713	0.51244876	skeletal
Vindija	GWAS	Response to zileuton treatment in asthma (FEV1 change interaction)	1	0.7222	1.38465799	0.51314869	other
Vindija	GWAS	White blood cell count	3	2.7246	1.10107906	0.51654835	immune
Vindija	GWAS	Feeling guilty	1	0.7308	1.36836344	0.51784822	behavior
Vindija	GWAS	Hepcidin/ferritin ratio	1	0.7251	1.37912012	0.51824818	digestive
Vindija	GWAS	Primary biliary cirrhosis	1	0.7351	1.36035913	0.520048	digestive
Vindija	GWAS	Childhood body mass index	1	0.7204	1.38811771	0.52024798	metabolic
Vindija	GWAS	Colorectal or endometrial cancer	1	0.7526	1.32872708	0.52384762	digestive
Vindija	GWAS	Uric acid levels	1	0.7504	1.3326226	0.52514749	metabolic
Vindija	GWAS	Obesity (extreme)	1	0.7472	1.33832976	0.53134687	metabolic
Vindija	GWAS	Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	1	0.7554	1.32380196	0.53334667	cardiovascular
Vindija	GWAS	Body mass index (age>50)	1	0.7596	1.31648236	0.53344666	metabolic
Vindija	GWAS	Pulse pressure	11	10.9419	1.00530986	0.53554645	cardiovascular
Vindija	GWAS	Sjogren's syndrome	1	0.7711	1.29684866	0.53754625	immune
Vindija	GWAS	Rheumatoid arthritis (ACPA-positive)	1	0.7643	1.30838676	0.54014599	immune
Vindija	GWAS	Monobrow	2	1.8152	1.10180696	0.54114589	integumentary
Vindija	GWAS	Age at voice drop	1	0.7853	1.2733987	0.54414559	endocrine
Vindija	GWAS	Squamous cell carcinoma	1	0.7892	1.26710593	0.54794521	integumentary
Vindija	GWAS	Monocyte percentage of white cells	2	1.8456	1.08365843	0.55174483	immune
Vindija	GWAS	Cerebrospinal fluid t-tau:AB1-42 ratio	1	0.7933	1.26055717	0.55284472	nervous
Vindija	GWAS	Serum metabolite concentrations in chronic kidney disease	1	0.8082	1.2373175	0.55324468	urinary
Vindija	GWAS	Myocardial infarction	1	0.8225	1.21580547	0.55944406	cardiovascular
Vindija	GWAS	Cognitive ability (MTAG)	2	1.8543	1.07857413	0.56044396	nervous
Vindija	GWAS	Nose morphology	1	0.8169	1.22414004	0.56114389	skeletal
Vindija	GWAS	Response to fenofibrate (adiponectin levels)	1	0.8349	1.19774823	0.56544346	other
Vindija	GWAS	Experiencing mood swings	2	1.8855	1.0607266	0.56724328	behavior
Vindija	GWAS	Knee osteoarthritis	1	0.8403	1.19005117	0.57154285	skeletal
Vindija	GWAS	Joint mobility (Beighton score)	1	0.8476	1.17980179	0.57194281	skeletal
Vindija	GWAS	Seasonality and depression	1	0.8454	1.18287201	0.57564244	behavior
Vindija	GWAS	Presence of antiphospholipid antibodies	1	0.8659	1.15486777	0.58014199	other
Vindija	GWAS	Non-albumin protein levels	1	0.8788	1.13791534	0.58554145	other
Vindija	GWAS	Telomere length	1	0.8827	1.13288773	0.58734127	other
Vindija	GWAS	Nicotine dependence	1	0.8935	1.11919418	0.58854115	behavior
Vindija	GWAS	Serum uric acid levels	1	0.8916	1.12157918	0.58894111	other
Vindija	GWAS	Alzheimer's disease (late onset)	2	1.9772	1.01153146	0.58994101	nervous
Vindija	GWAS	Dialysis-related mortality	1	0.8909	1.12246043	0.59064094	other
Vindija	GWAS	Blond vs. brown/black hair color	3	3.0689	0.97754896	0.59144086	integumentary
Vindija	GWAS	Metabolite levels (Pyroglutamine)	1	0.9002	1.11086425	0.5920408	metabolic
Vindija	GWAS	Systolic blood pressure (cigarette smoking interaction)	1	0.8996	1.11160516	0.59224078	cardiovascular
Vindija	GWAS	Serum thyroid-stimulating hormone levels	1	0.9153	1.09253797	0.59764024	endocrine
Vindija	GWAS	Breast cancer	4	4.1966	0.95315255	0.59774023	reproductive
Vindija	GWAS	Sum eosinophil basophil counts	2	2.0235	0.98838646	0.60113989	hematologic
Vindija	GWAS	Cerebral amyloid deposition in APOEe4 non-carriers (PET imaging)	1	0.9074	1.10204981	0.60153985	nervous
Vindija	GWAS	Serum total protein level	1	0.9155	1.09229929	0.60273973	other
Vindija	GWAS	"Allergic disease (asthma, hay fever or eczema)"	2	2.0199	0.99014803	0.60343966	immune
Vindija	GWAS	Reaction time	1	0.93	1.07526882	0.60753925	behavior
Vindija	GWAS	Hippocampal atrophy	1	0.9372	1.06700811	0.60833917	nervous
Vindija	GWAS	Lung cancer	2	2.0699	0.96623025	0.61423858	respiratory
Vindija	GWAS	Primary biliary cholangitis	1	0.9599	1.04177518	0.6150385	digestive
Vindija	GWAS	Glucose homeostasis traits	2	2.0995	0.95260776	0.61573843	metabolic
Vindija	GWAS	Cognitive ability	2	2.0686	0.96683747	0.61633837	nervous
Vindija	GWAS	Hemoglobin	1	0.9615	1.0400416	0.61663834	hematologic
Vindija	GWAS	Vertical cup-disc ratio	1	0.965	1.03626943	0.61693831	nervous
Vindija	GWAS	Epstein-Barr virus copy number in lymphoblastoid cell lines	3	3.1788	0.94375236	0.61813819	immune
Vindija	GWAS	Asthma (childhood onset)	1	0.9633	1.0380982	0.61893811	respiratory
Vindija	GWAS	Adiponectin levels	1	0.9824	1.01791531	0.62143786	other
Vindija	GWAS	Morning vs. evening chronotype	1	0.9666	1.03455411	0.62253775	behavior
Vindija	GWAS	Endometrial cancer	1	0.9789	1.02155481	0.62373763	reproductive
Vindija	GWAS	Chronotype	1	0.9814	1.01895252	0.62373763	behavior
Vindija	GWAS	Urinary albumin excretion	2	2.1321	0.93804231	0.62773723	metabolic
Vindija	GWAS	Response to fenofibrate (total cholesterol levels)	1	0.9887	1.01142915	0.63083692	other
Vindija	GWAS	Body mass index (age <50)	1	0.997	1.00300903	0.6330367	metabolic
Vindija	GWAS	Craniofacial microsomia	1	1.011	0.98911968	0.63663634	skeletal
Vindija	GWAS	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	1	1.0216	0.9788567	0.64273573	other
Vindija	GWAS	White blood cell count (basophil)	1	1.0277	0.97304661	0.64333567	immune
Vindija	GWAS	Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)	1	1.0632	0.94055681	0.65123488	skeletal
Vindija	GWAS	Diabetic kidney disease	1	1.0573	0.94580535	0.65333467	metabolic
Vindija	GWAS	Systolic blood pressure	13	14.0255	0.92688318	0.65413459	cardiovascular
Vindija	GWAS	Calcium levels	1	1.0851	0.92157405	0.65463454	other
Vindija	GWAS	Systolic blood pressure x smoking status (ever vs never) interaction (2df test)	1	1.0618	0.94179695	0.65553445	cardiovascular
Vindija	GWAS	Multiple sclerosis	4	4.507	0.88750832	0.66193381	nervous
Vindija	GWAS	"Cholesterol, total"	1	1.0902	0.91726289	0.66913309	metabolic
Vindija	GWAS	Depression	2	2.2943	0.87172558	0.67123288	behavior
Vindija	GWAS	Lung cancer in ever smokers	2	2.3118	0.86512674	0.67293271	respiratory
Vindija	GWAS	Urate levels	1	1.1186	0.89397461	0.67333267	metabolic
Vindija	GWAS	High density lipoprotein cholesterol levels	1	1.1093	0.9014694	0.67373263	metabolic
Vindija	GWAS	Glycated hemoglobin levels	1	1.1365	0.87989441	0.67573243	metabolic
Vindija	GWAS	Heel bone mineral density	16	17.534	0.91251283	0.67643236	skeletal
Vindija	GWAS	Refractive error	1	1.1374	0.87919817	0.67673233	nervous
Vindija	GWAS	Feeling miserable	1	1.1427	0.87512033	0.68113189	behavior
Vindija	GWAS	HDL cholesterol levels	1	1.1568	0.86445367	0.6850315	metabolic
Vindija	GWAS	Manganese levels	1	1.156	0.8650519	0.69073093	other
Vindija	GWAS	Mean arterial pressure	1	1.1746	0.85135365	0.69133087	cardiovascular
Vindija	GWAS	Itch intensity from mosquito bite	1	1.1652	0.85822176	0.69233077	immune
Vindija	GWAS	Lung function (FEV1/FVC)	2	2.3937	0.83552659	0.69573043	respiratory
Vindija	GWAS	Diverticular disease	3	3.5685	0.84068937	0.69613039	digestive
Vindija	GWAS	Type 2 diabetes (age of onset)	1	1.1966	0.83570115	0.6970303	metabolic
Vindija	GWAS	Small cell lung carcinoma	1	1.1978	0.83486392	0.6990301	respiratory
Vindija	GWAS	Hemoglobin concentration	2	2.4504	0.81619327	0.70232977	hematologic
Vindija	GWAS	Idiopathic dilated cardiomyopathy	1	1.2237	0.81719376	0.7030297	cardiovascular
Vindija	GWAS	Verbal declarative memory	1	1.2096	0.82671958	0.70772923	nervous
Vindija	GWAS	Asthma	4	4.8103	0.83154897	0.70782922	respiratory
Vindija	GWAS	Refractive astigmatism	2	2.471	0.80938891	0.70832917	nervous
Vindija	GWAS	Feeling worry	1	1.2258	0.81579377	0.71142886	behavior
Vindija	GWAS	Chronic kidney disease	1	1.25	0.8	0.71242876	urinary
Vindija	GWAS	Mean platelet volume	3	3.7201	0.80642993	0.71412859	hematologic
Vindija	GWAS	Body mass index in physically active individuals	2	2.525	0.79207921	0.72312769	metabolic
Vindija	GWAS	Waist circumference adjusted for BMI in active individuals	1	1.3381	0.7473283	0.73732627	skeletal
Vindija	GWAS	Late-onset Alzheimer's disease	1	1.3427	0.744768	0.74122588	nervous
Vindija	GWAS	Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)	2	2.6254	0.76178868	0.74232577	skeletal
Vindija	GWAS	Hippocampal volume	1	1.3489	0.7413448	0.74262574	nervous
Vindija	GWAS	Obsessive-compulsive disorder	1	1.3732	0.72822604	0.74322568	behavior
Vindija	GWAS	Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)	1	1.3444	0.74382624	0.7450255	cardiovascular
Vindija	GWAS	Body mass index (joint analysis main effects and physical activity interaction)	2	2.6478	0.75534406	0.74532547	metabolic
Vindija	GWAS	Hematocrit	2	2.6924	0.74283167	0.74552545	hematologic
Vindija	GWAS	Hypothyroidism	1	1.3612	0.7346459	0.74692531	endocrine
Vindija	GWAS	Immature fraction of reticulocytes	1	1.3511	0.74013767	0.74762524	hematologic
Vindija	GWAS	Insulin resistance/response	1	1.3991	0.71474519	0.7520248	immune
Vindija	GWAS	Mild influenza (H1N1) infection	1	1.4115	0.70846617	0.75282472	immune
Vindija	GWAS	Tuberculosis	1	1.3885	0.72020166	0.7530247	immune
Vindija	GWAS	Nickel levels	1	1.4333	0.69769064	0.7560244	other
Vindija	GWAS	Resting-state electroencephalogram vigilance	1	1.4109	0.70876745	0.7560244	nervous
Vindija	GWAS	Gut microbiota (functional units)	1	1.4234	0.70254321	0.76182382	digestive
Vindija	GWAS	Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)	1	1.4365	0.69613644	0.76322368	cardiovascular
Vindija	GWAS	Acute lymphoblastic leukemia (childhood)	1	1.4416	0.6936737	0.76732327	lymphatic
Vindija	GWAS	Pulmonary function (smoking interaction)	1	1.4761	0.67746088	0.77432257	respiratory
Vindija	GWAS	Sum neutrophil eosinophil counts	1	1.5201	0.65785146	0.78162184	hematologic
Vindija	GWAS	Body mass index x sex x age interaction (4df test)	1	1.5069	0.66361404	0.78282172	metabolic
Vindija	GWAS	Mosquito bite size	2	2.888	0.69252078	0.78542146	other
Vindija	GWAS	Thiazide-induced adverse metabolic effects in hypertensive patients	1	1.5098	0.66233938	0.78612139	other
Vindija	GWAS	Central corneal thickness	1	1.5527	0.64403942	0.78612139	nervous
Vindija	GWAS	Diisocyanate-induced asthma	4	5.4258	0.73721847	0.78662134	respiratory
Vindija	GWAS	Granulocyte count	1	1.5431	0.64804614	0.78862114	immune
Vindija	GWAS	Myeloid white cell count	1	1.5512	0.6446622	0.79012099	immune
Vindija	GWAS	Bronchopulmonary dysplasia	1	1.5591	0.64139568	0.79042096	respiratory
Vindija	GWAS	Resting heart rate	2	2.952	0.67750678	0.79562044	cardiovascular
Vindija	GWAS	Visceral adipose tissue/subcutaneous adipose tissue ratio	1	1.6168	0.61850569	0.80471953	metabolic
Vindija	GWAS	Neutrophil percentage of granulocytes	1	1.635	0.6116208	0.80571943	lymphatic
Vindija	GWAS	Sum basophil neutrophil counts	1	1.6516	0.60547348	0.80891911	hematologic
Vindija	GWAS	Amyotrophic lateral sclerosis (sporadic)	4	5.5852	0.71617847	0.81111889	nervous
Vindija	GWAS	Hip circumference	1	1.6554	0.60408361	0.81321868	skeletal
Vindija	GWAS	Nicotine dependence and major depression (severity of comorbidity)	1	1.7435	0.57355893	0.81631837	behavior
Vindija	GWAS	Paclitaxel disposition in epithelial ovarian cancer	1	1.6727	0.59783583	0.82121788	other
Vindija	GWAS	Granulocyte percentage of myeloid white cells	1	1.7651	0.56654014	0.82671733	immune
Vindija	GWAS	Methadone dose in opioid dependence	1	1.7479	0.57211511	0.82671733	other
Vindija	GWAS	Mean corpuscular hemoglobin	2	3.1949	0.62599768	0.82781722	hematologic
Vindija	GWAS	Educational attainment	1	1.762	0.56753689	0.82821718	other
Vindija	GWAS	Metabolite levels	1	1.7915	0.55819146	0.83291671	metabolic
Vindija	GWAS	Hand grip strength	3	4.6097	0.65080157	0.83331667	skeletal muscle
Vindija	GWAS	Emphysema imaging phenotypes	1	1.8039	0.55435445	0.83331667	respiratory
Vindija	GWAS	Uterine fibroids	1	1.8143	0.55117676	0.8340166	reproductive
Vindija	GWAS	Intelligence	1	1.7647	0.56666856	0.83431657	other
Vindija	GWAS	Anti-saccade response	1	1.8236	0.54836587	0.83471653	nervous
Vindija	GWAS	Cognitive decline (age-related)	1	1.7845	0.56038106	0.83541646	nervous
Vindija	GWAS	Disease progression in age-related macular degeneration	1	1.8525	0.53981107	0.84071593	nervous
Vindija	GWAS	Hip circumference adjusted for BMI	1	1.8603	0.53754771	0.84661534	skeletal
Vindija	GWAS	Nasopharyngeal carcinoma (SNP x SNP interaction)	2	3.332	0.6002401	0.8470153	other
Vindija	GWAS	BMI in non-smokers	1	1.8556	0.53890925	0.84851515	metabolic
Vindija	GWAS	Intelligence (MTAG)	5	7.3611	0.67924631	0.85981402	other
Vindija	GWAS	Glomerular filtration rate	1	1.9757	0.50614972	0.86071393	hematologic
Vindija	GWAS	Familial squamous cell lung carcinoma	1	1.9962	0.50095181	0.86281372	respiratory
Vindija	GWAS	Monocyte count	1	2.0074	0.49815682	0.86331367	immune
Vindija	GWAS	Post bronchodilator FEV1 in COPD	1	1.94	0.51546392	0.86381362	other
Vindija	GWAS	Post bronchodilator FEV1/FVC ratio in COPD	1	2.1204	0.47160913	0.87761224	other
Vindija	GWAS	HDL cholesterol	2	3.6668	0.54543471	0.880012	metabolic
Vindija	GWAS	Subcutaneous adipose tissue	1	2.1192	0.47187618	0.88051195	metabolic
Vindija	GWAS	Cognitive function	1	2.1637	0.46217128	0.88631137	nervous
Vindija	GWAS	Schizophrenia	10	13.8726	0.72084541	0.88711129	behavior
Vindija	GWAS	Waist-to-hip ratio adjusted for body mass index	1	2.2066	0.4531859	0.88961104	skeletal
Vindija	GWAS	Major depressive disorder	3	5.1992	0.57701185	0.89071093	behavior
Vindija	GWAS	BMI (adjusted for smoking behaviour)	1	2.2278	0.44887333	0.89351065	metabolic
Vindija	GWAS	Body mass index (joint analysis main effects and smoking interaction)	1	2.2315	0.44812906	0.89391061	metabolic
Vindija	GWAS	Red cell distribution width	1	2.2937	0.43597681	0.89461054	hematologic
Vindija	GWAS	Waist-to-hip ratio adjusted for BMI	1	2.2403	0.44636879	0.89541046	skeletal
Vindija	GWAS	Blood pressure	1	2.3324	0.42874293	0.90270973	hematologic
Vindija	GWAS	Post bronchodilator FEV1	2	3.8922	0.51384821	0.90330967	other
Vindija	GWAS	Immune response to smallpox vaccine (IL-6)	1	2.4304	0.4114549	0.91150885	immune
Vindija	GWAS	Coronary artery aneurysm in Kawasaki disease	1	2.467	0.40535063	0.91380862	cardiovascular
Vindija	GWAS	Obesity	1	2.4274	0.41196342	0.9150085	metabolic
Vindija	GWAS	Allergic rhinitis	1	2.475	0.4040404	0.91570843	immune
Vindija	GWAS	Venous thromboembolism adjusted for sickle cell variant rs77121243-T	1	2.5249	0.39605529	0.92240776	hematologic
Vindija	GWAS	Rosacea symptom severity	2	4.1994	0.47625851	0.92350765	integumentary
Vindija	GWAS	Cognitive decline rate in late mild cognitive impairment	1	2.5283	0.39552268	0.92410759	nervous
Vindija	GWAS	Neuroticism	1	2.7916	0.35821751	0.93680632	behavior
Vindija	GWAS	Bipolar disorder	1	2.8067	0.35629031	0.93850615	behavior
Vindija	GWAS	Night sleep phenotypes	5	9.293	0.53803938	0.95390461	behavior
Vindija	GWAS	Loneliness	1	3.1215	0.3203588	0.95650435	behavior
Vindija	GWAS	Parkinson's disease	1	3.136	0.31887755	0.95820418	nervous
Vindija	GWAS	Itch intensity from mosquito bite adjusted by bite size	1	3.2287	0.30972218	0.9620038	immune
Vindija	GWAS	Spherical equivalent or myopia (age of diagnosis)	2	5.1528	0.38813849	0.96390361	nervous
Vindija	GWAS	Type 2 diabetes	4	8.2684	0.48376953	0.96690331	metabolic
Vindija	GWAS	Longevity	1	3.6918	0.27087058	0.97590241	other
Vindija	GWAS	Male-pattern baldness	1	3.8011	0.26308174	0.97760224	integumentary
Vindija	GWAS	Monoclonal gammopathy of undetermined significance	1	3.8066	0.26270162	0.97780222	hematologic
Vindija	GWAS	General cognitive ability	2	5.7518	0.34771724	0.97920208	nervous
Vindija	GWAS	Daytime sleep phenotypes	1	4.0712	0.24562782	0.98310169	behavior
Vindija	GWAS	Body mass index	11	19.9131	0.55240018	0.98990101	metabolic
Vindija	GWAS	Atrial fibrillation	1	4.4871	0.22286109	0.99040096	cardiovascular
Vindija	GWAS	Obesity-related traits	12	22.6834	0.52902122	0.99470053	metabolic
Vindija	GWAS	Post bronchodilator FEV1/FVC ratio	2	8.0361	0.24887694	0.99650035	other
Vindija	GWAS	Menarche (age at onset)	1	6.8312	0.14638716	0.99880012	reproductive
Vindija	HPO	Difficulty climbing stairs (HP:0003551)	3	0.0893	33.59462486	0.00019998	other
Vindija	HPO	Hypermelanotic macule (HP:0001034)	5	0.6475	7.722007722	0.00069993	integumentary
Vindija	HPO	Hypopigmented skin patches (HP:0001053)	5	0.6908	7.237984945	0.00089991	integumentary
Vindija	HPO	Thin bony cortex (HP:0002753)	2	0.0474	42.19409283	0.00109989	skeletal
Vindija	HPO	Rapidly progressive (HP:0003678)	3	0.2148	13.96648045	0.00149985	other
Vindija	HPO	Abnormal urine output (HP:0012590)	2	0.0867	23.06805075	0.00319968	urinary
Vindija	HPO	Adenoma sebaceum (HP:0009720)	2	0.0855	23.39181287	0.00339966	integumentary
Vindija	HPO	Angiofibromas (HP:0010615)	2	0.0855	23.39181287	0.00339966	cardiovascular
Vindija	HPO	Blepharitis (HP:0000498)	2	0.0966	20.70393375	0.00379962	nervous
Vindija	HPO	Abnormal blistering of the skin (HP:0008066)	4	0.6385	6.26468285	0.00439956	integumentary
Vindija	HPO	Bone marrow hypocellularity (HP:0005528)	3	0.3156	9.505703422	0.00479952	other
Vindija	HPO	Abnormality of the lower motor neuron (HP:0002366)	2	0.114	17.54385965	0.00559944	nervous
Vindija	HPO	Abnormality of renal excretion (HP:0011036)	2	0.1261	15.86042823	0.00629937	urinary
Vindija	HPO	Hamartoma of the eye (HP:0010568)	2	0.1241	16.11603546	0.00729927	nervous
Vindija	HPO	Lymphangioma (HP:0100764)	2	0.1329	15.04890895	0.00859914	lymphatic
Vindija	HPO	Episodic fever (HP:0001954)	2	0.1396	14.32664756	0.00929907	other
Vindija	HPO	Wide cranial sutures (HP:0010537)	2	0.1451	13.78359752	0.00939906	skeletal
Vindija	HPO	Skin nodule (HP:0200036)	2	0.1379	14.50326323	0.00989901	integumentary
Vindija	HPO	Visceral angiomatosis (HP:0100761)	2	0.1602	12.48439451	0.01219878	skeletal
Vindija	HPO	Abnormality of the anterior chamber (HP:0000593)	2	0.17	11.76470588	0.01279872	nervous
Vindija	HPO	Renal cell carcinoma (HP:0005584)	3	0.4493	6.677053194	0.01309869	urinary
Vindija	HPO	Aortic valve stenosis (HP:0001650)	2	0.1825	10.95890411	0.01339866	cardiovascular
Vindija	HPO	Uterine neoplasm (HP:0010784)	3	0.507	5.917159763	0.0139986	reproductive
Vindija	HPO	Joint swelling (HP:0001386)	2	0.1753	11.40901312	0.01439856	skeletal
Vindija	HPO	Lumbar hyperlordosis (HP:0002938)	3	0.5256	5.707762557	0.01479852	skeletal
Vindija	HPO	Abnormal cortical bone morphology (HP:0003103)	3	0.4896	6.12745098	0.01479852	skeletal
Vindija	HPO	Joint stiffness (HP:0001387)	2	0.188	10.63829787	0.01509849	skeletal
Vindija	HPO	Sensorimotor neuropathy (HP:0007141)	2	0.1986	10.07049345	0.01519848	nervous
Vindija	HPO	Conjunctival hamartoma (HP:0100780)	1	0.0152	65.78947368	0.01519848	skeletal muscle
Vindija	HPO	Hemangiomatosis (HP:0007461)	2	0.1844	10.84598698	0.01559844	cardiovascular
Vindija	HPO	Lymphedema (HP:0001004)	3	0.5238	5.727376861	0.01609839	lymphatic
Vindija	HPO	Megalocornea (HP:0000485)	2	0.2033	9.837678308	0.01749825	nervous
Vindija	HPO	Alopecia of scalp (HP:0002293)	1	0.0179	55.86592179	0.01759824	integumentary
Vindija	HPO	Melanoma (HP:0002861)	2	0.208	9.615384615	0.01789821	integumentary
Vindija	HPO	Weight loss (HP:0001824)	4	1.0103	3.959220034	0.01869813	metabolic
Vindija	HPO	Sacral dimple (HP:0000960)	3	0.5834	5.142269455	0.01879812	integumentary
Vindija	HPO	Exostoses (HP:0100777)	2	0.218	9.174311927	0.02029797	skeletal
Vindija	HPO	Autoimmune thrombocytopenia (HP:0001973)	1	0.0215	46.51162791	0.02159784	immune
Vindija	HPO	Abnormality of the musculature of the hand (HP:0001421)	2	0.2251	8.884940027	0.02239776	skeletal muscle
Vindija	HPO	Abnormality of the motor neurons (HP:0002450)	2	0.2342	8.53970965	0.02309769	nervous
Vindija	HPO	Abnormal neuron morphology (HP:0012757)	2	0.2342	8.53970965	0.02309769	nervous
Vindija	HPO	Highly arched eyebrow (HP:0002553)	4	1.0832	3.692762186	0.02329767	integumentary
Vindija	HPO	Poor speech (HP:0002465)	2	0.2416	8.278145695	0.02339766	other
Vindija	HPO	Carious teeth (HP:0000670)	4	1.1075	3.611738149	0.02409759	skeletal
Vindija	HPO	Pulmonary hypertension (HP:0002092)	3	0.6291	4.768717215	0.02459754	cardiovascular
Vindija	HPO	Leukopenia (HP:0001882)	3	0.6218	4.824702477	0.02589741	immune
Vindija	HPO	Pulmonary infiltrates (HP:0002113)	2	0.2693	7.426661716	0.02739726	respiratory
Vindija	HPO	Exercise-induced myalgia (HP:0003738)	1	0.0285	35.0877193	0.02829717	skeletal muscle
Vindija	HPO	"Intellectual disability, mild (HP:0001256)"	3	0.6635	4.521477016	0.02879712	nervous
Vindija	HPO	Hypotension (HP:0002615)	2	0.2761	7.243752264	0.03019698	cardiovascular
Vindija	HPO	Abnormality of the pleura (HP:0002103)	2	0.287	6.968641115	0.03249675	respiratory
Vindija	HPO	Back pain (HP:0003418)	1	0.0338	29.58579882	0.03329667	skeletal
Vindija	HPO	Benign neoplasm of the central nervous system (HP:0100835)	2	0.2823	7.084661707	0.03339666	nervous
Vindija	HPO	Premature birth (HP:0001622)	3	0.7028	4.268639727	0.0339966	reproductive
Vindija	HPO	Cafe-au-lait spot (HP:0000957)	3	0.6695	4.480955937	0.0339966	integumentary
Vindija	HPO	Neoplasm of the pancreas (HP:0002894)	2	0.2906	6.882312457	0.03439656	digestive
Vindija	HPO	Mucosal telangiectasiae (HP:0100579)	2	0.2823	7.084661707	0.03439656	integumentary
Vindija	HPO	Limb-girdle muscle atrophy (HP:0003797)	1	0.0373	26.80965147	0.0369963	skeletal muscle
Vindija	HPO	Increased intracranial pressure (HP:0002516)	2	0.3067	6.521030323	0.03809619	nervous
Vindija	HPO	Abnormality of intracranial pressure (HP:0012640)	2	0.3067	6.521030323	0.03809619	nervous
Vindija	HPO	Cerebral cortical atrophy (HP:0002120)	5	1.8778	2.662690382	0.04019598	nervous
Vindija	HPO	Prominent nose (HP:0000448)	2	0.3036	6.587615283	0.04019598	skeletal
Vindija	HPO	Type 2 muscle fiber atrophy (HP:0003554)	1	0.042	23.80952381	0.0409959	skeletal muscle
Vindija	HPO	Muscle fiber atrophy (HP:0100295)	1	0.042	23.80952381	0.0409959	skeletal muscle
Vindija	HPO	Abnormality of the vocal cords (HP:0008777)	1	0.0425	23.52941176	0.04139586	other
Vindija	HPO	Deep venous thrombosis (HP:0002625)	1	0.044	22.72727273	0.04329567	hematologic
Vindija	HPO	Fibroma (HP:0010614)	2	0.3332	6.00240096	0.04369563	reproductive
Vindija	HPO	Asymmetry of the thorax (HP:0001555)	1	0.0465	21.50537634	0.04589541	skeletal
Vindija	HPO	Generalized hyperpigmentation (HP:0007440)	2	0.3327	6.011421701	0.0459954	integumentary
Vindija	HPO	Fibrous tissue neoplasm (HP:0012316)	2	0.3415	5.856515373	0.0459954	other
Vindija	HPO	Bone cyst (HP:0012062)	1	0.048	20.83333333	0.04659534	skeletal
Vindija	HPO	Uterine leiomyosarcoma (HP:0002891)	2	0.3381	5.915409642	0.04889511	reproductive
Vindija	HPO	Leiomyosarcoma (HP:0100243)	2	0.3381	5.915409642	0.04889511	skeletal muscle
Vindija	HPO	Inappropriate behavior (HP:0000719)	1	0.0501	19.96007984	0.0489951	behavior
Vindija	HPO	Spinal muscular atrophy (HP:0007269)	1	0.0528	18.93939394	0.051594841	skeletal muscle
Vindija	HPO	Oligohydramnios (HP:0001562)	3	0.8068	3.718393654	0.051894811	reproductive
Vindija	HPO	Arteriovenous malformation (HP:0100026)	2	0.3688	5.422993492	0.053094691	cardiovascular
Vindija	HPO	Neonatal respiratory distress (HP:0002643)	1	0.0555	18.01801802	0.053794621	respiratory
Vindija	HPO	Camptodactyly of toe (HP:0001836)	2	0.3707	5.395198274	0.053794621	skeletal
Vindija	HPO	Hypomagnesemia (HP:0002917)	1	0.0559	17.88908766	0.054194581	other
Vindija	HPO	Rough bone trabeculation (HP:0100670)	1	0.0554	18.05054152	0.054294571	skeletal
Vindija	HPO	Hereditary nonpolyposis colorectal carcinoma (HP:0006716)	2	0.3631	5.508124484	0.054494551	digestive
Vindija	HPO	Aplasia/Hypoplasia of the nipples (HP:0006709)	2	0.3768	5.307855626	0.055394461	other
Vindija	HPO	Hamartoma (HP:0010566)	2	0.3845	5.201560468	0.056994301	other
Vindija	HPO	Abnormality of magnesium homeostasis (HP:0004921)	1	0.0591	16.92047377	0.057194281	other
Vindija	HPO	Transitional cell carcinoma of the bladder (HP:0006740)	2	0.381	5.249343832	0.058294171	urinary
Vindija	HPO	Bladder neoplasm (HP:0009725)	2	0.381	5.249343832	0.058294171	urinary
Vindija	HPO	Bladder carcinoma (HP:0002862)	2	0.381	5.249343832	0.058294171	urinary
Vindija	HPO	Flexion contracture of toe (HP:0005830)	2	0.3898	5.130836326	0.058494151	skeletal muscle
Vindija	HPO	Joint contractures involving the joints of the feet (HP:0100492)	2	0.3898	5.130836326	0.058494151	skeletal
Vindija	HPO	Ridged nail (HP:0001807)	1	0.0608	16.44736842	0.058994101	integumentary
Vindija	HPO	Congenital glaucoma (HP:0001087)	2	0.4064	4.921259843	0.061293871	nervous
Vindija	HPO	Abdominal situs inversus (HP:0003363)	1	0.0639	15.64945227	0.062093791	other
Vindija	HPO	Abnormality of abdominal situs (HP:0011620)	1	0.0639	15.64945227	0.062093791	cardiovascular
Vindija	HPO	Hand muscle atrophy (HP:0009130)	1	0.0673	14.85884101	0.065693431	skeletal muscle
Vindija	HPO	Muscle stiffness (HP:0003552)	1	0.0683	14.64128843	0.066593341	skeletal muscle
Vindija	HPO	Arthralgia (HP:0002829)	3	0.9084	3.302509908	0.066993301	skeletal
Vindija	HPO	Slow progression (HP:0003677)	3	0.9223	3.252737721	0.067393261	other
Vindija	HPO	Shoulder girdle muscle weakness (HP:0003547)	1	0.0703	14.22475107	0.067693231	skeletal muscle
Vindija	HPO	Insomnia (HP:0100785)	1	0.0705	14.18439716	0.067893211	behavior
Vindija	HPO	Asplenia (HP:0001746)	1	0.07	14.28571429	0.068093191	lymphatic
Vindija	HPO	Aplasia/Hypoplasia of the spleen (HP:0010451)	1	0.07	14.28571429	0.068093191	lymphatic
Vindija	HPO	Spinal cord compression (HP:0002176)	1	0.0709	14.10437236	0.068693131	nervous
Vindija	HPO	Depression (HP:0000716)	2	0.431	4.64037123	0.069193081	behavior
Vindija	HPO	Polyuria (HP:0000103)	1	0.0724	13.8121547	0.070392961	urinary
Vindija	HPO	Renal salt wasting (HP:0000127)	1	0.0731	13.67989056	0.070392961	urinary
Vindija	HPO	Decreased number of large peripheral myelinated nerve fibers (HP:0003387)	1	0.0739	13.53179973	0.070692931	nervous
Vindija	HPO	Abnormal trabecular bone morphology (HP:0100671)	1	0.0736	13.58695652	0.070892911	skeletal
Vindija	HPO	Chromosomal breakage induced by crosslinking agents (HP:0003221)	1	0.0741	13.49527665	0.071792821	other
Vindija	HPO	Distal upper limb amyotrophy (HP:0007149)	1	0.0748	13.36898396	0.072692731	nervous
Vindija	HPO	Upper limb amyotrophy (HP:0009129)	1	0.0748	13.36898396	0.072692731	nervous
Vindija	HPO	Malignant gastrointestinal tract tumors (HP:0006749)	2	0.4268	4.686035614	0.072792721	digestive
Vindija	HPO	Abnormal pupillary function (HP:0007686)	1	0.0756	13.22751323	0.072792721	nervous
Vindija	HPO	Gastrointestinal carcinoma (HP:0002672)	2	0.4268	4.686035614	0.072792721	digestive
Vindija	HPO	Spinal canal stenosis (HP:0003416)	2	0.4497	4.447409384	0.073292671	skeletal
Vindija	HPO	Vomiting (HP:0002013)	3	0.9702	3.092145949	0.074892511	digestive
Vindija	HPO	Abnormality of the neuromuscular junction (HP:0003398)	1	0.0801	12.48439451	0.076292371	nervous
Vindija	HPO	Fatigable weakness (HP:0003473)	1	0.0801	12.48439451	0.076292371	skeletal muscle
Vindija	HPO	Palmoplantar hyperkeratosis (HP:0000972)	1	0.0811	12.33045623	0.077892211	integumentary
Vindija	HPO	Retinopathy (HP:0000488)	2	0.4735	4.223864836	0.081591841	nervous
Vindija	HPO	Supranuclear gaze palsy (HP:0000605)	1	0.0863	11.58748552	0.082291771	nervous
Vindija	HPO	Hyperuricemia (HP:0002149)	1	0.0874	11.4416476	0.084291571	other
Vindija	HPO	Increased purine levels (HP:0004368)	1	0.0874	11.4416476	0.084291571	other
Vindija	HPO	Hyporeflexia of lower limbs (HP:0002600)	1	0.0891	11.22334456	0.085191481	skeletal
Vindija	HPO	Congestive heart failure (HP:0001635)	3	1.0348	2.899110939	0.085291471	cardiovascular
Vindija	HPO	Ectopia lentis (HP:0001083)	2	0.4824	4.145936982	0.085691431	nervous
Vindija	HPO	Arterial thrombosis (HP:0004420)	1	0.091	10.98901099	0.087091291	cardiovascular
Vindija	HPO	Aplasia/Hypoplasia of the lens (HP:0008063)	2	0.4853	4.121162168	0.087391261	nervous
Vindija	HPO	Teleangiectasia of the skin (HP:0100585)	2	0.4886	4.093327876	0.087591241	cardiovascular
Vindija	HPO	Neoplasm of the heart (HP:0100544)	1	0.0923	10.83423619	0.088391161	cardiovascular
Vindija	HPO	Ependymoma (HP:0002888)	1	0.0931	10.74113856	0.089191081	nervous
Vindija	HPO	Enlarged penis (HP:0000040)	1	0.0939	10.64962726	0.089391061	reproductive
Vindija	HPO	T lymphocytopenia (HP:0005403)	1	0.095	10.52631579	0.090590941	immune
Vindija	HPO	Pelvic girdle muscle weakness (HP:0003749)	1	0.0949	10.5374078	0.090790921	skeletal muscle
Vindija	HPO	Chromsome breakage (HP:0040012)	1	0.0952	10.50420168	0.090890911	other
Vindija	HPO	Palmar hyperkeratosis (HP:0010765)	1	0.0958	10.43841336	0.091290871	integumentary
Vindija	HPO	Atresia of the external auditory canal (HP:0000413)	2	0.5072	3.943217666	0.092390761	nervous
Vindija	HPO	Sloping forehead (HP:0000340)	3	1.0734	2.794857462	0.093290671	skeletal
Vindija	HPO	Shawl scrotum (HP:0000049)	1	0.0967	10.34126163	0.093390661	reproductive
Vindija	HPO	Athetosis (HP:0002305)	1	0.0982	10.18329939	0.093790621	nervous
Vindija	HPO	Atelectasis (HP:0100750)	1	0.1	10	0.094290571	respiratory
Vindija	HPO	Macroorchidism (HP:0000053)	1	0.099	10.1010101	0.094390561	reproductive
Vindija	HPO	Abnormality of the hip-girdle musculature (HP:0001445)	1	0.1018	9.823182711	0.097190281	skeletal muscle
Vindija	HPO	Abnormality of the musculature of the pelvis (HP:0001469)	1	0.1018	9.823182711	0.097190281	skeletal muscle
Vindija	HPO	Vertebral clefting (HP:0008428)	1	0.104	9.615384615	0.098890111	skeletal
Vindija	HPO	Abnormality of T cell number (HP:0011839)	1	0.1047	9.551098376	0.099690031	immune
Vindija	HPO	Broad metatarsal (HP:0001783)	1	0.1057	9.460737938	0.100689931	skeletal
Vindija	HPO	Thick nail (HP:0001805)	1	0.1076	9.293680297	0.101289871	integumentary
Vindija	HPO	Rimmed vacuoles (HP:0003805)	1	0.1078	9.276437848	0.101689831	skeletal muscle
Vindija	HPO	Increased connective tissue (HP:0009025)	1	0.1082	9.242144177	0.101689831	other
Vindija	HPO	Increased CSF protein (HP:0002922)	1	0.1072	9.328358209	0.102689731	other
Vindija	HPO	Proximal placement of thumb (HP:0009623)	1	0.1091	9.165902841	0.103289671	skeletal
Vindija	HPO	Hypermetropia (HP:0000540)	3	1.1307	2.653223667	0.104289571	nervous
Vindija	HPO	Flat capital femoral epiphysis (HP:0003370)	1	0.1106	9.04159132	0.104389561	skeletal
Vindija	HPO	High anterior hairline (HP:0009890)	1	0.1103	9.066183137	0.105089491	integumentary
Vindija	HPO	Palmoplantar keratoderma (HP:0000982)	3	1.1606	2.584869895	0.109489051	integumentary
Vindija	HPO	Renal cortical cysts (HP:0000803)	1	0.1149	8.703220191	0.109589041	urinary
Vindija	HPO	Specific learning disability (HP:0001328)	2	0.5467	3.658313517	0.109689031	other
Vindija	HPO	Widely patent fontanelles and sutures (HP:0004492)	1	0.1158	8.635578584	0.109989001	skeletal
Vindija	HPO	Respiratory failure (HP:0002878)	2	0.568	3.521126761	0.110188981	respiratory
Vindija	HPO	Hypoventilation (HP:0002791)	1	0.1171	8.53970965	0.111088891	respiratory
Vindija	HPO	Hypertensive crisis (HP:0100735)	1	0.1202	8.319467554	0.113088691	cardiovascular
Vindija	HPO	Eosinophilia (HP:0001880)	1	0.1198	8.347245409	0.113388661	hematologic
Vindija	HPO	Ptosis (HP:0000508)	6	3.2938	1.821604226	0.114888511	skeletal muscle
Vindija	HPO	Apathy (HP:0000741)	1	0.1225	8.163265306	0.115488451	behavior
Vindija	HPO	Neurodegeneration (HP:0002180)	1	0.1231	8.123476848	0.116188381	nervous
Vindija	HPO	Abnormality of purine metabolism (HP:0004352)	1	0.1223	8.176614881	0.116188381	metabolic
Vindija	HPO	Increased variability in muscle fiber diameter (HP:0003557)	1	0.1233	8.110300081	0.117588241	skeletal muscle
Vindija	HPO	Multiple lipomas (HP:0001012)	1	0.1251	7.993605116	0.117888211	other
Vindija	HPO	Buphthalmos (HP:0000557)	1	0.125	8	0.118288171	nervous
Vindija	HPO	Diminished motivation (HP:0000745)	1	0.1262	7.923930269	0.118488151	behavior
Vindija	HPO	Dolichocephaly (HP:0000268)	3	1.1889	2.523340903	0.118688131	skeletal
Vindija	HPO	Recurrent viral infections (HP:0004429)	1	0.1255	7.96812749	0.118988101	immune
Vindija	HPO	Areflexia of lower limbs (HP:0002522)	1	0.128	7.8125	0.119988001	nervous
Vindija	HPO	Aplasia/Hypoplasia of the fovea (HP:0008060)	1	0.1289	7.757951901	0.120287971	nervous
Vindija	HPO	Hypoplasia of the fovea (HP:0007750)	1	0.1289	7.757951901	0.120287971	nervous
Vindija	HPO	Granulocytopenia (HP:0001913)	1	0.1273	7.855459544	0.120387961	immune
Vindija	HPO	Abnormality of skeletal muscle fiber size (HP:0012084)	1	0.1269	7.880220646	0.120687931	skeletal muscle
Vindija	HPO	Abnormality of the preputium (HP:0100587)	1	0.1298	7.704160247	0.121487851	reproductive
Vindija	HPO	Kyphoscoliosis (HP:0002751)	2	0.5955	3.35852225	0.121487851	skeletal
Vindija	HPO	Subcapsular cataract (HP:0000523)	1	0.1319	7.581501137	0.122187781	nervous
Vindija	HPO	Pruritus (HP:0000989)	2	0.5895	3.392705683	0.122787721	integumentary
Vindija	HPO	Keratitis (HP:0000491)	1	0.1307	7.651109411	0.122787721	nervous
Vindija	HPO	Tubulointerstitial nephritis (HP:0001970)	1	0.1313	7.61614623	0.122887711	urinary
Vindija	HPO	Autosomal recessive inheritance (HP:0000007)	26	20.1339	1.291354382	0.124687531	other
Vindija	HPO	Papilloma (HP:0012740)	1	0.1324	7.552870091	0.124787521	other
Vindija	HPO	Verrucae (HP:0200043)	1	0.1324	7.552870091	0.124787521	integumentary
Vindija	HPO	Tracheoesophageal fistula (HP:0002575)	2	0.6069	3.295435821	0.124987501	respiratory
Vindija	HPO	Meningioma (HP:0002858)	1	0.1346	7.429420505	0.125787421	nervous
Vindija	HPO	Broad palm (HP:0001169)	1	0.1346	7.429420505	0.126587341	skeletal
Vindija	HPO	Hemoptysis (HP:0002105)	1	0.1355	7.380073801	0.127287271	other
Vindija	HPO	Distal sensory impairment (HP:0002936)	2	0.6062	3.299241175	0.127887211	nervous
Vindija	HPO	Easy fatigability (HP:0003388)	1	0.1369	7.304601899	0.127987201	other
Vindija	HPO	Biliary tract neoplasm (HP:0100574)	1	0.1369	7.304601899	0.128187181	digestive
Vindija	HPO	Macrotia (HP:0000400)	3	1.2477	2.40442414	0.128387161	other
Vindija	HPO	Chest pain (HP:0100749)	1	0.1405	7.117437722	0.129087091	other
Vindija	HPO	Autoimmune hemolytic anemia (HP:0001890)	1	0.139	7.194244604	0.131086891	immune
Vindija	HPO	Ascites (HP:0001541)	2	0.6356	3.146633103	0.133686631	digestive
Vindija	HPO	Abnormality of the fovea (HP:0000493)	1	0.144	6.944444444	0.133886611	nervous
Vindija	HPO	Sporadic (HP:0003745)	2	0.6419	3.115750117	0.134286571	other
Vindija	HPO	Meckel diverticulum (HP:0002245)	1	0.1488	6.720430108	0.137186281	digestive
Vindija	HPO	Gowers sign (HP:0003391)	1	0.1486	6.729475101	0.137986201	skeletal muscle
Vindija	HPO	EMG: neuropathic changes (HP:0003445)	1	0.1485	6.734006734	0.140085991	nervous
Vindija	HPO	Volvulus (HP:0002580)	1	0.1517	6.591957811	0.140285971	digestive
Vindija	HPO	Hyponatremia (HP:0002902)	1	0.1524	6.56167979	0.141385861	other
Vindija	HPO	Astrocytoma (HP:0009592)	1	0.1532	6.527415144	0.142285771	nervous
Vindija	HPO	Abnormality of the astrocytes (HP:0100707)	1	0.1532	6.527415144	0.142285771	nervous
Vindija	HPO	Premature graying of hair (HP:0002216)	1	0.1544	6.476683938	0.143085691	integumentary
Vindija	HPO	Choanal atresia (HP:0000453)	2	0.6698	2.98596596	0.143085691	respiratory
Vindija	HPO	Deviation of the thumb (HP:0009603)	1	0.1563	6.397952655	0.144285571	skeletal
Vindija	HPO	Hypotelorism (HP:0000601)	2	0.6691	2.989089822	0.144985501	other
Vindija	HPO	Cavernous hemangioma (HP:0001048)	1	0.1577	6.34115409	0.145585441	cardiovascular
Vindija	HPO	Glioma (HP:0009733)	1	0.1574	6.353240152	0.145785421	nervous
Vindija	HPO	Pulmonary embolism (HP:0002204)	1	0.1569	6.373486297	0.145985401	respiratory
Vindija	HPO	Patent ductus arteriosus (HP:0001643)	3	1.2984	2.310536044	0.146185381	cardiovascular
Vindija	HPO	Severe short stature (HP:0003510)	1	0.1573	6.357279085	0.146285371	skeletal
Vindija	HPO	Asymmetric septal hypertrophy (HP:0001670)	1	0.1595	6.269592476	0.149585041	cardiovascular
Vindija	HPO	Abnormality of the salivary glands (HP:0010286)	1	0.1609	6.215040398	0.150084992	digestive
Vindija	HPO	Severe Myopia (HP:0011003)	1	0.1649	6.064281383	0.150984902	nervous
Vindija	HPO	Mildly elevated creatine phosphokinase (HP:0008180)	1	0.1633	6.123698714	0.151684832	other
Vindija	HPO	Intrauterine growth retardation (HP:0001511)	6	3.5691	1.681096075	0.152784722	other
Vindija	HPO	Mediastinal lymphadenopathy (HP:0100721)	1	0.1685	5.934718101	0.154784522	lymphatic
Vindija	HPO	Hypoplasia of the iris (HP:0007676)	1	0.1689	5.920663114	0.155784422	integumentary
Vindija	HPO	Heterochromia iridis (HP:0001100)	1	0.1681	5.948839976	0.155984402	integumentary
Vindija	HPO	Synophrys (HP:0000664)	2	0.7171	2.789011295	0.159384062	integumentary
Vindija	HPO	Abnormality of chromosome stability (HP:0003220)	1	0.1753	5.70450656	0.160483952	other
Vindija	HPO	Milia (HP:0001056)	1	0.1737	5.757052389	0.160483952	integumentary
Vindija	HPO	Alkalosis (HP:0001948)	1	0.1773	5.640157924	0.162683732	other
Vindija	HPO	Limb-girdle muscle weakness (HP:0003325)	1	0.1796	5.567928731	0.165083492	skeletal muscle
Vindija	HPO	Elevated alkaline phosphatase (HP:0003155)	1	0.1814	5.512679162	0.165283472	other
Vindija	HPO	Long toe (HP:0010511)	1	0.1823	5.485463522	0.166083392	skeletal
Vindija	HPO	Plantar hyperkeratosis (HP:0007556)	1	0.1844	5.422993492	0.166783322	integumentary
Vindija	HPO	Subaortic stenosis (HP:0001682)	1	0.1809	5.527915976	0.166983302	cardiovascular
Vindija	HPO	Abnormality of the left ventricular outflow tract (HP:0011103)	1	0.1809	5.527915976	0.166983302	cardiovascular
Vindija	HPO	Congenital diaphragmatic hernia (HP:0000776)	2	0.7344	2.723311547	0.167183282	respiratory
Vindija	HPO	Colitis (HP:0002583)	1	0.1831	5.46149645	0.167683232	digestive
Vindija	HPO	Intestinal polyposis (HP:0200008)	1	0.1853	5.396654074	0.168983102	digestive
Vindija	HPO	Mask-like facies (HP:0000298)	1	0.1839	5.437737901	0.170282972	other
Vindija	HPO	Aplasia/Hypoplasia of the uvula (HP:0010293)	1	0.1923	5.200208008	0.172782722	skeletal
Vindija	HPO	Disproportionate tall stature (HP:0001519)	1	0.1912	5.230125523	0.173282672	skeletal
Vindija	HPO	Abnormality of T cells (HP:0002843)	1	0.1917	5.21648409	0.173782622	immune
Vindija	HPO	Neoplasm of the rectum (HP:0100743)	1	0.1949	5.130836326	0.176582342	digestive
Vindija	HPO	Hyperhidrosis (HP:0000975)	2	0.7667	2.608582236	0.179982002	integumentary
Vindija	HPO	Choreoathetosis (HP:0001266)	1	0.2031	4.923682915	0.181781822	nervous
Vindija	HPO	Deeply set eye (HP:0000490)	3	1.4752	2.03362256	0.182981702	nervous
Vindija	HPO	Broad ribs (HP:0000885)	1	0.2046	4.887585533	0.183981602	skeletal
Vindija	HPO	Abnormality of sodium homeostasis (HP:0010931)	1	0.2034	4.916420846	0.184781522	other
Vindija	HPO	Polycystic kidney dysplasia (HP:0000113)	2	0.7855	2.54614895	0.185681432	urinary
Vindija	HPO	Multicystic kidney dysplasia (HP:0000003)	3	1.4841	2.021427128	0.185881412	urinary
Vindija	HPO	Brachycephaly (HP:0000248)	2	0.7831	2.553952241	0.185981402	skeletal
Vindija	HPO	Abnormality of the carotid arteries (HP:0005344)	1	0.2079	4.81000481	0.188081192	cardiovascular
Vindija	HPO	Generalized muscle weakness (HP:0003324)	1	0.2107	4.74608448	0.189581042	skeletal muscle
Vindija	HPO	Blindness (HP:0000618)	2	0.8023	2.492833105	0.190080992	nervous
Vindija	HPO	Ketosis (HP:0001946)	1	0.2092	4.780114723	0.190280972	metabolic
Vindija	HPO	Abnormality of alkaline phosphatase activity (HP:0004379)	1	0.2148	4.655493482	0.192680732	other
Vindija	HPO	Fasciculations (HP:0002380)	1	0.2175	4.597701149	0.192980702	skeletal muscle
Vindija	HPO	Potter facies (HP:0002009)	1	0.2122	4.712535344	0.193280672	other
Vindija	HPO	Facial shape deformation (HP:0011334)	1	0.2122	4.712535344	0.193280672	skeletal
Vindija	HPO	Abnormality of the ileum (HP:0001549)	1	0.2169	4.610419548	0.194380562	digestive
Vindija	HPO	Gingivitis (HP:0000230)	1	0.2158	4.633920297	0.194480552	other
Vindija	HPO	Intestinal polyp (HP:0005266)	1	0.2177	4.593477262	0.195880412	digestive
Vindija	HPO	Abnormal enzyme/coenzyme activity (HP:0012379)	1	0.2215	4.514672686	0.198080192	other
Vindija	HPO	Abnormality of vision evoked potentials (HP:0000649)	1	0.2198	4.549590537	0.198780122	nervous
Vindija	HPO	Skin pits (HP:0100276)	1	0.2231	4.482294935	0.200079992	integumentary
Vindija	HPO	Enlarged kidneys (HP:0000105)	1	0.2209	4.526935265	0.200179982	urinary
Vindija	HPO	Fragile skin (HP:0001030)	1	0.2259	4.426737494	0.201779822	integumentary
Vindija	HPO	Abnormality of eosinophils (HP:0001879)	1	0.2274	4.397537379	0.202779722	hematologic
Vindija	HPO	Abdominal pain (HP:0002027)	2	0.8376	2.387774594	0.203379662	other
Vindija	HPO	Shallow orbits (HP:0000586)	1	0.2264	4.416961131	0.203579642	skeletal
Vindija	HPO	Achilles tendon contracture (HP:0001771)	1	0.2275	4.395604396	0.203979602	skeletal muscle
Vindija	HPO	Abnormality of the Achilles tendon (HP:0005109)	1	0.2275	4.395604396	0.203979602	skeletal muscle
Vindija	HPO	Intention tremor (HP:0002080)	1	0.2311	4.327131112	0.204079592	nervous
Vindija	HPO	Urticaria (HP:0001025)	1	0.2296	4.355400697	0.205679432	immune
Vindija	HPO	Amblyopia (HP:0000646)	1	0.2323	4.304778304	0.207679232	nervous
Vindija	HPO	Hammertoe (HP:0001765)	1	0.2326	4.299226139	0.208279172	skeletal
Vindija	HPO	Neoplasm of striated muscle (HP:0009728)	1	0.2337	4.278990158	0.209379062	skeletal muscle
Vindija	HPO	Abnormality of salivation (HP:0100755)	2	0.8602	2.325040688	0.210078992	digestive
Vindija	HPO	Abnormality of the renal cortex (HP:0011035)	1	0.2323	4.304778304	0.210978902	urinary
Vindija	HPO	Neonatal hypotonia (HP:0001319)	2	0.8607	2.32369002	0.211178882	skeletal muscle
Vindija	HPO	Urethral obstruction (HP:0000796)	1	0.2356	4.244482173	0.211478852	urinary
Vindija	HPO	Aplasia/Hypoplasia affecting the retina (HP:0008061)	1	0.2454	4.074979625	0.216078392	nervous
Vindija	HPO	Aplasia/Hypoplasia of the macula (HP:0008059)	1	0.2454	4.074979625	0.216078392	nervous
Vindija	HPO	Abnormal biliary tract morphology (HP:0012440)	1	0.2458	4.068348251	0.219078092	digestive
Vindija	HPO	Skin ulcer (HP:0200042)	2	0.8763	2.282323405	0.219278072	integumentary
Vindija	HPO	Inflammation of the large intestine (HP:0002037)	1	0.2491	4.014452027	0.219778022	digestive
Vindija	HPO	Gastrointestinal inflammation (HP:0004386)	1	0.2491	4.014452027	0.219778022	digestive
Vindija	HPO	Abnormality of the epiphysis of the femoral head (HP:0010574)	1	0.2506	3.990422985	0.219878012	skeletal
Vindija	HPO	Clubbing of toes (HP:0100760)	1	0.2489	4.017677782	0.221177882	integumentary
Vindija	HPO	Neoplasm of the small intestine (HP:0100833)	1	0.2543	3.93236335	0.223177682	digestive
Vindija	HPO	Scapular winging (HP:0003691)	1	0.2559	3.907776475	0.224477552	skeletal
Vindija	HPO	Progressive visual loss (HP:0000529)	1	0.2531	3.951007507	0.224577542	nervous
Vindija	HPO	Thick eyebrow (HP:0000574)	2	0.8972	2.229157379	0.225077492	integumentary
Vindija	HPO	Abnormality of the femoral head (HP:0003368)	1	0.2581	3.874467261	0.225677432	skeletal
Vindija	HPO	Optic nerve hypoplasia (HP:0000609)	1	0.2552	3.918495298	0.226377362	nervous
Vindija	HPO	Aseptic necrosis (HP:0010885)	1	0.2585	3.868471954	0.226977302	skeletal
Vindija	HPO	Taurodontia (HP:0000679)	1	0.2563	3.901677721	0.227177282	skeletal
Vindija	HPO	Abnormality of the dental root (HP:0006486)	1	0.2563	3.901677721	0.227177282	skeletal
Vindija	HPO	Abnormality of permanent molar morphology (HP:0011071)	1	0.2563	3.901677721	0.227177282	skeletal
Vindija	HPO	Pectus excavatum (HP:0000767)	3	1.6288	1.841846758	0.227477252	skeletal
Vindija	HPO	Autism (HP:0000717)	3	1.6336	1.836434868	0.228177182	nervous
Vindija	HPO	Adducted thumb (HP:0001181)	1	0.2622	3.813882532	0.229877012	skeletal
Vindija	HPO	Arachnodactyly (HP:0001166)	2	0.9078	2.203128442	0.230076992	skeletal
Vindija	HPO	Recurrent urinary tract infections (HP:0000010)	2	0.9219	2.169432693	0.230376962	immune
Vindija	HPO	Leukocytosis (HP:0001974)	1	0.265	3.773584906	0.231576842	immune
Vindija	HPO	Abnormality of the dental pulp (HP:0006479)	1	0.2639	3.789314134	0.233376662	other
Vindija	HPO	Polar cataract (HP:0010696)	1	0.2686	3.723008191	0.234576542	nervous
Vindija	HPO	Hemivertebrae (HP:0002937)	1	0.2663	3.75516335	0.235476452	skeletal
Vindija	HPO	Aplasia/Hypoplasia of the optic nerve (HP:0008058)	1	0.2684	3.725782414	0.237076292	nervous
Vindija	HPO	Hyperkalemia (HP:0002153)	1	0.2726	3.668378577	0.237476252	other
Vindija	HPO	Abnormal auditory evoked potentials (HP:0006958)	1	0.2705	3.696857671	0.237976202	nervous
Vindija	HPO	Esotropia (HP:0000565)	1	0.2751	3.635041803	0.239876012	nervous
Vindija	HPO	Abnormality of the pupil (HP:0000615)	1	0.2781	3.595828839	0.242975702	nervous
Vindija	HPO	Pulmonary hypoplasia (HP:0002089)	2	0.9365	2.135611319	0.245175482	respiratory
Vindija	HPO	Autosomal dominant inheritance (HP:0000006)	20	16.778	1.192037192	0.246175382	other
Vindija	HPO	Waddling gait (HP:0002515)	1	0.2821	3.544842255	0.246275372	other
Vindija	HPO	Abnormality of molar morphology (HP:0011070)	1	0.2835	3.527336861	0.247475252	skeletal
Vindija	HPO	Abnormality of molar (HP:0011077)	1	0.2835	3.527336861	0.247475252	skeletal
Vindija	HPO	Duodenal stenosis (HP:0100867)	1	0.2846	3.513703443	0.247875212	digestive
Vindija	HPO	Small intestinal stenosis (HP:0012848)	1	0.2846	3.513703443	0.247875212	digestive
Vindija	HPO	Craniofacial hyperostosis (HP:0004493)	1	0.2856	3.50140056	0.248075192	skeletal
Vindija	HPO	Xerostomia (HP:0000217)	1	0.2845	3.514938489	0.248675132	digestive
Vindija	HPO	Delayed skeletal maturation (HP:0002750)	3	1.7322	1.731901628	0.248775122	skeletal
Vindija	HPO	Furrowed tongue (HP:0000221)	1	0.2847	3.512469266	0.249675032	other
Vindija	HPO	Abnormality involving the epiphyses of the lower limbs (HP:0006500)	1	0.2909	3.437607425	0.250174983	skeletal
Vindija	HPO	Abnormality of femoral epiphyses (HP:0006499)	1	0.2909	3.437607425	0.250174983	skeletal
Vindija	HPO	Pancreatitis (HP:0001733)	1	0.2906	3.441156228	0.251674833	digestive
Vindija	HPO	Sepsis (HP:0100806)	1	0.2932	3.410641201	0.252974703	immune
Vindija	HPO	Lower limb asymmetry (HP:0100559)	1	0.2915	3.430531732	0.253274673	skeletal
Vindija	HPO	Aplasia/Hypoplasia of the patella (HP:0006498)	1	0.2922	3.422313484	0.253574643	skeletal
Vindija	HPO	Patellar aplasia (HP:0006443)	1	0.2922	3.422313484	0.253574643	skeletal
Vindija	HPO	Lower limb muscle weakness (HP:0007340)	1	0.2931	3.411804845	0.254874513	skeletal muscle
Vindija	HPO	Abnormality of nucleobase metabolism (HP:0010932)	1	0.2978	3.357958361	0.256674333	metabolic
Vindija	HPO	Dry skin (HP:0000958)	2	0.9884	2.023472278	0.257174283	integumentary
Vindija	HPO	Meningitis (HP:0001287)	1	0.297	3.367003367	0.257774223	nervous
Vindija	HPO	Tubulointerstitial abnormality (HP:0001969)	1	0.3	3.333333333	0.258274173	urinary
Vindija	HPO	Bruising susceptibility (HP:0000978)	2	0.9691	2.063770509	0.258374163	other
Vindija	HPO	Developmental regression (HP:0002376)	2	0.9751	2.051071685	0.258574143	behavior
Vindija	HPO	Neoplasm of the colon (HP:0100273)	1	0.3045	3.28407225	0.259474053	digestive
Vindija	HPO	Patellar dislocation (HP:0002999)	1	0.3011	3.321155762	0.260573943	skeletal
Vindija	HPO	Downturned corners of mouth (HP:0002714)	2	0.9925	2.01511335	0.261473853	skeletal muscle
Vindija	HPO	Abnormality of the shoulder girdle musculature (HP:0001435)	1	0.3071	3.256268317	0.262273773	skeletal muscle
Vindija	HPO	"Intellectual disability, moderate (HP:0002342)"	1	0.314	3.184713376	0.268473153	nervous
Vindija	HPO	Peripheral demyelination (HP:0011096)	1	0.3154	3.170577045	0.271472853	nervous
Vindija	HPO	Frontal bossing (HP:0002007)	4	2.6588	1.504438092	0.273072693	skeletal
Vindija	HPO	Acrocyanosis (HP:0001063)	1	0.3176	3.14861461	0.273172683	integumentary
Vindija	HPO	Prominent occiput (HP:0000269)	1	0.3144	3.180661578	0.273272673	skeletal
Vindija	HPO	Increased nuchal translucency (HP:0010880)	1	0.3149	3.175611305	0.273972603	other
Vindija	HPO	Emphysema (HP:0002097)	1	0.3179	3.145643284	0.274272573	respiratory
Vindija	HPO	Neoplasm of the thyroid gland (HP:0100031)	1	0.3207	3.118178983	0.276672333	endocrine
Vindija	HPO	Abnormality of the pericardium (HP:0001697)	1	0.327	3.058103976	0.277472253	cardiovascular
Vindija	HPO	Asymmetric growth (HP:0100555)	1	0.3245	3.081664099	0.278172183	other
Vindija	HPO	Pulmonic stenosis (HP:0001642)	2	1.0331	1.935921014	0.278872113	cardiovascular
Vindija	HPO	Hypoplastic toenails (HP:0001800)	1	0.3244	3.082614057	0.279572043	integumentary
Vindija	HPO	Congenital hip dislocation (HP:0001374)	1	0.3281	3.047851265	0.283071693	skeletal
Vindija	HPO	Mitral regurgitation (HP:0001653)	1	0.3343	2.991325157	0.283571643	cardiovascular
Vindija	HPO	Difficulty walking (HP:0002355)	1	0.3382	2.956830278	0.285671433	other
Vindija	HPO	Cranial hyperostosis (HP:0004437)	1	0.3359	2.977076511	0.285771423	skeletal
Vindija	HPO	Hypopigmentation of the fundus (HP:0007894)	1	0.3337	2.996703626	0.285971403	integumentary
Vindija	HPO	Abnormality of Sharpey fibers (HP:0100685)	1	0.3372	2.965599051	0.286471353	skeletal muscle
Vindija	HPO	Chondrocalcinosis (HP:0000934)	1	0.3372	2.965599051	0.286471353	skeletal
Vindija	HPO	Goiter (HP:0000853)	1	0.337	2.96735905	0.287171283	endocrine
Vindija	HPO	Wormian bones (HP:0002645)	1	0.3431	2.914602157	0.292770723	skeletal
Vindija	HPO	Abnormality of the peritoneum (HP:0002585)	1	0.348	2.873563218	0.294970503	digestive
Vindija	HPO	Pes cavus (HP:0001761)	2	1.0903	1.834357516	0.295270473	skeletal
Vindija	HPO	Decreased number of peripheral myelinated nerve fibers (HP:0003380)	1	0.3471	2.881014117	0.295670433	nervous
Vindija	HPO	Clinodactyly of the 5th finger (HP:0004209)	4	2.7543	1.452274625	0.298970103	skeletal
Vindija	HPO	Gynecomastia (HP:0000771)	1	0.3592	2.783964365	0.302069793	endocrine
Vindija	HPO	Nail dystrophy (HP:0008404)	1	0.367	2.72479564	0.303369663	integumentary
Vindija	HPO	Ovarian neoplasm (HP:0100615)	2	1.1024	1.814223512	0.305469453	reproductive
Vindija	HPO	Abnormality of the gallbladder (HP:0005264)	1	0.3635	2.751031637	0.307469253	digestive
Vindija	HPO	Sclerocornea (HP:0000647)	1	0.3641	2.746498215	0.308369163	nervous
Vindija	HPO	Cerebral edema (HP:0002181)	1	0.3729	2.681684098	0.311068893	nervous
Vindija	HPO	Pulmonary fibrosis (HP:0002206)	1	0.3704	2.699784017	0.311168883	respiratory
Vindija	HPO	Myelodysplasia (HP:0002863)	1	0.3824	2.615062762	0.312468753	hematologic
Vindija	HPO	Lactic acidosis (HP:0003128)	2	1.1352	1.761804087	0.313068693	metabolic
Vindija	HPO	High palate (HP:0000218)	3	1.9881	1.508978422	0.320067993	skeletal
Vindija	HPO	Venous abnormality (HP:0002624)	1	0.3845	2.600780234	0.320167983	cardiovascular
Vindija	HPO	Short philtrum (HP:0000322)	2	1.1635	1.71895144	0.320867913	integumentary
Vindija	HPO	Freckling (HP:0001480)	1	0.3915	2.554278416	0.323467653	integumentary
Vindija	HPO	Hypoplasia of dental enamel (HP:0006297)	1	0.3876	2.57997936	0.323567643	skeletal
Vindija	HPO	Sudden death (HP:0001699)	1	0.3926	2.547121752	0.324967503	other
Vindija	HPO	Infantile onset (HP:0003593)	4	2.8783	1.389709203	0.327367263	other
Vindija	HPO	Attention deficit hyperactivity disorder (HP:0007018)	2	1.1619	1.72131853	0.327667233	behavior
Vindija	HPO	Abnormality of the duodenum (HP:0002246)	1	0.3992	2.50501002	0.330266973	digestive
Vindija	HPO	Testicular neoplasm (HP:0010788)	1	0.4196	2.383222116	0.338566143	reproductive
Vindija	HPO	Pes planus (HP:0001763)	2	1.211	1.651527663	0.339066093	skeletal
Vindija	HPO	Childhood onset (HP:0011463)	1	0.414	2.415458937	0.340065993	other
Vindija	HPO	Abnormality of potassium homeostasis (HP:0011042)	1	0.4199	2.381519409	0.341165883	other
Vindija	HPO	Broad phalanges of the hand (HP:0009768)	1	0.4239	2.359046945	0.346365363	skeletal
Vindija	HPO	Broad finger (HP:0001500)	1	0.4239	2.359046945	0.346365363	skeletal
Vindija	HPO	Bundle branch block (HP:0011710)	1	0.425	2.352941176	0.348765123	cardiovascular
Vindija	HPO	Congenital sensorineural hearing impairment (HP:0008527)	1	0.432	2.314814815	0.349365063	nervous
Vindija	HPO	Restrictive lung disease (HP:0002091)	1	0.4328	2.310536044	0.351764824	respiratory
Vindija	HPO	Cutis marmorata (HP:0000965)	1	0.4326	2.311604253	0.355264474	integumentary
Vindija	HPO	Skull defect (HP:0001362)	1	0.4288	2.332089552	0.357564244	skeletal
Vindija	HPO	Psychosis (HP:0000709)	1	0.4496	2.224199288	0.360663934	nervous
Vindija	HPO	CNS demyelination (HP:0007305)	1	0.4394	2.275830678	0.360963904	nervous
Vindija	HPO	Splenomegaly (HP:0001744)	3	2.1419	1.400625613	0.361463854	lymphatic
Vindija	HPO	Hallux valgus (HP:0001822)	1	0.4543	2.201188642	0.361763824	skeletal
Vindija	HPO	Hypoplasia of the maxilla (HP:0000327)	1	0.4531	2.207018318	0.365263474	skeletal
Vindija	HPO	Epistaxis (HP:0000421)	1	0.4586	2.180549498	0.367263274	other
Vindija	HPO	Heart block (HP:0012722)	1	0.455	2.197802198	0.367963204	cardiovascular
Vindija	HPO	Abnormal atrioventricular conduction (HP:0005150)	1	0.455	2.197802198	0.367963204	cardiovascular
Vindija	HPO	Iris coloboma (HP:0000612)	2	1.2874	1.55351872	0.369163084	nervous
Vindija	HPO	High forehead (HP:0000348)	2	1.3008	1.537515375	0.370962904	skeletal
Vindija	HPO	Melanocytic nevus (HP:0000995)	1	0.473	2.114164905	0.374062594	integumentary
Vindija	HPO	Precocious puberty (HP:0000826)	1	0.4699	2.128112364	0.374162584	endocrine
Vindija	HPO	Deviation of the hallux (HP:0010051)	1	0.4745	2.10748156	0.374862514	skeletal
Vindija	HPO	Midline defect of the nose (HP:0004122)	1	0.4692	2.131287298	0.375262474	other
Vindija	HPO	Ventricular tachycardia (HP:0004756)	1	0.4665	2.143622722	0.377062294	cardiovascular
Vindija	HPO	Corneal dystrophy (HP:0001131)	1	0.4752	2.104377104	0.379662034	nervous
Vindija	HPO	Split hand (HP:0001171)	1	0.4803	2.082032063	0.380461954	skeletal
Vindija	HPO	Cellular immunodeficiency (HP:0005374)	1	0.4764	2.099076406	0.383061694	immune
Vindija	HPO	Abnormality of the fingernails (HP:0001231)	2	1.3302	1.503533303	0.383161684	integumentary
Vindija	HPO	Intestinal malrotation (HP:0002566)	1	0.4868	2.054231717	0.383461654	digestive
Vindija	HPO	Broad phalanx (HP:0006009)	1	0.4841	2.065688907	0.384261574	skeletal
Vindija	HPO	Narrow palate (HP:0000189)	1	0.4844	2.064409579	0.385161484	skeletal
Vindija	HPO	Aplasia/Hypoplasia affecting the fundus (HP:0008057)	1	0.4882	2.048340844	0.385461454	nervous
Vindija	HPO	Anonychia (HP:0001798)	1	0.4915	2.034587996	0.388161184	integumentary
Vindija	HPO	Obsessive-compulsive behavior (HP:0000722)	1	0.496	2.016129032	0.389261074	behavior
Vindija	HPO	Ventricular septal defect (HP:0001629)	3	2.2687	1.322343192	0.396960304	cardiovascular
Vindija	HPO	Muscular dystrophy (HP:0003560)	1	0.5069	1.972775695	0.399360064	skeletal muscle
Vindija	HPO	Broad long bones (HP:0005622)	1	0.5102	1.96001568	0.399960004	skeletal
Vindija	HPO	Chorioretinal coloboma (HP:0000567)	1	0.5101	1.960399922	0.401559844	nervous
Vindija	HPO	Microtia (HP:0008551)	1	0.5126	1.950838861	0.403659634	nervous
Vindija	HPO	Sudden cardiac death (HP:0001645)	2	1.3858	1.443209698	0.403859614	cardiovascular
Vindija	HPO	Low anterior hairline (HP:0000294)	1	0.5263	1.900057002	0.405659434	integumentary
Vindija	HPO	Oculomotor apraxia (HP:0000657)	1	0.5159	1.938360147	0.405959404	nervous
Vindija	HPO	Retinitis pigmentosa (HP:0000510)	2	1.4016	1.426940639	0.412658734	integumentary
Vindija	HPO	Abnormality of the renal medulla (HP:0100957)	1	0.5297	1.887861053	0.415258474	urinary
Vindija	HPO	Narrow mouth (HP:0000160)	2	1.4251	1.403410287	0.416458354	skeletal
Vindija	HPO	Opacification of the corneal stroma (HP:0007759)	2	1.423	1.405481377	0.417058294	nervous
Vindija	HPO	Neuroectodermal neoplasm (HP:0030061)	1	0.5338	1.873360809	0.417758224	nervous
Vindija	HPO	Neuroepithelial neoplasm (HP:0030063)	1	0.5338	1.873360809	0.417758224	nervous
Vindija	HPO	Nervous tissue neoplasm (HP:0030060)	1	0.5338	1.873360809	0.417758224	nervous
Vindija	HPO	Germ cell neoplasia (HP:0100728)	1	0.5406	1.849796522	0.420857914	reproductive
Vindija	HPO	Breast carcinoma (HP:0003002)	1	0.5438	1.838911364	0.424657534	reproductive
Vindija	HPO	Triphalangeal thumb (HP:0001199)	1	0.5535	1.806684734	0.425057494	skeletal
Vindija	HPO	Stage 5 chronic kidney disease (HP:0003774)	1	0.5513	1.813894431	0.425657434	urinary
Vindija	HPO	Congenital hepatic fibrosis (HP:0002612)	1	0.5574	1.794043775	0.430156984	digestive
Vindija	HPO	Stroke (HP:0001297)	1	0.5628	1.776830135	0.432356764	cardiovascular
Vindija	HPO	Low posterior hairline (HP:0002162)	1	0.5717	1.749169145	0.433456654	integumentary
Vindija	HPO	Drooling (HP:0002307)	1	0.5725	1.746724891	0.434156584	other
Vindija	HPO	Abnormality of chromosome segregation (HP:0002916)	1	0.5678	1.761183515	0.434756524	other
Vindija	HPO	Excessive salivation (HP:0003781)	1	0.5757	1.737015807	0.435956404	digestive
Vindija	HPO	Malignant neoplasm of the central nervous system (HP:0100836)	1	0.5712	1.75070028	0.436156384	nervous
Vindija	HPO	Radial deviation of finger (HP:0009466)	4	3.3975	1.177336277	0.441555844	skeletal
Vindija	HPO	Abnormality of the thymus (HP:0000777)	1	0.5726	1.746419839	0.442155784	lymphatic
Vindija	HPO	Respiratory insufficiency due to muscle weakness (HP:0002747)	1	0.6047	1.653712585	0.457954205	respiratory
Vindija	HPO	Single transverse palmar crease (HP:0000954)	2	1.5532	1.287664177	0.459354065	integumentary
Vindija	HPO	Thin upper lip vermilion (HP:0000219)	1	0.6127	1.632120124	0.461253875	integumentary
Vindija	HPO	Talipes equinovarus (HP:0001762)	2	1.5662	1.276976121	0.464253575	skeletal
Vindija	HPO	Lymphoma (HP:0002665)	1	0.6235	1.603849238	0.464853515	lymphatic
Vindija	HPO	Optic atrophy (HP:0000648)	5	4.4953	1.112272818	0.465253475	nervous
Vindija	HPO	Delayed gross motor development (HP:0002194)	1	0.6295	1.588562351	0.470652935	nervous
Vindija	HPO	Hematuria (HP:0000790)	1	0.6467	1.546312046	0.473652635	urinary
Vindija	HPO	Sandal gap (HP:0001852)	1	0.6512	1.535626536	0.475152485	skeletal
Vindija	HPO	Depressed nasal bridge (HP:0005280)	4	3.6253	1.103356964	0.488451155	skeletal
Vindija	HPO	Stereotypic behavior (HP:0000733)	1	0.6546	1.527650474	0.489151085	behavior
Vindija	HPO	Metabolic acidosis (HP:0001942)	1	0.672	1.488095238	0.489851015	metabolic
Vindija	HPO	Memory impairment (HP:0002354)	1	0.6744	1.482799526	0.491050895	nervous
Vindija	HPO	Dehydration (HP:0001944)	1	0.6825	1.465201465	0.492150785	other
Vindija	HPO	Radioulnar synostosis (HP:0002974)	1	0.674	1.483679525	0.492250775	skeletal
Vindija	HPO	Gingival overgrowth (HP:0000212)	1	0.6768	1.477541371	0.493750625	immune
Vindija	HPO	Hydrocephalus (HP:0000238)	3	2.6577	1.128795575	0.494150585	nervous
Vindija	HPO	Downslanted palpebral fissures (HP:0000494)	3	2.6654	1.125534629	0.495750425	integumentary
Vindija	HPO	Polycystic ovaries (HP:0000147)	1	0.6937	1.441545337	0.496250375	reproductive
Vindija	HPO	Facial asymmetry (HP:0000324)	1	0.7061	1.416229996	0.506349365	other
Vindija	HPO	Bradykinesia (HP:0002067)	1	0.7096	1.409244645	0.510048995	nervous
Vindija	HPO	Thin skin (HP:0000963)	1	0.7203	1.388310426	0.511648835	integumentary
Vindija	HPO	Dysarthria (HP:0001260)	3	2.7266	1.1002714	0.512448755	nervous
Vindija	HPO	Dementia (HP:0000726)	1	0.7311	1.367801942	0.514448555	nervous
Vindija	HPO	Prominent forehead (HP:0011220)	1	0.7279	1.373815084	0.520747925	skeletal
Vindija	HPO	Truncal obesity (HP:0001956)	1	0.7252	1.37892995	0.521247875	metabolic
Vindija	HPO	Primary amenorrhea (HP:0000786)	1	0.743	1.34589502	0.525647435	reproductive
Vindija	HPO	External ear malformation (HP:0008572)	1	0.7454	1.341561578	0.527747225	other
Vindija	HPO	Preaxial hand polydactyly (HP:0001177)	1	0.7692	1.300052002	0.535646435	skeletal
Vindija	HPO	Brachydactyly syndrome (HP:0001156)	3	2.8258	1.061646259	0.538746125	skeletal
Vindija	HPO	Neoplasm of the lung (HP:0100526)	1	0.7671	1.303611002	0.539146085	respiratory
Vindija	HPO	Smooth philtrum (HP:0000319)	1	0.7797	1.282544568	0.544145585	integumentary
Vindija	HPO	Open mouth (HP:0000194)	1	0.7924	1.261988894	0.544445555	other
Vindija	HPO	Neoplasm of the respiratory system (HP:0100606)	1	0.7786	1.284356537	0.545145485	respiratory
Vindija	HPO	Dysmetria (HP:0001310)	1	0.8036	1.244400199	0.550744926	nervous
Vindija	HPO	Hyperextensible skin (HP:0000974)	1	0.7957	1.256755058	0.552744726	integumentary
Vindija	HPO	Aganglionic megacolon (HP:0002251)	1	0.8091	1.235941169	0.554344566	digestive
Vindija	HPO	Underdeveloped nasal alae (HP:0000430)	1	0.7999	1.25015627	0.555344466	integumentary
Vindija	HPO	Microdontia (HP:0000691)	1	0.8124	1.230920729	0.557244276	skeletal
Vindija	HPO	Hypertelorism (HP:0000316)	5	4.9555	1.008979921	0.558044196	skeletal
Vindija	HPO	Tetralogy of Fallot (HP:0001636)	1	0.8232	1.214771623	0.564243576	cardiovascular
Vindija	HPO	Lethargy (HP:0001254)	1	0.862	1.160092807	0.572842716	behavior
Vindija	HPO	Pyloric stenosis (HP:0002021)	1	0.8448	1.183712121	0.574942506	digestive
Vindija	HPO	Retinal detachment (HP:0000541)	1	0.8624	1.159554731	0.577942206	nervous
Vindija	HPO	Aggressive behavior (HP:0000718)	1	0.865	1.156069364	0.583941606	behavior
Vindija	HPO	Vesicoureteral reflux (HP:0000076)	1	0.8675	1.152737752	0.584341566	urinary
Vindija	HPO	"Intellectual disability, severe (HP:0010864)"	1	0.873	1.145475372	0.585041496	nervous
Vindija	HPO	Aneurysm (HP:0002617)	1	0.8838	1.13147771	0.587541246	nervous
Vindija	HPO	Gastroesophageal reflux (HP:0002020)	1	0.8967	1.115200178	0.592840716	digestive
Vindija	HPO	Rigidity (HP:0002063)	1	0.9151	1.092776746	0.601339866	skeletal muscle
Vindija	HPO	Migraine (HP:0002076)	1	0.9394	1.064509261	0.609439056	nervous
Vindija	HPO	Ventricular arrhythmia (HP:0004308)	1	0.9522	1.050199538	0.616438356	cardiovascular
Vindija	HPO	Proteinuria (HP:0000093)	1	0.9596	1.042100875	0.618238176	other
Vindija	HPO	Narrow forehead (HP:0000341)	1	0.974	1.026694045	0.618838116	skeletal
Vindija	HPO	Astigmatism (HP:0000483)	1	0.9747	1.025956705	0.620537946	nervous
Vindija	HPO	Inguinal hernia (HP:0000023)	1	1.0419	0.959785008	0.646335366	digestive
Vindija	HPO	Polyhydramnios (HP:0001561)	1	1.0629	0.940822279	0.652434757	reproductive
Vindija	HPO	Delayed eruption of teeth (HP:0000684)	1	1.0978	0.910912735	0.667533247	skeletal
Vindija	HPO	Microcornea (HP:0000482)	1	1.1102	0.900738606	0.667833217	nervous
Vindija	HPO	"Low-set, posteriorly rotated ears (HP:0000368)"	4	4.556	0.877963126	0.673532647	other
Vindija	HPO	Long face (HP:0000276)	1	1.1165	0.895656068	0.677932207	skeletal
Vindija	HPO	Mandibular prognathia (HP:0000303)	1	1.147	0.871839582	0.682431757	skeletal
Vindija	HPO	Dysphagia (HP:0002015)	1	1.171	0.853970965	0.689831017	digestive
Vindija	HPO	Short palm (HP:0004279)	1	1.1691	0.855358823	0.696130387	skeletal
Vindija	HPO	Epicanthus (HP:0000286)	3	3.6188	0.82900409	0.703929607	integumentary
Vindija	HPO	Upslanted palpebral fissure (HP:0000582)	1	1.221	0.819000819	0.705129487	integumentary
Vindija	HPO	Micromelia (HP:0002983)	1	1.2453	0.803019353	0.707929207	skeletal
Vindija	HPO	Umbilical hernia (HP:0001537)	2	2.4737	0.808505478	0.709129087	reproductive
Vindija	HPO	Malar flattening (HP:0000272)	2	2.5105	0.796654053	0.710328967	skeletal
Vindija	HPO	Hepatomegaly (HP:0002240)	2	2.5811	0.77486343	0.735326467	digestive
Vindija	HPO	Recurrent fractures (HP:0002757)	1	1.426	0.701262272	0.758224178	skeletal
Vindija	HPO	Wide mouth (HP:0000154)	1	1.4912	0.670600858	0.776422358	skeletal
Vindija	HPO	Babinski sign (HP:0003487)	1	1.4826	0.674490759	0.778222178	nervous
Vindija	HPO	Blepharophimosis (HP:0000581)	1	1.5592	0.641354541	0.789021098	integumentary
Vindija	HPO	Hypothyroidism (HP:0000821)	1	1.6126	0.620116582	0.800019998	endocrine
Vindija	HPO	Photophobia (HP:0000613)	1	1.6652	0.600528465	0.801819818	nervous
Vindija	HPO	Short nose (HP:0003196)	1	1.6355	0.611433812	0.804319568	skeletal
Vindija	HPO	Heterogeneous (HP:0001425)	1	1.7594	0.568375583	0.835816418	other
Vindija	HPO	Cerebellar atrophy (HP:0001272)	1	1.9797	0.505127039	0.867013299	nervous
Vindija	HPO	Congenital onset (HP:0003577)	1	2.0203	0.494975994	0.868713129	other
Vindija	HPO	Constipation (HP:0002019)	1	2.0902	0.478423117	0.881111889	digestive
Vindija	HPO	Cryptorchidism (HP:0000028)	3	5.2259	0.574063798	0.893710629	reproductive
Vindija	HPO	Long philtrum (HP:0000343)	1	2.4328	0.411048997	0.915508449	integumentary
Vindija	HPO	Short neck (HP:0000470)	1	3.1373	0.318745418	0.9580042	skeletal
Vindija	HPO	Wide nasal bridge (HP:0000431)	1	3.4337	0.291231034	0.96770323	integumentary